Clustering O 0 2.1268951044817186e-08
of O 0 1.82365134104856e-09
missense O 0 1.749245726045956e-08
mutations O 0 1.0178015548423236e-11
in O 0 3.0875665522553386e-13
the O 0 7.355103193162904e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 2.1457147170167445e-09
in O 0 1.2639901061581305e-12
a O 0 7.223538987018857e-14
sporadic B-Disease 0 3.75095066118547e-09
T I-Disease 0 1.7038891542142665e-07
- I-Disease 0 2.3710043706159922e-07
cell I-Disease 0 7.296215898122682e-08
leukaemia I-Disease 1 0.9896396398544312
. O 0 8.660880901345536e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.759450611871216e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 7.399803494023867e-15
is O 0 1.1585729060253508e-17
a O 0 4.49111427013011e-17
recessive B-Disease 0 2.030911550043868e-11
multi I-Disease 1 0.9909138679504395
- I-Disease 1 0.9999997615814209
system I-Disease 0 7.494085730286315e-05
disorder I-Disease 0 4.635069672076497e-06
caused O 0 5.735473538161576e-14
by O 0 2.357577242339436e-17
mutations O 0 9.766337527445366e-16
in O 0 6.885620296085261e-16
the O 0 1.3527348254678724e-14
ATM O 0 2.4079671590016005e-10
gene O 0 1.2686654840814854e-13
at O 0 1.0624828794547625e-10
11q22 O 0 7.932755465844821e-07
- O 0 3.599064086756698e-07
q23 O 0 4.766884558193851e-07
( O 0 6.273816102048135e-13
ref O 0 3.5897634864667793e-10
. O 0 2.5132543615691283e-13
3 O 0 5.942921935814249e-13
) O 0 4.095753955175169e-14
. O 0 3.630996198156211e-11

The O 0 2.742457927418229e-10
risk O 0 9.886222951394075e-10
of O 0 1.3176922886160014e-09
cancer B-Disease 0 2.4500505446667376e-07
, O 0 4.092876645239718e-12
especially O 0 8.265212403379962e-10
lymphoid B-Disease 1 0.9999469518661499
neoplasias I-Disease 1 1.0
, O 0 6.285233618286146e-12
is O 0 7.995637301121822e-14
substantially O 0 1.610800104412391e-10
elevated O 0 3.5154025957578883e-12
in O 0 8.036034403018089e-13
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.2870652805504506e-07
and O 0 3.1398036839762333e-13
has O 0 3.4552747672570697e-16
long O 0 1.2036699228277375e-15
been O 0 1.11209221458151e-15
associated O 0 1.0018572343256649e-12
with O 0 2.2801196694621773e-12
chromosomal O 1 1.0
instability O 1 1.0
. O 0 4.125244856822974e-08

By O 0 7.778232403868671e-14
analysing O 0 3.4239719393092116e-10
tumour B-Disease 1 1.0
DNA O 0 2.1758838286700666e-08
from O 0 4.552921082680295e-13
patients O 0 2.091120550643758e-14
with O 0 4.496703033220763e-17
sporadic B-Disease 0 1.444667385719356e-09
T I-Disease 0 1.666874283046127e-07
- I-Disease 0 1.9541383153409697e-05
cell I-Disease 0 1.0887565622397233e-05
prolymphocytic I-Disease 1 0.9999752044677734
leukaemia I-Disease 1 1.0
( O 0 6.079167117617468e-13
T B-Disease 0 8.063780754241634e-09
- I-Disease 0 7.01687330462164e-09
PLL I-Disease 0 2.8901563382532913e-06
) O 0 3.2390194313561965e-14
, O 0 1.1938657282215058e-15
a O 0 7.891667056164967e-15
rare O 0 4.646759322810001e-13
clonal B-Disease 0 1.7899007831445601e-09
malignancy I-Disease 0 7.328975204501376e-09
with O 0 9.219256522747469e-15
similarities O 0 1.8746694463705332e-13
to O 0 4.035010986360582e-13
a O 0 1.3416997547699427e-12
mature B-Disease 0 9.462209682453704e-09
T I-Disease 0 3.3847882718873734e-08
- I-Disease 0 8.799506190371176e-08
cell I-Disease 0 5.256560342559169e-08
leukaemia I-Disease 1 0.9755921959877014
seen O 0 1.3218948505255845e-11
in O 0 6.307435585113652e-13
A B-Disease 1 1.0
- I-Disease 0 0.006342821288853884
T I-Disease 1 0.9999977350234985
, O 0 2.978823446047295e-14
we O 0 8.884723401328225e-16
demonstrate O 0 2.3768432968335196e-13
a O 0 2.18465086041582e-15
high O 0 5.351065422742104e-15
frequency O 0 9.945570164952497e-14
of O 0 8.287189294173269e-13
ATM O 0 6.027569998678928e-09
mutations O 0 1.5918415890991966e-11
in O 0 9.54435197542125e-10
T B-Disease 0 1.1753426178984228e-06
- I-Disease 0 3.095874035352608e-06
PLL I-Disease 0 9.639628842705861e-05
. O 0 2.497215056962432e-08

In O 0 1.5044828230448282e-11
marked O 0 4.502380759885405e-11
contrast O 0 4.356684013117479e-13
to O 0 3.241109637619477e-13
the O 0 1.4177527424621972e-12
ATM O 0 3.3180548086875206e-08
mutation O 0 1.0311823010061838e-12
pattern O 0 3.371328390067152e-12
in O 0 1.1549354137982415e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 3.270008504425992e-13
the O 0 8.027665988549759e-14
most O 0 2.5643943653947624e-16
frequent O 0 2.652051952221538e-16
nucleotide O 0 2.0534583148462682e-13
changes O 0 3.6671529121722404e-15
in O 0 1.2428365357263632e-14
this O 0 5.563182835406633e-13
leukaemia B-Disease 0 2.204385282311705e-06
were O 0 5.830985694288415e-10
missense O 0 5.198923531679611e-07
mutations O 0 7.410955848996537e-09
. O 0 4.833137445814373e-09

These O 0 1.1300815318249224e-11
clustered O 0 9.576733156491102e-11
in O 0 9.242638020223477e-15
the O 0 7.616636813444211e-14
region O 0 3.7145213120648446e-12
corresponding O 0 4.9663922280229755e-11
to O 0 3.625978683974296e-11
the O 0 2.2894301732190314e-10
kinase O 0 4.698851863160769e-10
domain O 0 2.349197281148463e-09
, O 0 2.6992702167947906e-14
which O 0 8.029985630627462e-16
is O 0 8.211040511289845e-16
highly O 0 3.46741461498129e-13
conserved O 0 2.5036817237478193e-12
in O 0 2.431627598928343e-12
ATM O 0 8.190486937564856e-07
- O 0 6.533820706700055e-10
related O 0 3.597399045318639e-10
proteins O 0 3.174018339824336e-12
in O 0 1.349458305516249e-12
mouse O 0 1.936217332298984e-11
, O 0 9.640564781481127e-15
yeast O 0 3.904183833863817e-12
and O 0 1.4315667249721609e-13
Drosophila O 0 1.7913548422399117e-10
. O 0 1.3346183880269535e-10

The O 0 4.3035522367951273e-10
resulting O 0 4.516163887302582e-09
amino O 0 5.961120486119853e-09
- O 0 4.1932898819929676e-10
acid O 0 2.0813866255520175e-11
substitutions O 0 1.6409075487278102e-10
are O 0 5.158897194526037e-14
predicted O 0 4.3742383847023e-12
to O 0 1.5434124247745706e-12
interfere O 0 2.300466483973196e-09
with O 0 3.8219335465536353e-13
ATP O 0 4.86271076738376e-08
binding O 0 2.7533963997683486e-10
or O 0 1.6879454431406593e-11
substrate O 0 5.945470782364737e-10
recognition O 0 3.6930227764742085e-09
. O 0 5.337809749761391e-09

Two O 0 3.2988976134129544e-11
of O 0 3.707063128688404e-11
seventeen O 0 1.1480775358174711e-10
mutated O 0 1.0149358567121403e-12
T B-Disease 0 3.207027005069918e-11
- I-Disease 0 4.151840329869039e-11
PLL I-Disease 0 3.1947422485245625e-08
samples O 0 4.3026454794869995e-12
had O 0 1.3090440190155483e-14
a O 0 7.142534918108147e-16
previously O 0 9.297236916970542e-15
reported O 0 4.4171117501504154e-13
A B-Disease 1 1.0
- I-Disease 1 0.9967073202133179
T I-Disease 1 1.0
allele O 0 8.204639101450084e-08
. O 0 3.3887270767252176e-09

In O 0 1.1054882703698254e-10
contrast O 0 2.5502508091412857e-11
, O 0 4.3321625448197384e-14
no O 0 6.43112407945623e-14
mutations O 0 8.379360031361693e-13
were O 0 1.284654457464618e-12
detected O 0 1.4909816003355614e-12
in O 0 1.7377743192462276e-14
the O 0 3.4467361690465603e-13
p53 O 0 4.402359011189405e-13
gene O 0 2.388015932458347e-14
, O 0 4.440523215652097e-15
suggesting O 0 1.4852564707637517e-12
that O 0 1.716263769319939e-15
this O 0 9.952160623383222e-13
tumour B-Disease 1 1.0
suppressor O 0 1.562335860683106e-08
is O 0 9.644758441602983e-15
not O 0 2.172998990490095e-14
frequently O 0 4.1947717001333817e-13
altered O 0 6.158272676526355e-12
in O 0 3.972454147311427e-13
this O 0 2.4347522262213595e-11
leukaemia B-Disease 0 6.413396477000788e-05
. O 0 9.5843084579883e-09

Occasional O 0 5.1216854757285546e-08
missense O 0 4.090066951789595e-08
mutations O 0 2.3838602966619327e-11
in O 0 1.867073119374285e-12
ATM O 0 6.791604079126046e-08
were O 0 2.1585937898249696e-11
also O 0 6.747216700690685e-15
found O 0 3.113471614991101e-15
in O 0 1.2267789086287898e-14
tumour B-Disease 1 1.0
DNA O 0 6.0760498854506295e-09
from O 0 6.491068533370781e-13
patients O 0 9.475984585763722e-14
with O 0 1.1941207910177477e-15
B B-Disease 0 3.1880187378874325e-10
- I-Disease 0 1.0947909939718059e-10
cell I-Disease 0 1.6386664469791867e-08
non I-Disease 1 0.9999960660934448
- I-Disease 1 0.9999997615814209
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 1.508268496763776e-06
( O 0 4.040336146974698e-15
B B-Disease 0 1.4443890528070824e-09
- I-Disease 0 7.613304951747946e-12
NHL I-Disease 0 1.870120769353889e-08
) O 0 5.872372882451167e-17
and O 0 2.887473113207846e-17
a O 0 3.05787893683867e-15
B B-Disease 0 5.350729234687712e-11
- I-Disease 0 1.4274618813370221e-11
NHL I-Disease 0 3.937049797286818e-08
cell O 0 2.94009172563392e-09
line O 0 1.0841936237682148e-09
. O 0 8.297272591217819e-11

The O 0 4.761794691193755e-12
evidence O 0 1.4155802181489707e-12
of O 0 9.864716465565748e-13
a O 0 2.6212322243313046e-14
significant O 0 1.2502028763367729e-13
proportion O 0 5.183076190462543e-12
of O 0 4.473608115895811e-12
loss O 0 2.8485451844528775e-11
- O 0 7.043361727188113e-11
of O 0 8.10235434300921e-09
- O 0 6.109072692161988e-10
function O 0 1.9287606234374977e-11
mutations O 0 4.8248728010949135e-14
and O 0 6.54753291854022e-17
a O 0 4.2775137366562565e-17
complete O 0 2.6181007774066234e-13
absence O 0 2.168997186718924e-12
of O 0 1.318680272399328e-13
the O 0 3.642294612752695e-15
normal O 0 9.669223971844887e-14
copy O 0 1.843516441932258e-12
of O 0 1.6922124508947367e-12
ATM O 0 3.1298771907550815e-10
in O 0 5.719993164017556e-14
the O 0 8.907367302513763e-14
majority O 0 4.154957356904826e-13
of O 0 7.503696448918351e-12
mutated O 0 3.391048331025104e-09
tumours B-Disease 1 1.0
establishes O 0 4.4480086280884734e-11
somatic O 0 2.500539497685139e-10
inactivation O 0 3.0970143116704207e-10
of O 0 1.817052758257276e-11
this O 0 6.772362483092528e-14
gene O 0 1.0832937296495742e-14
in O 0 2.7026188768484657e-14
the O 0 9.6742790644741e-14
pathogenesis O 0 2.0846931125806378e-10
of O 0 2.0280713219911206e-10
sporadic B-Disease 0 1.010052187666588e-06
T I-Disease 0 5.486524514708435e-07
- I-Disease 0 7.918122264527483e-07
PLL I-Disease 0 3.049594488402363e-05
and O 0 2.688502090224254e-13
suggests O 0 3.608566014902913e-14
that O 0 3.056744375910492e-17
ATM O 0 1.432191587547038e-10
acts O 0 3.1657048944061517e-12
as O 0 3.746640584584293e-12
a O 0 1.1702508961874969e-09
tumour B-Disease 1 1.0
suppressor O 0 1.5314709571612184e-06
. O 0 8.611662494217853e-09

As O 0 1.8785001765914133e-12
constitutional O 0 1.0388483476231336e-11
DNA O 0 3.0666964523362594e-09
was O 0 2.663493774493486e-12
not O 0 2.177504866956309e-14
available O 0 2.9562372515223867e-12
, O 0 5.2219462613615e-15
a O 0 1.6044664511924434e-12
putative O 0 8.586785327224788e-08
hereditary O 0 0.17622756958007812
predisposition O 0 6.673490861430764e-05
to O 0 0.001724709291011095
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.999998927116394
PLL I-Disease 1 0.9999995231628418
will O 0 2.698332356165789e-11
require O 0 8.058478363770494e-12
further O 0 1.4988333382585928e-13
investigation O 0 7.380415180911759e-13
. O 0 6.384987482309368e-13
. O 0 4.0297851860993106e-11

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 3.088582047894306e-07
kinase O 0 3.2275720290853016e-11
is O 0 7.110348195508076e-16
involved O 0 1.246130519803293e-15
in O 0 7.935223290257796e-16
the O 0 3.780949247537014e-15
modulation O 0 5.673847893253314e-13
of O 0 6.364633754925297e-13
the O 0 1.444176673864525e-13
Ca2 O 0 6.395997446950741e-12
+ O 0 1.7833332033312388e-10
homeostasis O 0 3.6459482100070773e-09
in O 0 3.0650208066029805e-11
skeletal O 0 1.0214772316885501e-07
muscle O 0 1.444381503290515e-08
cells O 0 3.190223907267864e-08
. O 0 2.2980062297506265e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.941811931364782e-09
DM B-Disease 1 1.0
) O 0 2.8627759884880533e-12
, O 0 1.0827855098812216e-14
the O 0 5.991609525147698e-14
most O 0 8.593919033437342e-14
prevalent O 0 4.972945362169412e-07
muscular B-Disease 0 1.1060081305913627e-05
disorder I-Disease 0 6.510501862067031e-07
in O 0 3.577531500209563e-12
adults O 0 5.125667668082201e-10
, O 0 7.863569279238647e-15
is O 0 7.483513854376878e-16
caused O 0 1.9740072342575368e-14
by O 0 3.575841066392332e-15
( O 0 4.907882538145603e-16
CTG O 0 7.188717503214814e-12
) O 0 1.0087843937262884e-17
n O 0 8.494825665377598e-16
- O 0 5.259771364654088e-15
repeat O 0 7.356371562016047e-16
expansion O 0 2.061933785808801e-15
in O 0 6.064999507031187e-18
a O 0 2.644613671183859e-18
gene O 0 1.3643562518383329e-18
encoding O 0 1.3845868218230126e-14
a O 0 2.454380665720124e-12
protein O 0 8.086008425334246e-12
kinase O 0 1.8072366519961136e-11
( O 0 4.307117813448502e-13
DM B-Disease 1 1.0
protein O 0 1.782099912084334e-09
kinase O 0 2.8585430897343223e-11
; O 0 4.5571934491036095e-14
DMPK O 0 1.911509571073111e-05
) O 0 1.0281052979712203e-15
and O 0 1.7660544306023556e-16
involves O 0 2.2533554815368055e-14
changes O 0 2.921033776187923e-15
in O 0 4.387887825980062e-14
cytoarchitecture O 0 3.236680701235173e-09
and O 0 1.6558682593495466e-12
ion O 0 2.324189951607991e-09
homeostasis O 0 2.033993382610788e-07
. O 0 1.5621182569702796e-08

To O 0 1.1075924205572463e-10
obtain O 0 2.9446152183254526e-09
clues O 0 7.099379417674356e-10
to O 0 2.108591892670958e-13
the O 0 2.752158310276309e-13
normal O 0 1.5832971045348643e-10
biological O 0 4.078972836579764e-12
role O 0 5.761431696310604e-12
of O 0 1.3146246313766596e-09
DMPK O 1 0.9999995231628418
in O 0 6.386231099497763e-09
cellular O 0 2.818144162475278e-09
ion O 0 1.1161969126760596e-09
homeostasis O 0 9.051492000367034e-09
, O 0 5.705514728206185e-13
we O 0 1.6946727766746494e-13
have O 0 9.292450333785608e-15
compared O 0 1.1363056762886403e-12
the O 0 3.903176610045578e-13
resting O 0 4.7190307217448435e-11
[ O 0 2.7089989322950925e-13
Ca2 O 0 1.736466466494349e-13
+ O 0 6.301314721748885e-13
] O 0 8.571860235506712e-12
i O 0 1.3212892151920341e-12
, O 0 4.454246102309682e-16
the O 0 1.734812732073624e-15
amplitude O 0 3.004237483783534e-14
and O 0 2.258664175830427e-15
shape O 0 1.4742837159409383e-11
of O 0 3.193544595436748e-10
depolarization O 0 1.4604453202338163e-09
- O 0 4.9742370222816135e-09
induced O 0 1.190798570860352e-10
Ca2 O 0 1.9107236626236812e-11
+ O 0 2.6817596754380446e-11
transients O 0 2.5321778007736384e-10
, O 0 5.2398798149743355e-17
and O 0 3.599127778896309e-18
the O 0 8.261180494253666e-17
content O 0 5.5070439988801415e-15
of O 0 1.17139642170222e-13
ATP O 0 1.0939747718818893e-10
- O 0 1.2751466549332235e-11
driven O 0 1.38210345945744e-11
ion O 0 6.899121898773508e-12
pumps O 0 9.964510987170438e-12
in O 0 6.764339522541407e-12
cultured O 0 1.120207642202331e-07
skeletal O 0 8.610581403445394e-08
muscle O 0 1.902186602675826e-10
cells O 0 1.2764832246769942e-10
of O 0 9.123170968683425e-11
wild O 0 4.604033625697779e-13
- O 0 9.549509620565555e-13
type O 0 8.780087117424284e-13
and O 0 3.754621938877045e-13
DMPK O 0 2.3599159248988144e-05
[ O 0 2.612084437636497e-10
- O 0 2.1607533817746827e-10
/ O 0 1.1851519765571084e-10
- O 0 2.6352775864268985e-11
] O 0 5.26220777022357e-12
knockout O 0 1.730904641839004e-09
mice O 0 7.776464888697987e-11
. O 0 7.805021386142474e-12

In O 0 2.6348079273930125e-09
vitro O 0 7.018452929941077e-09
- O 0 6.0031206672306325e-09
differentiated O 0 7.982628780212053e-09
DMPK O 0 1.6088593838503584e-05
[ O 0 1.665448334797759e-10
- O 0 2.6478447212596734e-10
/ O 0 8.050436983708664e-10
- O 0 7.827644643576548e-10
] O 0 7.511862659681512e-11
myotubes O 0 2.437385759890276e-08
exhibit O 0 2.1061359036997351e-13
a O 0 2.6469706756863422e-14
higher O 0 1.1664791528531726e-11
resting O 0 1.6214746212384057e-10
[ O 0 3.803108869493421e-12
Ca2 O 0 5.1832839235987915e-12
+ O 0 1.5979315093339608e-11
] O 0 3.6336978564976974e-11
i O 0 1.4771342786087938e-12
than O 0 8.69050891091818e-15
do O 0 3.5166063583249446e-14
wild O 0 4.1367381525478364e-13
- O 0 2.8544487194921697e-13
type O 0 1.8880838732748817e-12
myotubes O 0 3.6595686481177836e-09
because O 0 5.69994287771651e-14
of O 0 3.1929322467233456e-12
an O 0 2.2241643121305226e-15
altered O 0 1.5695927088436867e-13
open O 0 7.387002115685423e-14
probability O 0 2.6877547496667598e-12
of O 0 5.789344698081678e-12
voltage O 0 7.381460026545383e-12
- O 0 3.6159297778226573e-11
dependent O 0 4.148120388847154e-11
l O 0 3.5279616142532e-13
- O 0 9.679932636702526e-13
type O 0 8.31757351795609e-14
Ca2 O 0 5.180365142930243e-13
+ O 0 1.4641023853359525e-12
and O 0 3.114436876797133e-13
Na O 0 5.703105002141662e-11
+ O 0 5.949604524324581e-12
channels O 0 1.0846894216154368e-10
. O 0 6.291366039246071e-11

The O 0 6.88041568164266e-10
mutant O 0 5.517329926263415e-10
myotubes O 0 1.0904884994999975e-08
exhibit O 0 9.457049943498164e-13
smaller O 0 3.239600157144834e-14
and O 0 6.418495919355499e-16
slower O 0 2.7498665237241093e-12
Ca2 O 0 7.809368603173272e-12
+ O 0 1.6800727475896338e-11
responses O 0 4.2983284574867053e-13
upon O 0 1.1769600051503293e-12
triggering O 0 2.2490497420153688e-13
by O 0 3.4765628757434976e-15
acetylcholine O 0 6.21906554032492e-11
or O 0 2.2607202568303286e-11
high O 0 1.8595859227477085e-11
external O 0 1.6189817264589124e-09
K O 0 2.1459809484980497e-09
+ O 0 8.86011042311452e-10
. O 0 5.6436572082319e-10

In O 0 1.715168562732572e-10
addition O 0 9.434407248487542e-12
, O 0 6.342199850148042e-14
we O 0 3.434200894578826e-14
observed O 0 1.8114854980085492e-14
that O 0 9.744822890585107e-17
these O 0 1.0462294737018573e-15
Ca2 O 0 1.82885976328373e-12
+ O 0 7.043093191994032e-11
transients O 0 9.547266310860891e-10
partially O 0 4.565158581021356e-12
result O 0 1.3768581543990854e-13
from O 0 1.014149701716871e-13
an O 0 2.357336737921975e-15
influx O 0 4.2811030599460703e-14
of O 0 3.1566348385018983e-13
extracellular O 0 1.27379619981223e-13
Ca2 O 0 9.288839771144641e-14
+ O 0 2.2482393008914359e-13
through O 0 3.129836613404574e-13
the O 0 1.2456730796601284e-13
l O 0 6.667747815469402e-14
- O 0 3.2314924932989875e-13
type O 0 8.659389259249237e-14
Ca2 O 0 1.648679673685316e-12
+ O 0 4.433102149259405e-11
channel O 0 4.578458792647844e-11
. O 0 4.5451600816370785e-11

Neither O 0 1.6079615416941806e-09
the O 0 1.233937648240091e-12
content O 0 1.7487820002867749e-12
nor O 0 1.33996763337918e-13
the O 0 5.7067061816904515e-15
activity O 0 4.650030902865476e-13
of O 0 2.9383255811116227e-13
Na O 0 2.8018574873417412e-12
+ O 0 8.786352721779078e-13
/ O 0 6.23028191537589e-12
K O 0 6.197546382341601e-12
+ O 0 1.6215690899420987e-12
ATPase O 0 1.0043722104002839e-10
and O 0 3.65070034749268e-13
sarcoplasmic O 0 7.329433171499034e-10
reticulum O 0 1.0098357705601302e-09
Ca2 O 0 2.469178750352796e-10
+ O 0 3.2508720715362927e-10
- O 0 1.686684680812789e-10
ATPase O 0 5.204061626074008e-10
are O 0 5.8242798604835055e-15
affected O 0 1.1740962206369804e-13
by O 0 8.150911992880691e-14
DMPK O 1 0.8025964498519897
absence O 0 1.7175084110476746e-07
. O 0 3.5443923351863305e-09

In O 0 1.4407343373878945e-10
conclusion O 0 4.85960938156893e-10
, O 0 2.2643817159870294e-13
our O 0 1.2406215811611165e-11
data O 0 1.9743106888930884e-12
suggest O 0 2.0713172930314494e-13
that O 0 4.3919213121715924e-15
DMPK O 0 7.496610123780556e-06
is O 0 1.20583517197498e-14
involved O 0 2.9495107528240694e-13
in O 0 1.4316649807940424e-13
modulating O 0 8.451723695901414e-12
the O 0 7.127204913488089e-14
initial O 0 1.8731466844192773e-13
events O 0 2.428561366764337e-14
of O 0 1.2101657566668256e-12
excitation O 0 2.4571491508140753e-08
- O 0 3.846464124990234e-08
contraction O 0 1.7483067771273397e-10
coupling O 0 6.634188424309295e-12
in O 0 3.273280084481467e-12
skeletal O 0 1.8411517643812658e-08
muscle O 0 3.880800680811092e-10
. O 0 1.9915808585624362e-11
. O 0 1.3260977038687116e-10

Constitutional O 0 3.326933040170843e-08
RB1 O 0 8.533152140444145e-05
- O 0 1.678854744113778e-08
gene O 0 5.5065583169644494e-12
mutations O 0 6.40665645534888e-12
in O 0 4.168497144685368e-14
patients O 0 2.7331077939035664e-12
with O 0 2.4727366760624904e-14
isolated O 0 2.6039709277725365e-10
unilateral B-Disease 0 1.692138518194497e-08
retinoblastoma I-Disease 1 1.0
. O 0 1.8364984498475678e-05

In O 0 6.070090263765593e-11
most O 0 7.270068336402702e-13
patients O 0 1.0428044061941422e-12
with O 0 6.493291046180422e-15
isolated O 0 2.1243486570537984e-12
unilateral B-Disease 0 9.464078826182387e-11
retinoblastoma I-Disease 1 0.5246620774269104
, O 0 3.447215928507885e-13
tumor B-Disease 0 5.423126947512458e-10
development O 0 2.0069503836595004e-09
is O 0 7.395312313579288e-16
initiated O 0 1.3662893516216967e-13
by O 0 4.856406757754183e-16
somatic O 0 8.269571659391683e-12
inactivation O 0 3.31941071851638e-11
of O 0 2.9474033890614093e-12
both O 0 1.3934097202895207e-13
alleles O 0 2.7904748282035763e-13
of O 0 5.24669413817791e-12
the O 0 1.3948895857818222e-11
RB1 O 0 1.0240054137966581e-07
gene O 0 2.6567520752807106e-11
. O 0 1.7532432172728818e-09

However O 0 1.7579067368433954e-10
, O 0 3.2177629701382604e-14
some O 0 3.5033754919305956e-15
of O 0 4.4492941232363026e-13
these O 0 4.1946196407786907e-13
patients O 0 5.99433567019525e-12
can O 0 5.7395529301507153e-11
transmit O 0 2.910855023685599e-08
retinoblastoma B-Disease 0 2.4034236503212014e-06
predisposition O 0 1.639405127207283e-07
to O 0 2.980206303959676e-09
their O 0 6.52207043927433e-09
offspring O 0 1.2195462772979226e-07
. O 0 9.639748554945982e-09

To O 0 2.0173644005305746e-11
determine O 0 1.8353776831681046e-11
the O 0 6.419827234920017e-13
frequency O 0 9.238985444748327e-12
and O 0 2.3619454441879857e-15
nature O 0 8.880428944285645e-14
of O 0 1.3604773503508166e-13
constitutional O 0 4.409271212035826e-11
RB1 O 0 3.5080427096545463e-07
- O 0 3.531232251052785e-10
gene O 0 8.18479995150917e-13
mutations O 0 3.2286599609132605e-12
in O 0 1.8996311685129386e-13
patients O 0 5.94606482107185e-12
with O 0 7.824956774118291e-14
isolated O 0 3.6641960299288456e-11
unilateral B-Disease 0 1.7624929293802438e-10
retinoblastoma I-Disease 0 3.9307055885728914e-06
, O 0 6.584487864886093e-14
we O 0 7.319119370633159e-15
analyzed O 0 1.8273001113535553e-13
DNA O 0 1.2235847057784355e-10
from O 0 5.382650163261726e-13
peripheral O 0 7.052654571459982e-10
blood O 0 8.385172417524345e-11
and O 0 1.0747830576918194e-11
from O 0 3.559939565356274e-10
tumor B-Disease 0 1.510385772007794e-07
tissue O 0 8.5587096521067e-08
. O 0 1.272070715430118e-08

The O 0 1.0356532471889057e-11
analysis O 0 3.035836859677232e-11
of O 0 1.2323072562381299e-09
tumors B-Disease 1 1.0
from O 0 5.73754155297479e-10
54 O 0 5.747336384587243e-09
( O 0 4.848942089324092e-14
71 O 0 3.82793086117772e-09
% O 0 2.6830454524784386e-10
) O 0 1.9242443450678782e-15
of O 0 2.2438523478510164e-13
76 O 0 3.505789061830633e-11
informative O 0 2.8017680189784677e-11
patients O 0 3.953939633387707e-14
showed O 0 1.7173764580574735e-12
loss O 0 4.896280429711464e-12
of O 0 2.7768854923837516e-11
constitutional O 0 2.891541450722457e-09
heterozygosity O 0 0.04053092002868652
( O 0 3.210980423773435e-07
LOH O 0 0.0022757709957659245
) O 0 2.5666604258622883e-12
at O 0 2.3754148648080786e-10
intragenic O 0 2.076611238521764e-08
loci O 0 1.5591169466588894e-09
. O 0 1.7640676697183721e-09

Three O 0 3.600199860454012e-10
of O 0 1.8898620168794622e-10
13 O 0 9.06930530675254e-10
uninformative O 0 0.00017617037519812584
patients O 0 1.5828450772303881e-09
had O 0 6.382534778470728e-11
constitutional O 0 1.2495527279554608e-08
deletions O 0 2.4222316596933524e-07
. O 0 1.7675782615356184e-08

For O 0 6.531291618649959e-10
39 O 0 9.029248460024064e-09
randomly O 0 5.80373793468425e-09
selected O 0 1.375492075794682e-07
tumors B-Disease 1 1.0
, O 0 5.5972473184118243e-11
SSCP O 1 0.9971247315406799
, O 0 1.9928310737715726e-11
hetero O 0 3.377455826125697e-08
- O 0 5.7128381886206725e-11
duplex O 0 3.729653530459842e-10
analysis O 0 1.374400376494278e-12
, O 0 7.000161517517806e-17
sequencing O 0 2.3283126728695924e-12
, O 0 1.6803544427958033e-15
and O 0 4.4367979647500725e-15
Southern O 0 5.2641380837714635e-11
blot O 0 8.010719865225724e-10
analysis O 0 1.971977268977465e-12
were O 0 2.190711804669898e-13
used O 0 1.1965872086586171e-12
to O 0 3.137268916875158e-11
identify O 0 1.5575929879219075e-08
mutations O 0 2.3964050299696282e-08
. O 0 2.689719202919605e-08

Mutations O 0 7.875811114388398e-09
were O 0 2.9567008563713415e-11
detected O 0 3.992328689861324e-11
in O 0 7.571272439294702e-14
21 O 0 1.2132650569970926e-12
( O 0 5.130562206022839e-16
91 O 0 4.329187355822661e-11
% O 0 5.374602499164105e-11
) O 0 1.523376727769008e-14
of O 0 7.130030593716086e-11
23 O 0 8.004219012036629e-07
tumors B-Disease 1 1.0
with O 1 0.9997283816337585
LOH O 1 0.9999992847442627
. O 0 9.146432375928271e-07

In O 0 8.439022813888641e-10
6 O 0 1.3433059352363497e-11
( O 0 1.8453324263610626e-15
38 O 0 2.624888501001621e-11
% O 0 1.0198808811368032e-11
) O 0 6.86975060442286e-15
of O 0 2.6605551095570945e-11
16 O 0 2.616739536165369e-08
tumors B-Disease 1 1.0
without O 1 0.999976634979248
LOH O 1 0.9988901019096375
, O 0 2.478276373181487e-13
one O 0 1.8681979791282388e-13
mutation O 0 2.3358244049913324e-13
was O 0 4.595716168731556e-13
detected O 0 2.151580129339248e-12
, O 0 5.952714089847136e-16
and O 0 1.6755859649401168e-15
in O 0 7.266875903105818e-14
9 O 0 8.518299455563538e-13
( O 0 7.133086794977117e-16
56 O 0 2.927275435937737e-11
% O 0 9.605084089203686e-12
) O 0 2.1529972391769268e-15
of O 0 5.151606138203979e-12
the O 0 1.1682103062682359e-09
tumors B-Disease 1 1.0
without O 0 0.0018178409663960338
LOH O 0 0.022841153666377068
, O 0 3.7104212931293734e-12
both O 0 3.425263545020485e-11
mutations O 0 1.195055721048277e-10
were O 0 6.169762617469488e-11
found O 0 5.782307271884335e-11
. O 0 6.344160752291828e-10

Thus O 0 5.922110024592087e-10
, O 0 3.440691538647046e-14
a O 0 1.7925200915063465e-14
total O 0 2.839571243071215e-12
of O 0 1.5840748851525532e-12
45 O 0 7.35911262483846e-11
mutations O 0 2.7471211069829415e-11
were O 0 8.917167351740751e-12
identified O 0 5.710789827140239e-11
in O 0 1.718266084971276e-10
tumors B-Disease 1 1.0
of O 0 1.4620492549966002e-07
36 O 0 2.2917190563020995e-06
patients O 0 1.3273795396173682e-08
. O 0 5.4186656939236855e-08

Thirty O 0 2.7686138537319493e-07
- O 0 3.22006588060475e-10
nine O 0 6.546354430758683e-11
of O 0 3.835833126825117e-12
the O 0 3.466192827553116e-12
mutations O 0 8.338995292900275e-12
- O 0 2.6939906468820274e-12
including O 0 1.3709698524003167e-13
34 O 0 4.1235227854485856e-07
small O 0 2.3337573540338497e-10
mutations O 0 7.203016405554763e-09
, O 0 2.5599231935624633e-12
2 O 0 2.0722135118944607e-10
large O 0 1.0724200173728438e-11
structural O 0 6.437242205947769e-08
alterations O 0 3.946793469822296e-08
, O 0 1.7934999188909395e-12
and O 0 3.381400411409108e-12
hypermethylation O 0 2.424254489596933e-06
in O 0 1.6959438298158602e-09
3 O 0 2.6546791431769634e-08
tumors O 1 1.0
- O 0 3.566198725213354e-10
were O 0 4.99968339298662e-12
not O 0 8.784035917261748e-14
detected O 0 1.3867555107710539e-12
in O 0 1.3552235988493187e-15
the O 0 2.742550169916049e-15
corresponding O 0 1.6005418561684803e-12
peripheral O 0 2.362969819813543e-10
blood O 0 2.8672159091414073e-10
DNA O 0 2.1808247652188584e-07
. O 0 2.1883868939198692e-08

In O 0 1.9840113996139053e-09
6 O 0 5.270919464783752e-11
( O 0 4.1575688950064825e-15
17 O 0 4.141949099239345e-13
% O 0 4.4430523713293035e-13
) O 0 6.439239756233757e-17
of O 0 3.476233041113837e-14
the O 0 1.2508372701329484e-13
36 O 0 2.960133249629848e-10
patients O 0 1.2133836470307191e-11
, O 0 2.7775911182626595e-14
a O 0 5.12440892670718e-13
mutation O 0 2.0941759611148303e-12
was O 0 4.3554565336278994e-12
detected O 0 2.6412847603518586e-12
in O 0 6.3623575402268e-15
constitutional O 0 9.259780442416599e-13
DNA O 0 2.420188716101279e-09
, O 0 8.490897465381411e-14
and O 0 2.2473549307318666e-14
1 O 0 5.87162371674943e-13
of O 0 1.1320441112294688e-12
these O 0 1.2142969464147557e-13
mutations O 0 3.398150630242597e-13
is O 0 7.944430008998858e-16
known O 0 1.793921549869226e-15
to O 0 5.052569690758291e-13
be O 0 1.9999429629741217e-12
associated O 0 3.7571207256448247e-10
with O 0 5.840051532646218e-12
reduced O 0 1.3202892112929021e-08
expressivity O 0 3.0598439479945228e-06
. O 0 5.193058427721553e-09

The O 0 2.4780424240367083e-11
presence O 0 1.0465663708922324e-12
of O 0 6.622064441935693e-12
a O 0 2.0385121813227408e-13
constitutional O 0 8.680581427278344e-12
mutation O 0 4.157153137354652e-13
was O 0 1.4075287091993953e-14
not O 0 1.3259771393674038e-16
associated O 0 6.486730352487464e-15
with O 0 3.5926687390831885e-17
an O 0 2.4413851967698387e-17
early O 0 2.3397570773214804e-13
age O 0 1.6866324309416925e-11
at O 0 2.6542433615578398e-12
treatment O 0 3.330802855749937e-10
. O 0 6.16229733907403e-10

In O 0 1.0153584570349317e-11
1 O 0 2.001878871005225e-11
patient O 0 1.0109864057028517e-09
, O 0 2.498531878624994e-14
somatic O 0 2.696312062511197e-10
mosaicism O 0 3.7352172910232184e-08
was O 0 2.7970076883938877e-13
demonstrated O 0 4.489028980893088e-15
by O 0 1.979560872281531e-18
molecular O 0 1.2247389674181818e-16
analysis O 0 6.264981785577498e-16
of O 0 3.386016112473197e-15
DNA O 0 2.28024131694593e-12
and O 0 2.445481019292331e-14
RNA O 0 2.082825162341706e-10
from O 0 6.170892269397044e-11
peripheral O 0 4.998340159545478e-07
blood O 0 1.6322817941727408e-07
. O 0 5.681432213577864e-08

In O 0 2.88441187601407e-10
2 O 0 1.1837240909695623e-10
patients O 0 4.854971893258897e-12
without O 0 7.120364627771769e-12
a O 0 1.8414826954971097e-11
detectable O 0 1.4831732286779697e-08
mutation O 0 1.2098710054642137e-11
in O 0 3.0017316757224854e-12
peripheral O 0 2.9862849970641037e-08
blood O 0 1.0705026198820633e-08
, O 0 5.768942181599845e-12
mosaicism O 0 7.853851116124133e-07
was O 0 2.7070184635547e-11
suggested O 0 1.004926935936623e-12
because O 0 2.8653335248511906e-15
1 O 0 4.54740784687057e-14
of O 0 2.1704650067250891e-13
the O 0 2.0723960741930725e-13
patients O 0 1.475152248617273e-12
showed O 0 5.016175252947619e-10
multifocal O 1 0.9999980926513672
tumors B-Disease 1 1.0
and O 0 6.385076495307729e-12
the O 0 2.5487919066979892e-11
other O 0 1.384730139797688e-13
later O 0 8.079163206498041e-12
developed O 0 1.1973486091498842e-10
bilateral B-Disease 0 9.940777817973867e-05
retinoblastoma I-Disease 0 0.00011936045484617352
. O 0 3.001365911359244e-08

In O 0 3.13816056474181e-11
conclusion O 0 2.739394266981776e-10
, O 0 1.4435239841566888e-13
our O 0 7.01753195483934e-12
results O 0 1.2287894226442608e-12
emphasize O 0 1.1355371504206957e-11
that O 0 9.207267194895558e-16
the O 0 1.05349539855637e-13
manifestation O 0 3.2362099111615805e-10
and O 0 2.9446540691924206e-13
transmissibility O 0 1.8514098698574344e-08
of O 0 3.7697664434510614e-11
retinoblastoma B-Disease 0 2.432916534900187e-09
depend O 0 5.270648154032109e-11
on O 0 5.841886219562498e-13
the O 0 4.829246201608177e-14
nature O 0 2.7839677178148614e-13
of O 0 3.37655196771397e-13
the O 0 3.28429605289237e-14
first O 0 2.328831300978801e-13
mutation O 0 5.111549746840416e-14
, O 0 7.824516084051659e-16
its O 0 1.7116739095370047e-15
time O 0 1.9643332370856276e-13
in O 0 6.667455080882831e-14
development O 0 2.423753697744502e-10
, O 0 5.4636665946183015e-15
and O 0 2.1200950913737807e-15
the O 0 5.822394703956096e-14
number O 0 4.251580912415648e-14
and O 0 1.1591715339876775e-14
types O 0 5.579891149826155e-12
of O 0 6.913058233498637e-12
cells O 0 7.5754411424378e-12
that O 0 4.1035808784209774e-14
are O 0 2.9373378051698526e-14
affected O 0 2.5561857318334713e-12
. O 0 3.452475284826395e-12
. O 0 6.464390689409072e-10

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999998807907104
the I-Disease 0 3.562120696187776e-07
fifth I-Disease 0 3.380264388397336e-06
component I-Disease 0 1.4755434207813778e-08
of I-Disease 0 2.6374008532670246e-10
complement I-Disease 0 8.881835267260385e-10
in O 0 4.6843615791880566e-11
man O 0 6.744303338024338e-09
. O 0 2.13377422397798e-08

I O 0 0.00024908786872401834
. O 0 5.700710303813139e-08

Clinical O 0 1.4979832485551015e-07
, O 0 3.72608758084092e-12
immunochemical O 0 1.3052488156972686e-07
, O 0 4.848029529908038e-13
and O 0 3.065298394885202e-13
family O 0 5.828611898683889e-12
studies O 0 9.768524183995098e-11
. O 0 2.4569968282150967e-10

The O 0 1.919523220927921e-11
first O 0 3.9525240719262555e-13
recognized O 0 2.5126407031395015e-13
human O 0 9.945082951601236e-13
kindred O 0 1.1649293440996189e-07
with O 0 8.935618087471675e-13
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 0 0.0004980932571925223
fifth I-Disease 1 0.9628568291664124
component I-Disease 1 0.9798577427864075
of I-Disease 1 0.9943389296531677
complement I-Disease 0 0.00015368442109320313
( O 0 2.4104888224352194e-11
C5 O 0 3.396377360331826e-05
) O 0 1.181938336265731e-12
is O 0 1.0331090773444893e-13
described O 0 8.926697922517768e-12
. O 0 9.038549353412861e-10

The O 0 1.0644312986585192e-08
proband O 0 5.060624971520156e-06
, O 0 1.5062788256275939e-13
a O 0 4.77474979584773e-14
20 O 0 7.88825385220071e-14
- O 0 7.258034742608967e-15
year O 0 1.9723824895394315e-13
- O 0 4.93495799780419e-11
old O 0 1.3495374817651395e-09
black O 0 8.770551125636405e-12
female O 0 5.285499815599337e-10
with O 0 2.3538729992944596e-11
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 6.981835031183437e-05
age O 0 5.035120921093039e-06
11 O 0 7.60702667523816e-10
, O 0 2.529326032472967e-13
lacked O 0 1.3971196421991294e-09
serum O 0 1.959775230986338e-09
hemolytic O 0 3.348148647219773e-09
complement O 0 7.433858528749226e-10
activity O 0 1.0152007012820263e-09
, O 0 1.6909267904060762e-14
even O 0 1.6584835650537526e-14
during O 0 7.039843014089442e-11
remission O 0 5.919981660440499e-08
. O 0 3.570847506573216e-10

C5 O 0 7.045883194223279e-06
was O 0 1.8419341607511797e-09
undetectable O 0 1.7662964424403071e-09
in O 0 6.850964430092296e-14
her O 0 3.617786815566723e-14
serum O 0 2.7773489346023805e-13
by O 0 1.7070571564579951e-15
both O 0 1.5807428066158535e-12
immunodiffusion O 0 1.392584891846127e-07
and O 0 7.119050488002543e-11
hemolytic O 0 6.365875293568024e-08
assays O 0 3.3361278184429466e-08
. O 0 5.198422670105174e-08

Other O 0 1.0452557873061319e-12
complement O 0 4.318513428802628e-12
components O 0 3.869121342758852e-11
were O 0 1.7943750597795155e-13
normal O 0 1.4634450595796267e-10
during O 0 8.230049280966156e-11
remission O 0 9.44286853155063e-08
of O 0 4.1908512771193784e-10
lupus O 0 2.429261236613911e-10
, O 0 6.8446494132234914e-12
but O 0 5.4224413154058126e-11
C1 O 0 7.394082331302343e-06
, O 0 2.647561614388394e-10
C4 O 0 1.729655565441135e-07
, O 0 1.0497896822669883e-11
C2 O 0 7.567425086563162e-08
, O 0 3.807064472699517e-12
and O 0 3.103860571340711e-11
C3 O 0 2.9523266675823834e-06
levels O 0 1.2021214956803306e-07
fell O 0 4.334671999117745e-08
during O 0 7.916357702697496e-08
exacerbations O 0 0.00038552997284568846
. O 0 4.860374147597213e-08

A O 0 1.2513443437001115e-07
younger O 0 5.912328404633627e-09
half O 0 4.6288708976938153e-10
- O 0 1.4828181738035795e-10
sister O 0 7.594874035232735e-11
, O 0 3.1487799292875124e-14
who O 0 6.950971238482359e-14
had O 0 4.412112602353302e-12
no O 0 1.224311776092113e-12
underlying O 0 2.4592856107119587e-07
disease O 0 3.9520778316592953e-10
, O 0 3.4227944948012155e-15
was O 0 3.5803391501554316e-11
also O 0 1.5021280660304503e-12
found O 0 2.191198611445344e-11
to O 0 2.7212482933691717e-08
lack O 1 0.7488519549369812
immunochemically O 1 0.9970360994338989
detectable O 0 0.0002548025222495198
C5 O 0 2.756030880846083e-05
. O 0 1.4703383044434304e-07

By O 0 1.5369687467181592e-10
hemolytic O 0 6.206104785633215e-07
assay O 0 1.4250213453692595e-08
, O 0 5.8381914753991015e-12
she O 0 2.5334782557430435e-13
exhibited O 0 1.9910319866336262e-13
1 O 0 9.344371251166633e-14
- O 0 9.965888791291233e-14
2 O 0 9.781516993134873e-15
% O 0 7.621931514753544e-13
of O 0 6.601036178170011e-14
the O 0 9.433624129258356e-14
normal O 0 9.336600242937365e-11
serum O 0 1.5669262762307845e-11
C5 O 0 4.99467522896424e-10
level O 0 2.1819993034633e-10
and O 0 8.844693640680523e-14
normal O 0 7.903522281083042e-11
concentrations O 0 2.1643893274858605e-12
of O 0 4.810100343206891e-13
other O 0 3.1899829999737506e-14
complement O 0 3.0812102869148816e-11
components O 0 7.548264235879287e-09
. O 0 3.3282261391320844e-09

C5 O 0 6.668029527645558e-06
levels O 0 9.808089895813055e-10
of O 0 2.56438134615955e-11
other O 0 1.0259397904789289e-13
family O 0 8.988793596172856e-14
members O 0 1.4160513006047839e-14
were O 0 6.949489811738929e-13
either O 0 7.497015161450626e-12
normal O 0 3.737196330177994e-09
or O 0 3.212882976159903e-13
approximately O 0 4.2543735461614274e-13
half O 0 2.5883405661841774e-12
- O 0 8.990500184602457e-12
normal O 0 2.0754095664266003e-10
, O 0 1.1454657785714504e-14
consistent O 0 7.619492710386755e-12
with O 0 1.9258461267227835e-14
autosomal O 0 5.542410974612721e-10
codominant O 0 3.0250137950105227e-09
inheritance O 0 2.1267225480681162e-10
of O 0 2.1291688898084082e-11
the O 0 2.399777251915758e-11
gene O 0 5.843043271447357e-10
determining O 0 4.600025476975134e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 5.519955266208854e-07

Normal O 0 2.8805783585994504e-05
hemolytic O 0 4.611850272340234e-06
titers O 0 3.202533491730719e-07
were O 0 2.05667462227499e-11
restored O 0 1.1182058751169066e-10
to O 0 8.369520354545301e-13
both O 0 4.974970088666986e-12
homozygous O 0 4.779429900736432e-07
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 7.450199568381777e-09
C5D B-Disease 1 1.0
) O 0 6.556444298068398e-13
sera O 0 1.6705600444644197e-11
by O 0 3.49512263816726e-17
addition O 0 3.143745504262212e-14
of O 0 4.4360773734930525e-12
highly O 0 1.819121298041182e-09
purified O 0 1.2990815534408284e-08
human O 0 8.455509181715115e-09
C5 O 0 1.1929412721656263e-05
. O 0 4.574293299697274e-08

In O 0 2.4370963025432957e-09
specific O 0 6.895840010123777e-10
C5 O 0 2.7017773618354113e-07
titrations O 0 1.1209942130108175e-07
, O 0 2.1621723508835622e-13
however O 0 3.352289149397003e-13
, O 0 2.7760640872653494e-15
it O 0 2.300313579940309e-16
was O 0 2.4801395746149035e-13
noted O 0 1.675682569047751e-14
that O 0 1.6892228512837762e-16
when O 0 2.807106150716325e-15
limited O 0 4.116627828551489e-13
amounts O 0 1.2543953506125027e-12
of O 0 2.3256509565361405e-11
C5 O 0 2.718507863264108e-09
were O 0 7.223908971010218e-11
assayed O 0 2.8591733425287202e-09
in O 0 1.4165788496649928e-13
the O 0 2.6903745073761365e-13
presence O 0 4.686340833622016e-13
of O 0 1.3654388383854688e-11
low O 0 1.2589339293267443e-10
dilutions O 0 9.308106285743634e-09
of O 0 5.53348589171776e-10
either O 0 1.3706210211239522e-07
C5D B-Disease 1 1.0
serum O 0 1.368670723422838e-07
, O 0 3.496423257257769e-13
curving O 0 1.0014316632889209e-11
rather O 0 1.4032137539594924e-13
than O 0 3.566441541776651e-15
linear O 0 1.4034829722009423e-11
dose O 0 1.608500416194758e-10
- O 0 3.727011321091878e-12
response O 0 1.760174613756136e-14
plots O 0 1.5385231977305125e-10
were O 0 1.525308958999494e-12
consistently O 0 7.844402211132362e-13
obtained O 0 3.7819050733960136e-13
, O 0 4.077885541042955e-15
suggesting O 0 6.666581349457079e-13
some O 0 1.350283342711929e-14
inhibitory O 0 5.20027909622911e-11
effect O 0 1.9275102347560136e-11
. O 0 1.6259229518311713e-09

Further O 0 1.1477205991150541e-10
studies O 0 1.6199461477101051e-12
suggested O 0 2.132971262721467e-13
that O 0 1.445900699314378e-15
low O 0 1.2990547006153097e-11
dilutions O 0 4.960870825243546e-08
of O 0 3.1419027379797626e-08
C5D B-Disease 1 1.0
serum O 0 1.6378986344989244e-07
contain O 0 5.374753159897994e-12
a O 0 2.1987994107755537e-13
factor O 0 2.6620041891287083e-13
( O 0 9.10416528576458e-16
or O 0 1.258922436783716e-13
factors O 0 6.49484589373972e-13
) O 0 6.785987516268882e-15
interfering O 0 4.842704570684475e-10
at O 0 6.439627303622686e-11
some O 0 1.4149471084547432e-14
step O 0 3.396150114604035e-12
in O 0 1.5981495098647824e-13
the O 0 3.999933630843833e-12
hemolytic O 0 4.152921562194933e-09
assay O 0 1.5823440335793748e-09
of O 0 2.0662165312046454e-08
C5 O 0 1.1028676993873887e-07
, O 0 8.959165061304258e-14
rather O 0 4.30348871772665e-13
than O 0 2.8586535265676116e-14
a O 0 1.2447925719707986e-12
true O 0 1.8578956428871862e-10
C5 O 0 1.0117337723158926e-07
inhibitor O 0 1.8392194711669418e-10
or O 0 1.0869054267725886e-10
inactivator O 0 5.316926490195328e-07
. O 0 8.07513877987276e-09

Of O 0 4.049964275054663e-08
clinical O 0 2.929357378889108e-08
interest O 0 5.3127360150062586e-11
are O 0 3.2692398728483354e-14
( O 0 1.7711693978730283e-15
a O 0 4.986469069145731e-14
) O 0 6.215800405681953e-16
the O 0 1.242820543744319e-13
documentation O 0 2.123591436031802e-08
of O 0 8.030086595667285e-10
membranous O 0 2.2354985048878007e-05
glomerulonephritis B-Disease 1 1.0
, O 0 2.081093769534803e-10
vasculitis B-Disease 1 1.0
, O 0 9.788924011655542e-12
and O 0 2.101820106847896e-11
arthritis B-Disease 1 1.0
in O 0 1.3074023808012925e-10
an O 0 1.0196931596621536e-13
individual O 0 2.367674112324636e-11
lacking O 1 0.9990707039833069
C5 O 0 0.02071070857346058
( O 0 1.1129782533959853e-13
and O 0 2.1803475095272945e-14
its O 0 5.311387858393871e-15
biologic O 0 3.695793237418199e-12
functions O 0 3.16964228301575e-13
) O 0 4.707565598867066e-16
, O 0 6.100507574857618e-16
and O 0 1.0390503400782851e-15
( O 0 6.820184221583008e-17
b O 0 1.8015860545473987e-14
) O 0 5.52361699258656e-17
a O 0 1.0308823801920882e-14
remarkable O 0 1.8950299662812142e-11
propensity O 0 3.555686634015842e-09
to O 0 3.143529880844653e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 5.10373915438983e-13
the O 0 4.1278476947334553e-13
proband O 0 1.7871785162881793e-09
, O 0 2.721892942156648e-15
even O 0 1.5252077588910878e-15
during O 0 9.751294823695522e-13
periods O 0 8.80656714219441e-10
of O 0 1.756236822636481e-11
low O 0 5.5202634130502304e-11
- O 0 1.417914939107201e-12
dose O 0 3.0528005253924184e-13
or O 0 2.7095038994569276e-14
alternate O 0 1.171450159098697e-09
- O 0 2.97877278399028e-10
day O 0 2.03766017947693e-10
corticosteroid O 0 7.281325906660641e-07
therapy O 0 1.5078614978847327e-07
. O 0 1.5672588227211293e-10

Other O 0 1.991606315629446e-12
observations O 0 2.068653191453218e-12
indicate O 0 1.7231798399210824e-13
that O 0 5.3069065908817523e-17
the O 0 1.3103312380448318e-13
C5D B-Disease 1 1.0
state O 0 1.885618614375084e-12
is O 0 3.9903849200092177e-16
compatible O 0 2.676164498338629e-11
with O 0 5.781954047625682e-15
normal O 0 3.787438418445532e-11
coagulation O 0 6.5370053120572535e-12
function O 0 1.8353112432589747e-11
and O 0 7.314458148324418e-15
the O 0 7.794300957691264e-14
capacity O 0 2.6162101998683518e-12
to O 0 2.8981461328014824e-12
mount O 0 2.978325364111356e-09
a O 0 9.234890074871771e-10
neutrophilic O 0 0.010046438314020634
leukocytosis O 0 3.471904346952215e-05
during O 0 3.7718946259701625e-06
pyogenic B-Disease 0 0.0003360146365594119
infection I-Disease 0 5.057885914538929e-07
. O 0 1.1646495400030599e-11
. O 0 2.4916838037292166e-10

Susceptibility O 0 5.754841936322919e-07
to O 0 1.1757220619301734e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 3.342968923902845e-08
twins O 0 1.2591458986577209e-09
: O 0 1.8390980521110342e-16
the O 0 4.013285302771185e-15
role O 0 1.5299058948956695e-13
of O 0 8.625490946490011e-12
genes O 0 1.907278154855696e-12
, O 0 2.837425661181975e-13
HLA O 0 1.868651722247705e-08
, O 0 6.755632294894176e-13
and O 0 2.9378382322350904e-13
the O 0 3.926312747148941e-11
environment O 0 1.6130421442994702e-09
. O 0 2.570351986808106e-10

OBJECTIVE O 0 1.6306852330671973e-06
To O 0 5.5530718912066845e-12
determine O 0 6.0244348572269235e-12
the O 0 7.942195620787296e-14
relative O 0 6.390891288399203e-11
effects O 0 9.266517241035555e-12
of O 0 1.951562175750432e-12
genetic O 0 7.120676877997445e-12
and O 0 6.123149083175081e-15
environmental O 0 3.246416400677979e-14
factors O 0 2.5559979818985147e-14
in O 0 9.533302458271473e-15
susceptibility O 0 4.575115286620246e-11
to O 0 1.0104470149485678e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 5.416245230094319e-09
AS B-Disease 1 1.0
) O 0 1.0161019161486484e-12
. O 0 2.9952876984262744e-11

METHODS O 0 3.5561842537390476e-07
Twins O 0 3.0306619436260007e-09
with O 0 4.5159434527920934e-15
AS B-Disease 1 0.9999741315841675
were O 0 2.951456489147866e-14
identified O 0 5.078457609547201e-15
from O 0 4.597497373140514e-16
the O 0 2.7954116750333532e-14
Royal O 0 8.256526018435295e-11
National O 0 7.054376527371176e-10
Hospital O 0 3.184868262451346e-07
for O 0 3.1328051264267742e-09
Rheumatic B-Disease 1 0.9999992847442627
Diseases I-Disease 1 0.9657106399536133
database O 0 4.693652044807095e-08
. O 0 1.8124932665841698e-08

Clinical O 0 1.287448636588806e-08
and O 0 2.5552582510850186e-13
radiographic O 0 8.568670217812269e-09
examinations O 0 1.7759784753934582e-09
were O 0 3.510884345834381e-13
performed O 0 2.3729930238684804e-13
to O 0 1.604257498328751e-13
establish O 0 5.501228639293032e-11
diagnoses O 0 1.4496606137726076e-09
, O 0 9.64016599836956e-14
and O 0 6.417541411479766e-12
disease O 0 3.6888224030917627e-07
severity O 0 4.76007677718826e-09
was O 0 3.062401244049995e-12
assessed O 0 2.75547380051977e-12
using O 0 1.0985082879140864e-13
a O 0 7.17620272016814e-14
combination O 0 2.917305882543103e-13
of O 0 1.3467378254250484e-12
validated O 0 1.2416330463782543e-10
scoring O 0 4.2995404458956443e-10
systems O 0 1.7284314424159675e-08
. O 0 4.9599222506913065e-09

HLA O 0 1.5796555317137972e-06
typing O 0 7.782010413848184e-08
for O 0 6.702644689271509e-11
HLA O 0 6.743226066419084e-08
- O 0 4.289181454453228e-09
B27 O 0 4.844268097770055e-09
, O 0 1.2310214425517024e-14
HLA O 0 1.6755774545629265e-10
- O 0 1.0491871260676078e-11
B60 O 0 3.331099632242207e-11
, O 0 1.963549922985924e-17
and O 0 3.930601466940907e-17
HLA O 0 1.5199899672246886e-10
- O 0 4.499310091166109e-10
DR1 O 0 0.018414897844195366
was O 0 3.619058449189777e-13
performed O 0 1.0712735697983831e-14
by O 0 4.894138833006361e-17
polymerase O 0 6.241848807568215e-14
chain O 0 4.567346070712694e-15
reaction O 0 7.347421203090428e-17
with O 0 2.2459801552303145e-17
sequence O 0 6.780893121310916e-14
- O 0 2.0915752379298443e-14
specific O 0 4.577218239712943e-15
primers O 0 1.5133434869835094e-12
, O 0 1.6093924576945614e-15
and O 0 9.839713238808927e-15
zygosity O 0 3.1612208406528453e-09
was O 0 1.3066980223547242e-12
assessed O 0 1.6394831672816856e-11
using O 0 1.8144057220212395e-12
microsatellite O 0 5.279709114347497e-09
markers O 0 3.32686167503482e-09
. O 0 5.270412106739286e-09

Genetic O 0 3.1349931539637055e-09
and O 0 5.392100611498196e-14
environmental O 0 8.616071655513473e-15
variance O 0 1.881772291971711e-14
components O 0 2.9774802415283297e-12
were O 0 2.1172515170665533e-14
assessed O 0 1.4240809052823433e-12
with O 0 5.586748211029995e-16
the O 0 2.1944827953510743e-14
program O 0 1.811382803734024e-13
Mx O 0 1.105778229398835e-12
, O 0 1.1536951873892481e-17
using O 0 2.753324799582038e-16
data O 0 7.578351601854674e-14
from O 0 6.735357710033532e-16
this O 0 8.9219473229865e-16
and O 0 4.244859557748419e-16
previous O 0 4.111176243187797e-12
studies O 0 7.010196459780738e-13
of O 0 1.2542733778680981e-12
twins O 0 6.426596754760538e-11
with O 0 1.3309919572740414e-12
AS B-Disease 1 1.0
. O 0 2.840887880495302e-08

RESULTS O 0 6.518453687931469e-08
Six O 0 1.2681994121521711e-08
of O 0 4.4848644242811986e-10
8 O 0 1.8899738718491932e-10
monozygotic O 0 7.353258268949503e-08
( O 0 1.0894348791146147e-11
MZ O 0 1.4730625252923346e-06
) O 0 5.721719755977239e-13
twin O 0 2.76275474719867e-10
pairs O 0 2.2985519737561688e-11
were O 0 2.5615962129243997e-10
disease O 0 5.165011751628867e-10
concordant O 0 8.745636992379957e-10
, O 0 3.243976310515176e-15
compared O 0 9.863868619466865e-13
with O 0 4.37136255199231e-15
4 O 0 9.891507101247865e-13
of O 0 1.1153914597494818e-11
15 O 0 1.28015939862558e-11
B27 O 0 2.454084713221505e-09
- O 0 2.0021090341160175e-10
positive O 0 1.4058935222591162e-12
dizygotic O 0 3.1861113747311265e-09
( O 0 4.1784792585621705e-14
DZ O 0 4.624408411757486e-09
) O 0 7.505073595741579e-15
twin O 0 2.7491429271941925e-12
pairs O 0 1.174255191780521e-13
( O 0 3.4189431418691686e-16
27 O 0 2.7337385827275185e-12
% O 0 5.729126808379226e-12
) O 0 2.1358095907183773e-16
and O 0 3.8630597744108985e-15
4 O 0 2.1097544284504055e-13
of O 0 1.926547289754499e-11
32 O 0 1.9463525235963175e-10
DZ O 0 5.4370936197756237e-08
twin O 0 5.114668757966179e-11
pairs O 0 3.938115892415661e-12
overall O 0 9.148376278744763e-09
( O 0 2.9337768786595955e-14
12 O 0 4.139408000397582e-12
. O 0 1.400777687203189e-13
5 O 0 3.5418103996529005e-13
% O 0 8.791381793556152e-13
) O 0 9.322593695279546e-15
. O 0 1.6976767214238464e-11

Nonsignificant O 0 1.613034874026198e-05
increases O 0 1.0532272970431578e-11
in O 0 2.2720339132764784e-14
similarity O 0 7.515652596795652e-13
with O 0 1.1216735865830546e-16
regard O 0 3.706444060089936e-13
to O 0 5.1921764413973e-13
age O 0 5.599588570603942e-10
at O 0 4.4545971078502333e-11
disease O 0 9.736381145764028e-11
onset O 0 4.631102792918007e-11
and O 0 7.484003651178628e-15
all O 0 5.0214871052511184e-14
of O 0 3.859891139351701e-12
the O 0 2.83439972881272e-11
disease O 0 3.081921523540032e-11
severity O 0 2.411488706204751e-13
scores O 0 1.1878432265577388e-13
assessed O 0 1.7677227953996622e-12
were O 0 1.2589086674161254e-12
noted O 0 1.30641821687906e-13
in O 0 8.451783652281553e-13
disease O 0 1.726515180822119e-10
- O 0 3.642399576397892e-11
concordant O 0 8.980333809915919e-09
MZ O 0 7.879689292167313e-07
twins O 0 3.398434589296784e-10
compared O 0 1.2834354239099621e-11
with O 0 1.6673558963630625e-13
concordant O 0 5.248446086625336e-07
DZ O 0 2.524582487239968e-05
twins O 0 9.105486498128812e-08
. O 0 4.846393508728397e-09

HLA O 0 0.0005429291049949825
- O 0 2.3625814264960354e-06
B27 O 0 1.5320098611937283e-07
and O 0 2.3179033562317763e-13
B60 O 0 2.2976029967480827e-09
were O 0 2.562998539800982e-14
associated O 0 1.067586164328442e-13
with O 0 1.1251239223541358e-15
the O 0 6.193797102808929e-13
disease O 0 1.4686536708996556e-11
in O 0 1.2769975777770365e-13
probands O 0 1.5366924799309345e-07
, O 0 1.5904217572364383e-14
and O 0 5.320472710269647e-15
the O 0 6.566434028465462e-12
rate O 0 1.3545706223361265e-10
of O 0 3.3732129502833663e-12
disease O 0 3.310880736240307e-11
concordance O 0 6.717721517945918e-11
was O 0 1.20123843597858e-12
significantly O 0 3.4957665234758295e-11
increased O 0 4.777872888994672e-11
among O 0 4.9855232789330906e-12
DZ O 0 6.670209273806904e-08
twin O 0 6.16435097411383e-11
pairs O 0 4.076971778840116e-13
in O 0 1.4922411179993378e-13
which O 0 2.3262673576584505e-15
the O 0 5.853062175556478e-13
co O 0 8.10541824630695e-12
- O 0 2.3306776647524785e-11
twin O 0 2.7498836541184346e-11
was O 0 1.9070480600496403e-13
positive O 0 8.293648564141123e-15
for O 0 2.3382067105664735e-15
both O 0 3.548023962303415e-13
B27 O 0 6.657459028502899e-09
and O 0 1.3464918416361549e-11
DR1 O 0 7.71784907556139e-05
. O 0 4.99394392505792e-09

Additive O 0 9.446770032894847e-10
genetic O 0 1.3056373690534251e-11
effects O 0 1.7328501101480237e-13
were O 0 1.4237073773051313e-14
estimated O 0 4.427769440565289e-15
to O 0 7.94291932573743e-15
contribute O 0 3.4715190791456685e-12
97 O 0 8.324958500338653e-09
% O 0 8.39487424020291e-10
of O 0 1.4675637007716125e-12
the O 0 2.832591745795948e-13
population O 0 5.838205082136366e-15
variance O 0 1.015102390165834e-12
. O 0 2.131591708698366e-10

CONCLUSION O 0 6.058809844944335e-07
Susceptibility O 0 1.0184867171858514e-08
to O 0 1.1247948128456642e-09
AS B-Disease 1 1.0
is O 0 1.2721215140315545e-12
largely O 0 3.528373990549505e-12
genetically O 0 9.414440018849172e-15
determined O 0 1.7571616037215243e-11
, O 0 5.481623184880324e-14
and O 0 7.017176688892471e-14
the O 0 2.455523197969489e-12
environmental O 0 1.1233373172631067e-12
trigger O 0 1.4530523052141975e-12
for O 0 8.898943729259909e-14
the O 0 3.5594083236389906e-11
disease O 0 4.937530384552247e-10
is O 0 1.2127092678584223e-13
probably O 0 2.5197571806856445e-10
ubiquitous O 0 8.225631731306748e-09
. O 0 5.549364079371344e-09

HLA O 0 2.033675082202535e-05
- O 0 6.995173862378579e-08
B27 O 0 1.1582469205961843e-08
accounts O 0 4.643337038652551e-14
for O 0 4.572904830308169e-16
a O 0 1.8316634321747464e-15
minority O 0 6.62068124390909e-14
of O 0 1.6004890826277346e-13
the O 0 2.913841585551469e-13
overall O 0 1.884894323955777e-10
genetic O 0 9.443985524160148e-12
susceptibility O 0 1.50156467121354e-11
to O 0 8.902256154463828e-10
AS B-Disease 1 1.0
. O 0 4.6255971142272756e-07

Cell O 0 8.827744757411438e-09
cycle O 0 4.428762689911991e-09
- O 0 3.2086866497138544e-10
dependent O 0 9.266239164862355e-11
colocalization O 0 1.0200501066037759e-07
of O 0 1.1286931389520305e-09
BARD1 O 1 0.9999938011169434
and O 0 7.22402866693006e-12
BRCA1 O 0 3.192745373636896e-11
proteins O 0 9.198184206492266e-14
in O 0 4.768861222798418e-14
discrete O 0 3.97645354144327e-11
nuclear O 0 1.1006524580636778e-08
domains O 0 3.0182434329617536e-08
. O 0 4.720628776766489e-09

Germ O 0 1.053167216014117e-05
- O 0 1.6449334339085908e-07
line O 0 6.469694779909219e-10
mutations O 0 2.549203686683099e-12
of O 0 2.8324108683475124e-11
the O 0 1.2835976725966702e-10
BRCA1 O 0 9.178539039922384e-10
gene O 0 1.059059998444016e-13
predispose O 0 5.991949297845522e-11
women O 0 4.709217842509804e-16
to O 0 3.6472167212091896e-15
early O 0 1.6401033309243473e-10
- O 0 2.6439209932505037e-08
onset O 1 0.9999085664749146
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.2801763989156445e-11
compromising O 0 3.324148423189399e-08
the O 0 1.9662244055140832e-11
genes O 0 2.613144423069258e-11
presumptive O 0 9.866658245982762e-08
function O 0 3.747694654610001e-10
as O 0 8.257762420908754e-13
a O 0 1.5550200016534177e-11
tumor B-Disease 0 1.5373455397593716e-08
suppressor O 0 1.618071898690232e-08
. O 0 3.2791838133761075e-09

Although O 0 9.603530470858601e-11
the O 0 2.0131169300996454e-11
biochemical O 0 3.0809238493745283e-10
properties O 0 3.031914996842744e-10
of O 0 9.846196080687264e-10
BRCA1 O 0 3.2572522457030573e-10
polypeptides O 0 1.0479996037648931e-10
are O 0 2.383341708193866e-15
not O 0 2.1951597864341673e-15
understood O 0 2.8707684016429647e-13
, O 0 9.014964378438128e-17
their O 0 3.32569677871685e-15
expression O 0 8.41706261980879e-14
pattern O 0 3.3330158294778145e-13
and O 0 2.516158168389235e-15
subcellular O 0 2.7182123218949528e-09
localization O 0 4.509194440061037e-08
suggest O 0 2.3083318242966833e-11
a O 0 2.1395638895565366e-13
role O 0 3.6237434494074128e-12
in O 0 4.6096069669654405e-12
cell O 0 2.9504185761197732e-08
- O 0 6.497733906485337e-09
cycle O 0 2.8039588428896423e-08
regulation O 0 9.423518632090122e-10
. O 0 3.554233851676969e-10

When O 0 2.9671101131611977e-09
resting O 0 5.29935232407297e-06
cells O 0 1.4946005322258316e-08
are O 0 1.3065485108751385e-12
induced O 0 9.613335821834212e-11
to O 0 1.0640013176077545e-11
proliferate O 0 1.0262941607663834e-09
, O 0 4.984488621411756e-15
the O 0 3.6870539173866623e-13
steady O 0 1.7972695554036022e-09
- O 0 2.4017266040538e-12
state O 0 2.634189524494679e-13
levels O 0 1.730397942989459e-11
of O 0 4.26795664781876e-12
BRCA1 O 0 5.427961682555327e-13
increase O 0 3.723078431921295e-14
in O 0 1.739650560751867e-15
late O 0 1.5732352486724777e-12
G1 O 0 3.284620145316275e-11
and O 0 6.912968342974142e-15
reach O 0 6.352993651981276e-12
a O 0 2.1913330186334144e-14
maximum O 0 1.8805076853339875e-12
during O 0 4.301113284976843e-11
S O 0 3.1309175252403065e-09
phase O 0 1.56709294429902e-08
. O 0 1.3543421495398889e-08

Moreover O 0 1.9995923139504157e-08
, O 0 2.621673494615506e-13
in O 0 7.679102579510877e-13
S O 0 2.843401958330105e-09
phase O 0 1.8900045972713997e-08
cells O 0 9.494494079831384e-10
, O 0 4.649199861900266e-12
BRCA1 O 0 1.2049823638893287e-10
polypeptides O 0 1.7850926292695135e-10
are O 0 2.392060887475983e-13
hyperphosphorylated O 0 4.888775606559648e-09
and O 0 2.2930802764421776e-13
accumulate O 0 3.2833096050982613e-12
into O 0 3.053547215428609e-12
discrete O 0 3.409239335283587e-09
subnuclear O 0 4.626484496839112e-06
foci O 0 2.6067024805342953e-07
termed O 0 1.4977397100324197e-08
" O 0 8.221882730197194e-09
BRCA1 O 0 6.006914077261172e-08
nuclear O 0 5.0646235649765003e-08
dots O 0 6.564443566503542e-08
. O 0 1.4813411830516543e-08

" O 0 1.3985567148822042e-09
BRCA1 O 0 1.1009799294470213e-08
associates O 0 6.306515726306472e-11
in O 0 1.4137615774248435e-12
vivo O 0 1.4010015370047313e-10
with O 0 1.0886086072837108e-14
a O 0 2.8074903513086724e-12
structurally O 0 4.110994655803779e-09
related O 0 3.882300347868295e-08
protein O 0 1.1128392429782252e-07
termed O 0 8.446244947890591e-08
BARD1 O 1 0.9999669790267944
. O 0 2.966591061692725e-08

Here O 0 1.5866717939516661e-09
we O 0 1.0770007932356385e-12
show O 0 3.7053837103652454e-13
that O 0 4.659592101189195e-17
the O 0 1.835577994940482e-14
steady O 0 6.361997595405455e-10
- O 0 6.407374630867935e-13
state O 0 2.630840423983871e-13
levels O 0 1.2580890496050046e-10
of O 0 3.388685165806038e-11
BARD1 O 0 8.852246537571773e-06
, O 0 2.0813266051361882e-15
unlike O 0 3.1294631735187886e-15
those O 0 3.220966660503013e-15
of O 0 5.658145393189207e-13
BRCA1 O 0 1.725266804419867e-11
, O 0 5.38253142618318e-15
remain O 0 4.626854021444471e-12
relatively O 0 9.084301778698733e-13
constant O 0 1.3430208551171163e-12
during O 0 1.439017932591824e-10
cell O 0 2.717989389111608e-09
cycle O 0 8.061197043218726e-09
progression O 0 2.962224465719032e-09
. O 0 7.893733999786434e-10

However O 0 1.4478148679941683e-09
, O 0 1.0966289725258815e-12
immunostaining O 0 2.0394468336348837e-08
revealed O 0 2.7397392687866784e-10
that O 0 1.5219319944928533e-12
BARD1 O 1 0.9987742304801941
resides O 0 5.125080915213687e-10
within O 0 8.448246963110861e-11
BRCA1 O 0 3.469065312788899e-11
nuclear O 0 9.239959491980088e-11
dots O 0 3.0252474136904794e-11
during O 0 5.1758767410925444e-11
S O 0 1.3404503895753095e-10
phase O 0 9.727202154863335e-09
of O 0 4.723508806314669e-10
the O 0 9.964321034949819e-12
cell O 0 7.317636947778983e-12
cycle O 0 2.103336081693552e-11
, O 0 2.6361957601467334e-16
but O 0 1.2289884258354382e-16
not O 0 7.762974375873305e-16
during O 0 8.536227280586672e-12
the O 0 1.393697440441044e-12
G1 O 0 1.8526876699453965e-09
phase O 0 5.192255958519354e-09
. O 0 2.07455563838721e-09

Nevertheless O 0 6.775197789465892e-07
, O 0 9.972730280471964e-11
BARD1 O 0 0.0005724510992877185
polypeptides O 0 3.778430457401782e-09
are O 0 3.692506302349456e-14
found O 0 1.6074574532782063e-14
exclusively O 0 4.640072505911197e-13
in O 0 1.1251717161881846e-14
the O 0 5.161091687485783e-14
nuclear O 0 1.6083339521300033e-11
fractions O 0 8.718788468975447e-10
of O 0 3.297255524170595e-11
both O 0 1.95668329629195e-12
G1 O 0 3.0197622180594408e-09
- O 0 1.0039854364540801e-10
and O 0 6.793245436662043e-13
S O 0 9.416390334138214e-09
- O 0 3.065523876411014e-11
phase O 0 3.7091885118911705e-09
cells O 0 3.02454478129377e-10
. O 0 4.1419926516406136e-11

Therefore O 0 1.3577031166001063e-10
, O 0 1.0641335902727977e-14
progression O 0 3.5157647192834984e-12
to O 0 2.951424098607963e-13
S O 0 4.64049354498286e-11
phase O 0 8.875045143241778e-10
is O 0 7.42089122627871e-15
accompanied O 0 2.0930167863621174e-13
by O 0 2.689913266172621e-16
the O 0 1.1083896387514836e-13
aggregation O 0 3.0612860336953762e-12
of O 0 2.2477473441556706e-12
nuclear O 0 2.2561823520561575e-09
BARD1 O 0 3.485681736492552e-05
polypeptides O 0 9.083660934550153e-09
into O 0 1.4792764790882984e-09
BRCA1 O 0 8.449221766682058e-09
nuclear O 0 1.0043120113323312e-08
dots O 0 3.70959334361487e-08
. O 0 1.114270364865888e-08

This O 0 1.1922387556373426e-11
cell O 0 7.691717401892006e-11
cycle O 0 6.89158008437829e-10
- O 0 3.81544032479475e-11
dependent O 0 5.3356662838011104e-11
colocalization O 0 4.1324902610995196e-08
of O 0 5.154668358819947e-10
BARD1 O 1 0.9969852566719055
and O 0 1.7754337496705963e-12
BRCA1 O 0 3.774169518577786e-11
indicates O 0 9.752243500596447e-13
a O 0 7.425394053426314e-15
role O 0 2.6032209157408892e-14
for O 0 1.815415764765127e-13
BARD1 O 0 1.7211274098372087e-05
in O 0 4.49614429021139e-10
BRCA1 O 0 2.1147035056401364e-07
- O 0 2.3074152366575618e-08
mediated O 0 2.3652319214306772e-07
tumor B-Disease 0 4.178898791451502e-07
suppression O 0 2.3231989132455055e-07
. O 0 3.0492799396597547e-09

Ethnic O 0 1.5610369885621367e-08
differences O 0 9.777588738657528e-10
in O 0 5.746974077180944e-13
the O 0 5.162298106348162e-12
HFE O 0 1.0749199645943008e-06
codon O 0 1.3264683573765979e-08
282 O 0 1.0720437160216534e-07
( O 0 6.176732736395962e-11
Cys O 0 0.00012357402010820806
/ O 0 6.773531424641988e-08
Tyr O 0 2.2745773264887248e-08
) O 0 2.350693966736428e-13
polymorphism O 0 6.162970134226953e-09
. O 0 5.576842876386934e-10

Recent O 0 1.569184192307116e-11
studies O 0 6.002432708859806e-13
have O 0 1.4161066065622837e-16
shown O 0 8.404618689374088e-13
that O 0 2.0522897617447633e-11
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 1.7374075511611409e-09
HH B-Disease 1 0.9999990463256836
) O 0 1.4655851944371523e-13
is O 0 2.56216624522701e-15
likely O 0 5.664589077750831e-14
to O 0 2.3434552909318285e-13
be O 0 3.0586289252211574e-13
caused O 0 9.204577204602327e-13
by O 0 2.714640815468846e-14
homozygosity O 0 1.8290796433007017e-08
for O 0 2.6396061985484165e-13
a O 0 1.4847212001511956e-12
Cys282Tyr O 0 1.9752109281512276e-08
mutation O 0 5.853843343221754e-13
in O 0 1.0501410125599714e-13
the O 0 9.28180015485891e-12
HFE O 0 1.68076603586087e-05
gene O 0 3.9267114559926597e-10
located O 0 3.542300133774212e-11
4 O 0 1.438005547971244e-10
. O 0 1.3742033067032366e-09

5 O 0 3.5251910279754384e-09
Mb O 0 3.9507031601715425e-07
telomeric O 0 1.2012803551897377e-07
to O 0 1.2325446219207947e-09
HLA O 0 2.832866357493913e-06
- O 0 3.622776887368673e-07
A O 0 1.298519549663979e-07
. O 0 1.6750699716183703e-09

Population O 0 1.5479288857644935e-12
studies O 0 1.8769556221764905e-13
of O 0 9.856097058294488e-14
this O 0 3.046668074616933e-14
polymorphism O 0 2.8705210430857164e-10
are O 0 6.670186253917958e-15
facilitated O 0 9.076719410805456e-12
by O 0 3.22517154381142e-15
the O 0 1.1018427516955656e-13
fact O 0 2.4831106273806927e-14
that O 0 2.3027715636741227e-16
the O 0 4.1074904436923243e-13
Cys282Tyr O 0 1.5839655134186614e-06
mutation O 0 4.214120441492497e-10
creates O 0 1.14014891278158e-11
a O 0 4.272789067005789e-11
Rsal O 0 1.3476702633852256e-06
restriction O 0 7.356590336904389e-10
site O 0 6.380712069820049e-10
. O 0 4.479393245215846e-10

We O 0 1.320081405298268e-10
have O 0 6.035044697056541e-14
studied O 0 4.714536595319674e-13
the O 0 9.368981285229339e-14
codon O 0 2.5154259231108256e-10
282 O 0 9.07460417920447e-09
( O 0 1.1417555095816212e-10
Cys O 0 0.0005993629456497729
/ O 0 2.689789084797667e-07
Tyr O 0 3.805162762660075e-08
) O 0 5.0094145140604923e-14
polymorphism O 0 7.180444433485533e-11
in O 0 8.723723613878864e-15
different O 0 3.499043299570216e-14
ethnic O 0 2.316865883172925e-12
groups O 0 9.02309707528394e-14
. O 0 7.146586794570808e-11

In O 0 1.5532790982250577e-12
agreement O 0 1.4561825703585107e-11
with O 0 1.9483800830317685e-14
previous O 0 5.175642692201166e-10
observations O 0 6.015366676992429e-11
the O 0 1.3914132433040516e-12
Tyr O 0 6.602510205233614e-10
allele O 0 1.2841993961287823e-11
appeared O 0 3.4153522024404914e-12
to O 0 2.556497982059147e-12
be O 0 3.1498525576018066e-12
rare O 0 1.0745417056146067e-10
or O 0 3.4092312306555073e-10
absent O 0 6.890902000122878e-07
in O 0 6.706557531543922e-11
Asiatic O 0 1.6494535515221287e-08
( O 0 9.373302169699872e-15
Indian O 0 5.968737309958172e-11
, O 0 3.1976222207184476e-14
Chinese O 0 3.014321084404692e-11
) O 0 2.170883373238397e-13
populations O 0 6.744354423895982e-13
. O 0 4.7949633846799955e-11

The O 0 4.966032099429363e-11
highest O 0 2.063178100586427e-10
allele O 0 1.3815762769930906e-11
frequency O 0 2.0150261667573055e-11
( O 0 3.378312030180564e-16
7 O 0 5.753631620621091e-13
. O 0 1.1439461167607815e-14
5 O 0 7.615155522226053e-14
% O 0 7.808664739122895e-13
) O 0 2.1795884885972158e-16
was O 0 1.744011022836861e-13
found O 0 1.5738946875388377e-13
in O 0 1.95559020366165e-12
Swedes O 0 1.408129719493445e-07
. O 0 3.09114511765074e-08

Saamis O 1 0.7476829290390015
( O 0 1.5554159522868094e-13
2 O 0 1.635406653849314e-12
% O 0 1.1447947624587673e-11
) O 0 6.059501651089854e-16
and O 0 1.591074955164043e-13
Mordvinians O 0 7.78561025072122e-06
( O 0 1.0774327910501665e-15
1 O 0 8.30561629265288e-15
. O 0 7.88525311093012e-16
8 O 0 5.701614243128032e-15
% O 0 2.071932543883017e-14
) O 0 2.7931424287690337e-17
had O 0 4.280716897625417e-15
significantly O 0 7.797944554617173e-14
lower O 0 1.5334825423374276e-12
frequencies O 0 2.3621651509819763e-12
of O 0 3.8707062728626784e-12
the O 0 1.3522338630778119e-11
Tyr O 0 7.83913822743898e-09
allele O 0 1.062767207571369e-09
. O 0 4.901782091337736e-09

Comparisons O 0 4.29711377591957e-10
with O 0 1.8988741243460006e-13
allele O 0 1.3241028933019816e-11
frequencies O 0 2.5707868125945943e-11
based O 0 1.156398009305188e-14
on O 0 4.778879657447999e-13
prevalence O 0 3.0338787038175496e-12
estimates O 0 9.188311868085428e-14
of O 0 2.17228015089721e-12
HH B-Disease 0 0.00016855436842888594
showed O 0 3.020522498786704e-09
some O 0 5.467946516575506e-13
disagreements O 0 4.438741818546532e-09
with O 0 1.4269452454493056e-14
the O 0 1.4940361231161048e-12
RFLP O 0 2.022892608977145e-08
data O 0 2.8027047349610257e-10
, O 0 2.64730023926546e-13
particularly O 0 8.195219134386755e-13
in O 0 1.9563113282106137e-11
Finns O 0 6.574417170668312e-07
. O 0 1.7450002331997894e-08

The O 0 5.563902116811903e-10
newly O 0 1.2710442698349311e-09
described O 0 3.455830413501282e-11
HFE O 0 0.00030140584567561746
marker O 0 1.4502808731720052e-08
provides O 0 5.279345753964049e-13
a O 0 9.883952922611072e-15
new O 0 6.244772108851603e-16
approach O 0 4.6584443794865996e-14
to O 0 9.857031674448489e-15
the O 0 3.819527024306532e-14
screening O 0 9.356740209021108e-12
of O 0 1.61252382974153e-11
HH B-Disease 0 8.531524508725852e-05
as O 0 1.2845221847995747e-12
well O 0 1.7940328584688248e-13
as O 0 1.769757817466429e-15
studies O 0 1.0300455285808599e-13
of O 0 1.3769580365242257e-13
the O 0 1.4621398709835365e-13
relationship O 0 7.380953487290398e-12
between O 0 3.45617354180483e-11
the O 0 3.737406564785495e-11
HFE O 0 2.99924295177334e-07
Tyr O 0 1.9477202073403532e-09
allele O 0 1.5282750065459538e-10
and O 0 1.359175359066933e-13
different O 0 1.0339208655896215e-10
disorders O 0 0.02617819420993328
including O 0 1.3598731030128874e-09
cancer B-Disease 0 0.2522949278354645

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999115467071533
associated O 0 7.767159138083457e-10
with O 0 5.133523814371266e-14
a O 0 5.214268144863865e-13
missense O 0 1.6901659238843791e-10
mutation O 0 2.7256736364472678e-12
encoding O 0 2.269769927565335e-09
Gly23 O 0 2.2456351871369407e-05
- O 0 2.0261691133782733e-06
- O 0 3.1278040069082635e-07
> O 0 4.861838931446982e-08
Val O 0 3.5443854518035778e-09
in O 0 6.978396593221303e-12
neurophysin O 0 2.211045710964754e-07
II O 0 2.252332478747121e-06
. O 0 2.6254282303739274e-08

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 4.9101989835209636e-11
ADNDI B-Disease 1 1.0
) O 0 5.0558542812398355e-14
is O 0 5.709449721406608e-15
an O 0 5.050488564688205e-13
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 2.184028069507349e-09
by O 0 9.52351194324734e-14
progressive O 0 2.2813197574578226e-05
degeneration O 1 0.999997615814209
of O 0 1.7502529425783564e-09
the O 0 2.0719110021411025e-12
magnocellular O 0 2.5798804759169514e-10
neurons O 0 2.202075154167371e-11
of O 0 2.013834194888875e-12
the O 0 7.696141358752573e-13
hypothalamus O 0 1.52862982688573e-11
leading O 0 1.8932370862007053e-12
to O 0 2.7176067386031066e-12
decreased O 0 4.1182046661703e-10
ability O 0 1.625549000960902e-11
to O 0 7.953786067271817e-12
produce O 0 2.0567698932882905e-10
the O 0 2.5154739402566406e-10
hormone O 0 1.552654879666271e-11
arginine O 0 1.8733685713812065e-09
vasopressin O 0 1.5892037685816263e-09
( O 0 5.61995220325906e-13
AVP O 0 5.797877022928333e-08
) O 0 1.5765364274472615e-12
. O 0 4.800520536640818e-10

Affected O 0 3.6999039387808352e-09
individuals O 0 1.4963460158445852e-12
are O 0 3.014000385533587e-14
not O 0 3.2572225082058703e-13
symptomatic O 0 2.640291318911636e-09
at O 0 3.973972192983233e-12
birth O 0 6.909898347950971e-11
, O 0 4.510634080872114e-14
but O 0 1.9478610890043269e-13
usually O 0 2.9480642926849043e-10
develop O 0 9.149135621555615e-06
diabetes B-Disease 1 0.917918860912323
insipidus I-Disease 0 0.00025814518448896706
at O 0 1.7181801581500622e-07
1 O 0 6.603042113084712e-09
- O 0 7.755190978286919e-08
6 O 0 1.9555446151287015e-09
yr O 0 1.3429515774987522e-06
of O 0 4.970953093597075e-10
age O 0 1.1895211482482182e-09
. O 0 4.273369991203424e-10

The O 0 2.663789674950401e-11
genetic O 0 8.745827846656784e-12
locus O 0 3.071329301995718e-11
of O 0 2.4818739077780982e-11
the O 0 8.338967016907617e-11
disease O 0 5.778573175518886e-10
is O 0 8.220824059467988e-15
the O 0 3.693603756182995e-11
AVP O 1 0.9999897480010986
- O 1 0.9999998807907104
neurophysin O 1 1.0
II O 1 1.0
( O 0 4.3846568736904956e-11
NPII O 1 1.0
) O 0 6.218581828946676e-14
gene O 0 4.612240426279772e-14
, O 0 2.0242054560304368e-15
and O 0 1.1986394576814653e-14
mutations O 0 9.2775125689476e-13
that O 0 4.6208497538589594e-15
cause O 0 2.5701545058876007e-11
ADNDI B-Disease 0 0.002415046561509371
have O 0 1.4721832422830844e-13
been O 0 4.6519801628463336e-14
found O 0 3.4737788902041095e-15
in O 0 1.261878026963053e-15
both O 0 5.9248290240696954e-15
the O 0 1.6815352279000995e-14
signal O 0 2.716129838403747e-12
peptide O 0 6.752373183163685e-13
of O 0 4.588486535173075e-11
the O 0 1.1936727994932284e-10
prepro O 0 4.0943868953036144e-06
- O 0 2.4428045435342938e-06
AVP O 0 0.016725651919841766
- O 0 0.00021273190213833004
NPII O 1 0.9997038245201111
precursor O 0 3.548836557953905e-09
and O 0 5.997877975533195e-13
within O 0 4.282835197599866e-10
NPII O 0 0.1988500952720642
itself O 0 4.150106300282452e-11
. O 0 3.196774511771139e-10

An O 0 5.986702886900952e-12
affected O 0 3.4191538489380946e-11
girl O 0 5.841160333197593e-10
who O 0 2.8280124485138662e-14
presented O 0 2.4289437648705725e-12
at O 0 1.1819722717937298e-12
9 O 0 1.9266334946692332e-13
months O 0 1.1629124041772493e-13
of O 0 3.558854599905459e-13
age O 0 7.225640658720112e-12
and O 0 1.9313650884752315e-13
her O 0 1.633869472009164e-12
similarly O 0 3.103253602438488e-13
affected O 0 1.7177006345070467e-12
younger O 0 1.8751611374767663e-11
brother O 0 1.9660894440276522e-11
and O 0 2.1057020873054694e-13
father O 0 3.735254466841198e-11
were O 0 1.5437076963942253e-11
all O 0 2.2555323223299312e-13
found O 0 2.0574287987271817e-14
to O 0 5.357420033318995e-14
have O 0 3.3983999459202916e-15
a O 0 1.9360444034077252e-14
novel O 0 3.44252282387901e-14
missense O 0 1.196987925444759e-10
mutation O 0 7.593920745051566e-14
( O 0 1.9618513903161075e-16
G1758 O 0 3.715954280392175e-11
- O 0 2.983450986260294e-11
- O 0 1.625102656610533e-11
> O 0 2.0974018962588437e-12
T O 0 1.4264452249598825e-13
) O 0 4.299941250040529e-18
encoding O 0 1.8313475735887152e-13
the O 0 1.5099290632918094e-13
amino O 0 4.938182566853466e-13
acid O 0 2.0801133574941885e-14
substitution O 0 1.3907977417307316e-12
Gly23 O 0 8.176877486221201e-08
- O 0 3.0835369813075886e-08
- O 0 2.2172850222546003e-08
> O 0 2.2329029292222913e-08
Val O 0 1.1739984095981981e-08
within O 0 4.162318489875361e-09
NPII O 1 0.9992076754570007
. O 0 2.0757271457227944e-09

The O 0 2.687531863720949e-10
mutation O 0 2.035347931861331e-11
was O 0 3.109575585306251e-13
confirmed O 0 3.108405934450047e-14
by O 0 3.1604980371897125e-16
restriction O 0 1.6586109926903375e-13
endonuclease O 0 2.7064763624684574e-11
analysis O 0 2.4331692910495306e-11
. O 0 2.8049884637226796e-10

A O 0 2.0169816927761985e-09
T1 O 0 9.756375263236805e-09
- O 0 9.806485051083724e-13
weighted O 0 1.0511263829281713e-14
magnetic O 0 6.404548928955894e-14
resonance O 0 8.976073356814496e-12
imaging O 0 3.0024978059373097e-09
of O 0 1.1075269867877324e-10
the O 0 1.0954008533570203e-10
fathers O 0 3.771929968365839e-08
pituitary O 0 3.1187727245196584e-07
gland O 0 6.778569261456369e-09
demonstrates O 0 1.1033354091471992e-10
an O 0 2.0430860237126425e-13
attenuated O 0 8.943787044302098e-09
posterior O 0 2.0275983843021095e-05
pituitary O 0 0.0024280697107315063
bright O 0 5.043598889642453e-07
spot O 0 9.168289579974953e-06
. O 0 2.4779705398714214e-08

This O 0 2.590867242968642e-10
mutation O 0 1.3487905237141717e-10
may O 0 2.6106956765685474e-13
be O 0 7.370985739092381e-14
valuable O 0 5.72603769954938e-11
for O 0 1.588157468761838e-14
developing O 0 3.3058560229559664e-12
models O 0 1.1681044152778153e-11
of O 0 2.6743275996499172e-11
dominantly B-Disease 0 3.2783580536488444e-05
inherited I-Disease 1 0.6650636792182922
neurodegeneration I-Disease 1 1.0
, O 0 6.900983419693557e-14
as O 0 2.204893862594234e-16
the O 0 9.62296026046363e-16
early O 0 1.3405198988607897e-13
age O 0 8.904246155509721e-13
of O 0 1.3241198502239593e-12
onset O 0 3.142993989513343e-07
of O 0 2.2045579584073494e-08
symptoms O 0 1.4246537602957687e-06
suggests O 0 9.98615795090585e-13
that O 0 3.4945394559830756e-15
this O 0 4.769145690343424e-13
mutation O 0 1.81650510605591e-11
may O 0 2.3660296812055837e-12
be O 0 2.6544271988782064e-11
particularly O 0 1.8660996359276538e-10
deleterious O 0 1.847229036400222e-09
to O 0 1.771211094458991e-10
the O 0 1.0537004602184652e-09
magnocellular O 0 9.241890666089603e-07
neuron O 0 1.951361383589756e-08
. O 0 8.262213135878937e-11
. O 0 2.71043099075996e-09

Frequent O 0 2.0960013724646842e-09
inactivation O 0 1.0423589991148674e-08
of O 0 2.2390446474673809e-07
PTEN O 0 8.293302380479872e-05
/ O 0 8.128474291879684e-05
MMAC1 O 1 0.9999994039535522
in O 0 4.2840442304736825e-10
primary O 1 0.9944911003112793
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.025130119269306e-07

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 3.1613471840330476e-09
the O 0 7.475889907126998e-10
most O 0 1.8933021383310544e-12
common O 0 1.6709944539172739e-10
male B-Disease 0 4.637975781207615e-09
cancer I-Disease 0 6.91492141324801e-11
in O 0 1.9852472096792972e-11
the O 0 9.588033700325127e-10
Western O 0 5.005597270013595e-09
world O 0 1.9443904223249292e-13
, O 0 1.3175827252227585e-15
yet O 0 8.2696394152512e-15
many O 0 8.880076366821351e-17
of O 0 9.48357400097112e-15
the O 0 7.53005175032316e-15
major O 0 2.4891708093051183e-14
genetic O 0 1.4174761624879961e-13
events O 0 2.26122454467174e-15
involved O 0 3.232688368295239e-13
in O 0 1.427662106373226e-13
the O 0 4.644535082053147e-13
progression O 0 4.28479612901711e-10
of O 0 1.1432210430054046e-12
this O 0 4.067521493233972e-12
often O 0 7.70302599484296e-10
fatal O 0 0.0071951099671423435
cancer B-Disease 0 9.744379349285737e-05
remain O 0 6.130064633680377e-08
to O 0 4.521263918810803e-10
be O 0 1.271798444335559e-09
elucidated O 0 3.3623337003518827e-06
. O 0 3.909981671768037e-08

Numerous O 0 2.0803794797963349e-10
cytogenetic O 0 3.1205519235300017e-07
and O 0 3.089624259558499e-12
allelotype O 0 2.792867270784427e-08
studies O 0 2.314780745554801e-12
have O 0 1.469174517726966e-15
reported O 0 5.2991363738447844e-14
frequent O 0 1.339819504257364e-13
loss O 0 1.2062188921302397e-11
of O 0 8.306920151746056e-10
heterozygosity O 0 9.754842722031754e-06
on O 0 6.072481628649484e-09
chromosomal O 0 1.7885517081595026e-05
arm O 0 5.286725581754581e-07
10q O 0 5.297586653796316e-07
in O 0 9.805560530207202e-11
sporadic B-Disease 1 0.9999817609786987
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.171800800482742e-07

Deletion O 0 1.3829328793235618e-07
mapping O 0 1.3251306718586875e-08
studies O 0 2.6466263208790863e-11
have O 0 3.755164378776467e-14
unambiguously O 0 2.302347201776911e-11
identified O 0 2.6984493198961568e-12
a O 0 8.496685343153954e-13
region O 0 3.357560618422184e-10
of O 0 1.0085032808859751e-10
chromosome O 0 3.1449944870587387e-09
10q23 O 0 1.0711075759672894e-07
to O 0 6.2129919264908295e-12
be O 0 5.372721039766104e-13
the O 0 1.2340789197831659e-12
minimal O 0 2.161657297605757e-09
area O 0 3.617985772086385e-11
of O 0 1.601055746314195e-11
loss O 0 1.8174426408279487e-09
. O 0 1.3302130064118955e-08

A O 0 8.359823482351203e-07
new O 0 8.910269744255572e-11
tumor B-Disease 0 2.4402033727000116e-09
suppressor O 0 6.1674942930523e-10
gene O 0 5.224903409234427e-12
, O 0 3.915780460300722e-12
PTEN O 0 1.8121564835382742e-06
/ O 0 3.854639089695411e-06
MMAC1 O 1 1.0
, O 0 7.932072425102799e-13
was O 0 1.1003484581828538e-11
isolated O 0 5.824144552052379e-12
recently O 0 2.813475330259909e-14
at O 0 9.142837210246186e-15
this O 0 5.391838518328492e-16
region O 0 1.9942786571441884e-12
of O 0 7.720165110490507e-13
chromosome O 0 2.090326002568421e-11
10q23 O 0 3.4848854912894467e-09
and O 0 1.2784940478256096e-13
found O 0 8.057148833751429e-14
to O 0 1.2445783065164612e-13
be O 0 5.3294919170920104e-15
inactivated O 0 1.0237617130177002e-14
by O 0 8.474462066883318e-17
mutation O 0 3.4479195757178283e-13
in O 0 4.710797724127858e-13
three O 0 1.0715419662687964e-09
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 9.0937710695016e-08
lines O 0 4.551321819423748e-10
. O 0 5.77300984794249e-10

We O 0 1.9798709893770194e-10
screened O 0 2.865757631198562e-09
80 O 0 6.287605547328212e-09
prostate B-Disease 0 0.0005860066739842296
tumors I-Disease 1 1.0
by O 0 2.9075002225698726e-14
microsatellite O 0 5.065024510919613e-10
analysis O 0 1.8841888119180972e-11
and O 0 5.692902339858932e-14
found O 0 3.3862070591104965e-13
chromosome O 0 2.8870855359186542e-11
10q23 O 0 6.190444157283537e-09
to O 0 1.3530490963753472e-11
be O 0 1.2282651458417337e-11
deleted O 0 8.917789284801358e-10
in O 0 1.649708256286353e-12
23 O 0 3.220200772702242e-10
cases O 0 1.2010442987375747e-11
. O 0 1.4284875504699812e-09

We O 0 1.4936380257624116e-11
then O 0 1.3509813825637613e-14
proceeded O 0 5.647934377128738e-13
with O 0 7.64211229928487e-19
sequence O 0 8.867522279751858e-16
analysis O 0 7.192437123041805e-15
of O 0 2.6452698335282555e-14
the O 0 1.9907281389747872e-13
entire O 0 5.218078857893715e-09
PTEN O 0 2.4379119167861063e-07
/ O 0 2.594667947164453e-08
MMAC1 O 0 0.0007744321483187377
coding O 0 3.017248104697501e-07
region O 0 6.031638521974969e-10
and O 0 3.893803258747967e-15
tested O 0 2.273361484955369e-13
for O 0 1.4115507604461376e-14
homozygous O 0 5.8539024322401545e-12
deletion O 0 5.837868383151701e-12
with O 0 1.6838718529883952e-14
new O 0 7.118092465278891e-13
intragenic O 0 1.4938224879301742e-08
markers O 0 6.493031112775327e-11
in O 0 2.54997086814035e-13
these O 0 4.021509484469256e-14
23 O 0 3.798461978982148e-12
cases O 0 6.33455893533745e-14
with O 0 5.738033610541357e-14
10q23 O 0 8.914293658790484e-08
loss O 0 2.6037834111036773e-09
of O 0 3.408447923902713e-08
heterozygosity O 0 7.696863758610561e-05
. O 0 1.0305943760613445e-06

The O 0 5.05482483127706e-13
identification O 0 1.9857329669470403e-10
of O 0 2.9088358458051466e-11
the O 0 2.472668337444306e-12
second O 0 5.4020430489964966e-11
mutational O 0 9.117887556087112e-10
event O 0 6.826513746643892e-12
in O 0 1.5929705471373623e-12
10 O 0 7.225788977577308e-13
( O 0 2.6119631004378535e-15
43 O 0 1.243162128794495e-09
% O 0 1.2374967717221352e-08
) O 0 7.343884528276945e-11
tumors B-Disease 1 1.0
establishes O 0 1.4826463390349431e-09
PTEN O 0 2.9073879659335944e-07
/ O 0 8.189252866941388e-07
MMAC1 O 1 0.9999808073043823
as O 0 5.033793477535187e-13
a O 0 4.853337512693984e-14
main O 0 1.1057838943551862e-13
inactivation O 0 5.431648512042864e-13
target O 0 1.295604682566287e-12
of O 0 1.2710186202136153e-11
10q O 0 2.567904466843629e-08
loss O 0 2.8295721321569545e-10
in O 0 5.131377614486787e-11
sporadic B-Disease 1 0.9996969699859619
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.0671803985526935e-10
. O 0 2.431737033958825e-10

Risk O 0 5.727772744990034e-08
reversals O 0 1.4119608815477136e-09
in O 0 6.324155608916637e-13
predictive O 0 1.2254444126114095e-09
testing O 0 1.0648703273330451e-11
for O 0 2.544551375160964e-11
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 3.2520395265578372e-09

The O 0 4.884589911366422e-13
first O 0 6.724630567152149e-15
predictive O 0 6.225815436106119e-12
testing O 0 2.9279142586997875e-13
for O 0 9.331645699217628e-12
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.6115920506948906e-16
HD B-Disease 0 2.579458646678745e-09
) O 0 2.899892998494758e-16
was O 0 5.0719333382709744e-15
based O 0 3.216898784773824e-17
on O 0 4.815033327566429e-15
analysis O 0 1.0884057598335023e-13
of O 0 6.74786425737886e-14
linked O 0 2.1660865375666694e-12
polymorphic O 0 9.346002270704812e-12
DNA O 0 6.816736064507722e-10
markers O 0 4.89573876230609e-12
to O 0 5.858344950641914e-13
estimate O 0 3.127504765582101e-12
the O 0 1.087432552858425e-13
likelihood O 0 1.765254088736956e-11
of O 0 2.2346976699672005e-11
inheriting O 0 2.3018062123014715e-08
the O 0 2.8000599061606124e-10
mutation O 0 1.5527556671002252e-11
for O 0 8.342526322535626e-12
HD B-Disease 0 4.5489064177672844e-06
. O 0 1.8899468656741192e-08

Limits O 0 4.467036809896463e-11
to O 0 4.081484499332544e-13
accuracy O 0 1.974915231350849e-10
included O 0 1.0495643525294807e-13
recombination O 0 6.97905871548804e-13
between O 0 9.155201553465164e-13
the O 0 1.8081863046789937e-13
DNA O 0 7.579465943763353e-10
markers O 0 5.690576482253462e-11
and O 0 2.3311598961947566e-13
the O 0 1.2860427132943553e-11
mutation O 0 4.701706905752001e-12
, O 0 9.227142568892996e-14
pedigree O 0 1.953739253712783e-10
structure O 0 9.27706175768428e-11
, O 0 1.7370453626918206e-14
and O 0 1.2003685060366955e-15
whether O 0 1.598476955861532e-15
DNA O 0 7.611420521635992e-11
samples O 0 7.714894803730055e-13
were O 0 9.304515301679708e-14
available O 0 5.31234561548799e-13
from O 0 2.5478219794344836e-13
family O 0 1.4032065440150454e-12
members O 0 3.4057895392791693e-12
. O 0 2.5630342292970454e-09

With O 0 3.1794152813985344e-13
direct O 0 6.298074041455326e-12
tests O 0 1.8123236201691983e-12
for O 0 1.5460867991683863e-13
the O 0 2.8707919288301076e-12
HD B-Disease 0 1.7532315155222022e-07
mutation O 0 3.141824257354986e-12
, O 0 4.339313789883522e-15
we O 0 8.41644885973521e-15
have O 0 1.5699107167758215e-16
assessed O 0 4.2536331038402556e-14
the O 0 2.0528139938239508e-15
accuracy O 0 2.961283648850177e-11
of O 0 1.4720567972047183e-13
results O 0 7.660516000024004e-15
obtained O 0 1.7039588327567162e-13
by O 0 8.377018629007575e-15
linkage O 0 9.322328325955809e-11
approaches O 0 7.963288882473218e-12
when O 0 2.351634512121059e-14
requested O 0 1.976578839837928e-12
to O 0 6.612371240832804e-12
do O 0 1.9669736759514445e-12
so O 0 2.2719343022018813e-14
by O 0 2.9310905983706732e-15
the O 0 3.5277596815985746e-13
test O 0 8.571860235506712e-12
individuals O 0 9.33631037064453e-12
. O 0 1.3859855485520711e-09

For O 0 4.148595009190181e-11
six O 0 5.07751609854501e-12
such O 0 6.189300450531511e-16
individuals O 0 9.617571225094962e-15
, O 0 2.7504394347867755e-15
there O 0 5.072416994083857e-15
was O 0 5.001436005798443e-13
significant O 0 5.617144661733409e-13
disparity O 0 4.474403833554241e-11
between O 0 6.325377721605463e-12
the O 0 7.618591521540985e-12
tests O 0 1.235773705587917e-10
. O 0 1.49026735396518e-09

Three O 0 1.5402526476471223e-10
went O 0 1.6743953445974569e-10
from O 0 6.761807368367567e-13
a O 0 2.7173270144426054e-12
decreased O 0 1.8756602937486377e-09
risk O 0 2.0596413029955185e-12
to O 0 5.932821942056243e-12
an O 0 1.0767188735657379e-13
increased O 0 7.36556822478196e-12
risk O 0 1.3267135870811964e-12
, O 0 2.5074006947475727e-15
while O 0 8.393396011042737e-15
in O 0 5.384626562178214e-15
another O 0 3.5433759875899695e-14
three O 0 1.2070116499167394e-13
the O 0 1.2930470496413937e-12
risk O 0 9.665656296176106e-12
was O 0 2.9467359108359403e-11
decreased O 0 1.9388847860568603e-08
. O 0 1.6966459348566332e-09

Knowledge O 0 1.792373723219498e-06
of O 0 1.0021893315226293e-09
the O 0 3.95363472863175e-12
potential O 0 1.2741880033723119e-12
reasons O 0 4.3654343378010663e-13
for O 0 4.653060299260672e-15
these O 0 4.842110006274833e-15
changes O 0 6.610961286729463e-15
in O 0 1.9349986988826924e-15
results O 0 4.69661310710523e-13
and O 0 7.549152004470566e-14
impact O 0 1.7587635991675454e-12
of O 0 9.883322459047772e-13
these O 0 6.980319236038826e-14
risk O 0 1.1984503829869791e-13
reversals O 0 8.75704456865245e-12
on O 0 8.39378859387313e-13
both O 0 2.2488739657381546e-13
patients O 0 3.282570612897495e-12
and O 0 6.376887966920474e-15
the O 0 7.705145115693979e-13
counseling O 0 1.9787336699716995e-11
team O 0 5.220205778061482e-14
can O 0 2.6099226404195652e-14
assist O 0 6.940820834744343e-11
in O 0 1.884380916280029e-13
the O 0 5.219761255170763e-13
development O 0 8.705423187871375e-11
of O 0 4.504437729931088e-13
strategies O 0 6.749041863568506e-12
for O 0 1.5981485611878815e-14
the O 0 3.6625989242346224e-13
prevention O 0 2.957863121100246e-11
and O 0 2.536086312539287e-15
, O 0 3.203686923681229e-16
where O 0 1.5501129627600876e-15
necessary O 0 1.1963070291332034e-11
, O 0 2.8526388303124536e-15
management O 0 1.8817599388432082e-12
of O 0 7.800730547624646e-13
a O 0 2.765757458125795e-12
risk O 0 3.599619300548307e-12
reversal O 0 1.2641089564002783e-11
in O 0 6.980852527982417e-14
any O 0 4.955921198597502e-13
predictive O 0 3.1557129132053774e-10
testing O 0 3.1803086639886624e-12
program O 0 6.212636741859123e-12
. O 0 4.873971777390185e-13
. O 0 6.658505691259364e-11

A O 0 2.0943629053249424e-09
novel O 0 3.2248425392740476e-13
common O 0 4.284456903841383e-12
missense O 0 2.340373450593347e-09
mutation O 0 4.5983841734376085e-12
G301C O 0 3.5398572961753416e-10
in O 0 6.013338969563381e-14
the O 0 6.374972706842119e-13
N O 0 1.3987853930697014e-10
- O 0 4.959153643291359e-10
acetylgalactosamine O 0 3.4729746403172612e-06
- O 0 1.1503670904744467e-08
6 O 0 5.060360463993163e-10
- O 0 2.0826265711981762e-10
sulfate O 0 1.5619698243152236e-11
sulfatase O 0 1.5016776711007651e-09
gene O 0 4.356833361966739e-13
in O 0 1.3778493320251717e-12
mucopolysaccharidosis B-Disease 0 6.747329166501004e-07
IVA I-Disease 1 0.9986804127693176
. O 0 3.0853732368996134e-07

Mucopolysaccharidosis B-Disease 0 0.00046155788004398346
IVA I-Disease 1 0.9999880790710449
( O 0 3.099781320514694e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 5.093103456338399e-12
is O 0 3.388843025642352e-13
an O 0 2.0609234804847e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 3.553177974069399e-09
by O 0 8.132307761227198e-14
a O 0 6.333596758167914e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.768066331704233e-10
N O 0 2.5761939248525323e-09
- O 0 9.355428653989861e-10
acetylgalactosamine O 0 2.0071522612852277e-06
- O 0 7.274659985512244e-09
6 O 0 4.962815713938085e-10
- O 0 1.111480685267452e-09
sulfate O 0 1.7899501325580047e-11
sulfatase O 0 1.960134055067897e-09
( O 0 1.2362544968031342e-14
GALNS O 0 2.096022910791362e-07
) O 0 1.0087248961468398e-13
. O 0 2.276001609402556e-11

In O 0 1.7924416118031417e-10
previous O 0 1.5647504403304424e-09
studies O 0 8.065337460394506e-12
, O 0 6.0758228113131415e-15
we O 0 1.2123615608335744e-14
have O 0 4.863157504464682e-15
found O 0 2.038305166470432e-14
two O 0 1.0649051525844517e-14
common O 0 3.2085963118204386e-13
mutations O 0 2.0721154013556703e-13
in O 0 2.3327566549442846e-13
Caucasians O 0 2.6781471484937924e-10
and O 0 2.5434716182173855e-13
Japanese O 0 8.196282763606177e-09
, O 0 5.840794427974805e-13
respectively O 0 6.519371709146071e-09
. O 0 1.2108841040969764e-08

To O 0 1.2064876209194608e-08
characterize O 0 4.2383601339679444e-07
the O 0 3.204918830324033e-10
mutational O 0 1.3240877194675704e-07
spectrum O 0 1.0208233564013014e-10
in O 0 1.6638097082260876e-14
various O 0 3.682589240603003e-14
ethnic O 0 9.865581658899392e-13
groups O 0 8.427115545639983e-15
, O 0 4.736930537082478e-15
mutations O 0 1.1436785221120849e-13
in O 0 1.6978887913687846e-13
the O 0 1.1085196996440949e-11
GALNS O 0 2.3842811060603708e-05
gene O 0 2.341834625524397e-12
in O 0 1.0162845391625819e-11
Colombian O 0 7.592518613819266e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 4.227214844831906e-08
were O 0 1.7850202219116262e-11
investigated O 0 5.215484294440742e-12
, O 0 3.2287538579035954e-15
and O 0 4.242093042263568e-15
genetic O 0 1.0736966871149889e-12
backgrounds O 0 1.5855447163537484e-11
were O 0 2.569823423070189e-13
extensively O 0 6.156272865619206e-13
analyzed O 0 3.8877294395930906e-13
to O 0 7.006717526059775e-14
identify O 0 1.571241075616625e-12
racial O 0 1.960934127749614e-13
origin O 0 4.95562846401093e-13
, O 0 5.717725842106214e-17
based O 0 2.1419931297566807e-17
on O 0 1.0150509955947264e-14
mitochondrial O 0 4.832022369033462e-13
DNA O 0 1.4080686616679827e-10
( O 0 4.930358896214175e-14
mtDNA O 0 6.78941833309743e-11
) O 0 7.410276277146355e-13
lineages O 0 1.6952153569782524e-10
. O 0 1.065598720373373e-09

Three O 0 2.141085919671326e-10
novel O 0 8.634577428057177e-12
missense O 0 5.5620507311004985e-08
mutations O 0 2.013459815541907e-10
never O 0 7.305033661308968e-11
identified O 0 7.473448249140091e-11
previously O 0 1.4864248720769524e-11
in O 0 1.1529979174109556e-13
other O 0 5.690361918643527e-14
populations O 0 1.7573199433172995e-14
and O 0 9.617455605097662e-16
found O 0 3.7412520320244044e-14
in O 0 3.7091081481156404e-14
16 O 0 1.4259597842791738e-11
out O 0 7.717985322022725e-13
of O 0 2.523921523167605e-11
19 O 0 3.886171384692716e-10
Colombian O 0 5.797683115815744e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 6.801466501116238e-09
alleles O 0 4.740553435911288e-12
account O 0 5.993818180498323e-13
for O 0 5.793296615000387e-13
84 O 0 1.10611368953073e-08
. O 0 1.493571843980135e-08

2 O 0 1.2105294544539902e-10
% O 0 5.03700858800471e-10
of O 0 3.3476455114922476e-12
the O 0 5.452897248320321e-13
alleles O 0 1.474689917705871e-13
in O 0 4.91517633885441e-14
this O 0 2.1993069529175485e-13
study O 0 3.036802363395874e-12
. O 0 1.7486836978442e-10

The O 0 2.6761468596703253e-09
G301C O 0 3.9087970549189777e-07
and O 0 1.0383307711900325e-12
S162F O 0 6.774213634486159e-09
mutations O 0 1.4803807051738671e-12
account O 0 1.6231804854209553e-13
for O 0 6.356081026087645e-13
68 O 0 1.6381672196530417e-07
. O 0 7.75007436004671e-08

4 O 0 6.775968119931974e-10
% O 0 8.880937651944976e-10
and O 0 3.1660232161639934e-13
10 O 0 2.363888251810664e-11
. O 0 3.406449289311553e-10

5 O 0 3.033002182739608e-10
% O 0 2.4006022170119934e-10
of O 0 3.675771926420213e-12
mutations O 0 1.8155195771231425e-13
, O 0 7.492172436921948e-15
respectively O 0 2.6220314114366872e-11
, O 0 4.514927013255388e-15
whereas O 0 1.2094019362363095e-12
the O 0 1.0665730451608901e-12
remaining O 0 4.216325510952856e-09
F69V O 1 0.990721583366394
is O 0 1.9315198583353538e-13
limited O 0 7.293512582079442e-13
to O 0 8.911552051849014e-13
a O 0 1.4997433633520685e-12
single O 0 8.154982938934907e-11
allele O 0 1.2957350747910823e-09
. O 0 2.7365076871177507e-09

The O 0 3.2141994621426306e-10
skewed O 0 3.593094488607562e-09
prevalence O 0 4.56614718258308e-10
of O 0 3.310525464872427e-12
G301C O 0 1.78048253918206e-09
in O 0 1.9111726361643183e-14
only O 0 1.1965426276205372e-14
Colombian O 0 3.889433775050577e-10
patients O 0 2.5332667821093002e-12
and O 0 9.520001499900739e-15
haplotype O 0 1.2529271240305229e-12
analysis O 0 2.6297303364845176e-14
by O 0 3.0824251575567116e-16
restriction O 0 4.3648993517915805e-14
fragment O 0 2.897902620993542e-12
length O 0 6.387463474810673e-12
polymorphisms O 0 7.500251808512104e-11
in O 0 1.0764196608711862e-12
the O 0 9.044235499411357e-11
GALNS O 0 0.007740257773548365
gene O 0 3.0090763214474237e-11
suggest O 0 2.8692659359563777e-11
that O 0 2.853962658105717e-14
G301C O 0 1.2420156458858855e-08
originated O 0 3.0150625052183244e-11
from O 0 7.380668884220121e-13
a O 0 1.5002869823213527e-12
common O 0 3.0427989988757176e-11
ancestor O 0 8.65858584830903e-09
. O 0 7.917275723912098e-09

Investigation O 0 2.3264341564299684e-09
of O 0 1.9323775912738483e-10
the O 0 5.410980691289424e-12
genetic O 0 2.050547448853579e-12
background O 0 1.6769174753222121e-13
by O 0 1.7443343882523872e-16
means O 0 1.3191795746048118e-11
of O 0 1.0349508056117784e-10
mtDNA O 0 7.0708550126141745e-09
lineages O 0 5.792849533392541e-11
indicate O 0 9.771855200013668e-12
that O 0 5.416951457027806e-15
all O 0 2.341118835250122e-13
our O 0 3.291514283354502e-10
patients O 0 2.314780745554801e-12
are O 0 2.768502835903447e-15
probably O 0 3.5729557333608053e-12
of O 0 4.52654884061654e-12
native O 0 7.957108930090051e-12
American O 0 4.224066929570114e-10
descent O 0 3.846963954856619e-05

Low O 0 4.4463761561530646e-09
frequency O 0 4.579183560116107e-11
of O 0 7.690836856255601e-11
BRCA1 O 0 1.659502812945135e-10
germline O 0 4.139990572582519e-09
mutations O 0 1.0926933186397592e-12
in O 0 3.755307696751142e-14
45 O 0 1.0006454692623734e-10
German O 1 0.9995297193527222
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.1954947726499086e-07
. O 0 1.3619555261357164e-08

In O 0 4.691977709136985e-12
this O 0 3.182386469689595e-14
study O 0 4.4313684835581724e-15
we O 0 3.141290506319537e-16
investigated O 0 9.212998643333154e-15
45 O 0 1.1622855455861725e-12
German O 0 2.519515646781656e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 9.384990562466555e-10
for O 0 9.392573524502623e-12
germline O 0 1.3794140052425519e-08
mutations O 0 7.060238244732675e-12
in O 0 1.1864444973350152e-12
the O 0 2.9517534250178556e-11
BRCA1 O 0 2.05866546032496e-10
gene O 0 8.194566553099136e-12
. O 0 7.95849830481643e-10

We O 0 2.1792792570529684e-10
identified O 0 7.131377433022834e-11
four O 0 3.345156183304221e-12
germline O 0 6.463891821795187e-08
mutations O 0 6.087226556150682e-11
in O 0 7.909455967784751e-13
three O 0 1.292865814406241e-10
breast B-Disease 0 4.475332460174286e-08
cancer I-Disease 0 8.57441950774529e-10
families O 0 2.1256224211341213e-11
and O 0 4.4425270753767343e-13
in O 0 5.976988348699308e-10
one O 1 0.9999747276306152
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 9.85549995675683e-05
. O 0 3.634611275143973e-12
among O 0 1.1066836974550544e-15
these O 0 1.5386300547315162e-16
were O 0 9.844518456718701e-15
one O 0 2.6601605033343967e-14
frameshift O 0 2.1164602015399936e-10
mutation O 0 1.2064321980656545e-12
, O 0 9.526691366118153e-14
one O 0 2.9587304828382344e-12
nonsense O 0 1.3079224814305235e-08
mutation O 0 3.934948894501744e-11
, O 0 8.073547391610272e-14
one O 0 7.727290487168081e-14
novel O 0 5.367302739409108e-13
splice O 0 7.700121429365936e-09
site O 0 5.651905679582292e-11
mutation O 0 1.2298616118566752e-11
, O 0 4.373433039328578e-14
and O 0 3.208351282129457e-13
one O 0 2.0308379977684865e-11
missense O 0 8.712518706488481e-07
mutation O 0 1.382632941471229e-08
. O 0 1.0482605894424069e-08

The O 0 8.094009906756128e-10
missense O 0 1.0215941159685826e-07
mutation O 0 4.139363157795728e-11
was O 0 2.000603849250382e-11
also O 0 6.722710089350839e-14
found O 0 4.121915482546701e-13
in O 0 6.162804641607345e-13
2 O 0 3.1005781275794675e-10
. O 0 4.744649118038069e-09

8 O 0 5.385133450275248e-10
% O 0 1.1940833877233104e-09
of O 0 5.0824574583663296e-12
the O 0 9.920208101157901e-13
general O 0 1.9935446522734157e-12
population O 0 5.435956928188414e-14
, O 0 5.382036229546392e-16
suggesting O 0 1.3128128412923795e-13
that O 0 9.680618851974415e-16
it O 0 1.2256042645133612e-15
is O 0 1.8684144129869212e-14
not O 0 1.3822589774170613e-11
disease O 0 4.231520023267876e-09
associated O 0 1.9587700350598425e-09
. O 0 3.5816967169921554e-08

The O 0 8.727497891047875e-12
average O 0 8.942204615669525e-12
age O 0 7.38975720893098e-12
of O 0 7.103516993373082e-12
disease O 0 5.900327448848941e-10
onset O 0 3.799849879193573e-10
in O 0 4.383373004845925e-13
those O 0 1.5545327611971027e-12
families O 0 2.1899286203885815e-11
harbouring O 0 1.6423408055743494e-07
causative O 0 2.58828514176912e-09
mutations O 0 1.1585329223740004e-10
was O 0 1.6111740414048725e-11
between O 0 1.0424792973307007e-10
32 O 0 1.3948437960209503e-08
. O 0 5.113113044075135e-09

3 O 0 1.0186260723799023e-09
and O 0 1.7984199199294615e-11
37 O 0 1.8476423946367504e-08
. O 0 5.0032777920705485e-09

4 O 0 2.999897552591335e-10
years O 0 9.213364446369887e-12
, O 0 3.5303678908607484e-15
whereas O 0 4.923529574492325e-13
the O 0 1.8377543952764752e-13
family O 0 7.737972589072495e-13
harbouring O 0 1.1010991007864845e-09
the O 0 2.587536088172193e-12
missense O 0 5.32190735924587e-10
mutation O 0 1.2690485598140788e-12
had O 0 1.858352678013077e-14
an O 0 7.397198947120399e-17
average O 0 6.421636632820624e-14
age O 0 6.095561880768707e-13
of O 0 1.660872177636219e-12
onset O 0 8.12697520391481e-10
of O 0 2.2545474376300945e-09
51 O 0 7.6798983172921e-08
. O 0 9.449805560279856e-08

2 O 0 2.1412340789339623e-09
years O 0 3.5004388276860254e-10
. O 0 1.906379054616991e-09

These O 0 2.6991082979765935e-12
findings O 0 5.589378786197141e-13
show O 0 3.332901175098074e-13
that O 0 1.7589731822237505e-14
BRCA1 O 0 6.849201206193811e-10
is O 0 6.299064866715706e-14
implicated O 0 4.945256704136369e-11
in O 0 1.0739382473590187e-12
a O 0 3.6254910206791335e-13
small O 0 1.6913782589669628e-14
fraction O 0 1.3446696880969888e-11
of O 0 3.727218000904031e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.0754275782161073e-11
suggesting O 0 1.3029144820334015e-13
the O 0 9.667701599528787e-16
involvement O 0 1.9092061644739727e-13
of O 0 7.013861605224825e-13
another O 0 9.392652806786486e-14
susceptibility O 0 3.4251377775684766e-12
gene O 0 4.754223815843506e-13
( O 0 2.133280395865897e-13
s O 0 1.299269136723069e-09
) O 0 3.929386260814738e-10

Paternal O 0 9.815873636398464e-05
transmission O 1 0.9999983310699463
of O 0 1.2680247891694307e-06
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.000833141733892262

We O 0 1.2465140031281408e-10
report O 0 5.651210293992903e-13
a O 0 1.2940622084642826e-14
rare O 0 9.292769665206722e-15
case O 0 7.983260116883363e-15
of O 0 2.8879888064325954e-11
paternally O 1 0.9999991655349731
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.311943690993303e-09
DM B-Disease 1 1.0
) O 0 1.0475714913582568e-11
. O 0 1.495403106899218e-10

The O 0 3.270732351623451e-09
proband O 0 4.450028882274637e-06
is O 0 6.839409545439032e-14
a O 0 2.1371361237231164e-14
23 O 0 2.255213973467035e-13
year O 0 5.016846855478152e-13
old O 0 9.15410236501657e-09
, O 0 1.9202033626347648e-12
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 9.752504411153495e-05
who O 0 1.9361923175864604e-10
suffers O 1 0.9999305009841919
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999847412109375

He O 0 1.84200259212286e-11
presented O 0 3.843561580119115e-11
with O 0 3.2350710651996017e-12
respiratory O 0 0.03730107471346855
and O 0 6.035544893728817e-12
feeding O 0 1.6295895743922983e-09
difficulties O 0 1.0516593818010733e-07
at O 0 4.655364982397714e-09
birth O 0 3.7363147953328735e-07
. O 0 1.7170073363104166e-07

His O 0 1.3826091382895811e-08
two O 0 3.113063695714402e-10
sibs O 0 9.363520075567067e-05
suffer O 0 1.1304199887263167e-07
from O 0 1.9563095587926682e-09
childhood O 1 0.9983637928962708
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 3.532702066877391e-06

Their O 0 1.9552779534359743e-11
late O 0 1.3833015288788886e-10
father O 0 1.6976703029469853e-11
had O 0 1.178082425449395e-13
the O 0 3.916057778887653e-15
adult O 0 2.4129276796568642e-14
type O 0 2.5505837134183473e-13
of O 0 2.465784000593718e-11
DM B-Disease 1 1.0
, O 0 1.4925180232341906e-12
with O 0 6.407346848187265e-14
onset O 0 2.47297506916766e-08
around O 0 2.8296124124360666e-12
30 O 0 4.824169275857715e-12
years O 0 4.616390603118248e-12
. O 0 2.8659749573556326e-10

Only O 0 4.934569246273224e-12
six O 0 1.3168153091373813e-13
other O 0 1.9283500791993423e-17
cases O 0 8.182020633121321e-17
of O 0 8.63674163111873e-14
paternal O 0 8.351346991730679e-08
transmission O 1 1.0
of O 0 2.9193342925282195e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 2.4577384571955463e-09
been O 0 3.7396578889126175e-12
reported O 0 8.427283935789898e-13
recently O 0 1.9861703427770383e-12
. O 0 6.460147694564711e-11

We O 0 6.906389522776113e-12
review O 0 1.1961689505655265e-13
the O 0 5.894778412683481e-15
sex O 0 8.239881453748262e-15
related O 0 5.900765580367853e-14
effects O 0 1.157998799931545e-13
on O 0 3.026375265842429e-13
transmission O 0 1.4046668184164446e-06
of O 0 9.22571796735383e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.9363662179093808e-05

Decreased O 0 5.9608025182456e-09
fertility O 0 2.9118946837103366e-11
of O 0 4.2389574109961276e-14
males O 0 2.622467367774991e-14
with O 0 1.3846374796872143e-17
adult O 0 1.1482400317022745e-13
onset O 0 9.984434806709075e-11
DM B-Disease 1 1.0
and O 0 1.0664261357665183e-13
contraction O 0 1.4417700540392264e-11
of O 0 2.2520902243777785e-12
the O 0 5.188857427496779e-14
repeat O 0 1.1324732248968114e-13
upon O 0 5.294482300494119e-13
male O 0 2.9054020474206244e-12
transmission O 0 2.280937374740666e-12
contribute O 0 3.626547169120406e-14
to O 0 3.6531084282804063e-14
the O 0 1.1725542140971629e-13
almost O 0 7.756531961861102e-13
absent O 0 4.362966585236272e-11
occurrence O 0 1.2427151321880991e-11
of O 0 7.699444922772136e-13
paternal O 0 4.820239762892697e-09
transmission O 0 1.503417365711357e-06
of O 0 4.5590917707727385e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.451130512781674e-06

Also O 0 9.50646245750919e-12
the O 0 8.216160499348313e-13
fathers O 0 9.272745765676049e-11
of O 0 3.4074464170391616e-12
the O 0 1.7470683103329443e-12
reported O 0 1.123745107384222e-11
congenitally O 0 1.7465828250351478e-07
affected O 0 1.3016514949226732e-11
children O 0 1.9903750956423716e-13
showed O 0 7.2380686513828785e-12
, O 0 1.2402688400500565e-15
on O 0 7.938656242795217e-13
average O 0 3.724348607292427e-11
, O 0 1.0688697241753933e-13
shorter O 0 1.6477956776839164e-09
CTG O 0 7.377703070687858e-08
repeat O 0 9.266486189485335e-11
lengths O 0 3.1076072826152767e-09
and O 0 2.47676391115087e-13
hence O 0 3.752163163506239e-11
less O 0 5.123727397221556e-12
severe O 0 1.1702748492492532e-10
clinical O 0 8.517268140773027e-11
symptoms O 0 4.602209672383006e-12
than O 0 1.6051059945254218e-16
the O 0 6.500924507101078e-15
mothers O 0 6.307829286027536e-14
of O 0 1.1270194169186662e-13
children O 0 8.591858778259076e-13
with O 0 8.84755810282023e-11
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 4.035264646518044e-05

We O 0 3.246257158483895e-13
conclude O 0 9.633508574191652e-11
that O 0 8.262350061465367e-16
paternal O 0 1.9958637520467448e-10
transmission O 0 1.2046501751683536e-06
of O 0 4.58927618129934e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 1.019971440641143e-09
rare O 0 2.8821983862059586e-12
and O 0 3.9226214371959264e-15
preferentially O 0 4.1262181388682095e-13
occurs O 0 5.849600046969189e-14
with O 0 7.920007534500454e-17
onset O 0 3.288608829699058e-10
of O 0 9.964178371291155e-10
DM B-Disease 1 1.0
past O 0 4.399144604150251e-09
30 O 0 4.5647227317480166e-12
years O 0 3.18517998434964e-14
in O 0 1.2373531408873704e-15
the O 0 9.809243769630296e-15
father O 0 9.83398150238013e-13
. O 0 1.1390007860490048e-12
. O 0 1.061322349449334e-10

The O 0 9.985006571566757e-11
RB1 O 0 8.224976966175745e-08
gene O 0 1.5917072347659822e-12
mutation O 0 6.769305168491391e-13
in O 0 3.081553567006734e-13
a O 0 2.0279823653712725e-10
child O 0 8.74849774845643e-06
with O 0 5.819114790028834e-07
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.01647298038005829

The O 0 1.6088441689987576e-10
RB1 O 0 2.2599698468184215e-07
gene O 0 6.544602533520294e-12
mutation O 0 2.234675118562013e-12
was O 0 5.230903600897396e-13
investigated O 0 1.0934000016157852e-12
in O 0 7.241168114343471e-14
a O 0 1.4592466124341286e-11
child O 0 2.7412419001393573e-08
with O 0 1.1567444224702683e-10
ectopic B-Disease 0 0.21151913702487946
intracranial I-Disease 0 2.478957685525529e-05
retinoblastoma I-Disease 0 1.465477907913737e-07
using O 0 1.430844158434308e-12
DNA O 0 9.739486994675417e-10
obtained O 0 2.2484902828523445e-11
from O 0 4.058065461356314e-13
both O 0 2.660750309316229e-13
the O 0 3.692707164354436e-12
pineal B-Disease 0 3.503828693851574e-08
and I-Disease 0 1.3406158128059786e-11
retinal I-Disease 0 5.799364316771971e-06
tumours I-Disease 1 1.0
of O 0 6.562790417774522e-07
the O 0 1.596225196465184e-08
patient O 0 1.2791709025350428e-07
. O 0 6.218573656013859e-09

A O 0 1.1758240958670285e-07
nonsense O 0 1.4818871818533808e-07
mutation O 0 5.477262740583022e-11
in O 0 1.4776027623675247e-11
exon O 0 2.2804089172545616e-10
17 O 0 1.9199516976264874e-11
( O 0 2.2239702145306593e-14
codon O 0 3.2775940295159955e-10
556 O 0 1.7096878079936317e-10
) O 0 1.2714555767284232e-14
of O 0 2.55211802212274e-12
the O 0 1.458728970948897e-11
RB1 O 0 2.8245449357200414e-07
gene O 0 1.1663316796736711e-12
was O 0 1.1774097322114763e-11
found O 0 1.1992301953995393e-13
to O 0 3.6009357388261387e-13
be O 0 6.516051804031364e-13
present O 0 1.8478624186357706e-10
homozygously O 0 3.5924840631196275e-06
in O 0 6.111222205368305e-12
both O 0 3.099671908035617e-11
the O 0 3.5721009483680177e-10
retinal B-Disease 0 2.65769877216826e-08
and I-Disease 0 2.5794327784822713e-10
the I-Disease 0 1.0069363298725875e-07
pineal I-Disease 0 0.016373800113797188
tumours I-Disease 1 1.0
. O 0 1.2583105899466318e-06

The O 0 2.8243930631777214e-12
same O 0 2.336069434682314e-13
mutation O 0 1.0221915680433749e-13
was O 0 1.2268357445395506e-13
present O 0 1.0663187997514423e-12
heterozygously O 0 6.625191506515193e-10
in O 0 2.0906738254673762e-14
the O 0 2.7162361173217048e-14
DNA O 0 9.513195786681194e-11
from O 0 3.9311791127059903e-13
the O 0 1.589030827493093e-13
constitutional O 0 1.0909424405514123e-11
cells O 0 6.327022239460689e-11
of O 0 2.261751029519754e-11
the O 0 1.9095577549754772e-11
patient O 0 4.887411586551593e-10
, O 0 8.140067260650405e-14
proving O 0 3.86250920136888e-10
it O 0 5.4571884866377006e-15
to O 0 1.5006188566063505e-12
be O 0 7.207884029220013e-12
of O 0 4.801463115988724e-10
germline O 0 1.0950556372790743e-07
origin O 0 3.0925886296273575e-09
. O 0 5.568831173974331e-09

The O 0 1.7584860650954326e-11
initial O 0 1.579827414721624e-11
mutation O 0 3.6951783863661825e-13
was O 0 1.949053982444604e-13
shown O 0 5.266984764995541e-13
to O 0 2.4326575909922044e-12
have O 0 8.550101680262698e-14
occurred O 0 2.3189195008654906e-10
in O 0 4.341882417296071e-14
the O 0 7.272703489782928e-13
paternally O 0 2.8831155240993667e-09
derived O 0 1.1623620815859326e-10
RB1 O 0 3.7318883983061824e-07
allele O 0 3.3149472056237528e-09
. O 0 6.6839866974532924e-09

The O 0 1.7355353265635642e-10
mutation O 0 2.248626415277122e-12
is O 0 9.381917977081106e-16
in O 0 3.41564680727581e-15
an O 0 3.370358708443201e-15
area O 0 8.306416535500127e-13
of O 0 1.7086093824503212e-13
the O 0 1.657109101630902e-13
gene O 0 3.22595907269413e-15
that O 0 3.949844652604206e-15
encodes O 0 8.811623441540642e-14
the O 0 9.145502063989674e-12
protein O 0 5.736212286416853e-12
- O 0 1.4809143494831645e-12
binding O 0 1.2842239424659674e-11
region O 0 9.85845360901294e-09
known O 0 2.0113773927660228e-12
as O 0 1.5669036164053796e-13
the O 0 2.4350898901459583e-12
pocket O 0 1.6792718326996692e-07
region O 0 6.283648712468448e-09
and O 0 5.1283127050494315e-12
has O 0 9.090744514583457e-14
been O 0 1.7998602825156085e-12
detected O 0 5.0378708149612095e-11
in O 0 3.270886504897798e-14
other O 0 2.3394301226038403e-14
cases O 0 4.707842189005662e-13
of O 0 8.57186543967714e-11
retinoblastoma B-Disease 0 3.646360369202739e-08
. O 0 2.7977375971488527e-10
. O 0 7.563872195248678e-09

Low O 0 5.789862367322485e-09
levels O 0 3.258903563674309e-11
of O 0 3.694165199435995e-12
beta O 0 3.328108622024928e-11
hexosaminidase O 0 7.546435476513125e-09
A O 0 7.325055145779302e-11
in O 0 4.350893492602141e-14
healthy O 0 2.432086866968608e-12
individuals O 0 3.991635140639365e-15
with O 0 2.1735214404119615e-14
apparent O 0 2.3689256067882525e-06
deficiency O 1 0.999997615814209
of O 0 0.009352239780128002
this O 0 4.424001165403979e-09
enzyme O 0 5.659268165203457e-09
. O 0 6.318116696490961e-09

Appreciable O 0 3.295840045325349e-08
beta O 0 5.757900267688854e-10
hexosaminidase O 0 4.125060968362959e-07
A O 0 2.3618365929678475e-08
( O 0 3.461597667037998e-14
hex O 0 3.7337124503267205e-09
A O 0 1.3101340012866558e-09
) O 0 9.331916139897027e-15
activity O 0 4.671593667460172e-11
has O 0 6.59508905396822e-16
been O 0 6.091642083339358e-14
detected O 0 8.772964993353227e-11
in O 0 8.177985198754012e-12
cultured O 0 0.00012736956705339253
skin O 0 1.4116558304522187e-05
fibroblasts O 0 9.872907867247704e-06
and O 0 3.7124688739842426e-11
melanoma B-Disease 0 2.509613636902941e-07
tissue O 0 9.548508650425447e-09
from O 0 1.24697160149706e-12
healthy O 0 4.519086927584626e-12
individuals O 0 7.417406109217232e-16
previously O 0 4.378507783122168e-14
reported O 0 1.2403199669587528e-13
as O 0 8.1078373181942e-14
having O 0 1.7484301506609512e-10
deficiency B-Disease 0 3.361999176831887e-07
of I-Disease 0 1.3443850832572934e-07
hex I-Disease 0 1.0207780576365622e-07
A I-Disease 0 3.0410207685349633e-09
activity O 0 5.504986050341998e-11
indistinguishable O 0 4.632896150047472e-11
from O 0 1.958001996147751e-15
that O 0 2.954144201451865e-17
of O 0 8.565081119121711e-15
patients O 0 2.9281640995379096e-14
with O 0 1.3248530744691678e-11
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.514508070296301e-10
TSD B-Disease 1 1.0
) O 0 2.545803845510619e-11
. O 0 8.376017102129651e-10

Identification O 0 8.308841614734774e-09
and O 0 2.1549192551900687e-12
quantitation O 0 0.00011555360833881423
of O 0 4.405037543619983e-07
hex O 0 6.814993298576155e-07
A O 0 5.4373220592651705e-08
, O 0 3.576804651073129e-14
amounting O 0 1.6432313842962287e-10
to O 0 1.0696198093906872e-10
3 O 0 2.4618671545795223e-09
. O 0 6.51069775869928e-09

5 O 0 4.354341776036108e-09
% O 0 4.6007968990124937e-08
- O 0 2.284554767584268e-09
6 O 0 2.6286622878402e-10
. O 0 4.465582070789509e-10

9 O 0 4.9493895093455365e-11
% O 0 1.4902117734250098e-11
of O 0 4.1720628145801297e-13
total O 0 3.068657524266105e-12
beta O 0 8.370835274940092e-12
hexosaminidase O 0 1.5419052701304281e-09
activity O 0 2.006260435560847e-10
, O 0 1.733106998300267e-14
has O 0 1.2517565391087358e-16
been O 0 6.546686944384149e-16
obtained O 0 1.5879975828227144e-13
by O 0 7.883903152170434e-15
cellulose O 0 4.9347224223561525e-11
acetate O 0 3.691385391801916e-11
gel O 0 1.7619752878950123e-10
electrophoresis O 0 1.0146659901177912e-10
, O 0 9.372203534085966e-13
DEAE O 0 2.0464938188524684e-06
- O 0 4.917474205612393e-10
cellulose O 0 8.449153598988346e-10
ion O 0 2.6132167540993123e-09
- O 0 1.7373976701762217e-09
exchange O 0 3.4976008200793274e-11
chromatography O 0 4.0573983062230923e-10
, O 0 1.567300468281827e-14
radial O 0 1.0691028140899506e-12
immunodiffusion O 0 3.0505249437595694e-09
, O 0 9.788833663733256e-15
and O 0 5.140107632063684e-14
radioimmunoassay O 0 1.275837462344498e-07
. O 0 4.52407844520053e-09

Previous O 0 6.056729944248218e-07
family O 0 1.6899716001606002e-11
studies O 0 8.252802195969633e-13
suggested O 0 3.6553039376796895e-14
that O 0 1.47657350933991e-16
these O 0 9.750033202001905e-16
individuals O 0 1.1822235356472033e-14
may O 0 4.7630434617034964e-14
be O 0 1.9122227876123242e-14
compound O 0 1.710362233786622e-11
heterozygotes O 0 8.856089195319328e-10
for O 0 4.2934698765012547e-13
the O 0 1.4399445177892822e-12
common O 0 2.770322762423588e-13
mutant O 0 3.774707976744729e-12
TSD B-Disease 0 5.803530456205408e-08
gene O 0 4.893171371561644e-12
and O 0 8.818873908043867e-13
a O 0 1.2412842455289397e-11
rare O 0 7.108789251697445e-12
( O 0 2.7298266762571053e-15
allelic O 0 1.2872943162822725e-11
) O 0 1.8677408523872646e-14
mutant O 0 1.4116928979956977e-11
gene O 0 5.338880813138269e-12
. O 0 9.087988694922444e-10

Thus O 0 7.414048264209327e-10
, O 0 1.452749460442368e-13
the O 0 5.16346730997097e-13
postulated O 0 2.2735415980412732e-11
rate O 0 8.771551193720306e-13
mutant O 0 1.3894095733147944e-14
gene O 0 1.4658605013208336e-15
appears O 0 8.851270682109363e-15
to O 0 2.277804748746122e-14
code O 0 2.9379652871771786e-14
for O 0 2.7413174405162624e-14
the O 0 2.6363256738250185e-13
expression O 0 3.1742906914100644e-12
of O 0 5.4245904643202e-12
low O 0 7.837288110157381e-12
amounts O 0 1.6136358471207507e-13
of O 0 1.3105224370979496e-11
hex O 0 6.741294189538394e-09
A O 0 8.645734084211654e-08
. O 0 2.01569818614189e-08

Heterozygotes O 0 3.246066171413986e-06
for O 0 7.542513835723241e-11
the O 0 5.1604498452206826e-11
rare O 0 5.510183021667503e-12
mutant O 0 1.5667796920970645e-11
may O 0 5.395362365971483e-14
be O 0 1.1692846669207613e-13
indistinguishable O 0 2.1782498027533848e-09
from O 0 1.6045245644288886e-12
heterozygotes O 0 6.601934110506136e-09
for O 0 1.0391396944309239e-11
the O 0 1.2480937117143043e-10
common O 0 6.956250575562706e-10
TSD B-Disease 0 1.6403041627199855e-06
mutant O 0 3.911755364072178e-09
. O 0 4.147443721791433e-09

However O 0 6.135156271902531e-11
, O 0 1.1216062157000124e-14
direct O 0 1.424029297258933e-12
visualization O 0 1.6986114736994296e-09
and O 0 3.9299574879081423e-13
quantitation O 0 1.388366217724979e-05
of O 0 3.131331283157124e-08
hex O 0 2.1370773595208448e-08
A O 0 9.524816352302068e-11
by O 0 8.817834797670329e-16
the O 0 6.400112339784766e-15
methods O 0 9.420544205829273e-12
described O 0 1.895677693053606e-14
may O 0 1.9121050923843032e-15
prevent O 0 2.7482646353430527e-14
false O 0 4.184063848427372e-13
- O 0 4.2706092026438547e-13
positive O 0 5.2458278470895667e-14
prenatal O 0 8.77403635857199e-11
diagnosis O 0 1.5202973602246317e-10
of O 0 4.734262027544789e-13
TSD B-Disease 0 5.089753685183496e-08
in O 0 1.5145650575712488e-12
fetuses O 0 1.642599167794856e-09
having O 0 5.710446763888821e-13
the O 0 6.488296228415735e-13
incomplete O 0 1.1146827461061548e-08
hex B-Disease 0 1.210385676131409e-07
A I-Disease 0 3.7330522673073574e-07
deficiency I-Disease 0 2.50116045208415e-05
of O 0 1.27407888683706e-08
the O 0 1.1920847642343801e-10
type O 0 1.0238800030037964e-08
described O 0 1.4513184490999587e-12
in O 0 6.831704256124449e-14
the O 0 3.0263998772317446e-12
four O 0 3.425302749771042e-11
healthy O 0 2.107377827798018e-09
individuals O 0 6.617938835828951e-11

The O 0 5.147515191872287e-10
tumor B-Disease 0 4.580481327565167e-09
suppressor O 0 1.183115383440736e-09
gene O 0 1.1299867291869603e-11
Smad4 O 0 4.990984507458052e-06
/ O 0 1.838460832459532e-07
Dpc4 O 0 4.598547548084753e-06
is O 0 1.8357696361447984e-15
required O 0 5.285744173084972e-13
for O 0 8.424543106579172e-15
gastrulation O 0 1.8233079046581224e-08
and O 0 1.1752629576998463e-14
later O 0 2.690518164163991e-13
for O 0 5.920901247589982e-14
anterior O 0 4.516527951636817e-08
development O 0 4.290114041793913e-09
of O 0 6.719131501187192e-11
the O 0 2.3567571505456186e-11
mouse O 0 1.0842406139577321e-10
embryo O 0 1.4322305563752025e-09
. O 0 4.118725360768849e-09

Mutations O 0 3.816476024098847e-10
in O 0 1.670973472436832e-12
the O 0 2.3880699501210856e-11
SMAD4 O 1 0.9991759657859802
/ O 0 4.991289870304172e-07
DPC4 O 1 0.6500242352485657
tumor B-Disease 0 1.0601292066425572e-09
suppressor O 0 3.705104972828721e-11
gene O 0 1.6558989964811366e-13
, O 0 8.216716796706752e-15
a O 0 4.631054112240462e-13
key O 0 6.104273753138045e-10
signal O 0 7.058231688006344e-08
transducer O 0 2.3703481843995178e-08
in O 0 3.378771915030221e-11
most O 0 6.401273261458229e-11
TGFbeta O 0 0.11480017751455307
- O 0 9.858359462100452e-09
related O 0 2.271745014326143e-09
pathways O 0 1.347499750670167e-10
, O 0 2.0271796004664834e-16
are O 0 2.2313759506434458e-18
involved O 0 1.3738163955580242e-15
in O 0 2.338939351714201e-14
50 O 0 8.668574191794676e-11
% O 0 2.013538669132231e-08
of O 0 1.3992245584404372e-08
pancreatic B-Disease 1 0.9877082109451294
cancers I-Disease 1 0.9999862909317017
. O 0 1.476008037570864e-05

Homozygous O 0 1.6209343129958143e-06
Smad4 O 0 5.0791622925316915e-06
mutant O 0 3.028448825048713e-09
mice O 0 5.3658549825641444e-11
die O 0 4.726184998915528e-10
before O 0 2.0473634940176844e-11
day O 0 1.2244489866475305e-09
7 O 0 3.6720495533160147e-09
. O 0 1.1892465900942284e-09

5 O 0 1.8107784161003337e-09
of O 0 1.2705448915184547e-09
embryogenesis O 0 9.10393828235101e-06
. O 0 5.656540835730084e-08

Mutant O 0 6.518240169839373e-09
embryos O 0 1.3517607033719514e-09
have O 0 3.225870091883021e-13
reduced O 0 2.427998774257034e-12
size O 0 9.156877730023827e-13
, O 0 1.7643157578352622e-14
fail O 0 1.6753161080629297e-09
to O 0 5.83109727170239e-10
gastrulate O 0 0.0003524799249134958
or O 0 3.1382699217097354e-10
express O 0 2.779524527207755e-11
a O 0 7.805612167906262e-13
mesodermal O 0 2.999940562631309e-08
marker O 0 7.983279592949089e-10
, O 0 6.63954907221577e-14
and O 0 1.242737602278124e-13
show O 0 6.583370515400588e-10
abnormal O 0 1.3772241125309392e-08
visceral O 0 1.5012281417980944e-09
endoderm O 0 9.82300107921219e-08
development O 0 9.814064227953168e-09
. O 0 1.736748189706816e-09

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 3.8897476350996385e-09
the O 0 1.049217657200785e-10
Smad4 O 0 8.46433749757125e-07
- O 0 2.6186491863811057e-10
deficient O 0 4.473405673666164e-11
embryos O 0 2.8000197646593783e-12
results O 0 2.5874324384445035e-12
from O 0 7.186575011301766e-13
reduced O 0 8.344340843291498e-12
cell O 0 1.305811622026587e-11
proliferation O 0 1.7634377291741998e-10
rather O 0 3.1566485536593802e-12
than O 0 3.528890233413934e-13
increased O 0 1.9365321846098738e-10
apoptosis O 0 1.367966184773195e-09
. O 0 3.836051032379828e-09

Aggregation O 0 7.60958074330631e-10
of O 0 3.376621759976217e-10
mutant O 0 3.2430563789986877e-10
Smad4 O 0 2.0300335563661065e-06
ES O 0 3.7883832959551e-08
cells O 0 1.29622755671438e-12
with O 0 1.1448493079924387e-15
wild O 0 1.0813537700904777e-13
- O 0 1.2297179333847774e-12
type O 0 2.951792976713108e-11
tetraploid O 0 2.4679621901668725e-07
morulae O 0 2.6882071324507706e-05
rescues O 0 1.5457524682460644e-07
the O 0 9.893933589077974e-11
gastrulation B-Disease 0 1.4239353731682058e-05
defect I-Disease 0 1.2019478162983432e-05
. O 0 7.038145177773458e-09

These O 0 2.5978665833120695e-12
results O 0 2.8176671065804904e-12
indicate O 0 2.9277426837059917e-12
that O 0 8.467620661177684e-15
Smad4 O 0 2.8880592140012595e-08
is O 0 6.999337645627703e-16
initially O 0 1.3444112021017939e-14
required O 0 9.104023958317331e-13
for O 0 3.697594598670202e-14
the O 0 6.890636065209899e-13
differentiation O 0 5.161840399559026e-10
of O 0 9.42854821994743e-11
the O 0 3.540922069444896e-11
visceral O 0 2.598409265530677e-10
endoderm O 0 1.3250675223730468e-08
and O 0 5.768297758933574e-14
that O 0 9.261232722756313e-16
the O 0 1.079709103157453e-13
gastrulation B-Disease 0 6.790345175033963e-09
defect I-Disease 0 2.7250228740172133e-09
in O 0 4.3964937484868016e-13
the O 0 8.980783131051773e-12
epiblast O 0 3.8868833485139476e-07
is O 0 2.0459363912241069e-13
secondary O 0 4.8283372855451034e-09
and O 0 3.628991638443546e-13
non O 0 1.1890956841398292e-07
- O 0 2.875576399219426e-08
cell O 0 4.4392012910066114e-07
autonomous O 0 0.00015352242917288095
. O 0 2.0703625480678056e-08

Rescued O 0 7.597042213092209e-07
embryos O 0 5.608733388839937e-08
show O 0 5.994364449257716e-10
severe O 0 3.795503633607922e-10
anterior O 0 5.037334267399274e-05
truncations O 0 0.0008756816969253123
, O 0 7.463682449859732e-13
indicating O 0 1.0911303111038606e-10
a O 0 6.303875607280296e-13
second O 0 4.471110981452142e-11
important O 0 4.029585345954878e-11
role O 0 2.727703479754595e-11
for O 0 3.700563466768614e-11
Smad4 O 0 5.883061021449976e-05
in O 0 2.0088183894095835e-10
anterior O 0 3.730082244146615e-05
patterning O 0 4.978301603841828e-06
during O 0 7.892234066275705e-07
embryogenesis O 0 0.00021742870740126818
. O 0 2.5568445138901552e-08

Prevalence O 0 2.529159530695324e-07
of O 0 7.897860143657454e-10
p16 O 0 3.188520736330247e-08
and O 0 1.490235296275344e-10
CDK4 O 1 0.9999606609344482
germline O 0 0.0002717998868320137
mutations O 0 3.927522307378695e-09
in O 0 2.6924766236002817e-11
48 O 0 9.607391859844938e-08
melanoma B-Disease 1 0.9994412064552307
- O 0 9.131240403803531e-06
prone O 0 9.156678402177931e-07
families O 0 5.728607588295631e-10
in O 0 3.252062508174447e-10
France O 0 8.111384453002302e-09
. O 0 5.193236507494703e-09

The O 0 5.010022263718383e-08
French O 0 4.7630583139834926e-06
Familial B-Disease 1 0.9999996423721313
Melanoma I-Disease 1 0.9999980926513672
Study O 0 1.1767193885958704e-09
Group O 0 5.259398385554226e-12
. O 0 3.419429739359714e-10

Germline O 0 0.00011103344877483323
mutations O 0 1.1249191578244222e-09
in O 0 4.799087342799435e-12
the O 0 2.1188625506929348e-11
p16 O 0 9.547744816984505e-09
and O 0 6.684996306516311e-12
CDK4 O 0 0.031602174043655396
genes O 0 4.586762220037954e-11
have O 0 5.124601508118068e-14
been O 0 2.5165147269083817e-14
reported O 0 3.461901243646294e-14
in O 0 3.054755884010496e-14
a O 0 7.555581052302862e-13
subset O 0 2.2445063863063552e-10
of O 0 1.4634254918988177e-10
melanoma B-Disease 0 1.734728698465915e-07
pedigrees O 0 5.146421244717203e-08
, O 0 4.308662801544294e-13
but O 0 3.9538888114108717e-13
their O 0 2.441616353543452e-11
prevalence O 0 1.1904676133767111e-09
is O 0 1.6058294136019361e-15
not O 0 9.515486814291874e-14
well O 0 1.5662839081276303e-11
known O 0 9.132363615327321e-11
. O 0 1.4004206683182474e-08

We O 0 3.4340308374680717e-10
searched O 0 5.423964610784537e-10
for O 0 5.90425874424233e-13
such O 0 1.7094154867655642e-12
germline O 0 8.834584832584369e-07
mutations O 0 7.423118231209003e-10
in O 0 3.14719986183043e-11
48 O 0 3.680620750401431e-07
French O 0 1.1990018720098305e-06
melanoma B-Disease 1 0.999998927116394
- O 0 9.744578164827544e-06
prone O 0 1.9488359370711805e-08
families O 0 1.0051033356300865e-12
selected O 0 1.7697597402312193e-13
according O 0 2.4385036700926184e-14
to O 0 1.3162570974844818e-14
two O 0 2.514872372375303e-15
major O 0 1.7571422358049656e-14
criteria O 0 5.084889215418997e-13
families O 0 6.815929114514785e-14
with O 0 1.8739490109675756e-15
at O 0 9.41698216801179e-13
least O 0 5.375273793781221e-13
three O 0 4.403940320057975e-12
affected O 0 3.8556641213105536e-10
members O 0 2.3448571209727653e-11
( O 0 1.2804028670654333e-12
n O 0 2.1459592436379182e-10
= O 0 4.3440591401822104e-11
20 O 0 3.0775160198004414e-11
) O 0 4.56368858244645e-15
or O 0 5.991654926113671e-14
families O 0 7.635765527898644e-14
with O 0 1.0875994098787046e-15
two O 0 8.617801296791766e-14
affected O 0 5.905430224689701e-13
members O 0 1.9005615156208848e-14
, O 0 1.6092328978631223e-15
one O 0 7.949982733484583e-15
of O 0 1.6157608833788223e-13
them O 0 2.7753986581819864e-14
affected O 0 9.381426570916757e-14
before O 0 1.4067483885670667e-13
the O 0 1.4899175372184298e-13
age O 0 1.654852470334145e-11
of O 0 2.0960552737925298e-11
50 O 0 4.5859139402582016e-11
( O 0 1.4576977930389097e-14
n O 0 4.910418859721544e-13
= O 0 1.333242462828524e-13
28 O 0 2.3539527532062676e-12
) O 0 1.485291119493492e-15
, O 0 4.769038485618454e-16
and O 0 5.4385026221839155e-16
one O 0 3.813075513160475e-15
additional O 0 6.166071207227772e-14
minor O 0 7.918909451787304e-12
criterion O 0 6.726395440637134e-09
. O 0 5.3815627509834485e-09

Sixteen O 0 2.921567876512654e-08
different O 0 1.9554578789549026e-10
p16 O 0 1.1684782919019199e-08
germline O 0 1.0195230260023891e-07
mutations O 0 2.8078775415885104e-11
were O 0 1.888706855843192e-12
found O 0 8.62330972145435e-14
in O 0 8.14534410650521e-15
21 O 0 3.2774778984528963e-12
families O 0 4.863220503387167e-12
, O 0 4.944513494389152e-14
while O 0 1.031384829972004e-12
one O 0 2.7486500488865806e-12
germline O 0 1.3288644140629913e-07
mutation O 0 6.582237532803958e-11
, O 0 6.384732152697747e-13
Arg24His O 0 4.389970399643062e-06
, O 0 1.0184710063157465e-12
was O 0 3.227233411062791e-11
detected O 0 3.8417657943767836e-11
in O 0 1.502007069068001e-13
the O 0 1.0260289146080126e-11
CDK4 O 0 7.227942842291668e-05
gene O 0 4.721103508131819e-10
. O 0 1.1431360746883001e-08

The O 0 8.94431924358674e-12
frequency O 0 6.4937716662272216e-12
of O 0 8.903397225208665e-13
p16 O 0 8.576488477740618e-12
gene O 0 9.095735402115269e-15
mutation O 0 3.589452885854709e-15
in O 0 5.785528103146621e-15
our O 0 9.003198360446607e-12
sample O 0 7.978959832254107e-13
( O 0 9.235967185777596e-17
44 O 0 1.1335960815872514e-11
% O 0 2.5297916539379628e-11
) O 0 9.49359503601185e-16
is O 0 1.0068478414895711e-15
among O 0 8.409736970661167e-16
the O 0 5.3937262371305666e-14
highest O 0 2.2262995266753016e-11
rates O 0 1.3022907947336793e-13
yet O 0 6.192870059129477e-15
reported O 0 3.5440451436183004e-14
and O 0 1.5863643847157955e-15
the O 0 3.096844070245297e-13
CDK4 O 0 8.975788432508125e-07
mutation O 0 4.5482016590436825e-12
is O 0 2.0822636353340883e-15
the O 0 6.798868515704368e-14
second O 0 4.913927598160228e-11
mutation O 0 2.2254587062064957e-11
detected O 0 1.0487649811097288e-11
in O 0 3.951022113104184e-14
this O 0 1.1536843529114105e-13
gene O 0 1.0390955674025038e-12
worldwide O 0 4.1314490890898e-12
. O 0 9.418559265839122e-10

In O 0 2.0877440401467773e-11
summary O 0 3.605888157509618e-11
, O 0 1.2477151066893691e-14
our O 0 1.1707044838757397e-12
results O 0 8.10023651886399e-13
show O 0 1.556152559242796e-12
frequent O 0 1.7442439907786739e-13
involvement O 0 2.290048142436496e-12
of O 0 2.9506995805061997e-12
the O 0 1.2509046532979684e-12
p16 O 0 1.6723972207088877e-10
gene O 0 6.708751392955903e-13
in O 0 2.2885198510541604e-12
familial B-Disease 0 1.0254791504848981e-07
melanoma I-Disease 0 5.244883709565329e-07
and O 0 3.9078991236583815e-13
confirm O 0 9.555604918443095e-11
the O 0 1.2524230784405344e-12
role O 0 3.9218571966370686e-12
of O 0 3.2955645157262126e-11
the O 0 6.388210099794733e-11
CDK4 O 1 0.9999423027038574
gene O 0 6.67699402712163e-12
as O 0 1.1334613803093418e-12
a O 0 1.8999194578706025e-11
melanoma B-Disease 0 5.099556801724248e-06
- O 0 4.1789942173409145e-08
predisposing O 0 4.748723636538443e-09
gene O 0 3.5406434728546543e-12
. O 0 1.8105244734001325e-11
. O 0 4.931506869532143e-10

Progression O 0 3.8822381043246423e-07
of O 0 1.3408735455300302e-08
somatic O 0 1.7722054224122985e-07
CTG O 0 3.6454744076763745e-06
repeat O 0 7.834993764888054e-10
length O 0 3.403784545885635e-11
heterogeneity O 0 3.762612096891438e-11
in O 0 7.944404174493967e-15
the O 0 2.3643579634283554e-14
blood O 0 4.054114249169016e-12
cells O 0 4.042119416958201e-10
of O 0 3.33437055743957e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 4.717167030321434e-06
. O 0 9.12157993582241e-09

The O 0 5.397773699365727e-13
genetic O 0 1.14691364586951e-13
basis O 0 5.780661539722676e-12
of O 0 4.6091960109739816e-11
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.1023305601653988e-09
DM B-Disease 1 1.0
) O 0 3.6427574823770514e-13
is O 0 4.356012515043049e-16
the O 0 2.3157135388938987e-15
expansion O 0 2.066921937424193e-12
of O 0 1.456898620841307e-12
an O 0 1.9225184053235644e-13
unstable O 0 1.3016560274081712e-08
CTG O 0 4.562120992090968e-08
repeat O 0 1.0759727310516443e-11
in O 0 3.293222086090536e-14
the O 0 2.203483536855188e-14
34 O 0 1.1011562755375293e-12
UTR O 0 1.0177526377219692e-08
of O 0 5.913119820177837e-12
the O 0 1.621539014173834e-11
DM B-Disease 1 1.0
protein O 0 4.5246714708291336e-10
kinase O 0 3.8843164795743235e-11
gene O 0 4.1852450866942947e-13
on O 0 8.407909785068668e-12
chromosome O 0 5.795424556920281e-11
19 O 0 1.4372220080716147e-09
. O 0 4.180865431635539e-09

One O 0 6.173961949323958e-12
of O 0 4.110831466896947e-12
the O 0 4.3046951636940833e-13
principal O 0 6.873824426323338e-12
features O 0 3.063175052693025e-14
of O 0 2.50752760569406e-13
the O 0 2.6856447621348423e-11
DM B-Disease 1 1.0
mutation O 0 3.8374376593042214e-11
is O 0 4.791472597918782e-14
an O 0 1.9500272233009992e-14
extraordinarily O 0 1.1548528799920632e-10
high O 0 6.545217839937223e-11
level O 0 9.155708191599388e-09
of O 0 1.9797539996257996e-10
somatic O 0 3.5007945431431153e-09
mosaicism O 0 8.063015144443852e-08
, O 0 9.786667800487127e-15
due O 0 3.731947910423639e-12
to O 0 4.604753535940309e-13
an O 0 9.469186299329059e-15
extremely O 0 1.8919447172111026e-12
high O 0 1.6421707743630165e-12
degree O 0 6.530668783533145e-10
of O 0 1.4050988150771104e-10
somatic O 0 3.481990518139355e-08
instability O 0 1.620752954067939e-08
both O 0 4.6687675427092845e-12
within O 0 4.4064717152902944e-11
and O 0 2.0905183102182603e-14
between O 0 1.733122109368046e-12
different O 0 1.1797812726754842e-11
tissues O 0 6.235008065402781e-10
. O 0 3.706873974440583e-10

This O 0 2.410045274459094e-09
instability O 0 1.3303555590482574e-07
appears O 0 2.674469153085557e-12
to O 0 9.975910885123146e-14
be O 0 4.889518355629362e-14
biased O 0 4.953384230566016e-11
towards O 0 1.9298582176752177e-10
further O 0 3.587499221302526e-13
expansion O 0 1.8148357816549776e-11
and O 0 3.762905751694603e-15
continuous O 0 1.5289718102717842e-10
throughout O 0 1.1061347150731482e-12
the O 0 1.3494111698268002e-13
life O 0 7.194379098539316e-13
of O 0 7.98447083189685e-13
an O 0 3.8784897500945565e-15
individual O 0 2.3491701205829996e-13
, O 0 5.483923726365067e-14
features O 0 1.310076315009026e-13
that O 0 1.1672423180190006e-15
could O 0 6.557541375141682e-14
be O 0 8.335964297306875e-14
associated O 0 5.476079659172406e-12
with O 0 5.3140051902008864e-14
the O 0 1.959485525226956e-11
progressive O 0 3.878015064628926e-08
nature O 0 3.776265064536766e-11
of O 0 8.08693390030868e-12
the O 0 6.752225861772487e-11
disease O 0 1.5833010458266017e-09
. O 0 1.8288753844686312e-10

Although O 0 1.6839868041684802e-11
increasing O 0 1.674131644945065e-12
measured O 0 2.501880809729212e-13
allele O 0 1.8150565685853826e-12
size O 0 1.466751389398932e-13
between O 0 5.9609292328566266e-12
patients O 0 1.9596936920440733e-12
clearly O 0 8.654159745595524e-13
correlates O 0 8.358298775323902e-11
with O 0 1.33870444467461e-15
an O 0 4.930137270043526e-16
increased O 0 1.0195627843509122e-13
severity O 0 1.2044349025075451e-11
of O 0 1.0347859721870911e-12
symptoms O 0 3.57957240237905e-12
and O 0 1.3415408403776095e-16
an O 0 1.0218132328365499e-17
earlier O 0 1.5012014052098906e-14
age O 0 1.4468463319788905e-12
of O 0 9.289659970088127e-13
onset O 0 1.856056454363486e-11
, O 0 4.044297243612974e-16
this O 0 3.265378715509924e-16
correlation O 0 1.4063050854037917e-14
is O 0 2.4809480874153925e-17
not O 0 4.3584726163592305e-16
precise O 0 9.10468835740863e-12
and O 0 9.175230291248032e-14
measured O 0 8.039242882507125e-12
allele O 0 1.811274047414102e-11
length O 0 6.907153668467281e-12
cannot O 0 1.5855681568047175e-12
be O 0 5.117685992323505e-14
used O 0 1.297686323632405e-13
as O 0 3.3185493029496815e-15
an O 0 2.258163102902567e-16
accurate O 0 1.5923951046659113e-10
predictor O 0 4.492811456202617e-09
of O 0 7.408880800530149e-12
age O 0 2.2806581068124387e-09
of O 0 2.872937887588023e-09
onset O 0 7.566472390863055e-07
. O 0 1.1002662780867922e-08

In O 0 1.408417132919837e-11
order O 0 1.209148232927948e-12
to O 0 9.350276629349619e-13
further O 0 7.662540849225075e-13
characterize O 0 2.0004906065018702e-10
the O 0 1.7352654686428326e-12
dynamics O 0 5.136210123879437e-09
of O 0 6.273041890381137e-07
DM B-Disease 1 1.0
CTG O 0 0.0012215781025588512
repeat O 0 6.522832052269223e-08
somatic O 0 1.7246664185677218e-07
instability O 0 3.801629588906508e-08
, O 0 1.9448493108944337e-14
we O 0 1.2168745523765453e-14
have O 0 5.123052200154245e-16
studied O 0 1.2894352062866113e-14
repeat O 0 6.15462677567083e-14
length O 0 3.236068910669049e-13
changes O 0 5.450967876673065e-15
over O 0 1.3609898815168707e-15
time O 0 1.471781071039728e-14
in O 0 4.110874170910016e-14
111 O 0 2.291056233616473e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.690091565644593e-10
with O 0 1.4277477244635343e-15
varying O 0 3.5112459272589047e-13
clinical O 0 3.675211177056603e-12
severity O 0 2.1934608643303655e-11
and O 0 7.721622820311413e-13
CTG O 0 1.0923933757567283e-08
repeat O 0 3.366189965658961e-11
size O 0 9.502560413890415e-13
over O 0 4.9394797469902094e-14
time O 0 1.0367476191777691e-12
intervals O 0 5.785354972864809e-10
of O 0 3.212420607301425e-11
1 O 0 1.1498279758881402e-11
- O 0 1.1924758402948044e-10
7 O 0 1.497069135325546e-11
years O 0 1.9852321175850562e-11
. O 0 2.164552426187072e-10

We O 0 8.45369538260421e-11
have O 0 3.2039041558684644e-14
found O 0 4.759735205121405e-15
a O 0 7.447005675559034e-16
direct O 0 1.8171999549652235e-13
progression O 0 8.117365113413655e-11
of O 0 1.1111190960366724e-11
the O 0 7.567627947902e-12
size O 0 1.5163405253648676e-11
heterogeneity O 0 3.2611685574224225e-10
over O 0 2.4888112946409857e-13
time O 0 4.016383579885652e-13
related O 0 1.7471425348136727e-11
to O 0 4.632752514943661e-12
initial O 0 2.7769558874624067e-10
CTG O 0 6.888866010967831e-08
repeat O 0 3.265187772938383e-11
size O 0 8.350959355453436e-13
and O 0 1.0135883391014077e-14
the O 0 2.413849556435338e-13
time O 0 2.0633412513293425e-12
interval O 0 1.3718927382999624e-10
and O 0 4.52657829025805e-14
always O 0 5.147802214881814e-13
biased O 0 2.7597568327819566e-11
towards O 0 1.3072876114961218e-10
further O 0 1.044536766109383e-11
expansion O 0 7.216324204861735e-10
. O 0 8.742701007591336e-10

Attempts O 0 4.730103952965692e-08
to O 0 3.254797473206672e-11
mathematically O 0 2.678608446160524e-09
model O 0 2.7826964690835787e-11
the O 0 2.865185085715316e-12
dynamics O 0 2.365310169949453e-10
have O 0 1.1901433614666668e-12
proved O 0 5.853877826922371e-09
only O 0 7.330750047794543e-13
partially O 0 1.1096578517166833e-11
successful O 0 1.55541356704203e-12
suggesting O 0 3.0009000384460804e-13
that O 0 1.5574492408477102e-17
individual O 0 4.453294778430797e-16
specific O 0 3.368079131023903e-14
genetic O 0 5.991911827818441e-12
and O 0 1.5437412632934855e-13
/ O 0 1.544966932165437e-09
or O 0 5.3230792169955965e-12
environmental O 0 2.0933931671462958e-12
factors O 0 1.1485078296388784e-12
also O 0 9.619878119326809e-16
play O 0 7.686990800837012e-12
a O 0 1.1671111993516448e-11
role O 0 1.4293208283611136e-10
in O 0 1.9029776365808715e-10
somatic O 0 1.101908893019754e-07
mosaicism O 0 2.6263654717695317e-07
. O 0 1.0330061805952084e-10
. O 0 1.1008512990073882e-09

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 3.0851151494593054e-11
Palestinian O 0 2.109000888594892e-06
Arabs O 0 1.0838926556289152e-07
. O 0 2.1237238634341793e-09

Aspartylglucosaminuria B-Disease 1 1.0
( O 0 5.0130308792972755e-09
AGU B-Disease 1 1.0
) O 0 1.1611681939322632e-13
is O 0 4.292163277358138e-15
a O 0 1.6981803062279116e-13
rare O 0 1.344476086018176e-09
disorder B-Disease 1 0.9999992847442627
of I-Disease 0 3.7375946249085246e-06
glycoprotein I-Disease 0 1.3591117919986573e-07
metabolism I-Disease 1 0.9999923706054688
caused O 0 2.934307311019957e-11
by O 0 1.6755923176872212e-15
the O 0 1.4092950981550723e-12
deficiency B-Disease 0 3.127374270661676e-07
of I-Disease 0 7.328947226881155e-09
the I-Disease 0 4.19681067675981e-10
lysosomal I-Disease 0 1.1522511833561566e-08
enzyme I-Disease 0 1.7201825901203005e-12
aspartylglucosaminidase I-Disease 0 1.9040677923243265e-09
( O 0 2.515708520949185e-14
AGA O 0 8.548643393169186e-08
) O 0 1.7437923934687793e-12
. O 0 2.0423761293297815e-10

AGU B-Disease 1 1.0
is O 0 2.68766536803966e-10
inherited O 0 5.904802037548507e-06
as O 0 1.969343264851542e-11
an O 0 1.152765491570229e-12
autosomal O 0 3.0058890843065456e-05
recessive O 0 5.719442128793162e-07
trait O 0 2.5305952888743377e-09
and O 0 3.653705840618105e-15
occurs O 0 3.4322119256934014e-13
with O 0 2.5919713758771983e-16
a O 0 2.66738128980315e-13
high O 0 1.0304278263983946e-11
frequency O 0 8.929613298791494e-11
in O 0 1.0561758715874059e-12
Finland O 0 5.120185941898114e-10
because O 0 2.300246852802307e-13
of O 0 1.0772582478835169e-11
a O 0 1.0095901545326136e-11
founder O 0 2.1941398697933323e-10
effect O 0 5.7747574083721886e-11
. O 0 9.653065013992546e-10

While O 0 1.24660504141616e-09
very O 0 2.5264741687625047e-11
few O 0 4.447158353376723e-12
patients O 0 6.158906717956825e-12
with O 0 5.827430009895662e-13
AGU B-Disease 1 1.0
have O 0 9.275743151002103e-13
been O 0 5.263005336446705e-14
reported O 0 2.0136717542983823e-13
from O 0 6.87968345486345e-13
non O 0 3.843688145543922e-10
- O 0 1.2169971627673526e-11
Finnish O 0 2.6723112611648503e-09
origin O 0 6.159991267074005e-11
, O 0 6.868391624762285e-14
we O 0 1.0340854691634482e-12
diagnosed O 0 2.199234359068214e-06
the O 0 3.1501246056109267e-11
disorder O 0 8.468247614246138e-08
in O 0 5.114000043750233e-13
8 O 0 5.926898555275173e-11
patients O 0 1.5207308069059566e-12
originating O 0 3.6260563995860196e-10
from O 0 3.687329955259777e-12
3 O 0 8.282216058808078e-12
unrelated O 0 4.494075597771818e-11
families O 0 1.497402462441455e-12
, O 0 3.0940305147857203e-15
all O 0 4.028040193195881e-15
Palestinian O 0 3.433307327327384e-08
Arabs O 0 2.5548150262011404e-09
from O 0 1.3382468961112282e-12
the O 0 1.44048011366249e-12
region O 0 1.7863323320543856e-10
of O 0 5.7906179851130446e-11
Jerusalem O 0 2.9850946248188848e-06
. O 0 4.9478206420872084e-08

The O 0 3.2386780757232e-11
clinical O 0 1.0079923562500426e-09
diagnosis O 1 0.5279093980789185
of O 0 0.00010265222954330966
AGU B-Disease 1 1.0
is O 0 2.081379651963644e-10
often O 0 1.2919105889241944e-12
difficult O 0 9.010496349048935e-09
, O 0 2.2182932303115716e-14
in O 0 1.9000868383572435e-14
particular O 0 1.8191974619427564e-13
early O 0 2.4888743409973157e-12
in O 0 9.720589066205924e-15
the O 0 8.236176362230382e-14
course O 0 4.7812372117039814e-11
of O 0 3.912003099931782e-12
the O 0 1.6476046872312966e-12
disease O 0 2.923312199948347e-12
, O 0 5.635121203856504e-16
and O 0 7.875362942479742e-16
most O 0 6.460775145401224e-15
of O 0 2.2307900156021826e-13
the O 0 3.3402263160259293e-13
patients O 0 3.681579780617783e-13
are O 0 3.88673942748434e-15
diagnosed O 0 1.0903219516480989e-12
after O 0 1.198205759871812e-13
the O 0 5.02599318500524e-13
age O 0 7.562941245486954e-11
of O 0 2.2171969121798085e-11
5 O 0 1.3654493334624984e-11
years O 0 1.6614402562065145e-11
. O 0 1.1365089980230891e-09

However O 0 3.8743516728168004e-10
, O 0 7.24301938955299e-14
since O 0 1.272982641607051e-13
these O 0 5.534265943739e-14
patients O 0 5.6481576550136345e-14
excrete O 0 7.06105963629855e-12
early O 0 4.4806679525520587e-13
large O 0 1.8292265183854958e-15
amounts O 0 8.799983853592652e-14
of O 0 3.5335952913717605e-11
aspartylglucosamine O 0 3.4924596548080444e-08
in O 0 7.905904403360253e-11
urine O 0 9.388051447345447e-10
, O 0 3.809246416019117e-14
biochemical O 0 2.506285760525695e-12
screening O 0 1.4533772622893348e-11
is O 0 4.512475869312624e-14
easy O 0 1.3829050751756888e-11
by O 0 1.290897591729387e-13
urine O 0 2.298417151047616e-10
chromatography O 0 4.09496520026309e-10
. O 0 4.50396109297202e-11
. O 0 4.65064126098369e-10

Detection O 0 3.377565249707004e-08
of O 0 3.465764827903506e-11
heterozygous O 0 2.3313068055891284e-13
carriers O 0 3.71216381947286e-15
of O 0 5.407377562209603e-13
the O 0 6.88187284936248e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.4025704209164047e-11
ATM O 0 2.582483489277365e-07
) O 0 4.797375443473255e-16
gene O 0 1.994304001852278e-17
by O 0 1.2340952404139936e-16
G2 O 0 2.288507924830263e-11
phase O 0 2.2525177556520504e-10
chromosomal O 0 1.2340532151711159e-08
radiosensitivity O 0 1.0337527101000887e-07
of O 0 7.840764149058543e-10
peripheral O 0 4.859850832872326e-07
blood O 0 5.6040818208202836e-08
lymphocytes O 0 1.8605172957819605e-09
. O 0 1.9346364510397507e-08

In O 0 1.8241134966956452e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.8594219497458653e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5160671383660645e-13
patients O 0 4.042838383944841e-13
, O 0 1.4179391094041091e-16
mutations O 0 9.813505615904406e-16
in O 0 2.74624439823638e-16
a O 0 3.224149122104525e-16
single O 0 5.5096075440950066e-15
gene O 0 7.463073361172856e-16
, O 0 4.278674436491791e-16
ATM O 0 1.4664934544494912e-10
, O 0 4.311837893959165e-16
result O 0 1.921128153206577e-14
in O 0 3.2286830544195344e-13
an O 0 7.632216636466183e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 3.1972471545294034e-12
embraces O 0 1.2335705373844874e-12
a O 0 2.567714099273289e-15
variety O 0 1.3390210232386464e-15
of O 0 2.168953391727419e-14
clinical O 0 4.721006571783981e-13
features O 0 3.1860913918008854e-14
and O 0 5.242764637139116e-15
manifests O 0 2.1089792238970784e-12
extreme O 0 1.2855767665687079e-11
radiosensitivity O 0 1.5644529227643034e-08
and O 0 7.822957098736413e-14
a O 0 1.5024461709478576e-12
strong O 0 1.7640045240491231e-12
pre O 0 2.419452016511059e-07
- O 0 1.1234750019184503e-07
disposition O 0 4.380918596780248e-07
to O 0 3.439127382875995e-08
malignancy B-Disease 0 0.47435468435287476
. O 0 7.132839652257417e-09

Heterozygotes O 0 4.0355139674375096e-08
for O 0 1.844184744151378e-12
the O 0 3.4604326782511352e-12
ATM O 0 5.8086353504904764e-08
gene O 0 5.256627923742874e-13
have O 0 3.4839593368455116e-14
no O 0 3.960723096745793e-15
clinical O 0 2.241301863884198e-14
expression O 0 1.3463390829710625e-13
of O 0 6.78817557719924e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.8352540801246384e-11
may O 0 2.5374012786738565e-12
be O 0 5.753938991936991e-13
cancer B-Disease 0 6.2685599766521e-11
prone O 0 9.826636900023278e-12
with O 0 1.0293689652494053e-15
a O 0 7.527358727651978e-13
moderate O 0 9.70826370683131e-12
increase O 0 8.42209385999021e-13
in O 0 2.6745546424268574e-13
in O 0 2.1471373290449236e-11
vitro O 0 4.412935794562145e-09
radiosensitivity O 0 8.40835696180875e-07
. O 0 2.0624995045182004e-08

We O 0 2.2160681276139904e-11
performed O 0 2.3072885615982308e-11
a O 0 5.262529127747495e-12
blind O 0 8.509121185440449e-10
chromosomal O 0 8.99804497578316e-09
analysis O 0 2.8618328193341647e-11
on O 0 7.803369062031607e-12
G2 O 0 9.349203633490788e-10
- O 0 6.811049554217297e-12
phase O 0 7.336090623866198e-10
lymphocytes O 0 1.0398713140569171e-11
from O 0 5.726654502165307e-13
7 O 0 9.530677028829482e-13
unrelated O 0 4.856384738793906e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.070612926123431e-06
, O 0 2.416400175927428e-14
13 O 0 9.051232528235753e-13
obligate O 0 2.926045894469098e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 5.298405199027911e-07
( O 0 1.2827996348811158e-14
parents O 0 9.546112984565747e-15
of O 0 2.271630895000175e-14
the O 0 1.1898016853164033e-14
patients O 0 1.91816878949546e-15
) O 0 1.9170989339435186e-17
, O 0 9.746235715071347e-17
and O 0 3.6338690172076787e-16
14 O 0 2.9914536559677574e-13
normal O 0 1.01713061584352e-10
controls O 0 2.3469767795880614e-12
following O 0 2.4079391638173048e-14
X O 0 5.3886135137348745e-11
- O 0 1.5188414762001834e-11
irradiation O 0 1.3078923794679342e-12
with O 0 5.794892899411465e-15
1 O 0 5.484669250883922e-13
Gy O 0 6.64356208934791e-11
in O 0 1.0842233483091858e-15
order O 0 2.4901479041614235e-15
to O 0 1.3752826731171924e-14
evaluate O 0 5.64876379179069e-13
this O 0 4.1701011709775835e-15
cytogenetic O 0 5.908559752576537e-10
method O 0 2.4479114915654243e-11
as O 0 2.3300163678346454e-14
a O 0 8.188667978284783e-14
tool O 0 1.7416269815218044e-10
for O 0 3.391725241592633e-14
detection O 0 5.770106170643885e-09
of O 0 5.744352771230865e-10
ATM O 0 5.7040438150579575e-06
carriers O 0 1.7733855495194462e-09
. O 0 1.6304982253245726e-08

Both O 0 5.06872854799667e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 1.6809728549560532e-05
and O 0 1.9502960715584577e-13
heterozygotes O 0 3.3370090024575916e-10
showed O 0 4.418982812049582e-13
significantly O 0 2.0646512114991938e-13
increased O 0 7.193263996604915e-14
levels O 0 1.2520265857060564e-12
of O 0 3.0359278459235473e-12
radiation O 0 4.3064883925580943e-07
- O 0 5.791654089648546e-08
induced O 0 1.2514059122281651e-08
chromatid O 0 1.3369173757382669e-05
damage O 0 1.0175973841342056e-08
relative O 0 1.425917162123369e-10
to O 0 1.75805157649582e-13
that O 0 2.5631047577325677e-15
of O 0 2.6757550168621247e-12
normal O 0 3.728936714963993e-09
controls O 0 3.4054830067020703e-09
. O 0 6.759895976315988e-10

These O 0 8.342359057245466e-14
results O 0 9.655991961956059e-14
show O 0 3.721793313533721e-14
that O 0 1.9743130316803413e-17
the O 0 5.895632645410787e-15
G2 O 0 4.654048813002021e-10
- O 0 3.115592853153437e-11
phase O 0 5.724591467526352e-09
chromosomal O 0 1.6641058664390584e-06
radiosensitivity O 0 1.6148490544765082e-07
assay O 0 3.647648502691503e-11
can O 0 1.8086614901624033e-14
be O 0 3.9610238463816275e-16
used O 0 5.10035436414579e-16
for O 0 2.0427436985233832e-16
the O 0 3.808772585788423e-15
detection O 0 1.7158360843261278e-10
of O 0 7.83714593222129e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 0.00025069323601201177
. O 0 5.6100386558455284e-08

In O 0 3.6418368321022854e-11
combination O 0 1.2506238232512512e-11
with O 0 3.690499511890821e-14
molecular O 0 3.708192607143612e-12
genetic O 0 5.484975321157215e-12
analyses O 0 3.435771805948562e-11
, O 0 3.775904742819641e-15
this O 0 7.209687796045586e-15
test O 0 5.193008566564683e-13
may O 0 1.2282212363313744e-14
be O 0 6.963202478944006e-15
of O 0 4.158951083369812e-14
value O 0 1.6591963263382081e-13
in O 0 6.8009660233916535e-15
studies O 0 1.0010205555091578e-12
of O 0 9.668215663824475e-13
familial B-Disease 0 3.5161504263747645e-10
and I-Disease 0 1.7856969158555613e-12
sporadic I-Disease 0 1.272298888466139e-08
cancers I-Disease 0 1.8248144328936178e-08
aimed O 0 4.945806542089315e-10
at O 0 1.5632775022395018e-12
determination O 0 1.7471300794991151e-10
of O 0 6.441749477587022e-12
the O 0 7.440580676544226e-14
potential O 0 1.630863345303095e-14
involvement O 0 3.069278121589636e-12
of O 0 2.706327939527853e-10
ATM O 0 4.091162736585829e-06
mutations O 0 1.2003400495785854e-09
in O 0 6.039509170552293e-11
tumor B-Disease 0 3.15232057346293e-07
risk O 0 5.167719030474416e-11
or O 0 1.0147500244597762e-12
development O 0 6.507850924819536e-10
. O 0 7.078022629808389e-12
. O 0 1.6168946737060708e-10

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 3.6546876636123216e-12
identification O 0 1.2762794154852486e-09
and O 0 9.503451323144337e-16
detection O 0 5.2513618453708943e-11
of O 0 3.1546685836519872e-12
founder O 0 7.675216018299125e-11
- O 0 6.38880753855986e-11
effect O 0 1.1022993498879807e-12
mutations O 0 4.1003986772820966e-13
in O 0 3.183193861494918e-14
the O 0 2.95838467655532e-13
ATM O 0 7.457635398111506e-09
gene O 0 7.621273132984302e-14
in O 0 1.6743415464856581e-13
ethnic O 0 6.528921153714506e-11
populations O 0 5.322013663100478e-12
. O 0 1.6602363581141866e-11

To O 0 3.3810922811516875e-11
facilitate O 0 5.114612622314496e-10
the O 0 6.380848540515904e-13
evaluation O 0 2.1949193573789216e-09
of O 0 3.6743735831734625e-10
ATM O 0 9.826727591644158e-07
heterozygotes O 0 3.7652739592886064e-08
for O 0 1.0319856080798218e-11
susceptibility O 0 1.1763200413739128e-09
to O 0 2.444404123558286e-10
other O 0 3.739816789583017e-11
diseases O 0 3.755735065169574e-07
, O 0 1.5886066333931081e-13
such O 0 2.3632547199552156e-13
as O 0 2.674747368036634e-10
breast B-Disease 0 1.2362021095668752e-07
cancer I-Disease 0 3.626682598678599e-08
, O 0 1.547655233136158e-11
we O 0 4.95728545019114e-12
have O 0 3.248832477456727e-14
attempted O 0 5.4285981959667495e-11
to O 0 1.5431062460810607e-12
define O 0 1.3772333273820436e-10
the O 0 1.5574531681689097e-12
most O 0 8.939223195220461e-15
common O 0 2.1667329795594867e-14
mutations O 0 9.11887210706952e-15
and O 0 4.722008040013344e-16
their O 0 8.793423075196399e-14
frequencies O 0 1.3408593679820058e-10
in O 0 1.8016250713515092e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.2624989054188518e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.409687625560015e-13
homozygotes O 0 6.189690537894421e-08
from O 0 2.8246608069042167e-13
10 O 0 1.5805339350673242e-13
ethnic O 0 1.4501230077845761e-12
populations O 0 2.300237908134384e-13
. O 0 3.7321760265607296e-12

Both O 0 4.8582905060046144e-11
genomic O 0 7.977256188951287e-09
mutations O 0 1.2911254530789673e-11
and O 0 7.647498628284011e-14
their O 0 3.2417358727943046e-12
effects O 0 4.684367910928744e-12
on O 0 3.688687376379729e-12
cDNA O 0 7.938823820552443e-09
were O 0 8.486765457060841e-11
characterized O 0 1.4916087809346834e-10
. O 0 1.0685824447520531e-09

Protein O 0 4.0858527672327227e-10
- O 0 1.6854713805192212e-11
truncation O 0 6.047788936314191e-10
testing O 0 3.758148740123923e-12
of O 0 6.136448770996394e-13
the O 0 4.860785981618959e-14
entire O 0 1.9262386824481226e-11
ATM O 0 7.647860122972361e-11
cDNA O 0 1.5426722399514148e-10
detected O 0 1.4864675462744614e-11
92 O 0 6.325103635296259e-11
( O 0 2.4838292501331433e-15
66 O 0 3.189758179811264e-10
% O 0 1.9883357113559263e-11
) O 0 7.01789581986469e-15
truncating O 0 2.1791959903261215e-10
mutations O 0 1.3412212963512249e-12
in O 0 1.1371681591168525e-13
140 O 0 4.584040178695625e-12
mutant O 0 5.5564407241970315e-12
alleles O 0 9.585682941848361e-12
screened O 0 2.293994771918051e-09
. O 0 8.967427689299257e-09

The O 0 1.0886944679100452e-09
haplotyping O 0 0.0014643442118540406
of O 0 7.899130238797625e-09
patients O 0 1.7148284181534024e-10
with O 0 1.5234937877223187e-13
identical O 0 1.1846795766601304e-10
mutations O 0 1.6875107214375795e-11
indicates O 0 2.76437154417275e-11
that O 0 5.83170537481561e-15
almost O 0 3.3639784751196555e-13
all O 0 4.8482119469235585e-14
of O 0 2.9224631612270735e-13
these O 0 8.206316926180363e-15
represent O 0 1.659272220490282e-13
common O 0 2.8569540396622406e-13
ancestry O 0 1.782125315374916e-11
and O 0 6.797221206028548e-14
that O 0 2.2029707431089202e-14
very O 0 2.272703509761942e-12
few O 0 2.2727913301379132e-11
spontaneously O 0 3.848005292184098e-08
recurring O 0 5.684634629687935e-07
ATM O 0 2.9101476684445515e-05
mutations O 0 2.85829688806416e-08
exist O 0 6.672232899518349e-08
. O 0 3.032664253055373e-08

Assays O 0 5.00171071227129e-10
requiring O 0 3.939453364215639e-12
minimal O 0 1.2405742232102224e-11
amounts O 0 4.381790882825726e-14
of O 0 9.110949299694082e-14
genomic O 0 1.1255919807329207e-11
DNA O 0 6.516371886533534e-10
were O 0 1.8233043113519143e-12
designed O 0 9.459810322229312e-13
to O 0 1.5676518243246118e-12
allow O 0 7.954817360378286e-12
rapid O 0 3.991772884459621e-11
screening O 0 2.0628268190825416e-11
for O 0 1.8063594240183556e-13
common O 0 7.165227612626612e-12
ethnic O 0 2.387802178205334e-10
mutations O 0 6.540366581653245e-10
. O 0 7.910223032148167e-10

These O 0 1.4064467472596487e-11
rapid O 0 7.73576688817279e-11
assays O 0 6.851601924706685e-11
detected O 0 4.1655467269974267e-11
mutations O 0 5.732925663056235e-14
in O 0 9.694111663307702e-15
76 O 0 7.461213591408722e-11
% O 0 1.657693288192874e-10
of O 0 1.8474140620061696e-11
Costa O 0 4.4687090139383656e-10
Rican O 0 4.3318206621734134e-07
patients O 0 1.5751352444581812e-09
( O 0 1.5141633757011778e-16
3 O 0 1.3964094112392566e-15
) O 0 6.331478222906983e-18
, O 0 3.0242329104737387e-18
50 O 0 1.2718964150258217e-15
% O 0 2.094306715896832e-13
of O 0 1.1200383068926678e-12
Norwegian O 0 2.184337063226849e-06
patients O 0 1.2925730485946474e-09
( O 0 1.3084867560395497e-15
1 O 0 7.37416041857869e-15
) O 0 9.895639753821695e-17
, O 0 8.843904089506652e-17
25 O 0 1.313463328714553e-14
% O 0 5.28824488539581e-13
of O 0 3.8366285517489607e-13
Polish O 0 6.845438633718004e-07
patients O 0 8.084601432756244e-09
( O 0 2.0048933165912755e-15
4 O 0 4.0343627012240715e-14
) O 0 1.824869619132836e-16
, O 0 6.416631917475948e-17
and O 0 3.573383188537637e-17
14 O 0 5.9390854356049325e-15
% O 0 2.9032402567089055e-13
of O 0 5.341169672344603e-13
Italian O 0 5.68944003020988e-10
patients O 0 1.172368174762184e-10
( O 0 6.461536310383451e-16
1 O 0 2.1552580548164432e-14
) O 0 2.8779420337875445e-15
, O 0 4.851206716611871e-15
as O 0 4.088617872001141e-15
well O 0 2.1777499982912445e-14
as O 0 3.71723712331044e-15
in O 0 7.490033170510363e-14
patients O 0 2.0548072791892746e-12
of O 0 4.6649240026397365e-11
Amish O 0 1.0393497262839446e-07
/ O 0 2.0570023462340714e-09
Mennonite O 0 2.2679015998505747e-08
and O 0 1.4320426355157734e-12
Irish O 0 1.5047420254266086e-10
English O 0 2.7041197059318733e-10
backgrounds O 0 7.394689305328939e-09
. O 0 1.2989965769705236e-09

Additional O 0 2.0246211374086442e-09
mutations O 0 2.8674182472876453e-10
were O 0 1.2111547008364365e-11
observed O 0 1.256131158290652e-12
in O 0 3.8279451765495243e-13
Japanese O 0 1.03574515630811e-09
, O 0 9.824827990013649e-14
Utah O 0 3.992343955427913e-11
Mormon O 0 1.2967307783107174e-10
, O 0 2.887267019503867e-15
and O 0 5.397397277923967e-15
African O 0 3.2949924039238354e-11
American O 0 1.9783374591297864e-11
patients O 0 9.421913943485904e-11
. O 0 4.6483619731141346e-10

These O 0 1.8117775075349174e-12
assays O 0 4.3483492089164966e-13
should O 0 4.124805660606686e-15
facilitate O 0 1.349453101345821e-12
screening O 0 1.1738572353731103e-12
for O 0 1.9896814230924154e-12
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 3.1423994641954778e-06
in O 0 4.3864950734218144e-12
the O 0 8.50871890306637e-13
populations O 0 1.1787065701469087e-14
studied O 0 3.131913131615427e-14
. O 0 7.076206753799802e-14
. O 0 3.301144774203735e-11

The O 0 7.885942565621917e-09
von B-Disease 0 0.06814241409301758
Hippel I-Disease 1 0.992816686630249
- I-Disease 0 0.0034677546937018633
Lindau I-Disease 0 9.113237319979817e-05
tumor I-Disease 0 1.1327331961297205e-08
suppressor O 0 6.586582668166585e-11
gene O 0 9.393919798668989e-15
is O 0 8.113022520378068e-17
required O 0 4.319730337321026e-13
for O 0 5.349353907968882e-14
cell O 0 2.9539162782477035e-11
cycle O 0 1.4968071226917345e-10
exit O 0 1.5405259012890582e-10
upon O 0 3.284206587239602e-11
serum O 0 2.4564168477070325e-09
withdrawal O 0 5.422509108399254e-09
. O 0 4.3443204589266315e-09

The O 0 5.2332138622546154e-11
inactivation O 0 5.943429637333963e-10
of O 0 1.5264280117666118e-10
the O 0 4.084372284829385e-10
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 7.103347909875879e-10
VHL I-Disease 0 0.42872560024261475
) I-Disease 0 5.333242528160476e-12
tumor I-Disease 0 6.411301711750639e-08
suppressor O 0 2.7061552998475236e-08
gene O 0 9.226523017824562e-11
predisposes O 0 3.290479355655407e-07
affected O 0 8.253629724119804e-11
individuals O 0 5.614782354606152e-15
to O 0 4.5772640641953896e-14
the O 0 8.700347706820308e-14
human O 0 1.9806264961452769e-10
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.999961256980896
and O 0 9.035078525729441e-15
is O 0 5.235347063740892e-16
associated O 0 1.660736110263572e-12
with O 0 1.9329544475449323e-12
sporadic B-Disease 1 1.0
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 2.061769921457568e-10
RCC B-Disease 0 3.986551382695325e-05
) O 0 4.4933300136218435e-11
and O 0 1.049092146487851e-09
brain B-Disease 0 0.026965511962771416
hemangioblastomas I-Disease 0 1.9705394151969813e-05
. O 0 1.5726744351240995e-08

VHL O 0 0.00059040158521384
- O 0 5.100014277559239e-06
negative O 0 3.0140767659503354e-09
786 O 0 4.198154329060344e-06
- O 0 6.209189109540603e-07
0 O 0 3.066067538748385e-11
RCC B-Disease 0 1.7642108218751673e-07
cells O 0 2.4011850285887704e-09
are O 0 1.408196150833041e-12
tumorigenic O 0 1.5989743928912503e-07
in O 0 3.4403882520628315e-11
nude O 0 8.347027957711362e-09
mice O 0 3.5479261889515e-11
which O 0 1.4327243818418323e-14
is O 0 1.149882695402379e-15
suppressed O 0 5.4901822834057395e-14
by O 0 2.8973623816857174e-15
the O 0 2.082338424955199e-12
reintroduction O 0 5.566335836704184e-09
of O 0 2.5482729815173855e-10
VHL B-Disease 0 1.4867923709971365e-06
. O 0 4.5536534543089147e-08

Remarkably O 0 1.548795012240589e-07
, O 0 5.387071522780463e-15
this O 0 4.867330306400212e-16
occurs O 0 4.7146844872722644e-15
without O 0 1.252856511975908e-14
affecting O 0 2.80762284081415e-13
the O 0 3.2692771422980146e-14
growth O 0 8.220032185306259e-13
rate O 0 6.07412557751541e-13
and O 0 8.164439934905466e-16
cell O 0 1.06449050962798e-11
cycle O 0 1.7326015622209923e-10
profile O 0 3.498826879264061e-12
of O 0 1.1999908879067878e-11
these O 0 2.1152181297733746e-13
cells O 0 9.42487494298705e-12
in O 0 1.8954846373042677e-12
culture O 0 1.0087115587253948e-09
. O 0 4.4591558223672223e-10

The O 0 5.146634673991457e-09
786 O 0 3.5793898405245272e-06
- O 0 1.462994987377897e-07
0 O 0 1.7646136288296255e-12
cell O 0 6.970816979201544e-11
line O 0 2.3069288146437827e-10
, O 0 1.2729795584071231e-14
like O 0 9.657349586363918e-15
many O 0 1.7114724215746766e-14
cancer B-Disease 0 3.858453812531637e-13
cells O 0 4.107764746841963e-13
, O 0 1.0660833965899061e-15
fails O 0 1.3171224094027378e-12
to O 0 6.210124862265909e-12
exit O 0 4.504131467797379e-08
the O 0 3.652745120263923e-11
cell O 0 1.540179234149619e-10
cycle O 0 6.983327111020898e-11
upon O 0 1.1696873504496441e-11
serum O 0 6.04119476665943e-10
withdrawal O 0 1.5293664112903116e-09
. O 0 1.7641282878955167e-09

Here O 0 8.442423649057673e-09
, O 0 9.164385559017746e-14
it O 0 1.54221445993628e-16
is O 0 1.1794064423692339e-17
shown O 0 1.011926651041308e-15
that O 0 2.889610878782928e-17
reintroduction O 0 3.789149116001367e-12
of O 0 8.745018869205784e-14
the O 0 4.1682745444268296e-14
wild O 0 1.2495835529507948e-12
- O 0 2.00945336759073e-11
type O 0 2.5542668674605196e-11
VHL B-Disease 0 1.1385517240114496e-07
gene O 0 1.7911821114866e-12
restores O 0 3.303084541994572e-11
the O 0 7.259201106977337e-14
ability O 0 1.2710599066323436e-11
of O 0 8.472129248149329e-11
VHL O 0 5.149807111592963e-05
- O 0 3.5035859013987647e-07
negative O 0 1.4775246304221668e-10
RCC B-Disease 0 2.4402977416571048e-08
cancer I-Disease 0 5.800132509697908e-12
cells O 0 1.1145820594596345e-13
to O 0 8.902696424029424e-14
exit O 0 5.445710202223175e-11
the O 0 3.8139085531234407e-13
cell O 0 4.698524555535322e-12
cycle O 0 2.1704591249283034e-11
and O 0 1.851842213373891e-14
enter O 0 1.0546741258110615e-08
G0 O 0 0.00048764044186100364
/ O 0 3.4005134352810273e-07
quiescence O 0 3.6844314763584407e-06
in O 0 1.114668843338329e-10
low O 0 2.126167908400589e-09
serum O 0 7.132427981559886e-10
. O 0 1.7190494860930272e-10

Both O 0 1.818663331043524e-09
VHL O 0 5.082263214717386e-06
- O 0 2.7846744909965082e-09
positive O 0 1.7982989229670121e-12
and O 0 5.254018655689516e-14
VHL O 0 1.9199019618554303e-07
- O 0 2.418083233646229e-10
negative O 0 2.56569966010714e-13
RCC B-Disease 0 4.566338418499072e-10
cells O 0 3.2829482188301284e-11
exit O 0 1.2385587000451892e-09
the O 0 3.3245967285579214e-13
cell O 0 1.1922835765551532e-12
cycle O 0 1.3052632976198741e-12
by O 0 8.10415374131318e-15
contact O 0 7.196490070526806e-10
inhibition O 0 1.7941435004331652e-08
. O 0 1.5347489945582993e-09

The O 0 2.7023163706729747e-09
cyclin O 0 1.360189799015643e-06
- O 0 1.5983614503056742e-06
dependent O 0 3.251499265388702e-07
kinase O 0 2.6132667141354204e-09
inhibitor O 0 1.9680901353069657e-10
, O 0 3.3847154679716995e-13
p27 O 0 1.1115653952842308e-09
, O 0 4.0767344232676365e-15
accumulates O 0 1.0284672012682641e-13
upon O 0 2.4737755789129567e-13
serum O 0 1.2578244869276833e-11
withdrawal O 0 7.829402404180286e-11
, O 0 8.228761605216708e-15
only O 0 4.643130955536484e-15
in O 0 1.2345767786445076e-14
the O 0 1.448938896381896e-13
presence O 0 1.4722007250431157e-12
of O 0 5.6631286465824715e-11
VHL B-Disease 0 1.735014507175947e-06
, O 0 1.1059384744799283e-12
as O 0 4.062105740752081e-14
a O 0 4.515540773328969e-14
result O 0 6.397873225129358e-13
of O 0 2.4224433223252184e-12
the O 0 5.471138949872389e-13
stabilization O 0 4.7182164841785834e-09
of O 0 2.2237796326596282e-10
the O 0 3.4726815867358596e-10
protein O 0 1.1950858080922444e-09
. O 0 4.980861278980342e-10

We O 0 2.6705760866607697e-11
propose O 0 7.223050282889609e-12
that O 0 7.310046800735118e-16
the O 0 4.2322279036367816e-14
loss O 0 3.6870484963758e-12
of O 0 7.585388046849051e-12
wild O 0 4.561100303869525e-13
- O 0 7.233883088895998e-13
type O 0 1.3049446506013807e-12
VHL B-Disease 0 1.988993858503818e-09
gene O 0 1.1025337442332767e-14
results O 0 1.3867071824592153e-13
in O 0 8.70201924163842e-15
a O 0 6.618531220179075e-15
specific O 0 2.9729728878366557e-13
cellular O 0 4.877975454120609e-11
defect O 0 5.025521665480426e-10
in O 0 3.8095919648040155e-12
serum O 0 4.454788538055254e-09
- O 0 2.942908361447394e-09
dependent O 0 4.3745784772397656e-09
growth O 0 6.1413348365069176e-12
control O 0 2.224007610018841e-11
, O 0 2.8637163271966453e-15
which O 0 1.2289000697111277e-15
may O 0 4.4701341152947327e-13
initiate O 0 1.3622873940022373e-09
tumor B-Disease 0 1.9827526287485853e-08
formation O 0 2.8084549796858482e-08
. O 0 3.6492824762035525e-08

This O 0 4.742898088161418e-11
is O 0 2.0197571100420003e-13
corrected O 0 1.2812714778043244e-10
by O 0 1.8156701795811643e-15
the O 0 1.7667951249158292e-13
reintroduction O 0 2.9094920916961087e-10
of O 0 3.794348949620607e-12
wild O 0 1.62068865272591e-11
- O 0 7.094195231260869e-10
type O 0 5.038510053623213e-09
VHL B-Disease 0 0.0015708893770352006
, O 0 5.91923871029465e-11
implicating O 0 1.4328879842651077e-05
VHL B-Disease 1 0.9151520729064941
as O 0 2.5286806069196865e-12
the O 0 9.965475710263516e-13
first O 0 9.770749747478602e-13
tumor B-Disease 0 7.735498006034014e-12
suppressor O 0 3.655273132785464e-12
involved O 0 3.220539882952539e-13
in O 0 1.0568442957792704e-13
the O 0 1.3698518231200496e-12
regulation O 0 1.0499798946961292e-11
of O 0 2.1610068335481403e-12
cell O 0 2.6201404327436117e-12
cycle O 0 7.016356939892887e-11
exit O 0 4.131508468674383e-10
, O 0 6.417173489166599e-16
which O 0 5.43798129987466e-17
is O 0 7.922666423861445e-17
consistent O 0 9.83510690423517e-13
with O 0 8.31737438051019e-16
its O 0 2.6325607817810626e-14
gatekeeper O 0 2.857338497752604e-11
function O 0 1.6690686376399921e-12
in O 0 3.2999452237621185e-13
the O 0 3.971259519147674e-12
kidney O 0 1.8078719077330163e-10
. O 0 7.69301983227777e-12
. O 0 2.9613417273921527e-10

Piebaldism B-Disease 1 1.0
with O 0 2.5811143586906837e-06
deafness B-Disease 1 1.0
: O 0 7.86894909041852e-13
molecular O 0 8.180257686507542e-13
evidence O 0 6.572442378749779e-14
for O 0 3.729097786857663e-14
an O 0 6.869771136501501e-13
expanded O 0 4.757556126833151e-08
syndrome O 1 0.9301313161849976
. O 0 1.2685720029992353e-08

In O 0 2.959047937234338e-11
a O 0 4.008686178141874e-12
South O 0 5.8000139413483254e-11
African O 0 1.0245367922101511e-11
girl O 0 1.9474664936236508e-10
of O 0 1.4968207229237862e-11
Xhosa O 0 0.02201581932604313
stock O 0 3.5760511305632514e-12
with O 0 1.213897993896599e-14
severe O 0 2.5920892099406956e-09
piebaldism B-Disease 0 0.0033937629777938128
and O 0 6.400177610110802e-10
profound O 0 0.0009161527268588543
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 4.74113456827574e-11
identified O 0 4.2303878092621663e-14
a O 0 3.44223535677858e-17
novel O 0 3.9600072414088e-18
missense O 0 1.7520228703157142e-13
substitution O 0 6.31781411040977e-13
at O 0 5.328887288033601e-13
a O 0 3.01451775325777e-14
highly O 0 4.244663431504647e-13
conserved O 0 6.312866895896718e-12
residue O 0 5.675588332643144e-10
in O 0 7.537041737254446e-13
the O 0 6.589381817967421e-12
intracellular O 0 6.993083195849792e-11
kinase O 0 6.27999735547391e-12
domain O 0 4.965672317780445e-11
of O 0 6.700560939432165e-11
the O 0 4.604075454217593e-10
KIT O 0 0.004257688764482737
proto O 0 7.457592437276617e-05
- O 0 1.8456984207659843e-06
oncogene O 0 4.1216830481971556e-07
, O 0 5.828333909246863e-12
R796G O 0 1.735231620614286e-07
. O 0 3.7372374639410566e-10

Though O 0 2.595573711516863e-08
auditory B-Disease 0 0.0007542464300058782
anomalies I-Disease 0 1.1918067599481219e-07
have O 0 4.857683808152935e-13
been O 0 2.767080184776227e-13
observed O 0 4.0370823546111156e-13
in O 0 2.203261986917504e-13
mice O 0 2.7973079581855576e-12
with O 0 6.729483642423442e-14
dominant O 0 6.73451054922225e-08
white O 0 2.377019137078662e-10
spotting O 0 2.003315239562653e-05
( O 0 3.246023458705616e-12
W O 0 1.3072689597493081e-08
) O 0 1.584961782858437e-14
due O 0 1.3811272125963114e-09
to O 0 1.209024963477745e-10
KIT O 1 0.9869598746299744
mutations O 0 1.051172091592889e-07
, O 0 3.594496228442878e-11
deafness B-Disease 1 1.0
is O 0 2.1332408495916555e-12
not O 0 5.03709704155475e-13
typical O 0 4.6707294282244405e-11
in O 0 3.060776187623765e-13
human O 0 1.9765609288180386e-11
piebaldism B-Disease 0 7.028093591543438e-07
. O 0 8.409767104922139e-09

Thus O 0 1.928437964870966e-10
, O 0 3.7596057113321e-15
the O 0 9.783719278797735e-15
occurrence O 0 2.799326916103073e-11
of O 0 1.5223022842292266e-10
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 6.586037049061133e-09
this O 0 1.6427572843702443e-11
patient O 0 2.9704835813326724e-10
extends O 0 5.461002337186008e-14
considerably O 0 3.935040634268569e-14
the O 0 1.2559519727058251e-15
phenotypic O 0 7.361856892325325e-13
range O 0 1.1730716224789273e-12
of O 0 3.5571261648020824e-12
piebaldism B-Disease 0 1.5282524135074027e-09
due O 0 1.6105511368991188e-10
to O 0 1.3296453348077275e-11
KIT O 0 5.355460075406882e-07
gene O 0 1.0383056393836743e-11
mutation O 0 2.3398609438896045e-12
in O 0 6.318064832162157e-14
humans O 0 1.1125994223148972e-11
and O 0 4.7772641284483594e-14
tightens O 0 1.1600817962503784e-12
the O 0 1.2559957007817271e-14
clinical O 0 4.616361546500025e-13
similarity O 0 3.7330994415510355e-13
between O 0 2.9567561506821383e-12
piebaldism B-Disease 0 2.923996822445929e-09
and O 0 6.986909660588233e-15
the O 0 4.220947711768312e-15
various O 0 2.5912623351849635e-14
forms O 0 1.800723112288516e-11
of O 0 3.0417632856938326e-09
Waardenburg B-Disease 1 0.999996542930603
syndrome I-Disease 0 6.546588701894507e-05
. O 0 9.275328421987084e-11
. O 0 4.291243360654562e-09

Cycloheximide O 0 8.154711963470618e-07
facilitates O 0 6.389331425049605e-11
the O 0 9.598040678210351e-14
identification O 0 1.2662603188218213e-09
of O 0 5.29503496604633e-10
aberrant O 0 5.889829068905783e-09
transcripts O 0 1.3596136438920325e-09
resulting O 0 2.190630316034614e-11
from O 0 2.7556985014200175e-13
a O 0 2.6114462832850863e-14
novel O 0 4.7226250823395946e-14
splice O 0 6.9813625991344e-09
- O 0 2.824825269531761e-11
site O 0 3.644677008113328e-12
mutation O 0 4.058847171122676e-13
in O 0 1.3842125687855977e-13
COL17A1 O 1 0.9835221767425537
in O 0 7.591872443202252e-12
a O 0 7.146355035514418e-11
patient O 0 1.4429474504140671e-07
with O 0 3.305618279103584e-11
generalized O 0 8.373484888579696e-05
atrophic B-Disease 1 0.9999996423721313
benign I-Disease 1 0.9999996423721313
epidermolysis I-Disease 1 0.9986518025398254
bullosa I-Disease 0 0.014435634948313236
. O 0 3.5420491428794776e-08

Patients O 0 1.4186869066179497e-06
with O 0 1.0212557188804539e-10
generalized O 0 1.3560343177232426e-05
atrophic B-Disease 1 0.9999996423721313
benign I-Disease 1 0.9999908208847046
epidermolysis I-Disease 1 0.9816175103187561
bullosa I-Disease 0 0.0002633327094372362
often O 0 2.8947027067016684e-13
show O 0 4.173941194843961e-13
decreased O 0 5.5457470213293725e-12
expression O 0 1.800831077140852e-13
of O 0 1.7733862338678574e-12
type O 0 2.506487899178733e-11
XVII O 0 1.5037795009220645e-08
collagen O 0 1.8757320141560285e-09
, O 0 2.5833395752433708e-12
a O 0 2.2990078590856555e-11
transmembrane O 0 8.959935571262179e-10
hemidesmosomal O 0 1.020306505949975e-08
protein O 0 2.360922221611439e-12
encoded O 0 2.1387480274217413e-13
by O 0 1.5447317903982682e-12
COL17A1 O 0 0.00251900521107018
. O 0 1.0447495313314903e-08

This O 0 1.4207662824006206e-11
report O 0 2.3872657323176227e-13
documents O 0 2.3434743728900642e-12
a O 0 1.2020881523262111e-13
novel O 0 2.889490133706901e-13
splice O 0 4.700084588193931e-08
- O 0 6.994697182571841e-11
site O 0 1.042025580405559e-11
mutation O 0 1.7204089715339155e-12
in O 0 5.009885193328623e-13
COL17A1 O 1 0.99998939037323
in O 0 2.6615652390371558e-11
a O 0 2.567426826693975e-10
patient O 0 6.883545893288101e-07
with O 0 6.182025030776472e-11
generalized O 0 4.938985512126237e-05
atrophic B-Disease 1 0.9999996423721313
benign I-Disease 1 0.9999542236328125
epidermolysis I-Disease 0 0.1041543111205101
bullosa I-Disease 0 0.0002166169142583385
, O 0 4.835946909847316e-14
and O 0 1.1124486036940672e-15
applies O 0 2.9019267457769393e-14
a O 0 5.359850001438078e-15
new O 0 1.1177828995585196e-15
methodology O 0 5.726286198687314e-12
to O 0 3.6429518256164695e-13
define O 0 2.4273438814503834e-10
and O 0 3.6945864119800054e-13
characterize O 0 3.0992375332772326e-09
the O 0 1.3483809555014936e-11
resulting O 0 6.470630281585343e-11
mRNA O 0 2.568657508916772e-09
splice O 0 2.899019868607411e-08
variants O 0 9.93889637257439e-10
. O 0 2.817628130813432e-09

Mutational O 0 5.484473035721749e-07
analysis O 0 1.783129199850464e-10
of O 0 1.4752725707722902e-09
COL17A1 O 1 0.9999998807907104
identified O 0 9.219565555440568e-09
a O 0 6.720694833983742e-11
maternally O 0 7.56318385697341e-08
inherited O 0 6.599405821816617e-08
G O 0 4.143759113617307e-09
- O 0 5.140323722230278e-10
to O 0 3.971907247546369e-10
- O 0 1.4255518010486412e-07
T O 0 7.345181352036434e-09
transversion O 0 1.273981297345017e-06
at O 0 8.911217250218151e-12
the O 0 2.3718166645113337e-13
- O 0 1.1784059242726103e-13
1 O 0 7.477096944526716e-15
position O 0 5.785249883316634e-12
of O 0 7.104085548992334e-12
exon O 0 1.9044373023024974e-10
32 O 0 2.1117516624258315e-09
. O 0 4.150506160982559e-09

This O 0 2.0434884253489605e-12
acceptor O 0 2.8928872630729074e-09
splice O 0 1.1407073543523438e-06
- O 0 1.8126168344068105e-09
site O 0 4.9292098180941935e-11
mutation O 0 1.2598382623588145e-12
led O 0 7.962429543831306e-14
to O 0 1.141361988645298e-13
the O 0 6.411041944716367e-13
formation O 0 1.2426499829132354e-09
of O 0 4.56542670335125e-09
aberrant O 0 3.737255482860746e-08
transcripts O 0 6.26702600925455e-08
present O 0 2.2203561211853184e-09
at O 0 6.586309830858283e-10
extremely O 0 9.469355299884796e-10
low O 0 9.100864950539744e-09
levels O 0 1.0512299475351483e-08
. O 0 2.703656853952907e-09

Based O 0 3.929994892883093e-13
on O 0 1.1764236503356007e-12
our O 0 2.691966875106866e-12
recent O 0 2.075183456334579e-14
finding O 0 5.637107534234298e-13
that O 0 2.1887964514179193e-15
cycloheximide O 0 2.8693347697839044e-09
stabilized O 0 3.48865114574437e-08
mutant O 0 6.606818425680672e-10
COL17A1 O 0 3.985423063568305e-06
transcripts O 0 8.837797715877116e-10
in O 0 9.139289802381767e-13
keratinocytes O 0 3.090785583026445e-08
homozygous O 0 5.7194995267684234e-11
for O 0 3.026225374892083e-13
a O 0 5.834562867568227e-12
frameshift O 0 3.865807940428567e-08
mutation O 0 3.096740919250607e-11
, O 0 8.142703057775671e-15
the O 0 6.019110990879151e-14
effects O 0 6.566681334981006e-13
of O 0 1.322552419143197e-12
the O 0 4.53502600056277e-12
splice O 0 2.214418426405018e-09
- O 0 3.850633353841282e-12
site O 0 2.561465308522498e-13
mutation O 0 5.850129400209575e-16
on O 0 1.8268416971225013e-15
splicing O 0 1.144307413582235e-12
of O 0 1.3040768985506102e-11
COL17A1 O 0 9.142881935986225e-06
transcripts O 0 2.0029988778702545e-10
were O 0 2.2099740115168187e-14
determined O 0 6.937299364384022e-15
using O 0 3.3318538612104416e-16
reverse O 0 2.2503059935201006e-14
transcriptase O 0 2.022234749175355e-14
polymerase O 0 1.153120584722377e-14
chain O 0 3.910400445832941e-15
reaction O 0 5.632069238268428e-16
of O 0 1.8743047478647634e-13
total O 0 2.620725034555016e-12
RNA O 0 4.662042626946139e-11
from O 0 8.436391342458993e-12
keratinocytes O 0 2.068967859258919e-07
incubated O 0 1.1068855831908309e-09
for O 0 6.936102083313078e-13
2 O 0 4.3337146371502655e-11
. O 0 6.635461069492976e-10

5 O 0 1.2817676087184537e-10
h O 0 8.769129519747842e-12
in O 0 1.0993131725018854e-13
the O 0 3.4908060058021217e-13
presence O 0 6.337510811277314e-13
or O 0 1.5693599848473627e-12
absence O 0 5.813232117901634e-09
of O 0 2.6499276106761727e-09
10 O 0 2.1444944431348034e-10
microg O 0 3.286630700927162e-08
cycloheximide O 0 4.9048146877339605e-08
per O 0 1.8143298419204257e-08
ml O 0 9.609920681441508e-08
. O 0 3.772878010011027e-09

Using O 0 6.123295772340887e-13
this O 0 1.599978660573719e-14
approach O 0 6.703714840183839e-12
, O 0 2.724615983675481e-14
an O 0 1.6339833064610114e-14
abnormally O 0 8.24449970099339e-12
spliced O 0 6.329185509024171e-10
transcript O 0 4.408552634060925e-09
was O 0 7.935814332060698e-12
identified O 0 4.881677527490691e-12
that O 0 1.4886490757337633e-15
contains O 0 2.340570408945346e-16
an O 0 2.613923988328192e-17
extra O 0 6.421734888642505e-14
264 O 0 1.4658690927760176e-11
bases O 0 1.5415368981308575e-10
upstream O 0 1.6514848516502312e-11
from O 0 2.3698460728527326e-12
exon O 0 1.930881704526044e-10
32 O 0 1.6168608119038197e-10
, O 0 1.8019091129134815e-14
resulting O 0 2.9648256506115134e-12
in O 0 8.650297817457131e-13
a O 0 2.1090042906513062e-11
premature O 0 3.48594242360889e-09
termination O 0 1.2983680797162833e-08
codon O 0 3.7888170822952816e-08
27 O 0 1.511762803829697e-08
bp O 0 2.24461143005783e-08
downstream O 0 3.906806256281925e-08
from O 0 2.2496840501595727e-10
the O 0 2.3487314315673302e-09
cryptic O 0 9.644571008493585e-08
splice O 0 6.864390798000386e-07
site O 0 1.023265028265996e-08
. O 0 5.876408248894904e-09

Three O 0 6.616275860515941e-10
other O 0 1.297632574309704e-12
splice O 0 2.489884520784358e-09
variants O 0 6.3979620212872845e-12
, O 0 2.779359680704879e-15
including O 0 4.384152537737613e-16
one O 0 4.945000792443708e-15
derived O 0 2.839125690188432e-13
from O 0 4.4151913570524004e-13
the O 0 6.565407505848553e-12
skipping O 0 1.0490366797455408e-08
of O 0 1.0878937750646855e-08
exon O 0 6.151531728448845e-09
32 O 0 1.412858630089886e-08
, O 0 4.972076569909056e-12
were O 0 9.079182544668996e-11
also O 0 2.446593925717333e-12
identified O 0 8.990029276567668e-10
. O 0 8.613074697905176e-09

These O 0 1.4406607417444262e-13
results O 0 2.510705402261615e-13
indicate O 0 6.365871913806276e-13
the O 0 2.0200912475990332e-14
usefulness O 0 8.499790454807865e-11
of O 0 1.9527873242053406e-12
cycloheximide O 0 1.1733307658801095e-09
treatment O 0 1.0653395700332968e-11
in O 0 3.2783000760653463e-14
evaluating O 0 2.0310151130353837e-12
the O 0 1.0618598014766611e-12
abnormal O 0 4.634893857602407e-11
processing O 0 8.788444971763454e-10
of O 0 1.468107579949418e-11
mRNA O 0 2.77172257368008e-10
due O 0 4.764191263717521e-09
to O 0 1.266289295642764e-09
splice O 0 2.7604564820649102e-06
- O 0 5.439185990496753e-09
site O 0 1.5907922201741087e-10
mutations O 0 1.302498386923645e-11
, O 0 1.889385932321401e-14
because O 0 7.290894369358161e-14
( O 0 5.2863029776609345e-15
i O 0 2.1280228013759173e-12
) O 0 8.069814178598544e-16
aberrant O 0 1.3067628576446388e-12
splicing O 0 1.4906438930428756e-11
often O 0 3.0324870490140016e-14
generates O 0 3.4781432698164846e-14
a O 0 4.282107979834693e-14
premature O 0 1.9894395159036904e-11
termination O 0 1.1622866558091971e-10
codon O 0 2.248453645492532e-09
, O 0 2.737379279412616e-13
( O 0 8.657481402238841e-16
ii O 0 1.0902726638173377e-11
) O 0 8.749840180741555e-14
transcripts O 0 7.067655349857205e-10
with O 0 2.1636699051343078e-13
premature O 0 4.230751582401382e-10
termination O 0 2.529561560216109e-10
codons O 0 2.1671094085906617e-10
can O 0 1.91626662454647e-12
occur O 0 5.413079012805966e-11
at O 0 2.1022931659397948e-11
low O 0 3.3817779132583325e-10
or O 0 5.18554817141581e-12
undetectable O 0 5.40900241263742e-11
levels O 0 7.408269418925084e-13
due O 0 1.8337499487625086e-12
to O 0 1.5145159432128352e-12
nonsense O 0 5.207795306105822e-10
- O 0 2.9656797850829975e-12
mediated O 0 4.1170639814014365e-11
mRNA O 0 1.053211753920813e-10
decay O 0 2.5447675078282828e-09
, O 0 1.6347593580472858e-14
and O 0 2.652893214756839e-15
( O 0 9.029211737308741e-17
iii O 0 9.910732174170378e-13
) O 0 1.1080444558848185e-14
the O 0 1.5588083124642993e-12
levels O 0 7.287804387745567e-11
of O 0 3.438877654859951e-12
these O 0 2.1211976402799038e-13
transcripts O 0 5.632030258828635e-11
can O 0 4.01624534410866e-13
be O 0 3.2908812936001397e-13
increased O 0 3.1958936365372725e-12
by O 0 1.1374267413349903e-12
cycloheximide O 0 1.4278501794251497e-06
. O 0 1.226352264183106e-08

A O 0 6.983469091892403e-08
deletion O 0 7.496741005752483e-09
mutation O 0 1.132593324681963e-11
in O 0 1.0780491083162147e-12
COL17A1 O 0 0.10643787682056427
in O 0 1.0444565134645756e-12
five O 0 8.459315062672723e-13
Austrian O 0 7.48305084563583e-10
families O 0 4.1944139134164615e-12
with O 0 1.6545075856230773e-12
generalized O 0 1.1033786222469644e-06
atrophic B-Disease 1 0.9999741315841675
benign I-Disease 1 0.9999802112579346
epidermolysis I-Disease 1 0.9526904225349426
bullosa I-Disease 0 4.390294270706363e-05
represents O 0 8.957568194134513e-12
propagation O 0 1.3755458994069159e-09
of O 0 3.8079667891155466e-11
an O 0 4.0664100233768485e-13
ancestral O 0 8.790292937987942e-09
allele O 0 3.0011924057049555e-09
. O 0 2.365848184027186e-09

Patients O 0 3.5344880870979978e-06
with O 0 1.8219432906807498e-10
generalized O 0 0.0009723831317387521
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999967813491821
bullosa I-Disease 1 0.9457445740699768
, O 0 2.5199133144720998e-12
a O 0 8.828366098063978e-13
usually O 0 2.5499624113634045e-12
nonlethal O 0 4.0318980154552264e-08
form O 0 4.5615120569664214e-08
of O 0 4.2927873437292874e-05
junctional B-Disease 1 0.9999997615814209
epidermolysis I-Disease 1 0.9999725818634033
bullosa I-Disease 1 0.5385313034057617
, O 0 1.323565042288255e-11
have O 0 1.4954550998143995e-13
generalized O 0 1.1066437696771736e-11
blistering B-Disease 0 1.9615806201578323e-10
, O 0 2.2734135266596484e-13
nail B-Disease 1 0.8350855708122253
dystrophy I-Disease 1 0.9946817755699158
, O 0 4.905988948422646e-10
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 7.606141827487534e-10
and O 0 4.434859590674023e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.8063164949417114

Skin B-Disease 1 1.0
fragility I-Disease 1 0.9999290704727173
in O 0 3.350417816447293e-12
most O 0 6.854646312907421e-15
cases O 0 8.781313383962683e-16
is O 0 4.348323374941001e-17
due O 0 4.862457550318389e-13
to O 0 3.143597036327217e-13
mutations O 0 9.200429860242026e-14
in O 0 1.4740987225900053e-14
the O 0 6.011011323024326e-14
gene O 0 8.093248192117281e-15
encoding O 0 4.9682868930034374e-11
type O 0 4.580515966523535e-09
XVII O 0 2.543685241107596e-06
collagen O 0 7.289260395282326e-08
( O 0 1.5006140427487047e-11
COL17A1 O 1 0.9834998846054077
) O 0 7.783212442602494e-12
. O 0 2.5719457119599554e-10

Recently O 0 4.51673004553399e-10
, O 0 4.1854669415638396e-14
we O 0 9.173335478545024e-15
reported O 0 3.232347861050443e-14
five O 0 1.9642909193195827e-14
Austrian O 0 6.415720732455554e-11
families O 0 4.304993427711734e-12
with O 0 4.330217174414175e-12
generalized O 0 8.010107194422744e-06
atrophic B-Disease 1 0.9999960660934448
benign I-Disease 1 0.9999945163726807
epidermolysis I-Disease 1 0.9999005794525146
bullosa I-Disease 1 0.9658682346343994
who O 0 2.9917308214111316e-11
share O 0 1.5272491604712002e-10
the O 0 1.907242766496786e-11
same O 0 1.8539134116757339e-10
COL17A1 O 0 0.26457732915878296
mutation O 0 3.3236648988577144e-09
. O 0 1.441746610986172e-09

Affected O 0 8.402119000550101e-09
individuals O 0 1.1947695437164452e-12
in O 0 3.277114094413919e-13
three O 0 7.383358247708971e-13
families O 0 3.2660191825323315e-13
are O 0 7.505731740341595e-15
homozygous O 0 4.253391801094242e-13
for O 0 2.2065380393069406e-13
4003delTC O 0 1.950911077130968e-08
, O 0 5.620528117900557e-14
whereas O 0 3.457933939188251e-11
those O 0 9.740959124385218e-13
in O 0 6.48871689885866e-13
two O 0 6.172266257126191e-12
others O 0 1.0265006726573045e-11
are O 0 3.196446471225023e-13
compound O 0 1.1955235690308541e-09
heterozygotes O 0 5.1445958604290354e-08
. O 0 2.871394677583794e-08

To O 0 2.48288833937238e-10
determine O 0 1.6879010689141438e-10
if O 0 1.8922217308661726e-13
the O 0 3.7864161675851826e-13
occurrence O 0 4.121888247388128e-11
of O 0 1.3184470876170806e-12
4003delTC O 0 1.2230392254508615e-09
in O 0 1.8944957432790073e-14
these O 0 3.167198067802494e-15
unrelated O 0 7.010490820670567e-13
families O 0 9.016348933199754e-15
signifies O 0 3.002091034532556e-13
propagation O 0 3.069642803832373e-11
of O 0 6.1542099541456174e-12
an O 0 8.66095864189391e-14
ancestral O 0 8.312630583873215e-09
allele O 0 7.038507554568696e-09
or O 0 2.141330862626134e-10
a O 0 1.6470729224948855e-09
mutational O 0 6.856526511000993e-07
hot O 0 6.051981138455176e-09
spot O 0 7.639032517658961e-09
, O 0 1.363378946414931e-13
haplotypes O 0 4.2163213892498774e-11
were O 0 4.604349670631058e-13
determined O 0 6.652700959564051e-12
for O 0 1.4730321996891949e-12
polymorphisms O 0 1.5949248588498222e-09
both O 0 4.2759441820638955e-11
within O 0 3.3508447128127727e-09
and O 0 6.517947293005477e-11
flanking O 0 2.8874837880721316e-06
COL17A1 O 1 0.9998891353607178
. O 0 7.404762527585262e-07

Five O 0 5.95085092314207e-09
intragenic O 0 3.848967011776949e-08
polymorphisms O 0 2.793567877024117e-10
were O 0 5.38081298268045e-13
chosen O 0 4.152044159877466e-12
based O 0 1.1021721458680939e-14
on O 0 3.644837036353987e-12
their O 0 3.1224699909015996e-11
informativeness O 0 1.429186681889405e-06
. O 0 1.0679555018100473e-08

One O 0 1.8667617451839646e-10
of O 0 1.845005398459776e-11
these O 0 8.769990078117199e-14
, O 0 1.1683649543114678e-15
not O 0 3.2086664715594597e-15
previously O 0 6.349186042371724e-13
reported O 0 4.077080741158451e-13
, O 0 1.8754292010429024e-15
was O 0 9.250866132154423e-13
2988 O 0 1.1541538391668382e-08
A O 0 4.988593538257646e-09
or O 0 5.9920493046539125e-12
C O 0 1.6794697188515784e-08
that O 0 5.799629168839332e-14
introduces O 0 7.092181659659746e-13
a O 0 1.333209394662263e-13
new O 0 2.1973979439423447e-14
restriction O 0 1.4220959479449569e-13
site O 0 3.2315911556966836e-13
for O 0 1.7303136191654939e-13
Eco0109 O 0 1.3478974381087028e-07
I O 0 5.351472509573796e-07
. O 0 6.2995617611250054e-09

All O 0 1.5197456140758625e-11
the O 0 3.53998677159878e-13
4003delTC O 0 1.1381810077759624e-10
alleles O 0 3.106605413454727e-13
showed O 0 2.4628861233430555e-13
the O 0 2.739277446366095e-15
same O 0 9.70610056764314e-15
haplotype O 0 5.4755887324287045e-12
for O 0 6.104168684189712e-14
these O 0 1.474403010705977e-13
five O 0 7.253367611398387e-12
polymorphic O 0 7.021113135330381e-10
markers O 0 2.9477844609715476e-09
. O 0 2.1460966337372156e-08

Fourteen O 0 4.654894247835273e-09
microsatellite O 0 1.1938146027290486e-09
polymorphisms O 0 6.632331489564436e-11
were O 0 1.779087131521112e-13
selected O 0 1.52979218919283e-13
based O 0 1.5974651750060367e-15
on O 0 4.3048182206406604e-13
their O 0 4.018991302950914e-12
high O 0 4.099456538120272e-11
heterozygosity O 0 1.7983032307711255e-07
and O 0 1.1011834890120586e-12
their O 0 2.4169572593324418e-11
location O 0 1.1003307154311415e-09
within O 0 2.7619448950133574e-09
10q23 O 0 2.866978320525959e-06
- O 0 1.5876435099926312e-07
q25 O 0 1.5819908867342747e-06
near O 0 2.078236605029815e-07
COL17A1 O 0 0.007757621351629496
. O 0 4.592152436089236e-08

Three O 0 7.478995200926875e-11
families O 0 1.7907619831447619e-12
shared O 0 1.2322401779507608e-11
microsatellite O 0 3.1580507098283306e-09
polymorphisms O 0 3.90401844185817e-09
covering O 0 2.407850097085884e-08
at O 0 2.046975033920262e-09
most O 0 2.3028863972013314e-12
19 O 0 7.680912850194233e-11
cM O 0 1.5124196339755258e-09
, O 0 1.5706079286529478e-13
whereas O 0 3.197339962235368e-11
the O 0 3.65024468984565e-11
others O 0 9.741112430572407e-12
shared O 0 3.0284527663404504e-10
smaller O 0 1.3901002744731716e-12
regions O 0 1.7105285937679682e-11
consistent O 0 1.478126995801965e-11
with O 0 5.716357698607941e-15
cross O 0 3.4219546640734677e-10
- O 0 1.1018407297669341e-09
over O 0 6.672204021923589e-13
events O 0 4.1492238247661795e-13
during O 0 1.0618806181583729e-11
passage O 0 1.9239061298942373e-12
of O 0 2.2254894528248546e-14
this O 0 2.8303961686340293e-15
mutation O 0 2.6123131368033063e-14
through O 0 5.40675597555159e-14
several O 0 3.017629752305982e-14
generations O 0 6.784710016027873e-10
. O 0 9.625706898219732e-10

These O 0 1.142861304724574e-12
results O 0 8.979356429412999e-13
indicate O 0 4.22876230560254e-12
that O 0 1.0750884156104034e-15
4003delTC O 0 5.345580644799952e-10
occurs O 0 6.724813441565461e-14
on O 0 8.948196662263673e-15
a O 0 6.375525514424815e-15
single O 0 1.1063372440389685e-12
ancestral O 0 7.886540309698375e-10
allele O 0 1.828701079453765e-10
. O 0 1.6754774651017712e-11
. O 0 1.1611660521992917e-09

The O 0 7.803956925123146e-10
haptoglobin O 0 9.84331109066261e-07
- O 0 2.7452278228423665e-09
gene O 0 2.5304756120364535e-12
deletion O 0 1.3510383090054034e-10
responsible O 0 9.688586044553915e-11
for O 0 2.2776791563927645e-10
anhaptoglobinemia B-Disease 1 0.9750729203224182
. O 0 5.219475696094378e-08

We O 0 5.95331978159308e-11
have O 0 1.9027741350857025e-14
found O 0 3.849819378895893e-15
an O 0 3.7076173965982525e-17
allelic O 0 3.2319209808395755e-11
deletion O 0 4.146065712973268e-10
of O 0 7.714601402142307e-09
the O 0 5.2952500162462e-09
haptoglobin O 0 8.33532521937741e-06
( O 0 3.8297124260906756e-13
Hp O 0 1.894661337542569e-11
) O 0 3.641238786183942e-15
gene O 0 9.868807973514165e-15
from O 0 2.0996182223398385e-13
an O 0 6.904588222510482e-15
individual O 0 4.0365890426226347e-13
with O 0 8.654560575138692e-12
anhaptoglobinemia B-Disease 0 9.45814826991409e-06
. O 0 5.618101894810934e-08

The O 0 5.218531856643338e-11
Hp O 0 1.0145608311806775e-11
gene O 0 1.8578060453005663e-15
cluster O 0 7.448518391699535e-14
consists O 0 2.6100768004159655e-14
of O 0 5.42837530568413e-13
coding O 0 1.4232447220763333e-08
regions O 0 3.381276370006958e-09
of O 0 3.893021016665443e-09
the O 0 5.5857395098168894e-11
alpha O 0 2.199870060420883e-12
chain O 0 2.0697167056929998e-14
and O 0 8.492427503345684e-16
beta O 0 5.696109274359873e-13
chain O 0 3.4799084864785626e-14
of O 0 3.421662096454031e-13
the O 0 7.207633470097952e-13
haptoglobin O 0 2.445841529308268e-09
gene O 0 1.0225892669527697e-13
( O 0 3.1628498771073233e-16
Hp O 0 3.852761751126088e-13
) O 0 1.1972809385950555e-16
and O 0 4.1167414834323516e-15
of O 0 3.696540469555476e-12
the O 0 1.5826707349189673e-12
alpha O 0 3.678589551026068e-13
chain O 0 1.0718908027070474e-14
and O 0 2.7024524772259776e-15
beta O 0 1.1008496631631504e-12
chain O 0 1.3871251423967085e-13
of O 0 6.110182347064674e-13
the O 0 2.374986492192921e-12
haptoglobin O 0 1.9777978366164461e-07
- O 0 9.42634081901872e-10
related O 0 3.8340741692621805e-10
gene O 0 3.8361016294931327e-13
( O 0 5.994234903767713e-15
Hpr O 0 3.82156262190847e-09
) O 0 1.0083665503881744e-14
, O 0 2.8613139299999953e-15
in O 0 1.1799257046678918e-14
tandem O 0 2.530381737475551e-10
from O 0 2.0960911825684825e-11
the O 0 1.7888998615767093e-10
5 O 0 3.158205641451417e-10
side O 0 2.2327100168695324e-09
. O 0 6.080977499323126e-09

Southern O 0 4.3096724766655825e-07
blot O 0 2.8497620974121673e-07
and O 0 3.8151456278022466e-13
PCR O 0 2.0722766558289862e-10
analyses O 0 5.292667346057378e-12
have O 0 4.092313688508248e-16
indicated O 0 7.390268444136625e-15
that O 0 2.4771925219982792e-18
the O 0 2.424634193795599e-16
individual O 0 2.053808834020501e-15
with O 0 1.7006161061688366e-15
anhaptoglobinemia B-Disease 0 1.2168915874966046e-09
was O 0 2.9229442217310053e-12
homozygous O 0 1.5290022937000658e-12
for O 0 1.5457883725204097e-14
the O 0 3.608443838870601e-13
gene O 0 1.0359367443729672e-13
deletion O 0 4.6824562456582175e-12
and O 0 5.632050815301826e-15
that O 0 8.335893167715129e-16
the O 0 7.315703625570061e-14
gene O 0 2.6006350935595113e-14
deletion O 0 2.4336691516191333e-12
was O 0 2.8114236199500153e-12
included O 0 3.4618434421179733e-13
at O 0 1.3336704787411668e-12
least O 0 4.421273460189501e-14
from O 0 4.95278189120707e-14
the O 0 6.571392193420456e-13
promoter O 0 2.329960002711573e-09
region O 0 2.18661373452278e-08
of O 0 8.275580221095424e-09
Hp O 0 1.762396228954799e-09
to O 0 1.2026089013517094e-09
Hpr O 0 8.330092526875887e-08
alpha O 0 7.48114591109239e-12
but O 0 8.494444839364512e-14
not O 0 2.587134879158265e-13
to O 0 1.0510784603789958e-10
Hpr O 0 2.84641032521904e-07
beta O 0 7.032572857390562e-10
( O 0 2.064864772222119e-12
Hpdel O 0 7.134420343390957e-07
) O 0 5.122564265130913e-12
. O 0 1.0144535211864536e-09

In O 0 1.1381288966827441e-10
addition O 0 5.0350439963209315e-12
, O 0 2.0097032355339065e-14
we O 0 1.461656655627787e-14
found O 0 1.2101206504683184e-14
seven O 0 8.9592511198517e-14
individuals O 0 4.577322848281929e-15
with O 0 1.4758768141528815e-14
hypohaptoglobinemia B-Disease 0 9.414540258489978e-09
in O 0 9.069931763104611e-13
three O 0 1.8020311805255762e-12
families O 0 1.7318796136783776e-12
, O 0 5.242084469682471e-15
and O 0 2.6996085641055713e-15
the O 0 6.255068620182602e-13
genotypes O 0 8.624363445619565e-10
of O 0 2.917249497524921e-10
six O 0 3.306893647803122e-10
of O 0 2.1515413062278554e-10
the O 0 3.888065217005909e-12
seven O 0 1.993867961361251e-12
individuals O 0 4.8830412640882975e-14
were O 0 7.577348470899636e-12
found O 0 1.4568485307009382e-12
to O 0 3.808794599158283e-11
be O 0 7.585311934121819e-09
Hp2 O 0 0.4827260971069336
/ O 0 0.0005454713245853782
Hpdel O 0 0.0008063318091444671
. O 0 1.0231795499748841e-07

The O 0 6.762078896827006e-09
phenotypes O 0 1.8193294648582992e-09
and O 0 4.3936769912426843e-13
genotypes O 0 6.247754397170624e-11
in O 0 7.658928152061081e-14
one O 0 2.3570231663249015e-14
of O 0 5.1388333556978347e-14
these O 0 5.560384310546705e-16
three O 0 1.472985721297313e-14
families O 0 3.268280015112507e-14
showed O 0 7.831486110651542e-13
the O 0 1.3302755435835173e-13
father O 0 3.68691492266815e-12
to O 0 6.58827922772609e-11
be O 0 1.6204431130262265e-09
hypohaptoglobinemic B-Disease 0 0.265389621257782
( O 0 2.441043721324032e-11
Hp2 O 0 0.00011987647303612903
) O 0 1.3414669765635101e-12
and O 0 1.259538567194296e-11
Hp2 O 0 0.0002582815650384873
/ O 0 1.0664760452527844e-07
Hpdel O 0 2.1798775833303807e-06
, O 0 2.033466744869126e-14
the O 0 4.624796097300876e-13
mother O 0 2.664737191755001e-13
to O 0 2.5643408837344728e-12
be O 0 6.477594155507305e-11
Hp2 O 1 0.8561713099479675
- O 0 7.360652887200558e-08
1 O 0 7.471951529725018e-11
and O 0 4.636060979557044e-11
Hp1 O 0 0.00023744320787955076
/ O 0 1.0559765506457097e-08
Hp2 O 0 6.873103330917729e-08
, O 0 3.3105946577233387e-16
one O 0 2.674157394562507e-16
of O 0 1.8527749660554073e-14
the O 0 3.205633797146758e-14
two O 0 4.4038689660024985e-14
children O 0 2.2102816538832615e-14
to O 0 2.692824479025302e-12
be O 0 2.787686192995409e-10
hypohaptoglobinemic B-Disease 0 5.969429184915498e-05
( O 0 2.8813916530534556e-11
Hp2 O 0 5.432856778497808e-05
) O 0 6.067540567200602e-12
and O 0 4.5782402174898706e-11
Hp2 O 0 0.00010405475040897727
/ O 0 1.8487673969502794e-07
Hpdel O 0 5.52820756638539e-06
, O 0 1.3023845612809403e-14
and O 0 1.2836483618942646e-15
the O 0 7.406641082787283e-14
other O 0 2.4272276286855902e-14
child O 0 2.3725370626448417e-12
to O 0 9.92291838974868e-12
be O 0 4.52630294356382e-10
Hp1 O 0 0.0005458098603412509
and O 0 3.3264808685373737e-09
Hp1 O 0 0.30301493406295776
/ O 0 4.869054464506917e-06
Hpdel O 0 1.4707895388710313e-05
, O 0 2.006058486643189e-13
showing O 0 3.125425265815274e-11
an O 0 6.230726926157587e-14
anomalous O 0 5.445494055678068e-10
inheritance O 0 1.6237047262279702e-08
of O 0 3.704093671785813e-07
Hp O 0 5.838734828955694e-09
phenotypes O 0 5.021602578203499e-10
in O 0 5.9353542046503e-13
the O 0 2.9346080687026044e-12
child O 0 1.2954867213699206e-11
with O 0 4.3149457531338475e-13
Hp1 O 0 2.2755418740416644e-06
. O 0 1.619609690806101e-08

The O 0 2.3743389476749144e-08
Hp2 O 0 0.00040709844324737787
/ O 0 2.007882500265623e-07
Hpdel O 0 1.3118645938448026e-06
individuals O 0 1.5276380421064273e-12
had O 0 4.95659546392857e-12
an O 0 3.2727835198864685e-14
extremely O 0 6.762562732021138e-11
low O 0 2.993670378259594e-08
level O 0 0.0010406333021819592
of O 0 1.5009689491307654e-07
Hp O 0 1.179331909906267e-10
( O 0 5.015196106848566e-15
mean O 0 1.4135136203879961e-12
+ O 0 1.0209001612832003e-12
/ O 0 2.9915708799066465e-11
- O 0 2.9776920512647465e-11
SD O 0 1.6280207182362005e-09
= O 0 1.8359615043539446e-12
0 O 0 1.3641897602333607e-14
. O 0 5.8197046120189114e-15
049 O 0 6.992226242452659e-12
+ O 0 8.561366134259007e-13
/ O 0 4.573300418919679e-11
- O 0 1.0817138851315633e-11
0 O 0 4.789131483555866e-15
. O 0 3.7606260472203626e-14
043 O 0 4.0779582488603694e-10
mg O 0 1.1020013894469383e-11
/ O 0 2.6147797468900613e-11
ml O 0 2.403560857289211e-11
; O 0 3.684273142102144e-15
n O 0 1.0428675067605808e-13
= O 0 2.0060152540815612e-14
6 O 0 8.84856949404057e-15
) O 0 7.191437935183956e-18
, O 0 4.193704789609119e-18
compared O 0 8.621331730115922e-15
with O 0 1.18925204563693e-15
the O 0 2.2541744946341646e-12
level O 0 3.745874277427674e-09
( O 0 1.0886739108769661e-16
1 O 0 4.310390526410544e-16
. O 0 3.752081994117673e-16
64 O 0 2.0123318159384618e-13
+ O 0 5.81742445014688e-13
/ O 0 4.4152629469218496e-11
- O 0 6.389632746517382e-12
1 O 0 5.905491685400353e-15
. O 0 5.404361159299818e-15
07 O 0 9.880043831678176e-13
mg O 0 1.4581516332920486e-13
/ O 0 7.920608477906751e-14
ml O 0 3.417401520729342e-14
) O 0 1.6081196575152332e-18
obtained O 0 3.126380312403962e-14
from O 0 3.587901121495339e-14
52 O 0 4.113068913236262e-11
healthy O 0 8.44117553633339e-11
volunteers O 0 2.933125313811513e-12
having O 0 2.561886900537269e-12
phenotype O 0 1.8582785310528038e-10
Hp2 O 0 4.0863866956897255e-08
, O 0 2.2773661550860337e-14
whereas O 0 8.921670910724822e-13
the O 0 9.43040892771585e-13
serum O 0 9.068829021074976e-12
Hp O 0 4.523571187770026e-12
level O 0 1.6538151403899803e-10
of O 0 1.8892331275777163e-12
an O 0 1.290723945740035e-15
individual O 0 4.156199581543951e-14
with O 0 1.0777756725283139e-12
Hp1 O 0 2.581097578513436e-05
/ O 0 1.5105226793821203e-06
Hpdel O 0 7.321542852878338e-06
was O 0 3.214260801964741e-10
0 O 0 2.0453885113402848e-11
. O 0 1.0474101447277562e-10

50 O 0 1.1287799139836352e-08
mg O 0 5.246478806952837e-10
/ O 0 5.116954637784943e-10
ml O 0 5.036691619331179e-10
, O 0 3.735617314749385e-15
which O 0 6.11403998498119e-17
was O 0 8.441947939579354e-15
approximately O 0 8.570539399433818e-15
half O 0 1.2502116515981064e-14
the O 0 1.2416027136540747e-13
level O 0 2.4770903106485775e-09
of O 0 1.5957912768982396e-10
Hp O 0 3.492681144301457e-11
in O 0 1.1295859213278359e-11
control O 0 1.8959292802378513e-08
sera O 0 2.702161827627947e-09
from O 0 1.8664713871685557e-12
the O 0 1.2784367314777612e-11
Hp1 O 0 7.089000177984417e-07
phenotype O 0 2.8840710375455103e-10
( O 0 1.426647958060643e-15
1 O 0 2.2516927558613453e-14
. O 0 8.008882016504858e-15
26 O 0 1.4124617274402507e-13
+ O 0 5.573845963773028e-13
/ O 0 1.554836120964964e-11
- O 0 3.720264547812935e-12
0 O 0 1.5113652288297028e-15
. O 0 4.7483828460458295e-15
33 O 0 1.7985698650899162e-12
mg O 0 1.4346179409360782e-12
/ O 0 6.984162380374581e-12
ml O 0 7.03345107849751e-12
; O 0 2.748027296711232e-15
n O 0 1.1394238417367086e-13
= O 0 5.4099330267301515e-14
9 O 0 1.5719326881824536e-13
) O 0 2.362692262549668e-16
, O 0 1.7432300690474044e-16
showing O 0 7.965573730131514e-14
a O 0 2.2342263943878754e-13
gene O 0 2.6815795677731513e-12
- O 0 9.533886180523865e-11
dosage O 0 8.714532429010546e-10
effect O 0 3.144919741293606e-11
. O 0 4.6553627619516647e-10

The O 0 4.3088091428167274e-10
other O 0 6.387655161754768e-13
allele O 0 2.8307852589781746e-11
( O 0 1.4341240190838753e-14
Hp2 O 0 8.145853058749708e-08
) O 0 1.430463481499021e-14
of O 0 6.816417222332838e-12
individuals O 0 2.803006741644576e-12
with O 0 4.370562592392879e-11
Hp2 O 1 1.0
/ O 1 0.999925971031189
Hpdel O 0 0.4937325119972229
was O 0 3.675773574407515e-11
found O 0 5.3602210018689755e-14
to O 0 1.5416697595176804e-13
have O 0 2.2106358830618032e-14
, O 0 1.155290577254124e-15
in O 0 8.792882159956283e-15
all O 0 5.685254784310034e-13
exons O 0 2.416174760266898e-10
, O 0 3.182690046297891e-14
no O 0 1.8205467176650968e-14
mutation O 0 2.6330114456606492e-15
, O 0 1.0499065198265046e-17
by O 0 7.318692227799726e-17
DNA O 0 8.263080497616926e-11
sequencing O 0 9.688739810442826e-10
. O 0 4.409704601471276e-09

On O 0 8.226266889899136e-11
the O 0 8.985828303231108e-14
basis O 0 2.957609157583363e-11
of O 0 3.2053605104366556e-13
the O 0 7.841526093819301e-14
present O 0 4.5254327629001834e-13
study O 0 9.816618038469092e-15
, O 0 5.888075417455384e-17
the O 0 4.177791806622179e-15
mechanism O 0 4.882990713162005e-12
of O 0 9.041263397679966e-12
anhaptoglobinemia B-Disease 0 2.1623309010010416e-07
and O 0 1.7104363715311766e-12
the O 0 4.444379239632035e-11
mechanism O 0 4.146312626573945e-09
of O 0 1.1329914090252302e-10
anomalous O 0 3.366173784158377e-09
inheritance O 0 1.9867540501650183e-08
of O 0 3.224518962952061e-08
Hp O 0 5.464652286235605e-09
phenotypes O 0 8.876975265970088e-10
were O 0 2.8167978366466784e-11
well O 0 8.48957883159418e-12
explained O 0 2.420861289209597e-10
. O 0 3.888417920983045e-10

However O 0 8.481009228233916e-10
, O 0 1.6045513171174947e-13
the O 0 4.5022904675284803e-13
mechanism O 0 9.627487695951231e-10
of O 0 1.7367507432197726e-10
hypohaptoglobinemia B-Disease 0 0.00021691538859158754
remains O 0 4.5640533130608674e-07
unknown O 0 6.599082553293556e-05

ATM O 0 6.836977263446897e-05
mutations O 0 1.180000874789755e-09
and O 0 6.921287544828236e-13
phenotypes O 0 1.1097055496733788e-09
in O 0 1.0071582456916417e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 7.621324726869716e-08
in O 0 1.1870148960979598e-12
the O 0 6.856640906091616e-13
British O 0 3.2724808106399106e-12
Isles O 0 1.8544802360409562e-09
: O 0 6.90257935152717e-17
expression O 0 1.3219079083854994e-14
of O 0 1.2312992693584018e-13
mutant O 0 3.6634654728209815e-13
ATM O 0 1.2641994118212097e-09
and O 0 2.1948217779365654e-14
the O 0 2.562867995083151e-13
risk O 0 2.645000104356532e-12
of O 0 6.958672353618578e-12
leukemia B-Disease 1 0.9587115049362183
, O 0 3.834974005023639e-10
lymphoma B-Disease 1 1.0
, O 0 2.281886146704437e-08
and O 0 5.111253358336398e-07
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999973773956299
. O 1 0.9969250559806824

We O 0 8.865882854258711e-12
report O 0 2.9072007117197235e-14
the O 0 2.6483025079409575e-15
spectrum O 0 9.708572921290903e-13
of O 0 7.88655870210403e-13
59 O 0 3.5109365414953686e-10
ATM O 0 6.828277605563926e-07
mutations O 0 7.558313003253048e-11
observed O 0 1.8731379294867345e-11
in O 0 9.837879400009797e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.007502608591949e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.3518019711424023e-13
patients O 0 4.0733634862474485e-14
in O 0 1.540850975119217e-15
the O 0 3.9850650448806924e-14
British O 0 1.9860045899489087e-11
Isles O 0 1.0341392453483422e-07
. O 0 1.0478162781879519e-09

Of O 0 5.27569568475883e-07
51 O 0 6.294090781011619e-06
ATM O 0 0.0025731236673891544
mutations O 0 3.139828175235948e-09
identified O 0 6.941999058929227e-11
in O 0 1.0874433948801498e-12
families O 0 3.591458293955574e-12
native O 0 3.274389765405006e-13
to O 0 2.9782114816835625e-13
the O 0 3.0713803896020853e-12
British O 0 2.6280005949175234e-10
Isles O 0 4.3920547909692687e-07
, O 0 1.176934797449819e-13
11 O 0 1.7895907195378258e-12
were O 0 5.091481489888361e-12
founder O 0 1.0160907705503153e-11
mutations O 0 2.332193032444918e-12
, O 0 1.4861108356281974e-14
and O 0 5.441099519321079e-15
2 O 0 4.2299784551794173e-13
of O 0 1.0252756976747435e-11
these O 0 8.870575579416826e-14
11 O 0 5.915350132466857e-13
conferred O 0 2.744346694338873e-10
a O 0 3.750816063990969e-12
milder O 0 3.828531242033861e-12
clinical O 0 2.935928139057714e-13
phenotype O 0 1.4560088432234025e-13
with O 0 2.0475496840567653e-16
respect O 0 2.3836909009145035e-12
to O 0 9.759901220540712e-11
both O 0 5.032677607985647e-10
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
and O 0 1.7400473284467921e-09
cellular O 0 9.479552254276769e-09
features O 0 4.400583716868134e-11
. O 0 2.1094759272699548e-10

We O 0 4.007535969741127e-10
report O 0 2.3799382603550967e-12
, O 0 4.037822735522399e-16
in O 0 4.328713701944227e-16
two O 0 2.4700825830255638e-14
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
families O 0 1.1667873334175738e-09
, O 0 5.2055107728661565e-14
an O 0 2.9449672003323615e-14
ATM O 0 8.475130641727446e-08
mutation O 0 1.7553862877162096e-11
( O 0 3.7639054199789523e-14
7271T O 0 1.4452446350787795e-07
- O 0 3.476310084238321e-08
- O 0 5.733278740649439e-09
> O 0 3.288765648701286e-10
G O 0 1.3296934733841859e-11
) O 0 2.26429615083628e-16
that O 0 2.3026827244763345e-17
may O 0 7.327687982397363e-17
be O 0 6.935254309211995e-17
associated O 0 1.7166835376727745e-14
with O 0 1.1949403483337755e-16
an O 0 1.809784491737829e-16
increased O 0 6.453256982605349e-13
risk O 0 1.4131557035668152e-11
of O 0 8.668231687991579e-10
breast B-Disease 0 2.142119001291576e-06
cancer I-Disease 0 3.82404863330521e-09
in O 0 1.8126505851867591e-10
both O 0 1.853114467431638e-10
homozygotes O 0 9.047422366847968e-08
and O 0 7.1856335985553965e-12
heterozygotes O 0 2.3207258337265557e-09
( O 0 2.5896331520142146e-13
relative O 0 2.325937220604146e-09
risk O 0 1.5321618973551665e-11
12 O 0 3.4265882232348277e-12
. O 0 1.7191353592418968e-13
7 O 0 3.1179809168585537e-12
; O 0 8.221423081168286e-14
P O 0 2.352747718870063e-10
= O 0 2.6992562915731377e-13
. O 0 5.2213411410239816e-14
0025 O 0 3.522870051231308e-10
) O 0 7.383698962476839e-16
, O 0 8.641837762494238e-17
although O 0 5.396262147895528e-16
there O 0 1.648990903871565e-16
is O 0 1.6975484903235714e-17
a O 0 3.1005880321051263e-15
less O 0 7.470903236328486e-13
severe O 0 3.25414917234923e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 9.091196684352099e-10
in O 0 1.2879308757722877e-14
terms O 0 4.8614534435813955e-14
of O 0 5.19199305876422e-15
the O 0 3.12209441039415e-15
degree O 0 8.767511716634147e-11
of O 0 2.1959610518873518e-10
cerebellar B-Disease 0 4.2521616705926135e-05
degeneration I-Disease 0 0.0004863115318585187
. O 0 6.807712082945727e-08

This O 0 4.183494176079883e-11
mutation O 0 4.4586217855767385e-13
( O 0 3.3655647137199787e-16
7271T O 0 5.872976549525788e-10
- O 0 1.6387806389683846e-10
- O 0 5.409321948701695e-11
> O 0 1.216235966106094e-11
G O 0 5.303904451053887e-12
) O 0 1.9006636823527024e-17
also O 0 8.690456709204084e-19
allows O 0 6.631840324624482e-18
expression O 0 6.198207531367482e-16
of O 0 1.2085706648781377e-14
full O 0 1.7278336422212048e-13
- O 0 3.474178477996977e-14
length O 0 6.310949484354678e-13
ATM O 0 1.4369157419480416e-08
protein O 0 2.8798257181716913e-11
at O 0 1.4388909334861477e-11
a O 0 7.364975057773393e-13
level O 0 6.837672095194591e-11
comparable O 0 1.4639886525280588e-11
with O 0 2.305963977912765e-15
that O 0 9.420938667378744e-16
in O 0 1.0495883405025469e-13
unaffected O 0 5.14775111426502e-10
individuals O 0 8.475788972582554e-13
. O 0 9.963000424662027e-10

In O 0 8.323918637698213e-11
addition O 0 2.9900918980391156e-12
, O 0 2.4782371386153704e-14
we O 0 6.676859857102785e-14
have O 0 2.596990522545713e-15
studied O 0 3.83533374330447e-13
18 O 0 1.2309746277860967e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.1823785207052424e-07
, O 0 3.19587225064942e-14
in O 0 7.869601000856045e-15
15 O 0 1.0348386508601468e-13
families O 0 6.17143665272886e-14
, O 0 4.596097333557821e-15
who O 0 6.133789765168374e-14
developed O 0 9.125020739020329e-10
leukemia B-Disease 1 0.9999998807907104
, O 0 6.0723772676851695e-09
lymphoma B-Disease 1 1.0
, O 0 6.78463596415213e-09
preleukemic O 1 0.9999964237213135
T O 1 0.9984163045883179
- O 0 4.042338787257904e-06
cell O 0 4.0421696212433744e-08
proliferation O 0 2.2618749426328577e-05
, O 0 6.825702654998655e-13
or O 0 3.365756562345723e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 6.411794706284724e-11
mostly O 0 3.701689291462501e-13
in O 0 6.869037131630729e-13
childhood O 0 5.133196268047868e-08
. O 0 7.892232645190234e-09

A O 0 8.651689142880059e-08
wide O 0 9.312554200002765e-11
variety O 0 7.848757993360322e-13
of O 0 4.762360297783097e-11
ATM O 0 1.7028575030053617e-06
mutation O 0 1.8321144948374446e-11
types O 0 1.6312080158842335e-11
, O 0 5.233854528160359e-14
including O 0 2.2156812517527824e-13
missense O 0 3.6099674360912104e-08
mutations O 0 1.6856684104116226e-10
and O 0 2.5874569414136017e-12
in O 0 2.282828509558854e-10
- O 0 1.2408924998652537e-09
frame O 0 4.762964689319915e-09
deletions O 0 4.891198002177077e-10
, O 0 8.718732895753641e-15
were O 0 2.988733121666448e-13
seen O 0 2.372143280415795e-12
in O 0 8.777169529378126e-14
these O 0 2.5417075128625344e-12
patients O 0 5.274972472713024e-11
. O 0 1.3053149672259678e-09

We O 0 2.8309271593585095e-10
also O 0 2.9783518181022636e-14
show O 0 5.406683469531305e-14
that O 0 2.4717377621668595e-17
25 O 0 8.884218569691661e-15
% O 0 1.5598067000348326e-13
of O 0 3.753868079553989e-14
all O 0 6.348823376745028e-13
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.242068385451603e-08
carried O 0 2.3812482541352153e-10
in O 0 6.660080820175551e-11
- O 0 1.3482871485948067e-09
frame O 0 7.715439842570504e-09
deletions O 0 3.6486751398001616e-09
or O 0 2.8940929513998626e-11
missense O 0 9.038397585925395e-09
mutations O 0 4.242925455422153e-12
, O 0 1.0270743529952934e-15
many O 0 9.526858152199424e-17
of O 0 1.3611462861505812e-14
which O 0 1.2142533612756636e-16
were O 0 5.901283964531573e-14
also O 0 2.0598807632331138e-16
associated O 0 8.880018133306227e-15
with O 0 1.3195242306169837e-15
expression O 0 2.4624599234690514e-12
of O 0 3.5900355604967515e-11
mutant O 0 2.6822777332569103e-10
ATM O 0 4.253313932167657e-07
protein O 0 9.194032202231028e-09
. O 0 4.540304132660822e-09

The O 0 2.701232848512092e-10
DMPK O 0 0.0004081335791852325
gene O 0 1.4363005229611758e-10
of O 0 6.38612995818022e-10
severely O 0 0.1511005461215973
affected O 0 0.0001294251997023821
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 2.6826495513887494e-07
is O 0 1.666726381476663e-13
hypermethylated O 0 4.857628521648394e-09
proximal O 0 2.9362936402321793e-06
to O 0 8.250532479436856e-10
the O 0 5.584293583105193e-10
largely O 0 4.710744239133646e-09
expanded O 0 2.11525064131024e-09
CTG O 0 1.7519890889161616e-06
repeat O 0 3.610766086126205e-08
. O 0 1.925400461288973e-08

Using O 0 8.255050532035568e-10
methylation O 0 6.513196808555222e-07
- O 0 6.147206477180589e-07
sensitive O 0 1.0106069758819558e-08
restriction O 0 5.812103402724755e-12
enzymes O 0 5.158771630361936e-13
, O 0 3.9669512241278355e-16
we O 0 4.005819713192763e-16
characterized O 0 8.252899820751969e-16
the O 0 3.122928102572485e-15
methylation O 0 4.391090355909677e-12
pattern O 0 1.5546078313555256e-11
on O 0 1.140085313482142e-12
the O 0 1.9776865420925022e-13
5 O 0 5.441146665174923e-13
side O 0 9.183485569219663e-12
of O 0 6.266539370747282e-11
the O 0 2.393625297969493e-10
CTG O 0 3.502049423786957e-07
repeat O 0 4.146063353749341e-11
in O 0 2.6697738529472825e-13
the O 0 1.4580995915877693e-12
DMPK O 0 1.1507136150612496e-06
gene O 0 3.1768815009214357e-13
of O 0 1.0363562221935019e-12
normal O 0 8.688818414759325e-11
individuals O 0 1.7694143879579648e-14
and O 0 5.135597181619555e-15
of O 0 9.290050282870221e-13
patients O 0 6.073940721045001e-13
affected O 0 1.5800013207500907e-12
with O 0 3.4882033784870703e-13
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 3.1127737106645403e-13
showing O 0 6.044692090617643e-12
expansions O 0 6.620640147225743e-11
of O 0 4.448541361667946e-12
the O 0 4.809854771414823e-12
repetitive O 0 2.9211078000912494e-10
sequence O 0 3.16314752168978e-11
. O 0 6.59347410003619e-10

The O 0 7.268619733880044e-11
gene O 0 4.4587239716314953e-13
segment O 0 1.3750414695756774e-10
analyzed O 0 5.763187236468292e-13
corresponds O 0 3.589143739157752e-12
to O 0 7.115649215683195e-13
the O 0 4.175504126485707e-12
genomic O 0 5.979933437316731e-09
SacI O 0 1.1812802540589473e-06
- O 0 1.5626030469562124e-09
HindIII O 0 1.4187619079564229e-08
fragment O 0 5.207613854030235e-11
carrying O 0 1.2303900953636315e-10
exons O 0 1.1138516775588414e-08
11 O 0 4.203331849250702e-10
- O 0 1.4584744523205018e-09
15 O 0 2.5220942001524804e-10
. O 0 1.254775283676679e-09

There O 0 3.159782852035775e-11
is O 0 1.733672477495854e-14
constitutive O 0 1.1806807753700355e-09
methylation O 0 7.823928172001615e-10
in O 0 3.685280691723136e-10
intron O 0 6.832492971398096e-08
12 O 0 4.636355466214326e-10
at O 0 5.201280725564139e-11
restriction O 0 1.7395237810954867e-12
sites O 0 1.9430576939094557e-11
of O 0 1.52379463214114e-11
SacII O 0 5.469295274451724e-07
and O 0 1.0866235689022119e-10
HhaI O 0 0.0005422811373136938
, O 0 4.01410328587648e-12
localized O 0 6.813859892984553e-11
1 O 0 1.4993144529726332e-12
, O 0 1.9570247318848565e-14
159 O 0 4.5326614683816047e-10
- O 0 2.6943788866695684e-10
1 O 0 3.664850974777201e-12
, O 0 1.778710506791445e-13
232 O 0 4.7986961626556024e-11
bp O 0 1.3801153275760925e-10
upstream O 0 1.215221479000661e-09
of O 0 9.38568778252602e-10
the O 0 3.4861884490311468e-09
CTG O 0 8.81956748344237e-06
repeat O 0 2.976850410618681e-08
, O 0 2.3716187434047464e-12
whereas O 0 1.1424221985079086e-10
most O 0 5.524660590117136e-13
, O 0 4.554037065528961e-15
if O 0 3.5981032098285435e-15
not O 0 3.727732708559868e-14
all O 0 3.780628425337912e-13
, O 0 3.7934116432899664e-14
of O 0 1.1029787109692601e-12
the O 0 2.825447395580355e-13
other O 0 6.62402871811664e-14
sites O 0 1.40621667088503e-10
of O 0 1.3081256911018357e-10
SacII O 0 9.808338745642686e-07
, O 0 2.2287297007927975e-11
HhaI O 0 3.663877123472048e-06
, O 0 5.100832083104745e-12
and O 0 6.797124495194762e-12
HpaII O 0 1.5102897123142611e-05
in O 0 1.6619948473017843e-11
this O 0 9.782801305147082e-12
region O 0 3.231523715285789e-09
are O 0 1.1185460110224588e-12
unmethylated O 0 1.5464070202142466e-07
, O 0 3.217382482938354e-14
in O 0 2.2881858151410812e-14
normal O 0 8.587099781243168e-11
individuals O 0 3.7924422987851286e-14
and O 0 7.418513604795767e-15
most O 0 3.7914295861933914e-14
of O 0 2.8808793458429127e-12
the O 0 2.2364969251564837e-11
patients O 0 4.0473787515926674e-11
. O 0 7.597905637979352e-10

In O 0 1.1378547409846007e-11
a O 0 1.3419831652178305e-13
number O 0 2.7770508806489007e-14
of O 0 2.797745759022807e-12
young O 0 2.1631769292485004e-11
and O 0 7.353609041138576e-12
severely O 0 1.0214319445367437e-05
affected O 0 9.272807410809492e-09
patients O 0 4.18836423876634e-11
, O 0 3.3081091983582986e-15
however O 0 5.3217240320426254e-14
, O 0 1.9983640689964842e-16
complete O 0 7.066992130377869e-11
methylation O 0 6.116616102502803e-10
of O 0 8.001752038744314e-11
these O 0 1.030933964498576e-13
restriction O 0 1.9910243972184188e-13
sites O 0 6.298491459291733e-13
was O 0 3.08791403905162e-13
found O 0 2.620117528972718e-14
in O 0 1.2832328075303417e-14
the O 0 8.408803167658796e-13
mutated O 0 2.146408398240318e-11
allele O 0 6.815579212116063e-10
. O 0 6.836570864976466e-09

In O 0 1.788172214467476e-11
most O 0 7.740360544357394e-14
of O 0 3.4349034575865967e-13
these O 0 2.3599427194874976e-14
patients O 0 4.785663645966512e-14
, O 0 6.110729277297508e-17
the O 0 5.131484836660635e-15
onset O 0 1.0249555371100172e-10
of O 0 1.1960150751721965e-11
the O 0 6.777854943962325e-10
disease O 0 6.008728450979106e-05
was O 0 2.036908881564159e-07
congenital O 1 1.0
. O 0 0.0001579426898388192

Preliminary O 0 3.0889806268419306e-09
in O 0 1.703334279179458e-10
vivo O 0 2.5751685228669885e-08
footprinting O 0 6.46358330413932e-07
data O 0 3.821959415617471e-11
gave O 0 5.5017551251574856e-14
evidence O 0 1.7449351357823155e-14
for O 0 1.1170929700471573e-14
protein O 0 5.828797730936253e-13
- O 0 5.091673068412239e-13
DNA O 0 6.388310436200584e-10
contact O 0 8.336634160777123e-10
in O 0 8.701497096648414e-13
normal O 0 1.009456962464128e-08
genes O 0 1.3551016862442533e-12
at O 0 1.0383386858658916e-12
an O 0 1.593958987999996e-15
Sp1 O 0 4.873025594154257e-12
consensus O 0 1.365537891095947e-11
binding O 0 1.2853285059552522e-12
site O 0 1.2931464059284803e-11
upstream O 0 2.3301222062954707e-11
of O 0 4.233063552461225e-12
the O 0 1.3000264059703781e-11
CTG O 0 1.4019445870872005e-07
repeat O 0 2.3800574358578963e-11
and O 0 1.8250315877142188e-14
for O 0 9.944958776571169e-15
a O 0 5.758752968167439e-15
significant O 0 3.623710286373462e-15
reduction O 0 5.068614365028035e-12
of O 0 1.0929997141737036e-12
this O 0 3.224521276617813e-14
interaction O 0 1.0141062468937978e-11
in O 0 9.632225572708819e-14
cells O 0 2.237694621612385e-12
with O 0 2.7037013849550567e-14
a O 0 4.590103037244164e-12
hypermethylated O 0 7.654028877368546e-08
DMPK O 0 1.894009801617358e-05
gene O 0 8.847419324942152e-12
. O 0 1.5114260537574253e-11
. O 0 2.6628563243313863e-10

The O 0 1.3367438267408716e-09
hemochromatosis B-Disease 1 1.0
gene O 0 2.52922465956984e-13
product O 0 3.3526344677889397e-13
complexes O 0 1.1691396548801913e-13
with O 0 9.437659627153136e-17
the O 0 3.435393178155381e-14
transferrin O 0 5.691716542521874e-11
receptor O 0 6.490227192484932e-13
and O 0 2.3998663299662493e-13
lowers O 0 3.9415306007104314e-14
its O 0 8.846540744252777e-16
affinity O 0 7.653185776898466e-15
for O 0 1.1685750396582106e-14
ligand O 0 4.715915158381989e-12
binding O 0 2.7246213618603576e-10
. O 0 4.747319870546107e-09

We O 0 3.5136480530661984e-11
recently O 0 1.8359150462908536e-13
reported O 0 8.5817278576341e-15
the O 0 1.555562560984485e-15
positional O 0 4.62245216062418e-12
cloning O 0 2.1110587236639056e-13
of O 0 8.425415042295076e-14
a O 0 3.7278889014353417e-14
candidate O 0 1.1720216464006228e-10
gene O 0 7.260541473597115e-11
for O 0 3.716852958746131e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 0 0.00048063931171782315
HFE O 1 0.9978304505348206
. O 0 6.683553266384479e-09

The O 0 6.178641626108927e-11
gene O 0 8.537879333646997e-14
product O 0 9.284841775633601e-13
, O 0 9.37762457882971e-16
a O 0 4.1600142791252057e-14
member O 0 2.3428620155030444e-12
of O 0 6.789215301061802e-10
the O 0 1.0313568887809765e-09
major O 0 3.301045548020909e-10
histocompatibility O 0 2.288554012963573e-09
complex O 0 7.316527383949278e-10
class O 0 2.081326951064444e-11
I O 0 1.8079356678413205e-08
- O 0 2.4964980083197474e-10
like O 0 3.669477509392685e-14
family O 0 1.628539154658465e-13
, O 0 3.6785277705604776e-16
was O 0 1.2518253848878974e-13
found O 0 1.8639010826307714e-14
to O 0 5.925117709838779e-13
have O 0 4.952822006687452e-13
a O 0 1.3201613413560409e-11
mutation O 0 1.7157435194814497e-11
, O 0 8.921857935599575e-13
Cys O 0 2.7136093194712885e-07
- O 0 4.345654947002231e-09
282 O 0 8.960420018411241e-06
- O 1 0.9905417561531067
- O 0 0.0002831370511557907
> O 0 2.536130239150225e-07
Tyr O 0 1.398934159624332e-07
( O 0 2.0814060144749933e-15
C282Y O 0 3.606493576002734e-11
) O 0 3.551989650919056e-18
, O 0 6.496324979231144e-19
in O 0 1.397596422035715e-17
85 O 0 1.1549222949519544e-12
% O 0 2.332563482643213e-11
of O 0 1.0105226551371249e-11
patient O 0 1.7505532579065175e-09
chromosomes O 0 3.2973095365207428e-09
. O 0 3.56425040592967e-08

This O 0 1.0849501158594066e-10
mutation O 0 2.2047018724546952e-11
eliminates O 0 4.404041367700451e-12
the O 0 1.7020846537763035e-13
ability O 0 3.1068932149214135e-11
of O 0 2.987478042726366e-10
HFE O 0 3.973665297962725e-05
to O 0 3.711798091110552e-10
associate O 0 1.4363799039074365e-10
with O 0 1.260849606145309e-13
beta2 O 0 0.00011776592873502523
- O 0 5.599034921033308e-06
microglobulin O 1 0.7711395621299744
( O 0 5.48168877911176e-13
beta2m O 0 1.8066916709358338e-06
) O 0 1.9511695319336664e-14
and O 0 9.499288156208582e-15
prevents O 0 1.5533056611782836e-12
cell O 0 7.647138033917145e-09
- O 0 2.9408546708964423e-09
surface O 0 1.5520805618507438e-07
expression O 0 8.376488835892815e-08
. O 0 6.682113085076935e-09

A O 0 3.32847527317881e-08
second O 0 7.375360877581727e-10
mutation O 0 1.844315845878075e-11
that O 0 3.383823101821108e-14
has O 0 4.4743266065111215e-15
no O 0 4.12629457512137e-14
effect O 0 5.3818674370558275e-14
on O 0 8.759416803005848e-12
beta2m O 0 5.520461598962356e-08
association O 0 5.14427129366668e-12
, O 0 7.929697480243969e-13
H63D O 0 7.745422044536099e-05
, O 0 1.1799624320164848e-13
was O 0 4.464953526264054e-13
found O 0 2.2559699334318006e-14
in O 0 1.4653573637501646e-15
eight O 0 1.45471823606233e-13
out O 0 1.1439113037066493e-14
of O 0 5.540267680390065e-13
nine O 0 1.7293059345613315e-11
patients O 0 3.6149327888729266e-13
heterozygous O 0 5.077590908494911e-13
for O 0 1.8722645504266888e-13
the O 0 1.2917764080633276e-10
C282Y O 0 9.813581414164219e-08
mutant O 0 3.974887530233673e-09
. O 0 4.289868460460866e-09

In O 0 3.732313069715332e-11
this O 0 1.2485775217549455e-13
report O 0 1.0178820676956524e-13
, O 0 7.012834586246608e-16
we O 0 2.9488327622420986e-15
demonstrate O 0 1.6185818310643363e-11
in O 0 7.157356304854368e-13
cultured O 0 2.1610222500356713e-09
293 O 0 1.2945042260348316e-10
cells O 0 1.887423273227995e-10
overexpressing O 0 4.0927904620957634e-08
wild O 0 3.222658806478762e-10
- O 0 4.3191933363218027e-10
type O 0 8.698817360874855e-11
or O 0 8.562807581047327e-12
mutant O 0 4.362974911908957e-11
HFE O 0 1.651141587899474e-07
proteins O 0 2.0654468803685266e-13
that O 0 1.2686926981912895e-16
both O 0 5.927177634674195e-16
the O 0 7.584218660267126e-15
wild O 0 1.0150069668221282e-13
- O 0 3.132093651277146e-13
type O 0 6.558270094526863e-13
and O 0 6.88513157078019e-13
H63D O 0 5.860584496986121e-05
HFE O 0 2.0952822978870245e-06
proteins O 0 6.7076925611142535e-12
form O 0 3.5470851516422597e-12
stable O 0 2.1674866346188537e-09
complexes O 0 2.5633432008953516e-12
with O 0 1.6387138795923083e-15
the O 0 5.793440271788242e-13
transferrin O 0 4.6099807304855744e-10
receptor O 0 1.5869994120926156e-12
( O 0 5.2933484283096063e-14
TfR O 0 6.7460015351628044e-09
) O 0 2.513048092105813e-13
. O 0 7.40768349438703e-11

The O 0 1.133979909972993e-09
C282Y O 0 3.6317777585281874e-07
mutation O 0 6.70232142355176e-12
nearly O 0 3.2730285495774503e-13
completely O 0 2.1223561103012045e-12
prevents O 0 1.0830732469734039e-13
the O 0 7.572109985472947e-14
association O 0 4.191354498173615e-14
of O 0 2.545811055455066e-13
the O 0 1.4234854885542686e-13
mutant O 0 1.2640439042699292e-11
HFE O 0 5.627689461107366e-07
protein O 0 5.330377111922857e-11
with O 0 8.152248949684637e-14
the O 0 7.315393429907502e-11
TfR O 0 2.3479967694584047e-06
. O 0 1.1889358386696358e-09

Studies O 0 3.064332398938774e-10
on O 0 7.226495443712899e-12
cell O 0 3.4504364643250796e-11
- O 0 4.562843158861796e-12
associated O 0 1.9992297747850607e-12
transferrin O 0 1.0005091866105431e-08
at O 0 6.227445642492668e-11
37 O 0 1.1763053205104956e-11
degrees O 0 7.541334917648967e-11
C O 0 3.185958163953728e-10
suggest O 0 2.01549687313049e-13
that O 0 2.1378392934182354e-16
the O 0 8.324889849741293e-14
overexpressed O 0 2.366596085767725e-10
wild O 0 2.211291696627149e-12
- O 0 5.4051320710901685e-12
type O 0 3.319815602975673e-11
HFE O 0 2.471924176461471e-07
protein O 0 3.461416266462014e-12
decreases O 0 9.453761829359558e-14
the O 0 6.789042340593155e-15
affinity O 0 5.628663225613895e-13
of O 0 6.115291866642947e-12
the O 0 6.564505883321914e-12
TfR O 0 1.0667055683200033e-08
for O 0 1.0252008660407985e-12
transferrin O 0 9.158049429913717e-09
. O 0 8.263797646179682e-09

The O 0 5.226658004175988e-07
overexpressed O 0 4.031088246847503e-05
H63D O 1 0.9999973773956299
protein O 0 5.010494796842124e-10
does O 0 1.2796154686257975e-14
not O 0 4.835649685986125e-15
have O 0 2.286944223659084e-16
this O 0 1.706177406863153e-16
effect O 0 7.705941529952305e-16
, O 0 2.394146400912038e-17
providing O 0 1.5042741019293503e-14
the O 0 9.83888166421296e-16
first O 0 1.392388842300172e-14
direct O 0 1.8091555814211957e-13
evidence O 0 5.584370314261344e-13
for O 0 4.6554421559083514e-14
a O 0 9.322319392129907e-13
functional O 0 8.011228125326397e-09
consequence O 0 8.403857471028786e-11
of O 0 1.8954926170322572e-11
the O 0 1.0895269408894848e-10
H63D O 0 0.00035982424742542207
mutation O 0 6.915495731618648e-09
. O 0 2.912697194545899e-09

Addition O 0 8.422283426234856e-10
of O 0 4.197365122138308e-09
soluble O 0 1.741833899338019e-09
wild O 0 1.3368042783845624e-10
- O 0 2.738826276882378e-09
type O 0 2.3836502549556826e-08
HFE O 1 0.9998453855514526
/ O 0 8.448831795249134e-05
beta2m O 0 5.232705461821752e-06
heterodimers O 0 6.029456045553161e-09
to O 0 1.1596509343070327e-11
cultured O 0 6.097187754683375e-10
cells O 0 1.9519540497836552e-11
also O 0 7.947583089145012e-16
decreased O 0 8.190151980008373e-14
the O 0 1.0709129534620235e-16
apparent O 0 1.8982538590593852e-14
affinity O 0 5.076158135323972e-13
of O 0 1.2819576997169513e-11
the O 0 6.971239124159423e-12
TfR O 0 1.2867064080879231e-09
for O 0 4.724623148358873e-15
its O 0 6.66728326024948e-16
ligand O 0 2.2939801981266585e-14
under O 0 3.729386591211359e-12
steady O 0 4.649046925209177e-09
- O 0 1.0374147721425864e-11
state O 0 3.004233146974844e-13
conditions O 0 4.488952959347259e-11
, O 0 2.9184719250389523e-15
both O 0 4.562940228837551e-15
in O 0 1.0353869861088813e-14
293 O 0 7.547255463820346e-13
cells O 0 1.1050380445756791e-12
and O 0 2.984762502260263e-13
in O 0 8.891301757352199e-12
HeLa O 0 2.2848434255706707e-08
cells O 0 1.494309120886328e-09
. O 0 5.1340749429584775e-09

Furthermore O 0 8.275880425401283e-09
, O 0 3.9041293527046494e-13
at O 0 7.763103853329623e-13
4 O 0 7.467765013140226e-14
degrees O 0 7.875983892846605e-11
C O 0 1.4888240640331674e-09
, O 0 2.965880782613249e-14
the O 0 4.671660194105476e-13
added O 0 9.127343846004887e-12
soluble O 0 3.51602150172603e-11
complex O 0 8.45678735372779e-12
of O 0 9.657424859810249e-11
HFE O 0 1.0370522431912832e-06
/ O 0 1.3027232625972829e-09
beta2m O 0 6.022740639544111e-10
inhibited O 0 2.7040600661387693e-12
binding O 0 1.1806045507531393e-12
of O 0 2.2577556144098843e-11
transferrin O 0 2.527310360989077e-09
to O 0 1.0567254848936614e-09
HeLa O 0 3.282872285126359e-07
cell O 0 2.293802481290186e-09
TfR O 0 2.5782744828006798e-08
in O 0 1.444363969789822e-13
a O 0 1.1819835474963236e-12
concentration O 0 2.146312239048598e-09
- O 0 8.624149727687325e-10
dependent O 0 9.82601000565353e-10
manner O 0 3.82452247649212e-09
. O 0 2.648765429213995e-09

Scatchard O 0 3.092238785029622e-06
plots O 0 3.3588305470289015e-09
of O 0 4.213797019647636e-11
these O 0 8.931576181772649e-14
data O 0 5.072257718008455e-13
indicate O 0 3.20518893544286e-13
that O 0 1.3582409419656753e-15
the O 0 1.888109243605718e-12
added O 0 2.2231085028412423e-11
heterodimer O 0 6.892943854586164e-11
substantially O 0 2.4968492551291632e-11
reduced O 0 1.2308560204052355e-12
the O 0 1.934192552215802e-13
affinity O 0 3.344200957822174e-11
of O 0 2.2647350661486598e-10
TfR O 0 4.1675079387459846e-08
for O 0 7.2661898199710695e-12
transferrin O 0 1.7602941326799737e-08
. O 0 9.663072120247307e-09

These O 0 1.323491121384135e-12
results O 0 2.4638928050602082e-12
establish O 0 4.2198130406623235e-11
a O 0 7.051147453461873e-14
molecular O 0 7.997700808906605e-13
link O 0 1.5687713281198334e-11
between O 0 2.6735115857268177e-11
HFE O 0 0.25345441699028015
and O 0 8.206360070650565e-12
a O 0 5.87794951600884e-11
key O 0 1.0183118348550124e-08
protein O 0 9.787116950210617e-11
involved O 0 5.732835386962343e-11
in O 0 2.4450929128616572e-11
iron O 0 3.9521177441770305e-09
transport O 0 1.2778341051955522e-08
, O 0 8.623375451211057e-14
the O 0 1.2012177277170855e-12
TfR O 0 4.306931700170935e-08
, O 0 5.146540423781607e-15
and O 0 1.4672703876615384e-15
raise O 0 9.173515218936432e-14
the O 0 3.1682569436898567e-14
possibility O 0 2.418684013922451e-13
that O 0 7.400593775763655e-15
alterations O 0 2.6930364188659794e-11
in O 0 4.3348239223400115e-14
this O 0 4.749245633805903e-14
regulatory O 0 1.1104242525483699e-11
mechanism O 0 1.8345003294228945e-10
may O 0 1.1724072233876282e-12
play O 0 1.7094596571620713e-10
a O 0 1.9023017536201614e-11
role O 0 2.4845923929373015e-11
in O 0 8.856126552589383e-13
the O 0 7.019994828494358e-12
pathogenesis O 0 2.8142276278231293e-06
of O 0 5.718640636587224e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.130266937821034e-07
. O 0 3.519619595770962e-10

Genomic O 0 5.550930382014485e-09
organization O 0 4.349603576619954e-12
of O 0 6.029587940048486e-11
the O 0 1.0748533313398312e-10
UBE3A O 0 4.2626441427273676e-05
/ O 0 5.067947839165754e-08
E6 O 0 7.544251161561988e-07
- O 0 5.6554732452696044e-08
AP O 0 3.182067530360655e-06
gene O 0 5.845118768339763e-13
and O 0 8.613245953601432e-15
related O 0 2.0263072469939303e-11
pseudogenes O 0 3.866004849584215e-09
. O 0 1.0300196112700277e-10

The O 0 6.530668783533145e-10
UBE3A O 0 4.077383266576362e-07
gene O 0 5.202545750974952e-13
encodes O 0 2.8862234325612024e-13
the O 0 9.789889168429489e-13
E6 O 0 1.354244005824512e-08
- O 0 2.1871684907637245e-08
AP O 0 5.824928166475729e-07
ubiquitin O 0 2.8826423470462714e-09
- O 0 1.2655546055562183e-10
protein O 0 1.0272634658062621e-13
ligase O 0 9.41318827355972e-14
and O 0 2.9549246231987516e-15
has O 0 7.771355237490795e-17
recently O 0 2.9490674962476065e-16
been O 0 7.959077590937049e-17
shown O 0 1.6444374929751424e-15
to O 0 1.2181982954665143e-14
be O 0 4.374392558251228e-14
mutated O 0 5.482972409431852e-10
in O 0 9.51363654522197e-10
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 9.101750464424185e-09
who O 0 8.537557596652312e-13
lack O 0 1.9667526274247393e-08
15q11 O 0 7.693598490732256e-06
- O 0 2.9730551887041656e-07
q13 O 0 6.64755077650625e-07
deletions O 0 5.4732374188404265e-09
or O 0 1.2516499121872915e-11
chromosome O 0 4.12313472253345e-09
15 O 0 2.8377726835060457e-09
paternal O 0 9.335202548754751e-07
uniparental B-Disease 0 0.0007250005146488547
disomy I-Disease 0 8.21450084913522e-05
. O 0 9.093528774428705e-08

Previous O 0 5.438459904638648e-09
UBE3A O 0 3.059538471461565e-07
cDNA O 0 2.510969210334224e-09
analysis O 0 3.4180893792451483e-12
has O 0 6.462592719287354e-17
shown O 0 2.578461888582762e-15
a O 0 1.1991882503279913e-14
coding O 0 5.8185900542184754e-09
region O 0 2.6983042467065843e-09
of O 0 1.6776784128591515e-10
approximately O 0 1.1889596078507036e-11
2 O 0 1.1956302614635206e-10
. O 0 7.827136716542782e-10

6 O 0 9.585296112391006e-09
kb O 0 6.882167440380726e-07
and O 0 4.988842672304372e-12
a O 0 1.536273365465579e-11
3 O 0 7.111291555617072e-10
- O 0 7.640711032763647e-07
untranslated O 1 0.9999427795410156
region O 0 1.1118697074152806e-07
( O 0 1.4042071542000323e-13
UTR O 0 4.020993173980969e-07
) O 0 7.266418505314301e-14
of O 0 3.836866935280625e-11
< O 0 1.498073221029017e-09
50 O 0 1.0362228436422427e-10
bp O 0 3.446496560366441e-11
, O 0 2.6297303364845176e-14
whereas O 0 1.681727153368673e-11
Northern O 0 9.01335742153897e-11
analysis O 0 2.4651715131024377e-12
has O 0 9.218865193525837e-16
indicated O 0 1.4696357737535581e-13
mRNA O 0 1.4456775186688642e-11
sizes O 0 2.3337070123585768e-11
of O 0 6.40995145850809e-10
5 O 0 1.307916774884177e-09
- O 0 1.4017007110567192e-08
8 O 0 9.467729933376745e-10
kb O 0 4.0154520775104174e-07
. O 0 3.6143334991578513e-09

We O 0 6.016540599063092e-10
have O 0 9.116790438898348e-14
analyzed O 0 2.815516916832017e-13
additional O 0 2.322690379873843e-14
cDNA O 0 6.495164961428657e-10
clones O 0 4.016862537037369e-11
and O 0 4.0172394219755575e-14
provide O 0 1.1149441829852447e-12
evidence O 0 2.6420087905626444e-13
for O 0 1.5385560664035736e-13
an O 0 1.0543678424920419e-13
additional O 0 1.6230891630719668e-11
0 O 0 6.417519987644837e-11
. O 0 3.3726264003774986e-09

5 O 0 7.914296995537029e-10
kb O 0 2.920209283274744e-07
of O 0 1.5510344120173158e-09
5 O 0 1.6873451524901384e-09
- O 0 7.403301793829087e-08
UTR O 0 4.313066256145248e-06
and O 0 7.501424481581864e-11
> O 0 3.1092661778586717e-10
2 O 0 7.307329220884728e-12
kb O 0 2.592555503611038e-08
of O 0 4.366149108925299e-10
3 O 0 3.980683782600636e-09
- O 0 1.633063391182077e-07
UTR O 0 2.147900522686541e-05
. O 0 1.7143330310886995e-08

We O 0 6.501110760837037e-11
have O 0 1.3692078375227793e-14
established O 0 8.121515375633052e-15
the O 0 1.0623241584908731e-15
genomic O 0 7.56416034409374e-13
organization O 0 3.620906946131229e-14
of O 0 3.8788507995823895e-12
UBE3A O 0 7.554481271654367e-07
and O 0 1.6273499204005198e-13
the O 0 3.9695609538141496e-13
sequence O 0 7.370290142083569e-12
of O 0 1.0536260752758153e-09
intron O 0 2.137175698635474e-07
- O 0 1.0861251666938188e-06
exon O 0 3.2343063338657885e-08
borders O 0 7.9099855554432e-09
. O 0 4.446556545190106e-08

We O 0 4.0964262537634966e-10
have O 0 5.190572364283108e-13
also O 0 3.7425727257957633e-14
mapped O 0 7.20318735214498e-11
two O 0 6.799299621593202e-13
highly O 0 1.4015087701491069e-11
homologous O 0 1.3720444225207018e-10
processed O 0 9.334499145863262e-11
pseudogenes O 0 2.003148980023184e-09
, O 0 1.2315928170966023e-13
UBE3AP1 O 0 0.0010663920547813177
and O 0 1.3215343749872765e-11
UBE3AP2 O 1 0.9999996423721313
, O 0 3.2201037626286566e-13
to O 0 7.331593665504954e-12
chromosomes O 0 8.538332540997118e-11
2 O 0 1.4873628587444565e-12
and O 0 1.5397654939269811e-13
21 O 0 1.46409759316235e-11
, O 0 1.6350058446349368e-14
respectively O 0 3.0242319065676426e-11
, O 0 1.5243882545146192e-14
and O 0 6.7099472510114954e-15
determined O 0 1.1167878254114694e-11
their O 0 2.8095864176846952e-11
genomic O 0 1.949035821624534e-09
organization O 0 2.192253323318738e-10
. O 0 2.303614854426428e-09

These O 0 1.7028062987423098e-12
results O 0 1.135138207389308e-12
will O 0 1.0128115251854808e-14
form O 0 2.143496494124049e-14
the O 0 7.178156994584045e-15
basis O 0 1.047552886448977e-12
for O 0 1.142497732772624e-15
studies O 0 5.438300837760056e-14
of O 0 1.5887853912262967e-13
mutation O 0 2.644508012095495e-14
and O 0 1.286865850425728e-13
imprinting O 0 1.25643850878987e-07
of O 0 1.2643380387089564e-07
UBE3A O 0 0.0004911405267193913
. O 0 2.4998342951221275e-07

Mutation O 0 6.302466881713542e-10
spectrum O 0 3.3379321529025674e-10
and O 0 4.964123730133441e-13
genotype O 0 1.643982372456776e-08
- O 0 4.088536176283242e-09
phenotype O 0 1.0855799592590643e-09
analyses O 0 1.2038565977423588e-10
in O 0 2.1444105172130357e-12
Cowden B-Disease 0 1.3174086234357674e-05
disease I-Disease 0 4.057846836325041e-10
and O 0 7.201366781540985e-13
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.002694860953508e-12
two O 0 1.3690121258846943e-10
hamartoma B-Disease 1 0.9994196891784668
syndromes I-Disease 0 2.0497971490840428e-05
with O 0 4.440655398951776e-09
germline O 1 0.9580186009407043
PTEN O 0 0.16449424624443054
mutation O 0 3.281575899904965e-08
. O 0 4.626049321387882e-09

The O 0 5.800254143650818e-07
tumour B-Disease 1 1.0
suppressor O 0 5.421939931693487e-06
gene O 0 3.3948324706933874e-10
PTEN O 0 1.2636098745133495e-07
, O 0 7.534206277522854e-14
which O 0 5.368031598554726e-16
maps O 0 4.929009891213587e-12
to O 0 1.6714150896657287e-10
10q23 O 0 1.6411177057307214e-06
. O 0 1.605060440112993e-08

3 O 0 3.932011779974459e-13
and O 0 5.506810006028462e-16
encodes O 0 3.948050213305448e-16
a O 0 1.2409307962983358e-16
403 O 0 1.9285432490334306e-15
amino O 0 1.456616470778445e-14
acid O 0 2.1480186336228502e-14
dual O 0 1.0811780637443036e-10
specificity O 0 2.2564071500141836e-08
phosphatase O 0 1.7972348587136366e-06
( O 0 4.4874801791161545e-11
protein O 0 5.568674765754622e-08
tyrosine O 0 8.387088001882148e-08
phosphatase O 0 6.716911116200208e-08
; O 0 2.3348936174262536e-13
PTPase O 0 2.158576428712422e-08
) O 0 1.9327265330016828e-15
, O 0 1.9127971977115488e-16
was O 0 1.0750356666336131e-14
shown O 0 1.1476729939660646e-13
recently O 0 5.624474613808404e-14
to O 0 6.703954882544827e-13
play O 0 3.337645715362214e-10
a O 0 5.867252517166577e-11
broad O 0 8.072374019230111e-11
role O 0 2.6893766727487112e-11
in O 0 1.8255218517393423e-11
human O 0 4.779199258564404e-09
malignancy B-Disease 0 0.0002357329212827608
. O 0 7.888560915603193e-09

Somatic O 0 9.143180795945227e-05
PTEN O 0 1.2665113899856806e-05
deletions O 0 4.540107312323016e-08
and O 0 3.208903845766664e-12
mutations O 0 9.798151873186e-12
were O 0 3.871294832012012e-13
observed O 0 1.3090972804472717e-13
in O 0 7.944241374761504e-14
sporadic B-Disease 0 2.8422052267274012e-08
breast I-Disease 0 3.69613957218462e-08
, I-Disease 0 1.1838274284470263e-11
brain I-Disease 1 0.9999996423721313
, I-Disease 0 2.2253496267943262e-10
prostate I-Disease 1 1.0
and I-Disease 1 0.9352205991744995
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9813014268875122
cell O 0 1.600018367753364e-05
lines O 0 1.1643241926151404e-09
and O 0 6.908042253462796e-14
in O 0 3.313833853591658e-13
several O 0 6.108154889002126e-13
primary O 0 1.0875191946979612e-06
tumours B-Disease 1 1.0
such O 0 9.816076423918574e-11
as O 0 2.6565114552568048e-09
endometrial B-Disease 0 0.05664435029029846
carcinomas I-Disease 1 1.0
, O 0 0.002402131911367178
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999997615814209
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.0010930272983387113

In O 0 1.0713568920905914e-11
addition O 0 1.588377107793193e-12
, O 0 5.641622626418978e-14
PTEN O 0 2.3308057706117324e-08
was O 0 2.7490644309569046e-12
identified O 0 1.3521919044537367e-12
as O 0 3.85559529656322e-15
the O 0 2.2836773975760255e-14
susceptibility O 0 1.7646127614678875e-13
gene O 0 3.5016250983450946e-15
for O 0 3.149586711229113e-13
two O 0 9.219068286547838e-10
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 0 0.0019155226182192564
( O 0 1.7273022815127333e-14
CD B-Disease 0 0.0006556800799444318
; O 0 1.669305145501898e-11
MIM O 0 8.281227223960741e-07
158350 O 0 7.398696322269416e-09
) O 0 1.6823629484961564e-14
and O 0 8.083968065265845e-13
Bannayan B-Disease 0 0.48355382680892944
- I-Disease 0 0.00011972375068580732
Zonana I-Disease 0 0.0008191801025532186
( I-Disease 0 3.0248186767833918e-12
BZS I-Disease 0 3.7864481328142574e-07
) I-Disease 0 5.331179206722941e-15
or I-Disease 0 6.262646515741918e-14
Ruvalcaba I-Disease 0 2.421860267887155e-09
- I-Disease 0 3.001620341169797e-10
Riley I-Disease 0 1.5311569541154313e-06
- I-Disease 1 1.0
Smith I-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 6.9260977161866855e-12
MIM O 0 0.26918843388557434
153480 O 0 9.283585882258194e-07
) O 0 1.2901203542969863e-12
. O 0 1.8853760219705862e-10

Constitutive O 0 4.621412585947837e-08
DNA O 0 9.077529838918963e-09
from O 0 2.928574700453157e-12
37 O 0 3.747871804571368e-11
CD B-Disease 0 7.128922785426539e-09
families O 0 1.1569064933478201e-12
and O 0 9.544983889647057e-15
seven O 0 1.0798667515743432e-11
BZS B-Disease 0 5.163510081729328e-07
families O 0 6.536951969310367e-13
was O 0 9.314463263188077e-13
screened O 0 2.0786887836021783e-11
for O 0 4.9059208084845096e-11
germline O 0 3.85935800295556e-06
PTEN O 0 6.501940788439242e-06
mutations O 0 4.472892101148318e-08
. O 0 2.3700769347101414e-08

PTEN O 0 1.7981941709876992e-05
mutations O 0 8.601890311155103e-10
were O 0 3.840803976945528e-12
identified O 0 6.210074230024454e-13
in O 0 2.084955336633873e-14
30 O 0 2.437427430029837e-12
of O 0 4.796893091074672e-11
37 O 0 1.4786840640823584e-09
( O 0 1.339650775294271e-13
81 O 0 4.108721363138557e-09
% O 0 2.5731430874920136e-10
) O 0 2.4558566223247804e-15
CD B-Disease 0 1.4838826833951657e-09
families O 0 9.849093112260232e-13
, O 0 5.589671639368325e-15
including O 0 3.190956749049914e-14
missense O 0 1.1509986297397745e-09
and O 0 4.043497481287517e-11
nonsense O 0 6.882640946059837e-08
point O 0 1.3221129746554539e-09
mutations O 0 5.644749424826845e-12
, O 0 8.902373196256752e-14
deletions O 0 7.731029358359898e-12
, O 0 3.563458122329832e-14
insertions O 0 2.8763744164272964e-10
, O 0 4.140659576280445e-14
a O 0 5.041194024724138e-12
deletion O 0 2.123286435562477e-09
/ O 0 6.2149805302169625e-09
insertion O 0 2.7333063812307046e-08
and O 0 4.623964822147997e-10
splice O 0 1.988931580854114e-05
site O 0 2.538505405880187e-08
mutations O 0 5.277413617221782e-09
. O 0 2.206067106769183e-09

These O 0 3.287164984655533e-11
mutations O 0 1.1261718120547659e-11
were O 0 6.470524528505439e-13
scattered O 0 3.189645596257673e-12
over O 0 2.1851227424707353e-14
the O 0 7.690531967762676e-14
entire O 0 2.7816685066461844e-10
length O 0 6.560316179182735e-11
of O 0 1.0883036138942259e-10
PTEN O 0 6.150769227275532e-09
, O 0 2.26214006023278e-14
with O 0 2.448082448055762e-16
the O 0 7.060675557678947e-14
exception O 0 1.5738166249824187e-13
of O 0 5.778100979451917e-13
the O 0 9.607052431142779e-14
first O 0 3.9798277520763925e-12
, O 0 5.016240921989004e-14
fourth O 0 5.911220402055051e-10
and O 0 3.92959189493558e-12
last O 0 2.276564048386831e-09
exons O 0 1.0797843685850239e-07
. O 0 9.753267526946274e-09

A O 0 5.183589564694557e-06
hot O 0 8.416956021051192e-09
spot O 0 3.5469283066191792e-09
for O 0 5.285393650522607e-12
PTEN O 0 7.042686434033385e-08
mutation O 0 2.5198940156734295e-12
in O 0 4.0978345391441684e-13
CD B-Disease 0 5.4639880175955113e-08
was O 0 3.2380495507133844e-10
identified O 0 3.4465966192165354e-10
in O 0 2.7666608587439967e-11
exon O 0 8.954024188767562e-10
5 O 0 6.156616449287666e-12
that O 0 1.6650606064825928e-14
contains O 0 2.1904502832474334e-15
the O 0 3.588888626386566e-13
PTPase O 0 1.0689626606108504e-07
core O 0 1.2277511229896731e-09
motif O 0 1.4107453920331192e-11
, O 0 1.203936314689649e-15
with O 0 6.329939154115654e-16
13 O 0 4.523571187770026e-12
of O 0 1.5977129341759877e-10
30 O 0 1.4128835254534344e-11
( O 0 4.62548768276165e-15
43 O 0 1.4314760488076672e-10
% O 0 7.899841371339367e-12
) O 0 3.638906480963678e-15
CD B-Disease 0 1.0809063644146022e-09
mutations O 0 2.1506036968627074e-12
identified O 0 1.4025563479722059e-12
in O 0 3.320439355327526e-13
this O 0 1.4097501811749513e-11
exon O 0 4.385272145412955e-09
. O 0 5.2737907374478254e-09

Seven O 0 1.65778981653375e-08
of O 0 6.389736517675715e-10
30 O 0 7.692040060458538e-11
( O 0 2.1323153204071132e-14
23 O 0 4.91264355584331e-11
% O 0 1.5767906424990485e-10
) O 0 1.3211618417655578e-14
were O 0 6.1213720724262455e-12
within O 0 2.0714152615397552e-10
the O 0 2.6177039702535154e-11
core O 0 1.5135797060139566e-09
motif O 0 2.2245930791919832e-11
, O 0 6.482623513242702e-15
the O 0 1.143905255891406e-13
majority O 0 9.89107342037887e-13
( O 0 5.02801129182405e-15
five O 0 6.888681465533342e-12
of O 0 1.032190305449987e-11
seven O 0 8.677734746054266e-12
) O 0 2.170857182979668e-14
of O 0 3.0907264594870476e-12
which O 0 1.593601823852292e-13
were O 0 4.992360413957897e-10
missense O 0 4.5774790180530545e-08
mutations O 0 1.1540118166619706e-10
, O 0 3.8912533677042116e-13
possibly O 0 4.29706464855073e-10
pointing O 0 3.3569349522366565e-09
to O 0 5.2079320023157294e-11
the O 0 1.6996605511909735e-10
functional O 0 3.049933638976654e-07
significance O 0 3.980188401087048e-10
of O 0 1.5406367154247036e-11
this O 0 1.4149621144904367e-12
region O 0 1.567486807019236e-09
. O 0 1.8860242256835136e-09

Germline O 0 0.0004898520419374108
PTEN O 0 5.248163233773084e-06
mutations O 0 6.400113078397496e-11
were O 0 1.2421670679899077e-12
identified O 0 1.8170507416412351e-13
in O 0 6.078883141351571e-15
four O 0 5.848662889716347e-14
of O 0 8.052666606445102e-13
seven O 0 3.471638341384642e-12
( O 0 9.034561835631616e-15
57 O 0 1.641665914320356e-09
% O 0 2.7557987003490325e-09
) O 0 5.895012342854722e-12
BZS B-Disease 0 6.054718596715247e-06
families O 0 1.0702749797530942e-10
studied O 0 1.3716422442300313e-09
. O 0 1.8630705866939934e-09

Interestingly O 0 3.1952402945734093e-09
, O 0 5.224698440813719e-14
none O 0 1.8330014155826246e-12
of O 0 6.422252595179867e-13
these O 0 7.295567280721574e-14
mutations O 0 1.7868075725610555e-12
was O 0 2.5125847583074012e-12
observed O 0 4.353004230944063e-13
in O 0 6.093725242288517e-13
the O 0 8.235497700459504e-11
PTPase O 0 1.3537654012907296e-05
core O 0 2.9139167168068525e-07
motif O 0 2.736723203611291e-08
. O 0 7.406151247835169e-09

It O 0 2.341316376885949e-12
is O 0 6.775252644211855e-15
also O 0 4.0966401739841454e-16
worthy O 0 6.55103818414382e-11
of O 0 2.441751315029883e-11
note O 0 1.4465346238543009e-12
that O 0 1.3576556421991226e-15
a O 0 6.726712150620026e-14
single O 0 2.995327597066222e-11
nonsense O 0 3.728154673865447e-09
point O 0 5.081723930544513e-11
mutation O 0 4.606352192043639e-13
, O 0 1.4342908845744844e-14
R233X O 0 3.5833966904874615e-09
, O 0 1.4055970505631819e-14
was O 0 3.5161785050426275e-13
observed O 0 5.0514202331675487e-14
in O 0 6.277184989248591e-15
the O 0 6.638789453068672e-14
germline O 0 4.612038528861717e-10
DNA O 0 1.0401282057870276e-09
from O 0 1.793010726870714e-12
two O 0 1.8122951598621706e-13
unrelated O 0 7.206921691371715e-12
CD B-Disease 0 1.568073670910053e-08
families O 0 3.0378624962801304e-12
and O 0 1.364286830209116e-13
one O 0 2.1537736871746205e-11
BZS B-Disease 0 2.9855567845515907e-05
family O 0 2.8062244195048436e-10
. O 0 2.77813860805054e-09

Genotype O 0 6.320457259789691e-07
- O 0 2.870582660463583e-09
phenotype O 0 4.7253177065664786e-11
studies O 0 3.2140720748925766e-13
were O 0 2.2103787238590168e-14
not O 0 1.4302661651739582e-15
performed O 0 9.636641528157353e-13
on O 0 6.187869769531951e-13
this O 0 2.4368902417346884e-14
small O 0 4.12886108495155e-14
group O 0 1.2804846938362698e-14
of O 0 6.177239275650948e-11
BZS B-Disease 0 7.718010601820424e-05
families O 0 2.999784420865126e-09
. O 0 2.3629091572274774e-08

However O 0 1.0949496864753883e-10
, O 0 1.8084278107129148e-13
genotype O 0 2.0656716337441594e-09
- O 0 1.4143941573507846e-10
phenotype O 0 8.248388777554183e-11
analysis O 0 2.4040227274146897e-12
inthe O 0 4.4923858411038964e-08
group O 0 1.4928267904603873e-14
of O 0 1.6790627048457463e-12
CD B-Disease 0 1.1961595191678498e-05
families O 0 2.3495129453099395e-11
revealed O 0 6.176956862669059e-11
two O 0 1.1239705387656833e-14
possible O 0 1.2617687385370335e-13
associations O 0 5.934219316026251e-14
worthy O 0 9.752587626365994e-11
of O 0 4.326265040655031e-11
follow O 0 1.7662586671018943e-10
- O 0 2.358057638041089e-10
up O 0 5.416753417336606e-12
in O 0 9.062322832258107e-13
independent O 0 3.531317946392498e-11
analyses O 0 1.9894490499439144e-09
. O 0 9.583244198196894e-10

The O 0 6.392939649879636e-11
first O 0 1.0070112278770527e-11
was O 0 6.0232396327519755e-12
an O 0 9.140396061292199e-15
association O 0 9.370518141808837e-14
noted O 0 6.716660918854728e-14
in O 0 9.308450786159241e-15
the O 0 1.0643554451423426e-13
group O 0 1.0193536476810704e-15
of O 0 2.556418618460121e-13
CD B-Disease 0 1.4778468084841734e-06
families O 0 2.2487144091254407e-10
with O 0 1.8529977552361743e-10
breast B-Disease 1 0.9999845027923584
disease I-Disease 0 0.2553156018257141
. O 0 3.484622084215516e-07

A O 0 3.983478880087432e-09
correlation O 0 4.270735848299623e-11
was O 0 2.8612458539620245e-13
observed O 0 1.216707432776052e-14
between O 0 3.5255113851060185e-14
the O 0 1.4584320011975897e-14
presence O 0 5.058024379650701e-14
/ O 0 4.900421735065663e-11
absence O 0 1.3413352373259357e-10
of O 0 2.7840237060150486e-11
a O 0 2.7613191681125082e-12
PTEN O 0 1.9754473612465517e-09
mutation O 0 1.2859654205214788e-13
and O 0 2.2112280808529201e-16
the O 0 4.443844855354755e-15
type O 0 6.369713350523609e-12
of O 0 1.5036107775534546e-11
breast O 0 2.312029734330423e-10
involvement O 0 1.2171219587742144e-08
( O 0 1.4789787450286696e-11
unaffected O 0 3.805678545631963e-07
versus O 0 0.00011041200923500583
benign O 0 0.00014405928959604353
versus O 0 1.6321369912475348e-05
malignant O 0 8.372569936909713e-06
) O 0 1.602082008722583e-11
. O 0 1.6506392919168889e-09

Specifically O 0 2.2942286959093394e-11
and O 0 2.085782718416751e-14
more O 0 8.282293452208469e-16
directly O 0 2.7663835848804053e-13
, O 0 8.276924322114061e-16
an O 0 7.013610150788938e-16
association O 0 3.9372930642819076e-14
was O 0 4.082171666669465e-12
also O 0 3.869017380645412e-15
observed O 0 4.5432377342646477e-14
between O 0 5.683043011878164e-13
the O 0 1.944316154476114e-13
presence O 0 1.3034887026090042e-13
of O 0 1.5983911243189208e-12
a O 0 1.878927569087807e-11
PTEN O 0 4.357806574262213e-06
mutation O 0 2.0239045284142776e-07
and O 0 1.4687601890273072e-07
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 0.9991570711135864
. O 0 5.19884899574663e-08

Secondly O 0 1.2049465567542939e-06
, O 0 7.164079659366385e-12
there O 0 1.6172593863064688e-13
appeared O 0 6.716702389587825e-13
to O 0 3.665009918815687e-13
be O 0 1.2157020182201883e-12
an O 0 1.5554582361715363e-12
interdependent O 0 7.220309328204166e-08
association O 0 1.500940344234536e-11
between O 0 2.189972425625797e-09
mutations O 0 9.198128370080383e-11
upstream O 0 3.8501871829632606e-11
and O 0 2.6016422157337966e-14
within O 0 5.051842277836727e-11
the O 0 4.446363069399162e-11
PTPase O 0 2.6165505460085114e-06
core O 0 8.154014352612649e-08
motif O 0 2.307233737397496e-09
, O 0 3.9671843826520614e-13
the O 0 6.525258198358808e-12
core O 0 2.398031551109625e-09
motif O 0 4.0989798361090735e-11
containing O 0 1.4372410325671353e-13
the O 0 5.4437597956985204e-14
majority O 0 1.967686647300071e-12
of O 0 9.284337187942526e-11
missense O 0 1.905195112783531e-08
mutations O 0 2.154036844725926e-11
, O 0 8.101247571271151e-15
and O 0 8.4301324652398665e-16
the O 0 1.9065014188668003e-14
involvement O 0 8.494781961188025e-11
of O 0 4.5250600488877524e-10
all O 0 4.595192282241811e-12
major O 0 1.847872202476175e-11
organ O 0 1.1692296020271442e-08
systems O 0 6.615852612412709e-07
( O 0 2.8397893411802322e-11
central O 0 0.21035654842853546
nervous O 0 6.902991572133033e-06
system O 0 0.0005890827742405236
, O 0 9.93537977583836e-12
thyroid O 0 1.4854245478090888e-07
, O 0 1.537225902126238e-11
breast O 0 0.45506376028060913
, O 0 1.2984968655871398e-08
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 0.9999765157699585
) O 0 2.7325841589487254e-10
. O 0 1.1642097064168411e-07

However O 0 1.2744695299105047e-09
, O 0 1.691643515804725e-13
these O 0 1.8423440941231495e-14
observations O 0 2.3301874752662544e-12
would O 0 5.002759206787326e-14
need O 0 5.302233261825218e-13
to O 0 4.235096431534635e-13
be O 0 1.1070396037588318e-13
confirmed O 0 1.3627010761116387e-12
by O 0 5.206530685237945e-15
studying O 0 4.706174686064379e-12
a O 0 7.640689161014444e-14
larger O 0 6.17322558631346e-14
number O 0 7.461856788926538e-14
of O 0 1.5324007254097216e-12
CD B-Disease 0 8.356430214462307e-08
families O 0 2.851672231685143e-10
. O 0 3.5878693349644664e-09

Molecular O 0 3.5769525652540324e-07
defects O 0 0.00013511819997802377
leading O 0 2.2067939142722537e-10
to O 0 1.0260073173007367e-11
human O 0 1.356951173647758e-08
complement B-Disease 1 1.0
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.1341453817759195e-11
an O 0 4.785296541887172e-15
African O 0 6.067725315250794e-12
- O 0 5.322978169353121e-12
American O 0 3.286578366228088e-13
family O 0 2.543055609843803e-12
. O 0 4.1270802747517266e-11

Complement B-Disease 0 0.000115910945169162
component I-Disease 1 0.9999978542327881
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.150910088400849e-12
C6D B-Disease 1 0.9999009370803833
) O 0 3.2667607768183116e-13
was O 0 1.0923630056058897e-10
diagnosed O 0 4.807231945846979e-08
in O 0 4.930060808379377e-13
a O 0 8.497734715331648e-14
16 O 0 3.702988707766225e-13
- O 0 2.258135457864751e-14
year O 0 2.998868785675929e-13
- O 0 3.50112972467842e-12
old O 0 2.89007318077239e-10
African O 0 3.0048225019285724e-10
- O 0 3.7993946096909204e-13
American O 0 2.722401585441474e-15
male O 0 2.356431022532135e-13
with O 0 1.8167924982362763e-15
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 8.162067133277162e-10

The O 0 1.4308455809075582e-10
patients O 0 2.4050006777742716e-11
father O 0 5.6113679675062755e-11
and O 0 3.435643696619861e-13
two O 0 2.5830784993602363e-12
brothers O 0 2.4027724254693794e-11
also O 0 5.858679969113212e-13
had O 0 3.4223571893088334e-11
C6D B-Disease 1 0.9999799728393555
, O 0 6.291596068999997e-14
but O 0 1.2555167036500548e-14
gave O 0 1.5522742054414895e-13
no O 0 1.1854208309132041e-14
history O 0 7.697642870341248e-12
of O 0 1.43197842472631e-10
meningitis B-Disease 1 1.0
or O 0 2.1836231434146924e-10
other O 0 4.255051519463926e-11
neisserial B-Disease 0 1.4452805771725252e-05
infection I-Disease 0 9.979394963011146e-05
. O 0 1.2543812211163186e-08

By O 0 1.3091913180450759e-14
using O 0 2.522840877178245e-13
exon O 0 1.0480311063432168e-11
- O 0 1.0163495479248441e-13
specific O 0 4.13542448914994e-15
polymerase O 0 1.6347253073228062e-14
chain O 0 3.5275004725760558e-15
reaction O 0 4.1110092276664775e-17
( O 0 2.880198690445659e-19
PCR O 0 8.232309826232756e-15
) O 0 1.5851582610841034e-18
/ O 0 3.7174619046788176e-16
single O 0 2.7976130289599725e-15
- O 0 6.933247370522594e-16
strand O 0 1.3247594236266073e-15
conformation O 0 1.407534045506963e-14
polymorphism O 0 2.0139251865562008e-13
as O 0 3.0038375730593556e-17
a O 0 2.9584293278971346e-17
screening O 0 1.9678260960282433e-15
step O 0 2.6583241359047494e-14
and O 0 4.7399440950203513e-17
nucleotide O 0 1.5803650705789596e-13
sequencing O 0 3.322013844564431e-11
of O 0 5.3433046182105315e-11
target O 0 5.798655999811331e-10
exons O 0 7.005823143835244e-10
, O 0 8.284288850073963e-15
we O 0 3.2445948563249085e-15
determined O 0 1.3096822888344906e-12
that O 0 4.881071298387045e-16
the O 0 1.4085768955309635e-13
proband O 0 8.177404531295451e-09
was O 0 1.038958741088336e-12
a O 0 7.427238891185434e-14
compound O 0 9.252529298287016e-12
heterozygote O 0 1.8867150064494354e-09
for O 0 2.7550639720985703e-12
two O 0 2.0551463308926543e-10
C6 O 0 0.00013139439397491515
gene O 0 1.6896704035929133e-09
mutations O 0 3.2627758272951723e-09
. O 0 7.449958427940828e-09

The O 0 4.139822928905801e-10
first O 0 8.336582119072844e-11
, O 0 3.5351962242996526e-13
1195delC O 0 2.6221453452990318e-08
located O 0 4.07252833886651e-12
in O 0 2.0236451403476963e-12
exon O 0 6.469830782229735e-10
7 O 0 3.966721118242589e-10
, O 0 1.217688385020399e-12
is O 0 1.1062115612902549e-14
a O 0 5.057127202352969e-14
novel O 0 1.99221979787622e-14
mutation O 0 3.37656497814004e-13
, O 0 8.205159032141467e-15
while O 0 3.5804172127118505e-13
the O 0 2.934261124007409e-12
second O 0 8.717852828521444e-11
, O 0 1.740070354515691e-13
1936delG O 0 1.9109003268624747e-09
in O 0 1.2260415772902267e-11
exon O 0 2.790032094246442e-10
12 O 0 6.867275498256831e-11
, O 0 2.872406089024504e-13
has O 0 4.9961772525673916e-15
been O 0 4.815210526858994e-14
described O 0 1.9146289371649305e-13
before O 0 2.895416545412033e-12
to O 0 9.28888979623288e-11
cause O 0 4.413922738422116e-08
C6D B-Disease 1 0.9999972581863403
in O 0 1.6454698714696292e-11
an O 0 2.640346437581681e-13
unrelated O 0 3.437366502545558e-10
African O 0 3.533854986415008e-09
- O 0 1.1179456665955101e-10
American O 0 7.835345219864287e-12
individual O 0 7.591181155897075e-11
. O 0 2.3502504387096224e-09

Both O 0 3.361102021703921e-11
mutations O 0 1.1751436629348078e-11
result O 0 1.8898393266963964e-11
in O 0 8.462079127691258e-12
premature O 0 2.084877159802545e-09
termination O 0 3.883120491821046e-09
codons O 0 4.9533794843625856e-09
and O 0 2.498813378437603e-10
C6 O 0 1.72306977219705e-06
null O 0 5.450560891517853e-08
alleles O 0 1.6005503589155978e-09
. O 0 1.4690789917892744e-08

Allele O 0 1.922471071225118e-09
- O 0 1.899994701501373e-12
specific O 0 1.5676980655472683e-14
PCR O 0 4.535389858811856e-12
indicated O 0 1.8457144721015922e-13
that O 0 1.6659348053646523e-17
the O 0 1.6817460120490237e-15
probands O 0 2.4571514267712757e-10
two O 0 2.2548516805348355e-14
brothers O 0 8.776253378542376e-13
also O 0 1.201908666044688e-14
inherited O 0 6.05657121677261e-11
the O 0 1.7513188165299565e-12
1195delC O 0 5.382145285004469e-10
mutation O 0 3.006824119116541e-13
from O 0 3.3592899783500135e-14
their O 0 5.407831300818788e-13
heterozygous O 0 5.304208461343052e-12
mother O 0 3.747881725021246e-13
and O 0 1.8737059125117136e-15
the O 0 1.3755221462720402e-13
1936delG O 0 2.1811920325465195e-10
mutation O 0 1.444504645021702e-13
from O 0 4.042427471321469e-14
their O 0 1.4343169664129962e-12
homozygous O 0 2.590643671807058e-11
father O 0 4.560539099141003e-11
. O 0 3.8408352887042696e-11
. O 0 1.3737683213221885e-09

PAX6 O 0 0.0004426171653904021
mutations O 0 8.010204943786903e-09
reviewed O 0 5.824408511045931e-09
. O 0 5.10883335635981e-09

Mutations O 0 1.4486055022189248e-08
in O 0 6.675596880834078e-11
PAX6 O 0 4.9223868700210005e-05
are O 0 5.405892205233298e-13
responsible O 0 1.2719378501835354e-11
for O 0 1.882894447996497e-12
human O 0 9.87146919761983e-10
aniridia B-Disease 1 1.0
and O 0 1.1811930773764079e-11
have O 0 2.333565435883641e-14
also O 0 8.852043282036378e-16
been O 0 6.20824455415509e-15
found O 0 9.91159160767998e-15
in O 0 5.606798645561807e-15
patients O 0 4.276932608526969e-14
with O 0 6.169129334980539e-14
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 5.666693850270299e-11
with O 0 1.877543231998402e-09
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 3.268888093543865e-08
with O 0 5.803936886650263e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 9.761217875658978e-12
and O 0 2.2598914926896807e-12
with O 0 1.0088115898199135e-09
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9998549222946167

No O 0 2.2911514352408346e-10
locus O 0 5.498542940407525e-11
other O 0 2.3758086630291074e-14
than O 0 7.027932652069885e-14
chromosome O 0 3.784688951125048e-10
11p13 O 0 1.82185885932995e-07
has O 0 3.4911984869885615e-13
been O 0 4.729868840341878e-12
implicated O 0 7.69445396286983e-09
in O 0 1.8519670241801123e-09
aniridia B-Disease 1 1.0
, O 0 1.5846862017054875e-11
and O 0 3.73848825160894e-12
PAX6 O 0 0.041040752083063126
is O 0 1.2016898977632029e-12
clearly O 0 3.945227824986297e-12
the O 0 2.4659098547819003e-12
major O 0 3.052553348981135e-11
, O 0 4.477444958306438e-14
if O 0 2.4232772364261856e-14
not O 0 7.576038863095491e-14
only O 0 2.1433461288352523e-13
, O 0 3.1517062587136865e-14
gene O 0 6.703200277832777e-13
responsible O 0 3.0451113852691947e-10
. O 0 1.976394337077636e-08

Twenty O 0 2.9392523970273032e-08
- O 0 1.2895558232361992e-10
eight O 0 2.0139580975131466e-11
percent O 0 2.8968487331137993e-11
of O 0 1.7051918687824297e-12
identified O 0 2.478250417381478e-11
PAX6 O 0 6.388987117134093e-07
mutations O 0 2.200857551759583e-11
are O 0 1.9786714042409337e-13
C O 0 7.190129167611303e-07
- O 0 8.781948963587638e-07
T O 0 1.7702907584293825e-08
changes O 0 8.142098106844742e-11
at O 0 3.088878874901724e-10
CpG O 0 6.125434381942796e-09
dinucleotides O 0 9.28401000521717e-09
, O 0 1.0052632757793188e-14
20 O 0 3.460430997737768e-13
% O 0 1.0789871600358492e-12
are O 0 1.2012245387090143e-16
splicing O 0 2.4171968246444742e-11
errors O 0 7.033676308054737e-09
, O 0 1.8180248972932134e-13
and O 0 1.8869190335658176e-14
more O 0 2.3038711712583364e-15
than O 0 1.2258994343196557e-14
30 O 0 9.025378534810446e-12
% O 0 1.1269093991295165e-10
are O 0 2.709576574883802e-14
deletion O 0 1.9298571421466626e-11
or O 0 9.045179535926984e-12
insertion O 0 1.0021721230657477e-09
events O 0 8.07381106415761e-10
. O 0 2.8294886433855027e-08

There O 0 1.149874570560705e-10
is O 0 2.843732465219323e-13
a O 0 2.8785834393224574e-12
noticeably O 0 1.2068973376244685e-08
elevated O 0 8.300073822686826e-11
level O 0 9.22207643583306e-10
of O 0 1.3492582051632951e-11
mutation O 0 1.1998113277639916e-13
in O 0 6.763287033282467e-14
the O 0 5.318996653715102e-13
paired O 0 8.259637006464982e-13
domain O 0 6.2240703042892864e-12
compared O 0 3.61480891877472e-13
with O 0 8.600010216767637e-16
the O 0 9.069477211343796e-14
rest O 0 4.011855084251614e-11
of O 0 3.259486647602672e-12
the O 0 4.6996534268373136e-12
gene O 0 3.550950549227605e-12
. O 0 8.504026927091957e-10

Increased O 0 7.369060917028492e-10
mutation O 0 1.0478327190296954e-12
in O 0 5.023594523223887e-14
the O 0 4.613456968879937e-13
homeodomain O 0 1.8403537582756258e-09
is O 0 3.6018801297403504e-15
accounted O 0 1.3179448851707853e-11
for O 0 6.0694289831107924e-15
by O 0 2.41111502914974e-14
the O 0 4.7803708908000786e-11
hypermutable O 0 2.1810285488754744e-07
CpG O 0 2.445936253536729e-08
dinucleotide O 0 3.472625564882037e-08
in O 0 9.827466618261838e-11
codon O 0 1.4251517299612715e-08
240 O 0 3.0966023079059823e-09
. O 0 5.118167667461648e-09

Very O 0 2.8406144103598763e-10
nearly O 0 1.8024548867345835e-11
all O 0 3.0680240791468305e-13
mutations O 0 8.326783815411354e-13
appear O 0 3.1630494664453e-12
to O 0 1.7276828839091207e-12
cause O 0 3.5016878285887287e-10
loss O 0 4.30265201245561e-09
of O 0 1.261588966627869e-08
function O 0 5.280615056335591e-09
of O 0 1.1480710132572014e-10
the O 0 7.182491905920185e-13
mutant O 0 1.088694293136655e-13
allele O 0 7.011119115829523e-13
, O 0 3.8319569363459574e-16
and O 0 1.6047632108795798e-16
more O 0 3.449583367596011e-17
than O 0 1.7915133293210637e-16
80 O 0 5.785290866158754e-13
% O 0 7.855261580091977e-12
of O 0 2.8257884313737103e-12
exonic O 0 2.455517345012481e-09
substitutions O 0 4.005890757996511e-11
result O 0 1.4962983976851696e-11
in O 0 4.112833337788224e-11
nonsense O 0 1.4191217978520854e-08
codons O 0 6.08294969950407e-09
. O 0 1.169363450514993e-08

In O 0 3.839839210484364e-11
a O 0 1.6222775076416007e-12
gene O 0 1.2664510011441837e-13
with O 0 1.810749765190564e-14
such O 0 2.960467428928665e-13
extraordinarily O 0 5.134281000351848e-09
high O 0 8.363434250702184e-11
sequence O 0 2.7627164445043206e-11
conservation O 0 1.4790710973697219e-12
throughout O 0 1.97424935015518e-13
evolution O 0 3.0006498587947794e-12
, O 0 7.928781498814808e-15
there O 0 4.9510248060612855e-14
are O 0 6.552043521450279e-13
presumed O 0 1.1055125469283666e-05
undiscovered O 0 5.2424660680117086e-05
missense O 0 6.367409241647692e-06
mutations O 0 1.6440953487517618e-08
, O 0 4.225940344187995e-12
these O 0 3.863787761959614e-12
are O 0 7.503477548499726e-13
hypothesized O 0 2.7455390391728507e-11
to O 0 1.1984310245571894e-11
exist O 0 1.8892936104464297e-09
in O 0 2.3215160696588022e-11
as O 0 2.1838189590006607e-10
- O 0 1.3230666562336069e-09
yet O 0 2.0638314668364188e-10
unidentified O 0 3.5556990951590706e-07
phenotypes O 0 4.507145323628947e-09
. O 0 1.1492754664610416e-11
. O 0 6.01718341819435e-10

Genetic O 0 5.694502203112961e-09
heterogeneity O 0 6.935451657419378e-10
and O 0 8.088159048763588e-14
penetrance O 0 7.283562553084266e-08
analysis O 0 9.624522533113744e-12
of O 0 2.923720987535461e-11
the O 0 2.363172435515537e-10
BRCA1 O 0 5.116332246757338e-09
and O 0 3.5795880148903336e-11
BRCA2 O 0 1.8975937265963694e-08
genes O 0 1.1942284661170532e-10
in O 0 2.167539481234826e-10
breast B-Disease 0 5.563303062672276e-08
cancer I-Disease 0 5.715644846304713e-09
families O 0 1.5458070379281708e-09
. O 0 4.5102351009518316e-07

The O 0 1.2649977179535199e-05
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 4.399837052915245e-06
Consortium O 0 5.691545568176082e-10
. O 0 6.273562780378938e-10

The O 0 6.100590085184043e-12
contribution O 0 7.987525224573133e-11
of O 0 2.470199392257122e-11
BRCA1 O 0 2.5476011925040787e-11
and O 0 4.1922921297649074e-13
BRCA2 O 0 3.208592147529998e-08
to O 0 9.150489290732366e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 4.955326815547778e-09
assessed O 0 1.2201534921318924e-11
by O 0 2.9539684500562435e-14
linkage O 0 9.626588415301285e-10
and O 0 2.8998850575608776e-14
mutation O 0 1.2100099432621123e-14
analysis O 0 8.575837590518894e-15
in O 0 4.1132724599968716e-15
237 O 0 2.469887142031446e-12
families O 0 1.482055174114108e-13
, O 0 1.1474858039198861e-15
each O 0 2.1413387623942133e-14
with O 0 5.076675875742651e-15
at O 0 8.920905463991047e-13
least O 0 6.898891587127018e-14
four O 0 3.816803305161341e-14
cases O 0 1.3025591347713694e-13
of O 0 8.677739082862956e-11
breast B-Disease 0 3.070393661541715e-10
cancer I-Disease 0 3.8761663150033154e-12
, O 0 1.9791335623576146e-15
collected O 0 1.7378347296360258e-13
by O 0 1.054402062623111e-13
the O 0 5.621135557021262e-08
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 8.442232797278848e-07
Consortium O 0 2.1838397756823724e-10
. O 0 6.841784916389315e-10

Families O 0 4.016709534426788e-11
were O 0 6.096027003500704e-13
included O 0 4.627599166492566e-14
without O 0 3.476393977373815e-13
regard O 0 1.2428098480898875e-11
to O 0 1.9440983111546073e-12
the O 0 9.11408795656321e-12
occurrence O 0 2.7855476218974218e-06
of O 0 5.221604169491911e-06
ovarian B-Disease 1 1.0
or I-Disease 0 1.7645485286266194e-06
other I-Disease 0 8.230139769693778e-08
cancers I-Disease 1 0.9999997615814209
. O 0 6.114473944762722e-05

Overall O 0 1.4075112630962394e-05
, O 0 1.453170223042477e-10
disease O 0 2.1478657075135743e-08
was O 0 1.6155075888146797e-10
linked O 0 1.4057669472933298e-09
to O 0 2.443104829552567e-09
BRCA1 O 0 4.354567906261764e-08
in O 0 3.1505494827582803e-12
an O 0 1.2313167605887626e-15
estimated O 0 3.7104525588095225e-14
52 O 0 1.7994184267622337e-11
% O 0 1.2415975192414663e-10
of O 0 2.458409994673949e-12
families O 0 1.6892230886647597e-12
, O 0 6.330766260612825e-14
to O 0 1.5710620304698608e-11
BRCA2 O 0 1.0614761847271836e-10
in O 0 1.2465508226339184e-12
32 O 0 9.367994574516203e-11
% O 0 4.034337794389664e-11
of O 0 1.5067623797965224e-12
families O 0 1.0555938718612157e-12
, O 0 6.214144138632716e-15
and O 0 1.5243875133607904e-15
to O 0 2.5427050872814383e-13
neither O 0 2.8699761751155295e-12
gene O 0 3.243519886811548e-14
in O 0 2.7443634387572247e-13
16 O 0 3.2477948282150226e-12
% O 0 1.4560041540490065e-12
( O 0 4.5869494306670334e-17
95 O 0 1.5898995661678406e-11
% O 0 2.8985400885028767e-11
confidence O 0 1.1924969900434235e-09
interval O 0 8.483387325952663e-10
[ O 0 4.4377300445486156e-11
CI O 0 3.89827414792876e-09
] O 0 5.6487345183320326e-12
6 O 0 1.6090420012007667e-12
% O 0 7.432702890664e-12
- O 0 6.527171923613462e-13
28 O 0 9.794241155949845e-13
% O 0 5.500522346629788e-12
) O 0 1.7992326582067474e-15
, O 0 2.952479662596502e-15
suggesting O 0 5.589719767780388e-13
other O 0 1.6175987415864568e-13
predisposition O 0 3.745202814542381e-09
genes O 0 1.612144084894851e-09
. O 0 1.5326904190260393e-08

The O 0 5.438892669573647e-10
majority O 0 5.607291714282425e-11
( O 0 4.746064940385668e-15
81 O 0 1.6407446234989465e-10
% O 0 9.015953955637812e-11
) O 0 1.6672206675530333e-15
of O 0 3.6567793064434806e-12
the O 0 4.304148149003595e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.649824738109601e-07
were O 0 1.618507758371912e-11
due O 0 1.2242522273719914e-10
to O 0 1.8497762349634073e-11
BRCA1 O 0 2.863165086963715e-11
, O 0 5.672890085337218e-15
with O 0 7.897595439762799e-16
most O 0 9.632624694633565e-15
others O 0 1.8273314176912858e-13
( O 0 6.935390363879148e-16
14 O 0 2.3811278469787478e-12
% O 0 7.978842413158826e-12
) O 0 1.3827335349102438e-15
due O 0 3.296570308397584e-11
to O 0 9.657373789551116e-10
BRCA2 O 0 6.961884935208218e-08
. O 0 2.2561232881912474e-08

Conversely O 0 2.176355984317979e-09
, O 0 3.45124548446654e-15
the O 0 1.0800334998355924e-15
majority O 0 3.720216138185933e-15
of O 0 1.4862893901734786e-14
families O 0 1.0818854526714692e-14
with O 0 9.429423819927864e-16
male B-Disease 0 2.3320765318857184e-09
and I-Disease 0 1.2142101560308483e-11
female I-Disease 1 0.9999972581863403
breast I-Disease 1 0.999421238899231
cancer I-Disease 1 0.9995089769363403
were O 0 0.001455326215364039
due O 1 0.9999927282333374
to O 0 1.0557695532042999e-05
BRCA2 O 0 4.767156980278742e-08
( O 0 6.566556109630084e-13
76 O 0 2.0250004340027772e-08
% O 0 1.2189707021548202e-09
) O 0 2.585714303261766e-13
. O 0 1.0073805678523229e-10

The O 0 9.972982439876432e-10
largest O 0 7.969701287802167e-12
proportion O 0 1.3465791849631703e-11
( O 0 2.7923993294113854e-15
67 O 0 3.3323106496396804e-09
% O 0 4.894641913999465e-10
) O 0 1.673207538775874e-14
of O 0 6.777821793396699e-12
families O 0 1.6255048522484383e-12
due O 0 8.916598570607448e-10
to O 0 1.5182853238537852e-11
other O 0 6.828397981599454e-13
genes O 0 1.9868447165283243e-12
was O 0 2.9068321100861327e-12
found O 0 1.0522462621283951e-13
in O 0 6.723116919275405e-15
families O 0 8.180628619175803e-14
with O 0 1.5394469121300246e-15
four O 0 7.610334210690281e-14
or O 0 7.977688334156324e-15
five O 0 2.3191801059338317e-14
cases O 0 1.4946987332738193e-14
of O 0 5.503673905504769e-11
female O 0 7.535186796303606e-06
breast B-Disease 0 5.10521260821406e-07
cancer I-Disease 0 6.661042561972863e-08
only O 0 4.073062775944436e-09
. O 0 4.11692155921628e-07

These O 0 5.337801381455343e-12
estimates O 0 6.809283172037883e-12
were O 0 3.9604856395293597e-13
not O 0 6.55500298680535e-14
substantially O 0 8.572122178751584e-12
affected O 0 8.884426262170328e-14
either O 0 4.4817424646676277e-14
by O 0 5.338502971222257e-16
changing O 0 2.6356833382479294e-12
the O 0 1.6293841547266458e-13
assumed O 0 3.6397607150462363e-11
penetrance O 0 1.3683211230741676e-09
model O 0 4.097842128559376e-13
for O 0 2.1581387122261014e-13
BRCA1 O 0 3.871173520630933e-11
or O 0 2.877669077420292e-14
by O 0 1.4610037202803959e-15
including O 0 1.7694143879579648e-14
or O 0 2.3596615113252728e-12
excluding O 0 3.4393601855420286e-10
BRCA1 O 0 3.313247010083842e-09
mutation O 0 8.00005825474237e-11
data O 0 1.0656556748145363e-09
. O 0 2.5400441749923175e-09

Among O 0 6.871582729911507e-12
those O 0 1.1828332638439548e-13
families O 0 1.0774035743427168e-12
with O 0 3.145528271446957e-13
disease O 0 7.891837183748862e-10
due O 0 6.092018001169208e-09
to O 0 1.4974933515432554e-09
BRCA1 O 0 1.5962646315870188e-08
that O 0 2.2912355064456935e-13
were O 0 5.654463645899353e-14
tested O 0 1.5525215009456052e-15
by O 0 1.915234799715069e-17
one O 0 9.748991351476782e-16
of O 0 9.628913843291644e-15
the O 0 1.687890283169288e-15
standard O 0 8.204876970170031e-15
screening O 0 7.510257437378775e-15
methods O 0 1.6235342063797287e-12
, O 0 5.082430617586297e-15
mutations O 0 8.534672128095513e-14
were O 0 2.2692805479781336e-13
detected O 0 2.1334767719843883e-12
in O 0 1.0595846845328633e-14
the O 0 1.8979869759183643e-13
coding O 0 7.012374014792044e-10
sequence O 0 1.978133629121359e-11
or O 0 1.6558785592701852e-11
splice O 0 9.181520432832713e-09
sites O 0 1.4929770961180644e-11
in O 0 5.981606404853804e-14
an O 0 1.0154570843654638e-15
estimated O 0 3.7163333391557196e-13
63 O 0 6.043510691888798e-10
% O 0 1.2309488151007741e-10
( O 0 4.736352437095977e-15
95 O 0 8.125921047152929e-10
% O 0 5.573702957506477e-11
CI O 0 8.413821306341163e-10
51 O 0 2.0809627632178973e-10
% O 0 1.0443101938761856e-10
- O 0 1.4803248904460276e-11
77 O 0 2.3007493479831886e-11
% O 0 6.173670602516168e-11
) O 0 7.110842947452567e-14
. O 0 3.8774473215541505e-11

The O 0 4.536549087774677e-12
estimated O 0 1.968819259099558e-13
sensitivity O 0 4.765383834065551e-12
was O 0 8.585382974208092e-14
identical O 0 3.011236347620107e-14
for O 0 3.556630465027723e-16
direct O 0 6.022590602226471e-14
sequencing O 0 7.628338238863108e-11
and O 0 1.6869135483019854e-13
other O 0 2.1326133404792752e-13
techniques O 0 4.6253898489112544e-08
. O 0 3.3772351581973226e-09

The O 0 1.5927724694719814e-09
penetrance O 0 1.7069552995963022e-05
of O 0 2.4553301614105294e-09
BRCA2 O 0 1.8946704205546894e-09
was O 0 2.0188566530326968e-12
estimated O 0 9.602655313706993e-14
by O 0 1.6549531952570677e-15
maximizing O 0 9.898714070644132e-10
the O 0 3.8860355905390165e-11
LOD O 0 1.8984896996698808e-06
score O 0 9.559892877319953e-10
in O 0 7.432933435413958e-11
BRCA2 O 0 3.077796506545383e-08
- O 0 4.953935039964108e-10
mutation O 0 3.695426777083899e-12
families O 0 8.615719357570051e-13
, O 0 2.4851182225206275e-15
over O 0 7.0823601093484255e-15
all O 0 2.4363652507139802e-14
possible O 0 2.6105041739388213e-11
penetrance O 0 9.175254263027455e-07
functions O 0 1.0481346457424934e-08
. O 0 4.791274488269437e-09

The O 0 2.786019895686942e-12
estimated O 0 5.032141695525405e-13
cumulative O 0 5.1027130437697465e-11
risk O 0 1.3959815248210106e-10
of O 0 5.2077386847315665e-09
breast B-Disease 0 8.940411930780101e-07
cancer I-Disease 0 3.5761111849552663e-09
reached O 0 1.2976496464034426e-06
28 O 0 1.9980319621026865e-09
% O 0 6.207546976444434e-11
( O 0 4.513494998178936e-16
95 O 0 9.601754114019201e-11
% O 0 1.1151425269306792e-11
CI O 0 9.773406389745887e-11
9 O 0 5.985215578360736e-13
% O 0 9.516018615457478e-13
- O 0 1.4612950064406272e-13
44 O 0 1.638199938116397e-13
% O 0 1.679999726573317e-14
) O 0 3.5308455185949166e-19
by O 0 5.661380035858388e-18
age O 0 2.4189917579328472e-14
50 O 0 1.1789944766456804e-14
years O 0 6.824198866585418e-15
and O 0 7.568088505973444e-16
84 O 0 8.564714692668729e-13
% O 0 2.185340667107405e-13
( O 0 1.119898738229924e-17
95 O 0 1.7660782775444361e-12
% O 0 6.655413524979392e-13
CI O 0 2.5070806541904744e-11
43 O 0 6.369823071783465e-12
% O 0 1.5052227042913757e-12
- O 0 2.8588074832761046e-13
95 O 0 4.2175260679677695e-12
% O 0 1.5090854184763441e-13
) O 0 8.429540679550131e-19
by O 0 1.4795273382201124e-17
age O 0 5.217292526824013e-13
70 O 0 9.994084552988891e-13
years O 0 2.5466573294607997e-12
. O 0 1.5383061491291983e-10

The O 0 5.147108339542683e-08
corresponding O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 5.6430387473938026e-08
were O 0 1.5830314836762227e-10
0 O 0 9.820683155581378e-11
. O 0 6.897840076902639e-10

4 O 0 7.381943667450486e-11
% O 0 2.8354540937414185e-11
( O 0 6.989678823051044e-16
95 O 0 2.720975667003245e-10
% O 0 4.805153150377883e-11
CI O 0 1.711809693993871e-09
0 O 0 1.5518302246518567e-13
% O 0 1.692716973533681e-11
- O 0 3.207341889906873e-13
1 O 0 5.048036844763036e-15
% O 0 3.119250666680333e-14
) O 0 2.6573037591537646e-19
by O 0 5.47444424845661e-18
age O 0 2.1815663899383934e-14
50 O 0 1.332087719752191e-14
years O 0 2.3939856512640058e-14
and O 0 8.943414314243475e-16
27 O 0 2.421375274765103e-13
% O 0 1.8833244967882135e-13
( O 0 2.3810038244675504e-17
95 O 0 4.871223216462717e-12
% O 0 2.3533241327866605e-12
CI O 0 4.371663100966039e-11
0 O 0 5.381279511487138e-15
% O 0 4.637824954807634e-13
- O 0 1.2475063300085298e-13
47 O 0 5.910895145740114e-13
% O 0 1.2081172650821315e-13
) O 0 1.2541355725889842e-18
by O 0 2.3544764730952198e-17
age O 0 4.1152148420701973e-13
70 O 0 2.737412076528334e-12
years O 0 2.861995146083429e-12
. O 0 1.23646454186499e-10

The O 0 1.104139557561723e-10
lifetime O 0 1.062781951333136e-08
risk O 0 2.0318445592693024e-08
of O 0 8.209147495108482e-08
breast B-Disease 1 0.9418192505836487
cancer I-Disease 0 1.4259206864153384e-06
appears O 0 4.1944100970248144e-10
similar O 0 3.966376272562799e-12
to O 0 4.052494728679079e-10
the O 0 2.545495592087832e-09
risk O 0 2.3585930430947144e-10
in O 0 1.7237405947057027e-11
BRCA1 O 0 9.219908170265967e-11
carriers O 0 1.4674397222531887e-13
, O 0 3.200024194398624e-15
but O 0 3.933875116933147e-15
there O 0 5.317814720881163e-15
was O 0 1.0170262933683824e-13
some O 0 3.0557101089772254e-15
suggestion O 0 4.6015248902908645e-12
of O 0 1.611761071829143e-11
a O 0 8.758586911294941e-11
lower O 0 3.3617981731737245e-09
risk O 0 1.1120144388643283e-10
in O 0 2.4708499135606132e-11
BRCA2 O 0 3.8169417626576774e-10
carriers O 0 4.824353156546168e-12
< O 0 2.4697532907680397e-10
50 O 0 5.7424624951007974e-12
years O 0 7.110833189633015e-13
of O 0 1.647083858191678e-11
age O 0 1.1204630556704842e-09
. O 0 1.6738213037825744e-09

Eye B-Disease 1 0.7735247015953064
movement I-Disease 0 7.625032338864912e-08
abnormalities I-Disease 0 5.164511821931228e-05
correlate O 0 1.3057663394988595e-08
with O 0 3.908165295291727e-14
genotype O 0 8.871118839515191e-10
in O 0 3.012901039767257e-11
autosomal O 1 0.9961965084075928
dominant O 0 0.027273762971162796
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 2.015918028064334e-07

We O 0 2.9255742273193164e-10
compared O 0 1.0565481822766287e-09
horizontal O 0 4.27661142055058e-08
eye O 0 1.7786560420063324e-06
movements O 0 5.964091087662382e-08
( O 0 4.152297429504959e-12
visually O 0 3.859315089727033e-09
guided O 0 2.9021457237377035e-08
saccades O 0 9.926626489686896e-07
, O 0 1.1820804751705438e-12
antisaccades O 0 4.104212081301739e-08
, O 0 2.011206380202104e-14
and O 0 6.912651976168343e-15
smooth O 0 2.3619774539018756e-11
pursuit O 0 5.746281228624639e-10
) O 0 5.152669130671465e-15
in O 0 1.191723721658336e-13
control O 0 7.895330500495845e-10
subjects O 0 5.521448631640169e-09
( O 0 4.546208787030437e-15
n O 0 1.6262577222370123e-13
= O 0 4.9762840061747665e-14
14 O 0 4.129223615052975e-14
) O 0 1.1043004776137259e-16
and O 0 4.366760039654726e-16
patients O 0 1.3145704643040853e-15
with O 0 5.84298588498318e-18
three O 0 3.350283180560327e-16
forms O 0 2.357371893177418e-12
of O 0 2.335894810912009e-10
autosomal O 0 3.263600228819996e-05
dominant O 0 2.2792648451286368e-05
cerebellar B-Disease 1 0.9999676942825317
ataxias I-Disease 1 0.7124091386795044
type I-Disease 1 0.9999734163284302
I I-Disease 1 0.9999998807907104
spinocerebellar B-Disease 1 0.9998871088027954
ataxias I-Disease 0 0.011501500383019447
1 I-Disease 0 7.433003518242387e-11
and I-Disease 0 1.1316425227447802e-12
2 I-Disease 0 1.1694681681384544e-12
( O 0 5.1732733765200156e-14
SCA1 B-Disease 0 9.515307283436414e-06
, O 0 2.1152342572806904e-13
n O 0 2.1302064116563574e-13
= O 0 1.1945753088972444e-13
11 O 0 1.2749824525142006e-13
; O 0 4.772717255587498e-15
SCA2 B-Disease 0 1.3222239658716717e-07
, O 0 3.773156036202506e-14
n O 0 9.111454131330646e-14
= O 0 5.692989076032731e-14
10 O 0 2.3613520129051394e-14
) O 0 7.089601182256266e-16
and O 0 2.796874331526672e-13
SCA3 B-Disease 1 1.0
/ O 0 3.6886160792448663e-09
Machado B-Disease 0 8.707109699912507e-09
- I-Disease 0 1.3530227604974243e-08
Joseph I-Disease 0 4.218208005113411e-09
disease I-Disease 0 1.998564357563737e-06
( O 0 3.4857140502990436e-14
MJD B-Disease 1 1.0
) O 0 1.1130191820279967e-12
( O 0 8.17803534310449e-15
n O 0 2.8446886773253466e-12
= O 0 1.4179906164188405e-12
16 O 0 3.813721474038578e-12
) O 0 2.608927207299952e-14
. O 0 1.0066002718855938e-11

In O 0 4.209774473462602e-10
SCA1 B-Disease 0 2.2366966732079163e-05
, O 0 7.067007298366262e-14
saccade O 0 5.604688269045255e-09
amplitude O 0 8.597407508137422e-11
was O 0 4.65084958392592e-12
significantly O 0 3.17977033592598e-11
increased O 0 3.83139483681183e-12
, O 0 3.189616277059237e-15
resulting O 0 1.750757633485478e-12
in O 0 5.497753727962129e-12
hypermetria B-Disease 0 5.864038712388719e-07
. O 0 1.9834144993069458e-08

The O 0 7.478057062471066e-10
smooth O 0 4.446579993100386e-09
pursuit O 0 4.000506237389345e-08
gain O 0 1.4108718460192904e-07
was O 0 1.6682237535814437e-10
decreased O 0 5.193140495407533e-08
. O 0 7.3420824975301e-10

In O 0 1.1221612528089508e-09
SCA2 B-Disease 0 3.5524088161764666e-05
, O 0 1.4733151493511593e-13
saccade O 0 6.80972256361656e-09
velocity O 0 1.338213206913963e-09
was O 0 1.0023092772426523e-10
markedly O 0 3.4004351334715466e-08
decreased O 0 1.3306749480079816e-08
. O 0 2.785395525339851e-10

The O 0 2.7936942689765765e-11
percentage O 0 2.969577084233066e-10
of O 0 2.152310881603503e-12
errors O 0 9.764696606850976e-09
in O 0 4.327635125256357e-11
antisaccades O 0 4.955337317369413e-06
was O 0 1.900629827134015e-11
greatly O 0 7.876040097887227e-12
increased O 0 1.895039897573114e-12
and O 0 1.4653908215515811e-15
was O 0 9.823253863984471e-14
significantly O 0 4.1433241386445996e-13
correlated O 0 3.7335217382972186e-12
with O 0 3.651949941318447e-15
age O 0 7.893353332066866e-11
at O 0 3.194897402192254e-10
disease O 0 9.594807615087575e-09
onset O 0 3.14293191472359e-09
. O 0 3.0594635713754315e-09

In O 0 2.7621844048142385e-11
addition O 0 2.8184358059207826e-12
, O 0 6.772590843175108e-15
a O 0 1.3463974096598105e-14
correlation O 0 4.621083789062286e-13
between O 0 5.08315568456541e-12
smooth O 0 3.5856440039339077e-10
pursuit O 0 1.9570072229413427e-09
gain O 0 1.1841990721350726e-09
and O 0 1.684270127880194e-14
the O 0 3.0675033910534943e-13
number O 0 3.0698973094503423e-13
of O 0 1.101060215225047e-11
trinucleotide O 0 2.8481568214999697e-09
repeats O 0 1.5733808700346685e-10
was O 0 9.321155652886048e-11
found O 0 3.601166240208009e-11
. O 0 5.956957704889021e-10

In O 0 3.7787351914175815e-08
SCA3 B-Disease 1 1.0
, O 0 6.000564489738736e-10
gaze B-Disease 0 6.810558261349797e-05
- I-Disease 0 1.834607701312052e-07
evoked I-Disease 0 7.954719660752119e-10
nystagmus I-Disease 0 3.1553276658158325e-10
was O 0 1.2836697850515666e-12
often O 0 2.105201922820445e-15
present O 0 1.1717577659575186e-14
as O 0 2.4783667875958595e-16
was O 0 2.884307105221334e-14
saccade O 0 2.018005318404903e-09
hypometria O 0 1.887752887341776e-08
and O 0 4.580900003943456e-13
smooth O 0 1.3116642216814967e-09
pursuit O 0 2.1489842794153446e-08
gain O 0 9.963332558982074e-08
was O 0 3.5425656852439147e-10
markedly O 0 6.161432963835978e-08
decreased O 0 2.99852764840125e-08
. O 0 5.131106095568327e-10

Three O 0 6.993804146926408e-11
major O 0 6.404726141800987e-12
criteria O 0 2.483701785904735e-11
, O 0 1.2127177381878948e-14
saccade O 0 8.374899107543854e-10
amplitude O 0 1.2464230168818258e-11
, O 0 7.450760149097738e-15
saccade O 0 4.2366057884102304e-10
velocity O 0 1.8259267708931048e-10
, O 0 4.931525091175955e-14
and O 0 7.43157146471064e-15
presence O 0 1.0384179410447003e-12
of O 0 2.9884541508096163e-09
gaze B-Disease 0 0.00016381953901145607
- I-Disease 0 9.070893156604143e-07
evoked I-Disease 0 1.3430587753049394e-09
nystagmus I-Disease 0 1.285391099115074e-10
, O 0 6.007119545444872e-16
permitted O 0 1.0999550201879968e-13
the O 0 1.3940143197017766e-15
correct O 0 1.7817706945283396e-12
assignment O 0 1.010744266061181e-11
of O 0 7.588393346850963e-13
90 O 0 2.0681019397006395e-11
% O 0 1.9909351944846776e-11
of O 0 3.980903876942693e-13
the O 0 8.655116554012743e-13
SCA1 B-Disease 0 3.6316600926511455e-07
, O 0 6.7277861883971446e-15
90 O 0 9.814686389997274e-12
% O 0 1.5805868766594067e-11
of O 0 5.548696268078968e-13
the O 0 1.2158666001099716e-12
SCA2 B-Disease 0 2.553389606418932e-07
, O 0 4.846988916051018e-15
and O 0 3.261681416695159e-16
93 O 0 1.9109961009455834e-12
% O 0 2.5778365986967033e-12
of O 0 1.7541594262218685e-13
the O 0 1.121112751245601e-13
patients O 0 9.412685474802229e-14
with O 0 2.1453502765510918e-13
SCA3 B-Disease 1 1.0
to O 0 3.9173606025677543e-10
their O 0 3.9135125695644035e-11
genetically O 0 1.6442549361991854e-12
confirmed O 0 1.959425677267035e-11
patient O 0 1.1548447753639834e-09
group O 0 8.758940025100498e-14
and O 0 3.1579055234480513e-13
, O 0 3.831486113082226e-14
therefore O 0 1.8334360071814437e-11
, O 0 1.827742872415744e-13
may O 0 1.4137136773728631e-11
help O 0 7.912701605050643e-09
orient O 0 1.4977432556406711e-06
diagnoses O 0 1.7856821159512037e-06
of O 0 2.0796819910628983e-07
SCA1 B-Disease 1 0.9987510442733765
, O 0 1.8166749354842082e-11
SCA2 B-Disease 0 0.0022436310537159443
, O 0 2.469659947466202e-13
and O 0 1.79652657767565e-12
SCA3 B-Disease 1 1.0
at O 0 8.919349286928835e-11
early O 0 4.876940431358667e-12
clinical O 0 1.2894070576877081e-12
stages O 0 9.205885359575561e-11
of O 0 4.2058877214312673e-11
the O 0 2.5649599111332577e-10
diseases O 0 1.4241782197998987e-09
. O 0 4.0126738737322754e-11
. O 0 2.0099384379079765e-09

Genetic O 0 7.482305053319038e-11
basis O 0 5.763413010728691e-11
and O 0 1.0459581055213807e-15
molecular O 0 4.719214927693949e-13
mechanism O 0 6.48075193510067e-09
for O 0 1.0828322238864985e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999904632568359

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999934434890747
causes O 0 8.92763409865438e-08
more O 0 1.3462646795969757e-13
than O 0 2.178799980332661e-15
300 O 0 1.4559200741705303e-13
, O 0 2.1328795714049267e-15
000 O 0 8.260322287290123e-11
sudden O 0 2.9721750234579236e-12
deaths O 0 5.976089848674926e-13
each O 0 1.9609079713722027e-13
year O 0 1.3538048720257434e-12
in O 0 5.082939819912868e-13
the O 0 8.447758985397069e-12
USA O 0 1.6995374552131182e-10
alone O 0 3.7197642188679936e-10
. O 0 1.2196008647435974e-09

In O 0 5.084014320644314e-10
approximately O 0 2.1925449303350497e-11
5 O 0 8.627662820281934e-12
- O 0 6.405618223348508e-12
12 O 0 2.4586257509062737e-12
% O 0 4.532313413463385e-11
of O 0 2.3328723935261975e-13
these O 0 2.812079081149655e-15
cases O 0 1.36703081461757e-15
, O 0 3.9422713310228053e-16
there O 0 1.397976422191677e-15
are O 0 6.225244823043839e-16
no O 0 1.4870246147716953e-13
demonstrable O 0 2.9395650358310377e-09
cardiac O 0 2.4117754904295907e-08
or O 0 3.512484192391696e-10
non O 1 1.0
- O 1 1.0
cardiac O 1 0.9999972581863403
causes O 0 6.939417790396973e-11
to O 0 2.518206454991956e-13
account O 0 6.476593062174725e-15
for O 0 1.1499572343017374e-15
the O 0 8.445623893163848e-14
episode O 0 9.941465185792087e-12
, O 0 2.2044733901452611e-16
which O 0 1.4558115737498495e-17
is O 0 6.484938838099352e-18
therefore O 0 1.4854789490495457e-14
classified O 0 4.831326311238726e-11
as O 0 5.309922501695041e-10
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 2.225780448839032e-08
IVF B-Disease 1 1.0
) O 0 7.712265721881995e-12
. O 0 7.041239119542908e-11

A O 0 4.567601297189583e-10
distinct O 0 1.5537443293772712e-12
group O 0 1.459450304206779e-14
of O 0 6.427577914358551e-11
IVF B-Disease 1 1.0
patients O 0 1.103529601031994e-09
has O 0 1.374440235323677e-15
been O 0 1.3666137567701657e-15
found O 0 7.831951445141775e-16
to O 0 2.1398403611105205e-14
present O 0 2.6025880669328094e-12
with O 0 8.159933910208486e-14
a O 0 5.963252114327133e-11
characteristic O 0 6.083703762982395e-09
electrocardiographic O 0 5.361525836633518e-07
pattern O 0 1.4938289893962065e-07
. O 0 3.2779723824205576e-08

Because O 0 6.875677110995682e-11
of O 0 4.78266204417821e-10
the O 0 3.923467800648339e-11
small O 0 1.4752245649021778e-13
size O 0 1.6504313649252922e-13
of O 0 1.2392965343180351e-12
most O 0 1.1113320956849734e-13
pedigrees O 0 2.4586388480685173e-09
and O 0 2.302406312479355e-13
the O 0 5.463799985366835e-12
high O 0 1.3662203313113963e-11
incidence O 0 2.7635914390256033e-11
of O 0 1.0657175662787122e-11
sudden B-Disease 0 4.742995059203725e-12
death I-Disease 0 3.6886522482293405e-12
, O 0 1.5740589441679692e-14
however O 0 7.915276913723554e-14
, O 0 9.035246450011234e-16
molecular O 0 9.862001894376388e-14
genetic O 0 6.895579485015346e-13
studies O 0 2.113303672682254e-12
of O 0 6.439897920484938e-11
IVF B-Disease 1 1.0
have O 0 8.949365771018791e-13
not O 0 1.5718876937922954e-13
yet O 0 4.164821699320642e-12
been O 0 1.6123444810181575e-12
done O 0 9.30733878856671e-10
. O 0 2.6395965413428257e-09

Because O 0 4.081041282688602e-09
IVF B-Disease 1 1.0
causes O 0 0.0013469734694808722
cardiac O 1 1.0
rhythm O 1 0.9982689619064331
disturbance O 0 2.775860874493219e-09
, O 0 6.600931993117499e-15
we O 0 1.0698685962487724e-14
investigated O 0 9.667569479329674e-13
whether O 0 2.3745098227077877e-13
malfunction O 0 4.024430211302388e-08
of O 0 2.4666436428122385e-12
ion O 0 1.2410790450889664e-10
channels O 0 3.344815258099487e-10
could O 0 1.6584822707874092e-12
cause O 0 2.0704582145980588e-11
the O 0 1.9930837037197835e-13
disorder O 0 1.5333713031945306e-12
by O 0 1.2187960386764578e-17
studying O 0 1.3895712719044252e-14
mutations O 0 2.354318420717729e-14
in O 0 1.617955918439655e-14
the O 0 1.905489221271095e-12
cardiac O 0 1.2012929540006212e-09
sodium O 0 1.2614619418482853e-11
channel O 0 1.9606416490347556e-10
gene O 0 1.6477406244996828e-11
SCN5A O 0 1.432079170626821e-05
. O 0 1.2786045111568e-08

We O 0 2.0558363345024588e-10
have O 0 1.6458291977536343e-13
now O 0 5.448818615272702e-14
identified O 0 1.6247548011855129e-12
a O 0 4.242469819459166e-13
missense O 0 3.443037410733041e-09
mutation O 0 5.812876764134389e-13
, O 0 2.899916397779926e-15
a O 0 9.211000153797402e-14
splice O 0 6.975692024013824e-09
- O 0 9.015713869908737e-11
donor O 0 3.7120032048143514e-10
mutation O 0 6.720438094909298e-11
, O 0 1.901152575211479e-14
and O 0 9.562550505940164e-15
a O 0 7.959033280525996e-13
frameshift O 0 1.8122641165518871e-09
mutation O 0 7.749079698228523e-13
in O 0 1.3482912906265763e-14
the O 0 1.691146815684455e-13
coding O 0 9.049041516107081e-09
region O 0 7.944135904658367e-10
of O 0 8.990470173886322e-11
SCN5A O 0 0.010277099907398224
in O 0 4.32421719959164e-12
three O 0 3.0148442770050465e-11
IVF B-Disease 1 1.0
families O 0 6.195789020724263e-11
. O 0 3.169647599943204e-10

We O 0 3.033012382913647e-11
show O 0 5.695511336861747e-13
that O 0 6.523972167716749e-17
sodium O 0 6.607403324834522e-16
channels O 0 2.1504619848625e-14
with O 0 9.008908423737505e-18
the O 0 6.521192311462979e-15
missense O 0 2.5612051368639754e-10
mutation O 0 3.5315049495832085e-12
recover O 0 2.6195845492793524e-09
from O 0 5.275261998061165e-12
inactivation O 0 6.309153754990859e-10
more O 0 8.75385850504333e-15
rapidly O 0 2.614129073798266e-13
than O 0 5.769149874078512e-16
normal O 0 1.4506928644464345e-12
and O 0 2.2410432435495775e-16
that O 0 1.1978154957941118e-16
the O 0 3.8884192632253345e-13
frameshift O 0 2.714695668259992e-08
mutation O 0 1.3826624740975735e-11
causes O 0 7.486651272883837e-13
the O 0 1.4734677237018823e-12
sodium O 0 2.544524649577412e-13
channel O 0 7.186095793941527e-13
to O 0 3.2805285181056187e-13
be O 0 1.6375603130447391e-12
non O 0 3.3028751289521097e-08
- O 0 1.1190710580422092e-08
functional O 0 4.509908251293382e-07
. O 0 1.4702836725888346e-09

Our O 0 3.6900285604879457e-10
results O 0 1.5896167845572129e-12
indicate O 0 1.8172943618693926e-12
that O 0 6.119573227709129e-16
mutations O 0 4.200590206617297e-14
in O 0 5.905663463682057e-14
cardiac O 0 2.82480511204497e-10
ion O 0 6.284365250408541e-10
- O 0 2.0156136315563344e-08
channel O 0 5.193828145344526e-10
genes O 0 2.2207626362846788e-13
contribute O 0 5.494951824287775e-13
to O 0 2.9479291051423204e-14
the O 0 1.8277139716515838e-14
risk O 0 2.766478723621041e-13
of O 0 7.296712604791533e-13
developing O 0 6.715495937115179e-10
IVF B-Disease 1 1.0
. O 0 3.8644084460193184e-11
. O 0 1.9486331992446537e-10

Molecular O 0 1.0016298901405207e-08
heterogeneity O 0 7.323609718667967e-09
in O 0 2.0905423225858755e-10
mucopolysaccharidosis B-Disease 0 0.00015883885498624295
IVA I-Disease 1 1.0
in O 0 1.6503622912722449e-09
Australia O 0 1.4540787844630199e-11
and O 0 4.349856724274702e-14
Northern O 0 2.9136904000637287e-10
Ireland O 0 2.2640429461762146e-11
: O 0 3.652324806337166e-16
nine O 0 1.258557467227403e-13
novel O 0 3.2234251736324186e-15
mutations O 0 2.3428565402820734e-13
including O 0 7.667975819190473e-14
T312S O 0 2.37664981028729e-08
, O 0 5.253297322431634e-14
a O 0 6.351327477187654e-14
common O 0 6.520191830027e-13
allele O 0 3.730555100944777e-11
that O 0 2.8851449224501224e-13
confers O 0 9.494349750838182e-10
a O 0 3.345963783818462e-10
mild O 0 1.9958112940088313e-09
phenotype O 0 8.22997936467118e-09
. O 0 1.7600750856772152e-09

Mucopolysaccharidosis B-Disease 0 0.0034070019610226154
IVA I-Disease 1 0.9999970197677612
( O 0 1.4993967178966727e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 5.1981643815757206e-12
is O 0 5.664494481111282e-13
an O 0 2.6961509413947482e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 5.642239120362547e-09
by O 0 1.564681679578142e-13
a O 0 7.528465850725752e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.1676047895778936e-10
N O 0 2.2603947602561902e-09
- O 0 7.476987917698352e-10
acetylgalactosamine O 0 7.044835683700512e-07
- O 0 5.9364531068695214e-09
6 O 0 3.185435526464886e-10
- O 0 4.695152044931206e-10
sulfate O 0 4.911901180931766e-12
sulfatase O 0 9.233833142552328e-10
( O 0 5.9850958417833125e-15
GALNS O 0 1.2128792548082856e-07
) O 0 8.770810006010141e-14
. O 0 1.5575490550090443e-11

Previous O 0 6.5497918200208e-10
studies O 0 9.561543397318406e-12
of O 0 1.7680330940614275e-12
patients O 0 1.6561547326685716e-13
from O 0 1.36823739187511e-13
a O 0 2.565660628828931e-13
British O 0 2.9160184683574286e-11
- O 0 1.680044714458262e-10
Irish O 0 6.884587344657689e-11
population O 0 2.590071406861124e-14
showed O 0 2.4200207335571718e-14
that O 0 1.0445375386246067e-17
the O 0 1.0260684378429578e-14
I113F O 0 4.352355142955844e-10
mutation O 0 7.027238491628951e-13
is O 0 1.2159968991882477e-15
the O 0 1.8315527249685402e-14
most O 0 1.1815421399927846e-15
common O 0 3.2730003179693183e-15
single O 0 1.6277440278902183e-13
mutation O 0 5.323503140045038e-13
among O 0 2.785614349864324e-13
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 3.1544644230052654e-08
and O 0 3.0410496711964774e-13
produces O 0 3.2507801788969615e-13
a O 0 1.1841068490309192e-12
severe O 0 1.1792239407171223e-10
clinical O 0 3.116010227621757e-10
phenotype O 0 1.0446015163978473e-09
. O 0 2.7445785644175658e-09

We O 0 4.714184043130842e-10
studied O 0 7.644651578431194e-11
mutations O 0 5.13570035023253e-13
in O 0 1.910210576142827e-14
the O 0 7.84649743183069e-13
GALNS O 0 6.5615909079497214e-06
gene O 0 6.460523305565347e-13
from O 0 6.960766056433865e-13
23 O 0 1.075833172548002e-11
additional O 0 3.281741267624483e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 6.603972906304989e-06
( O 0 4.3690223693656355e-14
15 O 0 8.120892847074401e-12
from O 0 3.738844737283253e-12
Australia O 0 1.0972251753005313e-12
, O 0 1.1536743325116445e-15
8 O 0 7.960045654304554e-14
from O 0 1.9634379571416977e-13
Northern O 0 2.479216276718432e-10
Ireland O 0 2.623662224976453e-11
) O 0 8.926377093542402e-15
, O 0 2.598506711521298e-15
with O 0 3.9549540612211624e-16
various O 0 2.873200538166393e-13
clinical O 0 5.4210969047119306e-11
phenotypes O 0 1.7257414941518334e-10
( O 0 1.2359721807218144e-13
severe O 0 7.569175841659614e-11
, O 0 7.472623594125677e-14
16 O 0 1.2229580412595475e-12
cases O 0 1.9624409993627794e-14
; O 0 2.840161293845569e-16
intermediate O 0 4.244560432298261e-12
, O 0 2.6359256625156776e-15
4 O 0 2.844604299291273e-14
cases O 0 1.978221223170127e-14
; O 0 7.240077813533766e-14
mild O 0 9.753624991004628e-12
, O 0 2.94795688782299e-14
3 O 0 6.061115015920313e-14
cases O 0 2.0062256570656592e-14
) O 0 3.731118468656633e-14
. O 0 5.641351275009754e-11

We O 0 1.4074035270539298e-09
found O 0 5.830924285077366e-12
two O 0 3.8928699131433875e-14
common O 0 5.973443040121346e-14
mutations O 0 9.969077192711288e-15
that O 0 5.566302159172256e-17
together O 0 1.569493267175679e-14
accounted O 0 4.69995153906666e-11
for O 0 4.033193456943682e-14
32 O 0 1.04738473449828e-09
% O 0 2.6804380937051064e-09
of O 0 1.5303452949311236e-11
the O 0 2.151600729180525e-12
44 O 0 1.3807333748561135e-11
unrelated O 0 1.1626585978696813e-11
alleles O 0 9.753098936110538e-13
in O 0 7.035084320650142e-13
these O 0 2.7121696815485263e-12
patients O 0 4.5307750606848884e-11
. O 0 5.035817318699287e-10

One O 0 1.2443381047777535e-10
is O 0 1.2902821714712298e-13
the O 0 1.1511351767634626e-12
T312S O 0 4.88717475377598e-08
mutation O 0 2.003070626033221e-11
, O 0 4.081745046667119e-15
a O 0 1.763565286643995e-14
novel O 0 7.336258065881313e-14
mutation O 0 2.141140780301254e-12
found O 0 9.763852459833064e-14
exclusively O 0 3.2976941490014955e-12
in O 0 9.31888789225399e-13
milder O 0 1.004865191056581e-09
patients O 0 1.6516525647158886e-10
. O 0 1.5042779244467397e-09

The O 0 2.6932281405045444e-10
other O 0 3.2226291405389185e-13
is O 0 3.832762676437033e-15
the O 0 5.2226858905310425e-14
previously O 0 1.6301807993779338e-12
described O 0 8.144233443023452e-13
I113F O 0 5.441935790884145e-09
that O 0 5.015635716948191e-15
produces O 0 8.428806562215882e-14
a O 0 1.1997707514976863e-12
severe O 0 6.516048811633368e-10
phenotype O 0 3.3168905844149776e-08
. O 0 7.579050276262933e-09

The O 0 4.167482359207497e-09
I113F O 0 1.5351632498550316e-07
and O 0 1.9750034940813066e-12
T312S O 0 1.2099675039678459e-08
mutations O 0 3.0696996593942982e-12
accounted O 0 1.5824941357323041e-10
for O 0 5.888378977123021e-13
8 O 0 4.841434111252374e-12
( O 0 1.5961008166862469e-15
18 O 0 5.134262806572032e-12
% O 0 3.3734896386777846e-12
) O 0 6.337308340756767e-16
and O 0 1.5467468750035226e-14
6 O 0 2.21657720932307e-13
( O 0 1.9499287398390132e-16
14 O 0 8.939244879263911e-14
% O 0 3.569902348992543e-13
) O 0 1.4037846594598978e-16
of O 0 9.374397552707261e-14
44 O 0 8.090879312014354e-13
unrelated O 0 1.975870422138426e-12
alleles O 0 4.783512453331029e-13
, O 0 1.3249175519723655e-13
respectively O 0 1.4637464851308124e-10
. O 0 2.4098154582929965e-09

The O 0 9.272219658740255e-10
relatively O 0 1.8053288031172343e-10
high O 0 1.0037283504349404e-11
residual O 0 6.806537555803516e-10
GALNS O 0 3.3556805192347383e-06
activity O 0 3.650042768033046e-11
seen O 0 1.4532178357808817e-13
when O 0 7.177687314814793e-16
the O 0 8.694653443129096e-15
T312S O 0 2.777646819149271e-12
mutant O 0 1.1756042103336362e-13
cDNA O 0 2.690932754401132e-10
is O 0 1.550220997577345e-13
overexpressed O 0 1.595989035374501e-10
in O 0 4.990989175765459e-14
mutant O 0 2.57842662151897e-12
cells O 0 6.9694050877644464e-12
provides O 0 1.1371805257978825e-14
an O 0 1.8751769241909636e-17
explanation O 0 3.885510890897642e-14
for O 0 4.1758317723822325e-15
the O 0 7.887069903428356e-13
mild O 0 1.4160312462527247e-12
phenotype O 0 2.4460164796402672e-11
in O 0 1.7398779086300747e-13
patients O 0 4.351941441764484e-13
with O 0 1.2197274440461925e-15
this O 0 6.685235589935778e-13
mutation O 0 4.207974246828172e-11
. O 0 4.6553272348148766e-10

The O 0 9.991440834411502e-12
distribution O 0 9.433466377842259e-13
and O 0 3.38607905760909e-16
relative O 0 2.002710497439608e-12
frequencies O 0 1.171384083481497e-11
of O 0 6.668056406512746e-13
the O 0 8.852123678168566e-13
I113F O 0 4.7501091948731755e-09
and O 0 1.3869380904169004e-12
T312S O 0 2.493512241130702e-08
mutations O 0 8.815398064299096e-12
in O 0 9.2198633710322e-13
Australia O 0 1.206761361845221e-12
corresponded O 0 1.144703082323062e-11
to O 0 3.871215847883747e-12
those O 0 1.2494905284043956e-12
observed O 0 6.343149963616845e-12
in O 0 5.908700612122786e-12
Northern O 0 1.7254668804866924e-08
Ireland O 0 1.2051784015199019e-09
and O 0 2.6317500696065865e-12
are O 0 3.5242156957472626e-13
unique O 0 5.084047766112931e-12
to O 0 6.724615222303276e-12
these O 0 1.2398024230517168e-12
two O 0 1.504169401880806e-12
populations O 0 3.7913159482531877e-13
, O 0 1.779207528784235e-15
suggesting O 0 2.908871602792795e-13
that O 0 3.0056400856408923e-15
both O 0 5.801069802476022e-13
mutations O 0 2.7562728575208917e-12
were O 0 1.1919250308967122e-11
probably O 0 1.8206076837085083e-12
introduced O 0 5.727525658610899e-14
to O 0 1.1595662581173616e-12
Australia O 0 4.766708945960763e-13
by O 0 3.861728238617815e-14
Irish O 0 8.580505750366285e-10
migrants O 0 5.351762921712577e-10
during O 0 9.825029678722785e-11
the O 0 4.324373758385347e-12
19th O 0 1.868735444165992e-10
century O 0 2.1760809820747795e-10
. O 0 1.7067692814620727e-09

Haplotype O 0 7.795644130226265e-09
analysis O 0 3.723041666625626e-11
using O 0 1.201195479888506e-11
6 O 0 1.173344088556405e-09
RFLPs O 0 9.878983291855548e-06
provides O 0 3.7290998197367364e-13
additional O 0 4.9682514233293645e-14
data O 0 6.296341486383694e-13
that O 0 3.7871398937111404e-16
the O 0 3.5479225894002875e-13
I113F O 0 1.0964784635802971e-08
mutation O 0 1.0035196632007803e-11
originated O 0 1.2813075253581552e-11
from O 0 5.18358739178687e-13
a O 0 1.3918008455807152e-12
common O 0 1.857597062282501e-11
ancestor O 0 8.79059491865064e-09
. O 0 6.002192964871256e-09

The O 0 9.149838109401287e-10
other O 0 3.6837712242589193e-13
9 O 0 2.3128389394638793e-12
novel O 0 1.2036567726412314e-14
mutations O 0 3.0398489172904497e-13
identified O 0 8.964891681654055e-14
in O 0 1.0136115478041625e-14
these O 0 1.504911240112275e-14
23 O 0 4.230851780029354e-12
patients O 0 2.7646111853789346e-13
were O 0 5.55924718152051e-13
each O 0 6.01030049297499e-14
limited O 0 2.2969630754723913e-13
to O 0 4.773113328193634e-13
a O 0 3.5738623432174377e-12
single O 0 6.152502396439274e-10
family O 0 1.849466829684232e-10
. O 0 9.56487777870052e-09

These O 0 3.820166405432701e-11
data O 0 5.987642326399367e-11
provide O 0 2.963083066669786e-13
further O 0 6.714508777542344e-14
evidence O 0 6.413439115719732e-13
for O 0 3.153782302586089e-13
extensive O 0 3.099832890374188e-10
allelic O 0 4.5597614573011924e-09
heterogeneity O 0 5.061289609642472e-09
in O 0 6.487414494493748e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 1.3326698078408583e-10
British O 0 4.222409533127802e-09
- O 0 1.3674248577899561e-07
Irish O 0 1.3662843079131903e-09
patients O 0 2.1636381922207626e-12
and O 0 3.038737051021907e-16
provide O 0 3.624097380430357e-15
evidence O 0 2.0486531985804482e-14
for O 0 4.080297467360262e-15
their O 0 2.15510834004895e-12
transmission O 0 2.4426681122236005e-08
to O 0 1.6660089106890208e-12
Australia O 0 2.196812339243931e-13
by O 0 1.3506619664393517e-14
British O 0 4.0657027744472884e-10
- O 0 9.97147919790109e-10
Irish O 0 2.6547120057784923e-10
migrants O 0 2.82659451400491e-10
. O 0 6.449589668756917e-13
. O 0 3.2784552850273485e-11

Identification O 0 3.325734496684163e-07
of O 0 4.055435098848648e-09
constitutional O 0 3.834216855125305e-08
WT1 O 0 0.0009491654927842319
mutations O 0 8.884055158198123e-10
, O 0 1.131662953179468e-14
in O 0 3.2479339449062797e-14
patients O 0 4.5060899456217385e-12
with O 0 5.991886132226953e-13
isolated O 0 7.805660828807959e-08
diffuse B-Disease 0 0.08614057302474976
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.6040945630710172e-14
and O 0 8.004200624224061e-17
analysis O 0 1.093140945059197e-13
of O 0 1.505464676532231e-11
genotype O 0 2.168486362696953e-10
/ O 0 1.1012356582185134e-09
phenotype O 0 6.607442024075816e-12
correlations O 0 6.680557257561504e-13
by O 0 3.1779069465359526e-16
use O 0 1.5024339736734171e-13
of O 0 2.566503650228147e-12
a O 0 2.5503954417110952e-12
computerized O 0 7.655865275069118e-09
mutation O 0 1.4832848838075563e-10
database O 0 1.0334738620443318e-09
. O 0 2.2673034560938277e-09

Constitutional O 0 1.3447326585591668e-09
mutations O 0 3.5103103149941584e-12
of O 0 6.7128507613700705e-12
the O 0 2.1548450957614707e-12
WT1 O 0 4.204737003021819e-09
gene O 0 2.409193450205599e-14
, O 0 1.7176512622271007e-16
encoding O 0 2.8525016550207116e-12
a O 0 7.658511845531901e-12
zinc O 0 5.333186670064549e-10
- O 0 9.11559627780889e-09
finger O 0 8.592010658503568e-08
transcription O 0 1.631708279603572e-08
factor O 0 2.756118111513217e-10
involved O 0 2.0984884663288739e-10
in O 0 6.778656524986104e-10
renal O 1 0.9999979734420776
and O 0 2.4029949141635143e-09
gonadal O 1 0.9992164373397827
development O 0 3.0657071192763397e-07
, O 0 5.349269289377451e-15
are O 0 6.466440101752461e-17
found O 0 8.682749453846621e-16
in O 0 1.4603796687565063e-15
most O 0 2.342903084742525e-15
patients O 0 2.7141591925350372e-14
with O 0 9.933475212092063e-14
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.0822293889111165e-10
DDS B-Disease 1 1.0
) O 0 5.856571737988814e-12
, O 0 4.635470135451632e-14
or O 0 4.87586394870565e-11
diffuse B-Disease 1 0.9951422214508057
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 4.250109379017042e-12
DMS B-Disease 0 3.486901789528929e-08
) O 0 5.629320086958996e-16
associated O 0 8.592771134387223e-14
with O 0 2.4987414345761447e-14
pseudohermaphroditism B-Disease 1 1.0
and O 0 3.273543935922163e-11
/ O 0 1.0688076201859076e-07
or O 0 2.986384195491354e-10
Wilms B-Disease 0 7.07419576428947e-06
tumor I-Disease 0 3.090590894316847e-08
( O 0 1.002966156307683e-12
WT B-Disease 1 0.9999994039535522
) O 0 1.6233237627380492e-12
. O 0 8.660178824060338e-11

Most O 0 3.058825970292389e-10
mutations O 0 1.1700544977344407e-09
in O 0 5.017141146979043e-10
DDS B-Disease 1 1.0
patients O 0 1.2781822533725062e-06
lie O 0 2.1186147023399826e-06
in O 0 4.20020601632487e-10
exon O 0 1.7086292380952273e-09
8 O 0 2.3176194297036545e-10
or O 0 1.6056314611212485e-10
exon O 0 4.2596662308547195e-10
9 O 0 8.819740771048856e-11
, O 0 5.813176546035081e-13
encoding O 0 1.573301311452724e-08
zinc O 0 4.072879278282926e-07
finger O 0 0.0062276083044707775
2 O 0 7.647605215765907e-09
or O 0 1.1132934929491967e-07
zinc O 0 3.987160823726299e-07
finger O 0 5.21665315318387e-05
3 O 0 1.8915343250047734e-11
, O 0 9.985900961109653e-15
respectively O 0 4.159843910306327e-12
, O 0 2.6875148394429112e-15
with O 0 2.47537289670423e-15
a O 0 5.169983798708477e-12
hot O 0 2.825085443358688e-10
spot O 0 2.526785003453824e-09
( O 0 2.21176599442003e-14
R394W O 0 6.786742279274449e-10
) O 0 9.755953538786739e-15
in O 0 1.7307006522360169e-12
exon O 0 2.2095231200225385e-10
9 O 0 5.739752562128331e-10
. O 0 2.936460186120371e-09

We O 0 7.904427112848111e-11
analyzed O 0 6.432933612882108e-12
a O 0 8.172421208730088e-15
series O 0 1.0414675815273357e-14
of O 0 1.278162281960829e-13
24 O 0 2.224355595548122e-11
patients O 0 2.9771452230570317e-12
, O 0 1.1924507808589412e-14
10 O 0 2.7470569222143304e-12
with O 0 3.332535983280316e-11
isolated B-Disease 0 4.698207703768276e-06
DMS I-Disease 0 0.00019594316836446524
( O 0 1.550098417679724e-11
IDMS B-Disease 0 0.00015152373816818
) O 0 9.02211587231784e-14
, O 0 4.186039366429594e-15
10 O 0 3.4432451735764286e-14
with O 0 4.621662820785029e-14
DDS B-Disease 1 1.0
, O 0 3.501167997015109e-13
and O 0 1.5624771238669823e-14
4 O 0 6.65679750905257e-13
with O 0 4.804910267407203e-13
urogenital B-Disease 0 1.4994482171459822e-06
abnormalities I-Disease 0 6.867218326078728e-05
and O 0 2.410324440038636e-10
/ O 0 7.628537446180417e-07
or O 0 4.871567327313642e-08
WT B-Disease 1 1.0
. O 0 7.424084902396544e-09

We O 0 4.743201387213958e-09
report O 0 1.9767541770132624e-10
WT1 O 0 1.881291836980381e-06
heterozygous O 0 5.217419829506298e-10
mutations O 0 1.3046067698363473e-11
in O 0 2.4787867613541847e-13
16 O 0 6.570947952422301e-11
patients O 0 2.547343586067896e-11
, O 0 2.6043034238474802e-14
4 O 0 4.805297652843432e-12
of O 0 3.5360089856162347e-11
whom O 0 2.010359101412007e-10
presented O 0 3.748547694470972e-09
with O 0 1.7086455583736893e-09
IDMS B-Disease 1 0.9997637867927551
. O 0 1.691103364009905e-07

One O 0 4.345468082589399e-11
male O 0 2.454288335063115e-11
and O 0 3.4752635272024095e-15
two O 0 1.820322050646167e-13
female O 0 1.147519856914414e-09
IDMS B-Disease 1 0.9999990463256836
patients O 0 1.2720554609657597e-09
with O 0 4.376610532319525e-11
WT1 O 1 1.0
mutations O 0 6.170000415295362e-05
underwent O 0 0.00023576643434353173
normal O 0 0.00011497403465909883
puberty O 0 1.4135508763502003e-06
. O 0 7.378456179374382e-10

Two O 0 5.0837063447772834e-09
mutations O 0 1.289738538190477e-09
associated O 0 1.898474988326626e-10
with O 0 2.064813597879578e-12
IDMS B-Disease 1 0.9999978542327881
are O 0 1.4641735293272583e-14
different O 0 9.546987122567314e-15
from O 0 2.999445310181148e-14
those O 0 2.5956796120048947e-14
described O 0 2.6552661978873626e-12
in O 0 3.1299607350376846e-10
DDS B-Disease 1 1.0
patients O 0 3.6559575278261036e-07
. O 0 6.198040303218022e-09

No O 0 8.01663979643763e-09
WT1 O 0 8.852735845721327e-06
mutations O 0 1.5612797166220105e-10
were O 0 1.531179480082634e-12
detected O 0 3.433182557688319e-12
in O 0 3.270741281098991e-15
the O 0 1.3328356159632987e-13
six O 0 5.222591890202688e-12
other O 0 1.714885503566188e-12
IDMS B-Disease 1 1.0
patients O 0 1.585770181833368e-09
, O 0 3.6308746265666103e-13
suggesting O 0 6.654747586321008e-11
genetic O 0 3.164186967996585e-10
heterogeneity O 0 5.9707359056915266e-09
of O 0 5.730345087329169e-10
this O 0 1.039860419993488e-09
disease O 0 2.4838698209350696e-07
. O 0 2.008263777497632e-09

We O 0 9.551345270253364e-10
analyzed O 0 8.300727882826209e-10
genotype O 0 8.564977171943156e-09
/ O 0 2.3969661810951948e-09
phenotype O 0 3.3988215020208656e-11
correlations O 0 1.1207847150362937e-11
, O 0 8.323151145210464e-16
on O 0 5.1537308864708486e-15
the O 0 6.169146360342779e-16
basis O 0 1.1731544555249052e-12
of O 0 6.199633363103418e-14
the O 0 1.735806661709756e-14
constitution O 0 8.401664916080423e-14
of O 0 2.3817592863240034e-12
a O 0 4.288634985333273e-12
WT1 O 0 1.8258734257869946e-07
mutation O 0 5.50397531370872e-12
database O 0 2.1757562765345462e-11
of O 0 2.1703968483555158e-11
84 O 0 6.901120119806592e-09
germ O 0 4.223875293973833e-05
- O 0 7.347618975472869e-06
line O 0 6.780084760293903e-08
mutations O 0 2.0148339593961673e-11
, O 0 1.5320185390617228e-15
to O 0 3.488787424644861e-14
compare O 0 5.2025085628404355e-12
the O 0 7.487190527939377e-14
distribution O 0 1.3455875953402585e-12
and O 0 1.678976955465331e-15
type O 0 1.8295722575834006e-11
of O 0 1.0953104742639219e-11
mutations O 0 3.9281062126986233e-13
, O 0 9.160951433339693e-16
according O 0 9.020688113581948e-14
to O 0 4.573173979262324e-13
the O 0 1.7470216896395274e-12
different O 0 1.48982326475533e-10
symptoms O 0 2.061555548493743e-08
. O 0 2.6777283168577526e-10

This O 0 1.9539479756414124e-10
demonstrated O 0 7.104895782816811e-09
( O 0 1.0821991936751322e-14
1 O 0 2.6632282533814444e-13
) O 0 2.7366351270871354e-15
the O 0 1.0220842997909346e-13
association O 0 4.2460867179065775e-14
between O 0 1.1178513843745908e-11
mutations O 0 7.844103513433842e-13
in O 0 5.20250563549457e-13
exons O 0 3.204905091314103e-11
8 O 0 1.0074524764772108e-12
and O 0 3.8163463817082743e-13
9 O 0 2.2482928713207784e-11
and O 0 4.53561667390634e-11
DMS B-Disease 0 7.484584330086363e-07
; O 0 7.077263037766346e-13
( O 0 5.318321670100094e-15
2 O 0 4.499849996200851e-14
) O 0 1.3393734948238226e-15
among O 0 2.2318305955778845e-15
patients O 0 4.169204925416094e-14
with O 0 1.8252265746986768e-14
DMS B-Disease 0 2.159213696728557e-09
, O 0 3.0069032658751327e-14
a O 0 8.210703709814193e-14
higher O 0 8.536113656198996e-12
frequency O 0 9.33146789006134e-12
of O 0 3.255430994220099e-11
exon O 0 6.059633350652405e-11
8 O 0 1.3640643302392785e-11
mutations O 0 3.694045503516152e-12
among O 0 1.4414001676260613e-13
46 O 0 1.556192813501056e-10
, O 0 9.414880984201512e-13
XY O 0 9.41569305723533e-05
patients O 0 3.8348695746703854e-11
with O 0 7.91548477560881e-15
female O 0 5.228711560945065e-12
phenotype O 0 1.692851588075417e-12
than O 0 7.946100781487317e-15
among O 0 3.987708719412368e-15
46 O 0 7.242353938785584e-11
, O 0 1.5841866663965365e-12
XY O 1 0.999974250793457
patients O 0 5.47208611756389e-10
with O 0 5.915844122081695e-14
sexual O 0 1.3906126250518014e-11
ambiguity O 0 3.0479684748341285e-11
or O 0 1.8978360549759543e-12
male O 0 6.078351016958194e-11
phenotype O 0 1.8576041746487526e-11
; O 0 1.4541716626421258e-13
and O 0 6.425514634256224e-12
( O 0 3.611857246122764e-14
3 O 0 1.7878984967870104e-12
) O 0 2.5294934739459804e-14
statistically O 0 1.9047531428636674e-14
significant O 0 3.11063267818926e-16
evidence O 0 3.4828548482339393e-15
that O 0 5.109117449380728e-16
mutations O 0 4.6448959180886776e-14
in O 0 7.354895230175795e-13
exons O 0 4.328700245470607e-11
8 O 0 1.5622968413744887e-12
and O 0 8.835588375310718e-14
9 O 0 4.9069199224704985e-12
preferentially O 0 5.059209301494505e-11
affect O 0 2.9101468457248814e-10
amino O 0 9.930534172752914e-11
acids O 0 1.4009460095904674e-13
with O 0 7.18201512377967e-16
different O 0 5.4213368007056256e-14
functions O 0 8.705801704533833e-12
. O 0 1.3605039404090968e-12
. O 0 7.744950514254612e-11

The O 0 1.053477416412818e-09
185delAG O 0 3.3232203122679493e-07
BRCA1 O 0 2.0797377153769503e-09
mutation O 0 4.726439508870306e-13
originated O 0 1.922701771015986e-13
before O 0 1.81604168823183e-14
the O 0 1.6675427518312268e-14
dispersion O 0 1.8033113197146733e-11
of O 0 4.582912174755371e-12
Jews O 0 2.399777251915758e-11
in O 0 6.357875380683109e-13
the O 0 1.1106864126336768e-12
diaspora O 0 3.105798673797011e-10
and O 0 2.7121683262958107e-13
is O 0 3.125152114630443e-14
not O 0 1.4196514786218167e-13
limited O 0 3.741514736921303e-11
to O 0 2.266875576140137e-09
Ashkenazim O 0 0.0001144862180808559
. O 0 8.94474609935969e-08

The O 0 3.2302280295049e-10
185delAG O 0 4.423049659862954e-08
mutation O 0 7.044231517538968e-12
in O 0 1.5568412444627588e-12
BRCA1 O 0 1.0062173316782719e-09
is O 0 9.347258617077234e-14
detected O 0 6.158002493344972e-12
in O 0 5.4729522780058715e-14
Ashkenazi O 0 7.712758764988337e-10
Jews O 0 2.5951031688148385e-12
both O 0 8.325541048671142e-14
in O 0 6.564827891367142e-13
familial B-Disease 1 0.9977688789367676
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.519431179985986e-06
in O 0 1.1782010089778083e-10
the O 0 3.8679035668787165e-11
general O 0 9.263583823637678e-12
population O 0 2.8220115588957484e-13
. O 0 2.368925368367858e-11

All O 0 2.681091182399342e-10
tested O 0 3.3134600618822674e-10
Ashkenazi O 0 1.3075227567327374e-09
mutation O 0 1.167043214454419e-13
carriers O 0 5.867497599034788e-15
share O 0 1.8510026681978903e-13
the O 0 4.879996350049508e-14
same O 0 5.747807286550499e-13
allelic O 0 1.310423769496083e-09
pattern O 0 6.318354173195928e-10
at O 0 1.0332072003516046e-10
the O 0 5.3186979126484957e-11
BRCA1 O 0 4.0120559652301324e-10
locus O 0 3.623007727160399e-10
. O 0 4.10420986085569e-09

Our O 0 3.6227261190902027e-09
previous O 0 6.460196960711428e-11
study O 0 5.2601149212174944e-14
showed O 0 6.888504252688249e-14
that O 0 6.438453603779587e-17
this O 0 2.8099465910016476e-14
Ashkenazi O 0 6.753522541202983e-08
mutation O 0 3.116246496959185e-11
also O 0 1.2366884317820126e-14
occurs O 0 3.394734919060817e-14
in O 0 2.9565032808541968e-15
Iraqi O 0 1.5722746127266873e-07
Jews O 0 4.3052930664977396e-10
with O 0 5.172178332325805e-14
a O 0 2.041508238501133e-13
similar O 0 8.739882461413634e-14
allelic O 0 7.425638992586414e-10
pattern O 0 1.1530180143992652e-09
. O 0 4.055612734532588e-09

We O 0 6.837658911296174e-11
extended O 0 2.7048918660455e-11
our O 0 1.893024148894029e-12
analysis O 0 3.627508720922129e-14
to O 0 5.382442064207245e-14
other O 0 1.0425572216513426e-13
non O 0 8.640355986244685e-09
- O 0 1.807141880583174e-09
Ashkenazi O 0 4.6203901149510784e-08
subsets O 0 8.721145333678848e-11
354 O 0 1.7810454500111206e-10
of O 0 5.106283017947133e-12
Moroccan O 0 8.118221650477153e-10
origin O 0 1.090595062175348e-11
, O 0 9.139663377792824e-15
200 O 0 9.502378267925438e-13
Yemenites O 0 4.241283235728588e-08
and O 0 2.1123143314235975e-14
150 O 0 1.5628929357289212e-12
Iranian O 0 1.0172868769586785e-08
Jews O 0 6.1586464816798525e-09
. O 0 1.1664408106071278e-08

Heteroduplex O 0 1.7389143636137305e-07
analysis O 0 1.9841105754897503e-12
complemented O 0 5.591628505705049e-13
by O 0 2.1496056729340063e-17
direct O 0 3.0776284840917933e-14
DNA O 0 1.4384170243797456e-10
sequencing O 0 7.1594050687906474e-09
of O 0 8.526798156438531e-10
abnormally O 0 5.63759733340774e-11
migrating O 0 5.546918176516091e-13
bands O 0 4.965877969248522e-12
were O 0 1.0560353806698952e-11
employed O 0 4.429649536064062e-09
. O 0 3.2162004170999126e-09

Four O 0 3.0710145537682365e-10
of O 0 2.816519795167949e-10
Moroccan O 0 5.420391175903205e-07
origin O 0 4.3368422741885126e-10
( O 0 1.5525392886374975e-15
1 O 0 5.486633554169923e-14
. O 0 4.0929241875049815e-15
1 O 0 2.3235411397660652e-14
% O 0 3.099999640668316e-13
) O 0 1.9244553820031976e-17
and O 0 7.459941986245975e-16
none O 0 4.413240606293556e-12
of O 0 6.211404220829442e-12
the O 0 4.047546586088968e-12
Yemenites O 0 1.2557264561507964e-08
or O 0 3.0872071392351597e-13
Iranians O 0 5.291885263325469e-10
was O 0 8.362372209622104e-13
a O 0 3.1086370050380577e-14
carrier O 0 2.7117701530479654e-13
of O 0 1.1390181332837646e-12
the O 0 1.048297039452084e-11
185delAG O 0 1.0364338010049323e-07
mutation O 0 7.973905424840666e-10
. O 0 1.0204422862258866e-09

BRCA1 O 0 7.86618954862206e-07
allelic O 0 3.637780920939804e-08
patterns O 0 4.385401417006385e-11
were O 0 1.6506108003848385e-13
determined O 0 5.379314615278075e-13
for O 0 4.306201577909457e-15
four O 0 4.267862918540949e-14
of O 0 1.7208568690038964e-14
these O 0 2.6049863018095566e-16
individuals O 0 1.1033620577523967e-15
and O 0 8.948464748191479e-16
for O 0 3.62157000352234e-14
12 O 0 4.697027922856423e-12
additional O 0 2.5226700936520352e-11
non O 0 6.752363646000958e-08
- O 0 1.4590762376087696e-08
Ashkenazi O 0 3.132986137188709e-08
185delAG O 0 3.421460226249451e-09
mutation O 0 5.554710879630831e-13
carriers O 0 2.888976289639779e-14
who O 0 5.032477798198876e-13
had O 0 1.5331207237068156e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999881982803345

Six O 0 2.7975538330338168e-08
non O 0 6.442487574531697e-07
- O 0 3.2354048329352736e-08
Ashkenazi O 0 4.589350766082134e-08
individuals O 0 5.359193991361089e-12
shared O 0 3.755773470004442e-10
the O 0 3.643808345332733e-12
common O 0 3.756386261072331e-12
Ashkenazi O 0 5.171993500141525e-09
haplotype O 0 3.0798734673709305e-09
, O 0 6.424959848004563e-13
four O 0 2.7939607225024865e-11
had O 0 1.6779974978953227e-11
a O 0 1.0897586001992754e-12
closely O 0 4.4325480785811777e-13
related O 0 4.233744257953198e-11
pattern O 0 3.163404205253073e-09
, O 0 1.0005003248136132e-14
and O 0 3.9901604562781953e-14
the O 0 6.687031484098327e-10
rest O 0 1.0115829809365096e-06
( O 0 4.877803347867748e-13
n O 0 5.11558573279558e-11
= O 0 3.277104629328953e-11
6 O 0 8.683810615028875e-12
) O 0 1.2704738655425554e-14
displayed O 0 1.6287107296522607e-12
a O 0 7.071002854422415e-13
distinct O 0 9.077827899106605e-12
BRCA1 O 0 3.725167396773088e-10
allelic O 0 3.011450644407887e-09
pattern O 0 5.412589043629623e-09
. O 0 6.922080242333095e-09

We O 0 2.7274850780689697e-11
conclude O 0 1.1531718913104783e-09
that O 0 1.3765555095270315e-14
the O 0 8.202725608127959e-13
185delAG O 0 1.85061608704018e-07
BRCA1 O 0 3.793394398599048e-08
mutation O 0 6.056463490444752e-12
occurs O 0 6.13957452585967e-13
in O 0 2.3123250682917026e-14
some O 0 3.004496879153301e-13
non O 0 2.6314853585063247e-06
- O 0 1.1591425391088706e-05
Ashkenazi O 0 0.4863467216491699
populations O 0 2.616538319344386e-09
at O 0 2.9170978133041814e-11
rates O 0 3.052136722612314e-13
comparable O 0 1.2732430127587735e-12
with O 0 2.8870906248926013e-15
that O 0 6.124507639319182e-14
of O 0 2.061569248645867e-10
Ashkenazim O 0 2.401235633442411e-06
. O 0 4.6077961002310985e-08

The O 0 1.0616199586088726e-10
majority O 0 1.5256705621080613e-11
of O 0 2.7605674690622806e-11
Jewish O 0 2.0534742795064176e-09
185delAG O 0 5.36419577201741e-07
mutation O 0 8.516944094427714e-11
carriers O 0 1.795916713953627e-12
have O 0 1.544577725269558e-13
a O 0 4.2666361437827816e-13
common O 0 2.604782925810789e-12
allelic O 0 1.0468255151607764e-09
pattern O 0 2.612348393160602e-10
, O 0 3.162726496170644e-14
supporting O 0 8.086579149357842e-12
the O 0 2.3789137326701848e-11
founder O 0 3.38495100005165e-11
effect O 0 9.155585361034224e-13
notion O 0 6.429438145078015e-12
, O 0 2.4953207343703055e-15
but O 0 8.656820716539983e-16
dating O 0 1.0347331498572476e-11
the O 0 2.0711819032851603e-14
mutations O 0 1.4913668444724998e-14
origin O 0 1.4417327466424712e-13
to O 0 1.2327325846304277e-13
an O 0 4.019275943290641e-15
earlier O 0 6.973643125636475e-13
date O 0 1.9590006006264815e-10
than O 0 4.1613338209317563e-13
currently O 0 1.4738528323135491e-12
estimated O 0 7.965525461450795e-11
. O 0 5.080876164242909e-09

However O 0 4.079708793014447e-10
, O 0 2.237961504753406e-14
the O 0 6.729480254291653e-15
different O 0 1.2187840187495406e-14
allelic O 0 2.1140961203869324e-10
pattern O 0 7.129242335368602e-11
at O 0 1.2606682191218521e-11
the O 0 1.1486836655472121e-11
BRCA1 O 0 1.3240125662505875e-10
locus O 0 4.187349772477589e-11
even O 0 1.7202251992656792e-12
in O 0 5.85973056101835e-13
some O 0 2.680279229897581e-13
Jewish O 0 4.561994670915226e-10
mutation O 0 4.038325923660935e-11
carriers O 0 3.1886843426115474e-12
, O 0 4.014622022405906e-13
might O 0 5.321252119494524e-12
suggest O 0 4.663162911366925e-11
that O 0 2.5447124537224773e-14
the O 0 3.5956188113722698e-12
mutation O 0 2.1329153720994753e-12
arose O 0 1.0006564153675068e-11
independently O 0 1.233063789962685e-10
. O 0 1.7790212011870032e-11
. O 0 1.8368400134249896e-09

Crystal O 0 1.745143585196729e-08
structure O 0 3.022649019968071e-09
of O 0 1.3872655246771615e-09
the O 0 1.4017721428061236e-09
hemochromatosis B-Disease 1 1.0
protein O 0 3.039321905262682e-09
HFE O 0 7.302229505512514e-07
and O 0 2.1461185693155693e-14
characterization O 0 1.075433631037015e-10
of O 0 2.8695617063090317e-11
its O 0 2.2513287349819333e-13
interaction O 0 1.638239023604715e-11
with O 0 1.0738149058093713e-13
transferrin O 0 3.533518144749337e-09
receptor O 0 6.29722454736914e-11
. O 0 4.870921443966836e-10

HFE O 0 0.0005773087032139301
is O 0 2.2512098522137203e-12
an O 0 8.162907334666528e-14
MHC O 0 9.09382293912131e-08
- O 0 4.188801838722611e-08
related O 0 3.7938070818199776e-07
protein O 0 2.861994197189688e-09
that O 0 5.1058667486874026e-15
is O 0 3.283376312754506e-17
mutated O 0 6.612244647523672e-16
in O 0 9.71242917430855e-16
the O 0 1.5765876017898028e-12
iron B-Disease 0 0.0005980642163194716
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.3602153558167629e-05

HFE O 0 2.324147345689198e-07
binds O 0 3.798990635961452e-12
to O 0 6.673556672553982e-12
transferrin O 0 3.7640926486837145e-10
receptor O 0 2.9604224345385066e-13
( O 0 1.5074672890855569e-15
TfR O 0 8.560790965006504e-10
) O 0 2.0486902668598024e-16
and O 0 2.80161653018517e-16
reduces O 0 6.231377870977552e-15
its O 0 7.272137311785159e-16
affinity O 0 6.360055304676163e-14
for O 0 1.878905234523054e-12
iron O 0 1.2494186796274676e-09
- O 0 1.6036084959925034e-10
loaded O 0 3.283563421163649e-10
transferrin O 0 1.5043246648360764e-08
, O 0 5.6414777363511526e-12
implicating O 0 1.5150483534398518e-07
HFE O 0 4.1553244955139235e-05
in O 0 3.992675523534217e-09
iron O 0 2.0742836568388157e-06
metabolism O 0 6.534588919748785e-06
. O 0 9.635154007980873e-09

The O 0 1.76914323191113e-08
2 O 0 3.3586320391520985e-09
. O 0 2.7306890082456903e-09

6 O 0 7.841261862040483e-09
A O 0 2.8008159347336914e-08
crystal O 0 5.053109486397034e-09
structure O 0 7.651573596945127e-09
of O 0 1.051370190907619e-08
HFE O 1 0.764803409576416
reveals O 0 1.075513705872666e-10
the O 0 2.613490749769215e-13
locations O 0 1.2495365853126827e-11
of O 0 1.3435783041693128e-10
hemochromatosis B-Disease 1 1.0
mutations O 0 2.753560490731388e-09
and O 0 1.0586263853376576e-12
a O 0 2.0311015022644874e-11
patch O 0 9.244624379789457e-05
of O 0 2.5541817194607574e-06
histidines O 0 0.009942734614014626
that O 0 1.3817970205554087e-12
could O 0 6.164333366670549e-13
be O 0 3.3768547311706365e-13
involved O 0 4.1062413885795124e-11
in O 0 2.506413965264187e-09
pH O 0 6.56710981274955e-05
- O 0 2.6051511170521735e-08
dependent O 0 1.3592332592793355e-08
interactions O 0 8.902634185403713e-09
. O 0 2.36288988375577e-09

We O 0 1.698947510453408e-10
also O 0 4.860044319570343e-14
demonstrate O 0 1.3732279202649522e-10
that O 0 6.002856631909248e-13
soluble O 0 4.524231544955626e-10
TfR O 0 4.735833947222545e-09
and O 0 1.0785502265603375e-13
HFE O 0 4.8089194848444095e-08
bind O 0 5.3848429187874913e-11
tightly O 0 9.658552846403268e-10
at O 0 9.943190368288946e-12
the O 0 1.120262628322155e-12
basic O 0 4.398834185792566e-09
pH O 0 2.0596915284443185e-09
of O 0 2.1885673828769825e-11
the O 0 2.1442958086231867e-12
cell O 0 6.638846156842293e-12
surface O 0 7.222031132847473e-12
, O 0 4.023295114625363e-15
but O 0 4.932454116912503e-15
not O 0 1.7376292733243398e-13
at O 0 5.275747547162091e-11
the O 0 1.0609807477024447e-09
acidic O 0 5.059477530267031e-07
pH O 0 2.6299747446500987e-07
of O 0 8.554417263439973e-08
intracellular O 0 4.161050526363397e-08
vesicles O 0 1.1533356314430421e-07
. O 0 1.875131871997837e-08

TfR O 0 2.223286355729215e-05
HFE O 0 6.709722947562113e-05
stoichiometry O 0 1.1013457879016642e-07
( O 0 5.990149240346632e-13
2 O 0 1.4530688935074365e-12
1 O 0 3.541405179090934e-13
) O 0 3.0608784922631343e-15
differs O 0 2.16967156047021e-12
from O 0 1.3063492345158356e-12
TfR O 0 5.2825193108674284e-09
transferrin O 0 1.3064905823867434e-09
stoichiometry O 0 5.169202843546827e-09
( O 0 4.4365125993501425e-14
2 O 0 1.6637628503634455e-13
2 O 0 4.8333468575124244e-14
) O 0 9.654176600943504e-16
, O 0 3.986611652926996e-16
implying O 0 1.1449857988815593e-13
a O 0 9.906823235703412e-16
different O 0 7.11569297340525e-16
mode O 0 6.848488789956697e-12
of O 0 4.702831955241335e-14
binding O 0 2.7265513523160034e-13
for O 0 6.866145672856927e-12
HFE O 0 5.043097644374939e-06
and O 0 2.605917391595991e-11
transferrin O 0 1.8878465013472123e-08
to O 0 1.237043023571971e-09
TfR O 0 6.331533768388908e-07
, O 0 4.882771229984713e-14
consistent O 0 3.744432715280244e-12
with O 0 1.4810420845927093e-15
our O 0 1.7623633672206318e-12
demonstration O 0 5.887595966314052e-12
that O 0 9.071651714325987e-15
HFE O 0 1.8971665127764936e-08
, O 0 7.68976574175859e-15
transferrin O 0 1.7164285270876434e-10
, O 0 6.032708241374835e-14
and O 0 4.9446266579909054e-14
TfR O 0 9.648100096626422e-09
form O 0 1.1631903122991116e-12
a O 0 2.041579362163648e-12
ternary O 0 4.4282412403617855e-08
complex O 0 3.27383595788433e-08
. O 0 1.1507029107349354e-08

Identification O 0 1.2678754046646645e-08
of O 0 1.0917604494065092e-11
three O 0 3.084810307044973e-14
novel O 0 7.150467911054776e-16
mutations O 0 1.8022699489490118e-14
and O 0 7.700593575681578e-16
a O 0 3.546296896005281e-14
high O 0 1.2721063352011397e-13
frequency O 0 1.396507475631692e-12
of O 0 2.935530507910955e-13
the O 0 2.0287375566366977e-13
Arg778Leu O 0 1.5442045864233478e-08
mutation O 0 1.4661842703475592e-12
in O 0 5.111657150618128e-14
Korean O 0 1.370397573197124e-09
patients O 0 6.781235729197421e-12
with O 0 1.2195897503702868e-12
Wilson B-Disease 0 1.9833734654639557e-07
disease I-Disease 0 2.705742296882363e-08
. O 0 7.077922137277426e-10

Four O 0 4.223281635518106e-08
mutations O 0 3.3817668665392375e-09
- O 0 7.768008458697295e-09
- O 0 3.405327131389413e-09
R778L O 0 9.595378003268706e-08
, O 0 1.3169760421094523e-13
A874V O 0 2.0651202969901306e-09
, O 0 2.868067323688454e-15
L1083F O 0 3.442666290931484e-11
, O 0 7.122016471403198e-17
and O 0 7.410813016514041e-17
2304delC O 0 2.521048994563735e-11
- O 0 1.2361661173854177e-12
- O 0 2.118918105212253e-12
in O 0 1.02144356341205e-12
the O 0 4.1424988439509036e-11
copper O 0 4.5213999211313194e-11
- O 0 1.2596580679577474e-12
transporting O 0 2.3054717857018403e-11
enzyme O 0 9.644442362788386e-12
, O 0 4.1761868485937215e-13
P O 0 1.2069092747424293e-07
- O 0 1.3987221381128734e-09
type O 0 3.882599797222497e-10
ATPase O 0 3.9519459704706605e-08
( O 0 6.61336084636574e-14
ATP7B O 0 8.987978617369663e-06
) O 0 7.174293359674263e-16
, O 0 1.9594421440639855e-17
were O 0 1.9687486207869216e-16
identified O 0 4.501581585654923e-15
in O 0 1.108927699490568e-15
Korean O 0 1.3435423606988905e-10
Patients O 0 2.3074030533476453e-11
with O 0 9.738618331894822e-13
Wilson B-Disease 0 6.277446686908661e-07
disease I-Disease 0 2.2355804958351655e-06
. O 0 2.926709896655666e-08

Arg778Leu O 0 0.00017875178309623152
, O 0 1.4842737499146108e-12
the O 0 8.137975970184952e-13
most O 0 1.1960680350601906e-14
frequently O 0 2.5759613626191724e-14
reported O 0 5.0745876007144905e-14
mutation O 0 6.332569017775125e-13
of O 0 2.42022200891423e-12
this O 0 2.3348399494187155e-13
enzyme O 0 1.029291886098238e-12
, O 0 1.969441726671836e-14
was O 0 7.055106282169432e-13
found O 0 1.2019223879784335e-14
in O 0 1.19323744153288e-15
six O 0 8.373763650797866e-14
of O 0 4.951223350584122e-14
eight O 0 7.724730685838843e-13
unrelated O 0 3.2928312854174635e-11
patients O 0 7.00057687600536e-13
studied O 0 2.2015355304830925e-13
, O 0 3.5486617378786324e-16
an O 0 1.033811189836611e-16
allele O 0 1.0721147277251153e-12
frequency O 0 5.2578462417240956e-11
of O 0 2.436249257886658e-10
37 O 0 3.6250920487646e-08
. O 0 2.0966261615740223e-08

5 O 0 9.08130015631059e-10
% O 0 2.7304181138276817e-09
, O 0 2.6122533362772302e-14
which O 0 1.5571775351775436e-15
is O 0 7.032176054201568e-16
considerably O 0 3.101769709135116e-12
higher O 0 2.8501359258803483e-12
than O 0 1.0011226399199609e-14
those O 0 4.9548415365216134e-14
in O 0 1.0463868270124688e-12
other O 0 1.7285860243188012e-12
Asian O 0 4.051984581199264e-10
populations O 0 2.0889420835473738e-12
. O 0 2.333217473393656e-11

The O 0 5.2619670773412786e-12
novel O 0 1.1986532643185055e-14
single O 0 2.982310036946101e-13
nucleotide O 0 1.759690657077151e-11
deletion O 0 2.6149292800536905e-11
, O 0 3.013707312133837e-14
2304delC O 0 2.3337138888024356e-09
, O 0 1.03322484980772e-14
was O 0 5.043480281845258e-13
found O 0 6.138798779205257e-14
in O 0 4.348952431900213e-14
one O 0 1.643126281737628e-12
patient O 0 7.178479588532127e-09
. O 0 3.6123832813927947e-09

Since O 0 6.598641077992795e-11
a O 0 1.981289481436943e-12
mutation O 0 1.3153443178398616e-13
at O 0 1.705257029332996e-12
cDNA O 0 7.390568712573042e-10
nucleotide O 0 2.216155037260137e-09
2302 O 0 8.875984747191978e-08
( O 0 2.6256606819861396e-14
2302insC O 0 1.8135608570446493e-09
) O 0 2.844582954061002e-14
had O 0 9.811574296081371e-13
been O 0 1.6682847865743394e-13
previously O 0 1.6854414999073475e-12
described O 0 5.4475927891914355e-14
, O 0 1.7537553798593252e-16
this O 0 1.2413195844211255e-15
region O 0 2.3398623316683853e-11
of O 0 9.109030370269e-12
the O 0 9.059256123045145e-11
ATP7B O 1 0.9999556541442871
gene O 0 7.39337063793144e-11
may O 0 2.4174549514976995e-11
be O 0 2.8279951297394135e-11
susceptible O 0 1.0627529967166538e-09
to O 0 6.762513882208054e-10
gene O 0 1.3750586447258684e-08
rearrangements O 0 0.00021411688067018986
causing O 0 3.9654500142205507e-05
Wilson B-Disease 0 6.786460289731622e-05
disease I-Disease 0 3.713537580551929e-06
. O 0 6.69781730078256e-10

Disruption O 0 6.874046931670819e-08
of O 0 2.8507748939254896e-10
splicing O 0 6.911031469325479e-11
regulated O 0 1.1246214463161985e-12
by O 0 1.1075115662818771e-15
a O 0 4.1395481335283757e-13
CUG O 0 2.310327545274049e-06
- O 0 8.122212624694924e-11
binding O 0 1.170714775122761e-10
protein O 0 1.7949913777570714e-09
in O 0 1.1340161448769592e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 4.692730044553173e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.639235105079024e-09
DM B-Disease 1 1.0
) O 0 9.417615992601824e-12
is O 0 7.603181864483666e-14
caused O 0 6.030696775294331e-13
by O 0 1.3840746209998079e-14
a O 0 4.406377172860854e-12
CTG O 0 4.737200853810464e-08
expansion O 0 4.0344842050510366e-11
in O 0 2.695516065128606e-13
the O 0 3.947860376281309e-13
3 O 0 4.103678768324626e-12
untranslated O 0 1.1289606618447579e-06
region O 0 1.6603132757531114e-10
of O 0 2.7990706974456714e-11
the O 0 3.2978236808034467e-10
DM B-Disease 1 1.0
gene O 0 5.677169290230211e-10
. O 0 7.314772787481161e-09

One O 0 1.8634336695216858e-12
model O 0 2.2324482540359014e-11
of O 0 8.456666478195984e-10
DM B-Disease 1 1.0
pathogenesis O 0 1.903267019542909e-07
suggests O 0 3.4120317248670373e-12
that O 0 2.5765939691758293e-15
RNAs O 0 1.7929560830812208e-12
from O 0 3.8539524761620203e-13
the O 0 1.8322419048557442e-13
expanded O 0 1.1175495208057273e-13
allele O 0 7.927651048643403e-14
create O 0 5.3736689204560584e-15
a O 0 4.279312940515343e-15
gain O 0 2.894269546249717e-11
- O 0 2.2865782618036734e-12
of O 0 5.0351237068646526e-11
- O 0 3.612221285975714e-11
function O 0 1.7294806212153624e-11
mutation O 0 3.471105103651159e-14
by O 0 9.530202608852098e-17
the O 0 2.4266246682820873e-15
inappropriate O 0 2.2838998284279745e-14
binding O 0 6.878801320870861e-14
of O 0 3.0268617473572235e-12
proteins O 0 2.58564518537327e-13
to O 0 3.6552171879533635e-12
the O 0 5.962433324846472e-11
CUG O 0 0.0033586479257792234
repeats O 0 4.938581099622752e-08
. O 0 2.065222659553001e-09

Data O 0 4.4634446139113493e-10
presented O 0 1.7996612229967401e-12
here O 0 3.941715443628313e-12
indicate O 0 9.479899504283296e-12
that O 0 1.3973472884701039e-15
the O 0 6.676761465755632e-13
conserved O 0 1.5969026101458894e-10
heterogeneous O 0 3.963068206935816e-10
nuclear O 0 3.4246268043602868e-09
ribonucleoprotein O 0 8.506058968293928e-09
, O 0 5.85748409411696e-13
CUG O 0 1.0613475751597434e-06
- O 0 1.0523863724909432e-10
binding O 0 9.280973212177912e-11
protein O 0 6.272781599703237e-11
( O 0 2.2334668091220956e-14
CUG O 0 0.013904504477977753
- O 0 7.358112696920216e-08
BP O 0 1.2888932587884483e-08
) O 0 5.685675454752959e-14
, O 0 2.591153576154536e-14
may O 0 5.376135192407261e-13
mediate O 0 3.415135951811976e-09
the O 0 3.693838290796947e-10
trans O 0 2.6136004471766228e-09
- O 0 3.4775018420418746e-09
dominant O 0 1.3005094778861803e-08
effect O 0 7.764495968919094e-13
of O 0 3.0926370405554016e-12
the O 0 2.7860728047529593e-12
RNA O 0 1.8349559649522007e-09
. O 0 2.064683091163033e-09

CUG O 1 0.9985124468803406
- O 0 1.2156126103946008e-05
BP O 0 1.1181136017057725e-07
was O 0 2.4975636142565705e-11
found O 0 2.912734547370725e-14
to O 0 2.8685050279639475e-15
bind O 0 4.782844042691692e-14
to O 0 4.311194955718134e-13
the O 0 2.471291617525684e-12
human O 0 5.668401859004746e-11
cardiac O 0 2.2556885596713983e-05
troponin O 0 1.2316779702814529e-06
T O 0 2.6178064160831127e-09
( O 0 2.898368233310582e-15
cTNT O 0 4.106429432604308e-11
) O 0 8.253651827190453e-17
pre O 0 6.3816547532513646e-12
- O 0 2.1133146773343048e-13
messenger O 0 4.0859321676946225e-13
RNA O 0 6.671316277184758e-12
and O 0 5.756592441228878e-14
regulate O 0 3.005481266963282e-14
its O 0 7.519799687046068e-16
alternative O 0 2.8012680608306695e-13
splicing O 0 3.539949930408959e-11
. O 0 1.9174055398973877e-10

Splicing O 0 2.3218547084979946e-09
of O 0 2.3662767301146914e-09
cTNT O 0 8.736141353438143e-06
was O 0 5.38759925561294e-10
disrupted O 0 9.312246618264908e-08
in O 0 8.627436265395971e-11
DM B-Disease 1 1.0
striated O 0 1.4254486302434088e-07
muscle O 0 2.7438038507909823e-09
and O 0 6.032491671990881e-13
in O 0 1.1030229464178976e-12
normal O 0 1.5893372173891862e-09
cells O 0 3.987139091110592e-11
expressing O 0 1.4843757733390417e-12
transcripts O 0 1.4346468457659967e-10
that O 0 1.684376006998601e-14
contain O 0 4.136629840750805e-12
CUG O 0 5.018222509534098e-06
repeats O 0 2.7995219475940303e-09
. O 0 1.8949632973885855e-09

Altered O 0 1.860435583367348e-09
expression O 0 1.0571039876783317e-10
of O 0 3.446452290223334e-10
genes O 0 6.666266497146189e-12
regulated O 0 2.787072005475122e-12
posttranscriptionally O 0 1.875441191234728e-10
by O 0 2.9837208550230476e-13
CUG O 1 0.9999997615814209
- O 0 1.5866111198192812e-06
BP O 0 2.9856128236360746e-08
therefore O 0 4.974033337989958e-11
may O 0 2.9060837937466832e-12
contribute O 0 1.1818659384488228e-09
to O 0 1.8630856857271283e-08
DM B-Disease 1 1.0
pathogenesis O 0 1.9577084913180443e-06
. O 0 2.735979220958029e-10
. O 0 1.1515519648952477e-09

Identification O 0 1.2567280549546922e-08
of O 0 2.8823865169669283e-11
a O 0 1.4754045424628104e-13
novel O 0 5.815180693750921e-14
nonsense O 0 5.012225079426003e-10
mutation O 0 1.1466993804151726e-13
and O 0 1.4276278693014979e-15
a O 0 6.410937420850676e-15
missense O 0 2.6554283945323665e-12
substitution O 0 1.70495778953339e-12
in O 0 7.832900587910821e-14
the O 0 6.887613851654095e-13
vasopressin O 0 7.421207537383623e-10
- O 0 6.433971133645855e-10
neurophysin O 0 2.5907151979254195e-09
II O 0 6.852497236309318e-09
gene O 0 2.1958949686807366e-13
in O 0 5.779662908206654e-14
two O 0 3.3156278016113067e-14
Spanish O 0 1.6922262202623273e-11
kindreds O 0 3.6417798554566616e-08
with O 0 5.887348768218725e-12
familial B-Disease 1 0.9998654127120972
neurohypophyseal I-Disease 1 0.9999996423721313
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999570846557617
. O 0 2.5918541268765694e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 3.009845497836672e-11
FNDI B-Disease 1 1.0
) O 0 4.085018320788489e-14
is O 0 9.614301466160323e-16
an O 0 8.595062697322724e-15
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 2.2529056398212788e-09
by O 0 5.837987970651326e-13
deficiency O 1 1.0
in O 0 1.733509833456992e-07
the O 0 9.810811718580226e-08
antidiuretic O 0 2.6401805186537786e-09
hormone O 0 2.0250890808010125e-12
arginine O 0 1.2410245053828817e-10
vasopressin O 0 5.4809625588125854e-11
( O 0 3.2108092531577762e-15
AVP O 0 2.9982998722699605e-11
) O 0 1.704699632155215e-17
encoded O 0 4.211086765954614e-16
by O 0 3.4073030562893224e-16
the O 0 2.1156913027065016e-12
AVP O 0 6.638903187194956e-07
- O 0 4.447014489983303e-08
neurophysin O 0 5.1821867685930556e-08
II O 0 5.9282868392074306e-08
( O 0 3.0789997287894444e-12
AVP O 0 1.5792076737852767e-05
- O 0 1.3035521817528206e-07
NPII O 0 0.0006336868391372263
) O 0 1.1280597597251429e-14
gene O 0 7.100187188272813e-15
on O 0 9.967242959804667e-13
chromosome O 0 2.6640536998634445e-11
20p13 O 0 1.148149237906182e-07
. O 0 1.2854824982255764e-09

In O 0 3.402155293596998e-11
this O 0 1.5496532822147774e-13
study O 0 2.1861357938756515e-14
, O 0 1.4349161642961475e-16
we O 0 1.0942579358770707e-15
analyzed O 0 4.3536910730203326e-14
two O 0 1.117100826277743e-15
families O 0 1.5905582989475357e-14
with O 0 5.687646246311335e-15
FNDI B-Disease 1 1.0
using O 0 2.6455905608596675e-12
direct O 0 1.735491438059622e-11
automated O 0 7.085188546973598e-10
fluorescent O 0 3.639231277441368e-12
, O 0 1.3741309624188108e-15
solid O 0 2.6948782832006413e-13
phase O 0 1.064155057475813e-12
, O 0 6.715676899504079e-17
single O 0 3.191320083832639e-15
- O 0 3.589398675746085e-15
stranded O 0 2.0372440035941117e-14
DNA O 0 1.5175889516404195e-13
sequencing O 0 9.351632966267398e-13
of O 0 4.427987056881966e-12
PCR O 0 1.1400197452715588e-09
- O 0 6.490363801958665e-09
amplified O 0 9.697229685912134e-09
AVP O 0 1.04306282082689e-05
- O 0 3.866183817535784e-08
NPII O 0 3.93939481000416e-05
DNA O 0 6.909341010441494e-08
. O 0 2.1762056046092937e-10

In O 0 1.2226390906644458e-11
one O 0 2.871222953403779e-13
of O 0 2.5149232197631266e-13
the O 0 9.369910310965887e-14
families O 0 1.6964774311907516e-13
, O 0 2.3472686925526736e-15
affected O 0 6.761624138200417e-14
individuals O 0 8.0712610167515725e-16
presented O 0 5.387909085899367e-13
a O 0 2.0107318045824163e-13
novel O 0 1.706511993347648e-13
nonsense O 0 8.811842922007429e-10
mutation O 0 1.6320661185356689e-12
in O 0 6.7230249145566745e-12
exon O 0 8.803069384555329e-11
3 O 0 1.5840024604474312e-12
of O 0 1.250337593877715e-11
the O 0 9.971978754894084e-13
gene O 0 2.2872608551626795e-14
, O 0 1.8329147115960778e-15
consisting O 0 3.403498448988052e-15
in O 0 9.579929927951928e-15
a O 0 1.4542353595197594e-13
G O 0 2.095658499165487e-12
to O 0 4.76910524960239e-11
T O 0 3.7075456593704814e-10
transition O 0 3.787183899817137e-08
at O 0 2.89948148823882e-10
nucleotide O 0 7.305005905733353e-11
2101 O 0 1.687168982300591e-08
, O 0 2.916813646286465e-15
which O 0 9.52122190894161e-18
produces O 0 1.2267816403100447e-17
a O 0 6.487519046040476e-16
stop O 0 2.0043755338209485e-13
signal O 0 6.659877510584167e-11
in O 0 7.267562419921436e-12
codon O 0 5.479703357735843e-09
82 O 0 1.2985464259429591e-08
( O 0 3.995038674875495e-12
Glu O 0 6.520605211335351e-08
) O 0 9.85967492546369e-13
of O 0 1.0206993028560873e-09
NPII O 0 0.21553084254264832
. O 0 1.0187046939336142e-07

The O 0 9.382538079805158e-10
premature O 0 6.139270869454094e-09
termination O 0 1.3079317628950093e-09
eliminates O 0 2.456967268527066e-11
part O 0 6.606001553069452e-13
of O 0 1.200645746018969e-11
the O 0 3.690962813163168e-11
C O 0 3.603247193950665e-07
- O 0 8.271852092178733e-10
terminal O 0 3.894880945543022e-11
domain O 0 2.6832997629400168e-11
of O 0 1.4301708255171075e-11
NPII O 1 0.9818882346153259
, O 0 2.4623916932710842e-14
including O 0 1.1802446972758278e-15
a O 0 2.822558911586264e-14
cysteine O 0 3.656362712600725e-11
residue O 0 8.879502466641043e-09
in O 0 1.7102144353464688e-12
position O 0 1.3026835166130013e-09
85 O 0 3.94930665947868e-09
, O 0 6.711589563192927e-14
which O 0 5.669707147279673e-16
could O 0 3.026097032459915e-14
be O 0 7.579826116809255e-14
involved O 0 7.445529436045373e-12
in O 0 3.648892386159952e-12
the O 0 1.7210892433450198e-11
correct O 0 4.05243660850374e-08
folding O 0 5.137023695311882e-09
of O 0 2.5135840631129724e-10
the O 0 1.125007198510275e-09
prohormone O 0 1.6114941900013946e-05
. O 0 1.5675025721861857e-08

In O 0 6.114323890943352e-12
the O 0 7.886739221765748e-13
second O 0 2.478647495585129e-11
family O 0 4.4313814770435833e-13
, O 0 4.956934745516692e-16
a O 0 2.0192157966963985e-15
G279A O 0 5.1704174795774716e-12
substitution O 0 8.40418555060618e-13
at O 0 2.3113572687749606e-12
position O 0 1.2071861565932096e-10
- O 0 4.141003512314612e-12
1 O 0 1.8411822359700597e-13
of O 0 2.4688226723385e-12
the O 0 3.6894036545449815e-13
signal O 0 6.792161017649123e-12
peptide O 0 1.779613105100039e-13
was O 0 1.5032967275521725e-13
observed O 0 4.308841356089575e-14
in O 0 8.574103714075864e-15
all O 0 5.5588627640877283e-14
affected O 0 6.205432760524043e-13
individuals O 0 4.879645407358801e-13
. O 0 3.543532134386851e-10

This O 0 5.058951590974914e-10
missense O 0 2.320612679795886e-07
mutation O 0 3.193587339023196e-10
, O 0 3.5983889479229703e-13
which O 0 3.7694107275602906e-13
replaces O 0 1.4927879021797708e-07
Ala O 0 6.110564640948724e-07
with O 0 7.76460406387569e-12
Thr O 0 0.002409572945907712
, O 0 1.5106636102636684e-13
is O 0 7.720480850491925e-15
frequent O 0 7.224107380007783e-13
among O 0 2.743893870796321e-12
FNDI B-Disease 1 1.0
patients O 0 1.4627789823862258e-06
and O 0 3.18721720023174e-13
is O 0 2.9459839786822456e-14
thought O 0 1.9885508170669475e-12
to O 0 1.3887254193822862e-11
reduce O 0 5.903656036254645e-11
the O 0 5.764487411713537e-12
efficiency O 0 1.7558469123102327e-09
of O 0 8.02718481962561e-12
cleavage O 0 3.0726535898972784e-11
by O 0 7.540363732710942e-13
signal O 0 1.6192821306049154e-08
peptidases O 0 7.697003070461506e-07
. O 0 7.255336609279794e-11
. O 0 9.493698049922727e-10

Genetic O 0 1.1429333923729246e-08
heterogeneity O 0 4.839668665823638e-09
of O 0 7.650187150431975e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.159248829960747e-14
due O 0 2.4292544864579213e-08
to O 0 5.618310261468196e-10
TWIST O 1 0.9999587535858154
and O 0 4.142650666949521e-10
FGFR O 1 1.0
mutations O 0 4.3578417319167784e-08
. O 0 9.595411576412971e-09

Thirty O 0 7.565241503471043e-06
- O 0 2.0145028756246575e-08
two O 0 2.4299155352777713e-13
unrelated O 0 1.243782854487563e-10
patients O 0 2.6288091712137196e-13
with O 0 8.855450207368912e-17
features O 0 5.6766267711840304e-14
of O 0 1.997059462244266e-10
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 4.024053659734683e-12
a O 0 1.4772110618066492e-11
common O 0 1.4020349325960524e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999920129776001
condition I-Disease 1 1.0
of O 1 0.9999706745147705
craniosynostosis B-Disease 1 1.0
and O 0 6.557522738148691e-07
limb B-Disease 1 1.0
anomalies I-Disease 0 0.20651991665363312
, O 0 8.063441407635263e-13
were O 0 4.524693120178114e-12
screened O 0 3.306412782455581e-11
for O 0 5.894225212077497e-12
mutations O 0 2.9470786921947933e-11
in O 0 2.3528316447918307e-11
TWIST O 0 1.5827725974304485e-06
, O 0 1.1226182310142274e-11
FGFR2 O 0 0.43325838446617126
, O 0 8.58216622767749e-12
and O 0 3.3827565748545396e-11
FGFR3 O 1 0.9907898902893066
. O 0 7.701740400989365e-08

Nine O 0 1.9434340803314853e-09
novel O 0 5.59335672396799e-13
and O 0 3.3595411066782155e-13
three O 0 4.267826543558062e-12
recurrent O 0 3.9755871483748706e-08
TWIST O 0 1.8852347238862421e-07
mutations O 0 3.560399544633164e-11
were O 0 4.279581029831281e-12
found O 0 1.7160624592345297e-13
in O 0 4.2379470700966426e-14
12 O 0 2.452500702521121e-11
families O 0 1.8503266627223347e-11
. O 0 1.4615934018635812e-09

Seven O 0 1.216434397655064e-09
families O 0 5.62808653847835e-12
were O 0 1.0046758347134754e-12
found O 0 4.7894258275050366e-14
to O 0 6.392128579918444e-13
have O 0 2.1617145465162302e-13
the O 0 4.761615754467208e-11
FGFR3 O 0 0.0018326645949855447
P250R O 0 6.390400812961161e-07
mutation O 0 3.642323248564949e-11
, O 0 2.8046936314759553e-14
and O 0 1.7242770186383198e-14
one O 0 6.600973158918735e-14
individual O 0 2.674222876562077e-13
was O 0 1.4802542872005553e-11
found O 0 2.9649487075580905e-13
to O 0 1.6725167258091478e-12
have O 0 2.375316198073574e-13
an O 0 4.970822473256142e-13
FGFR2 O 0 5.653307380271144e-05
VV269 O 0 3.176391828674241e-06
- O 0 2.077819694079608e-08
270 O 0 1.307994779153887e-08
deletion O 0 1.0179976328572593e-07
. O 0 6.2252074606306e-09

To O 0 4.0131713924251855e-11
date O 0 8.068484214085458e-10
, O 0 5.823772318341511e-14
our O 0 6.0473908866653936e-12
detection O 0 8.591756195386324e-10
rate O 0 1.903219118762345e-12
for O 0 6.9924022457347034e-15
TWIST O 0 2.0597633820784722e-08
or O 0 2.127833152731906e-11
FGFR O 0 0.0005153015372343361
mutations O 0 3.769536766062842e-11
is O 0 2.8229788705215128e-14
68 O 0 4.2593575888538737e-10
% O 0 2.4303907844580586e-11
in O 0 7.778900543457465e-14
our O 0 7.676771440756625e-10
Saethre B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.8854009459511332e-11
, O 0 3.159690444214065e-16
including O 0 1.3807885355051112e-15
our O 0 3.6031261307911677e-10
five O 0 2.118652475679994e-11
patients O 0 4.004717835560251e-13
elsewhere O 0 3.109130520314446e-13
reported O 0 7.422583056006238e-13
with O 0 2.972111218160073e-13
TWIST O 0 5.4201768762141e-06
mutations O 0 3.0171598552897194e-09
. O 0 4.954249011035472e-09

More O 0 3.476554981396429e-12
than O 0 6.51991481637193e-14
35 O 0 4.184180432686979e-11
different O 0 6.0296654821878626e-12
TWIST O 0 1.5733486691260623e-07
mutations O 0 1.7829956261428137e-11
are O 0 1.3723663386797959e-14
now O 0 2.3157235338826763e-14
known O 0 4.698203343701064e-15
in O 0 4.682960562298749e-14
the O 0 1.0790179513775477e-12
literature O 0 1.5132960162755893e-10
. O 0 1.7943991847957363e-09

The O 0 2.978325364111356e-09
most O 0 7.838928074363483e-13
common O 0 8.40610892526017e-13
phenotypic O 0 1.0151182845696827e-11
features O 0 1.1378754655091278e-13
, O 0 6.631897400086748e-16
present O 0 8.111440935164999e-14
in O 0 2.923454257537997e-14
more O 0 8.613011643112398e-16
than O 0 1.4826870225762771e-15
a O 0 4.030148204091713e-14
third O 0 1.6693155191482845e-10
of O 0 1.4033230133492225e-10
our O 0 6.687965736773549e-09
patients O 0 2.957535952252677e-11
with O 0 2.761481093706969e-13
TWIST O 0 2.765252133940521e-07
mutations O 0 6.172717198493771e-11
, O 0 1.2155042055338183e-13
are O 0 9.958573137132387e-14
coronal B-Disease 0 4.621339755317422e-09
synostosis I-Disease 0 1.996241394408571e-07
, O 0 8.204717287518815e-12
brachycephaly B-Disease 0 3.119153575426026e-07
, O 0 5.466971667034137e-11
low B-Disease 0 1.3224109807197237e-06
frontal I-Disease 1 0.9999924898147583
hairline I-Disease 1 1.0
, O 0 9.752489660286301e-08
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999998807907104
, O 0 4.265042097273408e-09
ptosis B-Disease 1 0.9965805411338806
, O 0 3.134549009242704e-10
hypertelorism B-Disease 0 6.717392534483224e-05
, O 0 5.499654551210931e-11
broad B-Disease 0 2.7753053188916965e-09
great I-Disease 0 1.7343431579774915e-07
toes I-Disease 0 0.001031340449117124
, O 0 7.221741434026985e-12
and O 0 5.396204316721054e-11
clinodactyly B-Disease 0 0.0005899705574847758
. O 0 4.614524584667379e-07

Significant O 0 1.2943575100621274e-08
intra O 1 0.9036876559257507
- O 0 3.8264661839093606e-07
and O 0 1.3082748426263002e-11
interfamilial O 0 3.011435182997957e-05
phenotypic O 0 2.9824086311691644e-08
variability O 0 6.746693204107146e-10
is O 0 7.010721239043209e-16
present O 0 8.2572227592774e-14
for O 0 2.7037684699644793e-14
either O 0 2.0719685689396528e-10
TWIST O 0 8.034435268200468e-06
mutations O 0 2.4512123442121947e-09
or O 0 8.958926933644307e-10
FGFR O 0 0.3264894485473633
mutations O 0 3.314822549782548e-08
. O 0 4.9265365120731985e-09

The O 0 2.4273263399265943e-09
overlap O 0 4.158247968177875e-09
in O 0 7.223267123324106e-13
clinical O 0 6.881436392935925e-11
features O 0 4.491055151465556e-13
and O 0 1.0624138592799873e-14
the O 0 1.5155677277403634e-12
presence O 0 6.598093382423342e-13
, O 0 9.053294816293092e-15
in O 0 2.439973780475873e-14
the O 0 1.8315955848356713e-13
same O 0 2.6946934267302325e-13
genes O 0 5.561846014127958e-13
, O 0 2.4538351358445107e-14
of O 0 3.8423699443533577e-13
mutations O 0 3.182914679435503e-14
for O 0 4.937520390376621e-14
more O 0 6.229143821579169e-15
than O 0 2.3416712023756857e-14
one O 0 3.859248803774612e-13
craniosynostotic B-Disease 0 3.328132436308806e-08
condition I-Disease 0 1.985573544516228e-05
- O 0 1.916474090535303e-09
such O 0 2.0217699042701653e-12
as O 0 7.232869858597724e-11
Saethre B-Disease 0 0.006100909784436226
- I-Disease 0 1.495753423341739e-07
Chotzen I-Disease 0 3.454430043348111e-05
, I-Disease 0 2.174112235728276e-12
Crouzon I-Disease 0 2.3079926904756576e-05
, I-Disease 0 8.267123422465994e-13
and I-Disease 0 8.973214532526086e-12
Pfeiffer I-Disease 0 7.994927727850154e-05
syndromes I-Disease 0 0.0012842934811487794
- O 0 1.2999295506688213e-07
support O 0 7.257267231608466e-09
the O 0 2.2989521397676072e-10
hypothesis O 0 7.43601014097095e-11
that O 0 3.2325864702316843e-15
TWIST O 0 2.0423975399808114e-08
and O 0 2.7021548721999598e-14
FGFRs O 0 4.519921326107124e-09
are O 0 1.4263370440294415e-16
components O 0 1.1776477362723803e-11
of O 0 7.939973548434787e-13
the O 0 3.393310887269893e-14
same O 0 7.481890303975228e-15
molecular O 0 1.0414794399885973e-14
pathway O 0 4.765578800721218e-14
involved O 0 1.8424670833070908e-14
in O 0 6.471480371305098e-15
the O 0 4.570529135825181e-14
modulation O 0 3.986175278747339e-10
of O 0 4.2966957769507985e-10
craniofacial O 0 4.140759483561851e-05
and O 0 4.028853695103862e-08
limb O 1 0.8748780488967896
development O 0 1.6620963094737817e-07
in O 0 2.007330282896569e-12
humans O 0 2.7733590163975252e-12
. O 0 3.5093913994428683e-13
. O 0 4.993215216297919e-11

Mutation O 0 1.3666380527244115e-10
analysis O 0 4.41436861023381e-12
of O 0 5.6356728311834914e-11
UBE3A O 1 0.9999969005584717
in O 0 6.885381299071014e-05
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.8522793254760472e-07
. O 0 1.5367085381967627e-09

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.2221563195378167e-09
AS B-Disease 1 1.0
) O 0 1.3545590430569243e-12
is O 0 4.597324684298392e-15
caused O 0 9.389607553934518e-14
by O 0 1.4990785712374818e-14
chromosome O 0 8.130587314525428e-10
15q11 O 0 6.559023404406616e-07
- O 0 3.480308707892732e-09
q13 O 0 6.369468064093553e-09
deletions O 0 4.205695167125434e-11
of O 0 8.749961475859602e-13
maternal O 0 7.857284267664966e-12
origin O 0 2.5831902806042195e-13
, O 0 2.3757699218596824e-16
by O 0 1.3160688020603072e-14
paternal O 0 5.94291371669442e-08
uniparental B-Disease 0 0.0001230540801770985
disomy I-Disease 0 0.00019750132923945785
( O 0 2.3201139620621092e-10
UPD B-Disease 1 1.0
) O 0 9.875446814466837e-13
15 O 0 3.952217459551877e-12
, O 0 1.8789380350269034e-15
by O 0 1.475628972312515e-14
imprinting O 0 7.065357294777641e-07
defects O 0 3.526781028995174e-06
, O 0 5.967066576094415e-14
and O 0 8.66022748305384e-15
by O 0 4.2667234898203024e-14
mutations O 0 9.524261804574885e-13
in O 0 9.378873545851096e-13
the O 0 5.059691901565522e-11
UBE3A O 0 9.271694239032513e-07
gene O 0 1.2003624483281072e-10
. O 0 2.0493307051339116e-09

UBE3A O 0 9.994841093430296e-05
encodes O 0 6.215736259029825e-10
a O 0 1.1799950773438983e-11
ubiquitin O 0 7.36996075278995e-10
- O 0 9.163093617203799e-10
protein O 0 1.7166297680212828e-12
ligase O 0 1.407089939356454e-12
and O 0 2.9929433497527524e-13
shows O 0 2.405222132573215e-10
brain O 0 2.520048667520314e-07
- O 0 9.742399942336277e-11
specific O 0 6.647909306378708e-11
imprinting O 0 2.976272241994593e-07
. O 0 1.1700678204107362e-09

Here O 0 2.0375872100686365e-09
we O 0 2.4568303121086377e-12
describe O 0 1.6604399799557967e-10
UBE3A O 0 7.61897535994649e-05
coding O 0 2.6805608285940252e-05
- O 0 1.0228552227431464e-08
region O 0 1.2747491950904077e-09
mutations O 0 5.28235268026922e-11
detected O 0 1.1139196119322459e-12
by O 0 7.015803966122327e-16
SSCP O 0 0.08836981654167175
analysis O 0 3.0528951762420764e-12
in O 0 3.2185239445380737e-14
13 O 0 7.589020557807746e-12
AS B-Disease 1 1.0
individuals O 0 9.247055161518136e-13
or O 0 7.861541279075013e-12
families O 0 2.8710178331947667e-11
. O 0 1.2159078188744843e-09

Two O 0 3.185235131208941e-10
identical O 0 2.6930380148115773e-10
de O 0 2.838280166450602e-10
novo O 0 5.557922566623574e-09
5 O 0 2.222110273564226e-09
- O 0 5.197913655052844e-09
bp O 0 3.2658123427786734e-10
duplications O 0 4.913026074859772e-08
in O 0 2.8080715530620637e-10
exon O 0 4.5826920036518e-09
16 O 0 1.21532062191676e-10
were O 0 1.3234040252552148e-10
found O 0 7.894512821238209e-11
. O 0 1.6158751003914062e-09

Among O 0 2.2371338115334538e-10
the O 0 7.906715213112925e-12
other O 0 2.4101142089005823e-13
11 O 0 1.2870389649866087e-11
unique O 0 2.9335128076679595e-11
mutations O 0 7.999596644825413e-12
, O 0 9.019380294711388e-14
8 O 0 3.486158237087089e-11
were O 0 5.033109484742226e-10
small O 0 2.691665466902915e-11
deletions O 0 3.937241088713961e-10
or O 0 9.47353740593515e-12
insertions O 0 1.1870053828744176e-09
predicted O 0 2.7047489248310796e-10
to O 0 8.986544147715492e-11
cause O 0 1.1198738825157761e-08
frameshifts O 0 0.21993117034435272
, O 0 4.855275253026758e-13
1 O 0 6.138497913102392e-13
was O 0 8.131784633678973e-13
a O 0 4.121535944023695e-14
mutation O 0 3.4319481257523085e-14
to O 0 2.9247941958979173e-13
a O 0 5.261523096551646e-13
stop O 0 1.7641870603268828e-11
codon O 0 1.1041491276841953e-08
, O 0 2.4953517442465045e-13
1 O 0 3.804978792980307e-13
was O 0 1.1156930414257804e-12
a O 0 3.965209779445422e-13
missense O 0 1.8336755447379005e-09
mutation O 0 3.880737745043383e-12
, O 0 4.058612915690783e-14
and O 0 1.7941653683030932e-14
1 O 0 2.433737618986326e-13
was O 0 1.1737050133880933e-12
predicted O 0 2.0365003086664224e-12
to O 0 1.688059414473031e-13
cause O 0 1.4660360599105804e-12
insertion O 0 5.060920571509087e-10
of O 0 1.0839330544243353e-09
an O 0 5.910548959986439e-12
isoleucine O 0 4.926670271743205e-07
in O 0 2.9779800587298455e-12
the O 0 9.560011636489119e-12
hect O 0 9.021984048729337e-09
domain O 0 1.1480907197158885e-10
of O 0 9.421837442180614e-12
the O 0 6.996095543165826e-12
UBE3A O 0 1.763270006449602e-06
protein O 0 3.0215854124326924e-11
, O 0 1.7419680428955547e-15
which O 0 5.0198421619735946e-17
functions O 0 5.468548723119686e-14
in O 0 2.0222694775261923e-14
E2 O 0 6.324629622106448e-12
binding O 0 1.943397699710747e-12
and O 0 6.739685849341259e-13
ubiquitin O 0 3.3451727499134165e-10
transfer O 0 2.4040643253897542e-08
. O 0 1.4040634432888055e-08

Eight O 0 8.276796137351994e-09
of O 0 5.2414652479404467e-11
the O 0 1.8808771814343705e-12
cases O 0 9.105182699389175e-14
were O 0 1.7824098317090198e-12
familial O 0 5.354652277134164e-10
, O 0 7.723827816479706e-14
and O 0 9.983124895328321e-14
five O 0 2.1886298329221177e-11
were O 0 6.724592410689567e-11
sporadic O 0 1.3003091225982644e-07
. O 0 3.112236157676307e-08

In O 0 4.664995473246947e-11
two O 0 5.298333386610787e-12
familial O 0 1.0297848795914888e-08
cases O 0 1.7387972572197041e-12
and O 0 1.5226338798742661e-13
one O 0 1.7626717685285953e-13
sporadic O 0 6.707507882453001e-10
case O 0 7.000683127818264e-13
, O 0 1.1838285614382965e-13
mosaicism O 0 8.190801281671156e-08
for O 0 2.545455513036643e-10
UBE3A O 0 0.0001429682451998815
mutations O 0 7.127396450812284e-10
was O 0 6.0915322265542304e-12
detected O 0 1.0006674308615793e-12
in O 0 1.81222402603526e-15
the O 0 3.562174020381795e-14
mother O 0 3.7795398863567364e-13
of O 0 9.070536205815771e-13
three O 0 4.897083606680841e-12
AS B-Disease 1 1.0
sons O 0 9.411644796841756e-10
, O 0 6.890931086785427e-15
in O 0 4.6584770749583636e-15
the O 0 1.360316481853474e-13
maternal O 0 1.3915074648096493e-10
grandfather O 0 1.8354733011261004e-10
of O 0 4.868060954343889e-10
two O 0 6.439922206613602e-11
AS B-Disease 1 1.0
first O 0 1.0540703865302703e-09
cousins O 0 2.196029136314337e-09
, O 0 1.652052552105019e-14
and O 0 1.1245833035755507e-15
in O 0 1.9093435532180174e-14
the O 0 8.32713347061198e-13
mother O 0 1.9278181481729995e-12
of O 0 5.048086254566542e-11
an O 0 2.447766815627528e-11
AS B-Disease 1 1.0
daughter O 0 1.565317802487698e-06
. O 0 4.259833303876803e-07

The O 0 1.290971662903928e-09
frequencies O 0 4.345619419865443e-10
with O 0 1.3676078769887107e-14
which O 0 2.7515727648702018e-15
we O 0 1.5822471100251229e-13
detected O 0 1.313169711858464e-11
mutations O 0 1.418277387893463e-12
were O 0 2.5739551549192052e-12
5 O 0 4.019939491960861e-13
( O 0 2.152462390810295e-16
14 O 0 1.7477306494401157e-13
% O 0 2.1547590101089753e-12
) O 0 6.0192077643933745e-16
of O 0 4.20814614708262e-13
35 O 0 1.2854884691437807e-11
in O 0 3.248586024750394e-13
sporadic O 0 2.2021697798635387e-09
cases O 0 2.248943652832791e-12
and O 0 1.5491390993344761e-13
8 O 0 4.314987223866945e-13
( O 0 1.1356923789068073e-16
80 O 0 4.0932096037268884e-13
% O 0 1.2341541634139364e-12
) O 0 6.585711869846523e-16
of O 0 1.4170111752812714e-13
10 O 0 1.2185567767504513e-13
in O 0 2.5608302370999647e-13
familial O 0 6.37289165883459e-10
cases O 0 3.120466125078325e-13
. O 0 5.10790975488673e-12
. O 0 3.2003985572792715e-10

The O 0 1.2143236460815388e-07
hemochromatosis B-Disease 1 1.0
845 O 0 3.8229639898190726e-08
G O 0 2.931714648823913e-09
- O 0 3.624979427740982e-09
- O 0 4.0576458859575837e-10
> O 0 3.2026929719375374e-11
A O 0 1.6119425239047303e-11
and O 0 1.0080809758769856e-16
187 O 0 5.732692305479266e-15
C O 0 1.038652774898452e-10
- O 0 2.2783307185303414e-10
- O 0 6.973254196296352e-10
> O 0 4.391742081111261e-09
G O 0 1.4523847013947488e-08
mutations O 0 7.526088779963302e-11
: O 0 7.419928996850629e-15
prevalence O 0 1.0654289082923096e-11
in O 0 2.686834417876382e-14
non O 0 2.001247167982001e-09
- O 0 4.5244235025165835e-09
Caucasian O 0 7.058513801894151e-06
populations O 0 4.0883474383690555e-10
. O 0 1.6575985029021467e-10

Hemochromatosis B-Disease 0 0.0012077982537448406
, O 0 3.3795882758980156e-12
the O 0 5.8149733916934565e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 2.0639298603519762e-10
leads O 0 1.5714809009637065e-08
, O 0 4.3387716379753027e-13
if O 0 3.1597408717276565e-11
untreated O 1 0.9792511463165283
, O 0 1.3129757426687955e-13
to O 0 6.000807850625733e-09
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 1.125063597839926e-08
premature B-Disease 0 1.3876467619411414e-06
death I-Disease 0 1.3174416224615015e-08
. O 0 1.841808483504792e-08

The O 0 1.5537392528131022e-07
hemochromatosis B-Disease 1 1.0
gene O 0 7.309943206301739e-10
, O 0 3.6377320426772553e-12
HFE O 0 0.0024727077689021826
, O 0 1.4508147287706219e-12
recently O 0 8.192343830225324e-13
has O 0 3.528548675848283e-16
been O 0 1.959683144789814e-15
identified O 0 6.261225533269604e-14
, O 0 2.7490427833358716e-16
and O 0 1.4836262762356637e-15
characterization O 0 9.88378545674351e-11
of O 0 1.0318419729760109e-11
this O 0 6.272141009691645e-13
gene O 0 5.093516076580193e-14
has O 0 5.697089075486445e-16
shown O 0 4.569544205914114e-14
that O 0 8.737002575862749e-17
it O 0 4.2497806041050074e-18
contains O 0 1.9694076438527488e-18
two O 0 5.774541900532276e-17
mutations O 0 1.7432111696247688e-15
that O 0 7.901147154789755e-17
result O 0 4.8634287244143926e-14
in O 0 7.858869262820922e-13
amino O 0 3.085019219251084e-12
acid O 0 2.9316639719133286e-13
substitutions O 0 4.1346795236728295e-13
- O 0 1.1963925672636017e-13
cDNA O 0 2.6850082487234195e-12
nucleotides O 0 2.918919988527391e-13
845 O 0 1.8505173088323446e-11
G O 0 1.3501592205367174e-11
- O 0 7.976278526555802e-10
- O 0 8.218492553169199e-10
> O 0 7.633708248855342e-11
A O 0 1.8262271694879928e-09
( O 0 5.960326269064992e-16
C282Y O 0 8.394598211003412e-11
) O 0 5.920211053380824e-18
and O 0 3.988298307283216e-17
187 O 0 1.0914943638317114e-14
C O 0 6.424639154012368e-10
- O 0 2.334488602429019e-09
- O 0 5.274595871185284e-09
> O 0 2.7371185318258995e-09
G O 0 3.080055765991574e-09
( O 0 2.1708751061968318e-13
H63D O 0 0.0006571615231223404
) O 0 4.837296470501518e-13
. O 0 3.67757629904375e-11

Although O 0 4.781728080160974e-07
hemochromatosis B-Disease 1 1.0
is O 0 1.543410364790443e-11
common O 0 1.7259240911449147e-12
in O 0 1.5510261261106328e-12
Caucasians O 0 1.1615237127671207e-07
, O 0 3.19172258067546e-11
affecting O 0 7.115555700210052e-09
> O 0 3.989188979147684e-09
= O 0 9.282637158936069e-11
1 O 0 6.657080268979154e-12
/ O 0 1.099756744005198e-11
300 O 0 6.205539554438033e-13
individuals O 0 3.4292019094120385e-13
of O 0 2.4659016148453894e-11
northern O 0 4.182768020832839e-11
European O 0 1.7665801547300797e-12
origin O 0 2.7186917647692432e-11
, O 0 3.64117170117452e-14
it O 0 4.632619594298413e-16
has O 0 1.4144707741828988e-16
not O 0 4.989035494272617e-15
been O 0 1.4329352591643807e-13
recognized O 0 2.4094302941701784e-12
in O 0 1.0138697607159353e-12
other O 0 2.0915374467078696e-12
populations O 0 1.3303810310338893e-11
. O 0 1.203191019039096e-10

The O 0 6.4067908964182685e-12
present O 0 9.919010599858391e-14
study O 0 4.114915836263443e-17
used O 0 1.9832882721987867e-17
PCR O 0 8.305715056694529e-14
and O 0 1.9222049014891267e-15
restriction O 0 4.682713093152879e-13
- O 0 4.2258655342380935e-13
enzyme O 0 2.8568168203247854e-14
digestion O 0 1.9152224944862795e-11
to O 0 2.110494938534213e-13
analyze O 0 2.444382803806766e-12
the O 0 3.2999875076468455e-14
frequency O 0 4.830252951087965e-13
of O 0 5.788732259379495e-14
the O 0 3.123060620877083e-14
845 O 0 2.6677238976896556e-12
G O 0 2.3454866521221973e-12
- O 0 3.058696004809569e-11
- O 0 1.2757086186032662e-11
> O 0 1.3658236867886142e-12
A O 0 4.230303173730077e-12
and O 0 1.8247722103439018e-16
187 O 0 5.922592010055997e-15
C O 0 3.675766635513611e-11
- O 0 1.1833827320839596e-11
- O 0 2.6948245718250163e-11
> O 0 4.1864473693253856e-11
G O 0 1.0662812993667004e-10
mutations O 0 7.583531784309538e-13
in O 0 1.5299262236864036e-13
HLA O 0 2.578557090071598e-10
- O 0 8.136753423815257e-12
typed O 0 3.071979823299209e-11
samples O 0 1.7599648951746594e-12
from O 0 3.3808763080789284e-13
non O 0 4.744938664202891e-09
- O 0 1.4729221176068563e-09
Caucasian O 0 1.0256291716359556e-05
populations O 0 1.3647879701372823e-11
, O 0 2.737176645838227e-16
comprising O 0 1.9160964386867076e-14
Australian O 0 4.2811917205787253e-11
Aboriginal O 0 9.884851159824848e-09
, O 0 1.2266004811384507e-15
Chinese O 0 1.7516470912637416e-11
, O 0 8.594344582790042e-14
and O 0 3.469910556802569e-12
Pacific O 0 9.676550671855466e-10
Islanders O 0 1.5491488980501344e-08
. O 0 2.540252674876342e-09

Results O 0 5.122266499846262e-10
showed O 0 2.5761962008097328e-11
that O 0 1.5697019760938825e-15
the O 0 1.295089405319418e-14
845 O 0 1.911433468101964e-12
G O 0 8.447437194192275e-12
- O 0 1.7596041290701692e-10
- O 0 2.9382404842515086e-10
> O 0 2.5178162332828435e-10
A O 0 3.9195205414621626e-10
mutation O 0 1.910641512625072e-13
was O 0 1.0302375340093435e-14
present O 0 6.600176439728548e-15
in O 0 1.1388513618138126e-15
these O 0 1.50553054825166e-15
populations O 0 1.2081544593576366e-16
( O 0 9.323357411286782e-19
allele O 0 4.4576074466817425e-14
frequency O 0 6.465318189673164e-13
0 O 0 3.735502965301505e-15
. O 0 2.069685196067362e-14
32 O 0 1.4976860029936034e-11
% O 0 8.803098007492682e-12
) O 0 9.31651009289413e-16
, O 0 3.096132215286095e-15
and O 0 1.381879958633472e-14
, O 0 1.0274662116125169e-15
furthermore O 0 1.8428159931187238e-13
, O 0 6.913255804780617e-16
it O 0 1.7338392529892124e-16
was O 0 7.04963106119838e-13
always O 0 6.87507939033799e-13
seen O 0 2.826020450638622e-12
in O 0 8.42583313775784e-14
conjunction O 0 3.4305461249495295e-11
with O 0 2.8465192009052842e-11
HLA O 0 3.961957645515213e-06
haplotypes O 0 2.747806604475045e-08
common O 0 9.681788010196257e-11
in O 0 6.043747100004104e-12
Caucasians O 0 1.0815828233035063e-09
, O 0 1.5903375621614813e-13
suggesting O 0 4.2713037967656575e-12
that O 0 6.177666071836146e-14
845 O 0 1.6792181534164285e-10
G O 0 3.584278207569014e-09
- O 0 3.0581063015233667e-07
- O 0 9.23298500765668e-07
> O 0 2.3514361657817062e-07
A O 0 4.110331133233558e-07
may O 0 2.6887290137389552e-12
have O 0 5.775296368660263e-15
been O 0 1.2280103251275081e-14
introduced O 0 5.7085349258235735e-15
into O 0 7.663877873791657e-15
these O 0 1.461042789675088e-15
populations O 0 4.480814878887089e-16
by O 0 1.8531909862874512e-15
Caucasian O 0 3.610421828170729e-08
admixture O 0 2.39728290551966e-08
. O 0 2.0804687750342055e-08

187 O 0 4.324821403778323e-11
C O 0 1.4131436021358468e-09
- O 0 8.45035777463643e-11
- O 0 1.0576761688696479e-11
> O 0 3.816442821491517e-12
G O 0 3.740214301467537e-12
was O 0 2.511384078940273e-14
present O 0 1.499307100726651e-14
at O 0 3.6311133543324645e-15
an O 0 2.606395238546918e-18
allele O 0 2.9791761505665315e-14
frequency O 0 1.0652399969057758e-11
of O 0 3.3648160646659875e-11
2 O 0 3.7700564892162447e-10
. O 0 6.9597447804881085e-09

68 O 0 2.3797872472641757e-07
% O 0 1.9366328540826316e-09
in O 0 1.391301082589308e-13
the O 0 2.4690007525453306e-13
two O 0 4.646827830834775e-14
populations O 0 2.6139167819306955e-15
analyzed O 0 5.2622626579585524e-14
( O 0 9.44083335372738e-16
Australian O 0 6.496302107361629e-11
Aboriginal O 0 1.7800521945332548e-08
and O 0 2.9659031442830566e-14
Chinese O 0 2.54174771507909e-11
) O 0 2.2059109638754293e-13
. O 0 3.0783450788440803e-10

In O 0 4.821283303146906e-11
the O 0 5.351339163461866e-12
Australian O 0 6.823756837359696e-11
Aboriginal O 0 4.283848276109836e-10
samples O 0 3.459881239473682e-14
, O 0 2.0417378468985187e-17
187 O 0 1.7815515230591716e-14
C O 0 5.298985694679459e-10
- O 0 6.684034437043351e-10
- O 0 9.204625950332002e-10
> O 0 9.052852356639107e-10
G O 0 3.241448220947518e-10
was O 0 7.382333459815538e-12
found O 0 2.507722524915882e-14
to O 0 2.3982907809217205e-14
be O 0 3.987862964112063e-14
associated O 0 3.8454166934043243e-11
with O 0 6.040865724310507e-12
HLA O 0 0.001336263376288116
haplotypes O 0 1.3803911258492008e-07
common O 0 1.9990323632534945e-11
in O 0 5.725387611926758e-13
Caucasians O 0 1.4312522000903272e-10
, O 0 2.0619807961373736e-15
suggesting O 0 2.0717280701295498e-13
that O 0 2.751728936569852e-16
it O 0 2.330982790075815e-16
was O 0 5.712306170614634e-14
introduced O 0 1.1386607158732093e-14
by O 0 3.455157717891671e-15
recent O 0 1.1760646709962908e-12
admixture O 0 8.898113912358951e-10
. O 0 1.5653386364888888e-09

In O 0 4.685970014794982e-11
the O 0 1.938126525588557e-12
Chinese O 0 6.945597742780141e-12
samples O 0 2.989599670252807e-13
analyzed O 0 4.557958150448391e-14
, O 0 2.9234720134661536e-17
187 O 0 3.442541162142318e-15
C O 0 1.335237059807426e-10
- O 0 1.4584904117764808e-10
- O 0 1.25988525168097e-10
> O 0 7.39899946866629e-11
G O 0 4.1936558392574597e-11
was O 0 1.1078618491339176e-12
present O 0 1.8089659815662823e-13
in O 0 2.03664455837734e-15
association O 0 1.7581035970242755e-15
with O 0 2.5306827187918373e-16
a O 0 4.962947303013658e-14
wide O 0 7.389289375693553e-13
variety O 0 2.0693861934369812e-13
of O 0 4.8127387491936346e-11
HLA O 0 2.983227886943496e-08
haplotypes O 0 3.116142677228595e-09
, O 0 1.6892994707078113e-13
showing O 0 4.857732271990045e-12
this O 0 5.3146943362067725e-14
mutation O 0 3.108650489802578e-13
to O 0 7.777361111897807e-13
be O 0 2.2867222438521795e-12
widespread O 0 1.6798900812076134e-11
and O 0 6.930782038777963e-14
likely O 0 5.230267607903016e-12
to O 0 8.009351862292569e-12
predate O 0 2.2088428863753506e-08
the O 0 1.266061040727795e-11
more O 0 6.343046883095296e-14
genetically O 0 4.96457563915146e-14
restricted O 0 3.49744538885588e-12
845 O 0 1.1691660140034088e-10
G O 0 2.0298720482259114e-09
- O 0 5.1943985113211966e-08
- O 0 2.955217048850045e-08
> O 0 5.6907127898853105e-09
A O 0 1.1959713219766854e-08
mutation O 0 2.2085540340999188e-10
. O 0 2.908730548090155e-11

Genotype O 0 4.094195446668891e-06
- O 0 8.237112325559792e-08
phenotype O 0 2.842566848570982e-09
correlations O 0 1.7111470018704722e-09
in O 0 4.437977485505229e-10
attenuated B-Disease 1 0.9999960660934448
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 5.448779575090157e-06

Germ O 0 6.047931947250618e-06
- O 0 1.7243061734006915e-07
line O 0 1.5229157934726345e-09
mutations O 0 4.214022186754818e-11
of O 0 3.4518271574413006e-10
the O 0 3.8272793267957184e-10
tumor B-Disease 0 1.8469870965986956e-08
suppressor O 0 4.16178647100196e-09
APC O 0 5.748981291020527e-09
are O 0 8.083290438908042e-13
implicated O 0 9.196347683371187e-09
in O 0 3.2729555954347234e-08
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.4410258803750935e-10
AAPC B-Disease 1 1.0
) O 0 1.4443854844266822e-14
, O 0 5.2749767574927154e-17
a O 0 1.1442467499295857e-15
variant O 0 2.7047244444133867e-09
of O 0 2.4299974938912783e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 6.169915273135373e-11
FAP B-Disease 0 1.0653472770627559e-08
) O 0 9.5229726881918e-13
. O 0 1.295517026989046e-10

AAPC B-Disease 1 1.0
is O 0 1.124224736741286e-12
recognized O 0 4.173129127416769e-13
by O 0 1.6604610269965888e-15
the O 0 5.129317652043108e-13
occurrence O 0 4.820586707587893e-10
of O 0 6.893600967838864e-11
< O 0 1.024278439842874e-08
100 O 0 6.160440491065344e-10
colonic B-Disease 0 1.5816107179489336e-07
adenomas I-Disease 0 5.5814563637568426e-08
and O 0 1.791949191299897e-14
a O 0 1.667593573808062e-14
later O 0 5.316359874031618e-13
onset O 0 3.777690551487467e-07
of O 0 1.360970509267645e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.2032213795503417e-13
age O 0 1.2068563162714874e-11
> O 0 1.5091790664389926e-11
40 O 0 1.2215407721796745e-12
years O 0 1.315178841483286e-13
) O 0 1.6631656243729954e-14
. O 0 2.6429287577900418e-11

The O 0 3.6724592117343136e-11
aim O 0 1.6205017328019267e-09
of O 0 5.187685350738214e-12
this O 0 4.525982656689541e-14
study O 0 1.8712318139760785e-14
was O 0 5.6533635195074594e-14
to O 0 9.259198225849974e-13
assess O 0 2.142778399161216e-09
genotype O 0 1.3084361398796318e-06
- O 0 2.9268673529259104e-07
phenotype O 0 3.3240848296145487e-08
correlations O 0 1.0525298854702214e-08
in O 0 4.03024086326198e-10
AAPC B-Disease 1 1.0
families O 0 1.0695225816093057e-09
. O 0 1.040711627986468e-09

By O 0 1.3391329061265833e-12
protein O 0 1.0678540517117252e-11
- O 0 5.028095995118775e-12
truncation O 0 1.653342907026456e-09
test O 0 4.674902687185067e-10
( O 0 2.0081169122302886e-14
PTT O 0 2.208542682069492e-09
) O 0 2.1961135720025552e-16
assay O 0 2.7989234736326696e-13
, O 0 4.465727766258612e-17
the O 0 2.433009761457168e-16
entire O 0 5.51047749097755e-12
coding O 0 1.085753931207023e-09
region O 0 8.651659250125121e-11
of O 0 2.5731697588654567e-12
the O 0 2.109872389646772e-12
APC B-Disease 0 4.1371073233875677e-10
gene O 0 3.4789608260171745e-13
was O 0 2.504121259308545e-12
screened O 0 1.1154807112723208e-11
in O 0 9.565893406169798e-14
affected O 0 2.1471320815064088e-12
individuals O 0 2.6880610909905955e-13
from O 0 3.851031646351366e-11
11 O 0 1.1509948549814908e-08
AAPC B-Disease 1 1.0
kindreds O 0 6.569699507963378e-06
, O 0 3.5994457739906005e-13
and O 0 3.3324098959886667e-14
their O 0 6.461808518820611e-12
phenotypic O 0 3.4721980846086353e-10
differences O 0 5.602664998605178e-10
were O 0 8.95702609304827e-11
examined O 0 9.458005933993263e-09
. O 0 4.573811107633219e-09

Five O 0 1.2355032552591183e-09
novel O 0 4.966692855601362e-12
germ O 0 8.886826208254206e-08
- O 0 1.091597656710519e-08
line O 0 8.847984567239564e-10
APC B-Disease 0 1.046029662887804e-08
mutations O 0 1.150052206244645e-10
were O 0 8.990328446978335e-12
identified O 0 6.876604320693591e-12
in O 0 1.0390796296305682e-12
seven O 0 2.1885016021627735e-10
kindreds O 0 5.936263391959073e-07
. O 0 8.74137118245244e-09

Mutations O 0 6.782477868227943e-08
were O 0 3.3786767827947983e-10
located O 0 3.0111072055888366e-12
in O 0 2.996527281677857e-15
three O 0 4.886327243703876e-15
different O 0 2.4136364768271266e-14
regions O 0 7.438375436430444e-12
of O 0 8.926220006200136e-12
the O 0 1.5365779829079607e-11
APC B-Disease 0 4.7493844412827e-09
gene O 0 3.671035697649927e-12
( O 0 2.05915996466478e-14
1 O 0 5.207194484629918e-12
) O 0 1.3419781507827827e-13
at O 0 1.0036139280744649e-10
the O 0 4.2384767570680104e-12
5 O 0 6.764967817700362e-13
end O 0 2.06670319746749e-10
spanning O 0 1.5200312120100534e-09
exons O 0 5.418140242019476e-11
4 O 0 2.400108920202343e-13
and O 0 1.398076533015713e-13
5 O 0 1.3917264693116826e-12
, O 0 2.0183090225153744e-13
( O 0 6.444501948418575e-16
2 O 0 3.153215671425694e-14
) O 0 3.047526500157328e-15
within O 0 7.776267477166421e-12
exon O 0 4.921297310639394e-12
9 O 0 2.341066359864974e-12
, O 0 1.3566526916621025e-13
and O 0 7.157001228642879e-13
( O 0 1.8999336524487325e-15
3 O 0 1.752661194344765e-13
) O 0 1.5790537280513384e-14
at O 0 3.3905385009996847e-12
the O 0 2.2145826839015115e-13
3 O 0 1.3585740334370183e-13
distal O 0 1.3906193974122516e-09
end O 0 8.643977200684105e-10
of O 0 6.630817561692481e-10
the O 0 7.545655211771418e-10
gene O 0 6.848779876555966e-11
. O 0 7.691357772898755e-09

Variability O 0 3.677700632920278e-08
in O 0 5.110841220720697e-13
the O 0 4.553277243093956e-13
number O 0 5.57286074925889e-12
of O 0 1.1676828393092364e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 7.208170060835073e-09
most O 0 1.3068943171580527e-13
apparent O 0 1.6078799749963402e-11
in O 0 1.0152412900166566e-13
individuals O 0 3.283727456615537e-13
with O 0 6.945872371190431e-13
mutations O 0 1.7933170226580586e-10
in O 0 3.5766553607707863e-10
region O 0 1.3575107971064426e-07
1 O 0 2.448258262788272e-10
, O 0 2.573724653537335e-12
and O 0 1.1517754805456804e-10
upper O 1 0.9999998807907104
- O 0 0.3464783728122711
gastrointestinal O 0 4.871604346590175e-07
manifestations O 0 8.075448931776918e-07
were O 0 7.627173892466033e-11
more O 0 1.5557830224848315e-14
severe O 0 1.0664104148350173e-12
in O 0 5.618987805426634e-13
them O 0 6.032299659786133e-12
. O 0 2.4491189076769615e-09

In O 0 1.5129028238525244e-11
individuals O 0 8.93345456203648e-13
with O 0 3.068667824186744e-13
mutations O 0 1.5388452664910623e-11
in O 0 6.084622822949415e-12
either O 0 7.061326190438422e-09
region O 0 1.4573415683116764e-06
2 O 0 3.6415817583623777e-10
or O 0 2.894922634943953e-10
region O 0 6.094400539780054e-09
3 O 0 1.5079123930408778e-12
, O 0 2.2652132228203605e-15
the O 0 1.5825270713548494e-14
average O 0 1.832001781179593e-12
number O 0 3.0291025764073165e-12
of O 0 2.4883309301948486e-10
adenomas B-Disease 0 1.7037105237704964e-07
tended O 0 2.4938628939707996e-09
to O 0 1.2090273227016723e-10
be O 0 2.8918581071457616e-11
lower O 0 2.4188906433408874e-10
than O 0 6.57358350153632e-14
those O 0 9.341288728864985e-14
in O 0 6.449180789012618e-14
individuals O 0 6.858782205382274e-14
with O 0 1.7154341640755744e-13
mutations O 0 4.839199787415316e-12
in O 0 1.684544864710702e-12
region O 0 1.750532357958079e-10
1 O 0 2.293876622937868e-13
, O 0 4.1490905716605e-16
although O 0 2.246196697879791e-15
age O 0 1.181787415323321e-12
at O 0 4.0613408361193926e-13
diagnosis O 0 1.199266241869168e-10
was O 0 1.2559635406347858e-12
similar O 0 2.445427541020173e-12
. O 0 8.899522230265688e-10

In O 0 8.808116902514485e-09
all O 0 2.3183778452562365e-08
AAPC B-Disease 1 1.0
kindreds O 0 6.439879143727012e-06
, O 0 5.224190221045366e-14
a O 0 9.451328473108686e-14
predominance O 0 3.6580820594878105e-09
of O 0 3.528009218101147e-09
right O 1 0.9875726699829102
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 0 0.0348701998591423
rectal B-Disease 1 1.0
polyp I-Disease 0 4.024774625577265e-06
sparing O 0 8.697660369705318e-10
was O 0 1.3580132678103762e-11
observed O 0 1.1906115850168764e-11
. O 0 1.5064649527829488e-10

No O 0 1.963375780178467e-06
desmoid B-Disease 1 0.9998058676719666
tumors I-Disease 1 1.0
were O 0 2.5090063360266868e-09
found O 0 5.257231715932731e-12
in O 0 3.8560257417663557e-13
these O 0 1.1917613597367538e-11
kindreds O 0 2.3506783008997445e-07
. O 0 1.0251990367748931e-08

Our O 0 1.669413336458092e-07
data O 0 6.022441989550487e-10
suggest O 0 2.6370058480579273e-12
that O 0 2.4732303268641502e-15
, O 0 4.476204478555184e-15
in O 0 8.230198206976569e-13
AAPC B-Disease 1 1.0
families O 0 3.726188801955743e-11
, O 0 3.33798722678151e-15
the O 0 1.338431911823831e-14
location O 0 3.82472872817452e-12
of O 0 2.373781726738855e-12
the O 0 3.629749625866374e-11
APC B-Disease 0 4.584468911161821e-07
mutation O 0 1.9619743607535156e-09
may O 0 1.4401684012010918e-10
partially O 0 1.3388310460271668e-09
predict O 0 2.68793182156557e-10
specific O 0 7.939663509981543e-11
phenotypic O 0 6.354081705239878e-09
expression O 0 7.527532375206647e-09
. O 0 1.5463237801327523e-08

This O 0 1.213200893912525e-11
should O 0 1.7654173750051433e-13
help O 0 5.565061215670464e-13
in O 0 1.8675119840849165e-15
the O 0 3.1914420565770435e-15
design O 0 9.379105565116008e-13
of O 0 4.562997115570289e-13
tailored O 0 2.8121760128896334e-11
clinical O 0 4.5342524179758925e-10
- O 0 3.3921529474234546e-10
management O 0 1.4719656049599905e-11
protocols O 0 2.76676820343269e-10
in O 0 4.824964619466396e-14
this O 0 6.944845157394637e-15
subset O 0 1.3802929068815195e-12
of O 0 8.368850317602705e-13
FAP B-Disease 0 8.207103885382594e-10
patients O 0 5.648099175858956e-12
. O 0 4.176953921630755e-12
. O 0 4.587210611362025e-10

Wilms B-Disease 0 0.009180193766951561
' I-Disease 0 5.128607085680414e-07
tumor I-Disease 0 5.913760592335393e-09
1 O 0 8.837721353349703e-12
and O 0 2.6172683811886976e-12
Dax O 0 3.4606523513502907e-06
- O 0 8.615567703706972e-10
1 O 0 5.2058734927029615e-12
modulate O 0 9.728028105282505e-11
the O 0 5.612296218038271e-12
orphan O 0 5.143584343170193e-12
nuclear O 0 5.414503914669133e-11
receptor O 0 6.668819684842175e-13
SF O 0 1.2351061684512388e-07
- O 0 4.014980292676995e-10
1 O 0 3.7737679328036025e-14
in O 0 1.3750223587166775e-15
sex O 0 3.468451180020822e-14
- O 0 3.09273264855229e-15
specific O 0 2.0532370867811043e-15
gene O 0 3.876877422879458e-15
expression O 0 7.782050286293807e-13
. O 0 2.972295673475678e-11

Products O 0 2.153156763995412e-08
of O 0 1.4210287169191815e-08
steroidogenic O 0 6.306109980869223e-07
factor O 0 5.4776704005998766e-11
1 O 0 3.7849936943348816e-13
( O 0 1.6970712732845773e-15
SF O 0 1.4837221229413444e-08
- O 0 2.697453926892024e-10
1 O 0 6.383438157404886e-14
) O 0 3.0895016413749884e-15
and O 0 3.8478872865788105e-12
Wilms B-Disease 0 0.0006906756898388267
tumor I-Disease 0 3.46352351243695e-08
1 O 0 6.43025953664389e-12
( O 0 5.8107866256337445e-15
WT1 O 0 9.656047073036689e-10
) O 0 6.075009236167304e-16
genes O 0 5.056864198622847e-15
are O 0 8.270260290401538e-17
essential O 0 6.438036952507997e-13
for O 0 2.554209217720503e-14
mammalian O 0 2.1587306942016937e-10
gonadogenesis O 0 2.740331073169955e-09
prior O 0 5.935929525691108e-10
to O 0 1.5064133274123037e-10
sexual O 0 2.7697932836190375e-10
differentiation O 0 3.1917744003351345e-09
. O 0 2.3696644646520326e-09

In O 0 1.0220580458353279e-11
males O 0 2.7479804889929405e-11
, O 0 1.2188257774738403e-14
SF O 0 1.6747665654293087e-07
- O 0 1.1600326255134519e-09
1 O 0 1.0143281613944621e-12
participates O 0 4.648543269064609e-12
in O 0 1.8648362070045402e-14
sexual O 0 1.2986637996535363e-14
development O 0 4.84998529510193e-15
by O 0 9.378290475766428e-19
regulating O 0 5.183087777873262e-15
expression O 0 2.7315677524801865e-14
of O 0 3.4912651654221694e-13
the O 0 1.194482446981171e-12
polypeptide O 0 4.177720669407137e-11
hormone O 0 3.01230221322335e-12
Mullerian O 0 3.060187214742882e-09
inhibiting O 0 2.7113708500614564e-10
substance O 0 1.2484229205966813e-09
( O 0 8.397407660724887e-13
MIS O 0 1.6216566223192785e-07
) O 0 7.160742810340126e-13
. O 0 2.886734462581586e-10

Here O 0 7.741502550118184e-09
, O 0 5.105491767201653e-13
we O 0 6.304040677061057e-14
show O 0 6.314693776557356e-13
that O 0 6.11595057367284e-14
WT1 O 0 1.8574512523628073e-06
- O 0 4.921757934539528e-08
KTS O 0 5.254433290247107e-06
isoforms O 0 1.19894894012873e-09
associate O 0 7.410693586562545e-11
and O 0 1.696489594583874e-14
synergize O 0 8.371289217379285e-10
with O 0 2.7392489860590674e-13
SF O 0 1.2389490393616143e-06
- O 0 1.4301505535385672e-09
1 O 0 1.159829502404841e-12
to O 0 1.0365069913476077e-11
promote O 0 2.7055154561139716e-08
MIS O 0 2.0697267245850526e-05
expression O 0 5.89290505281781e-10
. O 0 1.8172476023980977e-10

In O 0 1.9288866337507926e-10
contrast O 0 7.776849997309654e-11
, O 0 2.6535043693570737e-12
WT1 O 0 1.8578958815851365e-06
missense O 0 8.308005305934785e-08
mutations O 0 1.4442113303869686e-11
, O 0 2.8374555529746834e-15
associated O 0 5.466882914244298e-13
with O 0 1.4427945871451492e-13
male B-Disease 0 1.8399376244815357e-07
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.6296750970923313e-07
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.4255573284327472e-11
fail O 0 5.9004459984635105e-08
to O 0 2.9804608780992226e-10
synergize O 0 1.2970162970304955e-06
with O 0 1.7415538455800572e-10
SF O 1 0.9999963045120239
- O 0 1.7552907593199052e-05
1 O 0 5.993647356206111e-09
. O 0 2.491542527849333e-09

Additionally O 0 8.176686883132334e-09
, O 0 8.916580310474459e-14
the O 0 2.5197484615317733e-13
X O 0 3.3091431816956174e-08
- O 0 5.4053876930026945e-09
linked O 0 2.38922037709699e-09
, O 0 2.634298723982239e-14
candidate O 0 1.233143014783833e-11
dosage O 0 3.652130686759847e-08
- O 0 2.9079108565532863e-10
sensitive O 0 2.8050417544278616e-10
sex O 0 7.479732978821207e-12
- O 0 1.609579114957016e-12
reversal O 0 1.6364737256274742e-12
gene O 0 7.377160270464686e-14
, O 0 6.036759769368141e-14
Dax O 0 1.1868479532495257e-07
- O 0 1.4923146052225889e-10
1 O 0 2.3862108036037943e-12
, O 0 1.9091625253365302e-13
antagonizes O 0 1.5462779667796411e-10
synergy O 0 7.07736438898543e-11
between O 0 2.4458404745963946e-10
SF O 0 5.529291797756741e-07
- O 0 5.012684156646685e-10
1 O 0 1.5635241582337422e-13
and O 0 5.987736212886494e-14
WT1 O 0 7.236150878497938e-08
, O 0 5.9459087095115395e-15
most O 0 1.5915582319296813e-16
likely O 0 1.2874691581127393e-14
through O 0 2.944855053170145e-14
a O 0 4.644018730768501e-14
direct O 0 4.5178283857028045e-12
interaction O 0 1.7072047941990576e-10
with O 0 1.7428223794691e-11
SF O 0 0.000332358613377437
- O 0 9.891028867059504e-07
1 O 0 9.129633715687646e-10
. O 0 1.099680346783316e-09

We O 0 2.5907437306571524e-10
propose O 0 5.3962143781172145e-11
that O 0 4.2622925588292615e-13
WT1 O 0 1.5602682879034546e-06
and O 0 7.764459214465447e-11
Dax O 0 4.3043717596447095e-05
- O 0 1.4652277169346917e-09
1 O 0 3.0465838185556038e-12
functionally O 0 3.975279827539424e-10
oppose O 0 2.248917848821086e-12
each O 0 5.2426768845257807e-14
other O 0 7.832942261931826e-15
in O 0 1.980865287336958e-13
testis O 0 2.4947843790812385e-10
development O 0 4.038940189243778e-12
by O 0 1.5136048474697142e-14
modulating O 0 7.18280018796591e-11
SF O 0 3.592130610741151e-07
- O 0 1.0166196773297997e-08
1 O 0 9.24410270553011e-11
- O 0 3.655876157360183e-10
mediated O 0 6.04737726561666e-09
transactivation O 0 8.13662779819424e-07
. O 0 9.029872335974964e-12
. O 0 2.125573848876794e-11

A O 0 9.152211766227936e-10
mouse O 0 5.740105114317162e-13
model O 0 6.823242600269286e-13
for O 0 4.133966086117269e-11
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999992847442627
centre O 0 4.4875044125092245e-08
mutations O 0 1.50146717975419e-11
. O 0 4.09877427137717e-12

Imprinting O 0 1.302726104768226e-06
in O 0 8.35077319794042e-12
the O 0 3.452404681580923e-11
15q11 O 0 1.5405868225570885e-07
- O 0 2.5887196830609582e-09
q13 O 0 1.7791119688581603e-08
region O 0 1.5603381434137198e-11
involves O 0 1.1252506738890222e-11
an O 0 2.3275302583718183e-13
imprinting O 0 7.284657385753235e-06
centre O 0 1.7093896076403325e-08
( O 0 1.8204286412722495e-14
IC O 0 5.673277314599545e-07
) O 0 7.510332145684723e-14
, O 0 2.857256642182647e-15
mapping O 0 5.1947248586037276e-12
in O 0 8.345250658320803e-15
part O 0 1.535055448639161e-14
to O 0 5.376627420193569e-13
the O 0 1.5739946238740865e-12
promoter O 0 3.793694247633539e-10
and O 0 8.434391965232713e-13
first O 0 3.581973329058741e-10
exon O 0 6.5356315914755214e-09
of O 0 1.2147493677616694e-08
SNRPN O 1 0.9973466396331787
. O 0 2.855404375168291e-07

Deletion O 0 1.3437154500195447e-08
of O 0 2.4457191827309543e-10
this O 0 8.754273347899577e-12
IC O 0 3.394601435502409e-06
abolishes O 0 2.258834674861987e-09
local O 0 4.359445963941777e-12
paternally O 0 9.248776050574392e-11
derived O 0 6.211564330385264e-14
gene O 0 8.80811880036973e-16
expression O 0 5.842794730161064e-15
and O 0 5.2581006186354086e-17
results O 0 2.0693102992849072e-14
in O 0 1.2773575253088865e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.0083411439154588e-07
PWS B-Disease 1 1.0
) O 0 8.583218857882713e-11
. O 0 2.54242793484849e-10

We O 0 1.0394137633928935e-10
have O 0 4.142365839449394e-14
created O 0 1.0463816431708316e-14
two O 0 1.50394714721171e-14
deletion O 0 5.2179120399453716e-12
mutations O 0 1.2379239343676685e-12
in O 0 3.6111635600202807e-13
mice O 0 7.294698699256141e-12
to O 0 1.2971383515913981e-11
understand O 0 3.347881971649258e-08
PWS B-Disease 1 1.0
and O 0 2.0238467152156048e-11
the O 0 8.972752228719738e-12
mechanism O 0 1.5772447237161202e-10
of O 0 1.974898109630141e-12
this O 0 9.10056860599362e-13
IC O 0 1.372097813145956e-06
. O 0 1.2484068001583637e-08

Mice O 0 4.3346886968720355e-07
harbouring O 0 7.098354217305314e-06
an O 0 1.3275850904714837e-11
intragenic O 0 6.558125278388616e-06
deletion O 0 2.899261346556159e-07
in O 0 1.650929060126316e-09
Snrpn O 1 0.9591428637504578
are O 0 5.399241123638099e-11
phenotypically O 0 8.733674121685908e-07
normal O 0 3.3015840728012336e-08
, O 0 2.5871040810403027e-14
suggesting O 0 1.250556407560166e-12
that O 0 6.113300207580882e-15
mutations O 0 5.318411076121743e-12
of O 0 3.675824922222404e-10
SNRPN O 1 0.9996857643127441
are O 0 3.258038153500231e-12
not O 0 1.3226760181908603e-12
sufficient O 0 3.101520151815862e-09
to O 0 3.6972938044499415e-09
induce O 0 2.7454982046037912e-05
PWS B-Disease 1 1.0
. O 0 8.097736667878053e-07

Mice O 0 1.6322989626615936e-09
with O 0 4.8203286387394836e-14
a O 0 1.374882060414459e-13
larger O 0 4.204504040934698e-13
deletion O 0 9.636995194906017e-12
involving O 0 1.7818125447321975e-11
both O 0 5.713862022416194e-11
Snrpn O 0 5.762362343375571e-05
and O 0 6.734106409436377e-14
the O 0 2.8412723562798448e-12
putative O 0 6.08434191917695e-09
PWS O 1 1.0
- O 0 7.203318830306671e-09
IC O 0 5.742019197896298e-07
lack O 0 9.394625077874252e-10
expression O 0 8.540441032330037e-13
of O 0 1.1506829560373188e-12
the O 0 4.839881208480723e-13
imprinted O 0 1.8532769763268675e-10
genes O 0 2.4231469261670746e-11
Zfp127 O 0 4.008969511914984e-08
( O 0 3.1902449025610416e-14
mouse O 0 1.3361613031281916e-11
homologue O 0 2.1174060282902474e-09
of O 0 5.005616809938829e-09
ZNF127 O 1 0.9999991655349731
) O 0 2.7395391510864897e-11
, O 0 2.0742411260821214e-11
Ndn O 0 2.292465808295674e-07
and O 0 9.64004657350026e-12
Ipw O 0 1.8936308521233514e-08
, O 0 7.108551215110476e-14
and O 0 4.575570675927239e-14
manifest O 0 4.925622132390117e-10
several O 0 1.6016617828025492e-13
phenotypes O 0 5.704660702154918e-11
common O 0 6.227181530843451e-12
to O 0 1.9885776580963466e-08
PWS B-Disease 1 1.0
infants O 0 3.956532236770727e-05
. O 0 1.4009977178375266e-08

These O 0 2.5057983032289455e-12
data O 0 5.392566818432365e-13
demonstrate O 0 6.508610924521596e-13
that O 0 1.4560677681291694e-16
both O 0 2.297815097443705e-15
the O 0 1.2321959384363652e-14
position O 0 5.064536030136013e-12
of O 0 5.841362549913187e-13
the O 0 2.1364728291627805e-13
IC O 0 8.514584948215997e-08
and O 0 5.701138888238033e-14
its O 0 2.7444983880463812e-14
role O 0 2.802796514843331e-13
in O 0 2.1001819397068952e-14
the O 0 8.907536709103214e-14
coordinate O 0 5.043175078933704e-12
expression O 0 2.4429298861594617e-11
of O 0 1.9612363122423204e-10
genes O 0 2.729195775624804e-12
is O 0 9.633800376364354e-15
conserved O 0 3.3664063290445023e-12
between O 0 1.1766239024768588e-11
mouse O 0 1.5255888566323428e-11
and O 0 2.820460302756147e-14
human O 0 5.114253747058595e-13
, O 0 1.396856962272762e-15
and O 0 1.95577644354862e-16
indicate O 0 8.759341179904317e-14
that O 0 1.9651536607575417e-17
the O 0 1.4500412928220886e-14
mouse O 0 1.358770951656596e-13
is O 0 3.4927917093755347e-16
a O 0 2.2109508099115924e-15
suitable O 0 2.5603151543318603e-11
model O 0 2.858078357315108e-12
system O 0 8.49899144117483e-12
in O 0 8.142893640188803e-14
which O 0 3.3558744450451527e-15
to O 0 1.5112234380554312e-12
investigate O 0 2.5454640131816753e-11
the O 0 1.7002683982969558e-12
molecular O 0 5.892280587060927e-12
mechanisms O 0 7.283569858351768e-10
of O 0 1.2215278788474393e-10
imprinting O 0 7.937779322730876e-09
in O 0 5.75747403312038e-13
this O 0 1.9921449201636826e-13
region O 0 4.4373744262360404e-11
of O 0 2.044821777180683e-12
the O 0 1.7921825319362067e-13
genome O 0 1.1860327173499052e-12
. O 0 2.1508088279137416e-12
. O 0 2.8076646563235386e-10

Mutations O 0 4.0479522511738253e-10
of O 0 1.4564723038734684e-10
the O 0 5.3786117920617826e-11
ATM O 0 4.194662324152887e-07
gene O 0 3.0513000980059157e-12
detected O 0 3.0746585832908124e-11
in O 0 4.960120313611538e-13
Japanese O 1 0.9989997744560242
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
: O 0 1.00534772496416e-14
possible O 0 5.1838223248451207e-14
preponderance O 0 2.54219236807407e-12
of O 0 1.2441504532341441e-14
the O 0 8.183527504734486e-15
two O 0 3.369839943114655e-14
founder O 0 1.8776450880220175e-11
mutations O 0 3.9324581785349366e-11
4612del165 O 0 6.431165378018022e-09
and O 0 1.6847676032050174e-11
7883del5 O 0 5.062035484115768e-07
. O 0 2.9024929126819643e-09

The O 0 7.98670227175613e-11
ATM O 0 3.36392282918041e-08
( O 0 1.513482048021153e-12
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 1.3485749789012708e-13
mutated O 0 7.372922903442752e-15
) O 0 3.680729725351094e-17
gene O 0 3.7204410783729886e-16
on O 0 5.710999706996789e-14
human O 0 2.182462381389999e-13
chromosome O 0 7.124117268331176e-11
11q22 O 0 4.364563110925701e-08
. O 0 4.769253325598299e-10

3 O 0 1.4195643271985858e-10
has O 0 2.2586740014126153e-14
recently O 0 1.9689384196945776e-14
been O 0 2.405399716689789e-15
identified O 0 1.7035096342441283e-14
as O 0 9.887979399604964e-17
the O 0 8.61649453671239e-16
gene O 0 8.905286184914007e-16
responsible O 0 1.745134866151278e-14
for O 0 6.966815921496993e-15
the O 0 2.799377483292398e-13
human O 0 6.925048312567128e-10
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.04965861886739731
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.276877900970643e-12
. O 0 5.368352637424856e-11

In O 0 3.790618513521693e-11
order O 0 4.262059021681308e-12
to O 0 1.8011755281710506e-12
define O 0 2.7705423025214948e-11
the O 0 6.832043069303351e-14
types O 0 2.6299589676176405e-12
of O 0 2.1731599159080517e-11
disease O 0 6.038041622247192e-09
- O 0 6.9195421614765e-10
causing O 0 2.037186114245415e-10
ATM O 0 1.2965739188075531e-05
mutations O 0 2.683579920781387e-12
in O 0 4.125515643623075e-14
Japanese O 0 1.7786564443511566e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.664408136458633e-09
as O 0 8.459665666550251e-14
well O 0 1.6014777394837698e-14
as O 0 8.18976886700633e-16
to O 0 1.4537168398307682e-13
look O 0 1.1577453405686722e-12
for O 0 9.305934251272949e-14
possible O 0 9.992913441170259e-11
mutational O 0 2.6049473689226943e-08
hotspots O 0 3.2038188768623854e-10
, O 0 4.807526921587861e-15
reverse O 0 1.9519867493211773e-12
- O 0 1.6683652072704835e-12
transcribed O 0 5.267932357694294e-12
RNA O 0 1.7454770268043873e-11
derived O 0 7.54950138862065e-13
from O 0 7.251064169672833e-14
ten O 0 1.2544964199390218e-11
patients O 0 4.0141316919733994e-13
belonging O 0 2.1916418332934562e-11
to O 0 1.3830627181715682e-12
eight O 0 4.332068124363042e-12
unrelated O 0 6.0351996837570976e-12
Japanese O 0 1.5050469759358975e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 2.000643123389878e-10
was O 0 2.8106891813983736e-12
analyzed O 0 2.395969436307793e-13
for O 0 8.411404566776074e-16
mutations O 0 1.5541509805778856e-15
by O 0 1.1412600323482282e-16
the O 0 8.969350463088402e-15
restriction O 0 9.060342977447195e-15
endonuclease O 0 7.210149361239204e-13
fingerprinting O 0 1.0730216194743125e-11
method O 0 8.782294891318543e-10
. O 0 1.483008271740971e-09

As O 0 1.0643184944481021e-10
has O 0 1.1087928941970124e-14
been O 0 2.26500591150652e-15
reported O 0 1.8025028406578594e-15
by O 0 3.8634848261317426e-16
others O 0 2.1260136663300844e-13
, O 0 3.6906262280197305e-14
mutations O 0 3.0214207329647136e-13
that O 0 1.1810335390596057e-14
lead O 0 8.780711401035202e-12
to O 0 1.6769906296953963e-10
exon O 0 7.623778941479031e-09
skipping O 0 9.57461026018791e-08
or O 0 1.292965179366945e-09
premature O 0 1.1910046282537223e-07
protein O 0 1.2279338656995265e-09
truncation O 0 1.3206162066126126e-06
were O 0 1.532110882607185e-09
also O 0 8.510731182298503e-13
predominant O 0 5.834034366714036e-10
in O 0 7.423645032034187e-13
our O 0 2.056657066873413e-09
mutants O 0 1.501601332165592e-08
. O 0 2.228901951895068e-09

Six O 0 3.09814229826344e-10
different O 0 1.3030841596733955e-12
mutations O 0 1.0066074493039756e-12
were O 0 6.685780130476909e-14
identified O 0 1.7486976222527012e-13
on O 0 2.103390026172644e-13
12 O 0 1.2733595644923157e-12
of O 0 5.8879325026683915e-12
the O 0 8.670024767565288e-12
16 O 0 4.1968345465548396e-10
alleles O 0 9.506775228151909e-11
examined O 0 1.150141137884475e-08
. O 0 3.238436008246026e-08

Four O 0 5.875351871686973e-10
were O 0 1.6473225561419724e-11
deletions O 0 1.0741339762088131e-10
involving O 0 1.9114525934282867e-11
a O 0 6.189029757436293e-12
loss O 0 9.41924671593597e-09
of O 0 3.2321176490768266e-07
a O 0 2.9512499111206125e-09
single O 0 8.017438091201257e-08
exon O 0 4.0646678911571144e-08
exon O 0 7.695114767614086e-09
7 O 0 3.5785265861676407e-09
, O 0 6.913009747977483e-11
exon O 0 2.189930681240071e-09
16 O 0 5.116544410377344e-10
, O 0 4.701404196505443e-11
exon O 0 6.927377338428187e-09
33 O 0 1.6391323853781614e-08
or O 0 5.721436657779577e-09
exon O 0 1.968257947737584e-07
35 O 0 1.8001597368311195e-07
. O 0 3.952104421500735e-08

The O 0 5.844748574013181e-10
others O 0 8.097058613876218e-12
were O 0 7.737165075294428e-12
minute O 0 6.073602176748238e-10
deletions O 0 4.57051230196015e-10
, O 0 5.787142547944088e-14
4649delA O 0 8.003526730249177e-10
in O 0 9.160830080623406e-12
exon O 0 7.695859505219005e-10
33 O 0 1.7312612454745135e-09
and O 0 1.5477763168347813e-11
7883del5 O 0 8.105449467166181e-08
in O 0 1.369315077992539e-10
exon O 0 1.6689256199242664e-08
55 O 0 6.229770832533177e-08
. O 0 2.5265405767527227e-08

The O 0 7.16227575026096e-08
mutations O 0 1.2926058445827948e-08
4612del165 O 0 1.2983066710603453e-07
and O 0 2.2969204663270126e-12
7883del5 O 0 3.185414243489504e-08
were O 0 5.384316256740185e-12
found O 0 1.209579040661185e-13
in O 0 1.6683976198332432e-15
more O 0 1.7360762140633518e-16
than O 0 2.2417785740269126e-16
two O 0 5.700918405561863e-15
unrelated O 0 4.187475453193423e-12
families O 0 1.198619518525887e-13
; O 0 6.443813204753338e-16
44 O 0 2.8653229094954824e-11
% O 0 6.73472042023171e-11
( O 0 3.8466485110578465e-15
7 O 0 1.1035242164503245e-11
of O 0 3.857353672587216e-11
16 O 0 6.237427675054308e-12
) O 0 2.1994189645544934e-14
of O 0 6.045588292133419e-13
the O 0 3.620734151409989e-14
mutant O 0 4.831576897465842e-14
alleles O 0 4.456995211267467e-14
had O 0 6.402753219107715e-14
one O 0 1.724865875943251e-14
of O 0 5.882608853161053e-13
the O 0 1.7149672524099935e-12
two O 0 8.900957228219486e-12
mutations O 0 1.5342448145272414e-10
. O 0 1.7658754458693693e-09

The O 0 1.652725778455988e-08
4612del165 O 0 4.768257610976434e-07
mutations O 0 9.632162255301946e-12
in O 0 1.8511747514114545e-14
three O 0 5.007186563299329e-15
different O 0 3.7165844844245805e-15
families O 0 6.883723598733946e-14
were O 0 3.0198995973167164e-13
all O 0 3.980483951888762e-14
ascribed O 0 5.7755918103641335e-12
to O 0 3.185260486360947e-13
the O 0 5.104742583500466e-13
same O 0 1.362565984520947e-12
T O 0 4.4112900832171675e-11
- O 0 4.3864073484556343e-10
- O 0 3.480764843022399e-10
> O 0 6.296684007534026e-11
A O 0 2.9069666812597816e-11
substitution O 0 1.2870114045673842e-12
at O 0 5.3432356195842745e-14
the O 0 4.869004572899578e-15
splice O 0 4.857132404612052e-11
donor O 0 2.672740501141746e-12
site O 0 8.120954429757798e-12
in O 0 2.6660605147166283e-12
intron O 0 3.0928376304473204e-08
33 O 0 1.5999475522221474e-07
. O 0 8.59020872212568e-08

Microsatellite O 0 1.1237515451512081e-07
genotyping O 0 1.8179919436533964e-07
around O 0 5.037925805695398e-12
the O 0 2.5868896868369573e-12
ATM O 0 5.509500766720521e-08
locus O 0 3.172572968224152e-11
also O 0 3.9577119793215987e-14
indicated O 0 1.4752956885646928e-12
that O 0 1.1523767839155693e-15
a O 0 4.11338409893932e-14
common O 0 2.990101655858668e-13
haplotype O 0 4.5022520434034874e-11
was O 0 3.968351688921068e-12
shared O 0 3.086926330872486e-12
by O 0 1.2286000082895629e-15
the O 0 3.145826833620205e-14
mutant O 0 9.49492695296976e-14
alleles O 0 8.84617832003047e-14
in O 0 8.290963130885148e-14
both O 0 8.007213815608427e-12
mutations O 0 6.281776210315115e-10
. O 0 4.1995193988952906e-09

This O 0 1.3496365483534056e-11
suggests O 0 7.596445716386013e-13
that O 0 4.109710157058075e-16
these O 0 3.903544561157865e-15
two O 0 1.9483329879999012e-13
founder O 0 3.779810145432272e-11
mutations O 0 1.9458911912351162e-11
may O 0 5.498275446047529e-13
be O 0 1.3281366024325836e-12
predominant O 0 5.891196419582911e-10
among O 0 2.9243073891224713e-14
Japanese O 0 1.2547914096661117e-10
ATM O 0 4.2272308320434604e-08
mutant O 0 1.0475819517408169e-10
alleles O 0 7.205633312246107e-11
. O 0 2.5658271063377924e-09

W474C O 0 4.69669414471241e-09
amino O 0 5.507440857532853e-12
acid O 0 4.3428429526582574e-14
substitution O 0 3.3610793185104293e-13
affects O 0 8.986441046865152e-15
early O 0 1.1588134084575784e-14
processing O 0 1.4214297057099645e-12
of O 0 7.288738839913989e-14
the O 0 2.5843027736771433e-14
alpha O 0 1.3599681480242452e-14
- O 0 3.431463961719658e-14
subunit O 0 2.3672097539551712e-14
of O 0 2.096673962920237e-12
beta O 0 2.6203565359206316e-11
- O 0 7.834407428353174e-11
hexosaminidase O 0 6.489051962432768e-09
A O 0 4.6005382836611375e-10
and O 0 9.081623833214012e-15
is O 0 9.552008545636874e-16
associated O 0 1.1936807878948352e-12
with O 0 3.3413094339962424e-13
subacute O 0 2.7275625598122133e-06
G B-Disease 0 6.420694531605875e-10
( I-Disease 0 1.1837449423457436e-13
M2 I-Disease 0 4.532040964733142e-09
) I-Disease 0 1.128792697334402e-12
gangliosidosis I-Disease 0 8.361292458403113e-08
. O 0 1.7741433877560553e-09

Mutations O 0 6.357021159475451e-11
in O 0 1.1700922620139914e-13
the O 0 4.699516600523146e-13
HEXA O 0 4.7398729385861316e-09
gene O 0 1.6420993644033653e-15
, O 0 2.7299281283048737e-17
encoding O 0 1.627277685430778e-14
the O 0 5.287051924192897e-14
alpha O 0 4.022650522552502e-15
- O 0 5.9630810319676996e-15
subunit O 0 4.645912611735267e-15
of O 0 2.1284369666058067e-12
beta O 0 2.988782138446666e-11
- O 0 8.065729750761363e-10
hexosaminidase O 0 1.372373645835978e-07
A O 0 1.095859669675292e-08
( O 0 1.386039398624259e-15
Hex O 0 2.4952603872030465e-10
A O 0 3.872081821842954e-11
) O 0 2.8891383270425886e-16
, O 0 1.5331869416031213e-16
that O 0 2.49918685743937e-16
abolish O 0 5.743473405206423e-11
Hex O 0 6.056723456104862e-10
A O 0 5.900572391803749e-11
enzyme O 0 1.8065300991243483e-11
activity O 0 1.3493001160824747e-10
cause O 0 0.001102723996154964
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 5.912037352728827e-12
TSD B-Disease 1 0.999996542930603
) O 0 4.53129524733472e-14
, O 0 9.649905437306974e-16
the O 0 6.275153465427896e-14
fatal O 0 3.448847651910114e-09
infantile B-Disease 0 1.0397404537343391e-07
form I-Disease 0 5.01739982894378e-10
of I-Disease 0 4.250888707701961e-07
G I-Disease 0 6.432953059132274e-10
( I-Disease 0 9.957889412137363e-14
M2 I-Disease 0 6.722031264949635e-10
) I-Disease 0 2.438244376366805e-13
gangliosidosis I-Disease 0 2.0727055627389745e-08
, I-Disease 0 4.247984071708427e-13
Type I-Disease 0 1.207701993966026e-10
1 I-Disease 0 2.3705207935487138e-11
. O 0 2.0409078593797148e-10

Less O 0 6.493932147577652e-08
severe O 0 1.2437080840754788e-06
, O 0 5.385233231569586e-11
subacute O 1 0.9995143413543701
( O 0 5.114624544201585e-13
juvenile O 0 1.8789006617225823e-07
- O 0 1.1306625680163052e-07
onset O 0 0.30890902876853943
) O 0 1.878103575436718e-11
and O 0 1.3544894983397171e-08
chronic O 1 1.0
( O 0 1.655853232307436e-11
adult O 1 0.9554215669631958
- O 0 1.560825602098248e-08
onset O 0 5.21006071618757e-10
) O 0 1.6513080948476772e-15
variants O 0 3.206308103135408e-13
are O 0 1.1805240063901849e-15
characterized O 0 9.88436309831578e-16
by O 0 2.353768241054752e-16
a O 0 1.4499694644281615e-14
broad O 0 2.761943201001673e-14
spectrum O 0 6.832189436596636e-13
of O 0 1.455345447019113e-13
clinical O 0 4.79998202643217e-13
manifestations O 0 7.286393710614902e-13
and O 0 3.1784904992970516e-15
are O 0 1.1576016801809278e-16
associated O 0 1.1629805564481854e-14
with O 0 8.697435416965234e-16
residual O 0 1.0354385404642841e-10
levels O 0 9.494235259088768e-11
of O 0 5.414917472745806e-11
Hex O 0 1.2314637087840197e-09
A O 0 4.630736682997849e-09
enzyme O 0 1.7452482514723755e-10
activity O 0 1.901222734801422e-09
. O 0 9.684046897717735e-10

We O 0 8.562746345308625e-11
identified O 0 1.1091663611878522e-12
a O 0 2.1671256640338338e-14
1422 O 0 1.16727365620517e-11
G O 0 1.957259354590235e-11
- O 0 2.136114618522811e-09
- O 0 1.4447251173166364e-09
> O 0 3.83514220381187e-10
C O 0 2.9090496678207955e-09
( O 0 2.1551984395788243e-16
amino O 0 8.190089638383455e-14
acid O 0 9.54265370200916e-15
W474C O 0 5.318804207829486e-13
) O 0 8.599402606078807e-20
substitution O 0 1.5581401881220982e-15
in O 0 6.340209957996705e-16
the O 0 8.689215491607723e-15
first O 0 2.620363778391144e-13
position O 0 1.3304043977591107e-10
of O 0 8.331622197710331e-11
exon O 0 9.90751022889036e-11
13 O 0 2.336330261198949e-11
of O 0 9.111837395714417e-10
HEXA O 0 1.2522457836894318e-05
of O 0 4.263236430546158e-09
a O 0 4.1001996936573804e-11
non O 0 4.398022923624012e-08
- O 0 5.376186607009004e-09
Jewish O 0 6.708777977593172e-09
proband O 0 0.2164440006017685
who O 0 2.5404730402689424e-11
manifested O 0 3.975084705842846e-09
a O 0 8.692609999860768e-12
subacute O 0 4.359953891253099e-07
variant O 0 3.3596248005807183e-09
of O 0 3.4504554946579447e-07
G B-Disease 0 2.4329919412480194e-08
( I-Disease 0 2.548173260938369e-12
M2 I-Disease 0 8.086101388471434e-08
) I-Disease 0 3.899443268284841e-12
gangliosidosis I-Disease 0 1.8167717996675492e-07
. O 0 3.712161023017302e-09

On O 0 1.0231786529146802e-09
the O 0 1.1554913276201617e-11
second O 0 2.0137479184167972e-10
maternally O 0 2.652705859418347e-07
inherited O 0 9.445138715591384e-08
allele O 0 2.5965181116305303e-09
, O 0 6.069733067938857e-14
we O 0 4.0266750301947915e-14
identified O 0 1.2796387213742655e-12
the O 0 5.396435251783793e-13
common O 0 4.5768304701709894e-09
infantile O 1 1.0
disease O 1 0.9999732971191406
- O 0 1.5816160157555714e-05
causing O 0 7.725691375526367e-07
4 O 0 4.929084752802737e-05
- O 0 0.0002766557445283979
bp O 0 4.817335863549488e-09
insertion O 0 4.316718715813295e-08
, O 0 1.2918496133940138e-11
+ O 0 1.1165504076871002e-09
TATC O 0 1.9776987755903974e-05
1278 O 0 6.170359512225332e-08
, O 0 4.2743581027057664e-13
in O 0 1.8117291521180245e-12
exon O 0 4.892037885895206e-10
11 O 0 3.73324759994631e-10
. O 0 6.302578015038307e-09

Pulse O 0 2.9187421546339465e-07
- O 0 6.534007779279705e-10
chase O 0 8.7326266010046e-12
analysis O 0 3.1688323839929033e-13
using O 0 2.1685202190781933e-13
proband O 0 8.268433049352097e-09
fibroblasts O 0 4.9559503167984076e-09
revealed O 0 5.5548200587896e-12
that O 0 2.8889497960373755e-17
the O 0 9.646225079151154e-16
W474C O 0 2.2921981153445348e-12
- O 0 3.148298009892172e-15
containing O 0 6.78582816819568e-16
alpha O 0 6.968889034635398e-15
- O 0 4.5997826045047346e-14
subunit O 0 7.528890976372243e-14
precursor O 0 7.365385211455244e-12
was O 0 2.7301639681648338e-12
normally O 0 3.0912275777311704e-12
synthesized O 0 1.8598199369446178e-11
, O 0 3.7412356842885224e-15
but O 0 2.470825812085132e-15
not O 0 2.6262115922150338e-14
phosphorylated O 0 1.4693156413780883e-10
or O 0 2.039283238802758e-12
secreted O 0 8.060692738287578e-12
, O 0 3.777157928065104e-15
and O 0 2.6321978705148115e-15
the O 0 6.811410159859865e-13
mature O 0 8.375042881425543e-10
lysosomal O 0 6.370269645117332e-09
alpha O 0 1.3087688918722584e-11
- O 0 2.9254553640667424e-11
subunit O 0 1.151935231230583e-11
was O 0 3.184753502583071e-11
not O 0 1.4364230291330493e-11
detected O 0 3.797192782428738e-09
. O 0 2.524442599405319e-10

When O 0 4.704216074839784e-13
the O 0 4.4763712593424987e-13
W474C O 0 8.437537474259571e-11
- O 0 7.732406566169497e-14
containing O 0 4.114621783481848e-15
alpha O 0 1.02055654034529e-14
- O 0 4.8417060562622877e-14
subunit O 0 3.493561641148765e-14
was O 0 1.3032582825422967e-12
transiently O 0 1.0024545776810001e-10
co O 0 4.357398502349147e-13
- O 0 1.4158251936298438e-13
expressed O 0 6.10929035360858e-15
with O 0 2.433574957426113e-17
the O 0 1.0732608361475838e-15
beta O 0 3.4048100795068753e-15
- O 0 2.656871834389211e-16
subunit O 0 3.043828446953844e-17
to O 0 2.1665501898494692e-15
produce O 0 6.546781346206121e-14
Hex O 0 1.4759423683230466e-09
A O 0 5.757869736555676e-09
( O 0 5.813583528425578e-14
alphabeta O 0 1.2536563787080013e-08
) O 0 1.1400341797971822e-14
in O 0 2.914804899181722e-12
COS O 0 1.1106212838285501e-07
- O 0 3.8943628877241565e-10
7 O 0 2.6265647642964574e-12
cells O 0 1.2795776807919546e-12
, O 0 1.0221650559121259e-15
the O 0 3.626323806532215e-15
mature O 0 3.372394323433031e-13
alpha O 0 9.480102012920325e-15
- O 0 7.897331334889846e-14
subunit O 0 2.4074021449287455e-14
was O 0 4.5362007878267663e-13
present O 0 1.2990342308782932e-12
, O 0 1.02182984262325e-15
but O 0 1.394471717493294e-15
its O 0 1.7451672863373342e-15
level O 0 1.2882916088086116e-11
was O 0 4.60543875171332e-13
much O 0 3.863871909600726e-14
lower O 0 2.2701896514997627e-13
than O 0 2.851223014741118e-16
that O 0 3.8805303054040513e-16
from O 0 2.3492598383127727e-13
normal O 0 3.6610400822034705e-10
alpha O 0 9.335686737554916e-12
- O 0 5.5016272787478115e-11
subunit O 0 9.80104344038002e-13
transfections O 0 3.772546719460479e-09
, O 0 4.6919348763749084e-15
although O 0 9.41073721432025e-16
higher O 0 4.413892753900306e-14
than O 0 4.362312653460498e-17
in O 0 3.257503426682827e-16
those O 0 1.3581011815293783e-15
cells O 0 1.1013993807696548e-13
transfected O 0 2.5017973803720395e-11
with O 0 4.120527720706578e-15
an O 0 1.1091483092216803e-14
alpha O 0 1.3678468080424722e-12
- O 0 1.055660767135258e-11
subunit O 0 7.020075493135991e-12
associated O 0 1.8718790961713694e-09
with O 0 3.551766936116252e-10
infantile O 1 0.9893787503242493
TSD B-Disease 0 0.0004649765614885837
. O 0 5.045106998835536e-09

Furthermore O 0 2.888904948594728e-10
, O 0 3.02981440595553e-15
the O 0 1.9012387184622146e-15
precursor O 0 1.5214726993475342e-13
level O 0 8.247224431157107e-11
of O 0 3.5476534904210766e-12
the O 0 1.248173331185043e-12
W474C O 0 1.694610701763466e-10
alpha O 0 4.2678732184615875e-13
- O 0 1.7055886867775594e-12
subunit O 0 2.398173348273913e-13
was O 0 1.041856054553869e-12
found O 0 7.675229809350759e-15
to O 0 1.5974355288528828e-14
accumulate O 0 1.0041595071457517e-14
in O 0 1.7588144694252587e-15
comparison O 0 4.4927061203237084e-14
to O 0 4.906072428737321e-14
the O 0 6.441918396285495e-13
normal O 0 1.9652590665941716e-09
alpha O 0 4.451921817305582e-11
- O 0 5.3438854036302885e-11
subunit O 0 1.5550200016534177e-11
precursor O 0 2.735233151085481e-10
levels O 0 2.0134300893204227e-09
. O 0 3.892773881020162e-10

We O 0 5.6244512519620926e-11
conclude O 0 1.1003622457650408e-09
that O 0 4.5892118027295904e-15
the O 0 4.4202448233783553e-14
1422 O 0 2.5559726210544476e-11
G O 0 3.501679154971349e-11
- O 0 2.4043692037345465e-10
- O 0 7.207338198478297e-11
> O 0 5.6685968419234456e-11
C O 0 8.112030491780331e-10
mutation O 0 1.443986023688757e-14
is O 0 1.2088362050748905e-17
the O 0 2.3987459552517513e-16
cause O 0 1.020452494206181e-12
of O 0 1.7715287570219118e-10
Hex B-Disease 0 0.0005376209155656397
A I-Disease 1 0.9999905824661255
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.364296837954811e-11
the O 0 2.527092424209343e-10
proband O 0 7.53431436351093e-07
. O 0 2.322895875650488e-09

The O 0 1.2461901302551759e-11
resulting O 0 2.1304433911462084e-12
W474C O 0 4.1364110053843106e-11
substitution O 0 3.5556473130388122e-12
clearly O 0 5.831710982173721e-13
interferes O 0 5.226348433889916e-12
with O 0 1.7490069925663564e-14
alpha O 0 5.646781870219386e-13
- O 0 2.8741381019950496e-13
subunit O 0 9.236422661863114e-14
processing O 0 2.6863672744625866e-11
, O 0 1.5650791879051238e-16
but O 0 1.987067164109174e-17
because O 0 1.1102599334240887e-17
the O 0 2.1654170979940594e-16
base O 0 2.0587711765419903e-14
substitution O 0 9.465640077310766e-13
falls O 0 6.9889198595074475e-12
at O 0 1.3716813600760103e-13
the O 0 3.739939469769339e-14
first O 0 3.9256347738464425e-13
position O 0 2.7604479813092553e-10
of O 0 4.965220457009423e-10
exon O 0 1.9082188607022488e-10
13 O 0 4.811628179224314e-11
, O 0 1.6384468651611805e-13
aberrant O 0 3.310426238689601e-11
splicing O 0 9.321901583980718e-11
may O 0 2.0583844958371733e-12
also O 0 2.849399522212269e-14
contribute O 0 1.5746598469590367e-10
to O 0 4.038383849547245e-09
Hex B-Disease 1 0.5754311680793762
A I-Disease 1 0.5852673053741455
deficiency I-Disease 0 0.00013734363892581314
in O 0 1.55962395775866e-11
this O 0 6.374149472132551e-12
proband O 0 1.5016047427707235e-07
. O 0 2.709942339973459e-11
. O 0 3.764997202893028e-10

Two O 0 1.0203989736501384e-10
frequent O 0 4.81994999468327e-11
missense O 0 1.0616963663778733e-07
mutations O 0 3.837597262190684e-08
in O 0 7.952330349780823e-08
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.2304907361103687e-06

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.0475558748511702e-10
an O 0 9.404867000739614e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 8.668507578413198e-11
by O 0 1.575081455872115e-16
early O 0 7.557033887550801e-10
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999954700469971
goiter B-Disease 1 1.0
. O 0 7.277019176399335e-05

A O 0 4.2152700774344964e-10
century O 0 9.326427434161455e-13
after O 0 2.4638714598299374e-14
its O 0 3.0627573172192627e-16
recognition O 0 2.4521814700334543e-12
as O 0 6.934342423187134e-13
a O 0 8.620133079562109e-11
syndrome O 0 8.896213210540793e-10
by O 0 6.016275802198101e-14
Vaughan O 0 2.693876677284379e-09
Pendred O 0 0.001035806955769658
, O 0 4.8381244621481176e-14
the O 0 3.8889681405751553e-13
disease O 0 1.7095655403462362e-12
gene O 0 4.222525734149047e-15
( O 0 2.638058279718627e-15
PDS O 0 5.031454293202842e-07
) O 0 3.9224140835304386e-14
was O 0 1.2747794139733593e-11
mapped O 0 2.8440281379937815e-11
to O 0 2.128925334632381e-11
chromosome O 0 2.9116085098479516e-09
7q22 O 0 4.499092483456479e-06
- O 0 3.3439067692597746e-07
q31 O 0 6.547275006596465e-07
. O 0 1.3011091093417804e-09

1 O 0 2.2047998149421488e-10
and O 0 3.3562766281469703e-12
, O 0 4.68843917140159e-14
recently O 0 2.0861696430670568e-13
, O 0 1.2075423457043473e-15
found O 0 2.2484256650804908e-15
to O 0 3.0930303891035793e-13
encode O 0 5.110078471481927e-10
a O 0 3.5126715425271016e-10
putative O 0 2.582670504125417e-07
sulfate O 0 7.990309569549936e-08
transporter O 0 7.460753295163158e-07
. O 0 9.056227412429507e-08

We O 0 3.460942990529681e-11
performed O 0 4.283550077144316e-12
mutation O 0 1.162349161148643e-13
analysis O 0 4.83841990724012e-14
of O 0 2.95375540432935e-13
the O 0 1.4377709092738833e-12
PDS B-Disease 0 3.977168489655014e-06
gene O 0 1.6474537662888866e-12
in O 0 3.2607469784180776e-13
patients O 0 4.33501845531481e-12
from O 0 6.304909394051761e-13
14 O 0 1.6891982604350098e-11
Pendred B-Disease 0 2.2772128716042062e-07
families O 0 5.896496832469289e-12
originating O 0 1.4961849814643102e-10
from O 0 1.7618313763196475e-13
seven O 0 1.3223733089443024e-12
countries O 0 3.5019358832037717e-13
and O 0 3.3482570015175295e-13
identified O 0 7.855385786292857e-11
all O 0 2.7501619037639813e-11
mutations O 0 7.060985685036769e-10
. O 0 5.8292988214248e-09

The O 0 3.643617352278028e-10
mutations O 0 6.2883873455654715e-12
include O 0 7.099486607322139e-14
three O 0 9.90519041029099e-14
single O 0 6.261649185268503e-12
base O 0 4.899909922251311e-10
deletions O 0 1.1632498297942107e-09
, O 0 3.488589354460475e-13
one O 0 5.379461199411795e-12
splice O 0 2.3796441439571936e-07
site O 0 1.9180357302417406e-09
mutation O 0 3.9810313379184947e-10
and O 0 5.0165622524078746e-12
10 O 0 6.405187935598633e-09
missense O 0 3.687194066515076e-06
mutations O 0 7.060332762875987e-08
. O 0 3.4547284144537116e-08

One O 0 8.747738644565572e-10
missense O 0 8.379444693673577e-08
mutation O 0 2.6789785667613586e-11
( O 0 1.0758725351855004e-14
L236P O 0 5.571083594446691e-09
) O 0 5.638779645034814e-15
was O 0 5.552804310110515e-13
found O 0 1.3265123794867738e-14
in O 0 6.3936460902654264e-15
a O 0 2.4010187352316477e-14
homozygous O 0 4.3484901551989197e-13
state O 0 5.095808825361821e-14
in O 0 3.9302474442266463e-14
two O 0 3.6502203169808123e-13
consanguineous O 0 2.9057915185148886e-07
families O 0 6.6828547903852176e-12
and O 0 4.567514037346135e-14
in O 0 1.4578429067234333e-13
a O 0 4.342191211627322e-13
heterozygous O 0 3.473413397181435e-12
state O 0 1.999472771596969e-13
in O 0 1.0013255551328051e-13
five O 0 2.615287326979132e-12
additional O 0 3.068495457725362e-11
non O 0 6.226159854350044e-08
- O 0 1.0200248112823829e-07
consanguineous O 0 2.3893688194220886e-05
families O 0 3.671139170435822e-09
. O 0 1.2293686957320915e-08

Another O 0 6.385183493051727e-09
missense O 0 3.980861436048144e-07
mutation O 0 1.2582856978582413e-10
( O 0 5.3192273177272986e-14
T416P O 0 4.7938435443484195e-09
) O 0 2.054695423406392e-14
was O 0 3.775795214683297e-12
found O 0 8.708931877520962e-14
in O 0 8.870029920792204e-15
a O 0 1.765914786633089e-14
homozygous O 0 8.218746321529691e-13
state O 0 5.482637591537956e-14
in O 0 1.2680317679116676e-13
one O 0 2.593890813945565e-12
family O 0 1.5849936380735175e-12
and O 0 4.621680439070332e-14
in O 0 1.1418104417688923e-13
a O 0 1.386315785474948e-13
heterozygous O 0 1.4870650284076747e-12
state O 0 1.467115139227801e-13
in O 0 2.363173404792279e-13
four O 0 4.853851695574285e-12
families O 0 1.5929165972372594e-11
. O 0 1.1048796322299381e-09

Pendred B-Disease 0 0.0049485331401228905
patients O 0 2.0809716172465187e-09
in O 0 1.5383748962205512e-12
three O 0 7.63140418913455e-12
non O 0 4.421270105581243e-08
- O 0 9.114397236942295e-09
consanguineous O 0 9.259278886020184e-05
families O 0 5.1481384259755014e-12
were O 0 1.0165860395237175e-13
shown O 0 5.123314424614056e-13
to O 0 2.7625609590707645e-13
be O 0 9.898863412988179e-14
compound O 0 5.141458439550384e-11
heterozygotes O 0 2.120490005808051e-09
for O 0 1.9407168580509726e-11
L236P O 0 3.2054609278020507e-07
and O 0 2.4135204251818365e-11
T416P O 0 5.723993012907158e-07
. O 0 4.569486122818489e-09

In O 0 6.033798460869377e-11
total O 0 8.82415474023901e-10
, O 0 9.485026154255893e-14
one O 0 5.416520232554359e-14
or O 0 3.3382836967833784e-13
both O 0 1.3075656009331471e-12
of O 0 7.75206981940002e-12
these O 0 3.436030214694352e-13
mutations O 0 5.628523363533644e-13
were O 0 1.2800562476308897e-12
found O 0 8.538840207822362e-14
in O 0 2.5576022623006144e-14
nine O 0 2.6885714141111627e-11
of O 0 6.035614282667856e-12
the O 0 1.2396936775738165e-12
14 O 0 4.5443801499622793e-11
families O 0 1.8456142863998437e-11
analyzed O 0 1.2378525982015276e-09
. O 0 7.449588945718233e-09

The O 0 4.3120579806474324e-13
identification O 0 4.18438977911606e-10
of O 0 1.4079874419148375e-11
two O 0 2.5869094193164965e-12
frequent O 0 8.902947129518779e-11
PDS B-Disease 0 5.56006416445598e-05
mutations O 0 3.133106968311594e-11
will O 0 1.7050477783137064e-13
facilitate O 0 2.3534341142550375e-10
the O 0 9.355308411632124e-13
molecular O 0 1.2537985927263406e-10
diagnosis O 0 0.00014766881940886378
of O 0 1.5877070609349175e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 9.519069408270298e-07

Insertional O 0 5.544104624277679e-06
mutation O 0 2.6865364100014943e-11
by O 0 8.009252169902809e-14
transposable O 0 9.139555601223037e-08
element O 0 6.318393808157907e-09
, O 0 1.180818572261988e-12
L1 O 0 1.167536356661003e-05
, O 0 1.5119111203883845e-14
in O 0 1.818603115864327e-14
the O 0 1.7549032973324108e-12
DMD B-Disease 1 1.0
gene O 0 7.429225962717056e-13
results O 0 2.7443336231974813e-12
in O 0 2.5316630302557597e-12
X B-Disease 1 0.9999691247940063
- I-Disease 1 0.9999377727508545
linked I-Disease 1 0.8368598818778992
dilated I-Disease 1 0.9999986886978149
cardiomyopathy I-Disease 1 1.0
. O 0 1.1678804185066838e-05

X B-Disease 1 0.9997681975364685
- I-Disease 1 0.9999954700469971
linked I-Disease 1 0.9480963945388794
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 0 1.2438303165218656e-10
XLDCM B-Disease 1 1.0
) O 0 1.166463365344882e-15
is O 0 1.6014782450565602e-17
a O 0 1.0083194024167479e-16
clinical O 0 6.349219381588528e-14
phenotype O 0 2.8803517730657813e-12
of O 0 9.422358726585145e-12
dystrophinopathy B-Disease 0 1.5597750646634267e-08
which O 0 1.6410606055485e-14
is O 0 1.4360222040368044e-16
characterized O 0 1.340559446829097e-15
by O 0 2.1019520691600672e-15
preferential O 0 3.1355791296761026e-09
myocardial B-Disease 0 2.9889923098380677e-05
involvement I-Disease 0 1.8319835648483718e-09
without O 0 5.049642995413883e-12
any O 0 2.1223631576153257e-13
overt O 0 3.860251961834704e-12
clinical O 0 8.438531991228349e-12
signs O 0 4.001932899649896e-12
of O 0 1.4767083111877355e-09
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 5.528233941731742e-06

To O 0 1.0708772757439533e-10
date O 0 2.3754158640088008e-09
, O 0 9.770502684908547e-14
several O 0 5.1360794821797215e-14
mutations O 0 6.570643768660789e-12
in O 0 4.116716516289198e-12
the O 0 3.758263744657597e-08
Duchenne B-Disease 0 0.006880192086100578
muscular I-Disease 0 1.8128021110896952e-05
dystrophy I-Disease 0 0.08697143197059631
gene O 0 6.57529497516407e-08
, O 0 5.0119003391913e-10
DMD O 1 1.0
, O 0 1.4311960904594967e-12
have O 0 2.012356523889533e-15
been O 0 1.2787316532728086e-15
identified O 0 1.0795849958900212e-14
in O 0 2.850702724753267e-15
patients O 0 3.017186923481158e-14
with O 0 9.721627528599258e-15
XLDCM B-Disease 0 0.16284964978694916
, O 0 1.7412324837193238e-13
but O 0 1.960301055324836e-14
a O 0 4.165818487692971e-14
pathogenic O 0 9.183117807842756e-12
correlation O 0 2.7583504057238084e-12
of O 0 8.684021926032293e-13
these O 0 1.1031190609404884e-13
cardiospecific O 0 1.5831108646224834e-09
mutations O 0 1.2144463386321025e-11
in O 0 2.329925532021382e-12
DMD O 1 1.0
with O 0 6.680672182991787e-13
the O 0 2.0682795753845795e-11
XLDCM B-Disease 1 0.9997645020484924
phenotype O 0 1.1889845552559564e-07
has O 0 1.2720893945421946e-13
remained O 0 9.175751131129672e-11
to O 0 1.1118654608122114e-11
be O 0 1.5125890817646592e-10
elucidated O 0 1.9122048797726166e-06
. O 0 1.9669851525350168e-08

We O 0 4.83512431481703e-11
report O 0 4.315610504590853e-14
here O 0 4.919300542274591e-15
the O 0 3.929269110584656e-16
identification O 0 8.995646241793942e-12
of O 0 1.8982487023228023e-12
a O 0 1.2813533871100513e-12
unique O 0 1.1147660919363922e-11
de O 0 3.052570696215895e-11
novo O 0 4.741833037336107e-10
L1 O 0 4.4988343006480136e-07
insertion O 0 1.439707686401448e-09
in O 0 2.2830189128075773e-11
the O 0 1.4989613716931416e-10
muscle O 0 1.3303899093486393e-09
exon O 0 2.5444119033934953e-10
1 O 0 1.442679851450246e-12
in O 0 7.346991938439462e-12
DMD O 1 1.0
in O 0 2.0329384009531992e-11
three O 0 1.4734852227249462e-11
XLDCM B-Disease 1 0.9994617104530334
patients O 0 3.093682948707155e-11
from O 0 2.6456091549269256e-13
two O 0 1.340269312633674e-13
unrelated O 0 3.31494380556574e-11
Japanese O 0 5.717844531183403e-10
families O 0 4.293122107812408e-11
. O 0 2.0048613880163657e-09

The O 0 4.224604693847667e-11
insertion O 0 5.199041752668165e-10
was O 0 3.0845503234955274e-11
a O 0 7.360986277980819e-13
5 O 0 1.5771711193990345e-12
- O 0 3.063780132372962e-12
truncated O 0 4.748138687782344e-11
form O 0 6.769037153714352e-12
of O 0 5.910371497774847e-11
human O 0 2.2098508786760895e-11
L1 O 0 2.8289309739193413e-07
inversely O 0 1.0371843384149315e-09
integrated O 0 1.236903801604683e-09
in O 0 1.11955551166526e-12
the O 0 2.926871635680617e-12
5 O 0 7.497348575302709e-11
- O 0 3.2513820524826542e-09
untranslated O 0 0.0002623085747472942
region O 0 4.63049820709216e-09
in O 0 2.3641574808941357e-12
the O 0 1.3504889047333268e-11
muscle O 0 6.601096752545388e-11
exon O 0 3.256797262429778e-11
1 O 0 1.951654305830039e-13
, O 0 3.189507009809041e-15
which O 0 4.1102744927591834e-16
affected O 0 2.1765675741781954e-13
the O 0 4.779870957046829e-14
transcription O 0 1.1874949808199364e-12
or O 0 1.2294406757842186e-13
the O 0 1.7892835650623606e-12
stability O 0 1.7739600934874034e-06
of O 0 4.5029072137658943e-10
the O 0 1.5054100327427378e-11
muscle O 0 3.409912283092176e-11
form O 0 1.195634129896872e-11
of O 0 1.9892508473784432e-10
dystrophin O 0 8.765677073085953e-10
transcripts O 0 1.3241818752618428e-10
but O 0 2.2151635282747616e-15
not O 0 3.021721747298344e-16
that O 0 4.719036542555257e-16
of O 0 2.832053168366766e-12
the O 0 1.0558546398309332e-10
brain O 0 2.8347940883577394e-07
or O 0 3.702794668103415e-11
Purkinje O 0 2.1864890697997907e-07
cell O 0 3.4538703008735183e-09
form O 0 1.4688812666197038e-10
, O 0 4.776766005312738e-13
probably O 0 2.4134928430785685e-11
due O 0 9.538747569592942e-10
to O 0 2.2448820580223128e-11
its O 0 5.223715340493817e-13
unique O 0 7.579197686125028e-12
site O 0 2.4714719853990985e-11
of O 0 1.9219265068315394e-11
integration O 0 6.090379756074071e-09
. O 0 5.316563189694534e-09

We O 0 1.6025770988026267e-11
speculate O 0 3.159985944786725e-12
that O 0 1.3780402179937364e-17
this O 0 5.751611792207816e-17
insertion O 0 9.627514931109804e-12
of O 0 1.1706202847350244e-11
an O 0 1.6758624110831122e-13
L1 O 0 1.0757834161267965e-06
sequence O 0 3.9211633939828516e-11
in O 0 2.55186149988873e-11
DMD O 1 1.0
is O 0 1.3801527737507258e-13
responsible O 0 3.465020967634985e-13
for O 0 1.0595766377198643e-14
some O 0 7.523242875976657e-16
of O 0 1.8671211630830534e-14
the O 0 2.875790993617992e-15
population O 0 2.2559245536416515e-16
of O 0 7.443937828103197e-16
Japanese O 0 4.063837807932735e-12
patients O 0 1.8919654525776514e-13
with O 0 1.0796596364333333e-13
XLDCM B-Disease 0 4.953674306307221e-06
. O 0 2.781785357619526e-10
. O 0 4.994124669366329e-09

Severe O 0 2.261725740027032e-06
early O 0 0.06009736657142639
- O 1 0.9999990463256836
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 4.430067770955226e-11
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.502078011445974e-08
red O 0 5.131620355314226e-07
hair O 1 0.9981757402420044
pigmentation O 0 4.95559243063326e-06
caused O 0 9.47045775134825e-10
by O 0 9.178547678845295e-12
POMC O 0 0.000979528995230794
mutations O 0 2.2303137114931815e-09
in O 0 9.609792996079225e-12
humans O 0 3.998714900865785e-11
. O 0 1.0762873231540127e-10

Sequential O 0 2.138181187660848e-09
cleavage O 0 8.281308416790978e-10
of O 0 7.11826361743384e-11
the O 0 9.832686964986181e-13
precursor O 0 9.317341819956027e-13
protein O 0 7.552637714455107e-14
pre O 0 9.784467680518105e-11
- O 0 4.169473447057648e-11
pro O 0 3.3313654057565145e-08
- O 0 9.291601372751757e-07
opiomelanocortin O 0 1.1609567991399672e-05
( O 0 8.954889916612876e-15
POMC O 0 8.870395973303857e-09
) O 0 4.618979187474067e-16
generates O 0 6.816576417093077e-15
the O 0 2.0023799580785352e-14
melanocortin O 0 1.2512876845782728e-10
peptides O 0 1.144943254788311e-11
adrenocorticotrophin O 0 9.961353519827298e-09
( O 0 1.9033658723026543e-14
ACTH O 0 2.098433427022428e-09
) O 0 1.3389195486915653e-14
, O 0 1.0791079130528097e-13
melanocyte O 0 4.6842881573638806e-08
- O 0 6.355368782351434e-07
stimulating O 0 2.6341948622388145e-09
hormones O 0 2.3218170441818842e-11
( O 0 1.596422715675983e-16
MSH O 0 2.372737423206317e-11
) O 0 1.1458180291339669e-17
alpha O 0 8.018747753348664e-17
, O 0 1.320645133138887e-18
beta O 0 1.1656798598686717e-16
and O 0 6.838107571095807e-17
gamma O 0 7.04412345392259e-16
as O 0 3.930303284873694e-16
well O 0 4.834634940515314e-15
as O 0 3.5643720814678315e-16
the O 0 2.255608589176502e-14
opioid O 0 4.0446756187362265e-12
- O 0 1.3774052428153216e-12
receptor O 0 3.8698462023843e-14
ligand O 0 2.1526579130348722e-10
beta O 0 1.9864547340375793e-08
- O 0 6.599796620321285e-08
endorphin O 0 3.255647698097164e-07
. O 0 1.289797602055387e-09

While O 0 8.162000242339928e-11
a O 0 2.00590260547584e-12
few O 0 2.1331584231214923e-13
cases O 0 4.0317494351752026e-13
of O 0 1.6575549821595814e-09
isolated O 0 1.459341547160875e-06
ACTH B-Disease 1 0.9999799728393555
deficiency I-Disease 1 0.9507676959037781
have O 0 5.112345009133934e-12
been O 0 1.1855259612544855e-12
reported O 0 2.068191755008608e-12
( O 0 1.1692706231144958e-14
OMIM O 0 4.521561436376942e-08
201400 O 0 3.256347191893383e-09
) O 0 1.2559293611612982e-13
, O 0 1.0598864993126289e-13
an O 0 3.424693471518192e-12
inherited O 1 0.9580734968185425
POMC O 1 1.0
defect O 1 1.0
has O 0 2.630149353519129e-12
not O 0 3.188244752840713e-13
been O 0 9.458528795261434e-13
described O 0 7.39715743085928e-13
so O 0 5.197626183617299e-13
far O 0 1.4398436436191542e-11
. O 0 3.3076316685587415e-10

Recent O 0 8.44931000165694e-11
studies O 0 1.921408778610134e-12
in O 0 1.3537827746302154e-14
animal O 0 2.733391753228804e-14
models O 0 1.7613677443656384e-13
elucidated O 0 2.412969268839049e-10
a O 0 5.916715685103102e-13
central O 0 3.039075241462186e-11
role O 0 1.5528089231109377e-11
of O 0 2.583776970155327e-09
alpha O 0 1.2637847435215122e-09
- O 0 4.8893095794255714e-08
MSH O 0 1.099666178561165e-06
in O 0 8.443050945883268e-13
the O 0 6.449823856426173e-13
regulation O 0 1.2162562623707629e-12
of O 0 4.2499050069075284e-13
food O 0 5.5976307844572e-15
intake O 0 1.1548625873877442e-16
by O 0 6.189361872827896e-19
activation O 0 1.220904209979154e-13
of O 0 2.1382730655550297e-11
the O 0 4.487568372457673e-10
brain O 0 1.0781975845475245e-07
melanocortin O 0 3.241859758418286e-08
- O 0 5.269959579834449e-09
4 O 0 7.341405955374469e-11
- O 0 2.6930327412522104e-10
receptor O 0 4.153132644648533e-14
( O 0 3.395264229949556e-15
MC4 O 0 9.031712693285954e-07
- O 0 1.9185268484989138e-08
R O 0 2.3714491481641176e-10
; O 0 4.1791940696663584e-15
refs O 0 4.721679713881599e-10
3 O 0 3.3011917852099337e-13
- O 0 2.1443521329260473e-13
5 O 0 2.6408459710271595e-16
) O 0 5.136370258829783e-19
and O 0 3.241410627865608e-18
the O 0 1.6991830323012007e-15
linkage O 0 1.3214694616348055e-10
of O 0 4.2829780520781124e-12
human O 0 5.6779088097869135e-09
obesity B-Disease 1 1.0
to O 0 1.617691425259693e-09
chromosome O 0 1.8720817951400903e-10
2 O 0 1.456293766133321e-11
in O 0 1.5856869636787785e-11
close O 0 2.0824179713940794e-08
proximity O 0 4.1412544504737525e-09
to O 0 5.7959883420499736e-11
the O 0 1.6732459862112137e-10
POMC O 0 3.89540730338922e-07
locus O 0 1.228263463159962e-10
, O 0 4.158110487872957e-14
led O 0 3.759987723191312e-14
to O 0 5.18329818085736e-14
the O 0 6.310055966239278e-14
proposal O 0 9.975397921970289e-14
of O 0 5.147134346343563e-13
an O 0 2.560047477012748e-14
association O 0 5.202287168756814e-13
of O 0 1.8442111726635346e-10
POMC O 0 4.433168942341581e-05
with O 0 3.18327759984971e-11
human O 0 1.9964373620950937e-07
obesity B-Disease 1 1.0
. O 0 8.982372179389131e-09

The O 0 1.0293454456855589e-11
dual O 0 1.1398153532127253e-09
role O 0 2.2835863755510388e-10
of O 0 1.733096581801874e-07
alpha O 0 2.5949458404284087e-07
- O 0 0.00010451167327119038
MSH O 1 0.5507652163505554
in O 0 3.495353312343852e-11
regulating O 0 4.402296235883618e-11
food O 0 2.095494567797007e-12
intake O 0 1.2037223431557442e-12
and O 0 5.539998239209544e-15
influencing O 0 3.750406651903404e-09
hair O 0 5.674901260022125e-08
pigmentation O 0 9.062842032392382e-09
predicts O 0 7.122112686934468e-13
that O 0 1.659846028137323e-16
the O 0 4.2208346328698534e-15
phenotype O 0 7.447499648233213e-13
associated O 0 3.6494751990377716e-13
with O 0 3.8474116877433226e-15
a O 0 2.7782403114184895e-12
defect O 0 5.479099485228289e-08
in O 0 8.384160553320807e-12
POMC O 0 1.941888285728055e-06
function O 0 3.0064850609079485e-10
would O 0 9.25499585822942e-13
include O 0 5.810197375305526e-12
obesity B-Disease 1 1.0
, O 0 9.317977026903831e-14
alteration O 0 1.0566598973582586e-07
in O 0 6.130222995892609e-10
pigmentation O 1 0.9976003766059875
and O 0 1.5309582579448033e-07
ACTH B-Disease 1 0.999992847442627
deficiency I-Disease 1 0.8295633792877197
. O 0 6.766429549998065e-08

The O 0 5.7782612028489666e-11
observation O 0 2.0283055235381653e-08
of O 0 2.912705493463008e-11
these O 0 3.920765188208941e-12
symptoms O 0 7.535360779797884e-09
in O 0 3.6827596636319904e-13
two O 0 2.4719985173421444e-12
probands O 0 8.704805765091805e-08
prompted O 0 4.012465273234289e-12
us O 0 4.40835031239456e-13
to O 0 2.2265456839365427e-11
search O 0 6.796136986508827e-09
for O 0 3.493587016900612e-11
mutations O 0 4.0385206290238784e-10
within O 0 5.531670677072498e-10
their O 0 1.2653162961839826e-09
POMC O 0 1.552893445477821e-05
genes O 0 3.280873128730377e-09
. O 0 7.132962220879335e-09

Patient O 0 0.0010604752460494637
1 O 0 1.9373966320124225e-10
was O 0 2.8566083526415653e-11
found O 0 1.2538279063004781e-13
to O 0 2.0162005203404332e-13
be O 0 7.341226422336727e-14
a O 0 8.61026067068213e-14
compound O 0 2.333173064472671e-11
heterozygote O 0 1.7184308420681305e-09
for O 0 9.730021692869184e-13
two O 0 2.0400001132792056e-11
mutations O 0 2.4635274722961675e-11
in O 0 2.2556163534193097e-11
exon O 0 8.049419464306595e-11
3 O 0 5.067067425368332e-12
( O 0 1.0793590413810117e-13
G7013T O 0 1.212351463664163e-08
, O 0 6.48652342233845e-14
C7133delta O 0 3.734289322210316e-09
) O 0 2.8361770626199215e-16
which O 0 2.7448499702469628e-17
interfere O 0 8.020568801128669e-13
with O 0 3.179737861191002e-16
appropriate O 0 1.3987948169549846e-12
synthesis O 0 7.979713417816114e-11
of O 0 1.0910700121158357e-10
ACTH O 0 4.379882767580057e-08
and O 0 1.0944611189556142e-10
alpha O 0 1.7872986646239042e-08
- O 0 1.5684123866321897e-07
MSH O 0 6.708218734274851e-06
. O 0 3.89957532931362e-09

Patient O 0 1.862505087046884e-05
2 O 0 2.4769035780747295e-11
was O 0 5.470620050712638e-12
homozygous O 0 1.4712210399600578e-12
for O 0 3.754484041913232e-14
a O 0 4.1340563784741935e-13
mutation O 0 4.028244209551557e-13
in O 0 2.972600030709538e-12
exon O 0 2.2854598769050938e-10
2 O 0 1.3770197655749161e-11
( O 0 4.114955717750973e-13
C3804A O 0 3.325517994312577e-08
) O 0 7.849292369506086e-14
which O 0 1.0883371840460926e-13
abolishes O 0 2.1136739025706675e-09
POMC O 0 5.654377446262515e-07
translation O 0 3.539435411425984e-08
. O 0 2.2094031493224975e-08

These O 0 5.934474266167111e-12
findings O 0 2.5248721299483967e-13
represent O 0 2.3998422064679115e-14
the O 0 2.0361863135528752e-15
first O 0 2.195595161369056e-15
examples O 0 1.1087209810997905e-14
of O 0 3.2172737239079263e-13
a O 0 2.1341048719869526e-11
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 2.074661414885881e-10
the O 0 6.853921184941936e-13
POMC O 0 1.3165649015434155e-08
gene O 0 1.3127979335125078e-13
and O 0 5.30157032301872e-15
define O 0 2.5606764972319063e-11
a O 0 6.244213045930591e-12
new O 0 7.47793979516409e-11
monogenic B-Disease 1 1.0
endocrine I-Disease 0 0.30612823367118835
disorder I-Disease 0 7.523070735260262e-07
resulting O 0 1.542954132516261e-11
in O 0 1.85006740829885e-13
early O 0 9.14431325327314e-07
- O 1 0.9600158333778381
onset O 1 0.9999961853027344
obesity B-Disease 1 1.0
, O 0 1.1485002532340971e-10
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.1099562868821522e-07
red O 0 6.172595590214769e-08
hair O 0 1.0108643436979037e-05
pigmentation O 0 1.331028158801928e-07
. O 0 6.92881030328607e-11
. O 0 4.709447831707791e-10

A O 0 6.789033779597275e-10
European O 0 5.229709026943752e-12
multicenter O 0 2.024521528198875e-08
study O 0 3.672718032476929e-11
of O 0 1.1550741874088999e-06
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.6583935830496999e-12
classification O 0 4.0831218614534315e-12
of O 0 2.3139641244784848e-12
105 O 0 7.041521532524797e-11
mutations O 0 3.1202281427014644e-13
and O 0 3.660793388804255e-15
a O 0 1.0370709723113176e-14
general O 0 7.068810970324146e-15
system O 0 3.861889852504151e-14
for O 0 2.813570494411533e-15
genotype O 0 6.7136057997629894e-12
- O 0 4.047853632144216e-13
based O 0 1.1102615646242566e-14
prediction O 0 2.53107779180084e-09
of O 0 1.3631079598397378e-10
metabolic O 0 2.3258406756099248e-08
phenotype O 0 1.6656588330832278e-09
. O 0 8.889123326305537e-10

Phenylketonuria B-Disease 0 0.0074031469412148
( O 0 4.306421972494201e-12
PKU B-Disease 0 3.835925326711731e-06
) O 0 1.1244949199226695e-12
and O 0 2.8572825529205037e-12
mild B-Disease 0 3.025759554020624e-08
hyperphenylalaninemia I-Disease 1 1.0
( O 0 6.654290313212741e-11
MHP B-Disease 1 1.0
) O 0 5.367702267909669e-13
are O 0 7.222684500181667e-14
allelic B-Disease 0 9.483168916801787e-09
disorders I-Disease 0 6.821379572308217e-10
caused O 0 1.356377660064129e-14
by O 0 6.524668322920274e-17
mutations O 0 2.355359127748373e-15
in O 0 1.856502461594742e-15
the O 0 3.282241828588689e-14
gene O 0 7.225316400955376e-14
encoding O 0 7.757668951668961e-10
phenylalanine O 0 2.1669543457392137e-06
hydroxylase O 0 1.0952412594633643e-05
( O 0 1.1859388471258114e-10
PAH O 0 1.953011548039285e-07
) O 0 2.9162449365072174e-12
. O 0 2.752498229341427e-10

Previous O 0 1.992737974632064e-09
studies O 0 5.31273375986574e-12
have O 0 3.267684233313232e-16
suggested O 0 2.5828920826551386e-15
that O 0 8.775042130692225e-18
the O 0 9.14175639620549e-15
highly O 0 1.3649675140170459e-11
variable O 0 3.1105902298378396e-09
metabolic O 0 5.270244400890078e-07
phenotypes O 0 1.072769350685121e-06
of O 0 0.001061705988831818
PAH B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999983310699463
correlate O 0 0.11233613640069962
with O 0 3.0581450705113866e-09
PAH O 0 0.027183478698134422
genotypes O 0 6.561963914464286e-07
. O 0 1.4457754993202343e-09

We O 0 3.2938254901360153e-10
identified O 0 1.751454120624274e-10
both O 0 1.2756598728735913e-11
causative O 0 9.971860004398536e-10
mutations O 0 9.073812014259719e-12
in O 0 3.2297057281187314e-13
686 O 0 1.544689931520793e-09
patients O 0 9.385396626537812e-11
from O 0 9.920312488143068e-11
seven O 0 2.3211064181793972e-09
European O 0 1.952928041504265e-09
centers O 0 2.513451224928076e-09
. O 0 1.7844603572569895e-09

On O 0 1.0491597174366873e-10
the O 0 1.6785527232488634e-13
basis O 0 1.4661907105084637e-11
of O 0 2.380200257810078e-13
the O 0 1.164259660901834e-13
phenotypic O 0 1.3148514395322497e-11
characteristics O 0 5.001507888402479e-11
of O 0 1.0140719514106777e-10
297 O 0 6.069699742816681e-10
functionally O 0 5.827234161870365e-08
hemizygous O 0 2.128774667653488e-07
patients O 0 1.4449772975377861e-11
, O 0 1.506708347564817e-15
105 O 0 2.3767458487422566e-11
of O 0 1.0980947054428647e-11
the O 0 5.058869122220866e-12
mutations O 0 3.984686929373038e-13
were O 0 1.36396414453753e-13
assigned O 0 8.163564767758869e-13
to O 0 3.9277917940686025e-13
one O 0 5.235554828217359e-13
of O 0 1.0976548663055308e-11
four O 0 1.0239306147755145e-12
arbitrary O 0 3.2665956745114855e-11
phenotype O 0 1.3043885416230694e-10
categories O 0 9.722963406622043e-11
. O 0 1.0531439054162206e-09

We O 0 1.1828050691664593e-11
proposed O 0 1.520555870885426e-13
and O 0 1.93753217442793e-15
tested O 0 6.366245421454697e-14
a O 0 9.590711598579291e-16
simple O 0 1.8096403637878978e-15
model O 0 3.751525440531768e-15
for O 0 1.14794542517289e-15
correlation O 0 1.717637533940608e-13
between O 0 5.773738149909835e-13
genotype O 0 2.4644298754483707e-11
and O 0 4.904296912154604e-13
phenotypic O 0 2.7175472983032023e-10
outcome O 0 4.798575403697214e-08
. O 0 6.503130123292067e-08

The O 0 3.205962925689754e-11
observed O 0 1.7686334168043327e-12
phenotype O 0 1.8396360823569324e-11
matched O 0 1.0280250609118191e-11
the O 0 6.164591406787601e-13
predicted O 0 9.826767871645714e-12
phenotype O 0 7.011725401684377e-12
in O 0 7.619165715011533e-14
79 O 0 2.2925414344676653e-10
% O 0 1.0448586440503504e-09
of O 0 3.681953613526856e-12
the O 0 1.8177163062498697e-13
cases O 0 1.4877103726457924e-14
, O 0 3.327816266909117e-15
and O 0 2.200147963460548e-15
in O 0 2.4302479787689096e-14
only O 0 2.5089998506003415e-14
5 O 0 1.0641585269227649e-13
of O 0 3.5859393254268623e-13
184 O 0 2.3959717890265075e-11
patients O 0 5.052340490419027e-12
was O 0 1.0387850302162605e-11
the O 0 3.858485145974422e-12
observed O 0 4.8397444905867726e-12
phenotype O 0 3.660786951353856e-11
more O 0 7.671745962838702e-15
than O 0 5.192131548651096e-15
one O 0 4.088570861672568e-15
category O 0 2.2853737674001506e-13
away O 0 5.428085823704076e-13
from O 0 1.1747704588629948e-13
that O 0 4.56630311904474e-14
expected O 0 3.2850919207128015e-10
. O 0 5.909340572429755e-09

Among O 0 1.531569593371529e-10
the O 0 4.827657371087035e-12
seven O 0 1.1178619661877942e-11
contributing O 0 9.92897691148853e-12
centers O 0 1.3887829688336017e-12
, O 0 8.088856935090699e-17
the O 0 5.1986121977305386e-15
proportion O 0 1.6874808841937927e-12
of O 0 7.372662593277401e-13
patients O 0 4.0990222826241263e-13
for O 0 4.029744853778494e-12
whom O 0 1.9781572213606324e-10
the O 0 1.4799897418704688e-10
observed O 0 1.1689758536159722e-11
phenotype O 0 1.8981771016113314e-11
did O 0 7.128418406769643e-13
not O 0 5.854991242271873e-14
match O 0 3.572174153698704e-11
the O 0 1.3937142238906741e-11
predicted O 0 2.0174731329980489e-10
phenotype O 0 2.9698247333564964e-11
was O 0 4.84037939937898e-13
4 O 0 2.4544073913036757e-13
% O 0 1.2560814367790218e-11
- O 0 2.085944047700017e-12
23 O 0 4.118891859528073e-12
% O 0 1.4408250981201576e-10
( O 0 2.1255878459268407e-13
P O 0 3.118962865755748e-08
< O 0 3.637215251206527e-10
. O 0 1.2427470890471332e-13
0001 O 0 9.177409700245054e-12
) O 0 4.017235599739383e-16
, O 0 1.6823675754136307e-16
suggesting O 0 4.613621767610154e-14
that O 0 3.120818514077789e-16
differences O 0 4.2399298048195755e-13
in O 0 1.2316878668987784e-15
methods O 0 4.8440205839550554e-12
used O 0 1.398852686245941e-13
for O 0 1.922067512745082e-13
mutation O 0 4.6789235680355645e-11
detection O 0 4.163400646461923e-08
or O 0 2.1198337529781952e-10
phenotype O 0 3.1743077055779167e-09
classification O 0 1.5085948115722836e-11
may O 0 5.744286746571167e-14
account O 0 2.5542044743359985e-14
for O 0 7.018083014146033e-15
a O 0 6.504313824736221e-14
considerable O 0 3.187140005037059e-12
proportion O 0 6.660026696803101e-12
of O 0 2.460249885760657e-11
genotype O 0 2.92163008452917e-07
- O 0 6.730576842528535e-06
phenotype O 0 1.9369743142760854e-07
inconsistencies O 0 5.099986424283998e-07
. O 0 1.6430920624088685e-08

Our O 0 3.1448146309287495e-09
data O 0 1.677341598949056e-11
indicate O 0 4.155004790749872e-13
that O 0 7.900152552821221e-17
the O 0 1.0976831422981892e-13
PAH O 0 7.574552651767874e-10
- O 0 4.1893290052275045e-12
mutation O 0 3.5117667508775124e-14
genotype O 0 4.032620591620795e-12
is O 0 1.5054377452043764e-16
the O 0 3.067962228801022e-15
main O 0 2.3669774907447705e-12
determinant O 0 1.3651478558696084e-10
of O 0 1.0480016160441252e-10
metabolic O 0 3.164256767718143e-08
phenotype O 0 5.785322221285583e-10
in O 0 2.5917887627735503e-12
most O 0 5.663536046390805e-12
patients O 0 9.7547880884008e-10
with O 0 1.1461096072196142e-08
PAH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
. O 0 6.401133578037843e-05

In O 0 2.569541628083538e-11
the O 0 1.011721739371807e-12
present O 0 1.0865001389900875e-12
study O 0 5.849328742316183e-15
, O 0 2.2275753866010096e-17
the O 0 9.055916171506607e-16
classification O 0 3.432349348318764e-13
of O 0 2.948445307349168e-11
105 O 0 5.972412964183604e-07
PAH O 0 7.87549106462393e-06
mutations O 0 1.6593065810255325e-10
may O 0 1.4490992227781524e-13
allow O 0 1.427019445535485e-13
the O 0 3.4641354455106077e-13
prediction O 0 3.3818681188790833e-10
of O 0 4.856796388674756e-12
the O 0 6.838568340078455e-12
biochemical O 0 8.898431991255507e-11
phenotype O 0 1.1896453266935225e-10
in O 0 2.5780344872772254e-11
> O 0 3.4346925303907483e-10
10 O 0 5.501886706643644e-12
, O 0 5.591273632781467e-14
000 O 0 1.4941486936592696e-10
genotypes O 0 2.8488955639005553e-09
, O 0 1.435383658720396e-13
which O 0 2.2074955507615053e-15
may O 0 1.971369573659787e-14
be O 0 5.3685497074327376e-14
useful O 0 1.7939455476678745e-11
for O 0 4.118777665934256e-14
the O 0 4.195142063595503e-12
management O 0 5.100827538129238e-10
of O 0 1.6931448465484777e-09
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.3133445442292668e-08
newborns O 0 4.248975216114559e-08
. O 0 2.6356723470399857e-09

Somatic O 0 9.228960152540822e-06
instability O 0 0.00010222085984423757
of O 0 1.149011723100557e-06
the O 0 8.379365112887172e-08
CTG O 0 0.00016317596600856632
repeat O 0 4.4262185583399116e-10
in O 0 8.742822004553785e-13
mice O 0 2.937910873780647e-13
transgenic O 0 1.5674446332894498e-13
for O 0 4.662334886516633e-15
the O 0 8.373053986265866e-12
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 7.066085316864701e-08
is O 0 6.307901792047821e-14
age O 0 2.152392847287743e-12
dependent O 0 2.7822865539262054e-12
but O 0 5.953599768672609e-16
not O 0 2.2989549920324724e-15
correlated O 0 3.0222929194023695e-12
to O 0 1.6323392832730266e-13
the O 0 1.1636341846685272e-12
relative O 0 1.6523215018438009e-09
intertissue O 0 2.275419745956242e-07
transcription O 0 8.377347704424665e-09
levels O 0 1.9356107827661617e-08
and O 0 1.64690247550503e-10
proliferative O 0 5.528097062779125e-06
capacities O 0 1.34551794417348e-06
. O 0 8.086946223784253e-09

A O 0 6.825805030530319e-06
( O 0 1.0964726522566526e-11
CTG O 0 6.270015546760987e-07
) O 0 1.8446305409796498e-13
nexpansion O 0 1.528349358181913e-08
in O 0 5.70894351757667e-13
the O 0 1.6430228488503729e-12
3 O 0 2.134556593980097e-11
- O 0 5.9002176477918056e-09
untranslated O 0 0.000552679062820971
region O 0 9.560531255559113e-10
( O 0 1.0644497876720078e-15
UTR O 0 3.6104406131443056e-09
) O 0 5.647645644772843e-16
of O 0 8.432590021222042e-13
the O 0 5.984879258846831e-11
DM O 1 1.0
protein O 0 7.06921010618089e-09
kinase O 0 1.4453033214678612e-10
gene O 0 2.687026816328153e-12
( O 0 6.67749682587912e-14
DMPK O 1 0.7548702359199524
) O 0 1.0128038171856608e-14
is O 0 4.042723879913449e-16
responsible O 0 8.973103157857917e-14
for O 0 7.01247003173644e-13
causing O 0 6.422442311304621e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.1862969495624043e-09
DM B-Disease 1 1.0
) O 0 1.3982779344112739e-11
. O 0 2.6949081854965584e-10

Major O 0 5.264035962682101e-07
instability O 0 3.316823858767748e-05
, O 0 1.8159013789181833e-12
with O 0 1.1448985206066742e-13
very O 0 6.664852046991965e-13
large O 0 1.9684503593103697e-14
expansions O 0 4.218612004863731e-12
between O 0 1.0483825179513628e-12
generations O 0 3.667251224914736e-11
and O 0 3.697989316023623e-14
high O 0 1.7115164537354066e-12
levels O 0 1.3330860720861537e-11
of O 0 6.61079481087401e-12
somatic O 0 1.610047373201695e-10
mosaicism O 0 2.0832562341865923e-08
, O 0 1.7152901007119054e-13
is O 0 1.2579856352847116e-14
observed O 0 5.036040486537663e-13
in O 0 1.684991556005766e-12
patients O 0 4.2030889185751263e-11
. O 0 7.432355286773884e-10

There O 0 1.6579873585165217e-10
is O 0 9.804385358051435e-14
a O 0 3.137445273200534e-13
good O 0 2.921964406543687e-11
correlation O 0 2.01391958665198e-11
between O 0 1.1005227111560156e-11
repeat O 0 1.2026930840125516e-10
size O 0 6.8039475963066476e-12
( O 0 1.4765610473676735e-14
at O 0 4.981319718690147e-13
least O 0 1.2556603604379091e-14
in O 0 3.25126244557581e-14
leucocytes O 0 1.098116708675434e-09
) O 0 1.2952574566561532e-14
, O 0 3.298997664944684e-15
clinical O 0 6.327389241896075e-13
severity O 0 2.840042437335377e-12
and O 0 5.295385711954342e-15
age O 0 1.8060167944478067e-11
of O 0 6.257581952606728e-11
onset O 0 1.3347190908064022e-08
. O 0 3.4910858648373733e-09

The O 0 2.2085231421442586e-07
trinucleotide O 0 0.0022223780397325754
repeat O 0 8.636732218292309e-07
instability O 0 3.3271189749939367e-06
mechanisms O 0 1.4892451716264077e-08
involved O 0 3.5435688671564547e-12
in O 0 7.70457569271299e-12
DM B-Disease 1 1.0
and O 0 1.64851708672753e-11
other O 0 1.1315691222577029e-12
human O 0 1.682124128876694e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 3.04535483473551e-14
unknown O 0 8.920965355319055e-11
. O 0 1.578075309316418e-10

We O 0 1.2056956544270747e-09
studied O 0 5.515509160503029e-10
somatic O 0 4.9498285470406245e-09
instability O 0 6.543448560769605e-10
by O 0 2.8958833351048693e-14
measuring O 0 1.9677476661983384e-11
the O 0 1.746335389664344e-12
CTG O 0 1.2631804935381297e-08
repeat O 0 1.2565343730785994e-11
length O 0 9.040091591971944e-12
at O 0 3.149935011177024e-13
several O 0 3.3552474289059477e-15
ages O 0 1.9479771528468914e-12
in O 0 4.021944520590966e-15
various O 0 4.60055767353279e-13
tissues O 0 3.9170375276675884e-11
of O 0 2.064287109304619e-11
transgenic O 0 3.513633177812392e-12
mice O 0 5.280907005092428e-13
carrying O 0 3.5189063468665793e-11
a O 0 6.154518561451994e-11
( O 0 1.155124932337992e-12
CTG O 0 5.1553616486899045e-08
) O 0 1.1558074918156802e-13
55expansion O 0 1.7356520665146036e-09
surrounded O 0 4.161685319276076e-12
by O 0 3.9646685762141035e-15
45 O 0 1.7716121972211063e-11
kb O 0 6.540744390548525e-09
of O 0 2.2687376283192506e-11
the O 0 6.481471609420808e-12
human O 0 1.1566655411243687e-09
DM B-Disease 1 1.0
region O 0 1.4124760028266792e-08
, O 0 1.1302651794099089e-14
using O 0 3.247979142584345e-13
small O 0 2.8296232544577915e-12
- O 0 6.441261413137056e-11
pool O 0 1.0141126133289546e-10
PCR O 0 1.364508173118395e-09
. O 0 1.7202442803565532e-09

These O 0 9.951334895008657e-11
mice O 0 4.30138173343475e-12
have O 0 1.3839893671336667e-15
been O 0 3.2550438547622376e-16
shown O 0 2.050466018494162e-15
to O 0 1.0239960870342055e-14
reproduce O 0 9.774129422490674e-12
the O 0 3.6789684796853517e-13
intergenerational O 0 7.627152243117052e-09
and O 0 8.231893899174336e-13
somatic O 0 2.612859262285383e-08
instability O 0 2.918967823006824e-07
of O 0 3.195691267166012e-09
the O 0 7.240078536696615e-10
55 O 0 3.887242527866874e-08
CTG O 0 2.647554993018275e-06
repeat O 0 6.475028291319518e-10
suggesting O 0 5.826291532562422e-11
that O 0 9.971055014643126e-15
surrounding O 0 1.4779319261470913e-12
sequences O 0 3.098876407217621e-13
and O 0 3.796444360054316e-14
the O 0 1.4433129170987602e-12
chromatin O 0 3.877064502777472e-10
environment O 0 7.00435320855064e-10
are O 0 2.6997335438169387e-14
involved O 0 1.3513933028175273e-11
in O 0 3.9170822835332686e-11
instability O 0 1.5615469806107285e-07
mechanisms O 0 2.1715851517001283e-07
. O 0 3.9893790493295e-09

As O 0 1.5844200951242726e-11
observed O 0 7.130648610638446e-13
in O 0 2.296129628933611e-14
some O 0 2.2693560609653813e-15
of O 0 1.230923457780364e-13
the O 0 2.1523424318867224e-13
tissues O 0 1.3499848461329123e-10
of O 0 2.0191208427444707e-10
DM B-Disease 1 1.0
patients O 0 1.542260485987157e-10
, O 0 2.674701009720143e-14
there O 0 8.960937731856272e-15
is O 0 1.8321796458165387e-16
a O 0 9.462181336855266e-15
tendency O 0 6.392567139697214e-13
for O 0 3.099158706358282e-14
repeat O 0 1.2629015021248247e-11
length O 0 4.501144595936424e-11
and O 0 6.022294750558654e-13
somatic O 0 3.537609372106232e-10
mosaicism O 0 7.253807776663734e-09
to O 0 1.0699023047719414e-12
increase O 0 3.3915781966729897e-13
with O 0 4.989850975242586e-16
the O 0 7.562972871664325e-14
age O 0 1.0144234410813802e-11
of O 0 2.877145136720438e-12
the O 0 4.6409512517719964e-12
mouse O 0 1.167165114557278e-10
. O 0 8.303578380441934e-10

Furthermore O 0 8.107265969670152e-10
, O 0 8.931111160684607e-15
we O 0 8.727546379448941e-16
observed O 0 1.2146663163072296e-15
no O 0 4.9061395693332806e-17
correlation O 0 4.2138343290772703e-16
between O 0 5.743458835392697e-16
the O 0 1.5306048410727554e-15
somatic O 0 2.392473892609548e-11
mutation O 0 1.6913163577991774e-11
rate O 0 2.914233784845344e-11
and O 0 9.222958768234646e-13
tissue O 0 2.1011608009047222e-09
proliferation O 0 2.6232056526964698e-08
capacity O 0 1.3070919457902619e-08
. O 0 8.166551879185135e-10

The O 0 1.040822761311233e-09
somatic O 0 9.450868532212553e-08
mutation O 0 3.0480677010169543e-11
rates O 0 4.398498167253184e-13
in O 0 3.7986717178924156e-16
different O 0 3.2239984878827677e-14
tissues O 0 1.0015367007953913e-11
were O 0 2.7658366048843863e-12
also O 0 7.536829284450616e-16
not O 0 4.2557547837302737e-16
correlated O 0 5.69418644180697e-13
to O 0 1.6342396186308505e-13
the O 0 1.1379237396108577e-12
relative O 0 1.0561033825240429e-08
inter O 0 8.232681238951045e-07
- O 0 7.813883229346175e-08
tissue O 0 1.680700201234231e-08
difference O 0 3.791818942167069e-11
in O 0 2.171242413564079e-14
transcriptional O 0 5.789971366937374e-13
levels O 0 8.428457584641613e-13
of O 0 1.0894690911141675e-13
the O 0 1.501651010298293e-14
three O 0 5.189124412281754e-14
genes O 0 1.0680953327736956e-13
( O 0 5.254877631801326e-15
DMAHP O 0 1.463002263335511e-06
, O 0 1.4038437296318151e-12
DMPK O 0 6.894856778671965e-05
and O 0 3.3912434492522348e-12
59 O 0 2.632070339458892e-09
) O 0 1.7022436249198442e-13
surrounding O 0 2.162764412005913e-11
the O 0 1.044819179091272e-12
repeat O 0 4.475744080911781e-11
. O 0 8.391679712227429e-12
. O 0 4.1473624534660303e-10

A O 0 9.49098133418147e-10
novel O 0 1.8296831064135155e-12
missense O 0 1.2976896890393164e-08
mutation O 0 7.491598487396889e-12
in O 0 3.3461548690303516e-14
patients O 0 6.868001718556005e-13
from O 0 2.1796500964798432e-13
a O 0 6.968630316891988e-13
retinoblastoma B-Disease 0 2.501916469554999e-07
pedigree O 0 5.800218527696188e-09
showing O 0 2.2901640306383086e-10
only O 0 6.499356716878346e-13
mild O 0 2.184261208319424e-13
expression O 0 1.0575143191693392e-12
of O 0 1.64590541716636e-12
the O 0 3.955701651653376e-12
tumor B-Disease 0 5.672655678523597e-10
phenotype O 0 7.846400612576687e-11
. O 0 1.0705001329824881e-09

We O 0 2.8710766403206023e-12
have O 0 2.0190683335542375e-16
used O 0 8.097902982269578e-17
single O 0 3.5032151909453278e-15
strand O 0 5.231098028840109e-15
conformation O 0 4.19829102038527e-14
polymorphism O 0 4.669684344066338e-12
analysis O 0 5.68901615269693e-14
to O 0 1.7434588928805228e-13
study O 0 2.111131094158919e-13
the O 0 4.30863813594487e-13
27 O 0 4.2993844595606845e-10
exons O 0 1.7356164505599736e-08
of O 0 8.130459500099718e-11
the O 0 2.3509832969281774e-11
RB1 O 0 3.130877246348973e-08
gene O 0 5.046393600845363e-14
in O 0 8.691635464738029e-15
individuals O 0 1.3291368602518644e-13
from O 0 1.2729953809825778e-12
a O 0 6.4392558125903054e-12
family O 0 1.3727506111005372e-11
showing O 0 2.1694472884803417e-09
mild O 0 1.796301302148251e-11
expression O 0 2.310547413120201e-11
of O 0 6.29511096028601e-11
the O 0 2.6602456348889802e-11
retinoblastoma B-Disease 0 2.8774254090535578e-08
phenotype O 0 2.09425099484406e-09
. O 0 3.99213462287662e-09

In O 0 2.0132666367356222e-11
this O 0 1.4940445798930502e-12
family O 0 2.040209147458061e-12
affected O 0 1.5111255345992558e-12
individuals O 0 2.019309266782128e-14
developed O 0 1.4367325905373374e-11
unilateral B-Disease 0 9.099493603059727e-09
tumors I-Disease 1 1.0
and O 0 4.7362357091795815e-11
, O 0 2.8877917987663385e-14
as O 0 6.138679008746515e-15
a O 0 2.7751657241214915e-14
result O 0 2.318934757758462e-12
of O 0 8.098297726855108e-11
linkage O 0 3.9948009344925595e-09
analysis O 0 7.299003068617083e-11
, O 0 3.5723065673100296e-13
unaffected O 0 7.302930482566694e-11
mutation O 0 2.757601818333816e-13
carriers O 0 4.977157466549975e-14
were O 0 2.6578201445248695e-12
also O 0 6.237968719043432e-14
identified O 0 7.616427454004704e-12
within O 0 4.9522223127818066e-11
the O 0 1.4132904048447248e-11
pedigree O 0 1.2055858533699393e-08
. O 0 3.5007678977905243e-09

A O 0 6.638802285685586e-10
single O 0 4.176969967822908e-12
band O 0 4.597971742931195e-12
shift O 0 1.0001088499023147e-11
using O 0 8.549714213511306e-13
SSCP O 0 0.000243149625021033
was O 0 8.74099143760576e-12
identified O 0 5.328259968656601e-12
in O 0 8.970112521690388e-13
exon O 0 4.1267655959131844e-11
21 O 0 1.021120362744432e-12
which O 0 6.971836603412724e-16
resulted O 0 2.78042291881192e-13
in O 0 2.8183574587612933e-14
a O 0 9.326445865598387e-13
missense O 0 7.446416816492274e-10
mutation O 0 4.736339358907271e-13
converting O 0 1.1753774342704304e-10
a O 0 3.268484094487434e-11
cys O 0 2.67515883933811e-06
- O 0 1.238089112121088e-06
- O 0 2.151728750732218e-07
> O 0 2.9096653975102527e-09
arg O 0 8.046104060799308e-11
at O 0 2.5497679054936606e-12
nucleotide O 0 2.2049363203324734e-12
position O 0 9.538810713527468e-12
28 O 0 6.562978892982185e-12
in O 0 4.3361164268548857e-13
the O 0 2.7086090315098232e-11
exon O 0 6.506129857086762e-09
. O 0 6.2794920374642516e-09

The O 0 2.0311180515264482e-10
mutation O 0 5.1637971676399275e-11
destroyed O 0 9.015717616911445e-10
an O 0 9.158223224919881e-13
NdeI O 0 1.4708038520439004e-07
restriction O 0 1.784214442857035e-10
enzyme O 0 3.054389241530231e-10
site O 0 4.3840991947874386e-10
. O 0 3.918145252690408e-10

Analysis O 0 3.316431851363433e-10
of O 0 1.320690917738787e-10
all O 0 9.229792277687388e-12
family O 0 6.708060214070943e-13
members O 0 1.4875543491769082e-14
demonstrated O 0 1.877816045020575e-12
that O 0 7.617443527623176e-16
the O 0 4.763364182258645e-13
missense O 0 9.016220658963903e-09
mutation O 0 1.4877503395904768e-10
co O 0 1.1923377840616922e-09
- O 0 7.788781886119978e-08
segregated O 0 5.296674654431399e-09
with O 0 5.1352175414525955e-14
patients O 0 5.5180712429936385e-12
with O 0 5.14537482174289e-14
tumors B-Disease 1 1.0
or O 0 1.947229710808074e-09
who O 0 1.765041932055844e-11
, O 0 4.2550368068404454e-14
as O 0 1.3530005397034261e-14
a O 0 3.7791703089411904e-14
result O 0 1.2369757128316561e-11
of O 0 5.203198427672362e-10
linkage O 0 6.21549034462987e-09
analysis O 0 1.3223588023192345e-11
had O 0 2.264977891656625e-13
been O 0 4.071406162512933e-14
predicted O 0 7.834380523876264e-14
to O 0 8.1038948880445e-14
carry O 0 1.6266129068687185e-11
the O 0 2.8499961071681845e-11
predisposing O 0 1.7090513892981107e-07
mutation O 0 6.014868159098796e-09
. O 0 3.770273870884466e-09

These O 0 2.2986878026043378e-11
observations O 0 2.0465915073764052e-10
point O 0 2.5136104135625725e-12
to O 0 3.8957142497802674e-14
another O 0 8.694591270910768e-14
region O 0 1.3676126203732153e-11
of O 0 2.6878061408497356e-12
the O 0 2.4362189782883847e-12
RB1 O 0 5.867731189823644e-08
gene O 0 5.869327918649192e-13
where O 0 1.2980577984017527e-13
mutations O 0 2.0425677750741944e-13
only O 0 1.31608642034561e-14
modify O 0 6.753175275930889e-12
the O 0 3.335254164862911e-13
function O 0 1.7419383643857422e-11
of O 0 2.622615232622527e-12
the O 0 1.1087982745502933e-12
gene O 0 1.1467605023126465e-13
and O 0 1.1446365502567474e-13
raise O 0 2.1522614419844377e-12
important O 0 1.1989243148616269e-12
questions O 0 1.4550407319985359e-12
for O 0 9.457369512088504e-14
genetic O 0 2.166438903272727e-11
counseling O 0 2.357242526174197e-11
in O 0 2.0178654144202383e-14
families O 0 5.031335591210162e-13
with O 0 4.495026821192596e-15
these O 0 5.225867481806201e-13
distinctive O 0 1.1237257652174648e-11
phenotypes O 0 2.0264848826778703e-11
. O 0 1.1083083235885471e-11
. O 0 9.371555753645566e-10

Maternal B-Disease 0 1.2573245840030722e-06
disomy I-Disease 0 1.5694986359449103e-06
and O 0 5.5355156014513796e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.030701927840709686
with O 0 3.1580170776872047e-15
gamete O 0 1.7270134211599952e-09
complementation O 0 1.6286675119658867e-08
in O 0 1.0913700363357134e-13
a O 0 1.6900270720095027e-14
case O 0 1.6794518656630328e-14
of O 0 4.368937503440584e-11
familial O 0 1.912782998658713e-08
translocation O 0 4.4054111469904456e-08
( O 0 5.1878179486639087e-14
3 O 0 1.2516373571261341e-12
; O 0 3.8221336834984125e-15
15 O 0 4.1208385987388796e-13
) O 0 3.771051826367025e-16
( O 0 1.1742310545178979e-16
p25 O 0 1.0067576980410387e-11
; O 0 6.124340858531868e-15
q11 O 0 1.0171636449785026e-10
. O 0 3.3575217123693255e-14
2 O 0 1.3942232784946995e-13
) O 0 3.4046106455994443e-14
. O 0 3.0188719579715695e-11

Maternal B-Disease 0 0.3000856637954712
uniparental I-Disease 1 0.9982413053512573
disomy I-Disease 1 0.9871529936790466
( I-Disease 0 2.1827861740320031e-10
UPD I-Disease 1 1.0
) I-Disease 0 6.510162959931509e-13
for I-Disease 0 8.489784396326083e-13
chromosome I-Disease 0 1.4171268325480213e-10
15 I-Disease 0 4.312019491470309e-12
is O 0 1.0951850134378405e-15
responsible O 0 5.3723393328387534e-14
for O 0 3.4388087538118894e-14
an O 0 2.1650960460372704e-15
estimated O 0 1.848235885897661e-14
30 O 0 1.856546736006895e-13
% O 0 6.747094744886939e-13
of O 0 7.177578259322834e-16
cases O 0 5.362648704174925e-16
of O 0 1.1108871600384873e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.660631359205581e-07
PWS B-Disease 1 1.0
) O 0 3.3864751280976435e-11
. O 0 8.856557154324207e-11

We O 0 7.742306101787833e-11
report O 0 5.69257911208626e-13
on O 0 1.7087398932868342e-13
an O 0 2.794550687218293e-16
unusual O 0 6.239489058480459e-15
case O 0 5.378552827726632e-14
of O 0 8.625691827468529e-11
maternal B-Disease 0 1.984214577532839e-06
disomy I-Disease 0 3.789777838392183e-05
15 I-Disease 0 1.3290052391923268e-09
in O 0 5.879160352995072e-11
PWS B-Disease 1 1.0
that O 0 2.789314731879017e-13
is O 0 1.0041326562013238e-14
most O 0 4.042679463623277e-15
consistent O 0 8.329758757752437e-12
with O 0 4.001089214176849e-14
adjacent O 0 8.914468468956827e-11
- O 0 3.391929315546549e-12
1 O 0 6.534468197658475e-14
segregation O 0 2.956108968721338e-11
of O 0 5.218884677714308e-13
a O 0 5.428096123624715e-13
paternal O 0 7.739862972755418e-09
t O 0 2.7917327737742026e-12
( O 0 1.7477254317171606e-15
3 O 0 1.5882733767503404e-13
; O 0 6.845444994001398e-16
15 O 0 8.804080104925574e-14
) O 0 3.390355581375989e-17
( O 0 8.910917299652023e-18
p25 O 0 3.919374373662077e-12
; O 0 5.083067480483514e-16
q11 O 0 1.1766418568648351e-11
. O 0 3.61925981644991e-16
2 O 0 9.434275465831059e-17
) O 0 8.474906366269836e-19
with O 0 4.641636326196384e-18
simultaneous O 0 2.0654164142874798e-12
maternal O 0 5.336117103738047e-10
meiotic O 0 1.7178950884044752e-07
nondisjunction O 0 1.4107615697867004e-07
for O 0 2.7243237180063495e-11
chromosome O 0 3.7355696314023135e-10
15 O 0 4.5720296992790566e-10
. O 0 1.5785156515235599e-09

The O 0 5.9528407092557245e-08
patient O 0 8.549179142391949e-07
( O 0 5.623723803803958e-14
J O 0 1.170047836396293e-09
. O 0 8.318973765061854e-13
B O 0 4.8861793083831984e-11
. O 0 9.322452240777355e-15
) O 0 1.1933959690429145e-16
, O 0 8.781140933348578e-17
a O 0 1.7382440625429512e-15
17 O 0 5.780104720591941e-14
- O 0 4.473705816064079e-14
year O 0 5.695992288945462e-12
- O 0 5.930138602394663e-09
old O 0 1.1352809679010534e-06
white O 0 6.65109287090182e-11
male O 0 1.5776840944781156e-10
with O 0 3.787953024164681e-14
PWS B-Disease 1 1.0
, O 0 3.5123981631177137e-13
was O 0 6.381326456833536e-12
found O 0 3.4209703754679854e-13
to O 0 7.31226537653562e-12
have O 0 1.094055076568401e-12
47 O 0 2.3241576718735502e-10
chromosomes O 0 1.8612190955114016e-10
with O 0 8.519177117222165e-13
a O 0 4.155540148098602e-11
supernumerary O 0 2.571316372268484e-06
, O 0 5.015624634369109e-12
paternal O 0 1.4386379199038402e-08
der O 0 4.1460854305341854e-08
( O 0 1.9476754193822887e-13
15 O 0 2.4216995596348934e-12
) O 0 1.960190543994999e-16
consisting O 0 2.462128604837667e-14
of O 0 4.2407223566076624e-13
the O 0 2.87832366448193e-13
short O 0 2.8210656467103634e-12
arm O 0 6.477313130304196e-10
and O 0 1.4144244044229926e-13
the O 0 6.9535510162366254e-12
proximal O 0 2.9759305562038207e-06
long O 0 4.294139488436599e-10
arm O 0 1.7000002117129043e-07
of O 0 1.0577383413590269e-08
chromosome O 0 4.8643435945905367e-08
15 O 0 2.0134300893204227e-09
, O 0 1.5476859973728024e-13
and O 0 3.9099870259920455e-13
distal O 0 4.847427135246107e-07
chromosome O 0 1.055150960382889e-06
arm O 0 0.00018731722957454622
3p O 0 0.07078034430742264
. O 0 1.2393071529004374e-06

The O 0 3.2711182029743213e-07
t O 0 3.1655994492396644e-10
( O 0 1.8476436404609407e-14
3 O 0 9.162241278171113e-13
; O 0 1.6657776410482672e-15
15 O 0 2.6671321943540216e-13
) O 0 3.688827955896886e-16
was O 0 6.142617881357837e-14
present O 0 1.0943216412250337e-13
in O 0 3.0364212629441136e-15
the O 0 2.6059183768647153e-14
balanced O 0 3.4492349840035963e-13
state O 0 6.842785734063493e-15
in O 0 4.496810672579513e-15
the O 0 8.392791398924987e-14
patients O 0 3.0829706192461726e-13
father O 0 2.340673444997665e-12
and O 0 3.771251431798628e-13
a O 0 1.095135579443074e-10
sister O 0 1.2259218529209193e-08
. O 0 1.888170686470403e-08

Fluorescent O 0 1.035057928255867e-09
in O 0 3.322949988088242e-12
situ O 0 8.768737402853333e-10
hybridization O 0 3.3437592972251906e-12
analysis O 0 3.663190830858164e-14
demonstrated O 0 1.8089590697774327e-13
that O 0 4.482028253584031e-16
the O 0 6.374559083713316e-13
PWS B-Disease 1 1.0
critical O 0 6.928724705090872e-09
region O 0 1.1198306726356577e-09
resided O 0 4.551410803799172e-09
on O 0 5.704516286425543e-12
the O 0 8.911381832107934e-13
derivative O 0 4.0742787615899445e-11
chromosome O 0 1.637411213561979e-11
3 O 0 5.333300532976704e-13
and O 0 2.1606087619442486e-14
that O 0 1.8138355062174115e-15
there O 0 1.0833102467920457e-14
was O 0 1.379657835458986e-13
no O 0 1.611629598763202e-14
deletion O 0 4.3839524024869014e-12
of O 0 5.568355672391778e-12
the O 0 6.843373090426041e-11
PWS B-Disease 1 1.0
region O 0 2.4504844375883295e-08
on O 0 2.039120781949233e-11
the O 0 7.621669137827802e-13
normal O 0 1.3160790512944942e-10
pair O 0 2.603557473779272e-11
of O 0 2.6052911564211634e-11
15s O 0 3.2353164591825134e-09
present O 0 5.397449848176805e-11
in O 0 1.0104517916831313e-10
J O 0 2.3668158632972336e-07
. O 0 1.0041894427104125e-08

B O 0 6.0076170484535396e-05
. O 0 2.6583832024584808e-08

Methylation O 0 1.2185197295622174e-09
analysis O 0 1.1076030370649192e-10
at O 0 6.233387417342584e-11
exon O 0 3.8703540372608813e-11
alpha O 0 1.844729881003704e-12
of O 0 6.656652312697631e-11
the O 0 3.497667433460805e-11
small O 0 2.0062278661275856e-12
nuclear O 0 4.376648377046877e-09
ribonucleoprotein O 0 1.62714982820944e-07
- O 0 1.913636138439756e-09
associated O 0 1.4663033287565241e-10
polypeptide O 0 1.37600775218516e-09
N O 0 4.1689190988236646e-10
( O 0 8.265943598744093e-16
SNRPN O 0 4.113467255706382e-08
) O 0 1.2761385148443488e-16
gene O 0 7.190732680993693e-16
showed O 0 1.94984494181075e-14
a O 0 1.2344630644713387e-15
pattern O 0 1.1058709286845825e-12
characteristic O 0 1.6243573868791883e-13
of O 0 3.1141338422899234e-13
only O 0 7.444285937468695e-14
the O 0 5.81047146161473e-13
maternal O 0 1.6286068327264758e-10
chromosome O 0 2.2890099538042108e-11
15 O 0 1.3141619736867227e-11
in O 0 3.309516896643494e-11
J O 0 1.511077414306783e-07
. O 0 1.8090947406790292e-08

B O 0 5.897935261600651e-05
. O 0 4.12137595162676e-08

Maternal B-Disease 0 9.934411536960397e-06
disomy I-Disease 0 5.154954010322399e-07
was O 0 1.7931578531055203e-12
confirmed O 0 5.451092390516311e-15
by O 0 4.474012310965576e-18
polymerase O 0 3.492234044058886e-15
chain O 0 2.8168337417803894e-16
reaction O 0 2.728824338495483e-17
analysis O 0 2.214816880041098e-15
of O 0 1.481788934718127e-14
microsatellite O 0 7.551003225469977e-12
repeats O 0 7.498703047392752e-12
at O 0 4.7672969223514286e-14
the O 0 1.5765048365064607e-14
gamma O 0 5.536887680117342e-13
- O 0 2.545726303371243e-11
aminobutyric O 0 1.6752393916519281e-09
acid O 0 3.4190171527281876e-11
receptor O 0 7.77875593799271e-13
beta3 O 0 3.4732199338805003e-09
subunit O 0 8.312220703410311e-12
( O 0 8.072823686660138e-14
GABRB3 O 0 1.1679545650622458e-06
) O 0 2.5638554322117424e-13
locus O 0 5.186025220371704e-11
. O 0 3.3652283737417577e-10

A O 0 8.116438948491123e-06
niece O 0 6.122061222413322e-07
( O 0 1.2322343937321706e-13
B O 0 2.528046660899008e-10
. O 0 1.1636107489609426e-14
B O 0 1.8869857933145884e-12
. O 0 2.6563040576167544e-16
) O 0 2.6312100365380496e-18
with O 0 2.8554446798897926e-17
45 O 0 2.546087798059593e-13
chromosomes O 0 5.854337847832625e-12
and O 0 6.457033800873202e-14
the O 0 1.1768680648061025e-12
derivative O 0 3.1332905020553525e-12
3 O 0 6.240444088128488e-14
but O 0 9.400116479952865e-16
without O 0 8.752894920362533e-14
the O 0 1.2604367419580265e-12
der O 0 2.220263084495855e-09
( O 0 4.5813254177708845e-14
15 O 0 1.7738428998229083e-12
) O 0 9.469651532175338e-16
demonstrated O 0 1.0776728901623622e-12
a O 0 1.8145329531461807e-13
phenotype O 0 1.545537309244338e-11
consistent O 0 3.701945434225751e-12
with O 0 6.005103077634814e-16
that O 0 5.054065072369527e-16
reported O 0 4.3915886823332057e-14
for O 0 1.182564788280993e-13
haploinsufficiency O 0 1.3785019348233618e-07
of O 0 1.804190352672208e-09
distal O 0 1.5003150792836095e-06
3 O 0 1.0585576859512003e-08
p O 0 7.148614145080501e-08
. O 0 4.430368072405599e-09

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 9.228256381277333e-09
with O 0 4.4563454489054966e-12
unbalanced O 0 8.68054712555022e-07
segregation O 0 1.7699735010978657e-08
of O 0 2.2142367939181895e-09
non O 0 0.0003291473549325019
- O 0 3.891073447448434e-06
Robertsonian O 1 0.9995291233062744
translocations O 0 0.020584585145115852
has O 0 3.9475872250964786e-14
been O 0 6.79272100468308e-15
reported O 0 2.184189312162861e-14
previously O 0 4.957755668673347e-13
but O 0 4.56880974364555e-15
has O 0 1.2190523323174512e-16
not O 0 1.555900950646913e-15
, O 0 1.017721838708185e-15
to O 0 7.282280789673579e-13
our O 0 1.3345521909791103e-10
knowledge O 0 1.6105589750736726e-08
, O 0 1.190008784872007e-13
been O 0 1.7517121108680256e-13
observed O 0 2.6018819260578696e-13
in O 0 3.275243981191653e-14
a O 0 3.5252578850855643e-13
case O 0 1.1349065133850478e-12
of O 0 2.8236808446990835e-09
PWS B-Disease 1 1.0
. O 0 5.0480025493016e-07

Furthermore O 0 1.1462324778221955e-07
, O 0 3.3776165458271334e-12
our O 0 1.1049253872963405e-10
findings O 0 7.020111488648118e-13
are O 0 4.865826822918835e-16
best O 0 1.6492065214022446e-14
interpreted O 0 2.5448727123560978e-14
as O 0 1.3072650804197249e-14
true O 0 9.503307862868127e-12
gamete O 0 4.716968149409695e-08
complementation O 0 1.5077031889632053e-07
resulting O 0 1.7100213467458047e-09
in O 0 3.702521067516784e-10
maternal B-Disease 0 0.00024742435198277235
UPD I-Disease 1 1.0
15 I-Disease 0 4.2599225480444147e-07
and O 0 9.551663282536538e-08
PWS B-Disease 1 1.0

Schwartz B-Disease 1 1.0
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 1.2584594060172094e-06
2 I-Disease 0 2.148858001260745e-11
and O 0 8.50368928918821e-13
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 2.2137983720499355e-12
a O 0 2.6905951425182373e-13
case O 0 1.908956670919359e-15
for O 0 3.4455496114127286e-15
" O 0 3.651849601795515e-13
lumping O 0 1.9541481280360706e-11
" O 0 4.139773593370144e-11
. O 0 1.595191617687064e-10

Recent O 0 1.5692860205751558e-11
studies O 0 2.73262180027975e-13
demonstrated O 0 8.133082965780525e-14
the O 0 6.901585914228939e-15
existence O 0 3.253560832208735e-12
of O 0 1.0953161121152188e-12
a O 0 1.8340742065272447e-13
genetically O 0 4.511496970276141e-13
distinct O 0 1.9258373108038684e-12
, O 0 1.900346792768756e-15
usually O 0 1.0331493791721196e-15
lethal O 0 5.074352464368333e-15
form O 0 2.187604040786422e-14
of O 0 8.203757768596165e-13
the O 0 1.1414348632943216e-11
Schwartz B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.227946559879568e-12
SJS B-Disease 1 0.9999890327453613
) O 0 1.994978618066745e-12
of O 0 2.097806657275214e-07
myotonia B-Disease 1 1.0
and O 0 2.136428975063609e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 1.5754873534251645e-12
which O 0 7.889232344661379e-14
we O 0 6.5946753266543645e-12
called O 0 1.1199160487862514e-09
SJS B-Disease 1 0.9999984502792358
type I-Disease 0 3.862760422634892e-06
2 I-Disease 0 4.3850903352904425e-08
. O 0 5.918319168074504e-09

This O 0 5.984631124000828e-10
disorder O 0 0.00010182345431530848
is O 0 4.4486999804457805e-13
reminiscent O 0 2.221685335701551e-10
of O 0 1.2518940051275962e-10
another O 0 9.76768058796873e-12
rare O 0 7.535665667857128e-12
condition O 0 9.884059863907169e-07
, O 0 1.9351102954734932e-14
the O 0 1.6873788824534053e-11
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8325357897808203e-09
SWS B-Disease 1 1.0
) O 0 6.900852637806501e-14
, O 0 1.0228671403462813e-15
which O 0 2.8123243501274443e-16
comprises O 0 5.599940473897773e-14
campomelia B-Disease 0 4.638639250487131e-09
at O 0 4.273009029942543e-11
birth O 0 3.7077809711405507e-09
with O 0 2.4630294331862146e-11
skeletal B-Disease 0 0.0019653555937111378
dysplasia I-Disease 1 0.8943955898284912
, O 0 6.855441127967543e-12
contractures B-Disease 0 0.0003601322532631457
, O 0 8.62476160368858e-13
and O 0 1.1497171216370144e-13
early B-Disease 0 1.6720343998244402e-09
death I-Disease 0 9.392332467328401e-10
. O 0 3.0626980951353744e-09

To O 0 1.7071070945728906e-10
test O 0 2.293388916274619e-11
for O 0 2.1213433299468315e-13
possible O 0 5.015321144496987e-11
nosologic O 0 3.0936103030398954e-06
identity O 0 6.5731105003408175e-09
between O 0 3.423245020783838e-11
these O 0 3.877975685798868e-13
disorders O 0 4.7358200694347374e-11
, O 0 1.0586786875045682e-16
we O 0 4.1238593130463663e-16
reviewed O 0 9.992841379672865e-14
the O 0 5.944505684137708e-14
literature O 0 3.46971664724402e-13
and O 0 1.4341014244800073e-15
obtained O 0 5.874154786721097e-13
a O 0 4.908665027182277e-14
follow O 0 2.144132310935576e-12
- O 0 3.987775821362449e-12
up O 0 1.101752911993048e-12
of O 0 1.860159595801214e-12
the O 0 1.3858029578473624e-13
only O 0 2.8654663819689674e-14
two O 0 2.3265301496303362e-14
surviving O 0 3.135846859958491e-10
patients O 0 1.0549476873664143e-12
, O 0 4.3991147394761496e-15
one O 0 1.6001991940718663e-13
with O 0 3.612984043888101e-12
SJS B-Disease 1 0.8762833476066589
type I-Disease 0 4.0374854393121495e-07
2 I-Disease 0 5.44609690678044e-10
at O 0 1.2075132560518398e-10
age O 0 2.5512481016676247e-11
10 O 0 7.101924029331158e-14
years O 0 1.0234024863447697e-14
and O 0 3.074838389327273e-16
another O 0 1.7701638427096954e-14
with O 0 3.290517543771271e-13
SWS B-Disease 0 9.599178156349808e-05
at O 0 5.195272684277441e-11
age O 0 2.5569771994193857e-11
7 O 0 8.32761463953613e-12
years O 0 3.951765130405516e-12
. O 0 2.51419801644559e-10

Patients O 0 7.447926719805764e-09
reported O 0 5.88328517847625e-12
as O 0 9.528817757628941e-14
having O 0 2.0864305075307676e-11
either O 0 1.441488137743363e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 5.1660514088780474e-08
SWS B-Disease 1 0.9999830722808838
presented O 0 1.3885836653692446e-13
a O 0 1.3509653524652345e-15
combination O 0 4.584557780200902e-15
of O 0 4.689539297793484e-14
a O 0 6.016275802198101e-14
severe O 0 1.1682553795883122e-12
, O 0 4.506248821897589e-14
prenatal O 0 0.00018750775780063123
- O 0 1.573201529936341e-06
onset O 0 0.028875838965177536
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 4.739429877199941e-13
with O 0 2.0944647058374066e-11
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 0 0.03824791684746742
respiratory O 1 1.0
and O 0 1.779817893066138e-08
feeding O 0 7.435906468344911e-07
difficulties O 0 0.05179319530725479
, O 0 3.9938117916971105e-12
tendency O 0 1.1135984356869244e-09
to O 0 1.6472835318026569e-09
hyperthermia B-Disease 0 0.018220681697130203
, O 0 9.494660916861686e-13
and O 0 1.473975699524746e-13
frequent O 0 1.316695450587213e-12
death O 0 1.2565864147828787e-12
in O 0 8.096158834493272e-13
infancy O 0 2.4334174675288978e-09
) O 0 1.2250713749104199e-15
with O 0 4.80422476364299e-16
a O 0 9.008978730119105e-14
distinct O 0 2.31859097893361e-11
campomelic B-Disease 0 3.404451854294166e-05
- I-Disease 0 0.026908868923783302
metaphyseal I-Disease 0 0.0017748922109603882
skeletal I-Disease 1 0.9999885559082031
dysplasia I-Disease 1 0.9999996423721313
. O 0 1.635098669794388e-07

The O 0 2.957445399687231e-11
similarity O 0 6.180589373627754e-10
of O 0 1.947481342856605e-10
the O 0 4.937330405629936e-11
clinical O 0 2.0627650976212664e-10
and O 0 1.4367812495308385e-12
radiographic O 0 6.571170274582983e-08
findings O 0 3.908931858753739e-11
is O 0 1.9158042123199048e-14
so O 0 2.4484353008057645e-14
extensive O 0 4.1374053488807405e-11
that O 0 8.658084150884107e-14
these O 0 8.891047620362968e-12
disorders O 0 1.0555329943429115e-09
appear O 0 4.779666246124137e-12
to O 0 8.502132374868521e-13
be O 0 4.530994991095577e-13
a O 0 1.651386384408926e-12
single O 0 7.113553496251868e-11
entity O 0 1.773920921266381e-08
. O 0 4.6459117442054776e-08

The O 0 1.0494118074522163e-10
follow O 0 6.233934896071602e-11
- O 0 3.338828172272379e-11
up O 0 4.235581069905736e-13
observation O 0 9.915360754675362e-10
of O 0 1.5019532926402457e-12
an O 0 1.7785900417656864e-15
identical O 0 4.67514536198893e-13
and O 0 6.849885564227378e-16
unique O 0 6.921745891296655e-14
pattern O 0 2.5709389478434375e-11
of O 0 3.1419353230255354e-10
progressive O 0 0.016383150592446327
bone B-Disease 1 0.9998575448989868
dysplasia I-Disease 0 0.1200752779841423
in O 0 5.797292854103908e-11
the O 0 7.375286492639077e-11
two O 0 3.619488389561276e-12
patients O 0 1.5841112059253315e-12
( O 0 2.519462443916474e-15
one O 0 3.9103149971492224e-13
with O 0 1.6662503625128333e-12
SJS B-Disease 0 0.00010333992395317182
type I-Disease 0 2.024343137563278e-09
2 I-Disease 0 1.8568532128560022e-11
, O 0 1.7485799185543507e-14
one O 0 2.7543781803431554e-14
with O 0 8.723627560342645e-14
SWS B-Disease 1 0.5162332653999329
) O 0 7.57294820927755e-14
surviving O 0 8.951651087052426e-10
beyond O 0 9.261512445846165e-09
infancy O 0 6.798148888265132e-08
adds O 0 5.371809225739044e-13
to O 0 2.525527259111121e-13
the O 0 2.3525419893394295e-13
evidence O 0 4.5074027518222926e-13
in O 0 6.651247613656888e-14
favor O 0 1.3555779762586262e-11
of O 0 1.2272815576308549e-11
identity O 0 3.124285541389327e-08
. O 0 1.4244451840284e-08

The O 0 1.4008492976724796e-10
hypothesis O 0 1.630157536736121e-10
that O 0 1.3144471405421299e-12
SWS B-Disease 1 0.9999420642852783
and O 0 1.993002984868042e-10
SJS B-Disease 1 0.9999998807907104
type I-Disease 0 6.328672697009097e-08
2 I-Disease 0 2.5469744369122083e-11
are O 0 1.9340071197629892e-14
the O 0 4.98808893495406e-13
same O 0 3.1432943053966156e-11
disorder O 0 2.0961442304123779e-10
should O 0 3.088113057912907e-14
be O 0 5.453487122064789e-14
testable O 0 4.251496290436085e-12
by O 0 2.4840280911175112e-15
molecular O 0 1.1902205566613477e-12
methods O 0 1.3347456473411512e-10
. O 0 1.5094727551234755e-11
. O 0 1.017212647447252e-09

A O 0 4.0329475869960163e-10
mouse O 0 1.3954157924642163e-12
model O 0 9.309774088792078e-13
of O 0 3.705809530768489e-12
severe O 1 0.9998235106468201
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.07101909816265106
defects O 1 1.0
in O 0 6.159105936376363e-08
hemostasis O 1 1.0
and O 0 4.570453793206752e-09
thrombosis B-Disease 0 0.43545451760292053
. O 0 5.699296252714703e-07

von B-Disease 1 0.9999986886978149
Willebrand I-Disease 1 0.9997647404670715
factor I-Disease 0 7.295166869880632e-05
( I-Disease 0 1.86756765607754e-09
vWf I-Disease 1 0.9999513626098633
) I-Disease 0 2.2196009012986906e-06
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9511088728904724
humans O 0 8.243619475933883e-08
. O 0 7.103862498247793e-10

We O 0 9.716543541982148e-12
generated O 0 6.222998462021567e-13
a O 0 2.0690260350278086e-14
mouse O 0 1.2762378231046673e-13
model O 0 4.0113515265526034e-14
for O 0 6.169502537697099e-15
this O 0 4.5207029309227154e-14
disease O 0 5.166252489826814e-14
by O 0 1.841863383073248e-17
using O 0 4.9126830126708723e-14
gene O 0 3.150571708902816e-13
targeting O 0 2.560257839068214e-10
. O 0 6.386288164961229e-10

vWf B-Disease 0 0.000506402226164937
- I-Disease 0 0.10252813994884491
deficient I-Disease 0 0.0001336548157269135
mice O 0 4.744359571873247e-09
appeared O 0 2.0598349415035244e-11
normal O 0 7.3796138089221586e-09
at O 0 1.2790019694383647e-12
birth O 0 1.834232635569699e-12
; O 0 2.536570180110406e-15
they O 0 2.5680238168704524e-14
were O 0 5.161736489622815e-12
viable O 0 7.518625011471158e-08
and O 0 1.3214335875533223e-11
fertile O 0 7.265579711202008e-07
. O 0 4.1668064554301054e-09

Neither O 0 7.723238582002523e-07
vWf O 0 4.218248705001315e-06
nor O 0 1.6341103048489458e-07
vWf O 0 9.534110176900867e-06
propolypeptide O 0 7.207782618934289e-05
( O 0 2.4513033963780018e-11
von B-Disease 0 3.958664456149563e-05
Willebrand I-Disease 0 6.918954227330687e-07
antigen O 0 4.118725360768849e-09
II O 1 0.8201844096183777
) O 0 8.895920111662292e-11
were O 0 3.63296703831395e-09
detectable O 0 1.2435794616294515e-09
in O 0 9.210771793714823e-14
plasma O 0 2.9438244376900347e-12
, O 0 3.146232943566766e-15
platelets O 0 9.154803651267862e-12
, O 0 6.355253644304767e-14
or O 0 7.445965502159146e-13
endothelial O 0 5.945109855798325e-13
cells O 0 2.5736423409083997e-11
of O 0 2.1853231724211497e-10
the O 0 6.26994706154349e-11
homozygous O 0 2.357921670415042e-11
mutant O 0 1.4599767228506977e-10
mice O 0 1.877087374424491e-10
. O 0 2.0589992211217378e-10

The O 0 2.118851483157158e-10
mutant O 0 2.9469469087217703e-09
mice O 0 7.324398726415993e-11
exhibited O 0 1.2902194937436384e-11
defects O 0 1.9690533648031305e-08
in O 0 5.2241956420562286e-12
hemostasis O 0 0.0391121506690979
with O 0 3.3328901704460234e-12
a O 0 2.1023384422225178e-10
highly O 0 7.329663276323117e-08
prolonged O 0 0.00933980755507946
bleeding O 1 0.9999995231628418
time O 0 3.110906376946332e-08
and O 0 1.1845547112643295e-11
spontaneous O 0 3.727422370758404e-09
bleeding O 0 1.776012368281954e-07
events O 0 6.281191929427554e-13
in O 0 4.3668648070423893e-14
approximately O 0 7.546039497202586e-15
10 O 0 9.994422959591978e-14
% O 0 5.7846431637809115e-12
of O 0 2.2060046931532407e-12
neonates O 0 1.2478659217052268e-09
. O 0 5.9896589910124476e-09

As O 0 1.2077337394056364e-11
in O 0 1.9878673360174126e-13
the O 0 3.101093871710897e-13
human O 0 4.021981532542629e-12
disease O 0 4.0693934333368986e-11
, O 0 5.799490064853569e-16
the O 0 5.1228034265776365e-14
factor O 0 3.88627660868196e-13
VIII O 0 4.524777441616834e-09
level O 0 3.4506135193623777e-07
in O 0 4.738636566470333e-12
these O 0 3.334694445491365e-13
mice O 0 1.0486965029005146e-12
was O 0 1.9014183402690094e-13
reduced O 0 2.0118173620076174e-13
strongly O 0 9.538576932434026e-15
as O 0 7.030620160556581e-16
a O 0 5.105827361655355e-15
result O 0 2.2598256274077022e-13
of O 0 4.120722860156967e-12
the O 0 2.9660985039620114e-12
lack O 0 2.1827403773322374e-10
of O 0 2.977338211043734e-12
protection O 0 5.096475325094829e-12
provided O 0 9.197382438985713e-13
by O 0 5.064533861731668e-13
vWf O 0 2.2687496326057044e-08
. O 0 2.595804904359511e-09

Defective O 0 0.00022536971664521843
thrombosis B-Disease 0 4.564015398500487e-06
in O 0 5.3316989712115515e-11
mutant O 0 5.5848659030743875e-11
mice O 0 2.4046738992394845e-12
was O 0 1.1890491304240858e-13
also O 0 1.6334953625438337e-16
evident O 0 1.5139729747648545e-12
in O 0 3.804067741282899e-15
an O 0 4.2810236294314415e-17
in O 0 1.336586756427356e-15
vivo O 0 1.8845257385852188e-12
model O 0 5.906516942211226e-11
of O 0 1.9576680276855996e-09
vascular B-Disease 0 2.028140897891717e-06
injury I-Disease 1 0.9864873290061951
. O 0 4.25769684397892e-07

In O 0 1.5073084924308033e-12
this O 0 4.081340588434805e-15
model O 0 4.4566807926374463e-14
, O 0 3.491752770526168e-16
the O 0 2.773207892167208e-14
exteriorized O 0 8.003347318208398e-09
mesentery O 0 7.606801943893515e-08
was O 0 2.1011517525870715e-10
superfused O 0 6.511309180723401e-08
with O 0 5.249193549446141e-13
ferric O 0 4.23761026269176e-09
chloride O 0 8.150581598531659e-11
and O 0 9.497527764246172e-12
the O 0 4.806924858158368e-10
accumulation O 0 2.8831505005655345e-07
of O 0 1.7854152645213617e-07
fluorescently O 0 1.6854352580253362e-08
labeled O 0 5.3655069970348634e-11
platelets O 0 1.5937084985040428e-09
was O 0 2.5346891252553405e-11
observed O 0 1.3895719156494651e-13
by O 0 1.6761525029268878e-14
intravital O 0 2.741314064635958e-09
microscopy O 0 7.967391013607994e-08
. O 0 4.073793302694639e-09

We O 0 2.5448246288028997e-10
conclude O 0 3.565603634569925e-08
that O 0 1.741159300072681e-13
these O 0 1.4748643387303695e-13
mice O 0 5.188793405358494e-12
very O 0 1.2150104869695227e-13
closely O 0 1.8783265220978507e-10
mimic O 0 1.8788234967814788e-07
severe O 0 5.976013284225701e-08
human O 1 0.9999979734420776
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 4.428570932191178e-08
will O 0 2.2489791279278748e-11
be O 0 4.665382121425699e-13
very O 0 1.3814266266001015e-14
useful O 0 3.0352256081764284e-13
for O 0 8.058585698091504e-16
investigating O 0 5.299197360216987e-14
the O 0 2.2404098704281034e-13
role O 0 3.93042412852318e-12
of O 0 1.977858155033374e-11
vWf O 0 1.6746899422770412e-09
in O 0 1.5511690890090968e-11
normal O 0 1.0992639687401606e-07
physiology O 0 4.716425916484468e-09
and O 0 1.3293244272277044e-13
in O 0 2.765012340182754e-13
disease O 0 4.814826922577842e-13
models O 0 3.297755406424241e-13
. O 0 8.237265036736829e-13
. O 0 1.3263759535142583e-10

Oral O 0 1.763655177455803e-06
contraceptives O 0 3.263486902937984e-08
and O 0 6.05541482299847e-15
the O 0 4.3425471009904404e-13
risk O 0 3.0551599028427745e-09
of O 1 0.9999676942825317
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9991990923881531

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 1.6115311154862866e-05
Study O 0 4.973720046930197e-11
Group O 0 1.7205271495707164e-12
. O 0 2.4202798099004497e-10

BACKGROUND O 0 3.796535020228475e-05
Women O 0 6.598928001255722e-12
with O 0 7.1052266107925026e-15
mutations O 0 5.396020679978089e-14
in O 0 1.3210812042289792e-14
either O 0 6.199284141583661e-12
the O 0 7.255446243803476e-11
BRCA1 O 0 5.941343528270693e-10
or O 0 1.606554841417085e-12
the O 0 3.449217257298076e-12
BRCA2 O 0 3.7622030490958025e-11
gene O 0 5.2601250856128615e-14
have O 0 5.912614808970288e-15
a O 0 9.50860551862838e-15
high O 0 5.172029932153446e-14
lifetime O 0 5.584259096802491e-11
risk O 0 1.0045898335420134e-08
of O 0 9.047454113897402e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.1110297464256291e-06

Oral O 0 0.0001567110448377207
contraceptives O 0 5.870831955689937e-05
protect O 0 2.0045565207738036e-08
against O 1 0.9999969005584717
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 7.988159040905884e-07
general O 0 1.7484234893228034e-10
, O 0 1.4369195666229934e-14
but O 0 2.672160249691559e-15
it O 0 1.0772143491940035e-16
is O 0 9.113160643315523e-17
not O 0 2.689022346330787e-15
known O 0 5.69957289372515e-14
whether O 0 1.3297960551727356e-13
they O 0 9.62951289887326e-13
also O 0 6.924123004559829e-14
protect O 0 1.8400632580128917e-12
against O 0 1.4623998626644985e-12
hereditary B-Disease 1 0.9999979734420776
forms I-Disease 1 0.9999837875366211
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.10712970935856e-06

METHODS O 0 9.828585945115265e-08
We O 0 1.1617896748805645e-11
enrolled O 0 4.1170480219454575e-11
207 O 0 1.669114152447193e-11
women O 0 3.12443240767582e-13
with O 0 2.2971756441503288e-11
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.3297342787581554e-12
161 O 0 5.3843086239568905e-11
of O 0 7.802011481317095e-09
their O 0 3.6439135442378756e-07
sisters O 0 4.0508121301741085e-09
as O 0 3.952714891508613e-12
controls O 0 4.416899346271208e-10
in O 0 9.984216144814928e-13
a O 0 2.4650867284925493e-12
case O 0 3.903446576386527e-12
- O 0 6.08588290873513e-10
control O 0 1.155710749323191e-09
study O 0 2.6748582515612185e-11
. O 0 6.168691252250724e-11

All O 0 3.3401387124903925e-12
the O 0 6.467094112831695e-13
patients O 0 9.976919193143557e-14
carried O 0 6.052370247772859e-14
a O 0 1.199023587123045e-14
pathogenic O 0 3.96570319985412e-12
mutation O 0 6.185474224831844e-13
in O 0 5.297512645566216e-13
either O 0 9.669705036685627e-10
BRCA1 O 0 4.556883759221364e-09
( O 0 1.71449463513048e-14
179 O 0 3.3922109565764913e-10
women O 0 2.037591883413681e-12
) O 0 2.294435393632513e-14
or O 0 1.3869837570124055e-11
BRCA2 O 0 1.243316227750313e-09
( O 0 3.722020657176764e-14
28 O 0 7.967759785287853e-11
women O 0 1.867440013389454e-12
) O 0 2.0101872640412854e-13
. O 0 3.1303071246213676e-10

The O 0 3.297559447723586e-10
control O 0 6.745690117604397e-10
women O 0 8.062283208664506e-14
were O 0 1.4015126407508627e-13
enrolled O 0 6.73542341692035e-12
regardless O 0 9.452297972112333e-11
of O 0 1.4158779183814918e-11
whether O 0 1.6054268103717767e-13
or O 0 1.1594381054205738e-12
not O 0 4.2485025913974184e-13
they O 0 9.341347140257028e-13
had O 0 1.0225884375381078e-11
either O 0 4.515575691144136e-10
mutation O 0 2.6290849497456747e-09
. O 0 3.484114552421147e-09

Lifetime O 0 8.910737037126637e-09
histories O 0 4.5732702069756215e-09
of O 0 3.310200447081968e-10
oral O 0 2.7962502713307913e-07
- O 0 8.271489604361193e-10
contraceptive O 0 2.734835274909031e-11
use O 0 8.139503814333891e-15
were O 0 2.084020889886462e-14
obtained O 0 2.504530599838767e-13
by O 0 2.980862254351336e-15
interview O 0 1.934307965537063e-12
or O 0 1.4273719594723087e-15
by O 0 2.2856785380602044e-17
written O 0 8.048719484791665e-17
questionnaire O 0 1.1423276909084627e-15
and O 0 2.1499337327649448e-17
were O 0 7.765258400215577e-15
compared O 0 5.655005543697689e-13
between O 0 3.0582335708989605e-12
patients O 0 4.5359931631107353e-13
and O 0 4.490296565698654e-15
control O 0 7.743251179137545e-11
women O 0 4.484923581604336e-14
, O 0 3.087673850153932e-16
after O 0 2.706611620755233e-14
adjustment O 0 1.2513825912996435e-11
for O 0 4.7179409054379836e-15
year O 0 3.783102845746067e-13
of O 0 4.265254816004926e-12
birth O 0 8.213316832206274e-11
and O 0 1.2996668845299819e-11
parity O 0 1.064750492218991e-07
. O 0 8.933677797529072e-09

RESULTS O 0 1.9689734287453575e-09
The O 0 6.604417967376319e-12
adjusted O 0 3.357866415476529e-11
odds O 0 2.3185202022157902e-11
ratio O 0 2.1345128442540329e-10
for O 0 2.4069798931769526e-10
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.471826133192522e-10
with O 0 3.37714132476834e-15
any O 0 1.65973988432112e-14
past O 0 4.9777459850417274e-14
use O 0 1.4252779457959303e-14
of O 0 2.9137472599624625e-13
oral O 0 3.463823949889644e-10
contraceptives O 0 7.76283426429103e-10
was O 0 1.1902915285355586e-11
0 O 0 7.57099157672192e-12
. O 0 2.4872490178573514e-10

5 O 0 2.479460733950667e-11
( O 0 6.535012924546854e-15
95 O 0 1.6606942487840115e-09
percent O 0 1.7805674712434438e-09
confidence O 0 2.4306725521228145e-08
interval O 0 6.510238570456295e-09
, O 0 1.8615880050584094e-14
0 O 0 3.0554655282137057e-15
. O 0 2.9964243671747656e-15
3 O 0 9.064733996245761e-15
to O 0 1.0993220223021183e-12
0 O 0 1.617607279678565e-14
. O 0 2.1261866982205495e-14
8 O 0 3.002600609553624e-13
) O 0 3.123418068780824e-14
. O 0 2.3406210997167776e-11

The O 0 5.521677559627847e-10
risk O 0 1.6839972472038056e-10
decreased O 0 1.1297544844079965e-10
with O 0 6.999017361294523e-16
increasing O 0 8.986291122033488e-14
duration O 0 1.0857559296084673e-09
of O 0 3.510042733897989e-12
use O 0 9.438919914769861e-13
( O 0 1.4992700006835613e-14
P O 0 5.898054822317533e-10
for O 0 1.169066688073983e-12
trend O 0 3.674273732490185e-11
, O 0 7.048938306832139e-15
< O 0 7.900198507534983e-13
0 O 0 1.6378326476898086e-15
. O 0 3.6329285459384304e-15
001 O 0 7.901317621017423e-12
) O 0 2.172523373549278e-17
; O 0 1.7274337400335304e-18
use O 0 3.69737928289501e-16
for O 0 2.9312695340807807e-15
six O 0 1.0722414709590788e-12
or O 0 2.981501086600155e-14
more O 0 1.0235112030235497e-15
years O 0 1.065608105227378e-14
was O 0 1.4967585479949523e-14
associated O 0 3.28070836014098e-14
with O 0 3.197899306371318e-16
a O 0 6.953517758334984e-14
60 O 0 1.4407721543596708e-11
percent O 0 1.3391820638530838e-11
reduction O 0 6.811027436492978e-11
in O 0 1.1992221451984086e-11
risk O 0 1.5064369751627282e-09
. O 0 5.5457132219771665e-09

Oral O 0 0.003396307583898306
- O 0 2.334866593400875e-07
contraceptive O 0 5.3633741892156195e-09
use O 0 6.281087195497692e-12
protected O 0 5.843406114536265e-08
against O 1 0.9977738261222839
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.6377238854811154e-11
for O 0 4.8283344553437524e-14
carriers O 0 2.3478430232425594e-14
of O 0 1.0557815906253598e-11
the O 0 2.59621962817036e-10
BRCA1 O 0 1.2065146659523407e-09
mutation O 0 2.329343315454757e-12
( O 0 5.000772406306246e-15
odds O 0 1.5491392613142807e-09
ratio O 0 7.457685163858585e-11
, O 0 2.893658010145843e-14
0 O 0 3.3808276121547907e-15
. O 0 2.6845330717103393e-15
5 O 0 1.201972257043203e-15
; O 0 1.2620404620743013e-17
95 O 0 1.0292964397473625e-11
percent O 0 1.8229227155552863e-11
confidence O 0 5.41916678198362e-10
interval O 0 3.504319889824359e-10
, O 0 1.5368367589272368e-14
0 O 0 1.6649454311775899e-15
. O 0 3.9970142233709035e-15
3 O 0 5.5364068195131854e-15
to O 0 4.922008438844327e-13
0 O 0 3.3263564056245244e-15
. O 0 3.0666986674019554e-15
9 O 0 4.197714699167958e-14
) O 0 9.319810874410461e-17
and O 0 1.2069568341795578e-16
for O 0 7.948310478688467e-16
carriers O 0 4.4128742814845273e-14
of O 0 6.547824348696052e-12
the O 0 1.4261455905106857e-10
BRCA2 O 0 9.673121859066214e-09
mutation O 0 6.6612462074067125e-12
( O 0 1.660585562015659e-14
odds O 0 7.1050316741150255e-09
ratio O 0 3.009410776133592e-10
, O 0 1.3000398554983278e-13
0 O 0 1.4682004933650947e-14
. O 0 7.930596690420774e-15
4 O 0 4.455319187174735e-15
; O 0 7.363807981897348e-17
95 O 0 1.9814112156568697e-11
percent O 0 5.685445170211523e-11
confidence O 0 2.918280284092134e-09
interval O 0 7.45086381481741e-10
, O 0 4.6902816374684575e-14
0 O 0 3.4399155717640666e-15
. O 0 1.0650961585140575e-14
2 O 0 9.940710059307741e-15
to O 0 9.038534894492689e-13
1 O 0 1.1126746767876894e-13
. O 0 6.176028248929336e-14
1 O 0 1.511701191742737e-13
) O 0 6.773989463977614e-14
. O 0 4.671014269819196e-11

CONCLUSIONS O 0 1.9501728729665047e-06
Oral O 0 0.0004347661742940545
- O 0 8.629670844584325e-08
contraceptive O 0 2.060744686005478e-09
use O 0 8.302230024336346e-14
may O 0 8.649319731572278e-14
reduce O 0 9.198521935468995e-13
the O 0 3.7592295270595655e-13
risk O 0 3.6389451452123467e-09
of O 1 0.516223669052124
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.5970205420076127e-10
women O 0 3.133036297303486e-14
with O 0 2.180279746891514e-15
pathogenic O 0 1.146422149919668e-12
mutations O 0 1.449477880386893e-13
in O 0 1.3209005829233067e-13
the O 0 2.219617371845839e-11
BRCA1 O 0 3.6047982376885557e-09
or O 0 5.822231585739246e-09
BRCA2 O 0 4.806187234862591e-07
gene O 0 3.423798844437442e-08

A O 0 6.238552452408896e-10
Japanese O 0 2.037372631713552e-10
family O 0 5.576632363356315e-13
with O 0 9.65595469250638e-14
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.2070830717348519e-13
a O 0 2.638609545701359e-13
codon O 0 1.3204271009925606e-09
291 O 0 1.1461286364422563e-09
deletion O 0 1.752758382878028e-09
: O 0 1.292097261433242e-13
a O 0 1.3414720723137208e-12
clinical O 0 5.046632209348978e-11
, O 0 4.288205261802208e-14
biochemical O 0 2.0636494249548498e-11
, O 0 2.5394963909519674e-13
pathological O 0 1.6203873798303903e-09
, O 0 1.6829703050006556e-13
and O 0 1.9552163165424685e-13
genetic O 0 4.240856277260008e-11
report O 0 1.0772006550641144e-11
. O 0 4.857737545549412e-10

We O 0 8.36228135348005e-12
report O 0 1.9504214324346514e-14
a O 0 1.8304411636318584e-15
Japanese O 0 2.659686056463717e-12
family O 0 2.9555250933253896e-13
with O 0 5.622053929170423e-13
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.056309809927992e-11
ALD B-Disease 1 1.0
) O 0 1.335180999372269e-14
with O 0 7.766439270023167e-16
a O 0 3.1361452470330883e-14
three O 0 4.3875696804050734e-14
base O 0 2.2571011032423982e-11
pair O 0 9.557153679562447e-11
deletion O 0 1.7004646302165582e-10
( O 0 5.5351953082887276e-14
delGAG O 0 4.8281623143964225e-09
291 O 0 2.990720865403418e-11
) O 0 4.183022235071474e-15
in O 0 9.036048547860637e-14
the O 0 6.577493411041857e-11
ALD B-Disease 1 1.0
gene O 0 1.987602082920148e-09
. O 0 7.788317546442158e-09

A O 0 3.730859532424802e-08
variety O 0 2.335274335019122e-11
of O 0 3.015235283676532e-11
phenotypes O 0 2.3454890807350637e-10
were O 0 4.070198605238273e-12
observed O 0 4.4978872514554735e-13
within O 0 1.4231766806704904e-12
this O 0 2.937193674043548e-13
family O 0 1.5349992110724742e-11
. O 0 6.411772779379987e-10

While O 0 4.644768077100014e-12
the O 0 3.7908985846268894e-12
proband O 0 0.003784055123105645
( O 0 7.270982860935193e-13
patient O 0 1.5515205120664177e-08
1 O 0 7.434144445872537e-13
) O 0 6.4790888447538095e-15
was O 0 6.658676431417487e-13
classified O 0 4.979536314536626e-12
as O 0 2.3628522776613162e-14
having O 0 7.854433249632198e-13
a O 0 2.95725493789159e-14
rare O 0 1.817015267901404e-14
intermediate O 0 3.961447055805811e-12
type O 0 2.060263244729743e-11
of O 0 2.405275978389909e-11
adult O 0 4.652160434659436e-09
cerebral O 0 4.175225498670443e-08
and O 0 2.233010304442118e-11
cerebello O 1 0.9699159264564514
- O 0 0.00107521191239357
brain O 0 6.667868319709669e-07
stem O 0 1.9495207531639025e-11
forms O 0 1.4804899927528536e-13
, O 0 4.455212646311838e-17
his O 0 2.767269005360829e-14
younger O 0 3.883160806794628e-11
brother O 0 4.239049111731674e-09
( O 0 1.3226096921229585e-13
patient O 0 4.516551577182781e-09
2 O 0 7.115374912533556e-14
) O 0 7.518938889813421e-16
and O 0 2.700135376247116e-14
nephew O 0 4.5006018467574904e-08
( O 0 4.1662734460296003e-13
patient O 0 2.2348276562667024e-09
3 O 0 7.524889999305229e-13
) O 0 9.066774498615697e-15
had O 0 2.96297573065471e-13
a O 0 5.422428131507395e-12
childhood O 0 2.767943385606486e-07
ALD B-Disease 1 1.0
type O 0 2.671457195901894e-06
. O 0 9.424836022731142e-09

Another O 0 3.4348562882868805e-10
nephew O 0 8.962743436313758e-07
( O 0 2.399742730918586e-13
patient O 0 4.492537453160139e-09
4 O 0 4.494945539910977e-13
) O 0 4.246075791181558e-15
of O 0 2.7596305449129055e-11
patient O 0 3.123398073512362e-08
1 O 0 1.3368724530171683e-11
was O 0 5.356976147397052e-12
classified O 0 3.648760113494909e-12
as O 0 5.725505654438287e-14
having O 0 4.084010039873132e-12
an O 0 3.8147236021066067e-13
adolescent O 0 1.8913406951703848e-10
form O 0 2.9028666623243105e-11
. O 0 1.8350260200250545e-09

The O 0 3.1896867369596293e-09
tau O 0 6.359838211622559e-10
level O 0 7.539759927510659e-09
in O 0 1.558618034983028e-12
the O 0 1.8871163312561556e-11
cerebrospinal O 0 1.1017908363442075e-08
fluid O 0 1.0965386376682318e-09
( O 0 5.53149323220814e-13
CSF O 0 2.080141257465584e-06
) O 0 6.728716975962223e-13
in O 0 1.149539005651512e-10
patient O 0 0.3877022862434387
1 O 0 2.3098908202845436e-11
was O 0 3.2626106677424715e-11
as O 0 5.4342334702506354e-15
high O 0 1.56571397557162e-14
as O 0 2.2155668747763323e-17
that O 0 1.5436440927325677e-17
of O 0 4.145360947950885e-14
patients O 0 3.125065961215312e-12
with O 0 8.490148861728386e-11
Alzheimers B-Disease 1 0.9999935626983643
disease I-Disease 0 1.2307476149331364e-09
( O 0 3.573850115449811e-15
AD B-Disease 0 6.656376005942377e-10
) O 0 3.2111796945469284e-13
. O 0 2.3236745860799601e-10

His O 0 1.3749741345492339e-09
brain O 0 2.655083042313322e-09
magnetic O 0 2.579884049447312e-11
resonance O 0 1.181089948065761e-10
image O 0 7.1961802836084665e-12
( O 0 9.336076553975703e-16
MRI O 0 1.3219062111602398e-07
) O 0 4.543957034643456e-14
showed O 0 3.8634727361763765e-11
abnormalities B-Disease 0 1.247456471453745e-09
in I-Disease 0 8.859112851948223e-14
the I-Disease 0 4.06152889098621e-12
bilateral I-Disease 0 2.775260145426728e-05
cerebellar I-Disease 1 0.9999213218688965
hemispheres I-Disease 0 0.04317459836602211
and O 0 9.705867221043718e-10
brain O 0 1.8863119066736544e-07
stem O 0 4.1107083015301527e-11
, O 0 3.3606786041637422e-15
but O 0 1.8535090471591452e-15
not O 0 1.5882209962328822e-14
in O 0 1.5532435363938002e-12
the O 0 2.372372021053337e-10
cerebral O 0 2.097039669024525e-06
white O 0 5.957996682820488e-12
matter O 0 3.304660017855454e-11
, O 0 1.1841140496580038e-15
where O 0 5.374342523407362e-16
marked O 0 4.4173374674901997e-14
reductions O 0 7.568883887698608e-12
of O 0 9.909168971478088e-12
the O 0 2.3296644127701605e-11
cerebral O 0 1.8975139681742803e-08
blood O 0 1.1193608262516364e-09
flow O 0 1.3976767521128863e-09
and O 0 1.513135645427044e-12
oxygen O 0 4.455523450186405e-11
metabolism O 0 2.6073504466594954e-10
were O 0 2.296419890183976e-13
clearly O 0 1.6891527857771705e-15
demonstrated O 0 2.837260735396815e-15
by O 0 4.658312618217698e-17
positron O 0 1.882086500537561e-12
emission O 0 1.1234256580561208e-11
tomography O 0 2.1493203661293592e-08
( O 0 1.0000725941816668e-11
PET O 0 4.5982270080457965e-07
) O 0 2.6094822917072102e-12
. O 0 4.5801118453425715e-10

In O 0 8.255259587031105e-09
patients O 0 4.3321235487780996e-09
2 O 0 2.5918099263999572e-11
and O 0 3.5574497449404607e-13
3 O 0 3.35138926159384e-12
, O 0 3.854507282742472e-15
the O 0 2.7273351288427568e-14
autopsy O 0 4.886216431465584e-11
findings O 0 3.187863601566976e-12
showed O 0 8.542253709942216e-12
massive O 0 3.074671905967108e-10
demyelination B-Disease 1 1.0
of I-Disease 0 3.930019374820404e-06
the I-Disease 0 2.660574978108343e-07
cerebral I-Disease 1 0.6541849374771118
white I-Disease 0 8.134580682661596e-12
matter I-Disease 0 2.1927778603297865e-12
with O 0 2.9435601939036774e-16
sparing O 0 1.14704608658589e-11
of O 0 6.68411104243205e-10
the O 0 1.5508687667420418e-09
U O 0 3.496762292343192e-05
- O 0 6.002298391649674e-08
fibers O 0 2.1921385595646825e-08
, O 0 4.3063517568510054e-14
compatible O 0 4.657760843684855e-10
with O 0 8.228819732852713e-16
the O 0 1.5371298323269868e-14
findings O 0 1.1467015488195176e-13
of O 0 4.2377169481855326e-12
childhood O 0 2.3112831115668087e-07
ALD B-Disease 1 1.0
. O 0 1.6188782581139094e-07

Oleic O 0 0.0013517264742404222
and O 0 3.7134093133772694e-08
erucic O 1 0.997856080532074
acids O 0 1.0881992551503572e-07
( O 0 1.472220457522655e-12
Lorenzos O 0 2.9208555929471913e-07
Oil O 0 7.147159253317881e-11
) O 0 1.0444827858855006e-15
were O 0 1.0071753679544507e-13
administered O 0 8.092380064661508e-12
to O 0 1.7399493304481872e-11
patients O 0 1.9658793690147114e-11
1 O 0 1.819989471629757e-12
and O 0 1.650371598280534e-13
4 O 0 2.810651451162771e-12
, O 0 6.450432873115249e-15
but O 0 3.2314029534461332e-15
sufficient O 0 3.134204918167627e-12
effectiveness O 0 6.678547905675236e-12
was O 0 8.169187440225378e-13
not O 0 8.182235948896513e-14
obtained O 0 3.1892957719215076e-10
. O 0 1.1999327087508505e-09

The O 0 3.019266836545853e-09
findings O 0 2.4834270057061403e-11
in O 0 7.60734520082601e-14
this O 0 2.0495132758350902e-14
family O 0 1.0714253242212132e-13
suggest O 0 4.58832407831955e-13
that O 0 5.531695834018794e-16
delGAG291 O 0 4.5945661164559226e-10
is O 0 2.1802132548051547e-15
part O 0 1.6687271410607135e-13
of O 0 3.719696859555421e-12
the O 0 2.3174270662174035e-12
cause O 0 8.714095417472478e-11
of O 0 9.445486059966868e-11
Japanese O 0 1.2229681090047961e-07
ALD B-Disease 1 1.0
with O 0 6.354035787109469e-12
phenotypic O 0 4.846233969679759e-10
variations O 0 2.376174777773965e-11
. O 0 7.536967161492214e-10

Moreover O 0 4.175892520663638e-09
, O 0 6.971175600076511e-15
although O 0 7.894041077757884e-16
the O 0 2.4625263715096976e-15
scale O 0 8.014145987458865e-13
of O 0 5.437556871781823e-13
the O 0 3.5444593766108257e-13
study O 0 7.913345000977456e-14
is O 0 5.396509375637007e-16
limited O 0 3.7871238805532725e-13
, O 0 2.5382314658298558e-14
there O 0 2.1386255125762504e-13
is O 0 1.1743531596112005e-14
a O 0 1.5730483322179412e-13
possibility O 0 9.49846885173189e-12
that O 0 3.5908350945468293e-12
PET O 0 1.474445525673218e-06
can O 0 2.413760857855607e-10
detect O 0 1.719212860962216e-07
an O 0 8.053811784147769e-11
insidious B-Disease 0 1.439571661876471e-07
lesion I-Disease 0 6.9628276833100244e-06
which O 0 4.554484502213019e-13
is O 0 3.7577437635074457e-14
undetectable O 0 2.6696173483636843e-12
by O 0 7.633092461323699e-16
computed O 0 2.1300552988101629e-10
tomogram O 0 1.6696522209258546e-07
( O 0 4.350371042680275e-14
CT O 0 2.1358457225062466e-09
) O 0 2.0353941259889556e-15
or O 0 1.790790789041232e-14
MRI O 0 1.4142383930604296e-09
analysis O 0 2.705931724349131e-13
, O 0 4.1328970884191207e-17
and O 0 1.011126803784916e-17
that O 0 1.6860407950007643e-18
the O 0 8.548984422629446e-16
higher O 0 6.134026663343062e-13
level O 0 2.5317707999517047e-11
of O 0 4.081066647815268e-12
tau O 0 7.311689773602248e-13
reflects O 0 3.000228985063948e-14
the O 0 4.3605535645523975e-15
process O 0 5.552153181653807e-11
of O 0 2.643469609875382e-10
neuronal B-Disease 0 3.4998297451238614e-06
degeneration I-Disease 1 0.8409236073493958
in O 0 5.930051116820323e-08
ALD B-Disease 1 1.0
. O 0 9.835615628617234e-07

Lorenzos O 0 0.00011898068623850122
Oil O 0 6.528763085711375e-10
should O 0 1.3058701526808686e-13
be O 0 4.257088490045285e-15
given O 0 4.1826232825533174e-15
in O 0 1.6840315186989526e-15
the O 0 3.7649017848348076e-15
early O 0 9.997230907693444e-13
stage O 0 8.221243130712708e-12
. O 0 4.506107292856498e-12
. O 0 9.125751265770532e-10

Nonsense O 0 1.3173835213819984e-06
mutation O 0 4.601228772993515e-11
in O 0 1.193915886293917e-11
exon O 0 1.7886031544733783e-10
4 O 0 1.0408456214971995e-11
of O 0 3.307181958844829e-11
human O 0 9.182521930328758e-12
complement O 0 1.2327162624004018e-09
C9 O 0 3.569367254385725e-05
gene O 0 1.1428961076143107e-12
is O 0 2.767067115057851e-15
the O 0 2.692225951992245e-14
major O 0 8.147014421595877e-13
cause O 0 3.432333237074481e-11
of O 0 6.919291806184447e-10
Japanese O 0 1.92814013644238e-06
complement B-Disease 0 2.1205583834671415e-05
C9 I-Disease 1 0.9942436814308167
deficiency I-Disease 0 0.00021469932107720524
. O 0 1.0788908610948056e-07

Deficiency B-Disease 0 0.0007258771220222116
of I-Disease 0 3.226998401828496e-08
the I-Disease 0 2.7624441623075313e-10
ninth I-Disease 0 2.3238990820573235e-07
component I-Disease 0 6.242245831344917e-09
of I-Disease 0 9.673223333450665e-11
human I-Disease 0 1.2040673146029857e-11
complement I-Disease 0 2.0949781909251897e-09
( O 0 8.510760049181346e-14
C9 O 0 3.1607232813257724e-05
) O 0 3.2227689348565333e-14
is O 0 1.2397295977000108e-15
the O 0 1.3540745774805445e-14
most O 0 9.701511343134916e-15
common O 0 1.0728993388164909e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.376671511845508e-11
Japan O 0 3.569089121469027e-11
but O 0 2.5739771032369345e-14
is O 0 1.774483202520924e-15
rare O 0 1.5849927165016708e-13
in O 0 5.932533381648036e-14
other O 0 5.518191968905545e-14
countries O 0 9.155101156343992e-12
. O 0 2.602184911992822e-09

We O 0 3.513963078849436e-11
studied O 0 1.2469051399038866e-12
the O 0 6.070540713854064e-15
molecular O 0 8.924712504394458e-14
basis O 0 1.122946388654178e-10
of O 0 8.892939162841174e-10
C9 B-Disease 1 0.9659509658813477
deficiency I-Disease 0 2.6474920105101774e-06
in O 0 7.102341631481934e-11
four O 0 2.3368428719861e-11
Japanese O 0 7.515711608618858e-09
C9 B-Disease 1 0.9999148845672607
- I-Disease 0 2.1093208033562405e-06
deficient I-Disease 0 3.051981991575303e-07
patients O 0 4.4873288418401103e-10
who O 0 9.351918111438762e-13
had O 0 1.4791451050100157e-11
suffered O 0 1.9371458620298654e-05
from O 0 1.8409591007184645e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.007656346198928e-09

Direct O 0 7.825622094781437e-12
sequencing O 0 5.0933292305987976e-11
of O 0 4.69594606256063e-11
amplified O 0 1.2074826381824888e-11
C9 O 0 3.4844069851658332e-09
cDNA O 0 1.2250464531682326e-10
and O 0 3.47349576944149e-14
DNA O 0 5.686467408061446e-10
revealed O 0 3.276129714735454e-11
a O 0 4.740568831582137e-13
nonsense O 0 6.37742358922111e-11
substitution O 0 1.619980083238104e-12
( O 0 4.1970558769415835e-15
CGA O 0 1.9643943360847516e-08
- O 0 9.178964255340816e-09
- O 0 1.2567753504555412e-09
> O 0 2.471595705877405e-10
TGA O 0 3.5140539367262136e-09
) O 0 1.3140189399763044e-15
at O 0 4.869269592568115e-13
codon O 0 3.089266342737318e-11
95 O 0 4.6274234444254603e-10
in O 0 1.2428051643365023e-11
exon O 0 1.1545357031517156e-10
4 O 0 1.3406075295013808e-12
in O 0 5.394192037488921e-13
the O 0 1.1417397409452246e-11
four O 0 9.065361794569071e-10
C9 B-Disease 1 0.6617100238800049
- I-Disease 0 1.3751194273936562e-05
deficient I-Disease 0 8.352508302778006e-07
individuals O 0 1.6333663588330438e-10
. O 0 1.5767261274390876e-08

An O 0 4.221408921208092e-14
allele O 0 4.470102673431731e-12
- O 0 3.795838155514625e-13
specific O 0 6.535128883357333e-14
polymerase O 0 2.3184924032720877e-12
chain O 0 7.14895156961326e-13
reaction O 0 5.182734734540846e-14
system O 0 3.0095455207795885e-12
designed O 0 2.3832075635860095e-13
to O 0 5.790380111156401e-13
detect O 0 7.737353509632006e-13
exclusively O 0 9.309366428775223e-13
only O 0 3.4351685873694167e-15
one O 0 4.13425685423215e-15
of O 0 2.2263736535778345e-13
the O 0 2.8709822605214874e-13
normal O 0 5.314833989578105e-11
and O 0 1.1062875401456236e-14
mutant O 0 1.5983354505373637e-13
alleles O 0 7.199207457389209e-14
indicated O 0 4.826071725409775e-13
that O 0 1.4004637344412893e-15
all O 0 1.465970255614974e-14
the O 0 9.40425105952665e-14
four O 0 2.891722777030592e-13
patients O 0 2.27588960725238e-14
were O 0 1.0135907954969547e-13
homozygous O 0 1.379392802237922e-12
for O 0 9.43142929748543e-14
the O 0 1.7659176204665172e-11
mutation O 0 9.576108135622707e-12
in O 0 2.8726939230172555e-11
exon O 0 1.5631657079850925e-10
4 O 0 7.69699299955906e-13
and O 0 2.3119281486526193e-14
that O 0 1.0228281768307076e-15
the O 0 2.5733058804482123e-13
parents O 0 8.478069049751291e-13
of O 0 1.5300621880598442e-11
patient O 0 5.922110024592087e-10
2 O 0 1.8832688880587867e-11
were O 0 1.8830435821737268e-10
heterozygous O 0 2.304642032768811e-10
. O 0 1.6726467988448235e-09

The O 0 2.0599026651080266e-10
common O 0 3.3909541841126156e-11
mutation O 0 1.0433873817022876e-12
at O 0 1.0224284960336227e-11
codon O 0 5.334793717892694e-10
95 O 0 1.0281485174346017e-07
in O 0 8.78955075389598e-10
exon O 0 3.221400479702652e-09
4 O 0 1.3186664434006179e-11
might O 0 1.810271550717335e-12
be O 0 1.6814334484211574e-13
responsible O 0 2.226928016990648e-11
for O 0 3.5988640453149534e-12
most O 0 1.3448646710156886e-11
Japanese O 0 6.83068151374755e-07
C9 B-Disease 1 0.9800058603286743
deficiency I-Disease 0 4.850307391279784e-07
. O 0 6.46490569411462e-11
. O 0 1.0037560782549804e-09

BRCA1 O 0 4.7816566678404726e-11
required O 0 1.9227000200294775e-11
for O 0 4.153032084897035e-13
transcription O 0 1.3183012903539293e-08
- O 0 9.785055432587342e-09
coupled O 0 6.3651688364529946e-09
repair O 0 0.0022426536306738853
of O 0 6.311862144059432e-10
oxidative O 0 3.82009197608113e-08
DNA O 0 1.654542938922532e-05
damage O 0 4.4963636014472286e-07
. O 0 9.412883805737238e-10

The O 0 1.656934589533421e-10
breast B-Disease 1 0.9575738906860352
and I-Disease 0 0.0013993984321132302
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 4.589149682487914e-07
gene O 0 8.69593147490022e-11
BRCA1 O 0 9.493226205137262e-10
encodes O 0 2.5183418718432993e-12
a O 0 2.413242999529941e-12
zinc O 0 4.6703460543362496e-11
finger O 0 1.958575746030533e-09
protein O 0 2.7763612589493114e-11
of O 0 1.321849400770514e-11
unknown O 0 2.393672149381132e-09
function O 0 4.279734344692088e-09
. O 0 1.031075669288839e-09

Association O 0 2.8006940516744905e-11
of O 0 1.3088087905122059e-11
the O 0 1.1048589343767845e-12
BRCA1 O 0 1.486279523933709e-12
protein O 0 1.0890198417796027e-14
with O 0 6.064794283521213e-17
the O 0 1.2661364639295503e-14
DNA O 0 2.4926394281976627e-10
repair O 0 7.548684379798942e-07
protein O 0 6.100278615583932e-11
Rad51 O 0 2.9263234058163334e-09
and O 0 2.877535881489336e-15
changes O 0 1.0584005960000728e-15
in O 0 1.2883029667581046e-16
the O 0 3.9248348931057795e-16
phosphorylation O 0 5.603206802348975e-15
and O 0 4.922282627644518e-16
cellular O 0 1.1493165360393354e-12
localization O 0 2.7497502053108747e-09
of O 0 5.898524030323316e-11
the O 0 8.20246388172352e-12
protein O 0 8.781598712093164e-12
after O 0 4.925389523319224e-13
exposure O 0 1.9935028020695578e-12
to O 0 9.851967332219491e-13
DNA O 0 2.2930584009372978e-07
- O 0 9.778221565781564e-10
damaging O 0 1.0959651935982251e-10
agents O 0 1.5307531717884126e-12
are O 0 1.0640397178464183e-15
consistent O 0 6.727061941345924e-13
with O 0 8.971082281506067e-18
a O 0 9.314164870421419e-16
role O 0 1.9459513007588115e-14
for O 0 2.663664915806413e-13
BRCA1 O 0 2.0213247742262297e-10
in O 0 1.5853755808148406e-11
DNA O 0 1.0481045364940655e-06
repair O 0 0.0017182021401822567
. O 0 6.085981141268348e-08

Here O 0 3.4196399045782755e-09
, O 0 5.083451631100917e-14
it O 0 1.1498951361987918e-16
is O 0 1.1234501554718592e-17
shown O 0 1.0504410485705478e-14
that O 0 2.462883607655202e-15
mouse O 0 1.011995717260794e-12
embryonic O 0 1.7712009636738912e-10
stem O 0 1.6037857153428092e-10
cells O 0 5.165928240735695e-10
deficient B-Disease 0 1.1186058301859703e-08
in I-Disease 0 6.080472930714009e-11
BRCA1 I-Disease 0 1.2059532261687878e-09
are O 0 5.598103090028589e-14
defective O 0 1.8863894821197214e-11
in O 0 4.572029061768179e-14
the O 0 3.283631979061723e-14
ability O 0 3.8631961128340886e-13
to O 0 4.3916723691883944e-14
carry O 0 8.753404251438113e-12
out O 0 6.131488546057273e-13
transcription O 0 1.919610248535264e-08
- O 0 8.898933145928822e-09
coupled O 0 1.5681274945222867e-08
repair O 0 0.0007135896012187004
of O 0 3.27623761453566e-10
oxidative O 0 9.75631464505966e-10
DNA O 0 1.2949976735399105e-07
damage O 0 2.295452272704779e-09
, O 0 6.483885168817637e-15
and O 0 1.1603433405427328e-15
are O 0 8.515464470170396e-15
hypersensitive O 0 3.5177356583204755e-09
to O 0 3.7813863151825444e-09
ionizing O 0 1.7962103129320894e-06
radiation O 0 3.8863831264279725e-07
and O 0 8.474646331912972e-12
hydrogen O 0 6.81931122681334e-10
peroxide O 0 5.376763922981809e-08
. O 0 1.3561205491896544e-08

These O 0 1.855684876594932e-11
results O 0 4.1732450828391165e-11
suggest O 0 5.336693933988279e-11
that O 0 1.9297044973227984e-13
BRCA1 O 0 3.100016354729007e-10
participates O 0 5.290789941575502e-12
, O 0 3.8561266403310326e-14
directly O 0 1.3314192630342614e-11
or O 0 4.393050593437531e-12
indirectly O 0 2.058147263728216e-10
, O 0 8.458936032369486e-15
in O 0 4.649499101699872e-13
transcription O 0 1.884450462341647e-08
- O 0 9.638645437348714e-09
coupled O 0 8.525972816642025e-09
repair O 0 0.001278364798054099
of O 0 1.3101389972902666e-09
oxidative O 0 2.8447417754762228e-09
DNA O 0 1.356710868094524e-07
damage O 0 7.90669751893347e-09
. O 0 1.1175848441125069e-11
. O 0 8.18185796891413e-11

Truncation O 0 5.419143235485535e-06
mutations O 0 4.408154952173504e-10
in O 0 4.93858751636489e-13
the O 0 4.857602601410216e-12
transactivation O 0 1.6611073760941508e-06
region O 0 6.370853178339075e-09
of O 0 1.910926084036646e-09
PAX6 O 0 3.720181484823115e-05
result O 0 9.000015177562659e-10
in O 0 9.347932844461226e-11
dominant O 0 1.6453930129500804e-06
- O 0 6.7466321418407915e-09
negative O 0 1.0124021759816415e-10
mutants O 0 1.4379348822757265e-09
. O 0 1.7371548644007362e-10

PAX6 O 0 0.00047789461677893996
is O 0 1.3484393723145471e-12
a O 0 3.069545756895914e-13
transcription O 0 2.6797542049955547e-12
factor O 0 9.79952474418691e-14
with O 0 2.2271601088462835e-16
two O 0 1.486192997824081e-14
DNA O 0 3.564491757312993e-10
- O 0 1.3644105810450835e-11
binding O 0 5.0598050055361554e-12
domains O 0 1.189062848183653e-09
( O 0 3.4130938499727856e-15
paired O 0 7.547072342073413e-12
box O 0 1.5310343270957816e-11
and O 0 6.530493919069957e-14
homeobox O 0 2.5217463534010776e-11
) O 0 7.509136071635729e-16
and O 0 1.534874014181859e-14
a O 0 5.734724327355334e-12
proline O 0 1.0673286965356965e-07
- O 0 3.094147871252062e-08
serine O 0 9.190807759296149e-07
- O 0 4.116434695333737e-07
threonine O 0 7.172740197347593e-07
( O 0 7.137363887844278e-15
PST O 0 3.238887202883234e-08
) O 0 5.260315837432583e-14
- O 0 3.190887007745169e-12
rich O 0 7.35521778032211e-13
transactivation O 0 1.535306637379108e-07
domain O 0 3.5196348058263993e-09
. O 0 2.2293515644644657e-10

PAX6 O 1 0.9995161294937134
regulates O 0 6.656775752844624e-08
eye O 0 1.6585717332873173e-07
development O 0 5.273069447753187e-08
in O 0 6.482596577594979e-12
animals O 0 6.810344931225398e-13
ranging O 0 3.639397810895062e-12
from O 0 1.978351510389942e-12
jellyfish O 0 2.2289483626869444e-13
to O 0 1.393833746338169e-11
Drosophila O 0 2.4210275451075347e-10
to O 0 1.1715366177167397e-10
humans O 0 3.693176042762758e-10
. O 0 8.29526725087959e-10

Heterozygous O 0 3.026475425826902e-08
mutations O 0 6.860218643156557e-11
in O 0 1.2762038062615055e-13
the O 0 3.400471636043345e-13
human O 0 2.1087699728777887e-12
PAX6 O 0 1.8778323465085123e-06
gene O 0 4.019405034499934e-12
result O 0 3.9522248321266495e-12
in O 0 4.1562473542021763e-14
various O 0 4.08767041482766e-13
phenotypes O 0 5.487131148756985e-12
, O 0 2.9243225933638746e-15
including O 0 2.926746166384206e-14
aniridia B-Disease 1 1.0
, O 0 1.0963206037439832e-10
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.986354275507196e-10
autosomal B-Disease 0 0.004581634420901537
dominant I-Disease 0 1.6828162188176066e-06
keratitis I-Disease 1 0.999984860420227
, O 0 4.0695176395377786e-11
and O 0 8.792737093976655e-10
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999964237213135

It O 0 9.081178463290346e-14
is O 0 9.416985141097434e-16
believed O 0 2.9066630152048065e-14
that O 0 4.984785585869107e-18
the O 0 2.0153285507432117e-16
mutated O 0 4.233248853623931e-16
allele O 0 6.915006761643028e-13
of O 0 1.0439273577522723e-11
PAX6 O 0 1.5606939314238844e-06
produces O 0 7.160715163184728e-13
an O 0 4.66973964854153e-15
inactive O 0 3.660800829141664e-11
protein O 0 4.2006686323814435e-11
and O 0 3.09064991481367e-12
aniridia B-Disease 1 1.0
is O 0 6.789480002517001e-12
caused O 0 2.490542494459902e-11
due O 0 5.88059823058984e-10
to O 0 3.0058139310895626e-10
genetic O 0 5.8877280828539824e-09
haploinsufficiency O 0 3.216368327230157e-07
. O 0 7.776947086313157e-09

However O 0 9.645887422138344e-10
, O 0 2.7193321921505087e-13
several O 0 5.890162083120945e-14
truncation O 0 1.0397498861891563e-08
mutations O 0 4.1527746519332e-11
have O 0 2.856631489515926e-14
been O 0 6.860640256855371e-14
found O 0 7.616865851153148e-15
to O 0 3.8818964319051186e-14
occur O 0 1.746491948458051e-12
in O 0 1.5757231945027345e-14
the O 0 6.67256018233725e-13
C O 0 4.3883510159048456e-09
- O 0 4.2174153058738284e-11
terminal O 0 1.0428447168309152e-11
half O 0 6.405932641978529e-13
of O 0 3.696870283856346e-13
PAX6 O 0 9.043402826591773e-08
in O 0 4.106958100425634e-13
patients O 0 2.269151880285314e-12
with O 0 7.102303500091528e-14
Aniridia B-Disease 1 1.0
resulting O 0 2.0144662327137297e-10
in O 0 2.353228831415699e-13
mutant O 0 1.1713813512920224e-12
proteins O 0 2.6186885843907e-14
that O 0 7.535190805093271e-16
retain O 0 6.852487327568824e-12
the O 0 1.1358116053586387e-12
DNA O 0 1.1553669132524647e-09
- O 0 1.2414879020650194e-11
binding O 0 1.1505058190863782e-11
domains O 0 4.763562322374071e-10
but O 0 1.4894286975639104e-13
have O 0 2.691748394816583e-14
lost O 0 6.258620011134752e-11
most O 0 1.2630875688359085e-14
of O 0 1.2136561287207082e-12
the O 0 1.1043370211349934e-11
transactivation O 0 2.6856241674977355e-06
domain O 0 6.098984073332758e-08
. O 0 8.183130617567258e-09

It O 0 4.196302159920062e-12
is O 0 2.2308399905460706e-14
not O 0 7.203149209912552e-14
clear O 0 4.483251877379635e-12
whether O 0 1.2122143295666826e-13
such O 0 3.709136608422668e-14
mutants O 0 3.192265896068136e-10
really O 0 4.875665843284693e-12
behave O 0 1.4265194928086977e-12
as O 0 2.1296529264473035e-14
loss O 0 8.609222362787605e-11
- O 0 2.4061169723310627e-10
of O 0 2.3068460563990811e-07
- O 0 1.2816057903819456e-07
function O 0 3.090972588992713e-09
mutants O 0 1.0777293640851227e-10
as O 0 4.17264735201703e-15
predicted O 0 3.7329498216512325e-13
by O 0 2.442078318536621e-14
haploinsufficiency O 0 8.820073560400488e-08
. O 0 1.3135920129414558e-09

Contrary O 0 5.331643126993413e-09
to O 0 5.799878372708678e-12
this O 0 7.608941010898637e-14
theory O 0 2.060321097757667e-12
, O 0 9.71821017417356e-16
our O 0 4.0402327750738154e-13
data O 0 1.4840870503005088e-12
showed O 0 3.8285436561487363e-13
that O 0 1.661531094306767e-16
these O 0 1.4875649794403962e-15
mutants O 0 5.81355330629002e-13
are O 0 3.767530551586611e-15
dominant O 0 2.4278995480742083e-10
- O 0 2.254984046712316e-11
negative O 0 1.0727999434981261e-12
in O 0 2.649245026912356e-13
transient O 0 1.3016819566669113e-10
transfection O 0 7.033645887943862e-10
assays O 0 2.774941084207616e-12
when O 0 2.868118272720231e-14
they O 0 7.809104213697248e-15
are O 0 5.427790090620872e-15
coexpressed O 0 2.944412935690366e-09
with O 0 8.12224704269289e-14
wild O 0 2.1963214580367207e-10
- O 0 2.119119324461849e-09
type O 0 4.684011400968302e-08
PAX6 O 0 0.00021117138385307044
. O 0 3.407745907679782e-08

We O 0 2.0736832390122473e-11
found O 0 4.649558326243544e-14
that O 0 7.645502685141057e-17
the O 0 6.414802432188997e-15
dominant O 0 1.0897575897228506e-10
- O 0 4.1956858994052215e-12
negative O 0 3.294756774265689e-13
effects O 0 5.939181980420261e-13
result O 0 4.798846866757578e-13
from O 0 3.982663537068637e-14
the O 0 7.720893355537238e-15
enhanced O 0 1.8446234936655287e-13
DNA O 0 3.6522972146624255e-12
binding O 0 8.427862899750005e-13
ability O 0 6.162882010274373e-11
of O 0 1.986080397364809e-11
these O 0 4.284040136526279e-12
mutants O 0 1.7067368629497537e-09
. O 0 5.579396389343572e-10

Kinetic O 0 1.3301565404688631e-09
studies O 0 7.544452909624688e-12
of O 0 6.731194377926353e-13
binding O 0 2.2465770563306897e-12
and O 0 3.068047660544082e-13
dissociation O 0 2.971395907103158e-10
revealed O 0 9.428206132477968e-11
that O 0 2.834285743927821e-15
various O 0 3.939300600129536e-13
truncation O 0 9.238823928114925e-09
mutants O 0 2.1814001993636367e-10
have O 0 1.6388062781813595e-13
3 O 0 1.2377751818296034e-12
- O 0 5.1396812153492455e-12
5 O 0 2.4696657479478246e-12
- O 0 3.5596235160861855e-12
fold O 0 1.4098461981193466e-12
higher O 0 1.2288129498314038e-12
affinity O 0 5.1068626053234895e-14
to O 0 1.3660307016409232e-14
various O 0 1.1966047998388657e-13
DNA O 0 1.309228246648697e-11
- O 0 9.803038914478479e-14
binding O 0 1.5370571569001124e-13
sites O 0 1.0258111634436906e-12
when O 0 2.6390950480460664e-15
compared O 0 9.61310160163889e-14
with O 0 1.6582320333261095e-16
the O 0 7.4120959749676e-14
wild O 0 8.363078458917261e-12
- O 0 7.305926003065011e-11
type O 0 2.912791785547597e-09
PAX6 O 0 2.4527522327844054e-05
. O 0 1.642900926412949e-08

These O 0 5.56768335862462e-13
results O 0 1.1647155679153642e-12
provide O 0 6.452444373077071e-13
a O 0 3.7593063698885404e-14
new O 0 1.1516698713936145e-14
insight O 0 2.7813195540085656e-13
into O 0 1.6797977939186914e-14
the O 0 6.21565312782825e-14
role O 0 2.7485715526492926e-12
of O 0 5.387390533684311e-11
mutant O 0 1.5907807293658038e-09
PAX6 O 0 8.57765189721249e-06
in O 0 1.3149700772707718e-10
causing O 0 6.935560570298094e-09
aniridia B-Disease 1 1.0
. O 0 7.156971126853762e-10
. O 0 1.0863276944661493e-09

Reversal O 0 1.0470161271314282e-07
of O 0 4.238572159920295e-09
severe O 0 5.1943989092251286e-05
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.0981658249420434e-07
excellent O 0 8.228817627298213e-09
neuropsychologic O 0 2.7289031034882782e-09
outcome O 0 2.618134598009192e-10
in O 0 1.8492241700591994e-13
very B-Disease 0 3.5245972671493417e-14
- I-Disease 0 1.6991521579502733e-13
long I-Disease 0 2.11447179210289e-13
- I-Disease 0 1.631817077296649e-12
chain I-Disease 0 5.633174048752521e-13
acyl I-Disease 0 1.4817860827243123e-10
- I-Disease 0 1.7772185945119645e-09
coenzyme I-Disease 0 1.6527035739954954e-08
A I-Disease 0 1.0596045285637956e-05
dehydrogenase I-Disease 0 1.1464918316050898e-05
deficiency I-Disease 0 3.569078035070561e-05
. O 0 2.0899255659401206e-09

Very B-Disease 0 1.1719875070426156e-11
- I-Disease 0 4.184481320473887e-12
long I-Disease 0 4.3747533265241223e-13
- I-Disease 0 4.3123214417753464e-13
chain I-Disease 0 2.0726045798233686e-14
acyl I-Disease 0 7.078262130068291e-13
- I-Disease 0 1.0689335701308256e-12
coenzyme I-Disease 0 1.81064451626467e-12
A I-Disease 0 2.987357236583499e-11
dehydrogenase I-Disease 0 2.32073995437565e-12
( I-Disease 0 3.3272068267035677e-15
VLCAD I-Disease 1 0.5384661555290222
) I-Disease 0 1.1822759839272973e-13
deficiency I-Disease 0 1.3797640363577557e-08
is O 0 9.50138964495072e-15
a O 0 1.920298555585509e-12
disorder O 1 0.7661762833595276
of O 0 2.392232545389561e-06
fatty O 0 2.162568568664369e-09
acid O 0 1.0459094701431582e-09
beta O 0 1.117135620121168e-10
oxidation O 0 2.2003003585790992e-10
that O 0 1.3791211553836058e-13
reportedly O 0 1.5397546519052563e-12
has O 0 4.567674401858874e-16
high O 0 1.6457631969463843e-13
rates O 0 2.937798929906338e-13
of O 0 2.2677748622110944e-13
morbidity O 0 1.8173108573549257e-09
and O 0 1.6827047567835596e-12
mortality O 0 1.7575096933342138e-08
. O 0 8.659555850165646e-10

We O 0 2.1650386344829187e-11
describe O 0 3.597909947403166e-12
the O 0 1.1232424631255414e-13
outcome O 0 1.073761746184232e-09
of O 0 1.7825545206573423e-10
a O 0 5.381951937062646e-13
5 O 0 1.2197102323367043e-13
- O 0 1.2835191893698084e-14
year O 0 3.0462045104255597e-13
- O 0 3.792932634638646e-11
old O 0 1.7064731849814052e-09
girl O 0 1.390730863803924e-09
with O 0 2.2281846506766456e-12
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 4.187883113210278e-12
was O 0 7.597488718875944e-13
first O 0 3.3174784534045765e-12
seen O 0 2.1836209056214084e-12
at O 0 1.4060696780070908e-13
5 O 0 2.4490004411881726e-14
months O 0 7.15353137511511e-14
of O 0 2.1004153819871585e-13
age O 0 1.5368829472950374e-11
with O 0 7.803289806852798e-13
severe O 0 1.7254971851343726e-07
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
, O 1 0.7885005474090576
hepatomegaly B-Disease 1 1.0
, O 0 5.242912948233425e-07
encephalopathy B-Disease 0 9.664671779319178e-06
, O 0 5.5283954497609145e-12
and O 0 2.8672420340769555e-11
hypotonia B-Disease 0 3.7595765434161876e-07
. O 0 6.10086914321073e-08

Biochemical O 0 2.0412253221024912e-08
studies O 0 3.6614730691830744e-10
indicated O 0 3.6980052300350508e-06
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 7.727398276813346e-09
by O 0 3.6546696794087855e-14
a O 0 3.2079981032717697e-12
stable O 0 1.3453725955514528e-07
yet O 0 1.1120350300319881e-11
inactive O 0 1.828885792809487e-10
enzyme O 0 1.2034136187555333e-10
. O 0 8.829406650256999e-10

Molecular O 0 3.516167175129925e-12
genetic O 0 8.93339899667514e-14
analysis O 0 1.5575830013790648e-13
of O 0 3.0676743697360953e-12
her O 0 4.660566724212778e-11
VLCAD O 1 1.0
gene O 0 1.4191718633593808e-10
revealed O 0 1.3022238842808065e-09
a O 0 6.660750943854321e-12
T1372C O 0 5.488625998140151e-09
( O 0 1.189157347353427e-14
F458L O 0 5.32840771505505e-10
) O 0 2.3497380053521567e-14
missense O 0 3.0168951781206488e-09
mutation O 0 2.8499090240496905e-11
and O 0 2.335277804466074e-12
a O 0 1.1421634749098075e-09
1668 O 0 1.9047719206355396e-06
ACAG O 0 0.09825345873832703
1669 O 0 2.3001681256573647e-05
splice O 0 1.0667079550330527e-05
site O 0 1.5883015791473554e-08
mutation O 0 9.140733170376336e-10
. O 0 1.3630099271466634e-09

After O 0 3.0552192720190163e-12
initial O 0 3.643024770738634e-11
treatment O 0 7.231066856405732e-10
with O 0 1.8979399486491327e-13
intravenous O 0 1.6338742858668098e-10
glucose O 0 8.634124526452069e-10
and O 0 9.711146817248384e-13
carnitine O 0 2.7803795377145946e-10
, O 0 5.366355637989465e-15
the O 0 3.8123451335907166e-13
patient O 0 1.2848715147395495e-10
has O 0 2.1914031953130944e-15
thrived O 0 1.4107339428581778e-12
on O 0 2.1015613836834757e-13
a O 0 4.189790062201354e-13
low O 0 5.971814709404555e-10
- O 0 3.2175118125366e-10
fat O 0 9.394956167196877e-12
diet O 0 1.2848382297328542e-12
supplemented O 0 3.5644135212842265e-12
with O 0 5.3524130521611854e-15
medium O 0 1.6145956793778282e-10
- O 0 4.234349676446314e-11
chain O 0 1.8759043797500485e-12
triglyceride O 0 3.692739170002568e-10
oil O 0 3.079829447028004e-11
and O 0 1.7889892854876938e-13
carnitine O 0 8.413866131595782e-11
and O 0 3.16159248846086e-14
avoidance O 0 1.0680872852830703e-09
of O 0 1.6654069789900916e-10
fasting O 0 1.7583008826704827e-08
. O 0 9.975779091675463e-10

Her O 0 2.053103526122868e-05
ventricular O 1 0.9999516010284424
hypertrophy O 1 0.9999997615814209
resolved O 0 7.910416024969891e-05
significantly O 0 6.634071958444565e-09
over O 0 5.158437153991724e-13
1 O 0 1.8574641065700892e-13
year O 0 7.937263043003573e-13
, O 0 2.0305676899038533e-14
and O 0 8.474410816096054e-14
cognitively O 0 1.5368800632131752e-07
, O 0 2.6135208363795015e-13
she O 0 1.197947584229489e-13
is O 0 3.2854847365788994e-15
in O 0 1.0633991280042335e-14
the O 0 1.2870131663959145e-13
superior O 0 1.1390229905094973e-11
range O 0 7.895473337626857e-12
for O 0 6.271925795560407e-13
age O 0 9.524857569331857e-10
. O 0 2.1227641866516933e-09

Clinical O 0 2.2822288503476784e-09
recognition O 0 1.0483089596391437e-07
of O 1 0.9998470544815063
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 3.243019186527363e-10
important O 0 1.8288186937054363e-11
because O 0 3.9791079468659476e-15
it O 0 4.6366834995606617e-17
is O 0 8.077756171270237e-17
one O 0 2.5079076439665044e-15
of O 0 3.8488101052579216e-13
the O 0 1.428646155370028e-12
few O 0 5.839193711887347e-12
directly O 0 8.265780282457058e-10
treatable O 0 2.1166699752939167e-06
causes O 0 1.78169104469994e-10
of O 0 4.062139069560544e-09
cardiomyopathy B-Disease 1 1.0
in O 0 2.6412346088022787e-08
children O 0 1.2552407897825635e-11
. O 0 3.1784954442753977e-12
. O 0 1.5618752124968438e-10

Cloning O 0 7.652868894147957e-10
of O 0 7.71010338906919e-12
a O 0 3.6549275162379297e-14
novel O 0 3.952436996939278e-15
member O 0 1.7896581027028458e-13
of O 0 5.073808127115109e-12
the O 0 2.203104365605668e-11
low O 0 1.9424890584929244e-09
- O 0 2.0076461326734574e-10
density O 0 3.145814997385088e-10
lipoprotein O 0 2.4277397869809647e-08
receptor O 0 3.048361119084575e-09
family O 0 8.617672131450149e-10
. O 0 3.5761520411625725e-09

A O 0 3.137531900954116e-11
gene O 0 6.1358223901319e-15
encoding O 0 6.400302380096812e-13
a O 0 2.7522775386339647e-14
novel O 0 1.2494106972431827e-14
transmembrane O 0 5.028728735506638e-12
protein O 0 3.768208008537825e-14
was O 0 1.5207276163446026e-16
identified O 0 4.769925008168152e-18
by O 0 5.594219655418642e-21
DNA O 0 6.5701326046059116e-15
sequence O 0 3.826975588522714e-16
analysis O 0 1.6979122181825233e-16
within O 0 6.140853342322117e-16
the O 0 4.444183668533656e-15
insulin B-Disease 0 0.006631612777709961
- I-Disease 1 1.0
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 2.4365546039128994e-11
IDDM B-Disease 0 5.2786759624723345e-05
) O 0 8.282330509899911e-15
locus O 0 1.3239355358546367e-12
IDDM4 O 0 5.679005354863875e-08
on O 0 3.8801253876563635e-11
chromosome O 0 2.0467592898310016e-10
11q13 O 0 4.058485458813266e-08
. O 0 1.5776547845902655e-09

Based O 0 2.2073096388880442e-12
on O 0 3.998469090549239e-12
its O 0 1.3032028798112827e-13
chromosomal O 0 4.368741812754706e-09
position O 0 2.590008651992548e-09
, O 0 9.3456677197957e-15
this O 0 5.181901931747106e-15
gene O 0 4.4594679545503866e-15
is O 0 3.60209813484515e-16
a O 0 1.1789629670200426e-14
candidate O 0 1.3396853938696385e-11
for O 0 3.453316463081918e-13
conferring O 0 1.2075812350076376e-08
susceptibility O 0 4.3707447616725403e-07
to O 0 8.286513519806249e-08
diabetes B-Disease 1 0.999160647392273
. O 0 7.125580623323913e-07

The O 0 4.562653380113524e-11
gene O 0 5.151463294567754e-14
, O 0 3.2973874553119537e-15
termed O 0 1.0747380416176178e-11
low O 0 1.2105763058656294e-09
- O 0 2.988508399082157e-11
density O 0 2.1754865270340318e-11
lipoprotein O 0 6.594967627560067e-11
receptor O 0 1.5064578274062712e-12
related O 0 2.2589983217358167e-09
protein O 0 7.055513291664983e-12
5 O 0 2.4921270559349895e-13
( O 0 5.395004303968855e-17
LRP5 O 0 2.440641022616319e-09
) O 0 8.459347160986259e-17
, O 0 1.6163433424086282e-17
encodes O 0 1.8849029469205866e-16
a O 0 1.533422538523444e-14
protein O 0 5.995567540703628e-13
of O 0 6.735757351189475e-12
1615 O 0 5.701239924604806e-09
amino O 0 2.105055907364317e-09
acids O 0 1.4994925440214857e-11
that O 0 3.862324549812682e-14
contains O 0 2.6733327550487957e-15
conserved O 0 1.6111078942303292e-13
modules O 0 7.1617022208425585e-12
which O 0 4.38990918540539e-16
are O 0 1.0910983971046937e-15
characteristic O 0 2.4627181804265375e-12
of O 0 3.410112253340869e-12
the O 0 1.1424084768452136e-11
low O 0 2.040562385730027e-09
- O 0 2.2054347237343563e-10
density O 0 1.5899639937977383e-10
lipoprotein O 0 1.2957572792515748e-09
( O 0 5.933682364900328e-12
LDL O 0 1.673579497207811e-08
) O 0 1.1290151105680657e-11
receptor O 0 1.9954515470543832e-11
family O 0 2.4772201651090953e-11
. O 0 4.962427135879466e-10

These O 0 2.446891430793463e-13
modules O 0 5.007368478193719e-11
include O 0 1.7067967997058328e-15
a O 0 5.966675839795847e-15
putative O 0 6.607782029877107e-12
signal O 0 6.50304289584458e-12
peptide O 0 1.5819574925197977e-13
for O 0 3.5278404546604247e-13
protein O 0 2.416674716246292e-12
export O 0 3.211141907932813e-10
, O 0 8.393368058955478e-14
four O 0 1.3125438236283316e-11
epidermal O 0 1.3324215064614009e-09
growth O 0 3.3948305971920334e-11
factor O 0 2.678522551327611e-12
( O 0 1.7065315089867528e-13
EGF O 0 7.153877046306434e-09
) O 0 6.253920721132483e-14
repeats O 0 7.086870586897609e-12
with O 0 3.313484808254753e-14
associated O 0 1.5421596291642636e-11
spacer O 0 8.588797300035367e-07
domains O 0 2.681890487465921e-09
, O 0 3.0036228766770062e-15
three O 0 1.6019673922899186e-13
LDL O 0 2.7556554260677046e-10
- O 0 4.320876545449437e-09
receptor O 0 1.2502821044105272e-12
( O 0 1.1167356237873696e-13
LDLR O 0 0.06873171776533127
) O 0 3.198311366724334e-14
repeats O 0 3.257833022449197e-12
, O 0 6.621302209056679e-17
a O 0 6.84941493154606e-16
single O 0 6.057500421402517e-13
transmembrane O 0 1.361870251986863e-11
spanning O 0 6.061043333893679e-11
domain O 0 2.350005953721812e-11
, O 0 8.840067824348978e-15
and O 0 2.2711845086369718e-14
a O 0 1.1184975688693921e-11
cytoplasmic O 0 3.867740261398467e-08
domain O 0 3.9101159643450956e-08
. O 0 5.622719179143587e-09

The O 0 1.4768934686326673e-10
encoded O 0 6.685131337391681e-10
protein O 0 2.6100758707126026e-11
has O 0 1.066018280932086e-15
a O 0 2.0822795172018493e-15
unique O 0 4.6707039955519794e-14
organization O 0 4.003809003089165e-13
of O 0 1.6684115200504834e-10
EGF O 0 6.051822083463776e-07
and O 0 2.7001291827422058e-11
LDLR O 1 0.9999994039535522
repeats O 0 1.0738907540996934e-09
; O 0 1.3536407272049609e-14
therefore O 0 1.3600240725275548e-12
, O 0 7.556672301789469e-14
LRP5 O 0 2.748206679825671e-05
likely O 0 7.341671715010989e-11
represents O 0 2.76221320122394e-13
a O 0 9.508229435999799e-14
new O 0 1.7216579927654095e-14
category O 0 1.857171100932975e-12
of O 0 4.769157291306669e-12
the O 0 6.774401178910594e-11
LDLR O 1 0.6411794424057007
family O 0 1.7345798131174206e-09
. O 0 4.914963547264506e-09

Both O 0 4.499207117980575e-10
human O 0 3.2769297692025745e-11
and O 0 1.8417285058136557e-11
mouse O 0 1.8951800129229923e-09
LRP5 O 1 0.8781642913818359
cDNAs O 0 7.1957324507820886e-06
have O 0 8.057060877850186e-13
been O 0 2.4590993304152153e-12
isolated O 0 9.618282732770655e-12
and O 0 1.0893231642780145e-14
the O 0 2.1385603249206298e-13
encoded O 0 5.687435114878903e-13
mature O 0 9.281624080426099e-12
proteins O 0 1.4018621434855588e-14
are O 0 2.1848996498742963e-16
95 O 0 1.3439824773919806e-11
% O 0 4.247660166309397e-13
identical O 0 2.304563603752058e-13
, O 0 1.526907436378872e-15
indicating O 0 3.121325030039368e-12
a O 0 3.961105261070935e-13
high O 0 4.6870137979104776e-12
degree O 0 6.271995145468168e-10
of O 0 3.209144408544695e-11
evolutionary O 0 8.40928889023207e-12
conservation O 0 4.0953906932372774e-12
. O 0 7.550106373432897e-13
. O 0 1.699965307411233e-10

The O 0 1.3892196282228042e-09
APC B-Disease 0 4.4565560131104576e-09
variants O 0 2.735587867341849e-10
I1307K O 0 7.6311579277899e-08
and O 0 7.021705265841671e-13
E1317Q O 0 2.8176351918318687e-08
are O 0 2.4689521328541582e-14
associated O 0 1.8723111949725535e-09
with O 0 1.4161724948280607e-07
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 6.9002143408825045e-12
but O 0 1.0002293589737865e-14
not O 0 4.6320057706973616e-14
always O 0 1.9922209498410282e-13
with O 0 1.7124380391345465e-15
a O 0 1.0672874259723408e-12
family O 0 8.893926177130917e-13
history O 0 4.954908150445192e-10
. O 0 1.5225004590391222e-09

Classical O 1 0.9911289215087891
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.16275834446955e-11
FAP B-Disease 0 4.185157997937949e-09
) O 0 1.920197772217313e-14
is O 0 2.5523232988634414e-15
a O 0 1.2988905740904388e-12
high O 0 1.2626992429431994e-05
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 0 0.368740439414978
that O 0 7.018029651070356e-15
predisposes O 0 1.4953346894053254e-10
to O 0 4.157811248073351e-13
hundreds O 0 2.3696550364299407e-13
or O 0 4.865500363715469e-13
thousands O 0 4.719820454607282e-12
of O 0 6.166659431983135e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 0.272241473197937
carcinoma I-Disease 1 1.0
and O 0 1.8468043067043638e-11
that O 0 4.29174009969769e-14
results O 0 1.5966459057659144e-11
from O 0 1.620141520941587e-11
truncating O 0 2.200075011060676e-09
mutations O 0 6.715011576299834e-13
in O 0 1.0132023800686618e-13
the O 0 3.1928899628386187e-12
APC B-Disease 0 2.355236006224004e-09
gene O 0 6.529843332714336e-11
. O 0 1.1151654710772618e-08

A O 0 2.757749362203299e-09
variant O 0 1.5936537645089288e-09
of O 0 4.765616234969627e-10
FAP B-Disease 0 4.93802531309484e-07
is O 0 9.721874416612764e-10
attenuated B-Disease 1 0.9999982118606567
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 3.90821245808623e-13
which O 0 1.2859168484759097e-16
results O 0 4.992941078489112e-14
from O 0 1.2377822291437246e-12
germ O 0 3.056461395090082e-08
- O 0 1.061384224954054e-08
line O 0 1.1627528939683884e-09
mutations O 0 3.622167886810357e-12
in O 0 1.4036642941722688e-12
the O 0 2.35953552703283e-12
5 O 0 6.695623330950362e-13
and O 0 6.074803407161121e-15
3 O 0 1.4631915470908474e-13
regions O 0 1.9323904455748053e-12
of O 0 9.601470009681923e-13
the O 0 5.757696836666826e-12
APC B-Disease 0 1.2323730924634901e-09
gene O 0 6.270293312349295e-11
. O 0 1.0030255737092375e-08

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 2.6487978743716667e-07
have O 0 8.958925859199954e-14
" O 0 6.003394938287887e-13
multiple O 0 8.289557373863943e-10
" O 0 7.78696994530037e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 5.897618005935856e-13
typically O 0 1.0188688271978857e-13
fewer O 0 7.690352735591037e-15
than O 0 4.406149453982215e-16
100 O 0 4.833367863929516e-13
) O 0 7.6965410524245585e-16
without O 0 1.6266081905892682e-13
the O 0 1.4049284739053869e-12
florid O 0 1.6217169829246814e-09
phenotype O 0 1.203213917388979e-10
of O 0 7.570157695147017e-11
classical O 0 9.993338379032934e-10
FAP B-Disease 0 1.0937192485016567e-08
. O 0 3.83912546197962e-09

Another O 0 3.0146718454915344e-11
group O 0 1.1683082073391665e-13
of O 0 2.3188076458957596e-11
patients O 0 3.464074860293209e-10
with O 0 3.033772777265298e-13
multiple O 0 0.052879657596349716
adenomas B-Disease 1 1.0
has O 0 5.35567076798138e-11
no O 0 3.188271044743396e-12
mutations O 0 9.549582262111111e-13
in O 0 2.9458732545353805e-13
the O 0 1.3116546694266762e-12
APC B-Disease 0 9.286179464274014e-11
gene O 0 3.178869385604688e-13
, O 0 2.1336944594518327e-14
and O 0 9.985214864422377e-15
their O 0 4.13774835792205e-13
phenotype O 0 7.754002518192693e-13
probably O 0 9.230134966889056e-14
results O 0 1.0673484665546518e-12
from O 0 9.375140420930794e-12
variation O 0 8.184292826785011e-11
at O 0 2.7890675879937987e-11
a O 0 1.4683811892096665e-12
locus O 0 1.2214014522005101e-11
, O 0 2.4787442064189147e-13
or O 0 1.1948197422770312e-12
loci O 0 7.918913441651299e-11
, O 0 3.4697695020999286e-13
elsewhere O 0 2.3632198628553702e-12
in O 0 8.437749874886172e-14
the O 0 4.887414258025746e-13
genome O 0 8.904917775387489e-11
. O 0 8.930913231175452e-10

Recently O 0 1.5226138128099365e-09
, O 0 4.3005732980848366e-14
however O 0 7.137000002490138e-14
, O 0 3.653188515245569e-16
a O 0 6.560565367466674e-15
missense O 0 3.4038365875899146e-11
variant O 0 2.1723558715769364e-11
of O 0 2.9886824126634792e-09
APC B-Disease 0 4.312941115358626e-08
( O 0 1.7030629293965371e-12
I1307K O 0 7.146337566155125e-08
) O 0 1.1100414207612652e-14
was O 0 4.476601652304152e-13
described O 0 1.9302371455213498e-14
that O 0 3.750679625194375e-16
confers O 0 8.167817008679357e-13
an O 0 1.0305396706616291e-15
increased O 0 2.7566514609195236e-12
risk O 0 3.2795702264998283e-10
of O 0 1.603603095645667e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.758912876459462e-10
including O 0 5.67027761549932e-13
multiple O 0 1.2616075961702222e-09
adenomas B-Disease 0 5.936705065323622e-07
, O 0 5.022038340740664e-12
in O 0 3.0620073143694526e-10
Ashkenazim O 0 4.819249625143129e-06
. O 0 7.049473538245365e-08

We O 0 5.452163720498504e-11
have O 0 1.9525544308024272e-14
studied O 0 1.5923469953629116e-13
a O 0 1.325285113449497e-15
set O 0 2.4123569488570043e-14
of O 0 3.719728247208315e-14
164 O 0 5.422710197544589e-11
patients O 0 2.530765094016507e-12
with O 0 2.1829773774219297e-14
multiple O 0 1.232347699442471e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 4.081946099177003e-05
/ I-Disease 1 1.0
or I-Disease 1 0.9963828325271606
carcinoma I-Disease 1 1.0
and O 0 5.381364798218158e-10
analyzed O 0 1.1482702289011826e-10
codons O 0 2.2050014591989964e-10
1263 O 0 2.2644869090981956e-08
- O 0 5.5152806766045614e-09
1377 O 0 1.1653016329660204e-09
( O 0 1.7399145004533961e-13
exon O 0 1.4980552909271694e-10
15G O 0 3.2210487055372994e-10
) O 0 7.201713404363661e-16
of O 0 9.359836039904423e-14
the O 0 4.665684613831822e-13
APC B-Disease 0 1.0461363719738159e-10
gene O 0 2.88197688370212e-13
for O 0 7.49821645745774e-12
germ O 0 5.442553174361819e-06
- O 0 5.229869088907435e-07
line O 0 5.981690254230898e-09
variants O 0 3.4364044942947203e-09
. O 0 1.821829687109755e-09

Three O 0 1.5138908182610322e-10
patients O 0 2.1705241770586525e-12
with O 0 2.7183337097122853e-15
the O 0 1.3494222015839052e-12
I1307K O 0 1.225500478874153e-09
allele O 0 1.1349308645658418e-11
were O 0 3.358106165102931e-13
detected O 0 1.0871386256494642e-12
, O 0 7.615666611318514e-17
each O 0 1.1048493629044805e-14
of O 0 1.282067767921502e-11
Ashkenazi O 0 1.0082873558303618e-07
descent O 0 1.8840605662262533e-06
. O 0 2.109543117967405e-07

Four O 0 4.490515514987692e-09
patients O 0 1.6431968286045873e-10
had O 0 1.538938356089592e-12
a O 0 2.848983418970996e-12
germ O 0 5.298930432218185e-07
- O 0 4.805912681149493e-07
line O 0 2.654588193706786e-08
E1317Q O 0 5.055566134615219e-07
missense O 0 1.2153797968039726e-08
variant O 0 1.4270461201615348e-10
of O 0 9.473831441564329e-11
APC O 0 1.7769203886075502e-09
that O 0 1.0912244144314215e-13
was O 0 1.6886722055409198e-12
not O 0 4.585705594547726e-14
present O 0 4.017351121904378e-12
in O 0 2.149204208698463e-13
controls O 0 1.4357848243662374e-11
; O 0 1.7966949474967735e-15
one O 0 3.3310309263505367e-14
of O 0 1.3181194688256098e-13
these O 0 4.879286705846298e-15
individuals O 0 1.4899743223072137e-13
had O 0 2.6059968419311907e-11
an O 0 3.600503142159317e-13
unusually O 0 7.424876685702131e-13
large O 0 1.0682293333859512e-14
number O 0 5.121975434931036e-13
of O 0 2.6496937977071866e-10
metaplastic B-Disease 0 4.027773684356362e-06
polyps I-Disease 0 3.382245594707456e-08
of I-Disease 0 5.6942197623754964e-09
the I-Disease 0 2.6619588755494306e-09
colorectum I-Disease 0 2.629598839121172e-06
. O 0 2.373759500073902e-08

There O 0 2.966961398787049e-10
is O 0 7.496907689910279e-14
increasing O 0 7.814918417253791e-14
evidence O 0 1.0772756113813092e-13
that O 0 7.030807566596161e-16
there O 0 5.132345845651519e-15
exist O 0 2.2743254762119802e-12
germ O 0 3.433135331576409e-09
- O 0 1.8040680060948944e-11
line O 0 2.6100996364242235e-12
variants O 0 3.4343875399828194e-12
of O 0 3.941257042949786e-12
the O 0 4.484352884685794e-13
APC B-Disease 0 6.488549975092184e-11
gene O 0 2.817475866869791e-14
that O 0 1.3407128656716684e-15
predispose O 0 8.911595072991219e-11
to O 0 2.6556599801164094e-13
the O 0 1.1646193449725561e-13
development O 0 5.402859826197925e-10
of O 0 2.8834700252500234e-11
multiple O 0 0.000426209851866588
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 0 9.05031083675567e-06
carcinoma I-Disease 1 1.0
, O 0 7.941382469157932e-13
but O 0 3.7631874748528596e-14
without O 0 3.299934327530285e-12
the O 0 6.803366897623064e-11
florid O 0 2.697873213719504e-08
phenotype O 0 7.801918000538421e-10
of O 0 1.293576218364123e-10
classical O 0 3.4197947251790595e-10
FAP B-Disease 0 8.243752902536983e-10
, O 0 9.974441452366249e-15
and O 0 7.722833484502924e-16
possibly O 0 5.984142760311062e-13
with O 0 2.842363050112838e-15
importance O 0 5.704764216574176e-09
for O 0 6.030734311934793e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 5.0400288387209e-09
in O 0 2.2922584511954336e-13
the O 0 3.758899658548587e-13
general O 0 3.9833571554084846e-13
population O 0 4.110715267529111e-15
. O 0 6.19778818653112e-14
. O 0 4.30496228942534e-11

Genomic O 0 7.440837945793533e-10
structure O 0 1.513390628093969e-11
of O 0 2.2391689197265308e-11
the O 0 4.4976455892964395e-10
human O 1 0.9997724890708923
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 6.499570304185909e-08
CLD B-Disease 1 1.0
) O 0 4.133853849508373e-12
gene O 0 1.220465395412873e-11
. O 0 1.3003846888182125e-09

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 1.701189766833977e-08
CLD B-Disease 1 1.0
) O 0 3.456538982989088e-13
is O 0 1.605002709445416e-15
caused O 0 9.48744578857302e-15
by O 0 2.292639461438185e-16
mutations O 0 7.679099055853816e-14
in O 0 5.138321239577925e-15
a O 0 3.3524456556746672e-15
gene O 0 7.225709318363783e-16
which O 0 1.244145074574929e-15
encodes O 0 1.3074859120734694e-12
an O 0 7.917879134462791e-13
intestinal O 0 1.8999684048282006e-09
anion O 0 2.3964221718131284e-09
transporter O 0 1.009104622085033e-08
. O 0 4.341976111987833e-09

We O 0 5.780366810204107e-11
report O 0 5.676283011332717e-13
here O 0 7.219778160733048e-14
the O 0 2.317816933460168e-15
complete O 0 1.61267971632989e-12
genomic O 0 4.6945940190834534e-11
organization O 0 1.7814028518362696e-13
of O 0 1.6325269044589752e-12
the O 0 8.899372666744398e-13
human O 0 3.26132905403842e-11
CLD B-Disease 1 0.9999874830245972
gene O 0 1.1479915976164712e-11
which O 0 6.644261963534293e-14
spans O 0 1.998536752756408e-11
approximately O 0 1.410493764971918e-13
39kb O 0 8.46737169268863e-09
, O 0 2.7322569662487084e-13
and O 0 4.061960457660968e-13
comprises O 0 3.7012957802839974e-12
21 O 0 2.7684043946152315e-10
exons O 0 9.344982565551163e-09
. O 0 3.2636906510674635e-09

All O 0 1.084169287679515e-08
exon O 0 3.926588121316854e-08
/ O 0 2.207330851433653e-08
intron O 0 1.2857553244316478e-08
boundaries O 0 1.7788455430878258e-10
conform O 0 9.183127036571648e-10
to O 0 1.502742201509033e-11
the O 0 2.5745013759737034e-11
GT O 0 1.1174206804298592e-07
/ O 0 2.8283889719205035e-07
AG O 0 2.3216259137370798e-08
rule O 0 4.206991199851018e-09
. O 0 1.2646944824723505e-08

An O 0 1.4279235346220664e-13
analysis O 0 5.214616173761233e-13
of O 0 7.879927721617108e-13
the O 0 8.185580577073359e-13
putative O 0 3.6600067421233007e-10
promoter O 0 5.967237814985538e-10
region O 0 4.631650965536416e-11
sequence O 0 1.9094848965894862e-11
shows O 0 2.3826771718832296e-12
a O 0 1.9143695417951634e-13
putative O 0 1.7800003693224653e-09
TATA O 0 7.947311075895414e-08
box O 0 4.334278769224653e-10
and O 0 1.9013794445160714e-12
predicts O 0 2.4470149864730395e-11
multiple O 0 2.3418000177910514e-11
transcription O 0 2.3231682202973225e-11
factor O 0 1.7054521857240434e-12
binding O 0 7.17603546029899e-11
sites O 0 2.8040001431861583e-09
. O 0 3.2458242760213807e-09

The O 0 7.329947065981557e-11
genomic O 0 1.24921140098877e-09
structure O 0 9.827723704280977e-12
was O 0 2.436560237698438e-14
determined O 0 1.8290565188729818e-14
using O 0 6.030840703132728e-15
DNA O 0 1.585070824594581e-10
from O 0 8.573306994885677e-14
several O 0 4.182703327166833e-15
sources O 0 1.8827005926480567e-12
including O 0 9.959189988876225e-16
multiple O 0 1.9973545387075298e-12
large O 0 9.194089066466571e-12
- O 0 2.8223923198567036e-10
insert O 0 8.488663660877194e-10
libaries O 0 5.994127860731169e-09
and O 0 9.356796885689675e-15
genomic O 0 9.503022674328676e-11
DNA O 0 6.674050201382897e-09
from O 0 1.6271312422433404e-11
Finnish O 0 3.1857311114436015e-05
CLD B-Disease 1 1.0
patients O 0 4.213335014213726e-09
and O 0 4.233629072314393e-12
controls O 0 2.084886219222426e-08
. O 0 6.326799528721949e-09

Exon O 0 3.3119786735369416e-07
- O 0 1.5038985334836497e-10
specific O 0 3.997195803517872e-12
primers O 0 9.766697867119589e-11
developed O 0 5.763626880449235e-13
in O 0 3.0975734418458483e-15
this O 0 1.6738993105838967e-15
study O 0 1.2083718027179461e-15
will O 0 3.5421154966853367e-16
facilitate O 0 1.6767082514079767e-11
mutation O 0 1.742282262472833e-13
screening O 0 1.506569825490689e-12
studies O 0 1.70477889617493e-12
of O 0 6.294552552799093e-13
patients O 0 5.169774114008319e-13
with O 0 2.0845736635878402e-14
the O 0 8.37516653251491e-11
disease O 0 3.4581353336449183e-09
. O 0 3.2857810916553376e-10

Genomic O 0 2.303771756695383e-10
sequencing O 0 5.281569070980652e-10
of O 0 1.7778042926686055e-10
a O 0 4.16006284975623e-10
BAC O 0 1.8183911379310302e-05
clone O 0 2.73315578169786e-07
H O 1 1.0
_ O 0 3.6038255712966816e-11
RG364P16 O 0 2.8639940197194846e-08
revealed O 0 8.420155198085588e-12
the O 0 4.4833328537293923e-14
presence O 0 9.193167738565447e-14
of O 0 5.295108427248729e-13
another O 0 8.368195459490524e-13
, O 0 1.3443240424115214e-14
highly O 0 1.1278049891552677e-12
homologous O 0 2.3501135065773227e-11
gene O 0 1.8044792819259942e-13
3 O 0 1.4706067310091275e-12
of O 0 5.039954131119684e-12
the O 0 5.952124643854306e-12
CLD B-Disease 0 0.007206733804196119
gene O 0 5.366668481138204e-13
, O 0 2.3538321391027104e-15
with O 0 1.6273443151599914e-16
a O 0 3.6402947679642274e-15
similar O 0 2.8326211124282295e-15
genomic O 0 1.5089431440462597e-11
structure O 0 2.7949188102782685e-12
, O 0 8.660255964536691e-16
recently O 0 3.3781719521069117e-15
identified O 0 3.1803478307921434e-14
as O 0 8.010012805489443e-15
the O 0 2.90734519792224e-10
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 1.8142889968153497e-11
( O 0 1.0717768767756417e-13
PDS B-Disease 0 1.7766035398381064e-07
) O 0 1.1055962596167104e-13
. O 0 8.892929795334403e-12
. O 0 3.3024688539384783e-10

The O 0 5.129579538909468e-10
APCI1307K O 0 0.008859874680638313
allele O 0 5.1137984513616175e-08
and O 0 1.657477453897993e-11
cancer B-Disease 0 3.356065647608375e-08
risk O 0 1.655000789191341e-11
in O 0 4.334156460377575e-13
a O 0 8.675248019951454e-13
community O 0 1.3993257507588508e-12
- O 0 2.366452845313505e-13
based O 0 4.4665843018567436e-15
study O 0 1.574855561714203e-13
of O 0 9.367663979589769e-13
Ashkenazi O 0 1.5405001718704625e-09
Jews O 0 1.0174919795602477e-09
. O 0 3.879507826098916e-09

Mutations O 0 1.604866795013038e-09
in O 0 4.718218437477217e-12
APC O 0 3.293123551628696e-09
are O 0 1.3264599650879977e-13
classically O 0 3.4833685935709013e-10
associated O 0 7.46147676977671e-09
with O 0 2.486636049070512e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 7.674494720277814e-12
FAP B-Disease 0 1.066949195660527e-09
) O 0 4.350982939281371e-15
, O 0 1.8564589188072971e-16
a O 0 4.623020784006067e-14
highly O 0 2.5735873876442383e-08
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 4.665660924274562e-08
by O 0 6.236553157581981e-14
multiple O 0 3.866454711953793e-09
intestinal O 1 0.7435087561607361
polyps B-Disease 0 3.590626407312669e-10
and O 0 8.007533434173711e-16
, O 0 2.6607144522939892e-17
without O 0 4.3593665325801154e-14
surgical O 0 2.297560364183937e-08
intervention O 0 9.812656243113338e-10
, O 0 1.613215646781112e-15
the O 0 2.2016530308935356e-13
development O 0 6.531590202030202e-07
of O 1 0.9996236562728882
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.782884256895656e-10
CRC B-Disease 0 1.0514889225987645e-07
) O 0 2.142824112594255e-12
. O 0 2.6136193209680414e-10

APC B-Disease 0 7.248500111245448e-08
is O 0 2.1671156622687926e-12
a O 0 4.044585152906954e-11
tumour O 1 1.0
- O 0 7.446562921842315e-09
suppressor O 0 7.987997069358599e-11
gene O 0 8.000244482728527e-14
, O 0 2.673414281969969e-15
and O 0 1.606473709213265e-14
somatic O 0 2.1161758567700417e-08
loss O 0 1.0211008927285548e-08
occurs O 0 1.5590485569205725e-09
in O 0 4.225251537537389e-10
tumours B-Disease 1 1.0
. O 0 2.3715199404250598e-07

The O 0 1.5137039399704122e-09
germline O 0 1.2698453843995594e-08
T O 0 2.6406160244518695e-11
- O 0 1.4101529189139428e-12
to O 0 8.769877727667075e-13
- O 0 4.5707368445668806e-11
A O 0 1.8666977685821706e-10
transversion O 0 2.583776970155327e-09
responsible O 0 6.71138492003287e-14
for O 0 4.993449806477233e-16
the O 0 4.910507069732671e-15
APC O 0 7.493037223679777e-13
I1307K O 0 1.1874864806749041e-11
allele O 0 1.594018293011798e-13
converts O 0 8.279238162016075e-14
the O 0 1.1554057949107743e-14
wild O 0 1.2851335494639803e-14
- O 0 9.852708418285703e-15
type O 0 3.688367360555993e-14
sequence O 0 4.3629872934977665e-13
to O 0 1.0037626979597647e-11
a O 0 2.158179052136333e-10
homopolymer O 1 0.9994914531707764
tract O 0 3.083261617575772e-05
( O 0 2.7034968773202717e-13
A8 O 0 2.8105668548050744e-07
) O 0 1.8631297744290017e-14
that O 0 2.559314073535368e-15
is O 0 1.1153343602420679e-14
genetically O 0 2.4548490410586377e-12
unstable O 0 4.081016697909945e-07
and O 0 1.0964983088168623e-10
prone O 0 2.2527912335590372e-07
to O 0 6.715883404950773e-09
somatic O 0 1.4556812857335899e-05
mutation O 0 2.8050394007550494e-08
. O 0 6.163582089158126e-09

The O 0 2.8233562709978344e-10
I1307K O 0 5.538715264208349e-09
allele O 0 3.053764532912062e-11
was O 0 8.084250283091343e-12
found O 0 3.23593961955998e-13
in O 0 4.5199464288568636e-13
6 O 0 3.973225359832355e-10
. O 0 1.3893839412304487e-09

1 O 0 1.8097253695614768e-09
% O 0 3.6513974066565424e-09
of O 0 3.3580538350008737e-10
unselected O 0 0.00012179271288914606
Ashkenazi O 0 4.940762323712988e-07
Jews O 0 9.946463652710236e-10
and O 0 1.8324211505799104e-12
higher O 0 5.6695804301343244e-11
proportions O 0 2.3553717570096167e-12
of O 0 7.182988145254532e-12
Ashkenazim O 0 3.5204219983597795e-08
with O 0 3.2693910512887614e-13
family O 0 5.289457673945952e-12
or O 0 1.1635920092040175e-12
personal O 0 1.8678241175962285e-09
histories O 0 1.8258052705277805e-06
of O 0 1.9629205780802295e-05
CRC B-Disease 0 8.84056953509571e-06
( O 0 4.705537608867827e-12
ref O 0 1.2001981630760383e-09
. O 0 1.5033003054193417e-12
2 O 0 1.823780926626939e-12
) O 0 1.895519738349602e-13
. O 0 4.8778078798328295e-11

To O 0 1.9781422333498e-10
evaluate O 0 3.9169648080594754e-10
the O 0 4.033128431918387e-12
role O 0 5.448275858244145e-11
of O 0 1.5615245763100916e-09
I1307K O 0 3.7990532746334793e-06
in O 0 4.228506433889834e-11
cancer B-Disease 0 5.140588510421651e-10
, O 0 1.1852773536963346e-12
we O 0 2.5787968982449172e-11
genotyped O 0 3.14536578116531e-07
5 O 0 3.0936606054687843e-10
, O 0 2.791786116521089e-12
081 O 0 9.470101076658466e-07
Ashkenazi O 0 1.34825484110479e-07
volunteers O 0 3.569199935604672e-10
in O 0 1.832791730882466e-12
a O 0 3.3292431311782167e-12
community O 0 1.913334941872069e-11
survey O 0 8.555905983698153e-11
. O 0 1.2301414054061155e-10

Risk O 0 1.6919113932090113e-06
of O 0 1.275163583613903e-07
developing O 1 0.9999427795410156
colorectal B-Disease 1 1.0
, I-Disease 0 1.8715272176450526e-07
breast I-Disease 0 1.1147007171530277e-05
and I-Disease 0 4.5393990649733595e-11
other I-Disease 0 7.542629715251437e-11
cancers I-Disease 1 0.9999904632568359
were O 0 1.1860920778872241e-07
compared O 0 5.1341071838351127e-08
between O 0 2.4140398124927742e-08
genotyped O 0 8.416556624979421e-07
I1307K O 0 1.174061203812471e-08
carriers O 0 2.8580658889901245e-13
and O 0 4.5206510925063434e-14
non O 0 7.022878112383779e-11
- O 0 5.09138141802784e-13
carriers O 0 1.3119210511241923e-14
and O 0 5.990551580996577e-16
their O 0 1.366317947453996e-13
first O 0 1.4448587291882031e-11
- O 0 2.1389867307930466e-11
degree O 0 1.2621852452099347e-09
relatives O 0 3.803780068700746e-10
. O 0 2.7350244291568515e-10

Sperm O 0 4.326240407581672e-11
DNA O 0 1.3886652938666089e-10
analysis O 0 1.1167212987661657e-12
in O 0 2.5797536307679836e-13
a O 0 8.232717979561599e-11
Friedreich B-Disease 0 0.010787243023514748
ataxia I-Disease 1 0.9991315007209778
premutation O 1 0.9998668432235718
carrier O 0 9.797829214619469e-09
suggests O 0 7.809924235102628e-11
both O 0 1.9110069429673082e-12
meiotic O 0 1.6269867728624376e-06
and O 0 6.806699301420416e-12
mitotic O 0 1.5660232222103332e-08
expansion O 0 7.224655873550034e-10
in O 0 4.651503791516798e-13
the O 0 8.992763998738607e-12
FRDA B-Disease 0 1.6238760508713312e-05
gene O 0 1.186083592452647e-10
. O 0 1.9367401016268104e-09

Friedreich B-Disease 1 0.9999996423721313
ataxia I-Disease 1 1.0
is O 0 1.6722385698386688e-09
usually O 0 1.1080848044686675e-10
caused O 0 1.5231459756653853e-12
by O 0 1.3621532812699245e-15
an O 0 1.5252309464180189e-15
expansion O 0 7.591991618705052e-11
of O 0 3.8906208810196574e-10
a O 0 4.14655587643864e-10
GAA O 0 1.5799199900357053e-05
trinucleotide O 0 2.7625452503343695e-07
repeat O 0 6.515626371772498e-10
in O 0 2.044183225469176e-11
intron O 0 9.57589785244295e-10
1 O 0 9.453429358763366e-12
of O 0 3.584165256254046e-11
the O 0 6.444886985201848e-11
FRDA B-Disease 0 5.0497525080572814e-05
gene O 0 1.5682964649155196e-10
. O 0 2.432596346579885e-09

Occasionally O 0 1.746565381210985e-08
, O 0 4.14224915219058e-13
a O 0 5.028390898109691e-13
fully O 0 1.8986126559816796e-10
expanded O 0 2.4259308104013222e-11
allele O 0 1.8167693738302404e-10
has O 0 2.089488402857694e-15
been O 0 2.5769391774534828e-14
found O 0 1.5713923150434232e-14
to O 0 1.0807660647503547e-13
arise O 0 6.141384623070678e-11
from O 0 4.92053500809192e-13
a O 0 5.683032169856439e-13
premutation O 0 4.077775628275049e-08
of O 0 2.3017776573652782e-10
100 O 0 4.934819219926112e-10
or O 0 1.4408545537247797e-11
less O 0 2.666180054511358e-10
triplet O 0 1.1587869721552124e-06
repeats O 0 1.9784685889590037e-08
. O 0 8.081734392817452e-09

We O 0 5.544861444994886e-11
have O 0 7.482575553629557e-15
examined O 0 8.236475195454174e-14
the O 0 9.560429111923766e-16
sperm O 0 2.215832260786619e-14
DNA O 0 6.283870646051071e-11
of O 0 3.0880704243729795e-11
a O 0 9.89831203113134e-11
premutation O 0 2.324724619029439e-06
carrier O 0 1.7982236144575836e-08
. O 0 3.145044402685926e-08

This O 0 9.344397651489533e-12
mans O 0 9.035010933855503e-11
leucocyte O 0 2.282375677342685e-10
DNA O 0 1.1842345160051337e-10
showed O 0 1.3820158125538162e-12
one O 0 9.173190000636333e-16
normal O 0 2.4933058547470244e-13
allele O 0 9.574326466192662e-14
and O 0 5.132989484812314e-16
one O 0 1.0240229168028098e-15
allele O 0 1.5320703690077653e-12
of O 0 8.480737271297778e-13
approximately O 0 4.2455459720730504e-13
100 O 0 7.752960773377282e-11
repeats O 0 3.503752010747263e-10
. O 0 7.588520922752195e-10

His O 0 3.737037623796624e-10
sperm O 0 1.3639427087763778e-10
showed O 0 9.484204220588932e-12
an O 0 4.399767060724654e-16
expanded O 0 2.0788321354581717e-14
allele O 0 1.7069230143912373e-12
in O 0 3.971772455195477e-13
a O 0 9.652834087603424e-12
tight O 0 2.7661468671169587e-09
range O 0 1.244841313363665e-10
centering O 0 1.5809050735171581e-09
on O 0 5.645363516937341e-12
a O 0 9.754327337171964e-13
size O 0 3.336764024808314e-12
of O 0 1.1015916477619125e-11
approximately O 0 1.2126872422912882e-11
320 O 0 1.1060941051965756e-09
trinucleotide O 0 6.904808742547175e-07
repeats O 0 5.081004417206714e-08
. O 0 1.7524316220374203e-08

His O 0 2.2632173468650763e-08
affected O 0 2.873932203328877e-07
son O 0 6.747973202436697e-07
has O 0 1.6133711662653927e-13
repeat O 0 6.279769673017688e-12
sizes O 0 1.3035963367796777e-12
of O 0 2.5729047798545013e-12
1040 O 0 2.8337471258410574e-10
and O 0 9.798856604598116e-13
540 O 0 1.4641912127189016e-09
. O 0 1.6301646699190542e-09

These O 0 2.4137046528149853e-11
data O 0 3.5094017969417024e-11
suggest O 0 1.6366235623677117e-12
that O 0 1.3463959273521528e-16
expansion O 0 2.438705162290111e-13
occurs O 0 1.2025461430407915e-14
in O 0 1.658004393221535e-16
two O 0 5.277334486936288e-16
stages O 0 2.3463145489011072e-12
, O 0 4.665125542440481e-16
the O 0 5.41839861281819e-15
first O 0 2.8490352980449496e-14
during O 0 1.1247308423154023e-12
meiosis O 0 1.4159326489071589e-10
followed O 0 3.646747617422341e-13
by O 0 1.6569470472874333e-14
a O 0 7.614317162896178e-13
second O 0 2.6488434709537323e-11
mitotic O 0 2.7398515456411587e-08
expansion O 0 3.6744403075772425e-08
. O 0 1.0540648354151472e-08

We O 0 3.845954110737182e-10
also O 0 9.503968521461931e-14
show O 0 8.092329432420053e-13
that O 0 1.5461847945276365e-16
in O 0 1.8238961400484244e-15
all O 0 2.138836627068024e-14
informative O 0 5.330100076583744e-12
carrier O 0 9.519352672663142e-14
father O 0 1.9541993891147857e-12
to O 0 7.574183467917717e-12
affected O 0 2.927589282109011e-10
child O 0 1.501416352356344e-10
transmissions O 0 6.815556563566361e-09
, O 0 3.0808613229778433e-16
with O 0 2.4658517103640547e-17
the O 0 7.932139984450672e-15
notable O 0 4.063970907301935e-15
exception O 0 1.784258470952007e-14
of O 0 1.609228294239054e-13
the O 0 6.341731068233714e-13
premutation O 0 1.3151688627033309e-09
carrier O 0 1.2624584537490602e-11
, O 0 3.1043486466326986e-13
the O 0 4.01379710718297e-12
expansion O 0 1.6800319468934788e-10
size O 0 4.668927570949943e-12
decreases O 0 1.4494325011049636e-11
. O 0 4.684367910928744e-12
. O 0 1.0537466454962896e-09

The O 0 3.8744624175635067e-10
R496H O 0 7.000793544875705e-08
mutation O 0 4.625409083525156e-11
of O 0 8.521265637551068e-11
arylsulfatase O 0 0.00027353072073310614
A O 0 5.40862799880415e-07
does O 0 5.466938100134877e-12
not O 0 7.494874165736576e-11
cause O 1 0.663290798664093
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.9088032487957207e-08

Deficiency B-Disease 0 0.00016327667981386185
of I-Disease 0 1.1461968369985698e-06
arylsulfatase I-Disease 1 1.0
A I-Disease 1 0.9990038275718689
( O 0 1.2619810795325148e-12
ARSA O 1 0.5069595575332642
) O 0 1.315655483863365e-13
enzyme O 0 3.0439439857588013e-10
activity O 0 1.3780518060002578e-08
causes O 0 2.2529179943830968e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 5.1202129341954006e-11
MLD B-Disease 1 1.0
) O 0 4.2775080352774886e-12
. O 0 4.2355369211932725e-11

A O 0 7.811134516977347e-10
number O 0 4.80011917800699e-13
of O 0 7.672639606992604e-11
ARSA O 0 0.00047118630027398467
gene O 0 1.5318382673434883e-10
mutations O 0 1.072657865308635e-10
responsible O 0 2.7575694505621584e-10
for O 0 1.1888270368132225e-09
MLD B-Disease 1 1.0
have O 0 4.22696426471969e-12
been O 0 3.816892548552664e-13
identified O 0 1.0058114931210671e-11
. O 0 6.617888181903453e-11

Recently O 0 1.4598403041965469e-10
, O 0 1.2149774526845798e-14
the O 0 3.757342269890447e-14
R496H O 0 5.019993865040817e-10
mutation O 0 1.9106315921751937e-12
of O 0 1.2816869787712903e-10
ARSA O 0 0.0018506848718971014
was O 0 5.580649137248983e-11
proposed O 0 4.4217144594231594e-13
to O 0 8.891415707000527e-13
be O 0 8.349558024145498e-13
a O 0 5.646935610087445e-12
cause O 0 2.060913661949826e-09
of O 0 1.1374881125902903e-07
MLD B-Disease 1 1.0
( O 0 1.7333354196402695e-10
Draghia O 0 6.246535804166342e-07
et O 0 5.81137804545051e-10
al O 0 6.521581608076588e-10
. O 0 8.84351321556523e-14
, O 0 1.1784811746796443e-15
1997 O 0 2.6900665939591506e-13
) O 0 6.288237075144365e-14
. O 0 1.4200383924301008e-10

We O 0 8.969972542516302e-10
have O 0 2.475942356954669e-13
investigated O 0 9.17660045174351e-13
the O 0 2.1990552824882603e-13
R496H O 0 5.486717746805425e-10
mutation O 0 6.449586687200942e-14
and O 0 8.114172235255067e-16
found O 0 3.875236296544153e-15
this O 0 1.4536467732653713e-14
mutation O 0 5.358056663282151e-13
at O 0 8.207768666113058e-12
a O 0 9.86196909726067e-13
relatively O 0 7.799410423059427e-12
high O 0 1.8268505740277885e-13
frequency O 0 2.0394066481150414e-13
in O 0 3.443617952776515e-15
an O 0 3.2144720353799406e-16
African O 0 4.978631439403469e-13
American O 0 2.6211086252836413e-13
population O 0 7.36881733474741e-15
( O 0 3.845747542625931e-18
f O 0 2.9913080764151128e-15
= O 0 2.416851813894904e-14
0 O 0 1.8539120230838015e-15
. O 0 7.186869575479503e-15
09 O 0 3.308013368438778e-12
, O 0 2.1266815348683354e-14
n O 0 1.6617713064978612e-13
= O 0 8.518884382635594e-13
61 O 0 4.589842741986594e-11
subjects O 0 4.5645709434438686e-10
) O 0 4.861604283208643e-13
. O 0 1.4736491193989565e-10

The O 0 1.278962979966991e-08
ARSA O 0 9.322448750026524e-05
enzyme O 0 3.044710594757305e-10
activity O 0 1.5094469077436834e-11
in O 0 3.063845648677366e-15
subjects O 0 7.395863435566419e-12
with O 0 1.9823816160729796e-16
and O 0 2.707930715751904e-16
without O 0 4.271666096474121e-14
the O 0 2.5246506816546666e-13
R496H O 0 5.557644344733603e-10
mutation O 0 2.4130762492358127e-13
was O 0 1.438272108833169e-13
determined O 0 1.999345133896213e-11
and O 0 2.358445470168613e-13
found O 0 5.404655130554492e-13
to O 0 2.334631836811707e-12
be O 0 1.5215932680501254e-11
normal O 0 2.0002336498237128e-07
. O 0 4.602831005229291e-09

It O 0 6.917384200166854e-12
is O 0 1.2064747665534517e-14
therefore O 0 7.197051927945036e-14
concluded O 0 4.2599764319382893e-13
that O 0 1.986583031840259e-16
the O 0 5.125363837770597e-14
R496H O 0 1.6558866500204772e-09
mutation O 0 1.3427731149207034e-11
of O 0 2.353420791578742e-10
ARSA O 0 0.0003431769728194922
does O 0 3.458050902918619e-12
not O 0 1.4468518614099701e-12
negatively O 0 1.894741863406324e-10
influence O 0 5.994190560576484e-11
the O 0 5.185587636374889e-12
activity O 0 3.0287014562979664e-10
of O 0 2.6730935173691073e-11
ARSA O 0 3.264480983489193e-05
and O 0 1.6179882954270308e-12
is O 0 1.0771579076829588e-14
not O 0 6.35547183999198e-14
a O 0 1.1103691750780076e-11
cause O 0 3.1677771517024667e-08
of O 0 5.26546159562713e-07
MLD B-Disease 1 1.0

Down O 0 1.1001801247800813e-08
- O 0 8.592362932269282e-10
regulation O 0 1.0036311365313466e-10
of O 0 1.2524153936155358e-09
transmembrane O 0 1.1811592770527568e-07
carbonic O 0 2.2613116925640497e-06
anhydrases O 0 0.009449428878724575
in O 0 3.297009243397042e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.04881507158279419
lines O 0 4.290396163342258e-11
by O 0 1.1364937853655666e-13
wild O 0 1.573987190583992e-10
- O 0 1.8204620033657193e-08
type O 0 9.566170774633065e-05
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.999440610408783
transgenes O 0 0.0007369518280029297
. O 0 2.9956009228726543e-08

To O 0 1.1865487259399288e-08
discover O 0 7.5007272615224e-10
genes O 0 8.405744850170649e-12
involved O 0 1.0057846049071895e-11
in O 0 2.1053679633009637e-10
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 6.657823181654976e-10
VHL B-Disease 0 0.0013347166823223233
) O 0 1.5608262945998597e-11
- O 0 6.919027573104586e-10
mediated O 0 7.187193062918595e-09
carcinogenesis O 1 0.9999270439147949
, O 0 1.1322163367445681e-13
we O 0 1.3863309473647039e-14
used O 0 4.5738569182107724e-12
renal B-Disease 0 0.16173961758613586
cell I-Disease 1 0.9999849796295166
carcinoma I-Disease 1 1.0
cell O 1 0.9858723282814026
lines O 0 6.203507041391276e-08
stably O 0 1.3043356261732697e-07
transfected O 0 1.074122835120761e-08
with O 0 1.599875695248651e-13
wild O 0 1.1564614717241017e-11
- O 0 4.2065878558261716e-10
type O 0 4.227857619554243e-09
VHL O 0 0.00011978723341599107
- O 0 2.0707227577076992e-07
expressing O 0 8.467189727134894e-10
transgenes O 0 6.481187710960512e-07
. O 0 8.413003071972014e-10

Large O 0 1.9307437593152343e-12
- O 0 1.10199241225295e-12
scale O 0 4.10310761062016e-12
RNA O 0 3.877057286327812e-10
differential O 0 2.3741022481260643e-09
display O 0 1.5211956694294315e-11
technology O 0 3.405375634257801e-11
applied O 0 2.6270497821383187e-13
to O 0 1.4024966897476648e-13
these O 0 1.2817724380259805e-14
cell O 0 2.3897921835880354e-11
lines O 0 9.557126140827266e-13
identified O 0 3.8964076648322077e-13
several O 0 3.4999042238578054e-14
differentially O 0 2.411823518677636e-10
expressed O 0 2.517005701085928e-13
genes O 0 1.210634457265991e-12
, O 0 3.084979120711361e-15
including O 0 7.527811348177673e-15
an O 0 9.525201265757344e-14
alpha O 0 2.7782524544828213e-11
carbonic O 0 7.2068502277033986e-09
anhydrase O 0 1.3625894190738563e-08
gene O 0 6.356305759513958e-11
, O 0 2.2681318628814395e-11
termed O 0 5.884486853346971e-08
CA12 O 1 0.9999253749847412
. O 0 9.320580574012638e-08

The O 0 2.5617220150708775e-11
deduced O 0 5.2939822664521685e-11
protein O 0 1.344133029705652e-12
sequence O 0 7.266075761902524e-13
was O 0 4.997354526720121e-13
classified O 0 3.1867388502332394e-12
as O 0 1.1668021996996073e-14
a O 0 1.1026436382878535e-13
one O 0 1.4590843724210378e-12
- O 0 1.5028892019763873e-10
pass O 0 2.1858172161159928e-08
transmembrane O 0 4.126375188207021e-07
CA O 0 2.571154311681312e-07
possessing O 0 2.56269089282668e-10
an O 0 1.591451308843167e-13
apparently O 0 6.783852646297106e-11
intact O 0 3.4231051326827355e-09
catalytic O 0 6.243492944868478e-10
domain O 0 5.226645338751723e-09
in O 0 3.1429286256878797e-11
the O 0 2.8420139575047187e-09
extracellular O 0 8.949785978984437e-07
CA O 0 7.753475074423477e-06
module O 0 4.453921974345576e-06
. O 0 1.6351634712918894e-08

Reintroduced O 0 1.3941257037686228e-08
wild O 0 1.2755729805746796e-10
- O 0 2.5217763988116815e-10
type O 0 1.498921403664255e-10
VHL B-Disease 0 1.4220215405202907e-07
strongly O 0 1.5416117818065067e-12
inhibited O 0 4.438760123348651e-12
the O 0 2.107854872362893e-14
overexpression O 0 2.7272442117143303e-12
of O 0 1.6277348121717522e-13
the O 0 2.86454311605646e-14
CA12 O 0 8.838055620685736e-09
gene O 0 2.482294849949192e-15
in O 0 1.0763364551307116e-14
the O 0 1.2706519864069676e-12
parental O 0 3.776047563519569e-08
renal B-Disease 0 0.0171089805662632
cell I-Disease 1 0.99998939037323
carcinoma I-Disease 1 1.0
cell O 1 0.999981164932251
lines O 0 4.4124752207608253e-07
. O 0 2.2268462629426722e-08

Similar O 0 3.1116832201194544e-12
results O 0 1.8906714301797356e-12
were O 0 2.571353232335566e-13
obtained O 0 3.867503539645156e-12
with O 0 1.5601482914818013e-14
CA9 O 0 1.5111105540199787e-06
, O 0 5.693901161110335e-14
encoding O 0 2.311381641639798e-10
another O 0 8.541541085538285e-11
transmembrane O 0 6.047748257742569e-08
CA O 0 6.578644047294802e-07
with O 0 2.0639584063109756e-13
an O 0 1.4507336575531743e-13
intact O 0 5.567726724109434e-09
catalytic O 0 1.6307774020063448e-09
domain O 0 3.983891261327699e-08
. O 0 2.238018437239475e-09

Although O 0 2.3142302310596996e-11
both O 0 2.2797109252431502e-12
domains O 0 8.827874542483016e-10
of O 0 5.631761723634554e-11
the O 0 1.5124642857577975e-11
VHL B-Disease 0 3.187371433455155e-08
protein O 0 4.3461042056880395e-12
contribute O 0 4.847255409556883e-12
to O 0 2.532324827261845e-12
regulation O 0 7.595279266636723e-11
of O 0 1.1186138682006685e-09
CA12 O 1 0.9999934434890747
expression O 0 9.224063735047139e-10
, O 0 3.586512326275021e-14
the O 0 1.8787751844724643e-13
elongin O 0 2.7986715722683186e-10
binding O 0 3.5103857320972764e-11
domain O 0 1.2572571872482285e-09
alone O 0 5.390145274564162e-11
could O 0 1.9466744188845198e-11
effectively O 0 1.3411191268630773e-08
regulate O 0 1.3441230350963451e-08
CA9 O 0 0.0015864211600273848
expression O 0 8.777982429819531e-08
. O 0 1.641040547895045e-08

We O 0 4.7653094803479235e-09
mapped O 0 6.731865198617015e-08
CA12 O 0 0.0004372014373075217
and O 0 2.197091120148542e-11
CA9 O 0 6.781236606911989e-06
loci O 0 1.3722066538601752e-10
to O 0 1.3022698371056851e-11
chromosome O 0 4.5600957038205436e-11
bands O 0 4.712224499492379e-10
15q22 O 0 1.5531288966030843e-07
and O 0 2.1715853074089075e-11
17q21 O 0 7.857252057874575e-07
. O 0 4.104319106801313e-09

2 O 0 1.345301370303531e-10
respectively O 0 1.508996483323699e-09
, O 0 9.786977001394193e-13
regions O 0 5.395743851721591e-10
prone O 0 6.511612915538478e-10
to O 0 3.3427344225955835e-11
amplification O 0 5.370900879597684e-08
in O 0 2.103861702906773e-11
some O 0 2.6051905858276436e-12
human O 0 7.755286968169628e-10
cancers B-Disease 0 0.0004651813651435077
. O 0 2.562644496606481e-08

Additional O 0 1.5822465559978127e-10
experiments O 0 8.274766982729886e-11
are O 0 6.8081039700381655e-15
needed O 0 1.119340557742543e-11
to O 0 6.701244377113613e-13
define O 0 5.855949058997112e-11
the O 0 2.213882722978955e-12
role O 0 6.456279955102673e-11
of O 0 1.4116997570923218e-09
CA O 0 1.1245924724789802e-06
IX O 0 2.1742086175891018e-07
and O 0 1.7443330113664501e-10
CA O 0 1.5497377603423956e-07
XII O 0 5.792586965647217e-10
enzymes O 0 1.1972486804040505e-13
in O 0 6.60022683818891e-15
the O 0 2.647728092547777e-14
regulation O 0 1.548525413799795e-12
of O 0 8.65753215645304e-12
pH O 0 1.2797107817874576e-10
in O 0 2.4394074542473387e-13
the O 0 4.082958363765821e-12
extracellular O 0 6.791831541619331e-10
microenvironment O 0 2.2754321093998442e-08
and O 0 6.682440110159296e-14
its O 0 2.2602383018596045e-14
potential O 0 7.599605081516636e-13
impact O 0 2.1087468576874713e-11
on O 0 3.462760356232053e-10
cancer B-Disease 0 2.5746857978958815e-09
cell O 0 9.057329997119723e-09
growth O 0 2.247599467652961e-10
. O 0 6.500445182133774e-10

A O 0 3.093352310412634e-11
gene O 0 3.043868461319668e-14
encoding O 0 3.069993911863911e-11
a O 0 5.07237611288569e-12
transmembrane O 0 1.0460146637747414e-10
protein O 0 1.8618234124551103e-13
is O 0 1.6470851790019164e-17
mutated O 0 4.68342304228795e-15
in O 0 4.3800735447009913e-16
patients O 0 3.0230191180175003e-12
with O 0 6.599943573430689e-13
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.20921337604522705
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 0.00785707775503397
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 3.6068494111557436e-12
. O 0 1.4061093955852755e-10

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.49906538083178e-08
WFS B-Disease 1 0.9999933242797852
; O 0 1.0483889797963108e-11
OMIM O 0 1.0271581913912087e-06
222300 O 0 4.0011891022651014e-10
) O 0 1.2295283563997536e-15
is O 0 2.68586481926166e-15
an O 0 2.7813792935482695e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999998807907104
defined O 0 2.682328541410168e-14
by O 0 1.1589713589264176e-16
young O 0 6.073581308024822e-13
- O 0 1.118740777100724e-11
onset O 1 0.9637143015861511
non O 1 0.9999661445617676
- O 0 0.006170983426272869
immune O 0 0.0006306126597337425
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 6.937985119748191e-08
progressive O 1 0.9999974966049194
optic B-Disease 0 0.0009179652552120388
atrophy I-Disease 0 9.943898930941941e-07
. O 0 1.2893506706745939e-08

Linkage O 0 1.6394470776504022e-06
to O 0 6.247959927208058e-10
markers O 0 3.343949339651431e-09
on O 0 3.6455291563264325e-10
chromosome O 0 3.591525521429162e-09
4p O 0 2.1046048459538724e-06
was O 0 1.7139773975105577e-11
confirmed O 0 1.2207376602624276e-11
in O 0 3.490319741127762e-13
five O 0 5.767247790444685e-12
families O 0 8.657482716833975e-12
. O 0 3.9592532030674477e-10

On O 0 1.5864834446155385e-10
the O 0 1.061997603572784e-12
basis O 0 2.9425253900150494e-10
of O 0 3.2435620161974654e-11
meiotic O 0 1.1859257028845605e-05
recombinants O 1 0.8848845958709717
and O 0 7.772924526250335e-10
disease O 0 5.458247755996126e-07
- O 0 4.239701922870154e-10
associated O 0 4.148280330351639e-10
haplotypes O 0 1.2953854877650883e-07
, O 0 5.278326129583462e-14
the O 0 3.866168669930392e-12
WFS B-Disease 0 1.7675127992333728e-06
gene O 0 1.5213893513055243e-12
was O 0 3.26717971253776e-12
localized O 0 1.3524538433618005e-10
to O 0 2.932259990373609e-11
a O 0 2.793312248172697e-10
BAC O 0 3.6476862987910863e-06
/ O 0 1.5072538772642474e-08
P1 O 0 2.054298238363117e-05
contig O 0 8.546057301828114e-07
of O 0 2.0843314574303662e-10
less O 0 5.969394249738524e-12
than O 0 1.50340853590121e-13
250 O 0 3.5159340716628407e-11
kb O 0 3.540110427024956e-08
. O 0 1.3802239351434764e-09

Mutations O 0 9.301282660745258e-11
in O 0 7.458839996381597e-14
a O 0 6.925532806197239e-15
novel O 0 1.021264765768313e-15
gene O 0 1.4172646753017257e-14
( O 0 3.620407704912117e-15
WFS1 O 0 0.0004948427667841315
) O 0 1.0936997835164775e-13
encoding O 0 6.196953172832309e-09
a O 0 3.1838257030791794e-10
putative O 0 7.946204760855835e-08
transmembrane O 0 5.743994169193911e-09
protein O 0 1.834156437841017e-11
were O 0 7.773861307285024e-13
found O 0 2.0189895965478342e-14
in O 0 3.328971619849172e-15
all O 0 1.6970105198464355e-14
affected O 0 3.470299134861188e-13
individuals O 0 5.141804069650445e-14
in O 0 1.3453257605156033e-12
six O 0 4.2233255781454204e-10
WFS B-Disease 0 3.668814088086947e-06
families O 0 3.38858177628687e-11
, O 0 5.149822761155512e-14
and O 0 1.5115939912529325e-14
these O 0 5.2868808235375514e-14
mutations O 0 8.476484488276204e-13
were O 0 1.4626948469705775e-13
associated O 0 4.928868944931164e-12
with O 0 7.786159277002255e-14
the O 0 2.3721910547003233e-10
disease O 0 1.0040745124229034e-08
phenotype O 0 9.865332994962728e-10
. O 0 1.4187476748972472e-09

WFS1 O 1 0.861298680305481
appears O 0 1.0771472255810544e-11
to O 0 2.238778010633241e-13
function O 0 8.276689229813616e-12
in O 0 2.421328925122229e-13
survival O 0 5.663222850671445e-07
of O 0 3.988806784871457e-10
islet O 0 8.697395581513945e-10
beta O 0 2.350707850595768e-09
- O 0 3.709356433123645e-10
cells O 0 2.4011459487383036e-11
and O 0 9.319260857801326e-13
neurons O 0 5.231290400864452e-10
. O 0 5.182562278632785e-12
. O 0 1.1862374971194356e-10

Stable O 0 0.00011454257037257776
interaction O 0 1.2417923356267124e-09
between O 0 8.834632244519858e-13
the O 0 8.800231017806661e-15
products O 0 6.104840889536653e-15
of O 0 1.9269925011135974e-14
the O 0 6.172754635994787e-14
BRCA1 O 0 2.148078373162554e-12
and O 0 2.402183541059394e-13
BRCA2 O 0 7.728215983826558e-11
tumor B-Disease 0 2.002299992476253e-10
suppressor O 0 2.3007670421626436e-11
genes O 0 4.965705039002011e-13
in O 0 6.201456991157539e-13
mitotic O 0 6.5816037064792e-09
and O 0 1.392476550732269e-10
meiotic O 0 1.7036507415468805e-05
cells O 0 8.49809850933525e-07
. O 0 4.122193075772884e-08

BRCA1 O 0 2.6129995944756956e-07
and O 0 2.1699085236970284e-11
BRCA2 O 0 2.2029722490657377e-09
account O 0 3.896274036914449e-13
for O 0 4.737924530246081e-15
most O 0 5.115670308018924e-16
cases O 0 1.7606806947662967e-15
of O 0 2.8823671964842146e-13
familial O 0 3.6170627604192873e-10
, O 0 5.705051926344464e-15
early O 0 1.593269093047578e-11
onset O 0 4.7546169668066796e-08
breast B-Disease 0 3.152563721187107e-08
and I-Disease 0 3.756836175483613e-09
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3241381680018094e-07
encode O 0 1.141590086350952e-10
products O 0 2.5679727441718647e-12
that O 0 8.342605374426527e-16
each O 0 6.012372420267269e-15
interact O 0 5.093207756587392e-13
with O 0 6.734966994910788e-14
hRAD51 O 0 1.464071797130373e-08
. O 0 1.5217340720852235e-09

Results O 0 5.373477773851221e-10
presented O 0 2.2017644651928236e-11
here O 0 1.009852097777486e-11
show O 0 6.2396177634427286e-12
that O 0 2.4107011688517116e-14
BRCA1 O 0 1.1239749408975541e-10
and O 0 8.244888062211575e-13
BRCA2 O 0 4.605867354179338e-10
coexist O 0 7.683128577795628e-10
in O 0 3.9283460924292857e-13
a O 0 3.867826198211688e-13
biochemical O 0 1.9073737381192224e-11
complex O 0 6.807351904392078e-11
and O 0 9.580889684043803e-13
colocalize O 0 2.8505857585514605e-07
in O 0 1.252419556951878e-10
subnuclear O 0 6.710802722409426e-07
foci O 0 7.232159759951173e-09
in O 0 5.537911709069254e-13
somatic O 0 6.565611249120806e-11
cells O 0 1.5658297575216196e-11
and O 0 1.9145548387227047e-14
on O 0 2.925407854327544e-13
the O 0 1.0880605769668372e-14
axial O 0 2.1831202210581546e-13
elements O 0 7.430193613156e-12
of O 0 7.902618143207363e-11
developing O 0 1.910164471041753e-09
synaptonemal O 0 4.3626366164062347e-07
complexes O 0 3.38251493481323e-09
. O 0 1.731475962607476e-09

Like O 0 2.9678628443718935e-09
BRCA1 O 0 1.9431050546359074e-08
and O 0 1.7253630468783143e-10
RAD51 O 0 2.601819869596511e-05
, O 0 5.6724442851208146e-12
BRCA2 O 0 4.282457721771493e-11
relocates O 0 4.335944797650981e-12
to O 0 1.3345815338267064e-12
PCNA O 0 6.045775791108099e-08
+ O 0 3.6729844860028393e-11
replication O 0 5.698766458728244e-11
sites O 0 1.7664648498290358e-13
following O 0 1.1662860178215505e-14
exposure O 0 4.052421159056463e-12
of O 0 1.331167164345115e-12
S O 0 1.2011319716620505e-10
phase O 0 2.4360600203721106e-09
cells O 0 3.4728536713046765e-10
to O 0 4.4155518130750693e-10
hydroxyurea O 0 2.109836216845906e-08
or O 0 5.559690485767987e-10
UV O 0 3.0009309170964116e-07
irradiation O 0 2.2739645721969737e-09
. O 0 1.779334179996539e-10

Thus O 0 3.700879958046244e-08
, O 0 4.989882812500568e-11
BRCA1 O 0 2.4090465733372923e-10
and O 0 1.947973466559505e-12
BRCA2 O 0 1.1794955637189908e-11
participate O 0 2.5288462296435554e-11
, O 0 1.2749014761644431e-14
together O 0 1.5453498127416393e-13
, O 0 1.0499837354823252e-15
in O 0 1.2973095633774662e-14
a O 0 3.900251703634755e-13
pathway O 0 1.2457861131576209e-11
( O 0 1.839162003098552e-15
s O 0 4.995934763975252e-13
) O 0 3.486787833966278e-16
associated O 0 2.117034439462831e-13
with O 0 1.0045765226415087e-15
the O 0 5.743420740085894e-14
activation O 0 1.8513203394344285e-13
of O 0 8.225898261160491e-13
double O 0 9.300067226741815e-13
- O 0 4.2784976950205333e-11
strand O 0 1.7471758415044114e-11
break O 0 8.622707881045244e-09
repair O 0 0.00039391001337207854
and O 0 8.575818007117153e-12
/ O 0 8.594423783758742e-11
or O 0 3.929320248081264e-13
homologous O 0 4.7663040181333827e-11
recombination O 0 1.3298538659167747e-10
. O 0 5.593013274740599e-10

Dysfunction O 1 0.999861478805542
of O 0 1.1362470786480117e-06
this O 0 4.3112260983413364e-10
pathway O 0 9.630487518563768e-09
may O 0 4.167736034760283e-13
be O 0 1.075752036278424e-13
a O 0 8.169386797899844e-14
general O 0 1.1076013560094508e-13
phenomenon O 0 3.5492337286400014e-14
in O 0 1.129212444511414e-16
the O 0 6.913097515498599e-16
majority O 0 4.51036531731795e-15
of O 0 2.5178865391181074e-15
cases O 0 5.709602187337114e-15
of O 0 3.278734922451676e-12
hereditary B-Disease 0 0.19828501343727112
breast I-Disease 0 0.005893872119486332
and I-Disease 0 8.618795277470781e-07
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.4558106563054025e-06
. O 0 1.0924599891382059e-08

A O 0 1.4830705552526524e-09
novel O 0 1.6920252091795485e-12
Arg362Ser O 0 5.360656274433495e-08
mutation O 0 6.991209369235085e-13
in O 0 1.5385582686892364e-14
the O 0 2.7219733086426834e-13
sterol O 0 2.9176999705171625e-10
27 O 0 1.6326228147178767e-09
- O 0 3.1987708037917173e-09
hydroxylase O 0 2.8473433388853664e-08
gene O 0 3.729315467548844e-12
( O 0 3.249266158325721e-14
CYP27 O 1 0.9716190099716187
) O 0 1.821158106046425e-14
: O 0 1.2832755615183543e-16
its O 0 6.198325586584505e-16
effects O 0 3.1040555732329486e-15
on O 0 1.2228914509173662e-14
pre O 0 4.1615742969736136e-12
- O 0 3.065848085386652e-13
mRNA O 0 1.2222404512096663e-11
splicing O 0 7.150485759055414e-11
and O 0 7.191141128751188e-13
enzyme O 0 8.36754623922964e-12
activity O 0 1.7218847181421637e-10
. O 0 1.7635790050540834e-10

A O 0 5.956730109168973e-10
novel O 0 1.0031109650603456e-13
C O 0 3.2810465455668236e-10
to O 0 4.038476096503846e-13
A O 0 6.299314542212997e-11
mutation O 0 3.39634123234199e-14
in O 0 4.4239874384557985e-15
the O 0 4.865572056584125e-14
sterol O 0 4.190753299937455e-11
27 O 0 1.4234442791138946e-10
- O 0 1.1547516415300052e-10
hydroxylase O 0 1.2651883984915457e-09
gene O 0 1.6937163748332457e-13
( O 0 5.59778028577239e-15
CYP27 O 0 6.811505045334343e-06
) O 0 9.127115643470436e-16
was O 0 1.1361789093377542e-14
identified O 0 4.75989635313962e-16
by O 0 5.3239771999010704e-18
sequencing O 0 2.2482402224632825e-12
amplified O 0 3.803660511558782e-12
CYP27 O 0 3.997018716006551e-09
gene O 0 1.999669029130848e-15
products O 0 1.2144584755977971e-14
from O 0 1.2141480380226284e-14
a O 0 2.7053744444324734e-13
patient O 0 6.621212467194937e-10
with O 0 1.4208251545785866e-12
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 2.0609862774745302e-11
CTX B-Disease 0 4.52853527121988e-07
) O 0 7.488384044795904e-12
. O 0 5.580769180113521e-10

The O 0 4.7054950214064917e-11
mutation O 0 1.1177676622828314e-12
changed O 0 1.0048598238221462e-12
the O 0 3.0200093727866806e-13
adrenodoxin O 0 2.1356613699730076e-10
cofactor O 0 2.8705905708026336e-11
binding O 0 1.2640920428463875e-11
residue O 0 7.824126235789208e-09
362Arg O 0 3.1309892456476973e-09
to O 0 1.5514116033510383e-11
362Ser O 0 2.865453119227368e-08
( O 0 7.936718231411899e-13
CGT O 0 7.081533937025597e-08
362Arg O 0 1.4280495896912271e-08
to O 0 5.913438488880374e-11
AGT O 0 1.2112950571463443e-05
362Ser O 0 8.447058053029366e-10
) O 0 1.6957049032615377e-16
, O 0 2.5203634090396667e-17
and O 0 3.2006192085742906e-17
was O 0 5.588736260884672e-14
responsible O 0 2.4092557376204082e-12
for O 0 1.400995638944913e-11
deficiency O 0 2.458687617945543e-07
in O 0 5.292144847346414e-11
the O 0 3.700572626108567e-10
sterol O 0 3.0965194852683453e-09
27 O 0 8.656289907094106e-09
- O 0 1.8608473650871815e-09
hydroxylase O 0 1.2316288433567024e-08
activity O 0 3.7198546326555615e-11
, O 0 3.097347231109372e-16
as O 0 2.9504275135235417e-17
confirmed O 0 9.4656069498522e-16
by O 0 6.132633681662402e-17
expression O 0 6.108268323654423e-14
of O 0 9.67136391588283e-14
mutant O 0 3.4356815081706266e-14
cDNA O 0 9.782657323098576e-11
into O 0 4.936833719604294e-10
COS O 0 3.095023885180126e-06
- O 0 2.513342245435979e-08
1 O 0 4.272153811268886e-11
cells O 0 4.099146022618072e-10
. O 0 3.3173302993461107e-10

Quantitative O 0 5.212682369082344e-11
analysis O 0 1.7416841894494356e-13
showed O 0 1.0081824562474181e-13
that O 0 1.1380727234683266e-17
the O 0 7.131236557382959e-16
expression O 0 2.4707234481534564e-14
of O 0 1.1086164538459675e-12
CYP27 O 0 2.3941481686051702e-08
gene O 0 5.603356303664165e-15
mRNA O 0 8.834147822989191e-12
in O 0 1.7544070308930099e-13
the O 0 1.4466614755084817e-12
patient O 0 3.067367471132343e-10
represented O 0 1.1615414359511522e-11
52 O 0 1.0961631602413036e-07
. O 0 3.0197750078286845e-08

5 O 0 1.1461783605559717e-10
% O 0 1.6539855596242603e-10
of O 0 4.584267427470978e-12
the O 0 1.0687241022711014e-11
normal O 0 4.537379894031801e-08
level O 0 2.2831929413769103e-07
. O 0 4.493163174856818e-09

As O 0 4.274539489729223e-12
the O 0 1.0902846550933654e-12
mutation O 0 4.855580998039399e-13
occurred O 0 3.559618919068974e-11
at O 0 1.5835061397979217e-13
the O 0 7.942707567500616e-15
penultimate O 0 3.0813115947658787e-10
nucleotide O 0 2.673115340190435e-10
of O 0 4.768363925933272e-09
exon O 0 9.611030860057213e-10
6 O 0 3.838083739715614e-10
( O 0 2.139385456984e-12
- O 0 6.897760695956379e-10
2 O 0 5.193625477600827e-12
position O 0 9.032176784273815e-09
of O 0 7.654550771007962e-09
exon O 0 2.1754056334089e-09
6 O 0 1.868187382569886e-09
- O 0 2.0774868048079043e-08
intron O 0 5.249034096266314e-09
6 O 0 1.1782638753565777e-10
splice O 0 7.607103391649161e-09
site O 0 1.0431610436567595e-11
) O 0 2.1436218550002425e-15
of O 0 1.127669463883707e-12
the O 0 4.236868234724911e-12
gene O 0 2.344268984662279e-13
, O 0 5.5839840672373964e-14
we O 0 6.163886133274399e-13
hypothesized O 0 8.600667053548783e-12
that O 0 2.3195505981449607e-15
the O 0 9.045399520547781e-13
mutation O 0 5.4989281357553654e-12
may O 0 5.976101232797737e-13
partially O 0 1.1707125546767116e-10
affect O 0 3.281157637258225e-11
the O 0 2.9336624275677625e-12
normal O 0 3.8428671356172117e-10
splicing O 0 1.753613643185048e-10
efficiency O 0 1.698041263153982e-09
in O 0 2.9290288944272547e-11
exon O 0 4.583153023762776e-10
6 O 0 1.548552952534976e-11
and O 0 2.2628922932525775e-13
cause O 0 6.113539579091776e-13
alternative O 0 5.5372915454265925e-12
splicing O 0 9.93090852607903e-12
elsewhere O 0 9.45899825480212e-13
, O 0 8.03390739317325e-16
which O 0 5.1973574375331895e-17
resulted O 0 5.893952318390683e-13
in O 0 3.6662316791388067e-14
decreased O 0 6.652615264224337e-11
transcript O 0 2.8057373091527893e-10
in O 0 4.416488333901236e-13
the O 0 1.3923272257354569e-11
patient O 0 3.1900537322826494e-08
. O 0 4.540884113168886e-09

Transfection O 0 6.875317194499075e-05
of O 0 3.0952513441206975e-08
constructed O 0 6.276665853732766e-09
minigenes O 0 3.776069661398651e-07
, O 0 2.945259596105754e-14
with O 0 1.2197552902543335e-15
or O 0 5.097111900847877e-14
without O 0 4.674102359498999e-13
the O 0 1.6104051685922327e-12
mutation O 0 4.1789914085633983e-13
, O 0 2.7897163525509574e-15
into O 0 1.910774663493875e-11
COS O 0 7.699066486566153e-07
- O 0 5.863708407716217e-10
1 O 0 4.800403238976181e-13
cells O 0 5.371573953867614e-13
confirmed O 0 4.0935513306991286e-14
that O 0 4.460737302905019e-18
the O 0 1.2651211308296325e-16
mutant O 0 4.3443425397880764e-14
minigene O 0 3.844895929416836e-11
was O 0 1.412747279187429e-13
responsible O 0 8.66843272509521e-13
for O 0 1.3532645598730852e-13
a O 0 4.128201957793315e-13
mRNA O 0 9.084621943600268e-11
species O 0 2.19601423091971e-15
alternatively O 0 5.133528584860825e-12
spliced O 0 2.289930556287345e-08
at O 0 2.4610784521428286e-09
an O 0 1.5475577416768083e-11
activated O 0 8.234877668655827e-09
cryptic O 0 2.952714073245488e-09
5 O 0 4.0507458498595383e-11
splice O 0 7.01548152903797e-09
site O 0 1.2944449678808922e-10
88 O 0 2.1882939904571685e-09
bp O 0 9.576958115431466e-10
upstream O 0 1.2426975004586893e-09
from O 0 2.781306261689931e-11
the O 0 1.7025894583078127e-11
3 O 0 6.879936724490943e-12
end O 0 6.785179529344987e-09
of O 0 1.3988615599203058e-08
exon O 0 1.5389209906402357e-08
6 O 0 6.977701971777606e-09
. O 0 2.1360625268584954e-08

Our O 0 7.588438322159163e-09
data O 0 1.0100947855917752e-11
suggest O 0 7.973342038697373e-14
that O 0 1.9887430320302064e-17
the O 0 2.6691549767947007e-15
C O 0 9.942811331209445e-12
to O 0 3.709152668167348e-13
A O 0 2.508784846533274e-10
mutation O 0 8.310790207063934e-13
at O 0 5.191215838272478e-13
the O 0 1.9980534831905497e-14
penultimate O 0 4.67324456909779e-10
nucleotide O 0 9.402435774408247e-11
of O 0 4.109330375978715e-10
exon O 0 2.4489679728567637e-10
6 O 0 5.236296639343774e-12
of O 0 1.1151340267856469e-11
the O 0 3.081913847388651e-12
CYP27 O 0 2.3452654204447754e-05
gene O 0 3.537664952646402e-13
not O 0 1.2813868347470725e-13
only O 0 9.432477585460952e-13
causes O 0 4.3486519940572066e-11
the O 0 2.0999006353217275e-11
deficiency B-Disease 0 4.809981302145161e-09
in I-Disease 0 3.186325552365088e-12
the I-Disease 0 9.567404507526689e-11
sterol I-Disease 0 5.544031900228674e-09
27 I-Disease 0 2.3708727425741927e-08
- I-Disease 0 7.532444001867589e-09
hydroxylase I-Disease 0 5.1560402170025554e-08
activity I-Disease 0 4.635355987936407e-10
, O 0 9.52603237448519e-15
but O 0 8.36944954259091e-15
also O 0 9.389262811524985e-15
partially O 0 6.25770962825456e-12
leads O 0 3.3366332022636766e-14
to O 0 2.8542621689558664e-14
alternative O 0 1.5506268144505064e-12
pre O 0 1.716532471718324e-11
- O 0 3.679768349838103e-13
mRNA O 0 1.6870440808225418e-11
splicing O 0 5.463240276837311e-11
of O 0 2.431948913084181e-11
the O 0 1.7670497010069397e-11
gene O 0 9.234863741769406e-12
. O 0 7.149481007218128e-10

To O 0 2.486950090307971e-10
our O 0 1.6336998420740656e-10
knowledge O 0 2.210426286453071e-09
, O 0 4.4414188471147e-16
this O 0 8.097871880278546e-17
is O 0 1.0110650961112196e-17
the O 0 2.379461397322935e-16
first O 0 2.1328481041309362e-14
report O 0 7.896966941315937e-15
regarding O 0 3.3588491146416266e-13
effects O 0 3.0517861864974224e-14
on O 0 7.515619664154663e-14
pre O 0 2.3151914413377384e-12
- O 0 5.932295534796447e-14
mRNA O 0 3.429491282971875e-12
splicing O 0 1.6798453253419332e-11
of O 0 1.0922708050531416e-11
a O 0 6.409672055271431e-13
mutation O 0 3.5350544648656e-13
at O 0 2.629482352342616e-12
the O 0 6.641075276508923e-12
- O 0 3.3845377889196726e-11
2 O 0 4.471822760178379e-13
position O 0 1.1463363591701636e-09
of O 0 1.6767889854385487e-10
a O 0 2.7398945959267174e-11
5 O 0 1.6616914788603054e-10
splice O 0 3.256000979945384e-08
site O 0 9.1800095303185e-10
. O 0 6.640435978866321e-10

ATM O 0 1.5356099538621493e-05
germline O 0 1.1871518381667556e-06
mutations O 0 4.758927973913529e-11
in O 0 4.826403491274556e-13
classical O 0 2.874370466088294e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9992765784263611
in O 0 2.4319895056135188e-12
the O 0 9.82852471284601e-13
Dutch O 0 3.179188162727442e-11
population O 0 1.7177480886808837e-14
. O 0 1.5037162053727071e-12

Germline O 0 1.1474303391878493e-05
mutations O 0 3.067303355752671e-10
in O 0 5.992937808334264e-13
the O 0 1.3508075951199072e-12
ATM O 0 2.8101252436130153e-09
gene O 0 1.0553169937314172e-14
are O 0 4.1369979190239136e-17
responsible O 0 3.461952404436308e-15
for O 0 6.8383231409808835e-15
the O 0 3.0812383755574047e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.5463855024554505e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.694663494758666e-12
. O 0 1.2499995483139514e-10

In O 0 1.1174281500103689e-09
our O 0 2.4798416653482036e-09
study O 0 1.1183198464492783e-12
, O 0 9.612174354671531e-16
we O 0 1.2560861215488465e-15
have O 0 7.746846868557583e-17
determined O 0 4.410746941296839e-13
the O 0 6.954767165813502e-13
ATM O 0 2.600618387305076e-08
mutation O 0 6.011257897703404e-12
spectrum O 0 5.0601068474209754e-11
in O 0 2.375012621465278e-13
19 O 0 4.76715628777713e-12
classical O 0 2.562883949508432e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.490171541718155e-08
, O 0 1.5313794950546668e-14
including O 0 1.9682464361283182e-15
some O 0 7.512459617162518e-16
immigrant O 0 6.071102279757434e-13
populations O 0 1.501447722390952e-14
, O 0 2.1475249828211904e-16
as O 0 3.174031717862705e-15
well O 0 4.496883551294295e-13
as O 0 1.358061070284161e-13
12 O 0 1.8001633170228182e-11
of O 0 1.2249593700497385e-11
Dutch O 0 4.84716537740848e-11
ethnic O 0 6.617686260090849e-11
origin O 0 8.579556509680231e-10
. O 0 2.664945819574882e-09

Both O 0 1.0926958990409297e-11
the O 0 1.124509990332867e-12
protein O 0 1.3206058154576622e-13
truncation O 0 2.8662372475452003e-10
test O 0 3.059513059566754e-11
( O 0 4.1393642934975036e-14
PTT O 0 1.913210034842905e-08
) O 0 1.9321808320254142e-15
and O 0 1.4144445426313135e-15
the O 0 7.4706544119299e-15
restriction O 0 5.5416465653249005e-15
endonuclease O 0 9.013606376041816e-13
fingerprinting O 0 2.464490937714725e-11
( O 0 2.541176599387459e-14
REF O 0 1.0343291501069274e-10
) O 0 6.75797693079657e-17
method O 0 3.223606548797414e-13
were O 0 3.5688659194782826e-14
used O 0 3.2021142058443267e-14
and O 0 4.984945172170326e-15
compared O 0 9.698801007110291e-13
for O 0 4.364666587137675e-14
their O 0 2.3189258673006474e-12
detection O 0 2.850275016008652e-10
efficiency O 0 4.0982606197559335e-11
, O 0 7.93516188036912e-16
identifying O 0 5.267085595797583e-13
76 O 0 6.769763222225222e-11
% O 0 1.1077841768902807e-11
and O 0 2.1816858215839563e-15
60 O 0 5.049431359149814e-12
% O 0 1.1141049888196974e-11
of O 0 2.5450437113674895e-13
the O 0 6.448077206726299e-13
mutations O 0 4.099436989955102e-13
, O 0 1.2088733605721685e-13
respectively O 0 3.0462674049935856e-10
. O 0 3.6312768347812607e-09

Most O 0 6.815341346833037e-11
patients O 0 2.7362178495193845e-11
were O 0 6.419610502905737e-12
found O 0 8.948563461411152e-13
to O 0 2.246062927660497e-12
be O 0 9.361202785163059e-12
compound O 0 8.910294724273626e-09
heterozygote O 0 5.381359073908243e-07
. O 0 3.5352996974324924e-08

Seventeen O 0 5.03457400213847e-08
mutations O 0 4.7535666375386754e-11
were O 0 8.197157687871159e-13
distinct O 0 5.768410922535328e-13
, O 0 4.7238841121123934e-15
of O 0 2.3579911894583416e-13
which O 0 1.7629388846036767e-15
10 O 0 4.0357040625993434e-13
were O 0 2.7955639105708974e-12
not O 0 1.3040240545367232e-12
reported O 0 1.1716708159248412e-10
previously O 0 2.440426971617171e-09
. O 0 9.452235438800471e-09

Mutations O 0 9.784555032865683e-08
are O 0 4.766238185377469e-12
small O 0 1.1701068065861353e-11
deletions O 0 7.271885760218311e-09
or O 0 3.994023778375322e-09
point O 0 2.4655678316776175e-06
mutations O 0 4.9131198665008924e-08
frequently O 0 9.483562823930924e-10
affecting O 0 4.521964580561644e-09
splice O 0 4.1607341927374364e-07
sites O 0 7.926311162975708e-09
. O 0 4.715706491964511e-09

Moreover O 0 9.053325555896663e-08
, O 0 4.1856709070975384e-12
a O 0 1.1289720026896877e-11
16 O 0 1.3533963949541317e-09
. O 0 4.641152795414882e-09

7 O 0 5.747555764656909e-09
- O 0 1.0933307592608799e-09
kb O 0 5.222579702035546e-09
genomic O 0 8.423070574359315e-10
deletion O 0 1.2068782639929054e-09
of O 0 2.5081163812501472e-09
the O 0 5.712271280988723e-11
3 O 0 2.383508754949526e-12
end O 0 3.2592845089496336e-10
of O 0 9.631041623936465e-12
the O 0 1.2733838506209794e-12
gene O 0 8.412809159160858e-14
, O 0 1.0027393717063852e-14
most O 0 6.866606418122652e-15
likely O 0 6.694869810440485e-13
a O 0 1.4100983022295038e-13
result O 0 5.757927121208262e-12
of O 0 2.3643751886903708e-11
recombination O 0 1.3152201550070686e-11
between O 0 6.142345659876369e-11
two O 0 3.612653362225493e-12
LINE O 0 1.9399685413645784e-08
elements O 0 1.9843234694283396e-11
, O 0 4.3719151562870984e-14
was O 0 2.4309551767409676e-12
identified O 0 1.16584353282434e-10
. O 0 4.997190994338041e-10

The O 0 7.542964586271239e-10
most O 0 1.4931017576838568e-12
frequently O 0 1.705862014145243e-12
found O 0 2.42406436720341e-13
mutation O 0 4.613685735538331e-13
, O 0 3.1387049382480435e-15
identified O 0 5.755201003265764e-13
in O 0 9.189766731875632e-14
three O 0 1.1046645233747307e-13
unrelated O 0 2.955244989694128e-12
Turkish O 0 9.121649213739147e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
individuals O 0 2.55052923225918e-10
, O 0 9.220158274023116e-14
was O 0 1.6324460229769078e-12
previously O 0 2.618580265817405e-13
described O 0 2.3393220411997706e-15
to O 0 5.5472725581605636e-15
be O 0 7.653327549038012e-16
a O 0 1.9674508604326096e-15
Turkish O 0 2.5954682847384447e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 2.6830844035430346e-07
mutation O 0 4.246332174773215e-09
. O 0 4.1189746058378773e-10

The O 0 9.479402818257654e-10
presence O 0 4.615345258751624e-11
of O 0 1.671427857230512e-10
a O 0 1.173643543461722e-10
founder O 0 1.8681947100418483e-09
mutation O 0 2.5907684331194503e-10
among O 0 2.302415257147278e-13
relatively O 0 2.865139766064506e-13
small O 0 5.269207735202975e-16
ethnic O 0 6.94980504352058e-14
population O 0 1.6979130122759113e-15
groups O 0 1.051811235535806e-16
in O 0 1.5788519648033024e-14
Western O 0 2.1262630545137995e-11
Europe O 0 4.583207186166505e-13
could O 0 1.251090702390767e-12
indicate O 0 1.8103252230616818e-10
a O 0 2.1434045944374036e-12
high O 0 3.662447081720366e-12
carrier O 0 8.914645822748202e-13
frequency O 0 1.9295186975964995e-11
in O 0 2.736043000235028e-13
such O 0 4.3157854677164376e-13
communities O 0 6.308344818739542e-11
. O 0 9.148407031922545e-10

In O 0 8.41505337634274e-11
patients O 0 4.306875689419343e-11
of O 0 3.039231713519719e-11
Dutch O 0 9.185189414617767e-11
ethnic O 0 7.763285674033948e-12
origin O 0 1.3542832653923309e-11
, O 0 5.227825940564866e-15
however O 0 1.7500990890859103e-13
, O 0 1.3727379320337563e-14
no O 0 4.4293934568350596e-14
significant O 0 1.3295811934072033e-12
founder O 0 7.288245527925508e-12
effect O 0 7.419087046101058e-13
could O 0 1.845377366541112e-12
be O 0 1.893537757147179e-11
identified O 0 1.6539587477382156e-08
. O 0 1.2686034445152927e-08

The O 0 7.211821417829611e-11
observed O 0 3.4961449967702007e-12
genetic O 0 1.1238473259650439e-12
heterogeneity O 0 2.394650450154856e-12
including O 0 3.901237243409544e-15
the O 0 1.3481874037296615e-12
relative O 0 1.2681117267376862e-09
high O 0 1.464232346481964e-10
percentage O 0 4.05031536088174e-10
of O 0 1.2953391137493497e-10
splice O 0 4.1866852029670554e-07
- O 0 2.5975830375557507e-09
site O 0 4.747887638600901e-10
mutations O 0 9.478837853515998e-11
had O 0 2.7804349534560346e-12
no O 0 3.344905732602377e-13
reflection O 0 4.137855336150409e-11
on O 0 4.2814098620558294e-12
the O 0 6.1887578395314335e-12
phenotype O 0 2.4123769648554116e-09
. O 0 1.1422485179934938e-09

All O 0 7.63692321187337e-12
patients O 0 4.94289159570175e-14
manifested O 0 7.45881153607457e-14
classical O 0 7.786894393180255e-12
A B-Disease 1 1.0
- I-Disease 1 0.9999980926513672
T I-Disease 1 1.0
and O 0 2.0684519635300047e-12
increased O 0 1.7677775909774596e-11
cellular O 0 5.911654412521505e-12
radioresistant O 0 7.377045502243718e-11
DNA O 0 8.751276925345053e-10
synthesis O 0 1.7887813452688306e-09
. O 0 5.113520162858265e-10

Determination O 0 2.8832708665049722e-08
of O 0 1.416643052865041e-10
the O 0 1.2632743158838555e-12
genomic O 0 9.647557058789502e-11
structure O 0 4.646894848081562e-12
of O 0 2.282647812087979e-12
the O 0 3.8152329060771317e-13
COL4A4 O 0 3.641676357801771e-06
gene O 0 1.9175270095719843e-13
and O 0 6.747010871684502e-15
of O 0 2.627445515931276e-13
novel O 0 8.950599809931514e-12
mutations O 0 6.429934842344665e-07
causing O 0 0.0005639706505462527
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.656819901858398e-07

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.1952397405146087e-11
a O 0 6.858966727918414e-10
progressive O 1 1.0
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 2.969364913951722e-06
by O 0 7.923808831300505e-11
glomerular B-Disease 1 0.9999933242797852
basement I-Disease 1 0.9998598098754883
membrane I-Disease 0 5.143368071003351e-06
abnormalities I-Disease 1 0.6448951959609985
and O 0 1.5431435968459029e-13
associated O 0 3.742978149645637e-11
with O 0 1.5825097580014075e-13
mutations O 0 1.207118172780186e-12
in O 0 2.394261004734499e-13
either O 0 4.641438275387877e-12
the O 0 2.4864128117529916e-11
COL4A3 O 0 0.0440010167658329
or O 0 2.7976546860403184e-12
the O 0 1.3131547932365706e-11
COL4A4 O 0 7.703466508246493e-06
gene O 0 1.2841882776355035e-13
, O 0 1.1794887203704033e-15
which O 0 5.526146180027502e-17
encode O 0 1.1606993578078262e-12
the O 0 3.797752043399605e-12
alpha3 O 0 5.292012019708636e-07
and O 0 2.884025483707031e-11
alpha4 O 0 9.862714023256558e-07
type O 0 2.0589778770840894e-08
IV O 0 1.2856732610089239e-05
collagen O 0 1.5495750460559066e-07
chains O 0 1.4629796263321282e-09
, O 0 9.035156520523224e-13
respectively O 0 2.621933781199459e-09
. O 0 2.8639708382627305e-09

To O 0 4.720678362102326e-11
date O 0 1.6780657419168676e-10
, O 0 9.461135251165407e-15
mutation O 0 9.946362310164769e-15
screening O 0 1.6696854402559191e-13
in O 0 1.1607954655541534e-14
the O 0 2.264049272495891e-13
two O 0 5.821498339809994e-13
genes O 0 1.277235088525952e-11
has O 0 5.9133813737875535e-15
been O 0 7.158458396362699e-14
hampered O 0 3.6549716586620207e-09
by O 0 1.6904526213622033e-14
the O 0 1.5790824594089092e-12
lack O 0 1.906668989359872e-10
of O 0 2.3090570254458154e-12
genomic O 0 2.961850209537431e-10
structure O 0 1.2402910642972387e-10
information O 0 3.4145608562852203e-10
. O 0 1.5796119967603772e-09

We O 0 1.541898553281129e-10
report O 0 4.2803298882718166e-13
here O 0 3.9605742730569604e-14
the O 0 9.20930325034252e-16
complete O 0 5.487431798019415e-13
characterization O 0 7.374016328109967e-12
of O 0 1.1918243085148883e-12
the O 0 6.28376799378938e-13
48 O 0 5.216464482593608e-10
exons O 0 9.35710620098007e-10
of O 0 2.4821578820111156e-11
the O 0 2.01119797899052e-11
COL4A4 O 0 0.0002283180656377226
gene O 0 1.1268266051148168e-12
, O 0 1.0324367703535946e-14
a O 0 4.295635688925407e-15
comprehensive O 0 3.8385755078002015e-13
gene O 0 9.243091394608494e-16
screen O 0 3.667123896211599e-12
, O 0 1.0025060141294166e-14
and O 0 2.5601731767021206e-15
the O 0 1.625605642392898e-14
subsequent O 0 5.551713602724995e-13
detection O 0 2.684734656810406e-10
of O 0 1.2753375287256896e-13
10 O 0 6.3143870998084734e-15
novel O 0 9.496928110659295e-16
mutations O 0 4.048770392843688e-14
in O 0 3.360652769658851e-15
eight O 0 2.2017603018564813e-11
patients O 0 3.4931488257505805e-10
diagnosed O 0 4.4412084321265866e-07
with O 0 5.083890641799371e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 7.454850106114463e-07

Furthermore O 0 5.581272333188281e-09
, O 0 2.4080599168342653e-13
we O 0 1.0034056647633544e-13
identified O 0 8.104857388523123e-13
a O 0 1.5276023718549525e-13
glycine O 0 1.62572190952337e-12
to O 0 5.326319246767852e-12
alanine O 0 1.5585185919597677e-10
substitution O 0 1.297571911029749e-10
in O 0 2.4761891755792353e-12
the O 0 2.0651022558659804e-11
collagenous O 0 6.824495812907116e-08
domain O 0 7.190092271569526e-11
that O 0 2.8814574322768866e-15
is O 0 4.59257452353019e-15
apparently O 0 6.72379790733757e-11
silent O 0 1.8702284512728262e-11
in O 0 2.4705457406411224e-13
the O 0 7.178903196729258e-13
heterozygous O 0 2.736388806517942e-12
carriers O 0 1.0623515684770463e-13
, O 0 8.544721326981738e-14
in O 0 2.4792609371743213e-12
11 O 0 1.2611938160489444e-09
. O 0 9.746720763814665e-09

5 O 0 9.942512785299229e-11
% O 0 1.1627212387343988e-10
of O 0 1.4455278337169308e-12
all O 0 6.585454837698679e-14
control O 0 6.481447323292144e-12
individuals O 0 1.3899847933892748e-14
, O 0 8.574851750047408e-16
and O 0 6.2640971655432095e-16
in O 0 1.1237476843972607e-14
one O 0 4.525566170589376e-15
control O 0 4.911505230298374e-13
individual O 0 1.2800377145500037e-14
homozygous O 0 2.572083984599821e-13
for O 0 1.6268743283412955e-14
this O 0 9.583607914415496e-14
glycine O 0 1.3371860910216249e-11
substitution O 0 1.3904384588148133e-10
. O 0 9.360926478407805e-10

There O 0 4.587068572203812e-11
has O 0 3.645714508277234e-15
been O 0 2.917670420112613e-15
no O 0 8.68891267732908e-16
previous O 0 8.414884457644267e-13
finding O 0 9.166737681420845e-12
of O 0 2.3780415570745506e-12
a O 0 1.3420445581658474e-13
glycine O 0 1.2078620438907284e-12
substitution O 0 2.030778756961782e-12
that O 0 3.4375279976439936e-15
is O 0 2.52021100928361e-16
not O 0 1.5419387771817283e-15
associated O 0 2.5975182833641586e-13
with O 0 6.377034080103875e-15
any O 0 2.5311319880316763e-12
obvious O 0 8.442125470908834e-11
phenotype O 0 2.522246821123897e-11
in O 0 1.393114681773333e-13
homozygous O 0 3.673684967342439e-11
individuals O 0 1.0520988594220348e-11
. O 0 5.751448650670454e-09

Founder O 0 1.1317332564431126e-06
BRCA1 O 0 6.816794240194213e-08
and O 0 3.650070523608662e-11
BRCA2 O 0 2.2495305618264183e-09
mutations O 0 1.357608470087257e-12
in O 0 1.3622170882618412e-13
French O 0 7.176240851558546e-11
Canadian O 0 3.9805271967452427e-07
breast B-Disease 1 1.0
and I-Disease 1 0.9999947547912598
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.538224622294365e-07
. O 0 6.939983165921149e-08

We O 0 1.192894533152966e-10
have O 0 4.695885268634313e-14
identified O 0 2.729855458436653e-13
four O 0 1.0032788469904914e-14
mutations O 0 2.2160510070452473e-15
in O 0 2.7361744999825066e-16
each O 0 7.162210752319036e-15
of O 0 1.9834909756322183e-11
the O 0 7.248012856564401e-09
breast B-Disease 0 0.08079667389392853
cancer I-Disease 0 0.15395978093147278
- O 1 0.9996122717857361
susceptibility O 0 2.872482127713738e-06
genes O 0 9.211515106244406e-09
, O 0 4.121463934025904e-11
BRCA1 O 0 1.0364759051029182e-10
and O 0 3.1727775788581436e-12
BRCA2 O 0 2.314746658238498e-11
, O 0 1.1627359968604894e-15
in O 0 1.414757521305324e-15
French O 0 2.9607726318402194e-13
Canadian O 0 3.499684708696549e-10
breast B-Disease 0 6.317923517684676e-09
cancer I-Disease 0 8.148021146681117e-10
and O 0 2.79534031477624e-08
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 2.0201633788019535e-07
from O 0 4.915938767169337e-09
Quebec O 0 1.5516454254793643e-07
. O 0 2.0357304730822534e-09

To O 0 3.764958123042561e-08
identify O 0 2.6873817660089117e-07
founder O 0 3.971780682121562e-09
effects O 0 3.236236389980718e-09
, O 0 3.322986146230694e-13
we O 0 1.813533047692606e-13
examined O 0 7.301575143114913e-12
independently O 0 2.9511851296071256e-11
ascertained O 0 6.450473488683883e-10
French O 0 1.9110069429673082e-12
Canadian O 0 2.888914281407029e-11
cancer B-Disease 0 1.324339618004322e-12
families O 0 5.670704740333302e-15
for O 0 3.792156181643458e-16
the O 0 5.129331678908715e-15
distribution O 0 5.416646948683268e-13
of O 0 1.3678930221600744e-13
these O 0 8.356500441706466e-14
eight O 0 1.0871625127917284e-10
mutations O 0 2.2909854568986532e-10
. O 0 3.833352302251569e-09

Mutations O 0 4.344726800553644e-09
were O 0 7.191254969979299e-12
found O 0 1.304978802969814e-13
in O 0 3.1069239656055306e-14
41 O 0 3.662541658844276e-10
of O 0 1.0905186476062312e-10
97 O 0 1.6045041206780297e-07
families O 0 1.1747459671695992e-09
. O 0 3.3917096686764125e-08

Six O 0 9.42909195167374e-10
of O 0 3.277779783705803e-11
eight O 0 4.841612180617183e-11
mutations O 0 4.4620357755875695e-12
were O 0 3.957120221775856e-12
observed O 0 3.525891601255382e-12
at O 0 5.2879250457549265e-12
least O 0 1.6084835286617194e-12
twice O 0 2.1616768097754147e-10
. O 0 5.226406418756824e-09

The O 0 5.453750340222996e-09
BRCA1 O 0 1.1314419623431604e-08
C4446T O 0 4.847098722393639e-08
mutation O 0 1.2792124130800442e-11
was O 0 1.3131164992158384e-12
the O 0 1.183704420289547e-13
most O 0 2.171050687656468e-15
common O 0 5.11896467326068e-14
mutation O 0 9.851849696283776e-14
found O 0 1.180745293747655e-14
, O 0 4.872922312038866e-16
followed O 0 1.456510930473217e-14
by O 0 4.618717348414247e-15
the O 0 1.6860983095834392e-11
BRCA2 O 0 8.644114757316856e-09
8765delAG O 0 8.2043413840438e-08
mutation O 0 9.246998722289845e-10
. O 0 1.9796417838335856e-09

Together O 0 1.1974314872986724e-09
, O 0 1.4498982797792742e-13
these O 0 2.003655928510279e-14
mutations O 0 1.4433945575223484e-13
were O 0 2.1701669866529272e-13
found O 0 1.0016765147641705e-14
in O 0 6.38808743654907e-15
28 O 0 9.619970618712781e-12
of O 0 1.5128740274428232e-11
41 O 0 1.089882850635604e-09
families O 0 1.668732166337783e-11
identified O 0 1.1879401629055764e-10
to O 0 7.941768770391988e-11
have O 0 7.958915644590281e-12
a O 0 2.2185644987793296e-10
mutation O 0 1.7169695665231188e-09
. O 0 5.845108397295462e-09

The O 0 4.0739622786389873e-10
odds O 0 3.2840596908556563e-09
of O 0 5.7132167920193044e-12
detection O 0 3.881415189255222e-10
of O 0 7.472033408673084e-12
any O 0 9.584380815039206e-13
of O 0 2.2445224498457428e-11
the O 0 3.63957128324266e-12
four O 0 9.770214151605394e-12
BRCA1 O 0 1.3682367738798717e-10
mutations O 0 8.476290416087329e-13
was O 0 4.797147054591555e-12
18 O 0 4.2762973717636044e-10
. O 0 2.142798827264869e-09

7x O 0 3.32032359438017e-05
greater O 0 6.719288458967299e-10
if O 0 1.1535178194577167e-12
one O 0 1.6395347265159982e-13
or O 0 1.1858685725291227e-14
more O 0 1.3677760977320354e-16
cases O 0 8.507399700072998e-14
of O 0 6.336194235956327e-09
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.2060136889147088e-08
also O 0 3.3667946902626866e-14
present O 0 3.517184915709237e-13
in O 0 2.48496915319224e-13
the O 0 6.987080185261174e-12
family O 0 1.9399249567841892e-11
. O 0 1.6508849842722384e-09

The O 0 2.231516915696119e-10
odds O 0 1.5160037669659232e-09
of O 0 2.241479571396532e-12
detection O 0 4.696728006514661e-10
of O 0 4.208140780281866e-12
any O 0 6.246401508015753e-13
of O 0 1.858915625596591e-11
the O 0 2.240637363148945e-12
four O 0 5.652905660930019e-12
BRCA2 O 0 3.596541398032116e-10
mutations O 0 1.6844324329454152e-12
was O 0 1.5142106318810633e-11
5 O 0 1.5077873671831554e-10
. O 0 1.0459473287482979e-09

3x O 0 2.1510529677470913e-06
greater O 0 5.3016417644879965e-11
if O 0 1.5075348738444183e-13
there O 0 2.6703784311837148e-14
were O 0 4.848378304194399e-14
at O 0 2.556470795689672e-14
least O 0 1.1372536459170542e-15
five O 0 4.387483706560927e-15
cases O 0 1.1631669036965813e-14
of O 0 2.3137667129469186e-11
breast B-Disease 0 8.446208177304015e-09
cancer I-Disease 0 3.7404748742808636e-10
in O 0 7.173189819908998e-11
the O 0 1.0791189275494162e-08
family O 0 5.686936699333955e-09
. O 0 5.953499382371774e-08

Interestingly O 0 7.106685018243297e-09
, O 0 1.5977311433514746e-14
the O 0 1.5472957523533434e-14
presence O 0 5.832275851505586e-14
of O 0 8.453066024927125e-11
a O 0 1.8232002574336548e-08
breast B-Disease 0 1.7322847725154134e-06
cancer I-Disease 0 5.874276065576112e-10
case O 0 2.1941710601214304e-12
< O 0 9.0360714466442e-09
36 O 0 4.974339273822181e-10
years O 0 9.165755177412138e-13
of O 0 1.1670215575160237e-12
age O 0 2.2243203372934728e-12
was O 0 1.5168676183825378e-14
strongly O 0 1.3421967615161396e-15
predictive O 0 2.216364071438992e-11
of O 0 1.8905405398724623e-13
the O 0 2.2322489451505334e-14
presence O 0 9.820213693330186e-15
of O 0 8.851005730203462e-14
any O 0 9.655918100683059e-14
of O 0 2.917318730338847e-12
the O 0 2.6791561590772117e-12
eight O 0 6.76949191147358e-11
mutations O 0 6.52375245838166e-12
screened O 0 9.643141840598446e-11
. O 0 1.732622378902704e-09

Carriers O 0 1.130646895552978e-10
of O 0 5.881112263850241e-11
the O 0 3.0473742019393457e-12
same O 0 2.677684896729149e-12
mutation O 0 2.2508308151342193e-13
, O 0 4.0631320799863573e-16
from O 0 2.8988878880237224e-15
different O 0 8.35653296777164e-14
families O 0 1.0105548125735608e-12
, O 0 6.652246519611585e-15
shared O 0 1.6191058910264289e-12
similar O 0 2.6438085661689703e-13
haplotypes O 0 7.095125181821871e-11
, O 0 3.9308922057060963e-14
indicating O 0 1.803672315670024e-11
that O 0 4.644583617041025e-15
the O 0 9.954167888180307e-14
mutant O 0 1.1423077110953028e-12
alleles O 0 6.760234191015291e-13
were O 0 8.458234655207841e-13
likely O 0 1.1093350630458909e-13
to O 0 4.328214354845997e-14
be O 0 4.007425952358553e-15
identical O 0 1.4424149808595077e-13
by O 0 8.96965433615823e-16
descent O 0 1.180901487707331e-09
for O 0 6.707919809889606e-13
a O 0 1.5121750423022218e-12
mutation O 0 7.267114969684851e-13
in O 0 5.679713698057004e-14
the O 0 1.6097940038276026e-12
founder O 0 3.3759953166345724e-11
population O 0 2.885827156667159e-13
. O 0 4.9466528095898354e-11

The O 0 6.019492630043866e-13
identification O 0 2.6144519882365103e-10
of O 0 9.069935774652649e-12
common O 0 2.86553610701068e-11
BRCA1 O 0 1.1784195841357814e-09
and O 0 1.8551115504861215e-11
BRCA2 O 0 3.9725511769006516e-10
mutations O 0 1.8396201716900512e-13
will O 0 4.446229083694686e-14
facilitate O 0 4.7562238869591766e-11
carrier O 0 4.098108029142178e-13
detection O 0 1.2922889147670702e-10
in O 0 1.1238896640598794e-13
French O 0 6.560913271003166e-12
Canadian O 0 1.8449686223220851e-09
breast B-Disease 0 5.351309084744571e-08
cancer I-Disease 0 5.9978901845170185e-09
and O 0 2.1929083970917418e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.80702248448506e-05
. O 0 1.8037701465800637e-07

Are O 0 7.653273847996189e-11
Dp71 O 0 2.9832958716724534e-06
and O 0 4.346852391923228e-11
Dp140 O 0 3.1383651730720885e-06
brain O 0 5.07052800458041e-06
dystrophin O 0 2.8465290569101853e-08
isoforms O 0 3.030694861738681e-10
related O 0 6.489044718227532e-11
to O 0 3.888601246559986e-11
cognitive B-Disease 0 2.9808910767314956e-05
impairment I-Disease 0 0.000861500040628016
in O 0 1.635663267052223e-07
Duchenne B-Disease 1 0.9161466360092163
muscular I-Disease 1 0.9660950303077698
dystrophy I-Disease 1 0.9999998807907104
? O 0 0.013117220252752304

Molecular O 0 1.8570028847975095e-10
study O 0 4.467526066968819e-13
and O 0 2.8434584754718746e-15
neuropsychological O 0 4.961996525471024e-12
analysis O 0 1.1813834144887986e-13
were O 0 3.3389506844073644e-14
performed O 0 2.0203233346265809e-13
concurrently O 0 2.036058474597091e-11
on O 0 8.281153540679043e-13
49 O 0 1.5994844337896552e-10
patients O 0 7.107352033297598e-12
with O 0 4.732323474060385e-12
Duchenne B-Disease 0 8.907650772016495e-05
muscular I-Disease 1 0.7279174327850342
dystrophy I-Disease 1 1.0
( O 0 5.440078165719342e-09
DMD B-Disease 1 1.0
) O 0 5.74436602885503e-13
in O 0 8.619951066411898e-15
order O 0 2.8244545713222192e-14
to O 0 1.473214047498575e-13
find O 0 3.0078167062054517e-13
a O 0 1.1490757906410009e-15
molecular O 0 2.122208184467296e-14
explanation O 0 1.6183578186324682e-13
for O 0 2.2657026808089314e-14
the O 0 4.9599525875354544e-12
cognitive B-Disease 0 5.5439077328856e-08
impairment I-Disease 0 1.3983699753694623e-09
observed O 0 9.980084250335586e-13
in O 0 8.862395409550694e-13
most O 0 4.4601915910602585e-11
DMD B-Disease 1 1.0
patients O 0 1.5805319719675026e-08
. O 0 3.0238831438822444e-09

Complete O 0 1.3157426537180328e-10
analysis O 0 6.331832302398921e-13
of O 0 1.5201991683706784e-13
the O 0 2.1614703638581957e-14
dystrophin O 0 5.779826617313688e-11
gene O 0 1.0193566504128684e-13
was O 0 7.329631693253624e-13
performed O 0 8.83640220456644e-13
to O 0 1.5888558914725626e-12
define O 0 1.1615088058025691e-10
the O 0 1.636802325621911e-11
localization O 0 9.867408152786084e-07
of O 0 1.750406486422662e-09
deletions O 0 2.692192024866813e-09
and O 0 4.305305244256541e-12
duplications O 0 1.0406685291286522e-08
in O 0 2.3413610460154555e-12
relation O 0 2.4043048107991183e-10
to O 0 4.72229633868837e-12
the O 0 3.829969761476315e-12
different O 0 8.382342042700941e-11
DMD B-Disease 1 1.0
promoters O 0 6.392571094693267e-08
. O 0 6.654170547903959e-09

Qualitative O 0 4.298392475288182e-10
analysis O 0 2.0124787253328336e-12
of O 0 4.946801215183205e-12
the O 0 4.747140180949572e-12
Dp71 O 0 2.5754346211215307e-07
transcript O 0 9.08287722811707e-10
and O 0 7.687067094788638e-15
testing O 0 1.0686944222366296e-13
for O 0 1.9644659163264855e-15
the O 0 1.1352474272056587e-14
specific O 0 5.307036141924057e-14
first O 0 4.029706689862023e-12
exon O 0 7.826121972698274e-10
of O 0 6.12546569023209e-10
Dp140 O 0 3.6887939813823323e-07
were O 0 1.257942638943632e-10
also O 0 2.5164009873242243e-13
carried O 0 4.300186248751281e-11
out O 0 7.821965297694078e-12
. O 0 6.46590725406071e-10

Neuropsychological O 0 1.4964153649543732e-07
analysis O 0 2.2782557090872402e-11
assessed O 0 1.6900013333209785e-10
verbal O 0 9.339797379936954e-09
and O 0 1.685683537200333e-11
visuospatial O 0 0.09086401760578156
intelligence O 0 1.5171645273426293e-08
, O 0 9.765230751844836e-14
verbal O 0 3.0631652769841367e-09
memory O 0 3.4963286452693865e-05
, O 0 7.641173934910817e-13
and O 0 9.437097641968456e-14
reading O 0 3.0381089310971277e-10
skills O 0 1.92267930287926e-06
. O 0 1.85657189621935e-09

Comparison O 0 1.6211300746249435e-08
of O 0 6.668486318694988e-10
molecular O 0 9.36067195977941e-11
and O 0 5.772353948996223e-12
psychometric O 0 1.4469320852583678e-08
findings O 0 6.343464382246866e-12
demonstrated O 0 3.138123007978555e-12
that O 0 2.5363827317191785e-14
deletions O 0 1.0470740594015204e-11
and O 0 1.3548683659367344e-13
duplications O 0 3.6725957830441303e-09
that O 0 1.724962132767377e-13
were O 0 2.4085709555282664e-12
localized O 0 2.3820693681453342e-11
in O 0 6.749975063483418e-14
the O 0 8.570286407633132e-13
distal O 0 1.0325290134005627e-07
part O 0 6.532708402007259e-11
of O 0 2.52853005200393e-09
the O 0 1.2242855618183057e-09
gene O 0 2.1916668133115103e-11
seemed O 0 3.8651920553078867e-10
to O 0 3.307987998107942e-12
be O 0 1.2006978527753787e-12
preferentially O 0 2.5134067049847886e-10
associated O 0 5.994867380287872e-10
with O 0 3.8149313569268983e-11
cognitive B-Disease 1 0.9997785687446594
impairment I-Disease 0 0.017573926597833633
. O 0 1.8992809103224317e-08

Two O 0 3.3058594750556836e-10
altered O 0 1.2782429559266006e-09
Dp71 O 0 6.653106652265706e-07
transcripts O 0 2.001285359654048e-09
and O 0 1.6209157226079046e-13
two O 0 1.9527750998258459e-13
deleted O 0 5.835341324728072e-12
Dp140 O 0 5.190953916711649e-11
DNA O 0 9.258196639883032e-12
sequences O 0 2.66155082321402e-14
were O 0 1.9707493761358073e-14
found O 0 3.3050694088688397e-15
in O 0 1.0897672848280836e-15
four O 0 1.681863334582548e-13
patients O 0 6.824691419632378e-12
with O 0 8.309569937518801e-13
severe O 0 0.018224382773041725
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 0.9999879598617554
. O 0 3.6768740301340586e-06

These O 0 4.655484331372861e-11
findings O 0 3.3702994822054633e-12
suggest O 0 1.0155244700715826e-12
that O 0 7.470592896162106e-16
some O 0 7.336474228689452e-16
sequences O 0 3.1290961033207665e-13
located O 0 2.2449654169063443e-13
in O 0 8.08652020941724e-15
the O 0 7.150151781418201e-13
distal O 0 8.748414614956346e-08
part O 0 4.137375719803771e-10
of O 0 1.674795302442078e-09
the O 0 6.69380384454854e-11
gene O 0 2.391007042964327e-13
and O 0 6.261168341605006e-13
, O 0 1.122175506543862e-14
in O 0 1.4653805512770957e-14
particular O 0 2.9294169629108524e-13
, O 0 1.9478181190229127e-15
some O 0 6.212082460439099e-15
DMD B-Disease 1 1.0
isoforms O 0 3.2689970175248106e-10
expressed O 0 6.632527101320396e-13
in O 0 8.190078389785915e-13
the O 0 4.720102086963607e-11
brain O 0 2.6378463857668066e-08
may O 0 1.2711094113035393e-13
be O 0 1.0980216844265478e-14
related O 0 9.31981748719668e-12
to O 0 6.205945046050543e-12
the O 0 2.5514961671246894e-11
cognitive B-Disease 0 1.3713050748265232e-06
impairment I-Disease 0 1.6596152008219178e-08
associated O 0 5.784502737915531e-11
with O 0 1.0652887426354507e-11
DMD B-Disease 1 1.0
. O 0 3.428657635584642e-10
. O 0 3.0761970748471867e-10

I1307K O 0 1.7963095615414204e-06
APC O 0 1.983630149027249e-08
and O 0 3.944460643529046e-12
hMLH1 O 0 2.355843875534447e-08
mutations O 0 4.683519197468122e-12
in O 0 3.371813868694937e-14
a O 0 8.471097900832752e-14
non O 0 6.764487858745838e-10
- O 0 5.651054624244978e-11
Jewish O 0 1.6617159037668472e-11
family O 0 1.8709008951442452e-13
with O 0 3.974708457737909e-15
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0008787504048086703

We O 0 4.745295822949913e-11
describe O 0 3.4380599062133754e-11
a O 0 5.448291557491602e-13
French O 0 1.183808801853703e-12
Canadian O 0 3.154772276747764e-11
hereditary B-Disease 1 0.9999990463256836
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.2152381585225385e-10
HNPCC B-Disease 1 0.9999908208847046
) O 0 1.7419773306118214e-12
kindred O 0 5.230973876280132e-09
which O 0 6.076773182279961e-15
carries O 0 6.545770327680278e-14
a O 0 2.0614774468084678e-15
novel O 0 1.8818261632671564e-14
truncating O 0 3.575202356387308e-10
mutation O 0 5.148629352719203e-12
in O 0 5.608112498695084e-12
hMLH1 O 0 2.3540096094620822e-07
. O 0 8.271809015525378e-09

Interestingly O 0 5.0855781807968015e-09
, O 0 4.0696822810586814e-14
the O 0 8.828277464536377e-14
I1307K O 0 1.2453400810574777e-10
APC O 0 2.155421847949146e-11
polymorphism O 0 1.9070836576595696e-10
, O 0 1.2214689437857473e-15
associated O 0 5.074667357336804e-13
with O 0 2.592269372655954e-15
an O 0 1.9881684392895026e-15
increased O 0 3.711476005002767e-12
risk O 0 3.473158427524936e-10
of O 0 0.008553743362426758
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.272698473859691e-09
is O 0 2.919030373861077e-14
also O 0 5.658082678869792e-16
present O 0 8.603529808070068e-14
in O 0 1.4102320995538521e-14
this O 0 1.4310616222850542e-13
family O 0 3.9066714273283676e-12
. O 0 6.371810301608605e-10

The O 0 1.2680198002712473e-09
I1307K O 0 1.6829336857426824e-07
polymorphism O 0 1.0625917923334782e-07
has O 0 6.030545258040726e-14
previously O 0 5.717683271289076e-13
only O 0 2.7595103529705692e-14
been O 0 1.6693025474824423e-14
identified O 0 5.0614701096801315e-14
in O 0 2.154262282883651e-15
individuals O 0 2.6760483003260456e-14
of O 0 5.6489854460828326e-11
self O 0 6.367842786403344e-08
- O 0 1.7660886086900973e-08
reported O 0 1.261905913096939e-09
Ashkenazi O 0 6.742363893863512e-07
Jewish O 0 1.282864037221998e-09
origins O 0 9.242031140388463e-09
. O 0 7.64833030242329e-10

In O 0 7.160640136394392e-11
addition O 0 2.3787311096562513e-12
, O 0 9.039628786722091e-15
in O 0 4.726299426561489e-15
this O 0 4.9473246273345e-14
family O 0 1.3803008215573787e-12
, O 0 9.914125083225218e-15
there O 0 4.7817927901008545e-15
appears O 0 1.760873077124442e-14
to O 0 7.779063173783338e-14
be O 0 6.000784721557628e-13
no O 0 9.368664698194973e-13
relationship O 0 5.710789827140239e-11
between O 0 1.96464251117634e-11
the O 0 7.279753514409515e-13
I1307K O 0 4.149956073229433e-11
polymorphism O 0 9.990817201321889e-11
and O 0 3.202625432579642e-15
the O 0 9.300327570788483e-14
presence O 0 1.9660912709083128e-13
or O 0 9.750514198131333e-13
absence O 0 1.2767078505504514e-09
of O 0 1.9874228651683978e-10
cancer B-Disease 0 7.525830653110077e-11
. O 0 1.184907207074648e-11
. O 0 5.025368454703028e-10

Identification O 0 7.956438174971936e-09
of O 0 1.590469769774394e-11
a O 0 2.023075683485389e-14
novel O 0 2.2151717868459974e-15
mutation O 0 5.941445523505867e-14
of O 0 8.718209531036192e-13
the O 0 1.3047828876372458e-12
CPO O 0 3.483489940947493e-09
gene O 0 5.30799769372578e-14
in O 0 4.347509087758092e-14
a O 0 9.51253398967511e-13
Japanese O 0 4.844702417017288e-09
hereditary B-Disease 1 0.9995157718658447
coproporphyria I-Disease 1 0.9990569949150085
family O 0 1.4738831266569719e-09
. O 0 3.1625173591010025e-09

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 3.6557157301331245e-10
HCP B-Disease 0 0.009439089335501194
) O 0 3.426978481806814e-13
is O 0 2.9284840069414286e-13
an O 0 7.980653464467746e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 3.2043305508988595e-11
by O 0 2.5592175541310283e-14
a O 0 1.0511005260616102e-10
deficiency B-Disease 1 0.9999991655349731
of I-Disease 1 0.9999973773956299
coproporphyrinogen I-Disease 0 0.10699397325515747
oxidase I-Disease 0 2.4995653116755e-11
( O 0 1.990961318674837e-15
CPO O 0 3.8213196495995305e-10
) O 0 2.7086747812565077e-16
caused O 0 2.615352926292765e-15
by O 0 7.264703141835125e-17
a O 0 6.7408105905106e-15
mutation O 0 5.481223046516041e-15
in O 0 5.764599613085862e-15
the O 0 9.933063486317062e-13
CPO O 0 7.821111758232746e-09
gene O 0 1.9094266098806933e-11
. O 0 1.5788468310518056e-09

Only O 0 1.6411547121286674e-10
11 O 0 3.203022916342668e-11
mutations O 0 1.3347348400138959e-11
of O 0 5.229529483063988e-12
the O 0 3.1811395965336553e-12
gene O 0 2.1609148118887506e-13
have O 0 1.66636944179269e-14
been O 0 1.500165958253849e-13
reported O 0 1.1465357743073445e-12
in O 0 8.571516760258469e-12
HCP B-Disease 0 0.01643514260649681
patients O 0 6.8219812021652615e-09
. O 0 1.7847062494524835e-08

We O 0 1.6940348429583807e-11
report O 0 1.1345380201716743e-13
another O 0 2.2310356551568863e-14
mutation O 0 7.743017517306341e-14
in O 0 7.317835268685121e-15
a O 0 5.413115160106396e-13
Japanese O 0 1.4594817576707442e-09
family O 0 1.1359623658391271e-10
. O 0 2.6171373956884736e-09

Polymerase O 0 1.0294023446155709e-11
chain O 0 5.733548401679056e-14
reaction O 0 3.5385925807785877e-15
- O 0 1.241576692801935e-13
single O 0 3.061937029337318e-14
strand O 0 1.1157519136037464e-13
conformational O 0 2.187962843942879e-14
polymorphism O 0 1.4200123282098742e-12
and O 0 5.971224274373704e-17
direct O 0 3.3582054797159965e-15
sequence O 0 2.9116679634835427e-14
analyses O 0 1.3502788026153317e-13
demonstrated O 0 7.759580738370131e-13
a O 0 1.0578668339531958e-13
C O 0 1.3003586922522015e-11
to O 0 1.0739690387007172e-12
T O 0 1.0799177307604935e-12
substitution O 0 8.442181415740935e-13
in O 0 1.2325074771543654e-12
exon O 0 9.316387071522936e-12
1 O 0 3.723596816085015e-14
of O 0 6.561673405146295e-13
the O 0 3.5865139525782797e-13
CPO O 0 5.343328002282988e-10
gene O 0 2.3955614713590777e-14
at O 0 1.6289624813967118e-12
nucleotide O 0 2.8380225686880367e-12
position O 0 1.641649316486138e-10
85 O 0 8.640383963864906e-10
, O 0 2.1183138657889997e-14
which O 0 2.7941789456335667e-15
lies O 0 4.007233780911612e-12
in O 0 2.8300629458725794e-14
the O 0 4.008365254298818e-12
putative O 0 3.0401159367698938e-09
presequence O 0 1.3698651102345138e-08
for O 0 9.374567962183722e-12
targeting O 0 2.1455019982852264e-09
to O 0 9.918826648913637e-09
mitochondria O 0 5.063716344011482e-07
. O 0 5.2911236281261154e-08

This O 0 1.259337957266321e-13
mutation O 0 4.299078454339522e-15
changes O 0 1.0563913015002876e-16
the O 0 5.229638061676398e-16
codon O 0 3.3936877830501033e-13
for O 0 2.5374894226164136e-15
glutamine O 0 5.459549912850692e-12
to O 0 3.2592860159906534e-13
a O 0 3.329698712931095e-13
termination O 0 3.1542446432553106e-10
codon O 0 3.1270384059922662e-09
at O 0 1.9994339517381832e-10
amino O 0 7.090379949836745e-10
acid O 0 1.0411996265169421e-10
position O 0 2.8396189843959974e-09
29 O 0 1.933983462265587e-08
. O 0 2.0325229499462694e-08

MaeI O 0 3.3641384789007134e-07
restriction O 0 5.363182120632359e-12
analysis O 0 2.288991262158757e-12
showed O 0 1.5562356091292084e-12
two O 0 7.615209901741266e-15
other O 0 9.173435640191037e-16
carriers O 0 4.925104920248946e-14
in O 0 9.62521010702648e-14
the O 0 2.1127204152815438e-11
family O 0 1.881237943202052e-10
. O 0 6.300751032028984e-09

The O 0 2.395561804480195e-10
C O 0 2.748011525000038e-07
- O 0 1.9294184028240124e-08
T O 0 6.117351625256617e-10
mutation O 0 1.076555186142747e-12
is O 0 3.101901356689844e-15
located O 0 1.0023683712754878e-14
within O 0 6.925496553187097e-14
a O 0 7.590557854844377e-15
recently O 0 3.82385443093076e-15
proposed O 0 1.433576369931828e-15
putative O 0 6.980922459022543e-13
alternative O 0 6.519470293481211e-13
translation O 0 2.0787551367751345e-12
initiation O 0 4.612590517871773e-11
codon O 0 1.5258757590785876e-09
( O 0 8.251181855822853e-13
TIC O 0 1.205438593387953e-06
- O 0 3.5407368148554497e-09
1 O 0 4.693962774894589e-13
) O 0 1.0141757352745049e-15
, O 0 1.9741709551383292e-16
supporting O 0 4.957365355891252e-14
that O 0 5.6729038919742583e-14
TIC O 0 2.945406833987363e-07
- O 0 5.06864106242233e-09
1 O 0 3.858492518549195e-12
is O 0 1.7472997129578706e-14
the O 0 1.1697865170013505e-13
real O 0 5.195785208328418e-12
TIC O 0 4.603004366554586e-10
rather O 0 1.0756807770906374e-12
than O 0 4.051607411115904e-13
TIC O 0 2.019195832758669e-08
- O 0 1.72946490462067e-10
2 O 0 8.947829998641466e-13
. O 0 3.5190231804926864e-13
. O 0 8.05311633350625e-12

Human B-Disease 0 4.135795872439729e-11
complement I-Disease 0 2.2552013589915987e-09
factor I-Disease 0 8.359394598755898e-08
H I-Disease 1 1.0
deficiency I-Disease 0 0.021498309448361397
associated O 0 0.00026641719159670174
with O 0 0.031176462769508362
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9982473850250244

This O 0 1.1519457263076127e-12
study O 0 3.4095366504074964e-14
reports O 0 1.5781617176545849e-15
on O 0 1.2662081652685354e-15
six O 0 1.188640318442423e-14
cases O 0 1.0836739627395967e-14
of O 0 1.2924509552869612e-11
deficiency B-Disease 0 6.082404357954374e-09
in I-Disease 0 8.821503423572796e-12
the I-Disease 0 2.5863729560815507e-11
human I-Disease 0 1.2722549793189875e-12
complement I-Disease 0 1.514167263794164e-11
regulatory I-Disease 0 6.31999036437847e-11
protein I-Disease 0 3.795827541175356e-11
Factor I-Disease 0 1.3469241000318988e-10
H I-Disease 0 0.04499049112200737
( O 0 3.1155047481743955e-14
FH O 0 7.467143348094396e-09
) O 0 2.1839663254455405e-16
in O 0 2.6030990065239556e-16
the O 0 2.3704558489068457e-16
context O 0 2.074345605224473e-13
of O 0 1.229902681434969e-13
an O 0 8.525797255687362e-12
acute B-Disease 1 0.9999979734420776
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.540283787766384e-07

Five O 0 3.6588274077153926e-10
of O 0 7.382952756096461e-12
the O 0 1.459857489885183e-13
cases O 0 3.790596105773293e-15
were O 0 8.377658138882752e-15
observed O 0 3.822002393391588e-15
in O 0 5.592803967207271e-16
children O 0 1.1437099427992633e-15
presenting O 0 1.095040984971929e-11
with O 0 3.882466848015298e-10
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.330366654263344e-06
HUS B-Disease 1 1.0
) O 0 5.0808952600789326e-09
. O 0 7.325261464075083e-08

Two O 0 5.6135807807722315e-12
of O 0 6.585649994089726e-12
the O 0 4.610486038086892e-12
children O 0 4.0831742284183625e-13
exhibited O 0 1.7054822831763516e-11
a O 0 9.99708857363224e-11
homozygous O 0 2.3991171715920245e-08
deficiency O 0 1.0781091930311959e-07
characterized O 0 1.787700738310749e-12
by O 0 6.005670949698477e-14
the O 0 7.9727606461244e-11
absence O 0 1.5096016880988827e-08
of O 0 3.1647059972605973e-10
the O 0 2.887844043758525e-12
150 O 0 6.087292562378943e-12
- O 0 1.6984209177950405e-12
kD O 0 6.391549789430684e-11
form O 0 3.0431050474649668e-12
of O 0 1.741148752953947e-10
Factor O 0 6.85117407250857e-10
H O 1 0.9999998807907104
and O 0 1.082208541530738e-12
the O 0 1.6898127862263745e-12
presence O 0 3.015990235333277e-14
, O 0 8.182020633121321e-17
upon O 0 1.4596403784001427e-13
immunoblotting O 0 4.725013158513036e-10
, O 0 8.780212241131253e-15
of O 0 4.1021041272994163e-13
the O 0 4.696424998028303e-13
42 O 0 4.547518958619712e-11
- O 0 2.1215063126384104e-12
kD O 0 5.036948289016685e-11
Factor O 0 1.8231008369617996e-10
H O 1 0.9999964237213135
- O 0 1.874205679541774e-08
like O 0 1.149121379648288e-12
protein O 0 2.8918442076739104e-13
1 O 0 1.4246257304265444e-14
( O 0 5.196745125356553e-16
FHL O 0 1.829851470347421e-07
- O 0 1.3493044355439299e-11
1 O 0 6.593231193077536e-15
) O 0 6.481059361026478e-17
and O 0 3.6668429510531046e-16
other O 0 1.3048661137065112e-14
FH O 0 1.6548918324588158e-07
- O 0 1.2273385086025712e-10
related O 0 5.037373851379812e-10
protein O 0 9.446273624424961e-12
( O 0 2.1346538936711876e-15
FHR O 0 1.909324538473811e-07
) O 0 1.612751917418314e-14
bands O 0 1.6840004390950014e-10
. O 0 2.808462629122488e-10

Southern O 0 4.1732568512031776e-09
blot O 0 5.666642710622227e-10
and O 0 7.78735026355961e-17
PCR O 0 7.093665796908608e-14
analysis O 0 5.271660424980868e-16
of O 0 2.4798988584392057e-16
DNA O 0 1.5015523546768605e-12
of O 0 1.507181152885645e-13
one O 0 6.95282793470274e-14
patient O 0 6.935711727162897e-11
with O 0 1.7367545932216871e-13
homozygous O 0 4.40470937501658e-10
deficiency O 0 3.837397954953303e-09
ruled O 0 1.867088254836613e-11
out O 0 2.420214704102093e-14
the O 0 2.1078389481434846e-14
presence O 0 1.2937710832403113e-14
of O 0 1.5976647359684099e-13
a O 0 7.43437853189784e-15
large O 0 7.443028855871675e-16
deletion O 0 4.4723000801848156e-13
of O 0 9.565971062150402e-13
the O 0 1.4476826855347458e-12
FH O 0 3.96569639349309e-08
gene O 0 1.9617647621390094e-13
as O 0 6.366658095906599e-14
the O 0 1.007381461234913e-12
underlying O 0 8.995350242457789e-09
defect O 0 3.4881324495472654e-08
for O 0 7.395044646085758e-12
the O 0 4.511703899368058e-09
deficiency O 0 8.126923785312101e-05
. O 0 8.604080647955925e-08

The O 0 8.54722369270089e-12
other O 0 5.233293114722919e-15
four O 0 9.144999685360526e-15
children O 0 1.3764964342729164e-16
presented O 0 1.0623449955013756e-14
with O 0 4.656292153470921e-15
heterozygous O 0 1.1585992581997218e-10
deficiency O 0 7.069429130979188e-08
and O 0 6.207590431267507e-12
exhibited O 0 2.5577975848456447e-10
a O 0 1.7982346514622272e-11
normal O 0 1.0132844607824154e-07
immunoblotting O 0 8.796619965778518e-08
pattern O 0 3.8058481366398667e-10
of O 0 1.2063638282766576e-11
proteins O 0 2.2987951060933487e-13
of O 0 6.640720959238955e-12
the O 0 2.300187817994015e-11
FH O 0 1.462812406316516e-06
family O 0 3.7336515823493954e-11
. O 0 5.0306331322858e-10

Factor B-Disease 0 0.00040941991028375924
H I-Disease 1 1.0
deficiency I-Disease 1 0.750780463218689
is O 0 2.714647354563199e-13
the O 0 1.2472119691187e-12
only O 0 6.517823086804597e-11
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 2.0405563816439098e-07
with O 0 1.5948357912076716e-10
HUS B-Disease 1 1.0
. O 0 7.135121222745511e-07

These O 0 2.5974010268992043e-12
observations O 0 1.0721296246629652e-11
suggest O 0 1.762911322998606e-12
a O 0 3.054627812628871e-14
role O 0 2.577314175879891e-13
for O 0 2.140936733452392e-12
FH O 0 0.0002213101979577914
and O 0 2.776643359680975e-10
/ O 0 2.200095394755408e-07
or O 0 2.590318792794477e-10
FH O 0 3.7366748983913567e-06
receptors O 0 3.5092575004745663e-13
in O 0 6.586371666160787e-14
the O 0 1.9072226165994105e-13
pathogenesis O 0 6.129532992282805e-10
of O 0 7.683861324991881e-10
idiopathic O 0 1.901519794955675e-07
HUS B-Disease 0 0.0012757392833009362
. O 0 8.29825819170793e-10
. O 0 3.346801502601693e-09

Further O 0 9.673777057184196e-11
evidence O 0 2.733884516339935e-12
for O 0 1.91660465845506e-14
a O 0 4.73130750886213e-14
major O 0 3.2258269948466645e-13
ancient O 0 9.715238613594579e-10
mutation O 0 1.1526490872881823e-08
underlying O 0 1.0751152501597971e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.0456187027330088e-08
linkage O 0 2.1067604905056214e-07
disequilibrium O 0 4.879742050434288e-07
studies O 0 1.8899864312471593e-12
in O 0 2.1885961281258937e-15
the O 0 1.1075839240713963e-14
Japanese O 0 1.2048783845641786e-11
population O 0 2.376094113132332e-14
. O 0 6.734061658991708e-12

The O 0 1.9037457832382643e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.267306759007326e-10
DM B-Disease 1 1.0
) O 0 1.947735809443296e-12
mutation O 0 5.576350839420208e-11
is O 0 9.712383349826104e-14
an O 0 7.821707691257895e-13
unstable O 0 0.0001190819384646602
( O 0 7.497245012311193e-12
CTG O 0 1.5210143828880973e-06
) O 0 8.762115382213165e-14
n O 0 1.0482605452069582e-12
repeat O 0 1.0305693798340343e-11
, O 0 5.823835168186197e-15
present O 0 5.4207787753999745e-14
at O 0 2.709400730843952e-14
a O 0 1.578293298928985e-16
copy O 0 2.630348738298649e-13
number O 0 3.2987606651260423e-14
of O 0 3.802707931530036e-13
5 O 0 1.2477163399693403e-12
- O 0 3.220027022798888e-11
37 O 0 7.628367382217505e-11
repeats O 0 2.258892725648387e-11
on O 0 9.815790541489733e-12
normal O 0 8.489858122073812e-11
chromosomes O 0 3.570734853630686e-12
but O 0 4.246199881508331e-14
amplified O 0 4.771065812390896e-13
to O 0 2.859734747184123e-13
50 O 0 1.682243580547471e-11
- O 0 1.4769060540514856e-12
3000 O 0 6.811072430883136e-13
copies O 0 8.884843381851137e-12
on O 0 1.1882693717879533e-09
DM B-Disease 1 0.9999988079071045
chromosomes O 0 1.9866440936766594e-08
. O 0 5.6618381094608594e-09

Previous O 0 6.872418634173982e-09
findings O 0 4.69192393270923e-12
in O 0 2.0472948965462312e-13
Caucasian O 0 4.605537995416853e-08
populations O 0 3.6464486486732783e-13
of O 0 2.1793572155259788e-11
a O 0 4.1721346377698865e-09
DM B-Disease 1 1.0
founder O 0 5.728361429646611e-07
chromosome O 0 1.9319637090120523e-07
raise O 0 1.6274018244111232e-10
a O 0 3.7202123434783296e-13
question O 0 1.7159618994830317e-12
about O 0 3.255987767102834e-16
the O 0 2.4298298409544975e-15
molecular O 0 2.3128939356190786e-14
events O 0 3.375088836882201e-14
involved O 0 2.8440483475222766e-12
in O 0 1.1051624025648632e-12
the O 0 8.673845496021126e-12
expansion O 0 1.8611667762513662e-09
mutation O 0 1.0261487493057331e-10
. O 0 6.603492197498895e-10

To O 0 4.733970992987224e-10
investigate O 0 2.7573785268963924e-11
whether O 0 1.6235767613149987e-13
a O 0 1.9803969119984444e-13
founder O 0 5.855138964817874e-13
chromosome O 0 3.057278735729696e-11
for O 0 4.692977777220886e-13
the O 0 3.8432187987602617e-10
DM B-Disease 1 1.0
mutation O 0 8.010746233022559e-11
exists O 0 9.96064884219161e-13
in O 0 3.0588007204435195e-15
the O 0 8.344296052189247e-15
Japanese O 0 3.5316393906525967e-12
population O 0 1.1435572651105207e-15
, O 0 1.0973632116012641e-16
we O 0 3.917195682948994e-14
genotyped O 0 2.4284749766678715e-09
families O 0 3.5255332724373756e-13
using O 0 1.3374150962044973e-12
polymorphic O 0 1.715686370751257e-09
markers O 0 6.405481034477134e-09
near O 0 4.056589730794258e-08
the O 0 3.458100750197701e-10
( O 0 1.7253973857295213e-12
CTG O 0 1.7095501902986143e-07
) O 0 7.562270579707098e-13
n O 0 6.828848597706383e-11
repeat O 0 1.2248507763601424e-09
region O 0 2.6527442464896467e-09
and O 0 4.013092809451724e-12
constructed O 0 2.45319542457878e-09
haplotypes O 0 4.919137097658677e-09
. O 0 1.760014578522373e-09

Six O 0 4.622377480778539e-10
different O 0 6.464196582525727e-13
haplotypes O 0 7.535282120496589e-11
were O 0 1.0011350472585723e-12
found O 0 1.4733685463081542e-13
and O 0 2.923683972873292e-13
DM B-Disease 1 1.0
alleles O 0 5.041908210379198e-11
were O 0 3.343499435648489e-11
always O 0 1.4711684995227792e-11
haplotype O 0 4.373811091085145e-09
A O 0 1.1006905964450198e-07
. O 0 1.2767767287868992e-08

To O 0 1.0959693569345674e-10
find O 0 5.473688342860772e-12
an O 0 2.532459635096499e-16
origin O 0 1.0374914902883114e-12
of O 0 2.6050824691870034e-11
the O 0 8.379939971103756e-12
( O 0 3.895023748521666e-14
CTG O 0 9.050474147898058e-09
) O 0 5.912907882370038e-15
n O 0 5.576153688097163e-13
repeat O 0 4.546753598622111e-12
mutation O 0 4.4046689039178855e-13
and O 0 4.1838840910953055e-15
to O 0 1.746927526680847e-13
investigate O 0 4.612718085099388e-13
the O 0 5.0186051603513804e-14
mechanism O 0 7.668012926009826e-12
of O 0 4.2323349686013145e-13
the O 0 2.61053504524043e-14
expansion O 0 1.093746295789677e-12
mutation O 0 6.892456169606959e-15
in O 0 1.4012974266196243e-15
the O 0 4.4804070325229865e-15
Japanese O 0 1.5594505938312797e-12
population O 0 1.1072326806839936e-15
we O 0 4.0476930516380755e-16
have O 0 3.3313199657558753e-16
studied O 0 4.389025899447993e-14
90 O 0 1.93316456592596e-12
Japanese O 0 3.9585584810097885e-10
DM B-Disease 1 0.9999998807907104
families O 0 1.3424221803615133e-11
comprising O 0 2.8312645197065e-12
190 O 0 1.556227542665045e-11
affected O 0 4.6304735219770965e-12
and O 0 1.6259164696032224e-13
130 O 0 4.1957542995518793e-10
unaffected O 0 7.115894984366378e-09
members O 0 3.393671801910081e-11
. O 0 4.29960023140552e-09

The O 0 5.16739595557425e-10
results O 0 6.616499709233281e-11
suggest O 0 1.727548659680167e-11
that O 0 3.5435771579149424e-15
a O 0 9.206592194339891e-14
few O 0 2.2040060206583723e-13
common O 0 1.25502711521841e-12
ancestral O 0 1.591540410572634e-08
mutations O 0 1.4131018404028861e-11
in O 0 8.255746889070104e-13
both O 0 1.469797027142672e-11
Caucasian O 0 0.00017655127157922834
and O 0 1.5182853238537852e-11
Japanese O 0 2.3684410876967377e-08
populations O 0 7.255436214933381e-14
have O 0 5.076380287713839e-17
originated O 0 2.7005151011173702e-15
by O 0 2.2928131362795968e-17
expansion O 0 2.8538729539284713e-12
of O 0 5.205268074209846e-12
an O 0 3.068644242789492e-13
ancestral O 0 7.818755420885282e-09
n O 0 8.766337482313258e-12
= O 0 5.343057593587552e-12
5 O 0 1.5950866929376195e-12
repeat O 0 1.5165488656543324e-11
to O 0 1.6828276619418325e-11
n O 0 2.987697329120964e-12
= O 0 2.772713699264462e-12
19 O 0 4.393103242295027e-11
- O 0 1.87381343080828e-11
37 O 0 8.519051783451026e-12
copies O 0 1.54713880595736e-11
. O 0 2.1441058650761846e-10

These O 0 5.301140928136439e-13
data O 0 2.1230554207024577e-13
support O 0 2.3118222695342125e-14
multistep O 0 1.4885308263767882e-10
models O 0 1.185066073050578e-10
of O 0 2.3339186139281765e-09
triplet O 0 3.6598889892047737e-06
repeat O 0 6.268993657521094e-10
expansion O 0 1.4487532007390058e-10
that O 0 4.2837230175552226e-15
have O 0 4.797850840714902e-16
been O 0 5.315641551975863e-16
proposed O 0 4.1965577686290387e-16
for O 0 1.2010424901528257e-14
both O 0 1.0199904115770764e-10
DM B-Disease 1 1.0
and O 0 2.7211430886353583e-09
Friedreichs B-Disease 0 0.0033095884136855602
ataxia I-Disease 0 2.1875661332160234e-05
. O 0 7.222837328235698e-10
. O 0 7.093251319645333e-09

The O 0 2.085002309692996e-11
molecular O 0 6.436100350587504e-12
basis O 0 4.5411553628582624e-08
of O 0 6.242383278731722e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 9.12449782397573e-10
the O 0 5.538340272503994e-11
western O 0 3.0011107488014943e-10
Cape O 0 1.3643096374860164e-10
, O 0 2.6444273745589164e-14
South O 0 5.097369575046695e-12
Africa O 0 1.158956611235773e-11
. O 0 1.7327601853356356e-10

Deficiency B-Disease 0 0.0014890492893755436
of I-Disease 0 1.4312624330159451e-07
the I-Disease 0 6.101340543906986e-10
sixth I-Disease 0 4.59466809843434e-06
component I-Disease 0 3.616766548475425e-07
of I-Disease 0 1.8795144995920054e-08
human I-Disease 0 4.603138314962507e-09
complement I-Disease 0 3.721196480910294e-05
( O 0 1.1566511637361998e-11
C6 O 0 0.0586395300924778
) O 0 1.1504021476746451e-12
has O 0 2.5072668635419066e-15
been O 0 9.810141624554385e-15
reported O 0 9.843842524426792e-15
in O 0 1.217254637235802e-15
a O 0 1.7083666693944503e-15
number O 0 2.7438478243912425e-15
of O 0 3.8373147161988724e-14
families O 0 1.9617647621390094e-13
from O 0 4.1285404999216735e-13
the O 0 3.9964255862945386e-12
western O 0 5.190916585462446e-10
Cape O 0 1.7249163208887808e-09
, O 0 9.437984248295006e-13
South O 0 1.178468433948865e-10
Africa O 0 1.5859327739953244e-10
. O 0 6.014406750409762e-10

Meningococcal B-Disease 1 0.9999980926513672
disease I-Disease 0 0.01865857094526291
is O 0 2.6318103512473767e-12
endemic O 0 1.4613376697961145e-12
in O 0 1.2877712100617302e-14
the O 0 1.8787690587301897e-12
Cape O 0 6.398343660452e-11
and O 0 1.050985047539988e-16
almost O 0 4.098095747164443e-15
all O 0 4.179654961468783e-16
pedigrees O 0 2.0215484841656917e-10
of O 0 3.8753200648500297e-10
total O 0 0.0009805457666516304
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 3.393123559902733e-10
C6Q0 O 0 0.2345978021621704
) O 0 2.1783161212318713e-13
have O 0 1.6599458827338924e-14
been O 0 2.4739157459250684e-14
ascertained O 0 2.163013101963429e-10
because O 0 6.391991157293081e-14
of O 0 8.086058211898006e-11
recurrent O 0 0.00016208596935030073
disease O 0 5.0483631497399983e-08
. O 0 2.6374322725786215e-09

We O 0 1.6431427399266063e-11
have O 0 4.939797045532251e-15
sequenced O 0 2.2790890268770125e-12
the O 0 1.2686237761791626e-14
expressed O 0 5.957320276190128e-14
exons O 0 4.6090836702816773e-10
of O 0 2.818947852922804e-11
the O 0 5.224983206514322e-12
C6 O 0 1.1726668525113837e-08
gene O 0 1.668369794800926e-14
from O 0 2.5408809848888672e-14
selected O 0 4.2845528557336476e-13
cases O 0 9.651235702550637e-15
and O 0 1.7125229541875087e-15
have O 0 4.746209359503175e-15
found O 0 4.1932654045026205e-14
three O 0 6.298080275617818e-14
molecular O 0 1.037429239736376e-10
defects O 0 7.949005897955885e-09
leading O 0 1.0121994908907084e-10
to O 0 1.2945345906345551e-09
total O 0 0.00014659516455139965
deficiency O 1 0.9993621706962585
879delG O 1 0.9998562335968018
, O 0 4.776893399068005e-13
which O 0 7.28766480213687e-15
is O 0 6.6261604459349945e-15
the O 0 6.096329495906827e-13
common O 0 2.525760850469183e-11
defect O 0 4.451529278526323e-08
in O 0 5.626929824864568e-11
the O 0 3.001415560532905e-09
Cape O 0 1.069419397481397e-07
and O 0 1.7669619239990553e-11
hitherto O 0 7.281381897428219e-08
unreported O 0 3.230377743079771e-09
, O 0 1.3965486211041378e-14
and O 0 4.366856336712917e-14
1195delC O 0 3.826069683299238e-09
and O 0 1.491231834196971e-12
1936delG O 0 1.9559038832994702e-08
, O 0 3.0625150446205243e-14
which O 0 2.3942402693679504e-15
have O 0 5.62831370593854e-15
been O 0 2.718502235387471e-13
previously O 0 4.206495395064902e-12
reported O 0 2.9609585725128007e-13
in O 0 5.59307971031292e-13
African O 0 5.95892335475412e-10
- O 0 2.6317978352174975e-10
Americans O 0 2.7170810046328597e-10
. O 0 4.817023224745753e-09

We O 0 1.4376325130349699e-10
also O 0 2.1150558382606807e-14
show O 0 9.175895042705037e-14
that O 0 2.5351552181894625e-17
the O 0 1.2028810598681359e-14
879delG O 0 5.088932608643404e-10
and O 0 2.5394627806846204e-13
1195delC O 0 5.279892789644691e-08
defects O 0 1.339131046051989e-07
are O 0 3.566803563658308e-14
associated O 0 7.708199634137713e-10
with O 0 3.261013126198975e-10
characteristic O 1 0.9999985694885254
C6 O 1 1.0
/ O 1 1.0
C7 O 1 0.9999568462371826
region O 0 4.852639534647096e-08
DNA O 0 1.6338454145170545e-07
marker O 0 2.3366044654693496e-09
haplotypes O 0 1.5046422996434217e-09
, O 0 4.505312003457926e-14
although O 0 6.706419274082887e-14
small O 0 4.787252002149203e-14
variations O 0 1.0043956091094694e-13
were O 0 3.3178963049218524e-12
observed O 0 9.686239310635614e-11
. O 0 4.222224347927295e-09

The O 0 1.2143850369739084e-09
1936delG O 0 1.2827249520341866e-06
defect O 0 1.5224321714413236e-06
was O 0 4.8896567350631415e-11
observed O 0 1.8019108340844303e-12
only O 0 6.262073243843216e-14
once O 0 1.6698988925586272e-13
in O 0 2.8165251570897928e-14
the O 0 4.230827493900691e-12
Cape O 0 3.620072019927534e-10
, O 0 1.4700772430905023e-15
but O 0 3.711866510908374e-15
its O 0 1.9144416751209516e-14
associated O 0 3.365105069597085e-11
haplotype O 0 5.23056442602865e-09
could O 0 1.0641865166860498e-10
be O 0 1.6160406346443779e-10
deduced O 0 5.4966534435152425e-08
. O 0 6.2901963637784775e-09

The O 0 3.034929252354601e-10
data O 0 4.3010556921574405e-11
from O 0 1.5626834949742513e-13
the O 0 6.223259754745136e-13
haplotypes O 0 1.0707159464606875e-10
indicate O 0 8.597682461808365e-12
that O 0 2.4379071471395146e-15
these O 0 7.657741120088799e-15
three O 0 1.3540932969086789e-13
molecular O 0 1.0035795111607015e-10
defects O 0 8.727844225120407e-09
account O 0 1.8180848536733518e-12
for O 0 3.2674540156873988e-12
the O 0 4.919634477573709e-09
defects O 0 0.3649415969848633
in O 0 5.894317672838767e-11
all O 0 2.1556971485647836e-11
the O 0 2.7346578126974386e-11
38 O 0 1.2818905936740066e-09
unrelated O 0 6.065486446438229e-10
C6Q0 O 0 3.3257932955166325e-05
individuals O 0 3.0658435859476363e-12
we O 0 1.1555016925929307e-12
have O 0 2.8098822164976563e-14
studied O 0 3.059178995193368e-12
from O 0 5.288668266344165e-13
the O 0 1.8935160731037293e-11
Cape O 0 2.1003194738966613e-09
. O 0 4.5964770878370587e-10

We O 0 2.4485755090175587e-10
have O 0 7.653772770730913e-14
also O 0 6.861602147470273e-16
observed O 0 1.0915443387755994e-14
the O 0 7.267111039451976e-14
879delG O 0 6.047019329713521e-09
defect O 0 7.5533188592658e-09
in O 0 6.289010978655085e-12
two O 0 7.866229334574371e-10
Dutch O 1 0.9999637603759766
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 1 0.9999759197235107
, O 0 2.021136757306488e-13
but O 0 5.327702983507409e-15
the O 0 2.0583404772289704e-13
879delG O 0 1.856303555314298e-08
defect O 0 6.258915163925849e-08
in O 0 1.3306676940882944e-11
the O 0 7.169362881143115e-10
Cape O 0 6.3554392859543896e-09
probably O 0 4.78407157639138e-12
did O 0 5.839413154407058e-13
not O 0 1.1242541592777419e-13
come O 0 1.3976059892728543e-11
from O 0 1.255319893173068e-11
The O 0 1.6268619784653993e-10
Netherlands O 0 1.7491039172590206e-10
. O 0 4.336319150977097e-11
. O 0 1.6921569701011663e-09

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 8.752804037115425e-12
seven O 0 1.651021853954493e-11
further O 0 3.675680853437724e-12
molecular O 0 3.258407987871692e-10
defects O 0 1.3925583175478096e-07
and O 0 5.817790368380094e-13
their O 0 7.618159575395467e-11
associated O 0 2.2287967027523337e-08
marker O 0 3.583877230539656e-07
haplotypes O 0 2.3507634239194886e-07
. O 0 1.890163225937158e-08

Seven O 0 1.723146347831772e-10
further O 0 8.839907972291172e-13
molecular O 0 1.312546252241198e-11
bases O 0 3.8809213620538685e-09
of O 0 8.488188541377895e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.8766182465273e-10
described O 0 4.3531520055317685e-10
. O 0 1.8223856868004873e-09

All O 0 2.134039646384256e-11
these O 0 1.0016388217980177e-13
new O 0 4.228895337209104e-14
molecular O 0 1.5452621821010482e-12
defects O 0 1.241151712655375e-11
involve O 0 3.6369778716460743e-11
single O 0 2.149576489030025e-10
- O 0 3.8801717394676416e-10
nucleotide O 0 4.225567895588256e-09
events O 0 2.909292251551676e-10
, O 0 3.171777348143917e-13
deletions O 0 3.670658915710945e-11
and O 0 9.053938561333005e-14
substitutions O 0 1.4608897425105738e-11
, O 0 5.496172754518606e-15
some O 0 3.192952104563761e-15
of O 0 1.0322921987701572e-12
which O 0 1.4249932072003813e-13
alter O 0 1.3176350677213122e-08
splice O 0 3.7541593655987526e-07
sites O 0 2.1272266170768717e-09
, O 0 5.871657327016777e-13
and O 0 3.908525250412992e-13
others O 0 2.7987610493052095e-11
codons O 0 4.699125355500655e-08
. O 0 3.049537511401468e-08

They O 0 2.581198275952712e-11
are O 0 1.0271101189614912e-14
distributed O 0 4.297112999088713e-14
along O 0 5.284494087980096e-13
the O 0 1.306675687789971e-12
C7 O 0 3.9548800145894347e-07
gene O 0 1.0712930108985885e-12
, O 0 2.718345229360368e-14
but O 0 9.156449029708563e-15
predominantly O 0 1.1270695748216708e-12
towards O 0 1.0478817119574657e-10
the O 0 7.766781141838042e-12
3 O 0 1.6103845687509555e-11
end O 0 2.2384964992738787e-09
. O 0 4.862560132323779e-09

All O 0 1.0094308722230494e-10
were O 0 1.0492972810083323e-11
found O 0 2.2014306339229045e-13
in O 0 1.0703544543473175e-14
compound O 0 2.5327561228860596e-11
heterozygous O 0 4.190825464434056e-11
individuals O 0 2.789108787676353e-12
. O 0 3.514958768491283e-09

The O 0 1.1163250519530266e-06
C6 O 0 0.363039493560791
/ O 0 0.0001275521208299324
C7 O 0 0.0002289351832587272
marker O 0 3.2299727337203876e-08
haplotypes O 0 5.557392768196223e-09
associated O 0 1.0628340429974514e-09
with O 0 3.553364200103992e-11
most O 0 3.3746143657253924e-09
C7 B-Disease 1 1.0
defects I-Disease 1 0.9994613528251648
are O 0 3.3126351054596492e-12
tabulated O 0 4.830907229802506e-09
. O 0 5.562774546552518e-11
. O 0 1.3781510377341988e-09

A O 0 6.5145489003270995e-09
genome O 0 7.243200483841861e-10
- O 0 9.085367180805548e-11
wide O 0 5.017210605307021e-13
search O 0 3.8583528733093786e-12
for O 0 7.668209600283915e-14
chromosomal O 0 9.503050932835322e-07
loci O 0 1.960699691494483e-08
linked O 0 4.702846112536463e-08
to O 0 2.5486374122252187e-10
mental O 0 0.2133990377187729
health O 0 4.7908770700599845e-11
wellness O 0 1.3263252995887598e-10
in O 0 1.2111643644659251e-14
relatives O 0 6.140195773704504e-13
at O 0 1.333698451157217e-12
high O 0 9.256059460560628e-12
risk O 0 1.8094990783534826e-11
for O 0 3.2186350806817643e-10
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999995231628418
disorder I-Disease 1 0.9999997615814209
among O 0 6.985454749364184e-12
the O 0 2.250609767995293e-11
Old O 0 6.195593815760958e-09
Order O 0 1.4252589386476444e-10
Amish O 0 2.087862682742525e-08
. O 0 2.910219287777238e-10

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 4.7941726144529184e-09
BPAD B-Disease 1 1.0
; O 0 3.4221486657770583e-06
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.4624646939586103e-12
is O 0 1.2431352842468598e-14
characterized O 0 7.412913022948522e-15
by O 0 4.0645582717112967e-16
episodes O 0 7.622930620065915e-10
of O 0 1.8690597680670606e-10
mania B-Disease 0 2.5120996394178974e-09
and O 0 7.13519694717224e-12
/ O 0 1.806791161129695e-08
or O 0 2.0382032867027888e-11
hypomania B-Disease 0 8.046131938499457e-08
interspersed O 0 7.060592388530296e-11
with O 0 1.7271267551102385e-15
periods O 0 1.9995177735765424e-10
of O 0 1.1513866249313054e-10
depression B-Disease 0 3.6400538139247374e-10
. O 0 3.0248104021524114e-10

Compelling O 0 5.78505743309421e-10
evidence O 0 1.9738445253270065e-11
supports O 0 5.090293963248838e-13
a O 0 2.8366345662905572e-14
significant O 0 2.278744684267031e-13
genetic O 0 5.869096007804497e-12
component O 0 3.009259855191182e-11
in O 0 1.5279345442955478e-13
the O 0 1.4905614936777667e-11
susceptibility O 0 3.5135022669052773e-10
to O 0 1.0092042757037234e-09
develop O 0 0.001709006610326469
BPAD B-Disease 1 1.0
. O 0 2.762168151093647e-06

To O 0 4.542049028555262e-11
date O 0 7.513656918867184e-10
, O 0 3.778831495762289e-14
however O 0 2.766468152649859e-13
, O 0 6.907064099815306e-15
linkage O 0 2.4850202451354164e-10
studies O 0 5.975052267195857e-13
have O 0 9.45716097257689e-16
attempted O 0 5.3807566041674804e-11
only O 0 1.7606565077404879e-12
to O 0 2.737778927175416e-11
identify O 0 9.168605430431853e-09
chromosomal O 0 6.267974185902858e-06
loci O 0 3.454590569162974e-08
that O 0 3.5809656021706937e-12
cause O 0 4.578146473033229e-10
or O 0 2.6380122045144283e-12
increase O 0 3.9508756509432086e-12
the O 0 1.407159761976362e-12
risk O 0 9.686252668006379e-12
of O 0 7.417014918909004e-11
developing O 0 1.5077420130182873e-06
BPAD B-Disease 1 1.0
. O 0 1.861155396909453e-06

To O 0 6.503793614776043e-10
determine O 0 7.807544610827222e-10
whether O 0 5.361760081062927e-12
there O 0 6.314248711565551e-13
could O 0 5.554477776163746e-13
be O 0 1.2081057454340488e-13
protective O 0 3.3033539011823043e-12
alleles O 0 2.1305407525012976e-12
that O 0 4.144916340356871e-15
prevent O 0 1.920918632491997e-11
or O 0 5.9473242303154095e-12
reduce O 0 6.511349098792252e-11
the O 0 1.4174336617628347e-12
risk O 0 7.70798615906676e-12
of O 0 2.2285340239847073e-11
developing O 0 1.498168842317682e-07
BPAD B-Disease 1 1.0
, O 0 5.454621129774573e-14
similar O 0 3.967058903191255e-15
to O 0 4.109141819126291e-14
what O 0 1.4359954960291863e-15
is O 0 4.598181352245421e-16
observed O 0 5.3125049254447096e-14
in O 0 5.036460276066322e-14
other O 0 5.56810066804081e-12
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 4.4629052142503445e-15
we O 0 2.371588914292476e-14
used O 0 2.243033016269269e-11
mental O 0 1.0970227748430261e-07
health O 0 8.032361234477925e-12
wellness O 0 3.1177029707896153e-11
( O 0 1.2688040036145146e-16
absence O 0 8.679335462141724e-13
of O 0 1.6007555524166772e-12
any O 0 5.348504972246815e-11
psychiatric B-Disease 0 2.6957935915561393e-05
disorder I-Disease 0 1.6876042252533807e-07
) O 0 2.1729234775028474e-15
as O 0 1.4471256148352262e-15
the O 0 7.28722366737794e-14
phenotype O 0 1.1184542875186665e-12
in O 0 2.5112836208327285e-14
our O 0 6.206678834080881e-12
genome O 0 1.9281978791418908e-11
- O 0 1.5274845624468902e-11
wide O 0 1.1531437697082092e-12
linkage O 0 4.284690102718258e-10
scan O 0 7.77234987481279e-09
of O 0 1.6476054895409042e-11
several O 0 6.253005383448362e-13
large O 0 2.4277566177018095e-13
multigeneration O 0 4.508538431480247e-09
Old O 0 8.45411851635447e-10
Order O 0 3.0334755540817326e-11
Amish O 0 2.2019902345959963e-08
pedigrees O 0 6.815739084231609e-09
exhibiting O 0 2.5203486520020135e-10
an O 0 5.146967921310086e-13
extremely O 0 4.3997219756342076e-10
high O 0 8.693680220162037e-10
incidence O 0 4.393461949803168e-08
of O 0 6.963291525607929e-07
BPAD B-Disease 1 1.0
. O 0 1.4742691746505443e-05

We O 0 3.2114663706117597e-10
have O 0 2.2790314557416536e-13
found O 0 9.317621273065985e-14
strong O 0 1.4097688148833514e-15
evidence O 0 5.928016832566687e-15
for O 0 4.795548181647791e-15
a O 0 1.0206485450640207e-13
locus O 0 7.350888127366506e-12
on O 0 5.616582546275062e-11
chromosome O 0 2.442014590542385e-09
4p O 0 9.796871381695382e-06
at O 0 4.3343391098460415e-09
D4S2949 O 0 1.205130661929843e-08
( O 0 1.1758503750487672e-14
maximum O 0 1.4297024675258285e-10
GENEHUNTER O 0 1.9367282675375463e-06
- O 0 2.3407026317201485e-10
PLUS O 0 2.1295396002152245e-10
nonparametric O 0 2.1993795229491298e-08
linkage O 0 5.887242360280709e-10
score O 0 1.3293689933580044e-11
= O 0 1.5039362713086674e-13
4 O 0 4.409214082712852e-14
. O 0 1.013170836561706e-14
05 O 0 6.859290219152214e-11
, O 0 1.113205393751121e-13
P O 0 1.8408689850257787e-10
= O 0 1.4892981867273974e-13
5 O 0 3.934747899681998e-14
. O 0 1.6062337659551317e-15
22 O 0 3.830265708011822e-14
x O 0 6.239197526680673e-13
10 O 0 1.4643593412508316e-12
( O 0 1.7030708711774506e-14
- O 0 8.368535898972684e-12
4 O 0 5.882853205225677e-14
) O 0 9.078328663290956e-16
; O 0 5.74337423797709e-15
SIBPAL O 0 1.561891053825093e-06
Pempirical O 0 1.4560367844751454e-07
value O 0 4.0203215756484667e-10
< O 0 1.643901334502651e-11
3 O 0 2.6848006917700243e-14
x O 0 7.141020088620442e-13
10 O 0 1.9148927235534963e-12
( O 0 1.781850695096142e-14
- O 0 6.338614962769773e-12
5 O 0 2.9224730545718974e-14
) O 0 2.558912474039251e-16
) O 0 4.888786180349755e-16
and O 0 1.5102451759877247e-14
suggestive O 0 1.0000896812079052e-11
evidence O 0 4.824534868830277e-13
for O 0 5.09314677021519e-14
a O 0 7.829544304560621e-13
locus O 0 2.083793727847283e-11
on O 0 3.6343514309145064e-10
chromosome O 0 6.453873435674495e-09
4q O 0 2.816136941419245e-07
at O 0 3.039605900312381e-09
D4S397 O 0 1.8989405603520026e-08
( O 0 2.8361529433567484e-14
maximum O 0 1.960794998590032e-10
GENEHUNTER O 0 1.705161821519141e-06
- O 0 2.249675445931132e-10
PLUS O 0 1.1300325258867261e-10
nonparametric O 0 1.5302074274359256e-08
linkage O 0 8.719885369323777e-10
score O 0 8.696059497492747e-12
= O 0 9.985067650096144e-14
3 O 0 1.4265889833916905e-14
. O 0 2.1879866879203442e-15
29 O 0 1.471038785574863e-12
, O 0 2.956679633113815e-14
P O 0 7.14980435967405e-11
= O 0 4.328875040544855e-14
2 O 0 6.605717729269486e-15
. O 0 1.8148667688306936e-15
57 O 0 5.370303811022548e-13
x O 0 9.10572507152596e-13
10 O 0 5.280879466357247e-12
( O 0 2.3589032406546272e-14
- O 0 7.682871699943306e-12
3 O 0 1.7972033366717155e-14
) O 0 3.15191335826929e-16
; O 0 1.373030560741209e-15
SIBPAL O 0 3.80423813339803e-07
Pempirical O 0 5.412003289961831e-08
value O 0 1.355004858316633e-10
< O 0 8.229024232864202e-12
1 O 0 2.6230226825752108e-14
x O 0 2.2639036912491806e-12
10 O 0 1.9744319026959722e-11
( O 0 1.8709579512835722e-13
- O 0 9.219129799842296e-12
3 O 0 1.121572080272238e-14
) O 0 5.906161556112733e-17
) O 0 4.06565723078591e-17
that O 0 1.3509131275900803e-16
are O 0 2.3988294938761742e-15
linked O 0 2.3694608497493164e-09
to O 0 5.850442619248497e-08
mental O 1 1.0
health O 0 1.0072586746900924e-06
wellness O 0 8.755657177061948e-07
. O 0 9.657853405897754e-10

These O 0 3.08293841844165e-11
findings O 0 3.3616646792633542e-12
are O 0 2.5313888795720513e-15
consistent O 0 3.302194672219483e-12
with O 0 1.3424835880479036e-15
the O 0 1.3440068285727746e-13
hypothesis O 0 2.913536111589371e-13
that O 0 7.772926218910155e-17
certain O 0 1.6886263166839693e-13
alleles O 0 7.10733815550979e-12
could O 0 9.985229657005767e-12
prevent O 0 1.0058183175232216e-09
or O 0 8.718916560956913e-11
modify O 0 2.916037855626996e-09
the O 0 3.7015850454236165e-12
clinical O 0 3.482808832999673e-11
manifestations O 0 2.7252605727667856e-10
of O 0 2.5467278286228634e-10
BPAD B-Disease 1 1.0
and O 0 1.7732000763548417e-12
perhaps O 0 3.474928949188244e-13
other O 0 7.726082279372118e-14
related O 0 1.6501026323112455e-07
affective B-Disease 0 2.257461346744094e-06
disorders I-Disease 0 1.7852747987490147e-05
. O 0 1.80418773254587e-08

Segregation O 0 2.419411202936317e-06
distortion O 0 2.313557843081071e-06
in O 0 3.1181404125391055e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 3.5841376302414574e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.053239243186681e-09
DM B-Disease 1 1.0
) O 0 1.098038066721374e-11
is O 0 6.92849965767961e-13
an O 0 3.8541014997506284e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999995231628418
which O 0 1.1664958278825854e-13
, O 0 5.401534927992186e-16
in O 0 1.668836912295513e-15
the O 0 6.204956795770322e-14
typical O 0 1.398578627041791e-12
pedigree O 0 5.532825933518559e-12
, O 0 3.684257419053061e-16
shows O 0 6.194987556794318e-14
a O 0 4.478059904226145e-14
three O 0 1.9005736112513716e-13
generation O 0 3.311362295477238e-10
anticipation O 0 3.4160478890044033e-09
cascade O 0 2.400292187232367e-09
. O 0 8.092716718977044e-09

This O 0 6.734376104726783e-14
results O 0 2.797425485701055e-12
in O 0 1.3323845499124687e-11
infertility B-Disease 1 0.9999481439590454
and O 0 1.1594183391139268e-08
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.2567597136581288e-11
CDM B-Disease 0 4.793425318894151e-07
) O 0 7.810112288783599e-16
with O 0 1.0505922360106988e-16
the O 0 1.496636473606594e-13
disappearance O 0 2.4078430915785987e-10
of O 0 8.378430171873674e-10
DM B-Disease 1 1.0
in O 0 2.207702076706397e-11
that O 0 4.567716647627118e-13
pedigree O 0 5.235383238044733e-10
. O 0 2.613943506091232e-10

The O 0 1.9390296659982376e-11
concept O 0 2.2560682488848016e-11
of O 0 8.982101520893515e-12
segregation O 0 4.148786592050868e-10
distortion O 0 1.9073964629967577e-10
, O 0 1.8072388930335338e-16
where O 0 2.2919922753269237e-16
there O 0 8.051298964813851e-17
is O 0 6.132069379048518e-18
preferential O 0 1.8430795897719093e-13
transmission O 0 4.5273798598977066e-11
of O 0 6.215640930553809e-14
the O 0 1.508279043110558e-14
larger O 0 1.7934843538135008e-14
allele O 0 2.500851522396763e-12
at O 0 6.680178545742654e-12
the O 0 2.2159793097720204e-11
DM B-Disease 1 1.0
locus O 0 4.715451917824964e-10
, O 0 4.778578791345134e-13
has O 0 1.4960612492969489e-15
been O 0 2.6346604070507165e-14
put O 0 2.647164171892813e-13
forward O 0 2.91836520227573e-12
to O 0 1.0475015820021749e-11
explain O 0 2.931411224871283e-10
partially O 0 1.8586471250969794e-10
the O 0 7.785034010672487e-13
maintenance O 0 9.25952079455783e-08
of O 0 1.011538075523788e-09
DM B-Disease 1 1.0
in O 0 3.3762208306864494e-11
the O 0 1.4644662219009952e-11
population O 0 3.4528423956819987e-13
. O 0 3.1682920176301366e-11

In O 0 3.214271557250292e-11
a O 0 6.6342387312900986e-12
survey O 0 3.200274767412026e-11
of O 0 3.6544940684724025e-11
DM B-Disease 1 1.0
in O 0 3.5642336304597677e-10
Northern O 0 7.931516421422202e-08
Ireland O 0 1.525095938426091e-09
, O 0 5.404469731982997e-13
59 O 0 1.1303284974673034e-09
pedigrees O 0 8.702875753385797e-09
were O 0 3.1907804176611876e-10
ascertained O 0 1.1932101529055217e-07
. O 0 4.658313734751118e-09

Sibships O 0 4.086712942807935e-05
where O 0 6.408156340634297e-13
the O 0 7.330369492832001e-14
status O 0 2.4544368273926587e-12
of O 0 1.603239676434276e-12
all O 0 5.323642731074746e-14
the O 0 7.861383934234731e-14
members O 0 5.826679504823077e-15
had O 0 1.489635509128312e-14
been O 0 6.7010462052852736e-15
identified O 0 8.76886996174775e-14
were O 0 3.772004749020598e-14
examined O 0 2.4748752309664e-13
to O 0 6.205071992251149e-15
determine O 0 8.890466487998516e-13
the O 0 1.853769010040987e-13
transmission O 0 1.0877734268888162e-08
of O 0 6.352739514992045e-12
the O 0 6.960958892632263e-11
DM B-Disease 1 1.0
expansion O 0 8.857867328515567e-09
from O 0 1.119030996338255e-11
affected O 0 2.3643663416006433e-11
parents O 0 9.011470362236748e-14
to O 0 5.555346764204994e-13
their O 0 1.0457468224700506e-11
offspring O 0 2.8277176156166206e-09
. O 0 1.8370081011909178e-09

Where O 0 3.869164103692535e-12
the O 0 1.0891288955774958e-12
transmitting O 0 2.8827138454090573e-09
parent O 0 3.511623066984604e-12
was O 0 2.276578925375361e-11
male O 0 4.065656145080254e-10
, O 0 2.5180622561030153e-13
58 O 0 9.694141489546837e-09
. O 0 3.1068680073076393e-08

3 O 0 2.521882425110533e-10
% O 0 6.614156444761932e-10
of O 0 2.1980206283550574e-12
the O 0 3.5092108797811494e-13
offspring O 0 1.0709115018381343e-11
were O 0 1.0965620772518392e-12
affected O 0 1.3597517209418264e-12
, O 0 8.462740057335605e-16
and O 0 3.5217710887812685e-16
in O 0 3.994300753324374e-15
the O 0 2.128832490334593e-14
case O 0 6.226649309549505e-15
of O 0 9.502759907090153e-13
a O 0 2.500894673643228e-12
female O 0 1.9945051166203598e-10
transmitting O 0 1.0534895178437864e-09
parent O 0 4.751234995714615e-12
, O 0 1.9976973634344697e-12
68 O 0 1.1254245890768289e-07
. O 0 1.1197526816886239e-07

7 O 0 4.445155354915187e-09
% O 0 1.354349188353865e-09
were O 0 1.2794636877755394e-11
affected O 0 2.252105307798402e-10
. O 0 8.214120494898225e-10

Studies O 0 2.536034715561186e-10
on O 0 1.6295280012498803e-12
meiotic O 0 1.4168796802493944e-08
drive O 0 5.795773194705589e-09
in O 0 1.0823164413309438e-11
DM B-Disease 1 1.0
have O 0 1.7817595543510173e-13
shown O 0 1.514593029987299e-13
increased O 0 1.1423267930535386e-13
transmission O 0 6.933182760543444e-12
of O 0 5.5173680599577505e-15
the O 0 7.758207697962632e-16
larger O 0 4.850892043871966e-15
allele O 0 1.7921107035422795e-13
at O 0 2.8535737141288653e-12
the O 0 9.467287197251206e-12
DM B-Disease 1 0.999703586101532
locus O 0 4.841343992367797e-11
in O 0 1.8424347117407258e-11
non O 0 4.569925295072608e-06
- O 0 0.00027419705293141305
DM O 1 1.0
heterozygotes O 0 6.080551315790217e-07
for O 0 2.389373976452447e-10
CTGn O 0 1.3220113032730296e-05
. O 0 2.83327294958724e-09

This O 0 5.034662617364738e-11
study O 0 1.603542385680834e-12
provides O 0 2.3634157239778297e-14
further O 0 3.4396792495717827e-15
evidence O 0 4.5991690138377436e-14
that O 0 3.4227684485380874e-15
the O 0 4.783900706128996e-11
DM B-Disease 1 1.0
expansion O 0 5.807815739444777e-08
tends O 0 9.166956638217982e-10
to O 0 6.845958522294637e-11
be O 0 1.7315379685634014e-10
transmitted O 0 2.0062740802018197e-08
preferentially O 0 3.7059355584290188e-09
. O 0 3.2065838873052144e-09

Diagnosis O 1 1.0
of O 0 0.00040603376692160964
hemochromatosis B-Disease 1 1.0
. O 0 9.104793571168557e-05

If O 0 4.825145083486859e-07
untreated O 1 0.9999959468841553
, O 0 8.137502477412184e-11
hemochromatosis B-Disease 1 1.0
can O 0 1.2394607438181993e-06
cause O 0 0.1491566300392151
serious O 0 0.04974810406565666
illness O 1 0.9999978542327881
and O 0 1.2752839962434231e-13
early B-Disease 0 1.8223074091383573e-11
death I-Disease 0 2.0036502838827186e-12
, O 0 3.1471693384899557e-15
but O 0 2.1082398064857727e-15
the O 0 3.1885244770012144e-13
disease O 0 1.0371477114634597e-11
is O 0 1.296848629223394e-15
still O 0 1.044973535599316e-14
substantially O 0 3.1998355354279084e-11
under O 0 6.9811498804028815e-09
- O 0 0.00020622790907509625
diagnosed O 0 0.010741930454969406
. O 0 5.382129941722269e-08

The O 0 1.075987042520321e-11
cornerstone O 0 3.819900840085211e-09
of O 0 1.66827385239543e-11
screening O 0 2.899839569858731e-11
and O 0 1.928381465740505e-15
case O 0 8.192737188090864e-16
detection O 0 7.992641271048484e-12
is O 0 9.068909789266386e-17
the O 0 2.0989472197796826e-15
measurement O 0 1.1686125157839289e-11
of O 0 1.5002927285928669e-12
serum O 0 4.069715755800757e-13
transferrin O 0 2.659986987618712e-11
saturation O 0 1.8248960675926185e-10
and O 0 3.453863172027394e-13
the O 0 8.101229756474204e-12
serum O 0 1.5413634257832598e-10
ferritin O 0 5.81659254095257e-09
level O 0 1.023602713701166e-08
. O 0 9.814247192707626e-10

Once O 0 2.475530613832433e-10
the O 0 7.091991924279561e-13
diagnosis O 0 4.546727794263461e-08
is O 0 1.8354345075592172e-14
suspected O 0 3.8324510232001785e-10
, O 0 6.223592062711003e-13
physicians O 0 1.57187735050357e-11
must O 0 1.244694070035024e-10
use O 0 1.2316609954154956e-09
serum O 0 4.852695383306127e-07
ferritin O 0 2.2827171051176265e-05
levels O 0 1.289506371904281e-06
and O 0 9.924021326934707e-11
hepatic O 0 2.471777804657904e-07
iron O 0 1.4965382888476597e-07
stores O 0 1.0138109102220128e-10
on O 0 3.419877922516967e-11
liver O 0 1.782846925646453e-10
biopsy O 0 9.398639644331297e-10
specimens O 0 1.5947368208965584e-12
to O 0 1.1901342541684179e-12
assess O 0 2.407462007525396e-10
patients O 0 2.2680787369749877e-12
for O 0 1.3189243534134087e-13
the O 0 1.1336176788945274e-11
presence O 0 1.20728288477423e-10
of O 0 1.828542295356783e-08
iron B-Disease 0 1.0870457117562182e-05
overload I-Disease 0 5.0571601605042815e-05
. O 0 7.420322134521484e-08

Liver O 0 0.0009093783446587622
biopsy O 1 0.9997958540916443
is O 0 2.053553290956578e-12
also O 0 3.2120079635968187e-16
used O 0 1.3015502338278948e-14
to O 0 3.494583095120518e-13
establish O 0 2.1023223439886607e-10
the O 0 1.53298239987526e-12
presence O 0 2.351276996454682e-13
or O 0 9.421707121079481e-13
absence O 0 3.1842784409263913e-08
of O 0 5.607157849141231e-09
cirrhosis B-Disease 1 0.8150834441184998
, O 0 5.697344858260692e-14
which O 0 1.5687261941386456e-15
can O 0 1.80298620000921e-13
affect O 0 7.756115194545998e-10
prognosis O 0 4.672438365105336e-07
and O 0 1.6711973818694936e-11
management O 0 3.7745619962947785e-09
. O 0 4.165471523265296e-09

A O 0 4.840882555923187e-11
DNA O 0 4.99728348979378e-11
- O 0 2.2733007696337099e-13
based O 0 1.3786824410213225e-16
test O 0 2.2058552291075e-14
for O 0 3.1286396457358206e-15
the O 0 2.0618963893041797e-13
HFE O 0 5.922906325395161e-07
gene O 0 8.205851227465963e-14
is O 0 5.680076418740842e-16
commercially O 0 1.9846782637472637e-12
available O 0 1.7224767348122255e-13
, O 0 5.075472241924603e-16
but O 0 2.7910775874367543e-16
its O 0 2.6093824028058064e-16
place O 0 6.703247982728366e-14
in O 0 9.271771718444288e-15
the O 0 1.5916516151945337e-13
diagnosis O 0 1.6186203311008285e-07
of O 0 1.5239676187661644e-09
hemochromatosis B-Disease 1 1.0
is O 0 4.3324253906629195e-11
still O 0 2.0170988143664026e-11
being O 0 4.443294343570159e-11
evaluated O 0 1.3095625028824998e-08
. O 0 1.0924204651985292e-08

Currently O 0 8.249773780777403e-11
, O 0 9.514810034967017e-15
the O 0 1.5620063429548983e-14
most O 0 5.527814305538001e-16
useful O 0 5.500918730944049e-13
role O 0 6.679165141972032e-14
for O 0 8.025121332169618e-15
this O 0 2.534888226787043e-14
test O 0 1.660216560582517e-12
is O 0 9.05650274182258e-16
in O 0 1.3967610357914855e-15
the O 0 2.107440842658275e-14
detection O 0 1.6323115081817718e-09
of O 0 4.003354939219328e-11
hemochromatosis B-Disease 1 1.0
in O 0 2.5034572938981148e-12
the O 0 1.3348537769922175e-12
family O 0 2.15132450157203e-13
members O 0 5.516150619502662e-14
of O 0 3.724339846938873e-12
patients O 0 1.303939378347052e-12
with O 0 1.1031480125266255e-14
a O 0 1.1291588324080504e-12
proven O 0 1.8473699237020469e-09
case O 0 7.223377169844614e-13
of O 0 4.468152584036211e-11
the O 0 5.72781044816395e-10
disease O 0 1.7019591069811213e-08
. O 0 7.69832586566821e-10

It O 0 6.301808033737366e-13
is O 0 4.189316536902521e-14
crucial O 0 1.2325711118421623e-08
to O 0 7.884501940225164e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999996423721313
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 1.4812083115600672e-08
because O 0 1.3901558940446201e-12
phlebotomy O 0 1.9759096176130697e-05
therapy O 0 2.377240434725536e-06
can O 0 2.1977449374266378e-11
avert O 0 1.8342781515912066e-08
serious O 0 0.001473632757551968
chronic O 1 1.0
disease O 1 0.9045462608337402
and O 0 2.118236955197389e-14
can O 0 1.3887796349119214e-13
even O 0 4.0272435587089886e-14
lead O 0 6.722435108574842e-12
to O 0 1.0112900100667233e-11
normal O 0 4.0665753431312623e-08
life O 0 2.3935055326607113e-11
expectancy O 0 8.952521501903732e-10
. O 0 1.1738460680907337e-12
. O 0 2.0415892587610784e-10

Prevalence O 0 1.5010249398983433e-06
of O 0 8.935508583052254e-11
the O 0 4.585257867839587e-11
I1307K O 0 4.3067917232519903e-08
APC B-Disease 0 1.3918188823680566e-09
gene O 0 3.1489738659511157e-13
variant O 0 1.3841843253190045e-12
in O 0 2.9667518712962054e-14
Israeli O 0 4.731461333840059e-10
Jews O 0 6.380207126510662e-12
of O 0 3.5880125910311977e-13
differing O 0 3.4839710259001837e-15
ethnic O 0 7.922644745111951e-15
origin O 0 7.283166040747413e-14
and O 0 2.0162763806111893e-14
risk O 0 5.7484822457709583e-11
for O 0 7.204679075556442e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.8128135454608127e-05

BACKGROUND O 0 5.4352098231902346e-05
& O 0 1.2222563405828168e-08
AIMS O 0 2.0973541126068085e-08
Israeli O 0 9.328386063600647e-09
Jews O 0 5.092146704299694e-10
of O 0 1.0551218926346806e-10
European O 0 2.8259677584130394e-11
birth O 0 1.63410174280898e-10
, O 0 8.455117438436674e-14
i O 0 3.716795968222719e-12
. O 0 2.58498436414914e-13
e O 0 7.314353116238959e-13
. O 0 8.49264709663726e-14
, O 0 1.8935890792122663e-14
Ashkenazim O 0 4.682016996326865e-09
, O 0 1.6822594198941782e-15
have O 0 1.265541762097283e-15
the O 0 2.508168640228542e-13
highest O 0 1.220099329657387e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 2.586930349934846e-07
of O 0 1.070205521425116e-10
any O 0 2.8058254504526037e-12
Israeli O 0 3.297625639220314e-08
ethnic O 0 1.6666661384334702e-09
group O 0 3.888525352407912e-12
. O 0 4.6441792078688593e-10

The O 0 3.9922243288970094e-10
I1307K O 0 1.2938762061764919e-08
APC B-Disease 0 4.5251807856416804e-10
gene O 0 2.784435280001746e-13
variant O 0 2.8145102567989078e-11
was O 0 5.8214044695859e-11
found O 0 2.0696122766949987e-12
in O 0 2.298747997508954e-12
6 O 0 1.777147429216086e-09
. O 0 4.908509154688545e-09

1 O 0 8.502076126459812e-11
% O 0 2.528596498851954e-10
of O 0 1.95824411373946e-12
American O 0 9.712809576805162e-14
Jews O 0 7.305764608729615e-13
, O 0 3.6772648973756807e-16
28 O 0 2.004826697449974e-13
% O 0 2.737881969749889e-12
of O 0 8.904279765777068e-13
their O 0 6.908138949768272e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 2.5883641896484733e-09
, O 0 1.1154832686341952e-14
but O 0 2.1597175985804424e-15
not O 0 6.8074030502743126e-15
in O 0 1.0272208431083563e-12
non O 0 1.6882312436905522e-08
- O 0 1.9267401007994067e-09
Jews O 0 2.46134135295506e-09
. O 0 1.4652507651646829e-08

We O 0 6.137804708927774e-10
assessed O 0 4.234224970645073e-09
the O 0 1.0032885633393107e-10
I1307K O 0 1.621981340349521e-07
prevalence O 0 2.7590095139085058e-11
in O 0 3.6225748916472267e-16
Israeli O 0 2.2149651904279644e-11
Jews O 0 4.353346676200243e-12
of O 0 6.094376305693094e-13
differing O 0 7.837515392814052e-15
ethnic O 0 4.047944027500347e-14
origin O 0 5.396342552498046e-13
and O 0 2.9658242008123725e-14
risk O 0 4.2535339833671415e-11
for O 0 1.5484044268987418e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00015409190382342786

METHODS O 0 1.8937321044631972e-08
DNA O 0 1.674453464772796e-09
samples O 0 6.992746659495452e-12
from O 0 1.2584855033082043e-13
500 O 0 7.701574837939984e-13
unrelated O 0 2.6317715368096017e-11
Jews O 0 1.3174503155077844e-10
of O 0 1.328017029678108e-09
European O 0 1.345887290504777e-09
or O 0 6.168738436729271e-11
non O 0 2.4296806344636934e-08
- O 0 2.1947790806997602e-11
European O 0 1.1815281825838797e-12
origin O 0 1.1009677544637775e-11
, O 0 1.3277039219095e-15
with O 0 6.322551041582127e-17
or O 0 4.390095532653786e-15
without O 0 1.332894162880613e-13
a O 0 8.453842823257646e-14
personal O 0 1.5404554021269945e-10
and O 0 5.027002251967172e-12
/ O 0 1.3734707238199917e-07
or O 0 3.977682072608957e-11
family O 0 1.5528939896133909e-12
history O 0 2.1876490202688004e-11
of O 0 3.5072988350398626e-12
neoplasia B-Disease 0 2.000849208538824e-10
, O 0 4.811361016223608e-15
were O 0 6.050592833836341e-14
examined O 0 9.921399639345463e-13
for O 0 2.5063979347929657e-14
the O 0 2.1519895240795783e-13
I1307K O 0 1.2755334115321926e-11
variant O 0 4.6502566202052606e-15
by O 0 1.1241794806179472e-16
the O 0 2.1503798226666163e-14
allele O 0 1.7893313783781672e-12
- O 0 4.692261661685959e-13
specific O 0 1.584566625047884e-13
oligonucleotide O 0 1.341164512780324e-09
( O 0 2.7112941882942443e-13
ASO O 0 0.057457875460386276
) O 0 4.36286037408095e-14
method O 0 8.968792375441126e-10
. O 0 2.636676710299213e-10

RESULTS O 0 8.911722915172504e-09
In O 0 5.1480603634190825e-12
persons O 0 3.335779222291002e-11
at O 0 7.914240009870843e-13
average O 0 1.644364657459041e-12
risk O 0 4.7544797959764296e-12
for O 0 2.891550887618166e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.720425551494543e-10
I1307K O 0 7.694340098396424e-08
was O 0 1.5901209168833752e-11
found O 0 5.465069044009729e-13
in O 0 3.381591881512769e-13
5 O 0 6.730058871307065e-11
. O 0 5.207686504249409e-10

0 O 0 3.6797793978582405e-11
% O 0 1.0730363819710931e-10
of O 0 2.8230464840794944e-12
120 O 0 8.851913646523712e-11
European O 0 2.142487021128403e-10
and O 0 2.337658712436852e-11
1 O 0 9.642648901575512e-10
. O 0 2.557828171489973e-09

6 O 0 5.674159475610452e-10
% O 0 1.0592353383298558e-10
of O 0 2.222310443306119e-12
188 O 0 3.573093904085667e-11
non O 0 4.731439418037553e-08
- O 0 5.03363084547459e-09
European O 0 6.344680891778864e-10
Jews O 0 1.8069014728894217e-08
( O 0 9.593964078041806e-13
P O 0 5.3418118817205595e-09
= O 0 1.7078479472645847e-12
0 O 0 2.753469483397341e-14
. O 0 1.0815635801515126e-14
08 O 0 1.4061161089651275e-12
) O 0 2.241515655000085e-14
. O 0 2.3821920130950858e-11

It O 0 6.864678964157989e-12
occurred O 0 9.430278780087065e-10
in O 0 6.20053487720984e-13
15 O 0 6.190933876659699e-11
. O 0 6.935993446255395e-10

4 O 0 7.3157979674221e-11
% O 0 2.6502028002695077e-11
of O 0 5.913996506054509e-13
52 O 0 2.6427776633752842e-11
Ashkenazi O 0 1.0056672827829516e-08
Israelis O 0 1.0027435564552434e-05
with O 0 2.794446896103864e-10
familial O 1 0.9994211196899414
cancer B-Disease 1 0.8823446035385132
( O 0 2.3608500137467514e-12
P O 0 7.54546704229142e-07
= O 0 3.204238957499328e-11
0 O 0 2.3405116820335303e-13
. O 0 1.326158150308232e-14
02 O 0 1.3309056547811116e-12
) O 0 9.381770672757623e-17
and O 0 4.483362330475957e-16
was O 0 3.631794030008878e-14
not O 0 6.311593161631955e-15
detected O 0 4.0837973736169986e-13
in O 0 1.456763854511267e-14
51 O 0 6.289590376296061e-11
non O 0 2.5862818553434863e-09
- O 0 1.52944726328208e-10
European O 0 2.095060062934362e-11
Jews O 0 5.432381766645733e-10
at O 0 2.0862284122458163e-10
increased O 0 4.382827989424243e-10
cancer B-Disease 0 7.366699472655114e-10
risk O 0 7.60058405102626e-11
. O 0 1.6790525636523057e-09

Colorectal B-Disease 1 0.9999614953994751
neoplasia I-Disease 0 0.16111184656620026
occurred O 0 3.113747152383439e-05
personally O 0 1.4850952467782008e-08
or O 0 1.234519105865195e-12
in O 0 4.056151776759241e-14
the O 0 1.2796357127132368e-13
families O 0 1.0195745072869022e-13
of O 0 3.4324559253923193e-12
13 O 0 1.140334424110101e-10
of O 0 1.7825790843417622e-09
20 O 0 2.6943287601000065e-09
Ashkenazi O 0 5.8116942369679236e-08
I1307K O 0 1.2894318501821544e-08
carriers O 0 7.756162248920284e-13
, O 0 1.04898737062647e-14
8 O 0 1.0279421628137109e-12
of O 0 1.1545661128542495e-11
whom O 0 1.5444917567108973e-10
also O 0 9.076126352217107e-13
had O 0 7.33654543366713e-12
a O 0 1.8600886889791335e-12
personal O 0 1.317428388603048e-09
or O 0 4.69493437182944e-11
family O 0 9.447660535844005e-12
history O 0 5.176402639861521e-10
of O 0 1.6641377165171889e-09
noncolonic O 0 1.7635021549722296e-06
neoplasia B-Disease 0 2.057062192761805e-05
. O 0 1.9210246193779312e-07

CONCLUSIONS O 0 2.4912498020057683e-07
The O 0 3.225026079523019e-10
I1307K O 0 8.77774795071673e-08
APC O 0 2.946699551031884e-09
variant O 0 1.2611618693814108e-10
may O 0 2.5487418165576203e-12
represent O 0 1.7301471019748327e-11
a O 0 3.0861861677333735e-11
susceptibility O 0 7.127994861022557e-10
gene O 0 1.055016577572454e-11
for O 0 4.958198296378669e-10
colorectal B-Disease 1 1.0
, I-Disease 0 1.710732666637682e-09
or I-Disease 0 2.006455557257425e-10
other I-Disease 0 1.455299769581586e-11
, I-Disease 0 1.1291437619978528e-12
cancers I-Disease 0 2.0057274241480627e-07
in O 0 1.6348873643767803e-10
Ashkenazi O 0 1.271435650096464e-07
Jews O 0 5.459888652303846e-10
, O 0 4.666628411822971e-13
and O 0 2.69333681876191e-13
partially O 0 1.8282894642673853e-10
explains O 0 2.6058365534820105e-12
the O 0 1.7201629660609785e-12
higher O 0 3.5575029033729777e-10
incidence O 0 5.047487050546806e-08
of O 0 2.3247503122547641e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.6283653314630442e-09
European O 0 1.2363229884293503e-10
Israelis O 0 2.4384468133575865e-07
. O 0 3.6673737380255034e-09

Systematic O 0 3.025454886618206e-11
analysis O 0 2.1018310789738814e-12
of O 0 3.865025920840592e-12
coproporphyrinogen O 0 5.104654920984331e-09
oxidase O 0 2.2260044918454014e-09
gene O 0 5.297207117394009e-10
defects O 0 1.6341725768143078e-06
in O 0 4.286265439801262e-11
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
and O 0 5.305235140085074e-10
mutation O 0 5.949327142040772e-10
update O 0 1.8263813572616527e-08
. O 0 1.3891189309944707e-09

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
( O 0 3.245707739032988e-12
HC B-Disease 1 0.9999773502349854
) O 0 1.4671222570150633e-11
is O 0 5.462757850238642e-12
an O 0 2.1044034570483205e-11
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.09054398536682129
autosomal O 1 1.0
dominant O 1 0.999806821346283
inheritance O 0 1.8895612186042854e-08
caused O 0 3.030011658244902e-11
by O 0 1.354578223270982e-14
deficient B-Disease 0 4.033496203703635e-09
activity I-Disease 0 3.9068989710067115e-10
of I-Disease 0 9.980132692488652e-11
coproporphyrinogen I-Disease 0 2.965554246614488e-09
III I-Disease 0 5.340500663919556e-08
oxidase I-Disease 0 3.966257530740869e-11
( O 0 1.235892085286322e-13
CPO O 0 5.4054085651955575e-09
) O 0 6.077695313168319e-13
. O 0 1.6734694185949195e-10

Clinical O 0 3.6481276310951216e-07
manifestations O 0 6.378491548275633e-07
of O 0 4.475347203936053e-09
the O 0 5.453477114336636e-10
disease O 0 3.219207789229017e-09
are O 0 5.742713975794705e-16
characterized O 0 7.129527139016281e-15
by O 0 2.507190418818417e-15
acute O 0 5.793725676994654e-07
attacks O 0 5.430385030535945e-09
of O 1 0.9999997615814209
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 4.890470806095948e-10
precipitated O 0 2.626160400254207e-11
by O 0 5.343151170399433e-15
drugs O 0 1.8368652952849285e-12
, O 0 7.321688421562181e-15
fasting O 0 4.3937423144235765e-10
, O 0 5.985135889501059e-13
cyclical O 0 4.385846963383955e-10
hormonal O 0 1.8051438122057561e-09
changes O 0 1.6635996399894104e-11
, O 0 1.0759932007886608e-11
or O 0 2.3308322383286395e-08
infectious B-Disease 0 1.1956368553001084e-06
diseases I-Disease 0 6.048151846016481e-08
. O 0 3.179063901015411e-09

Skin O 1 1.0
photosensitivity O 1 0.9999957084655762
may O 0 5.47808332029831e-09
also O 0 1.6715600258121466e-12
be O 0 2.569873784261101e-12
present O 0 3.254923552908906e-10
. O 0 3.0840472398097063e-09

The O 0 1.571306307290854e-09
seven O 0 1.1278001865733245e-09
exons O 0 2.471106652635058e-09
, O 0 4.6638670844149216e-14
the O 0 9.341079342320424e-13
exon O 0 5.1428611369530586e-11
/ O 0 1.5020351629146944e-10
intron O 0 6.238017324911027e-10
boundaries O 0 9.512941823164311e-11
and O 0 1.1099996112149887e-13
part O 0 2.1227417393299142e-11
of O 0 3.3095440277186583e-10
3 O 0 2.1337506414531582e-11
noncoding O 0 2.3451054431689045e-09
sequence O 0 1.7573560662231813e-11
of O 0 9.395713373994141e-11
the O 0 2.4739620074765156e-11
CPO O 0 2.836711976428319e-09
gene O 0 4.6971036408256436e-14
were O 0 1.314010966008139e-12
systematically O 0 3.294601137043829e-12
analyzed O 0 7.457772734868057e-14
by O 0 3.6830347799332586e-16
an O 0 3.111405701632748e-15
exon O 0 1.4068753757465191e-12
- O 0 2.2541517263885424e-13
by O 0 3.0078451665124795e-13
- O 0 1.0645301307121713e-09
exon O 0 2.043490376912871e-10
denaturing O 0 3.782722757250667e-08
gradient O 0 6.948702030440401e-11
gel O 0 2.058669346105546e-10
electrophoresis O 0 3.512370116975916e-10
( O 0 2.6678481743636767e-14
DGGE O 0 5.389605576056056e-06
) O 0 2.3797337713550365e-16
strategy O 0 1.2435531933623761e-13
followed O 0 7.197209306666636e-16
by O 0 7.649466865508656e-18
direct O 0 4.471402564073905e-14
sequencing O 0 7.127733125944502e-11
in O 0 7.428857333978411e-13
seven O 0 2.6694861599008135e-11
unrelated O 0 1.8314237626437802e-10
heterozygous O 0 1.1515140230233811e-10
HC B-Disease 0 6.459392898250371e-05
patients O 0 8.60755644538358e-09
from O 0 6.901656468549788e-10
France O 0 1.0197924726895735e-09
, O 0 9.511245957494197e-13
Holland O 0 1.0337256745041046e-10
, O 0 5.622962151777787e-14
and O 0 5.6405462169496073e-14
Czech O 0 7.815743607864079e-09
Republic O 0 8.986248190012702e-08
. O 0 5.1999698769122915e-08

Seven O 0 1.9274229434707024e-10
novel O 0 1.5281240086251896e-13
mutations O 0 6.708341564534703e-13
and O 0 3.0722488507888392e-15
two O 0 3.4363889500881734e-14
new O 0 6.440502428248229e-14
polymorphisms O 0 4.768898609341932e-10
were O 0 2.936705045808452e-10
detected O 0 1.3610700122512753e-08
. O 0 3.659205827233336e-09

Among O 0 1.273652294742078e-10
these O 0 2.3121244502322114e-12
mutations O 0 1.1571631673701344e-11
two O 0 9.027525363532185e-13
are O 0 5.748607427753794e-13
missense O 0 1.2892670042674581e-08
( O 0 4.228157754471162e-12
G197W O 0 4.4669155840892927e-07
, O 0 2.2798588104194772e-12
W427R O 0 2.893208872478681e-08
) O 0 1.261797605419876e-13
, O 0 3.697594598670202e-14
two O 0 6.537513043934629e-13
are O 0 1.5588083124642993e-12
nonsense O 0 8.721041666603924e-08
( O 0 1.1871439161564856e-12
Q306X O 0 6.744203062680754e-08
, O 0 9.050818363005864e-13
Q385X O 0 8.070119683623034e-09
) O 0 1.7821496977265226e-14
, O 0 1.4915291359851937e-14
two O 0 1.4646210676552696e-13
are O 0 5.5489582384288944e-14
small O 0 3.633375609927991e-13
deletions O 0 2.0214779503091584e-11
( O 0 3.595231005807699e-14
662de14bp O 0 1.821569006743573e-09
; O 0 1.500835724145902e-13
1168del3bp O 0 4.189063318449371e-09
removing O 0 8.913044191594111e-10
a O 0 5.6225097494477794e-11
glycine O 0 2.7670107871635707e-10
at O 0 8.301150739020713e-11
position O 0 2.2515845091164444e-11
390 O 0 8.31231611320149e-12
) O 0 5.394533141891945e-16
, O 0 1.3285188999536567e-16
and O 0 1.5145908626417452e-16
one O 0 1.4729232737932768e-15
is O 0 7.48659401028023e-17
a O 0 7.917538830505902e-15
splicing O 0 3.650110595720957e-12
mutation O 0 2.6121850993029994e-13
( O 0 2.3338758311071623e-15
IVS1 O 0 2.6499699856685766e-07
- O 0 3.2608329925132296e-10
15c O 0 1.1094880569828547e-08
- O 0 7.32679195092345e-10
- O 0 1.3351836303243658e-10
> O 0 4.259092644537388e-12
g O 0 3.013672753189589e-14
) O 0 5.607820008477518e-17
which O 0 7.442032136320773e-17
creates O 0 1.7576341290132598e-15
a O 0 2.8422764409939813e-15
new O 0 1.1178730026882838e-14
acceptor O 0 7.662376844130847e-10
splice O 0 3.7453656887009856e-07
site O 0 9.520830346332332e-09
. O 0 4.986976609444582e-09

The O 0 8.127672423974275e-10
pathological O 0 6.342723679608753e-09
significance O 0 3.9531558582162063e-10
of O 0 1.5067984360239706e-10
the O 0 7.844545152346782e-11
point O 0 1.1653572551395541e-09
mutations O 0 8.66359501500158e-12
G197W O 0 3.229675193949788e-09
, O 0 3.5241685329527594e-13
W427R O 0 1.0325561738966371e-08
, O 0 2.1547113797522853e-14
and O 0 2.3419561019074947e-15
the O 0 4.798764467392469e-13
in O 0 1.3662014228255082e-12
- O 0 1.2061981621847018e-11
frame O 0 1.096613355677789e-10
deletion O 0 2.737596087321048e-11
390delGly O 0 1.0674614664418769e-10
were O 0 5.932360417520207e-15
assessed O 0 7.24832266283575e-15
by O 0 7.977098216889884e-18
their O 0 1.0028235667813423e-14
respective O 0 2.0067492806363774e-11
expression O 0 6.137651557781496e-14
in O 0 6.8294597882208145e-15
a O 0 1.853791956163528e-15
prokaryotic O 0 2.5761161866894033e-12
system O 0 1.2991656361815984e-12
using O 0 2.482534306163381e-13
site O 0 1.4194093816977116e-11
- O 0 6.797561645510708e-13
directed O 0 1.3491487929010587e-13
mutagenesis O 0 3.437769890979325e-08
. O 0 5.981986461733868e-09

These O 0 2.4883996772862016e-12
mutations O 0 4.579022165780711e-13
resulted O 0 5.433917747189876e-13
in O 0 1.0167289678632372e-14
the O 0 3.1953739242258916e-13
absence O 0 4.465369185524537e-10
or O 0 1.860078063797843e-12
a O 0 9.67790192603346e-13
dramatic O 0 1.6043326389603152e-11
decrease O 0 1.2803853532972198e-09
of O 0 1.3388055108976005e-09
CPO O 0 4.1304147657683643e-07
activity O 0 1.732319176994679e-08
. O 0 1.2498619916812004e-09

The O 0 1.608558841681429e-10
two O 0 2.078588386481006e-12
polymorphisms O 0 2.8991094247476923e-11
were O 0 1.221340303197982e-12
localized O 0 6.652155822711725e-12
in O 0 2.1387031685568547e-13
noncoding O 0 1.046452147157595e-09
part O 0 2.5379932530600335e-11
of O 0 8.658432304464725e-10
the O 0 4.051131999305291e-11
gene O 0 8.8390895012949e-15
1 O 0 7.775399248066694e-14
) O 0 1.7265535255631841e-15
a O 0 6.641248965696955e-13
C O 0 5.653903456526166e-10
/ O 0 3.640093781953624e-11
G O 0 1.299000230298164e-11
polymorphism O 0 6.163140831016989e-11
in O 0 3.9455567177153206e-13
the O 0 9.481418254686513e-12
promotor O 0 1.209593506246165e-06
region O 0 1.1161054302988305e-09
, O 0 6.989672512655587e-14
142 O 0 5.7588305651945504e-11
bp O 0 3.851340080185395e-11
upstream O 0 2.213757128999294e-11
from O 0 1.9351667078677803e-13
the O 0 5.383718102401625e-13
transcriptional O 0 1.2929293052854618e-11
initiation O 0 1.867652144049714e-10
site O 0 1.839137869774632e-11
( O 0 6.067508335902893e-15
- O 0 1.4138439030642047e-10
142C O 0 7.190963824399432e-09
/ O 0 1.319365797169958e-11
G O 0 3.7819213906387095e-12
) O 0 1.0111277930929287e-15
, O 0 1.3962709213523805e-15
and O 0 4.867088902010244e-16
2 O 0 9.172706133065214e-15
) O 0 2.3959107771586135e-16
a O 0 3.448312463480083e-14
6 O 0 1.3446067989499738e-13
bp O 0 2.7065199040277044e-13
deletion O 0 4.418797142427544e-13
polymorphism O 0 4.4088590417379336e-11
in O 0 2.1191282235932807e-12
the O 0 3.143778423350674e-12
3 O 0 2.109803868069471e-12
noncoding O 0 1.0977313502635866e-09
part O 0 1.9696400760382815e-11
of O 0 1.3806235321656146e-10
the O 0 8.758519604024073e-11
CPO O 0 2.4672932141811543e-08
gene O 0 6.564377405364474e-13
, O 0 8.060776167644751e-14
574 O 0 1.1838324764923414e-10
bp O 0 1.3729862732847486e-11
downstream O 0 2.7640605082535075e-11
of O 0 1.1307794978154817e-12
the O 0 1.3584703566042744e-13
last O 0 2.3922159283866484e-13
base O 0 9.310259160844048e-12
of O 0 1.511301392191633e-12
the O 0 8.269820375370052e-13
normal O 0 1.2310198416187745e-09
termination O 0 1.4234903533694165e-10
codon O 0 1.5434639677458506e-10
( O 0 1.4018219941238589e-14
+ O 0 3.36753819274449e-11
574 O 0 2.5086999144718902e-09
delATTCTT O 0 9.196947559075852e-08
) O 0 3.2819194410727004e-12
. O 0 5.931334867703697e-10

Five O 0 1.3306778612331982e-07
intragenic O 0 1.1459190318419132e-05
dimorphisms O 0 3.0692838208778994e-06
are O 0 3.724976869925317e-13
now O 0 4.630203962211962e-14
well O 0 4.671613031310973e-14
characterized O 0 2.0649032885042967e-13
and O 0 7.355954292410406e-15
the O 0 1.3845301858120274e-12
high O 0 3.733385996185223e-12
degree O 0 3.5907085638164915e-10
of O 0 7.295648807303934e-11
allelic O 0 2.3351776068381014e-10
heterogeneity O 0 1.6217129028550659e-10
in O 0 3.0296342691527034e-12
HC B-Disease 0 1.971903884623316e-06
is O 0 3.1567915057158225e-13
demonstrated O 0 8.386463398735167e-12
with O 0 3.406576990234848e-15
seven O 0 5.169091405452832e-14
new O 0 2.0966725657393904e-17
different O 0 7.271106843265265e-17
mutations O 0 1.1757370526283364e-16
making O 0 2.5914388568511713e-15
a O 0 1.2121442121793089e-14
total O 0 5.9607813476802995e-12
of O 0 2.220273617736801e-11
nineteen O 0 8.496038539362871e-09
CPO O 0 1.311989763053134e-06
gene B-Disease 0 1.2959335826678853e-08
defects I-Disease 0 2.658447328940383e-07
reported O 0 4.037894671404807e-11
so O 0 1.3316420448966637e-12
far O 0 4.580526496295034e-12
. O 0 3.638072048478547e-12
. O 0 3.0027999531334615e-10

Coincidence O 0 2.0678564638387797e-08
of O 0 4.887735702285845e-11
two O 0 1.5443774189181914e-13
novel O 0 4.305456612432347e-14
arylsulfatase O 0 1.413690942086987e-09
A O 0 7.28420518347761e-11
alleles O 0 5.8472372993848e-13
and O 0 3.1287860214994356e-13
mutation O 0 8.596382611823772e-13
459 O 0 2.853156079452024e-11
+ O 0 5.269142899777535e-10
1G O 0 3.695808103998388e-08
> O 0 4.2388367815782146e-10
A O 0 9.543364709596602e-11
within O 0 6.529765009949395e-12
a O 0 8.320433643287106e-13
family O 0 2.8461538681412435e-12
with O 0 2.366242965456955e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 4.0462767278469716e-14
molecular O 0 1.115828553144814e-13
basis O 0 9.501332012828989e-12
of O 0 7.070439286133157e-12
phenotypic O 0 5.67323965583455e-10
heterogeneity O 0 1.4780052737251026e-08
. O 0 3.805801540579523e-08

In O 0 2.2188978085480038e-11
a O 0 1.6473155305118947e-12
family O 0 4.328891642390621e-14
with O 0 4.0167758196677015e-16
three O 0 3.11814410283804e-14
siblings O 0 1.3092527279337518e-12
, O 0 9.041240266904242e-17
one O 0 1.2739157151022963e-16
developed O 0 6.227554957176709e-14
classical O 0 3.4980962571040664e-10
late O 0 0.002665408654138446
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.754454039328614e-11
MLD B-Disease 1 1.0
) O 0 7.709893379108379e-13
, O 0 1.443972132348422e-14
fatal O 0 5.306254741155314e-11
at O 0 5.496537686805469e-12
age O 0 2.409880671752629e-12
5 O 0 6.128854612404491e-14
years O 0 2.315272912354737e-14
, O 0 4.998443065701297e-16
with O 0 3.219762814926728e-15
deficient O 0 5.913576850424818e-10
arylsulfatase O 0 4.367694117490828e-08
A O 0 8.044627008985117e-08
( O 0 2.257977198228886e-13
ARSA O 0 5.896969241803163e-07
) O 0 1.0178543358369593e-14
activity O 0 8.544893959072652e-12
and O 0 6.022219601795574e-15
increased O 0 2.922486905254651e-12
galactosylsulfatide O 0 1.2092976620081686e-09
( O 0 7.954445072457308e-14
GS O 0 0.00019264586444478482
) O 0 2.2706151195373003e-12
excretion O 0 2.6633287242283643e-10
. O 0 1.436514102115538e-10

The O 0 6.906475946699686e-10
two O 0 3.2819194410727004e-12
other O 0 1.9769926527021114e-13
siblings O 0 1.5743167186554885e-11
, O 0 1.1966338530689565e-14
apparently O 0 1.2063304799525554e-09
healthy O 0 6.874361133668572e-06
at O 0 1.7664222085045367e-08
12 O 0 2.051968017724448e-08
( O 0 9.271038797775688e-13
1 O 0 2.3663659920458713e-10
/ O 0 8.3663576067039e-10
2 O 0 1.4941985366015431e-12
) O 0 7.295481222174133e-15
and O 0 1.426077375491549e-14
15 O 0 3.0898580135468867e-13
years O 0 1.3478343332921916e-13
, O 0 4.896475651324048e-16
respectively O 0 3.198221581231925e-13
, O 0 1.2227090000205276e-15
and O 0 1.1520999100209355e-15
their O 0 4.0969276040268843e-13
father O 0 3.356534494791674e-11
, O 0 4.405567978569419e-13
apparently O 0 8.718255561923627e-10
healthy O 0 3.952492499958993e-10
as O 0 2.0094042329035257e-14
well O 0 4.3466136045262546e-14
, O 0 3.9736318788619485e-15
presented O 0 1.1640343203223047e-11
ARSA O 0 2.0180407318548532e-06
and O 0 6.663723826211276e-12
GS O 1 0.9987831711769104
values O 0 1.2400135605827867e-11
within O 0 9.111789014276672e-13
the O 0 2.8625874863878395e-14
range O 0 1.8194378295643965e-12
of O 0 2.406606684768331e-11
MLD B-Disease 1 1.0
patients O 0 8.545982588259449e-09
. O 0 2.667259746402806e-09

Mutation O 0 3.086174371613737e-11
screening O 0 6.246535840664924e-12
and O 0 1.0470758713744012e-15
sequence O 0 8.36299006933515e-14
analysis O 0 6.219969607727457e-14
disclosed O 0 3.666263473367515e-12
the O 0 3.924749183959429e-14
involvement O 0 1.3363753680051271e-11
of O 0 1.097502123903471e-11
three O 0 3.927087604757573e-13
different O 0 1.0989034335273651e-11
ARSA O 0 7.270782225532457e-05
mutations O 0 5.284396184523921e-12
being O 0 4.584647480990016e-14
the O 0 1.3567296022537131e-14
molecular O 0 7.907883332533561e-14
basis O 0 5.3468725974559206e-11
of O 0 8.536296669525711e-11
intrafamilial O 0 4.0261733147417544e-07
phenotypic O 0 3.0325196576086455e-08
heterogeneity O 0 1.227785020319061e-07
. O 0 8.110923488402477e-08

The O 0 6.9889233289544e-11
late O 0 9.32479249371454e-09
infantile O 0 3.915148408850655e-05
patient O 0 6.927849405258257e-10
inherited O 0 4.6135717468587245e-09
from O 0 1.975072362603303e-11
his O 0 4.974227696408207e-09
mother O 0 9.286768021254943e-10
the O 0 2.9028016101939613e-10
frequent O 0 8.519770305914776e-11
0 O 0 1.432393786915398e-10
- O 0 1.3034746615403492e-08
type O 0 1.3813413524133011e-08
mutation O 0 1.4848020035707066e-10
459 O 0 9.904978226504824e-11
+ O 0 2.2294695603553016e-11
1G O 0 3.3503957941327656e-10
> O 0 2.2055378356977684e-12
A O 0 2.9353583366059643e-12
, O 0 9.05445993658182e-17
and O 0 3.5244706754283966e-17
from O 0 3.3967281146406484e-15
his O 0 1.0123510103127176e-12
father O 0 4.361600056818071e-12
a O 0 1.6806278862070007e-14
novel O 0 1.065002159032736e-15
, O 0 2.8754700607752114e-17
single O 0 3.2120604055241656e-14
basepair O 0 1.0109375836453438e-10
microdeletion O 0 2.880422123041626e-09
of O 0 1.7276384489672836e-10
guanine O 0 1.0874279948724919e-10
at O 0 6.962831006207537e-11
nucleotide O 0 3.983566601584165e-11
7 O 0 1.052885729990738e-11
in O 0 1.2982323549515229e-11
exon O 0 1.0215264745205843e-10
1 O 0 1.3823584204403216e-12
( O 0 9.075810307283827e-14
7delG O 0 1.188177112254607e-08
) O 0 1.8191359876795765e-12
. O 0 5.11406639258638e-10

The O 0 5.957898063790878e-11
two O 0 3.333996273502393e-12
clinically O 0 1.2948003131896257e-06
unaffected O 0 1.2740611898820475e-09
siblings O 0 3.2268439222743472e-12
carried O 0 4.8249398183417e-13
the O 0 1.5751419266130107e-12
maternal O 0 7.862943629532992e-10
mutation O 0 3.2489781264660733e-12
459 O 0 1.6031977828623312e-11
+ O 0 2.5301502559749167e-10
1G O 0 1.3857139435913268e-08
> O 0 1.7562680476590486e-10
A O 0 2.7829316628924516e-10
and O 0 2.225311067686163e-14
, O 0 4.356577644837545e-16
on O 0 1.7772819687852416e-14
their O 0 3.262605571992261e-14
paternal O 0 4.540392367635704e-12
allele O 0 1.934883676890653e-12
, O 0 1.4622749049759878e-15
a O 0 2.418178479248541e-15
novel O 0 5.273815170919564e-15
cytosine O 0 6.0233202973936084e-12
to O 0 7.629640192199916e-13
thymidine O 0 8.179272259489778e-10
transition O 0 6.34367980367756e-09
at O 0 1.8750513641752065e-10
nucleotide O 0 3.620182487118484e-10
2435 O 0 3.1829241464720326e-08
in O 0 1.174605898657255e-11
exon O 0 2.0082781271302252e-10
8 O 0 3.0126927428458794e-12
, O 0 2.5287059027116233e-15
resulting O 0 7.570434893116457e-14
in O 0 1.345016407142607e-14
substitution O 0 1.3302566513606617e-11
of O 0 2.006482341387894e-10
alanine O 0 3.947294435757698e-10
464 O 0 5.517203360838607e-10
by O 0 2.7594567256206126e-11
valine O 0 5.503427018993534e-06
( O 0 1.8916886286579615e-12
A464V O 0 2.6414664233698204e-08
) O 0 8.58386495564134e-13
. O 0 1.340429850449354e-10

The O 0 2.0626193808492843e-10
fathers O 0 3.2789507220520875e-10
genotype O 0 3.055221006742492e-11
thus O 0 6.7956469444740986e-12
was O 0 1.8180587590954644e-10
7delG O 0 1.5360785710072378e-06
/ O 0 8.396961561629723e-07
A464V O 0 1.2528457773441914e-06
. O 0 1.7068280122600754e-09

Mutation O 0 4.758835459028887e-08
A464V O 0 5.80143861839133e-08
was O 0 2.3548417989877057e-12
not O 0 4.381406668680851e-14
found O 0 3.223856863973987e-14
in O 0 7.991425514494895e-15
18 O 0 7.289844942970358e-12
unrelated O 0 7.381274702566998e-09
MLD B-Disease 1 1.0
patients O 0 1.3571057611017068e-09
and O 0 5.223854660472982e-13
50 O 0 2.519460418071162e-09
controls O 0 6.77345397548379e-08
. O 0 2.3607109156387196e-08

A464V O 0 3.4057752600347158e-06
, O 0 9.561065047319905e-13
although O 0 1.190908591360007e-12
clearly O 0 9.047922133742503e-12
modifying O 0 1.1692251611350457e-08
ARSA O 0 0.0007982160313986242
and O 0 8.360439562871136e-10
GS O 1 1.0
levels O 0 5.877036191037632e-09
, O 0 3.551664713198621e-14
apparently O 0 1.8932957632222802e-11
bears O 0 1.4025971356579348e-11
little O 0 1.2064662962239792e-13
significance O 0 1.6534349844138374e-12
for O 0 1.1786668104203646e-13
clinical O 0 8.76971967267437e-11
manifestation O 0 6.801246232868152e-09
of O 0 2.6047487722280493e-08
MLD B-Disease 1 1.0
, O 0 1.0352745744013347e-10
mimicking O 0 3.539615933689788e-09
the O 0 1.9881658819276282e-10
frequent O 0 5.304843675446591e-09
ARSA O 0 6.07911279075779e-05
pseudodeficiency O 0 1.7944124692803598e-06
allele O 0 5.071535369438607e-08
. O 0 6.031434462983043e-09

Our O 0 6.386450479567429e-09
results O 0 1.2230659193757099e-11
demonstrate O 0 4.5355649791467556e-11
that O 0 6.727090139072738e-16
in O 0 4.4374921082503474e-15
certain O 0 3.649781757202042e-13
genetic O 0 8.881860524834195e-12
conditions O 0 5.499636857031476e-10
MLD B-Disease 1 1.0
- O 0 1.1126953722850885e-06
like O 0 5.158934043847374e-11
ARSA O 0 0.2870538532733917
and O 0 4.0368319798034236e-11
GS O 1 1.0
values O 0 1.682606311226298e-11
need O 0 8.061329788379076e-14
not O 0 5.943274966441171e-16
be O 0 5.554683672932565e-15
paralleled O 0 2.7419021914054653e-11
by O 0 1.3088342936578082e-14
clinical O 0 2.754824979245285e-10
disease O 0 9.792621574744587e-12
, O 0 6.058762085447782e-16
a O 0 1.1818087436129329e-14
finding O 0 6.616029772643639e-12
with O 0 1.2538158445513092e-13
serious O 0 7.26815541085557e-09
diagnostic O 0 1.102991831203326e-07
and O 0 2.945696464529135e-11
prognostic O 0 8.814069474283315e-08
implications O 0 1.053893416980145e-09
. O 0 2.328334192114312e-09

Moreover O 0 1.2944937566317094e-07
, O 0 7.5383683670327e-12
further O 0 4.801637421003591e-10
ARSA O 0 0.0001396020088577643
alleles O 0 1.0355752921853423e-09
functionally O 0 1.510765379464374e-08
similar O 0 1.6591150111752717e-12
to O 0 9.196268746514136e-11
A464V O 0 1.3217385230746004e-07
might O 0 2.6850854439181004e-12
exist O 0 1.3069977392032861e-11
which O 0 3.156451337284205e-15
, O 0 7.835417927478413e-16
together O 0 3.1524411444987244e-13
with O 0 4.065849626378945e-14
0 O 0 3.03642770649315e-11
- O 0 2.0570611880543765e-09
type O 0 3.8651819522783626e-07
mutations O 0 3.641752144289967e-08
, O 0 1.3896204065916296e-12
may O 0 4.0007292617660895e-11
cause O 0 9.580510607065662e-08
pathological O 0 7.50854451325722e-06
ARSA O 0 0.0011407877318561077
and O 0 1.5824698496036405e-10
GS O 1 0.9999998807907104
levels O 0 8.915335830694815e-11
, O 0 5.208812168481375e-16
but O 0 2.800045813463605e-16
not O 0 1.474710936828457e-15
clinical O 0 1.581177029585934e-12
outbreak O 0 4.29851466920983e-14
of O 0 1.848335530853576e-13
the O 0 8.883113862545589e-12
disease O 0 8.727834427402215e-11
. O 0 4.645636306199741e-12
. O 0 1.1725700410636364e-09

Human O 0 0.0008691864204593003
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9908830523490906
to O 0 5.825633664358065e-08
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 7.42784889151693e-10
neurofibromatosis B-Disease 1 0.9999580383300781
type I-Disease 1 0.9997629523277283
1 I-Disease 0 3.6176661524223164e-05
. O 0 7.277813551809231e-08

Heterozygous O 0 3.0294076136527792e-09
germ O 0 1.412414185608668e-08
- O 0 2.5971605421837296e-10
line O 0 9.730472504132504e-12
mutations O 0 3.7655354501826485e-14
in O 0 1.4347416755090131e-15
the O 0 3.708082560623105e-14
DNA O 0 6.776346150871859e-09
mismatch O 0 0.002242466900497675
repair O 0 0.10250227153301239
genes O 0 2.1661962501529075e-10
lead O 0 4.819400989397593e-10
to O 0 1.8929944278767152e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.4615007987449644e-06

The O 0 2.7354626896958223e-10
disease O 0 4.954435750548214e-10
susceptibility O 0 1.46946066426068e-11
of O 0 1.2399267723672835e-10
individuals O 0 4.779105999830335e-10
who O 0 3.510824742036789e-09
constitutionally O 1 0.9999984502792358
lack O 1 0.9471457004547119
both O 0 2.594090046936781e-11
wild O 0 3.871334242760982e-12
- O 0 1.3635981449891532e-12
type O 0 2.940704320678056e-12
alleles O 0 7.282308436828977e-13
is O 0 2.2164324683330433e-14
unknown O 0 3.0764257807902595e-10
. O 0 3.046383423299659e-10

We O 0 1.9501417841683022e-11
have O 0 4.492009689834476e-15
identified O 0 4.578390279202059e-14
three O 0 1.3047285767317008e-15
offspring O 0 3.501655616942184e-13
in O 0 8.301117700670012e-15
a O 0 2.0040335710347357e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.1781922694353852e-05
who O 0 3.840212522976394e-11
developed O 0 3.150910643512361e-08
hematological B-Disease 1 0.9999997615814209
malignancy I-Disease 1 0.9999864101409912
at O 0 8.110281890516546e-10
a O 0 2.6853451645485193e-13
very O 0 7.183744870937082e-15
early O 0 1.893981065731465e-12
age O 0 9.829711697384447e-12
, O 0 3.909162507180529e-15
and O 0 3.216889890927878e-15
at O 0 4.96699361328401e-13
least O 0 2.584031723134022e-14
two O 0 6.4285701057136685e-15
of O 0 7.220728870513046e-14
them O 0 3.676046334601937e-15
displayed O 0 8.895627290339547e-12
signs O 0 2.5868120145933204e-11
of O 0 1.7619222747455865e-09
neurofibromatosis B-Disease 0 5.909433298256772e-07
type I-Disease 0 1.98907059711928e-08
1 I-Disease 0 3.97640226301732e-10
( O 0 1.8535934506042073e-12
NF1 B-Disease 0 2.0898154673432146e-07
) O 0 8.720725530597662e-12
. O 0 6.300195365405159e-10

DNA O 0 4.8256350304587414e-11
sequence O 0 1.5367758064363524e-13
analysis O 0 2.3130220070007035e-14
and O 0 2.2195692378010069e-16
allele O 0 4.905700411866887e-13
- O 0 2.211576259039845e-14
specific O 0 3.8439883193836996e-14
amplification O 0 1.4927372489134672e-12
in O 0 7.130968789092508e-15
two O 0 1.1977169202172927e-13
siblings O 0 3.4040249785594057e-11
revealed O 0 2.2855502213037227e-11
a O 0 1.9593948859253363e-12
homozygous O 0 1.112099232147834e-10
MLH1 O 0 1.6642594346194528e-05
mutation O 0 3.0339281087421455e-10
( O 0 2.1754509814658068e-13
C676T O 0 4.253131464793114e-07
- O 0 1.7937331904249731e-06
- O 0 4.275135552234133e-07
> O 0 7.052513240068947e-08
Arg226Stop O 0 1.3954585483588744e-05
) O 0 4.14659707395279e-13
. O 0 2.369594104267847e-11

Thus O 0 1.7720330758308478e-09
, O 0 1.4024217442724918e-13
a O 0 2.4091167429018956e-13
homozygous O 0 3.20957878330308e-11
germ O 0 3.09100940398821e-08
- O 0 2.845588431554802e-09
line O 0 1.411392780426013e-09
MLH1 O 1 0.9999854564666748
mutation O 0 3.1503140096589277e-09
and O 0 2.696708958568883e-13
consequent O 0 2.1914356693741865e-06
mismatch O 1 1.0
repair O 1 1.0
deficiency O 0 4.787733359989943e-06
results O 0 2.3466481535727723e-10
in O 0 1.8871154638944176e-12
a O 0 2.0512124984661817e-12
mutator O 0 2.5060133523879813e-08
phenotype O 0 2.3538953772272997e-11
characterized O 0 1.1658945191933296e-14
by O 0 4.362331380829566e-16
leukemia B-Disease 0 0.0012652188306674361
and O 0 9.949299197009598e-12
/ O 1 0.9999765157699585
or O 0 0.00017189198115374893
lymphoma B-Disease 1 1.0
associated O 1 1.0
with O 0 3.646603730089737e-08
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.8536952137947083
1 I-Disease 0 2.2443458647103398e-08
. O 0 7.087442438491465e-11
. O 0 4.2904554908851367e-10

Missense O 0 8.26090581540484e-06
mutations O 0 2.6029034483343594e-10
in O 0 7.479715089485361e-13
the O 0 2.4705172803340947e-13
most O 0 2.060989979347323e-15
ancient O 0 5.832704545044587e-12
residues O 0 2.890900296925736e-10
of O 0 1.4832671549336318e-11
the O 0 2.70066469187924e-11
PAX6 O 0 6.672921244899044e-06
paired O 0 8.738766932303577e-10
domain O 0 4.0910013154871194e-09
underlie O 0 7.467314766529398e-09
a O 0 3.9861617153781614e-13
spectrum O 0 5.697617377897757e-10
of O 0 7.632212639663294e-10
human O 1 0.9842479825019836
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.3398391902446747

Mutations O 0 3.1874063388670493e-09
of O 0 6.552963033312764e-11
the O 0 2.046929032523126e-12
human O 0 6.889627323508618e-12
PAX6 O 0 1.48595800055773e-05
gene O 0 7.656825729007721e-10
underlie O 1 0.7989518046379089
aniridia B-Disease 1 1.0
( O 0 6.299825550115656e-09
congenital B-Disease 1 1.0
absence I-Disease 1 0.999997615814209
of I-Disease 0 3.1630127068638103e-06
the I-Disease 0 2.753485495166075e-10
iris I-Disease 0 5.786246135008888e-11
) O 0 8.737382697779697e-14
, O 0 2.0083850828613893e-14
a O 0 8.268778999183379e-13
rare O 0 1.6495158572382707e-09
dominant O 1 0.9999978542327881
malformation B-Disease 1 1.0
of I-Disease 1 0.9685768485069275
the I-Disease 0 0.07048658281564713
eye I-Disease 1 0.9864059090614319
. O 0 1.9495148251280625e-07

The O 0 2.3015053751684889e-10
spectrum O 0 2.4585027347256982e-09
of O 0 7.774926258363735e-10
PAX6 O 0 0.00015049159992486238
mutations O 0 5.5550608557553005e-09
in O 0 5.075216913397185e-10
aniridia B-Disease 1 1.0
patients O 0 1.1156611634532965e-08
is O 0 9.502011536540594e-14
highly O 0 1.6077872540265492e-12
biased O 0 7.841194360480586e-11
, O 0 5.2524330947155504e-15
with O 0 3.9481706508026355e-16
92 O 0 1.708077707052169e-10
% O 0 5.982048884023428e-11
of O 0 4.0906891047264027e-13
all O 0 4.73968940809498e-14
reported O 0 1.596352824234648e-12
mutations O 0 3.924693469520291e-12
leading O 0 1.1499239060963617e-12
to O 0 5.599700390879203e-12
premature O 0 1.480905287287726e-09
truncation O 0 1.1446696817074553e-06
of O 0 2.2416886622522725e-06
the O 0 9.214382856725933e-08
protein O 0 3.583394692086017e-10
( O 0 1.5321838036600616e-13
nonsense O 0 9.73300662288068e-10
, O 0 1.1211699090288817e-14
splicing O 0 2.3550662288374102e-12
, O 0 1.4641623484923545e-14
insertions O 0 1.3214813791850855e-11
and O 0 2.33243972909674e-14
deletions O 0 1.0712950708827162e-12
) O 0 1.605436734421545e-16
and O 0 6.847903507130803e-15
just O 0 3.037513274760373e-13
2 O 0 4.104598673210398e-14
% O 0 3.6600708358189293e-13
leading O 0 1.40936552132134e-15
to O 0 3.3961950132794703e-16
substitution O 0 1.4180015668607826e-12
of O 0 2.7139771333062335e-11
one O 0 4.1677677476738284e-13
amino O 0 3.3766826140757544e-12
acid O 0 8.265510807259693e-14
by O 0 6.03525925050208e-15
another O 0 1.1088659287658564e-12
( O 0 3.03825331050573e-14
missense O 0 4.359602012726782e-09
) O 0 6.376820729445121e-13
. O 0 3.1135208300447914e-10

The O 0 4.945709466963599e-11
extraordinary O 0 1.4971033093780228e-11
conservation O 0 6.152727524515178e-13
of O 0 5.44023071762708e-14
the O 0 2.4340626085875283e-13
PAX6 O 0 2.1195252486450045e-07
protein O 0 1.8886514574489865e-10
at O 0 8.655006399072018e-12
the O 0 2.5058137856359686e-11
amino O 0 1.340963073914736e-08
acid O 0 2.6558073518145875e-09
level O 0 2.5566205863469804e-07
amongst O 0 1.589150144809537e-08
vertebrates O 0 1.9138779450145194e-08
predicts O 0 3.897288394782983e-11
that O 0 2.719966396211304e-12
pathological O 0 8.298709275322835e-08
missense O 0 6.40059852230479e-07
mutations O 0 1.0261825833524085e-09
should O 0 1.2772594613907895e-11
in O 0 7.696733007878098e-12
fact O 0 2.4822336894270158e-11
be O 0 8.249737698529103e-12
common O 0 4.465136940745573e-11
even O 0 3.9884279689691993e-13
though O 0 1.5232032215400926e-13
they O 0 8.424788237914108e-14
are O 0 7.71547878212521e-14
hardly O 0 2.0165651093417836e-10
ever O 0 6.271944075209035e-11
seen O 0 2.349621885944231e-10
in O 0 8.934405992810923e-10
aniridia B-Disease 1 1.0
patients O 0 6.07602942181984e-07
. O 0 1.945511840517611e-08

This O 0 2.4280313003222087e-12
indicates O 0 1.6327331847643123e-11
that O 0 8.354005908500978e-16
there O 0 3.911355051964497e-15
is O 0 1.3714176776607388e-16
a O 0 1.5433167303803216e-14
heavy O 0 1.7625860840309038e-11
ascertainment O 0 7.059456379465701e-07
bias O 0 4.946728443533388e-11
in O 0 3.156392722604255e-14
the O 0 3.321945312145108e-14
selection O 0 1.4731838795731256e-12
of O 0 1.5468663676354577e-12
patients O 0 3.020907905337128e-13
for O 0 2.0123662393574382e-13
PAX6 O 0 3.99969763975605e-08
mutation O 0 1.1130404323905774e-12
analysis O 0 4.071477855381589e-13
and O 0 2.306755741960211e-15
that O 0 1.501790580152177e-15
the O 0 1.2874042110144757e-12
missing O 0 2.4926046648943156e-07
PAX6 O 1 0.6194054484367371
missense O 0 3.207808913430199e-05
mutations O 0 3.984438379234234e-08
frequently O 0 4.478818357855907e-11
may O 0 3.520127939138362e-11
underlie O 0 8.470719592423848e-08
phenotypes O 0 4.206574200082969e-09
distinct O 0 6.264779493780903e-12
from O 0 5.139122634389981e-12
textbook O 0 2.6186866008970355e-08
aniridia B-Disease 1 1.0
. O 0 7.461252948814945e-08

Here O 0 2.2775672459118823e-09
we O 0 3.156486140173942e-12
present O 0 3.2962480401438343e-12
four O 0 1.9335765898565588e-13
novel O 0 1.779409546142155e-13
PAX6 O 0 1.6997312002331455e-07
missense O 0 1.585002884496589e-08
mutations O 0 1.5593384222745144e-11
, O 0 9.750782402643751e-15
two O 0 8.718998864099079e-15
in O 0 5.1668240676596214e-14
association O 0 1.7935982289229296e-13
with O 0 1.022581474249655e-13
atypical O 0 3.157761607752718e-09
phenotypes O 0 1.8065146045742608e-09
ectopia B-Disease 0 2.4935746978371753e-07
pupillae I-Disease 0 3.3872736366902245e-06
( O 0 3.6174229302125827e-13
displaced B-Disease 0 9.749691054494747e-10
pupils I-Disease 0 2.0797545019490826e-08
) O 0 4.489637481230879e-11
and O 0 2.2977094005227627e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 0 1.640779714762175e-06
( O 0 2.38616093030386e-12
searching B-Disease 0 9.650312193798527e-08
gaze I-Disease 0 8.733672451910479e-09
) O 0 2.045522056587628e-14
, O 0 4.987037343550044e-15
and O 0 3.063892447247702e-15
two O 0 2.872580103473188e-14
in O 0 5.096528464553808e-14
association O 0 3.216805822907863e-14
with O 0 1.9275291811889778e-14
more O 0 6.452654166197447e-13
recognizable O 0 1.0722171595034524e-08
aniridia B-Disease 1 1.0
phenotypes O 0 5.547884143197734e-07
. O 0 2.2714081282515508e-08

Strikingly O 0 4.848217471931093e-08
, O 0 7.766954397345205e-13
all O 0 2.3941786053693903e-13
four O 0 9.315120289704604e-13
mutations O 0 2.4492259891213675e-13
are O 0 9.322913873733608e-15
located O 0 7.322306416800498e-14
within O 0 1.6413878719742647e-12
the O 0 4.578177247027693e-12
PAX6 O 0 1.4926696394468308e-06
paired O 0 4.859368463172586e-10
domain O 0 3.2113824932622492e-09
and O 0 2.9318888896540107e-12
affect O 0 8.609839063922209e-09
amino O 0 8.39188107892852e-10
acids O 0 3.0706366269117602e-12
which O 0 2.2450830613123885e-15
are O 0 4.0645119495969937e-16
highly O 0 6.57066577796489e-13
conserved O 0 1.8463878429658687e-12
in O 0 2.9626930249382344e-13
all O 0 1.3031885683426059e-12
known O 0 5.150967326283951e-12
paired O 0 1.308255587195717e-10
domain O 0 7.433830218062099e-10
proteins O 0 5.546352960239531e-11
. O 0 1.0731658894869156e-09

Our O 0 2.5888282628727666e-09
results O 0 1.6583248663160077e-11
support O 0 1.5259490719621294e-12
the O 0 3.0898806462672374e-14
hypothesis O 0 1.1119187845855596e-14
that O 0 3.636511896487913e-19
the O 0 2.972003030876885e-17
under O 0 2.498698744115603e-14
- O 0 5.388515697014873e-13
representation O 0 1.3542141019673437e-10
of O 0 6.770671245881488e-10
missense O 0 5.251818038232159e-06
mutations O 0 6.903015492554232e-09
is O 0 1.7998044732087798e-13
caused O 0 2.9289322703296428e-12
by O 0 3.0607531483275996e-13
ascertainment O 0 7.877504685893655e-06
bias O 0 4.089969751763789e-10
and O 0 1.4231217387253997e-13
suggest O 0 1.91318792405748e-12
that O 0 2.67526965470137e-16
a O 0 3.8783715889984145e-15
substantial O 0 1.1324112220850724e-12
burden O 0 9.232847819617973e-10
of O 0 1.1236524599667064e-08
PAX6 B-Disease 1 0.9999995231628418
- I-Disease 0 0.02442362904548645
related I-Disease 1 0.9808195233345032
disease I-Disease 1 0.9988405108451843
remains O 0 1.0897035357393392e-10
to O 0 1.3888095317868276e-12
be O 0 2.851457134647739e-12
uncovered O 0 3.731370323833971e-09
. O 0 1.1198039023829764e-11
. O 0 4.0132194789599396e-10

The O 0 1.7108198191451152e-10
chromosomal O 0 3.980929008662315e-08
order O 0 6.78384909011398e-12
of O 0 2.0419516078007405e-10
genes O 0 2.759884543124258e-10
controlling O 0 1.2019581774325161e-08
the O 0 2.3248816205523326e-09
major O 0 3.9718108801878316e-09
histocompatibility O 0 4.688019714649272e-07
complex O 0 4.376049744791999e-08
, O 0 1.6132326594378577e-13
properdin O 0 7.475461916151005e-10
factor O 0 3.4338636534930744e-12
B O 0 3.3054827763834282e-09
, O 0 7.959116289754826e-15
and O 0 1.9903929172155818e-14
deficiency B-Disease 0 1.1633817109668598e-07
of I-Disease 0 6.031126531524933e-07
the I-Disease 0 6.058491486271578e-10
second I-Disease 0 8.452849087348113e-09
component I-Disease 0 6.4188609982807066e-09
of I-Disease 0 1.1317694559309643e-09
complement I-Disease 0 1.443090091868271e-08
. O 0 1.6539493330469668e-08

The O 0 8.287398545192559e-12
relationship O 0 1.878834414437147e-11
of O 0 2.8676724623394323e-12
the O 0 6.823525983612119e-14
genes O 0 2.697179273612846e-15
coding O 0 9.889451453928833e-13
for O 0 1.6735170446148008e-14
HLA O 0 5.861223312253472e-11
to O 0 8.814648365601876e-14
those O 0 6.975644545906224e-15
coding O 0 4.959614316457639e-11
for O 0 5.284692768028204e-14
properdin O 0 3.502488854500996e-10
Factor O 0 2.265752472793703e-12
B O 0 4.318811974712844e-11
allotypes O 0 4.788850982428983e-10
and O 0 1.4271160496431195e-15
for O 0 1.8429625975812346e-14
deficiency B-Disease 0 8.897944048236184e-10
of I-Disease 0 2.4933194398002456e-10
the I-Disease 0 3.279823244592417e-12
second I-Disease 0 5.64764901511694e-11
component I-Disease 0 4.0324013572679007e-10
of I-Disease 0 2.7627602983137933e-10
complement I-Disease 0 1.0986000997803558e-10
( O 0 3.312044174618063e-14
C2 O 0 5.576321626676872e-10
) O 0 6.518655447785952e-15
was O 0 1.5989787890014623e-13
studied O 0 5.610267499590697e-14
in O 0 1.3159953854796039e-15
families O 0 7.935140175149846e-14
of O 0 6.774484402269354e-13
patients O 0 2.0921398294349025e-12
with O 0 4.038510498238779e-11
connective O 1 0.7275881767272949
tissue O 1 1.0
disorders O 1 1.0
. O 0 7.5957195804221556e-06

Patients O 0 3.5325204983394087e-09
were O 0 1.7585455661106586e-12
selected O 0 1.0244697885158915e-12
because O 0 9.268730023130698e-15
they O 0 9.22083878029294e-15
were O 0 3.531543276130006e-13
heterozygous O 0 1.0578335950250928e-11
or O 0 5.819524983435853e-12
homozygous O 0 8.42874747775113e-09
for O 0 2.7394031576477573e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.0310043307981687e-06

12 O 0 9.92777526853672e-10
families O 0 1.998834257832538e-11
with O 0 1.8967600656349254e-13
15 O 0 8.67909563662117e-11
matings O 0 1.4799347809457686e-05
informative O 0 5.330578574103129e-07
for O 0 2.3974429552708898e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 9.958578850444155e-09
found O 0 7.098955451256828e-11
. O 0 3.3334784932392836e-10

Of O 0 2.200409198849229e-06
57 O 0 4.192145752313081e-06
informative O 0 2.0452439741802664e-07
meioses O 0 3.2790987347652845e-07
, O 0 3.2005878524733744e-14
two O 0 1.1156918081458092e-14
crossovers O 0 5.92388941719757e-12
were O 0 2.0603240251035326e-13
noted O 0 9.448912735143117e-14
between O 0 2.649490349337924e-11
the O 0 6.594030654838434e-09
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999940395355225
gene O 0 7.77277547880928e-14
and O 0 4.464301971580367e-15
the O 0 4.897398675832165e-13
HLA O 0 5.080931786416443e-10
- O 0 3.288891103903069e-10
B O 0 1.1657330656333897e-09
gene O 0 5.4841931675455886e-15
, O 0 7.008284431133077e-17
with O 0 2.4779675902322414e-18
a O 0 6.035943547244343e-17
recombinant O 0 1.9572551248465096e-15
fraction O 0 3.4781734783995155e-12
of O 0 2.121118905518138e-11
0 O 0 2.5115126991992476e-11
. O 0 9.108396814561104e-10

035 O 0 0.0001657044340390712
. O 0 1.267975022756218e-07

A O 0 3.281004357091888e-09
lod O 0 2.301455026554322e-08
score O 0 1.8266024803814673e-10
of O 0 1.110214611216298e-11
13 O 0 1.7933152792609652e-12
was O 0 1.1963857910000236e-13
calculated O 0 4.07804541004142e-13
for O 0 4.679320082454086e-13
linkage O 0 3.319333430340521e-08
between O 0 8.600783019119262e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.5966207305914693e-12
HLA O 0 1.752524347864437e-09
- O 0 4.2400011279752903e-10
B O 0 4.1858186361487526e-10
at O 0 1.6284707143963267e-13
a O 0 1.0745794149835526e-16
maximum O 0 7.917745824182387e-16
likelihood O 0 1.2488620951790698e-15
value O 0 2.1177846396035552e-14
of O 0 1.5967775536594557e-14
the O 0 3.154681673699154e-15
recombinant O 0 6.111388454218929e-15
fraction O 0 8.536732085118182e-12
of O 0 4.8409009439920325e-11
0 O 0 3.062858647262523e-11
. O 0 2.257327214039151e-09

04 O 0 1.7144893718068488e-05
. O 0 4.0813088730828895e-07

18 O 0 3.3063087823137494e-09
families O 0 1.7761391316040154e-11
with O 0 3.17069910908338e-14
21 O 0 1.00309292122569e-11
informative O 0 2.496649241512383e-11
matings O 0 1.5747747550420854e-09
for O 0 9.62778576481249e-13
both O 0 2.2868542129406144e-11
properdin O 0 2.0953113732957718e-07
Factor O 0 9.835797731838625e-10
B O 0 3.5423510791332546e-09
allotype O 0 5.932265789709845e-09
and O 0 7.961552966374852e-13
HLA O 0 2.1788034487713048e-08
- O 0 1.0725172971959296e-09
B O 0 2.1603754341015247e-09
were O 0 3.866640948396727e-12
found O 0 9.158171183215602e-13
. O 0 5.944692654802353e-12

Of O 0 1.2700993465841748e-06
72 O 0 5.560116278502392e-06
informative O 0 1.5995998126072664e-07
meioses O 0 9.75358744881305e-08
, O 0 4.27822179267269e-14
three O 0 3.696247816284068e-14
recombinants O 0 1.7109871297549262e-09
were O 0 3.4873072311814024e-12
found O 0 5.847795121402544e-13
, O 0 2.5316785648400123e-15
giving O 0 5.78300496140334e-14
a O 0 1.6167619407972053e-14
recombinant O 0 7.088935558355325e-13
fraction O 0 3.81698561646715e-10
of O 0 6.112665928981187e-09
0 O 0 1.371344038325617e-09
. O 0 1.511751257510241e-08

042 O 0 0.00022328240447677672
. O 0 1.862777025962714e-07

A O 0 1.9648627613833014e-08
lod O 0 1.2697320528332057e-07
score O 0 2.7233497679191032e-09
of O 0 1.3466903980852152e-10
16 O 0 9.59579898179852e-12
between O 0 7.694032043426002e-12
HLA O 0 7.673843227529176e-10
- O 0 7.31977603529721e-11
B O 0 3.610712770441005e-11
and O 0 1.5622706384102653e-15
Factor O 0 9.47468354315674e-14
B O 0 6.057988312380136e-12
allotypes O 0 1.2430423010356684e-11
was O 0 1.1486643443868721e-14
calculated O 0 1.0724311927867367e-13
at O 0 2.940359341099298e-14
a O 0 4.242706241177821e-16
maximum O 0 1.0945715498257916e-14
likelihood O 0 1.1133880140545491e-13
value O 0 1.8373091947593984e-13
of O 0 1.8957148947406494e-13
the O 0 3.2836258804245025e-14
recombinant O 0 4.369814175764729e-14
fraction O 0 1.702751828425164e-11
of O 0 6.484467823808515e-11
0 O 0 2.7375178512922815e-11
. O 0 1.3264372933363688e-09

04 O 0 2.0545097868307494e-05
. O 0 4.610653547842958e-07

A O 0 3.1547273682264176e-09
crossover O 0 1.2403240934322213e-10
was O 0 1.3802296978948636e-12
shown O 0 1.1640936695492266e-12
to O 0 2.3715914215099998e-12
have O 0 1.240762321445127e-13
occurred O 0 2.2798871124329878e-10
between O 0 2.532880155614592e-12
genes O 0 7.102100212184187e-14
for O 0 8.125315334841024e-14
Factor O 0 1.3959694945137047e-12
B O 0 1.2784903344331688e-11
and O 0 7.208334406802464e-13
HLA O 0 5.883518561233814e-09
- O 0 7.3080652640555854e-09
D O 0 2.1811796813153705e-10
, O 0 7.612856844213794e-15
in O 0 2.426254514884137e-15
which O 0 7.938613539629181e-16
HLA O 0 5.393199428715967e-11
- O 0 3.868095774239855e-11
D O 0 4.9443110196334406e-12
segregared O 0 3.523091818280477e-10
with O 0 2.1964550268654612e-14
HLA O 0 3.3265825649664293e-09
- O 0 3.261517167452155e-10
A O 0 4.770854822311321e-10
and O 0 1.301161191595221e-13
B O 0 9.229876418714866e-09
. O 0 3.761944922242577e-11

These O 0 4.192222523985434e-12
studies O 0 8.951244151282622e-13
suggest O 0 6.497072709476734e-14
that O 0 1.5223112701709476e-17
the O 0 2.2202732545290732e-15
genes O 0 4.840976591488112e-14
for O 0 2.408427461370738e-13
Factor O 0 6.359222481933102e-09
B O 0 0.009863113984465599
and O 0 6.7377045525063295e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.363998993925591e-11
located O 0 2.724805624187976e-12
outside O 0 8.007698237139094e-13
those O 0 1.7773971652660682e-14
for O 0 2.825943418074267e-13
HLA O 0 6.29810481544979e-10
, O 0 1.4011804513696085e-14
that O 0 5.510129845786107e-16
the O 0 2.532530087061887e-14
order O 0 5.260579840661583e-13
of O 0 3.804881409941174e-11
genese O 0 7.416045999519838e-09
is O 0 2.1611869466340444e-13
HLA O 0 4.5296102979541786e-10
- O 0 1.1903079910613457e-10
A O 0 1.3810350640852675e-09
, O 0 3.9156191852275646e-14
- O 0 1.524386845051795e-12
B O 0 4.768905062513262e-11
, O 0 1.3550692482705053e-14
- O 0 3.431755313948459e-12
D O 0 4.186524824728588e-12
, O 0 7.021962425044458e-16
Factor O 0 4.975036441839942e-12
B O 0 9.323440686159756e-09
allotype O 0 1.2886536751466338e-05
, O 0 2.807520049774581e-10
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 2.2713393886113773e-15
that O 0 5.445597151774436e-18
the O 0 4.771479316935086e-15
genes O 0 2.469067485189047e-12
coding O 0 1.7656898307905067e-06
for O 0 6.812921583332354e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.126434666711475e-10
Factor O 0 6.352285364386034e-10
B O 0 1.733482690724486e-08
allotypes O 0 1.99591898564222e-08
are O 0 9.17358027106678e-15
approximately O 0 8.9805804259031e-15
3 O 0 5.073009747740345e-14
- O 0 2.3644866446737023e-12
- O 0 1.101500726567728e-12
5 O 0 1.2544545751561748e-13
centimorgans O 0 9.008223611495225e-10
from O 0 2.1039318562083437e-13
the O 0 3.8633877455680754e-13
HLA O 0 1.874375515908966e-10
- O 0 1.18068853305342e-11
A O 0 4.204147099895472e-11
and O 0 1.218173375757206e-13
HLA O 0 8.244181337602186e-09
- O 0 1.1089368312511283e-10
B O 0 3.3584812014764154e-11
loci O 0 1.6408212679189238e-12
, O 0 4.120036415127391e-17
and O 0 1.4903799064977775e-18
that O 0 1.702300089765654e-19
the O 0 8.018594890371464e-17
apparent O 0 2.507260078807999e-13
lack O 0 4.91617753450857e-11
of O 0 3.037134085892568e-11
recombinants O 0 1.220164591586581e-08
between O 0 2.961519484506736e-12
the O 0 4.3054836497240234e-13
Factor O 0 1.6807874536617362e-11
B O 0 2.5793271518637084e-08
gene O 0 1.4910463974615595e-09
and O 0 2.2301665580926056e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.6589259480004337e-11
suggests O 0 5.998916370163893e-14
that O 0 4.989601100523146e-17
these O 0 2.180528298121974e-16
two O 0 8.265538081720595e-15
genes O 0 1.6421769543153997e-12
lie O 0 2.5268909187303734e-09
in O 0 1.0535206387829454e-11
close O 0 2.28414638314689e-08
proximity O 0 2.1374727765532953e-08
to O 0 1.5208743986416806e-10
one O 0 4.860515115390207e-11
another O 0 4.205304438009705e-10
. O 0 1.016227990646712e-08

Distribution O 0 2.921872743755216e-09
of O 0 1.0322248611416285e-09
emerin O 0 1.8777392369884183e-06
and O 0 1.16796182100809e-11
lamins O 0 5.471201347972965e-06
in O 0 2.090840521551396e-11
the O 0 3.9286965347606895e-10
heart O 0 3.367607348536694e-08
and O 0 2.2352078955095722e-12
implications O 0 6.09837961379478e-12
for O 0 1.010919733340776e-11
Emery B-Disease 1 0.7530854344367981
- I-Disease 1 1.0
Dreifuss I-Disease 1 0.9999973773956299
muscular I-Disease 1 0.9997568726539612
dystrophy I-Disease 1 0.9999229907989502
. O 0 1.1937728459088248e-06

Emerin O 0 0.07306086272001266
is O 0 7.876175406318353e-12
a O 0 9.871473213504678e-13
nuclear O 0 1.0956459073341307e-09
membrane O 0 4.4422882039540923e-10
protein O 0 7.951075214895909e-11
which O 0 8.393908465975826e-15
is O 0 9.988643653792862e-15
missing O 0 3.6701448546949678e-09
or O 0 1.648057905423439e-11
defective O 0 3.634561096532707e-09
in O 0 2.320112678366737e-11
Emery B-Disease 1 0.7872588038444519
- I-Disease 1 1.0
Dreifuss I-Disease 1 0.9999997615814209
muscular I-Disease 1 0.9996730089187622
dystrophy I-Disease 1 0.9999994039535522
( O 0 1.424579620934452e-10
EDMD B-Disease 1 1.0
) O 0 2.2682746306235124e-11
. O 0 1.241119290673609e-10

It O 0 2.4133524497392533e-13
is O 0 3.3588587538765664e-15
one O 0 4.521321264974211e-15
member O 0 1.7875089429464364e-13
of O 0 1.0304357193902103e-11
a O 0 1.4517621479970266e-11
family O 0 1.3396291888290168e-11
of O 0 1.1472506278309424e-09
lamina O 0 0.02224818989634514
- O 0 4.798411055162433e-07
associated O 0 4.0486263230832265e-09
proteins O 0 5.555487493646982e-12
which O 0 6.141770679003993e-15
includes O 0 3.863177511990567e-15
LAP1 O 0 1.4001635690874537e-06
, O 0 9.057047511062608e-14
LAP2 O 0 0.00017619474965613335
and O 0 8.004377716197553e-11
lamin O 0 1.7985362887884548e-07
B O 0 6.940751262618505e-08
receptor O 0 1.917825273589635e-11
( O 0 1.7263520257423948e-12
LBR O 0 9.762871400198492e-09
) O 0 1.5025435323029468e-12
. O 0 3.262014824922943e-10

A O 0 1.655242158449255e-06
panel O 0 2.919626207464887e-10
of O 0 6.016652454032823e-11
16 O 0 8.89995542541211e-12
monoclonal O 0 2.718419293921276e-13
antibodies O 0 1.9331487365742417e-13
( O 0 8.287196714181887e-15
mAbs O 0 4.451626844925727e-10
) O 0 1.487089158682276e-14
has O 0 2.547060100826999e-16
been O 0 5.697222377296519e-15
mapped O 0 7.276227688944592e-13
to O 0 9.211632379189233e-14
six O 0 3.7201630122794815e-13
specific O 0 1.142239650303925e-13
sites O 0 1.0155554782537157e-12
throughout O 0 4.808063669425877e-13
the O 0 6.761597710772463e-14
emerin O 0 1.5611924947256384e-11
molecule O 0 7.262937369307675e-15
using O 0 1.396408216922801e-13
phage O 0 2.7709702588030183e-11
- O 0 2.850875134921549e-12
displayed O 0 8.001576289572154e-13
peptide O 0 9.705555586644876e-13
libraries O 0 2.2997391751350404e-12
and O 0 8.943453277759049e-15
has O 0 2.0137607456974032e-16
been O 0 3.1713449293540143e-15
used O 0 1.7128316722857945e-13
to O 0 1.6198488383967202e-10
localize O 0 2.9276001441758126e-05
emerin O 0 3.3303538202744676e-06
in O 0 1.0145375858860994e-11
human O 0 1.0001322686692404e-10
and O 0 6.17516662804185e-11
rabbit O 0 3.1275529721597195e-08
heart O 0 2.1740241606948985e-07
. O 0 2.8367241000637478e-08

Several O 0 9.273523615682677e-11
mAbs O 0 5.799190461175385e-09
against O 0 1.9617881538008808e-12
different O 0 1.4497228070786683e-11
emerin O 0 8.049816102584373e-08
epitopes O 0 3.3472549176849498e-09
did O 0 1.0634656349983729e-11
not O 0 1.1455892658107647e-12
recognize O 0 1.1132452598650033e-10
intercalated O 0 2.9492145614540277e-08
discs O 0 4.413888987642167e-08
in O 0 1.935787901502506e-12
the O 0 1.1631621013585836e-11
heart O 0 1.2709060470683653e-09
, O 0 9.934252449524464e-14
though O 0 1.9777845268638405e-13
they O 0 1.7820791229413574e-13
recognized O 0 6.767904292548366e-11
cardiomyocyte O 0 2.2851534708934196e-07
nuclei O 0 2.555615807864342e-08
strongly O 0 2.154781492125224e-10
, O 0 1.654665337039174e-12
both O 0 5.976141803643031e-11
at O 0 2.0017054680465662e-09
the O 0 1.0768094194091304e-09
rim O 0 5.1608290974058946e-09
and O 0 6.952924022120277e-13
in O 0 1.2471602743591159e-11
intranuclear O 0 9.959929911929066e-07
spots O 0 8.319200617279421e-08
or O 0 1.0537823391665313e-10
channels O 0 7.287575876091523e-09
. O 0 1.620078404762637e-09

A O 0 7.277563440766244e-08
polyclonal O 0 4.5936417336633895e-08
rabbit O 0 1.2769489909914e-09
antiserum O 0 4.2410086109612166e-08
against O 0 1.5610018486156285e-11
emerin O 0 1.827050596148183e-06
did O 0 5.428650237671029e-11
recognize O 0 1.4057716102300333e-10
both O 0 1.2868278491395824e-11
nuclear O 0 2.7176472183754186e-09
membrane O 0 3.048090599366837e-11
and O 0 1.017066510492718e-14
intercalated O 0 1.787913046780165e-11
discs O 0 6.508456273923713e-11
but O 0 2.8155567866728444e-15
, O 0 8.737565058679285e-18
after O 0 3.2963795919838394e-16
affinity O 0 9.206955063254495e-15
purification O 0 1.473167074439452e-12
against O 0 2.5186180791230035e-14
a O 0 2.8902726566248926e-13
pure O 0 3.0788677163329226e-10
- O 0 3.451438579382682e-10
emerin O 0 1.5719935575475574e-08
band O 0 7.698718745841049e-11
on O 0 9.10605965631639e-12
a O 0 2.902332237389449e-13
western O 0 1.7287518638831045e-11
blot O 0 3.607365428592857e-08
, O 0 4.308356514430567e-14
it O 0 1.2863744527317079e-14
stained O 0 2.3466624199386388e-09
only O 0 7.005505116980393e-13
the O 0 1.749395767136619e-12
nuclear O 0 2.4140569543362744e-09
membrane O 0 2.3611912425280934e-09
. O 0 1.2310128472137194e-09

These O 0 7.077820534523438e-12
results O 0 4.38600978452941e-12
would O 0 2.034697551504122e-13
not O 0 2.7088323717363444e-14
be O 0 6.296854449536551e-14
expected O 0 3.1220647594976114e-11
if O 0 1.4297616909852984e-11
immunostaining O 0 3.2961056604108308e-06
at O 0 2.4294791178824937e-10
intercalated O 0 1.0650466286676874e-08
discs O 0 1.4216684718348915e-08
were O 0 4.8446116909794945e-12
due O 0 9.968090242118421e-11
to O 0 8.918489861550749e-13
a O 0 2.5588334077487895e-13
product O 0 1.422813776519316e-11
of O 0 1.2471126561997004e-11
the O 0 1.2459287074273462e-11
emerin O 0 4.5496253875398907e-08
gene O 0 1.468442880313281e-12
and O 0 4.492571137153234e-13
, O 0 5.679732417485138e-15
therefore O 0 2.1842946830614995e-13
, O 0 1.4273011263420945e-15
cast O 0 1.630619250736487e-12
some O 0 2.3942584805763164e-15
doubt O 0 1.556300878099992e-12
upon O 0 7.253253444909624e-13
the O 0 3.011904148395722e-13
hypothesis O 0 1.9616881036244038e-11
that O 0 6.783392749419581e-13
cardiac B-Disease 0 1.8498586769055692e-06
defects I-Disease 0 4.966096867065062e-07
in O 0 5.567830085873027e-10
EDMD B-Disease 1 1.0
are O 0 2.3362934850612582e-12
caused O 0 1.3938039090943821e-12
by O 0 5.579041799396757e-15
absence O 0 2.9670534917869418e-09
of O 0 4.625007932190783e-09
emerin O 0 3.6670721783593763e-06
from O 0 1.5843613088151187e-09
intercalated O 0 3.6547442050505197e-07
discs O 0 9.236340474672033e-07
. O 0 8.686524388679118e-09

Although O 0 8.09044831129313e-09
emerin O 0 5.903158125875052e-06
was O 0 3.5230179884493396e-10
abundant O 0 1.0037397996098818e-11
in O 0 4.362793627884706e-14
the O 0 5.5256229279654345e-12
membranes O 0 1.2211581745802391e-09
of O 0 2.616706851199524e-10
cardiomyocyte O 0 1.58308139930341e-08
nuclei O 0 6.329294310880584e-10
, O 0 5.660139444272315e-14
it O 0 1.850555866788543e-15
was O 0 4.67472848625361e-12
absent O 0 1.2045969777219057e-09
from O 0 2.054493727920992e-12
many O 0 1.4581405202197806e-13
non O 0 1.211110411958316e-08
- O 0 5.688680082549524e-10
myocyte O 0 3.719746644037514e-08
cells O 0 6.813093145208171e-11
in O 0 8.695822924578711e-13
the O 0 1.389568061310742e-11
heart O 0 3.89383014720579e-09
. O 0 3.22583360023998e-09

This O 0 1.316168094650516e-12
distribution O 0 4.172210493758044e-11
of O 0 1.4600650549700944e-11
emerin O 0 1.1545814260216503e-07
was O 0 5.687492143913175e-12
similar O 0 9.044665244626465e-15
to O 0 5.475604168757135e-14
that O 0 7.183196840620208e-15
of O 0 2.979026747507163e-11
lamin O 0 5.308720574248582e-09
A O 0 1.2243229763342356e-09
, O 0 2.9889925000955563e-15
a O 0 1.2792860575126103e-14
candidate O 0 5.695807974576139e-12
gene O 0 9.151093918009431e-14
for O 0 1.5017922615125773e-13
an O 0 5.859426306783697e-14
autosomal O 0 1.7078971126238685e-08
form O 0 3.4021592210109475e-09
of O 0 0.0010862837079912424
EDMD B-Disease 1 1.0
. O 0 3.080338956351625e-06

In O 0 9.609271156563182e-10
contrast O 0 7.090041886925746e-10
, O 0 2.8473175206489287e-11
lamin O 0 5.334341608431714e-07
B1 O 0 5.880934850210906e-07
was O 0 3.620722832664569e-09
absent O 0 3.4148843042203225e-07
from O 0 4.125248476150034e-10
cardiomyocyte O 0 2.084194932194805e-07
nuclei O 0 1.0704761521651562e-08
, O 0 5.163151807138777e-13
showing O 0 2.8603827639805957e-10
that O 0 1.6614338377296534e-11
lamin O 0 2.0731728511691472e-07
B1 O 0 2.0241431641920826e-08
is O 0 2.3201179408130317e-14
not O 0 1.2152927183475479e-14
essential O 0 2.2234264776543888e-11
for O 0 1.7729964902919032e-13
localization O 0 1.3841734016750706e-06
of O 0 2.3218547084979946e-09
emerin O 0 1.1124058119094116e-06
to O 0 3.815573412779827e-10
the O 0 2.3971799545385863e-10
nuclear O 0 6.598449431294284e-08
lamina O 0 0.0038916179910302162
. O 0 8.863668909953049e-08

Lamin O 0 0.005585214588791132
B1 O 0 3.6985118640586734e-05
is O 0 2.184930188164902e-11
also O 0 3.9853328428172963e-13
almost O 0 1.1155381306193757e-11
completely O 0 1.6275743419669197e-08
absent O 0 4.432965567957581e-07
from O 0 3.8641601030064976e-10
skeletal O 0 8.68321512825787e-06
muscle O 0 1.8223593656330195e-07
nuclei O 0 1.573846816427249e-06
. O 0 2.685720801309799e-08

In O 0 4.019042876279855e-09
EDMD B-Disease 1 1.0
, O 0 2.774976429198439e-13
the O 0 1.6477884188419514e-14
additional O 0 8.187528210750958e-14
absence O 0 3.666027204030087e-11
of O 0 5.355122456585093e-10
lamin O 0 1.553632529294191e-07
B1 O 0 2.0977147130452067e-07
from O 0 1.6611947373235125e-09
heart O 1 0.999993085861206
and O 0 1.2065375187830796e-07
skeletal O 1 1.0
muscle O 1 0.9686387181282043
nuclei O 0 0.006167328916490078
which O 0 8.639518787878497e-12
already O 0 5.104510997916423e-12
lack O 0 3.383400581924434e-08
emerin O 0 5.442566362034995e-07
may O 0 4.379781693569784e-12
offer O 0 7.487062456557753e-14
an O 0 5.12025805021949e-16
alternative O 0 6.824687841765209e-13
explanation O 0 1.5892348201318462e-12
of O 0 3.699178550281568e-12
why O 0 1.4273223445174232e-12
these O 0 2.514617420540377e-12
tissues O 0 1.7998116330630864e-09
are O 0 1.6402540946574423e-13
particularly O 0 1.7449170363822986e-12
affected O 0 6.1238358134430015e-12
. O 0 5.825866698783155e-12
. O 0 7.115131261947738e-10

Genetic O 0 1.1461155358105657e-09
mapping O 0 9.54124512730914e-09
of O 0 2.1082742218681005e-09
the O 0 4.542010323405066e-09
copper B-Disease 0 2.000660970224999e-07
toxicosis I-Disease 0 5.165488346392522e-06
locus O 0 8.359307135386018e-10
in O 0 2.523739828230731e-10
Bedlington O 0 3.085279240622185e-05
terriers O 0 6.751461683052185e-07
to O 0 1.452383990852013e-09
dog O 0 2.413386113175875e-08
chromosome O 0 2.6852122747555995e-09
10 O 0 5.0690614900039677e-11
, O 0 3.107949553098066e-14
in O 0 1.3561455560959224e-13
a O 0 5.947982124193674e-12
region O 0 5.560064408882681e-09
syntenic O 0 9.864135790849105e-06
to O 0 2.140620319890374e-10
human O 0 2.175026964090776e-10
chromosome O 0 4.527013430788429e-09
region O 0 2.1039209485707033e-08
2p13 O 0 1.1019421890523518e-06
- O 0 2.0367723507774826e-08
p16 O 0 2.361494466640579e-08
. O 0 7.265074652984538e-10

Abnormal O 1 1.0
hepatic B-Disease 1 0.9999998807907104
copper I-Disease 0 4.816189630219014e-06
accumulation I-Disease 0 1.918431813408006e-08
is O 0 4.3674811082148116e-14
recognized O 0 5.819721874550376e-13
as O 0 2.310289546475497e-13
an O 0 2.73702692454858e-11
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.944832916933592e-08
man O 0 1.482544531583585e-09
, O 0 1.750502954395161e-13
mouse O 0 9.939669226577408e-11
, O 0 1.1208952602898004e-12
rat O 0 2.3538753168850235e-09
and O 0 3.672837034507381e-11
dog O 0 1.9285025700810365e-06
. O 0 4.778873829991426e-08

The O 0 3.52016998883542e-10
major O 0 2.4348754124048355e-09
cause O 0 4.313098543207161e-05
of O 1 0.9999352693557739
hepatic B-Disease 1 1.0
copper I-Disease 1 0.8806118369102478
accumulation I-Disease 0 1.9783308744081296e-05
in O 0 1.274129246553457e-09
man O 0 1.1083058026883919e-08
is O 0 4.402821152365427e-13
a O 0 6.5897461098973764e-12
dysfunctional O 0 3.717335061992344e-08
ATP7B O 1 0.9919460415840149
gene O 0 1.3731284165263702e-10
, O 0 6.600396769938788e-13
causing O 0 7.751578934289682e-09
Wilson B-Disease 0 2.4525522803742206e-06
disease I-Disease 0 2.0949553203308824e-08
( O 0 7.682351662371273e-14
WD B-Disease 0 6.22132612093651e-09
) O 0 6.925183083233977e-13
. O 0 4.4777870300549694e-10

Mutations O 0 1.396352367066811e-09
in O 0 2.0543133166794902e-12
the O 0 1.876424189639625e-11
ATP7B O 1 0.997408926486969
genes O 0 4.3191415721732795e-11
have O 0 6.735698831377215e-14
also O 0 7.676016385321403e-16
been O 0 5.493384745572719e-15
demonstrated O 0 6.440235172412712e-13
in O 0 5.94682181102868e-13
mouse O 0 1.244164909985912e-10
and O 0 2.382364791553293e-11
rat O 0 1.9580799204277355e-08
. O 0 6.216036130268776e-09

The O 0 1.1914624842290777e-09
ATP7B O 0 0.004053517710417509
gene O 0 9.039332650451204e-12
has O 0 8.964732439459971e-15
been O 0 2.680635830768375e-14
excluded O 0 5.240472986112188e-12
in O 0 3.75301630322223e-14
the O 0 1.3301874792620572e-12
much O 0 2.2755327136469994e-11
rarer O 0 8.440721188662792e-08
human O 0 1.656803583216515e-08
copper B-Disease 0 0.0004168295126874
overload I-Disease 0 4.5810935262124985e-05
disease O 0 1.806619032151957e-08
non B-Disease 0 1.5724560853414005e-07
- I-Disease 0 1.0109385328860299e-08
Indian I-Disease 0 3.969765849376472e-09
childhood I-Disease 0 0.00012489620712585747
cirrhosis I-Disease 1 0.9999262094497681
, O 0 2.032401482353341e-13
indicating O 0 1.906082583436053e-11
genetic O 0 4.2206422384838405e-11
heterogeneity O 0 1.179004227580549e-09
. O 0 2.8935276397135112e-09

By O 0 4.0172338654394235e-13
investigating O 0 2.4551966362751365e-11
the O 0 4.397630523622631e-11
common O 0 1.0497632096928555e-08
autosomal O 1 0.9591628313064575
recessive O 1 0.9999792575836182
copper B-Disease 1 0.5964014530181885
toxicosis I-Disease 1 1.0
( O 0 2.235507612358134e-11
CT B-Disease 0 1.7819596905610524e-05
) O 0 2.249522833633333e-12
in O 0 5.315473061706655e-11
Bedlington O 0 3.895773988915607e-05
terriers O 0 2.004316144166296e-07
, O 0 1.5239936049238345e-13
we O 0 9.995585766421969e-14
have O 0 1.2154178251138573e-14
identified O 0 1.4693079381216528e-13
a O 0 3.3495056043147476e-15
new O 0 2.0843846323037927e-16
locus O 0 6.666831664633652e-14
involved O 0 1.2121773311675466e-13
in O 0 1.0608264960909608e-10
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.45014809049826e-08

We O 0 7.092811060704918e-11
examined O 0 1.693042928074817e-11
whether O 0 2.144604582625647e-14
the O 0 1.1948168149311655e-13
WD B-Disease 0 3.938482429077794e-09
gene O 0 5.104023974300542e-12
ATP7B O 1 0.9987785220146179
was O 0 3.7840180988624184e-10
also O 0 7.77777297319808e-14
causative O 0 2.761787977131891e-12
for O 0 2.751019355894113e-13
CT B-Disease 0 3.1204128170259082e-09
by O 0 3.0648176189843404e-14
investigating O 0 4.134736823757645e-12
the O 0 3.876557928828017e-12
chromosomal O 0 2.9329745743211788e-08
co O 0 1.9295490205628596e-10
- O 0 3.0030292141880466e-10
localization O 0 3.6514102248474956e-06
of O 0 1.2090354495342126e-08
ATP7B O 1 0.9999997615814209
and O 0 3.189309168323551e-13
C04107 O 0 1.7333882940118173e-10
, O 0 3.6965576609361735e-18
using O 0 3.548877995977978e-16
fluorescence O 0 6.455808543998076e-12
in O 0 3.327243645531719e-12
situ O 0 4.307299406036691e-09
hybridization O 0 4.813897613864526e-10
( O 0 2.4776049809861755e-13
FISH O 0 1.6027744687008294e-09
) O 0 2.388327166244486e-13
. O 0 1.8812090774034118e-10

C04107 O 0 2.0549761757138185e-05
is O 0 1.050163645280322e-12
an O 0 2.8079965517504787e-14
anonymous O 0 8.838833311097805e-12
microsatellite O 0 8.24905743712634e-09
marker O 0 9.803737377467314e-09
closely O 0 4.75355976803371e-10
linked O 0 5.78061793987672e-08
to O 0 5.6014638261103755e-08
CT B-Disease 1 0.9999957084655762
. O 0 3.90094299973498e-07

However O 0 1.0090584368072086e-08
, O 0 6.879363051437437e-11
BAC O 0 1.2517837603809312e-05
clones O 0 4.232470762755014e-10
containing O 0 1.807650036600439e-11
ATP7B O 0 0.00011597196134971455
and O 0 3.977748252309565e-12
C04107 O 0 4.815381160483412e-08
mapped O 0 7.110775857022134e-10
to O 0 7.62341838961289e-12
the O 0 2.5134007722305007e-11
canine O 0 1.0581964637879082e-08
chromosome O 0 3.6657092916669853e-09
regions O 0 6.1963389974550864e-09
CFA22q11 O 0 0.00014241434109862894
and O 0 3.832661271685467e-11
CFA10q26 O 0 0.0002969007764477283
, O 0 1.0396064976762875e-13
respectively O 0 8.642736526454087e-11
, O 0 7.45152756094795e-15
demonstrating O 0 2.289302601654608e-11
that O 0 4.715975331602562e-13
WD B-Disease 0 1.5867958058635168e-09
cannot O 0 6.730697162810051e-12
be O 0 4.27752451515051e-12
homologous O 0 1.8310437610580266e-09
to O 0 5.126393975984911e-09
CT B-Disease 0 5.87857466598507e-05
. O 0 2.960429945630949e-08

The O 0 5.358437960012452e-08
copper O 0 1.5941957087761693e-08
transport O 0 2.3131954129951282e-09
genes O 0 1.3084701377952257e-10
CTR1 O 0 0.00010727281915023923
and O 0 6.768107775612098e-12
CTR2 O 1 0.9999574422836304
were O 0 1.6008670777889478e-10
also O 0 5.452301275938633e-14
excluded O 0 5.590896235557752e-12
as O 0 2.509880426052307e-14
candidate O 0 6.494418891556109e-11
genes O 0 6.436677579824135e-12
for O 0 1.866766940680775e-12
CT B-Disease 0 1.2266590942999755e-07
since O 0 1.1770587759682427e-12
they O 0 1.188110617918528e-13
both O 0 8.189359563745557e-13
mapped O 0 4.4548373323571866e-10
to O 0 1.2599621346254253e-10
canine O 0 1.4589544150567235e-07
chromosome O 0 4.696087785305281e-08
region O 0 4.0183866190091067e-07
CFA11q22 O 1 0.5094352960586548
. O 0 1.2778589564277354e-07

2 O 0 2.6276524067725404e-08
- O 0 1.0973617747822573e-07
22 O 0 3.819871530197361e-09
. O 0 1.9544930118797765e-09

5 O 0 9.113930588000585e-08
. O 0 1.8879580565567267e-08

A O 0 1.6514392076061313e-09
transcribed O 0 8.566062442705302e-11
sequence O 0 2.530967839822762e-12
identified O 0 1.4672557873546266e-12
from O 0 3.504793975655715e-14
the O 0 6.589868624742867e-13
C04107 O 0 4.332941561102643e-09
- O 0 4.130141541269783e-12
containing O 0 1.2650724380818684e-13
BAC O 0 1.5893871818661864e-07
was O 0 3.6683739271063664e-13
found O 0 3.283217017620863e-15
to O 0 1.1929921196155314e-14
be O 0 4.311329938888608e-15
homologous O 0 9.45626042747616e-12
to O 0 8.3353013076784e-13
a O 0 7.33843053598443e-13
gene O 0 1.465840469838664e-12
expressed O 0 1.6599886612858605e-12
from O 0 2.9353526987546674e-12
human O 0 4.67087783381781e-12
chromosome O 0 5.341012354609376e-11
2p13 O 0 1.5995379243349817e-08
- O 0 1.386571690797922e-10
p16 O 0 2.098868717714808e-10
, O 0 4.83557557060324e-15
a O 0 3.9018643866036914e-14
region O 0 1.7040351768526918e-11
devoid O 0 1.1081742190555133e-09
of O 0 1.9318340330198858e-12
any O 0 1.5022655428659215e-12
positional O 0 5.426254112705919e-09
candidate O 0 1.5537652942043678e-08
genes O 0 2.8888953451655652e-09
. O 0 6.376445149669507e-09

Molecular O 0 2.291473608084793e-11
analysis O 0 2.599482478229942e-12
of O 0 2.7478533771302383e-12
the O 0 6.175642137430659e-13
APC B-Disease 0 8.021005387659486e-11
gene O 0 9.07584029225016e-15
in O 0 2.926807491569587e-14
205 O 0 1.6074200998028587e-11
families O 0 9.1099122603161e-13
: O 0 1.1771063343271322e-15
extended O 0 3.338032281141601e-11
genotype O 0 3.3882296968101855e-09
- O 0 5.370874855969987e-10
phenotype O 0 2.960024239606618e-11
correlations O 0 1.0390306670604588e-11
in O 0 2.965218741661675e-14
FAP B-Disease 0 1.923484982402357e-11
and O 0 3.0661825066997223e-16
evidence O 0 3.654207707639353e-15
for O 0 4.759530739308872e-17
the O 0 1.1188408437096402e-15
role O 0 5.759876218558793e-14
of O 0 2.999162116573695e-12
APC B-Disease 0 4.4517964314927383e-10
amino O 0 3.3449937264506957e-10
acid O 0 5.516063994459586e-11
changes O 0 2.902113618863389e-11
in O 0 3.4340931875931346e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 0 1.3691385447600624e-06
. O 0 2.1481347811658225e-09

BACKGROUND O 0 1.922534693221678e-06
/ O 0 1.7966515775125202e-10
AIMS O 0 1.500611995775003e-10
The O 0 1.487358515159503e-14
development O 0 1.8794150263845566e-11
of O 0 1.3294912393213565e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 7.707467476747443e-13
a O 0 2.0278273689128962e-14
variable O 0 2.1914304951849845e-13
range O 0 3.6826330830283527e-13
of O 0 1.8456872315220085e-12
extracolonic O 0 1.897582713183965e-08
manifestations O 0 1.442754751224129e-07
in O 0 1.2350731992682995e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.836131696124405e-13
FAP B-Disease 0 2.1063278898836302e-10
) O 0 8.657778922561564e-16
is O 0 3.5953971116156334e-17
the O 0 1.0235575913123017e-16
result O 0 1.0789632737067366e-14
of O 0 3.865068258935428e-13
the O 0 2.0473730946279217e-13
dominant O 0 1.8947779456546243e-10
inheritance O 0 7.769626364506621e-08
of O 0 1.0194670721830335e-05
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 4.4975096780489054e-13
APC B-Disease 0 3.7948016951006025e-10
) O 0 8.735453766589574e-13
gene O 0 9.975711229293083e-12
mutations O 0 4.037596368355878e-10
. O 0 6.801207597106895e-09

In O 0 4.620028318247371e-12
this O 0 1.641918480517479e-14
study O 0 2.3019035137218646e-15
, O 0 2.2421952662604862e-18
direct O 0 4.84388125804666e-16
mutation O 0 2.56576417648915e-16
analysis O 0 1.397230652033267e-14
of O 0 2.4729770640129212e-14
the O 0 1.726722402757043e-14
APC B-Disease 0 5.598664327283176e-12
gene O 0 2.529768420840659e-14
was O 0 4.5045754236069935e-13
performed O 0 2.607615187145973e-13
to O 0 3.7182049431559727e-13
determine O 0 6.595798213160364e-11
genotype O 0 9.883757812190197e-09
- O 0 2.834903978232717e-10
phenotype O 0 6.840202015911956e-11
correlations O 0 7.363998993925591e-11
for O 0 1.6191483375414817e-13
nine O 0 9.395192956951348e-11
extracolonic O 0 8.274558638277085e-08
manifestations O 0 1.764431045714332e-09
and O 0 1.293386191469079e-14
to O 0 3.853945157797356e-13
investigate O 0 3.8001724163294615e-12
the O 0 1.5364513047261275e-12
incidence O 0 1.1576625769116333e-10
of O 0 1.0263073724203764e-10
APC B-Disease 0 1.3452867708707572e-09
mutations O 0 8.505028625815925e-11
in O 0 2.5118779278798797e-10
non O 1 0.999998927116394
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8423695280489483e-07

METHODS O 0 4.651736773553239e-08
The O 0 4.2090737145672463e-11
APC B-Disease 0 7.150762759700058e-10
gene O 0 6.448532029537657e-13
was O 0 6.347967290709633e-12
analysed O 0 3.2489361895260416e-11
in O 0 5.919704559442102e-14
190 O 0 2.849037845920055e-12
unrelated O 0 5.083039024411651e-12
FAP B-Disease 0 4.3497636048606125e-11
and O 0 5.4836697011841854e-15
15 O 0 5.687166449580561e-12
non O 0 2.533147380745504e-06
- O 1 0.9999018907546997
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.7668609630927534e-11
using O 0 5.163395617102315e-14
denaturing O 0 1.1467950200572119e-10
gradient O 0 1.1789754285687626e-12
gel O 0 7.332208624977188e-12
electrophoresis O 0 1.8308184829285423e-11
, O 0 4.1780785272748245e-15
the O 0 1.434539912260977e-14
protein O 0 1.4352734427932994e-14
truncation O 0 2.2014326125918693e-11
test O 0 2.646705771214286e-12
, O 0 6.847037945337828e-16
and O 0 2.411223015262603e-16
direct O 0 3.411112267214661e-13
sequencing O 0 4.4974055035673643e-10
. O 0 1.4616575727544046e-09

RESULTS O 0 2.5260596885345876e-06
Chain O 0 8.845082999364706e-10
terminating O 0 3.0468483291912207e-10
signals O 0 2.1317532808429185e-11
were O 0 7.220177960284152e-14
only O 0 8.27895000140742e-15
identified O 0 3.074309470191272e-13
in O 0 5.088291916174707e-14
patients O 0 5.534279089690342e-13
belonging O 0 2.5978382639513242e-11
to O 0 4.098289849846504e-12
the O 0 1.1355349820163507e-11
FAP B-Disease 0 2.6985769174814322e-09
group O 0 2.2008259201612007e-13
( O 0 3.812284892607508e-14
105 O 0 2.6002663133795068e-08
patients O 0 5.908954436861791e-10
) O 0 5.6758204906859344e-12
. O 0 3.2897524704367243e-09

Amino O 0 2.8019385922561924e-07
acid O 0 1.3656321906641011e-10
changes O 0 4.3986578160230827e-13
were O 0 1.309441785687579e-13
identified O 0 2.4043150825305004e-13
in O 0 7.513179701046802e-15
four O 0 4.691382441486709e-14
patients O 0 1.2935736398603064e-14
, O 0 1.2809034722193483e-16
three O 0 1.9364543673541963e-14
of O 0 1.2098917354097516e-11
whom O 0 3.6392208691005123e-10
belonged O 0 1.4968484720156994e-05
to O 0 1.2074700128650306e-09
the O 0 7.0653816131027725e-09
non O 0 2.8935899081261596e-06
- O 0 5.728873375687726e-09
FAP O 0 2.2191598247900401e-07
group O 0 4.4081609890112006e-11
of O 1 0.9999785423278809
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.8464899659156799
. O 0 9.363305686349577e-09

Genotype O 0 0.00013617209333460778
- O 0 2.200293693022104e-06
phenotype O 0 1.5706598688325357e-08
correlations O 0 2.7890065812385956e-09
identified O 0 2.642566027111215e-11
significant O 0 1.501686904166466e-12
differences O 0 4.863723659931374e-11
in O 0 7.386565724310998e-14
the O 0 3.1543658744054293e-13
nature O 0 1.7470349169060317e-12
of O 0 6.161703525880968e-12
certain O 0 9.049119092940927e-11
extracolonic O 0 5.795537845187937e-07
manifestations O 0 1.3891693351197887e-09
in O 0 2.9948806021945495e-12
FAP B-Disease 0 2.8348889902218843e-09
patients O 0 2.9894589408108185e-12
belonging O 0 5.742224751248415e-11
to O 0 3.114624183564452e-11
three O 0 1.378812897190329e-10
mutation O 0 3.958157968053655e-10
subgroups O 0 6.292448784250837e-10
. O 0 3.5891285499189962e-09

CONCLUSIONS O 0 1.8996836104179238e-07
Extended O 0 7.081652153573259e-09
genotype O 0 3.5021653133071595e-08
- O 0 5.865901098189852e-10
phenotype O 0 3.43505779376585e-11
correlations O 0 2.799679238441044e-11
made O 0 5.661348668507815e-14
in O 0 1.1045080933300318e-14
this O 0 1.4953375655226385e-14
study O 0 1.7950791474465912e-14
may O 0 1.0038645702735178e-14
have O 0 2.6803377175225887e-15
the O 0 5.538141288879278e-14
potential O 0 3.9437189950329576e-14
to O 0 8.298304534845591e-14
determine O 0 4.523677266110582e-11
the O 0 5.039492694675074e-12
most O 0 5.99304948115803e-14
appropriate O 0 1.2724983393386236e-11
surveillance O 0 2.7086310971924377e-10
and O 0 5.0327150351867425e-14
prophylactic O 0 1.1193395099695636e-09
treatment O 0 4.475972110312698e-12
regimens O 0 1.1704148934754688e-11
for O 0 2.56159936842706e-15
those O 0 5.762246979074863e-15
patients O 0 5.15196439925935e-14
with O 0 4.232861071352766e-16
mutations O 0 3.4004523914547835e-13
associated O 0 6.143841511929704e-12
with O 0 4.591983802752775e-13
life O 0 5.884065457095744e-10
threatening O 0 4.13575262925292e-09
conditions O 0 1.527653523680783e-07
. O 0 8.953208840978277e-09

This O 0 1.2777078006731557e-11
study O 0 2.99519306926066e-13
also O 0 5.885899072176533e-16
provided O 0 4.281321679149757e-15
evidence O 0 7.635135504792476e-15
for O 0 1.2777467657133887e-15
the O 0 6.291047327175447e-13
pathological O 0 1.714561048693497e-09
nature O 0 1.5632396418996386e-11
of O 0 1.1578569353298818e-10
amino O 0 1.0126474658811446e-10
acid O 0 1.535004220086511e-12
changes O 0 2.201693925644229e-14
in O 0 6.29538942135098e-14
APC O 0 7.291517389873547e-11
associated O 0 3.1072842215928986e-11
with O 0 6.641841482184219e-14
both O 0 5.736460568714352e-13
FAP B-Disease 0 9.214704693727427e-11
and O 0 3.677901895798169e-13
non O 0 2.46542040258646e-05
- O 1 0.9999896287918091
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.3843000079560852e-09
. O 0 5.827263584862186e-13
. O 0 1.2159576297243735e-11

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 8.862603806392144e-08
cancer B-Disease 0 0.004184172488749027
risk O 0 9.476009310560585e-09
of O 0 2.0172122106032475e-07
the O 0 5.729192480430356e-07
APC O 0 7.231490599224344e-06
I1307K O 0 1.1508526768011507e-05
polymorphism O 0 1.610422714293236e-06
. O 0 7.058054585229456e-09

Germ O 0 1.0898337677645031e-05
- O 0 5.009903247810144e-07
line O 0 6.404513031021963e-10
and O 0 6.46843621959596e-14
somatic O 0 4.236024031545327e-10
truncating O 0 1.0677212003429304e-08
mutations O 0 8.766604629728558e-12
of O 0 6.535297043114285e-12
the O 0 7.642092254150912e-13
APC B-Disease 0 1.5481099041592117e-11
gene O 0 2.284906272975902e-14
are O 0 1.4168205759274802e-15
thought O 0 9.07671019508699e-14
to O 0 6.469685356023935e-13
initiate O 0 2.0699834735182776e-08
colorectal B-Disease 1 1.0
tumor I-Disease 0 7.4414788286958355e-06
formation O 0 6.206264657748761e-08
in O 0 2.1899825242144288e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.3481949657243604e-08
sporadic O 1 0.999946117401123
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.680538347370586e-10
respectively O 0 1.0556869511901823e-07
. O 0 4.1717786558592707e-08

Recently O 0 3.083851507490465e-10
, O 0 1.4166969938204758e-14
an O 0 7.1595070231514e-15
isoleucine O 0 1.1592175042096642e-07
- O 0 2.965401222354558e-07
- O 0 6.341601306303346e-07
> O 0 1.1046472536690999e-06
lysine O 0 1.6242674973909743e-06
polymorphism O 0 1.5932807073681943e-08
at O 0 1.2879647869057376e-11
codon O 0 1.8490577124996577e-10
1307 O 0 4.802351849519937e-10
( O 0 2.709586739279169e-14
I1307K O 0 2.485817995889761e-09
) O 0 3.578051822384666e-15
of O 0 4.3578308279654254e-13
the O 0 2.147373858590873e-12
APC B-Disease 0 1.5788047535991723e-09
gene O 0 2.2771120926357025e-12
has O 0 3.823054408312078e-14
been O 0 2.7982244342819595e-13
identified O 0 1.1894489299751898e-12
in O 0 1.3182226035572675e-13
6 O 0 3.567413075014625e-12
% O 0 4.064258304903312e-11
- O 0 5.60005004607983e-13
7 O 0 1.9059944594834732e-12
% O 0 4.31505733922144e-11
of O 0 2.0579449602764477e-12
the O 0 2.2761829313738824e-12
Ashkenazi O 0 1.877937139127539e-09
Jewish O 0 1.7373602556602918e-10
population O 0 1.8047932939802003e-12
. O 0 5.7277418918921796e-11

To O 0 8.028233633439186e-10
assess O 0 2.962569078945876e-09
the O 0 7.444635186093507e-12
risk O 0 2.1129461028057683e-11
of O 0 3.2745349400759016e-12
this O 0 1.5945869570512666e-13
common O 0 8.885244970335826e-13
APC B-Disease 0 5.779046685638889e-10
allelic O 0 3.3919023145756455e-09
variant O 0 1.3122202879856104e-08
in O 0 1.228746770998157e-09
colorectal O 1 1.0
carcinogenesis O 1 0.999602735042572
, O 0 1.720642898994651e-11
we O 0 2.742234065690463e-13
have O 0 1.1281071088668944e-14
analyzed O 0 1.3126876159414574e-13
a O 0 5.055803289856411e-15
large O 0 6.46412812532293e-15
cohort O 0 2.711772646712962e-11
of O 0 3.34914838917566e-11
unselected O 0 9.891852096188813e-05
Ashkenazi O 0 1.1848636631839327e-06
Jewish O 0 6.257599327597063e-09
subjects O 0 4.0742694551454406e-08
with O 0 3.795514683796464e-12
adenomatous B-Disease 0 2.2034164430806413e-06
polyps I-Disease 0 2.638408380661872e-09
and O 0 3.690175606491791e-14
. O 0 5.043396256176891e-12
or O 1 0.5040528178215027
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.208871974218596e-12
for O 0 2.746782835905126e-13
the O 0 1.2837984841862493e-10
APC O 0 2.3752720679226513e-08
I1307K O 0 2.438195565446222e-07
polymorphism O 0 3.3918365716090193e-07
. O 0 4.977701362207654e-09

The O 0 1.1874107253007082e-09
APC O 0 3.682900429069491e-09
I1307K O 0 3.4016141015058565e-09
allele O 0 3.548603078051826e-11
was O 0 1.092572430097527e-12
identified O 0 6.270813404131437e-13
in O 0 1.5216235389747812e-13
48 O 0 1.1149032808077664e-09
( O 0 1.5894666428851144e-14
10 O 0 7.391488137699354e-13
. O 0 1.4327243818418323e-14
1 O 0 9.537654682961055e-14
% O 0 1.6318731305489664e-12
) O 0 7.074877102655026e-16
of O 0 2.5473555014497717e-13
476 O 0 1.1149835221768711e-10
patients O 0 1.415560030304519e-10
. O 0 4.076474713343714e-09

Compared O 0 1.074078673224399e-10
with O 0 1.9127179207216417e-15
the O 0 3.5311038354369703e-14
frequency O 0 3.2440537886188614e-13
in O 0 7.76806927905104e-16
two O 0 1.2459974297514558e-15
separate O 0 1.9383102165416305e-13
population O 0 1.3148914897910947e-15
control O 0 1.7852090790880515e-13
groups O 0 9.930017115381603e-16
, O 0 4.931755102972782e-16
the O 0 3.126459594687825e-13
APC O 0 4.941412279357849e-10
I1307K O 0 9.623178698348056e-09
allele O 0 9.407566392560796e-11
is O 0 5.33357969809546e-15
associated O 0 1.996473597337331e-13
with O 0 1.2635061301667942e-15
an O 0 4.4386074918232037e-16
estimated O 0 7.445563940779512e-14
relative O 0 2.581371782994779e-10
risk O 0 1.296174417797502e-10
of O 0 6.3625676949286e-10
1 O 0 3.0486637658810878e-09
. O 0 1.3773791884830189e-08

5 O 0 9.402144485193276e-08
- O 0 6.148202658096125e-08
1 O 0 2.2929308451935526e-10
. O 0 5.95696936223078e-10

7 O 0 9.164968339803181e-09
for O 0 1.5040397816079576e-09
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.0007751856464892626
( O 0 7.112274311160682e-12
both O 0 1.7085860504195693e-10
P O 0 1.7409784902611136e-07
= O 0 4.454181121160694e-11
. O 0 5.321290283410995e-13
01 O 0 4.933746189372812e-10
) O 0 6.923832302852331e-14
. O 0 1.7223601017635204e-11

Furthermore O 0 4.039100609531943e-09
, O 0 1.2295907022598362e-13
compared O 0 2.6155317061488104e-12
with O 0 6.871549363589649e-14
noncarriers O 0 4.7463892371979455e-08
, O 0 5.235964656638559e-13
APC O 0 1.2862941822788798e-09
I1307K O 0 5.25408205831468e-09
carriers O 0 7.561707878779578e-13
had O 0 2.3799869410326413e-13
increased O 0 9.001924097633285e-13
numbers O 0 4.718090067939995e-13
of O 0 1.1483747980323145e-11
adenomas B-Disease 0 2.8600862833627616e-07
and O 0 2.2922015396886763e-09
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 1 0.9988484382629395
patient O 0 0.19777515530586243
( O 0 4.349811309756202e-12
P O 0 4.465765357508644e-08
= O 0 1.2297607376865471e-11
. O 0 2.831263056033567e-13
03 O 0 2.577193840280767e-11
) O 0 1.911521698441882e-15
, O 0 1.4751659788095898e-16
as O 0 2.343804751314877e-16
well O 0 2.8990649179096986e-15
as O 0 9.683794166735434e-16
a O 0 5.0703304131215904e-14
younger O 0 3.685532087849275e-11
age O 0 4.844947013027401e-11
at O 0 7.028613108195358e-11
diagnosis O 0 3.5934462516706844e-07
. O 0 1.5140936282520556e-09

We O 0 2.611759072901343e-11
conclude O 0 1.1736486227320597e-09
that O 0 6.390134715182584e-15
the O 0 1.318861334162133e-13
APC O 0 1.4040197893194772e-09
I1307K O 0 3.1512531251109976e-08
variant O 0 3.3165978852167655e-09
leads O 0 1.3354332917270284e-10
to O 0 9.269084805252348e-11
increased O 0 1.1336955196838971e-07
adenoma B-Disease 1 1.0
formation O 0 7.013091089902446e-05
and O 0 4.411155468675432e-11
directly O 0 3.68843816600517e-10
contributes O 0 1.8895655873318873e-11
to O 0 2.3473618881997282e-12
3 O 0 4.996403898255286e-12
% O 0 3.890522626281978e-11
- O 0 1.8629210316294803e-13
4 O 0 2.7456449318437846e-14
% O 0 2.2946249934874263e-13
of O 0 3.0370484908415554e-14
all O 0 1.2871898913500296e-13
Ashkenazi O 0 4.70578498834584e-07
Jewish O 0 5.560827048611827e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.4124664810851755e-08

The O 0 6.121164686234692e-11
estimated O 0 1.8402501744674282e-11
relative O 0 8.599905232387073e-10
risk O 0 2.963708098380202e-11
for O 0 7.666561070880651e-13
carriers O 0 3.4475662342298152e-12
may O 0 3.0740588026489934e-12
justify O 0 4.350112284279284e-11
specific O 0 2.0365274137207345e-12
clinical O 0 9.681446182935316e-13
screening O 0 2.860563619744988e-13
for O 0 3.1092716021221406e-14
the O 0 5.059783429912923e-13
360 O 0 1.346770056587232e-10
, O 0 1.5776327455790246e-14
000 O 0 8.564788461784545e-11
Americans O 0 1.8116324412842388e-12
expected O 0 1.3337041540606442e-11
to O 0 1.0289391734474851e-11
harbor O 0 7.941208107764552e-11
this O 0 1.724586355070657e-14
allele O 0 1.1934240921884776e-11
, O 0 5.301934547186039e-15
and O 0 2.6731900299971833e-15
genetic O 0 1.4682572106912428e-13
testing O 0 1.9462519974550868e-14
in O 0 1.0724791306163865e-15
the O 0 6.518754974157255e-15
setting O 0 1.1579904786798711e-12
of O 0 4.791475376186849e-13
long O 0 8.705913052096947e-13
- O 0 3.2882856593891008e-12
term O 0 2.817605315730276e-10
- O 0 1.3473654483786568e-11
outcome O 0 4.986736024115146e-10
studies O 0 5.1170860083937786e-12
may O 0 1.0232385007661812e-14
impact O 0 3.546093946911119e-14
significantly O 0 1.5966216196372507e-11
on O 0 1.844409069917674e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 2.569687929110387e-08
in O 0 3.7917963514595525e-15
this O 0 1.558961259509519e-14
population O 0 2.152669860942813e-14
. O 0 5.928726693610331e-12

Localization O 0 2.5436099804210244e-06
of O 0 1.205672672810465e-09
human O 0 4.949861354131002e-11
BRCA1 O 0 2.066854021265385e-09
and O 0 7.799763981387875e-13
its O 0 1.321674161173375e-13
loss O 0 3.264663279295421e-12
in O 0 1.1586112928438363e-12
high O 0 7.580502892068353e-11
- O 0 1.1678839319240186e-11
grade O 0 3.1433755598442303e-09
, O 0 1.6292296288120123e-12
non B-Disease 0 0.00018046263721771538
- I-Disease 1 0.9999282360076904
inherited I-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 7.280712452484295e-06

Although O 0 6.693493849463383e-12
the O 0 4.475380840657933e-13
link O 0 3.250192866580126e-12
between O 0 2.523523924546911e-13
the O 0 2.0264916047313397e-12
BRCA1 O 0 7.296404036516435e-10
tumour B-Disease 1 1.0
- O 0 4.5457518305092037e-10
suppressor O 0 2.0639682671297344e-11
gene O 0 4.003152247623182e-13
and O 0 1.4564374012371317e-12
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 7.885758157577527e-10
established O 0 1.473853504518896e-11
, O 0 2.5739220037437156e-15
the O 0 9.1601917294893e-14
role O 0 4.642604660085037e-13
, O 0 2.3369583957604575e-15
if O 0 1.513315310432519e-15
any O 0 1.4692264874334449e-13
, O 0 2.5987162251208014e-14
of O 0 9.52383050895067e-12
BRCA1 O 0 3.488548061536534e-10
in O 0 1.7414408803873016e-10
non B-Disease 1 0.9064748287200928
- I-Disease 1 0.9940766096115112
familial I-Disease 1 0.9999423027038574
cancers I-Disease 1 0.9999988079071045
is O 0 4.545270410050151e-12
unclear O 0 2.3523671899283727e-09
. O 0 1.8703267823383385e-09

BRCA1 O 0 4.388351590023376e-05
mutations O 0 6.559121246141331e-09
are O 0 4.153958806703967e-13
rare O 0 8.352154688348601e-13
in O 0 9.78742477689143e-13
sporadic B-Disease 0 1.6788123957667267e-07
cancers I-Disease 0 3.0420778784900904e-06
, O 0 3.572918125097947e-14
but O 0 2.2819098092216952e-14
loss O 0 6.758835852105349e-11
of O 0 9.512221010865574e-10
BRCA1 O 0 1.1817480327636076e-10
resulting O 0 3.5123751129795266e-11
from O 0 6.420635507639605e-13
reduced O 0 5.51189410953612e-13
expression O 0 1.530010926981129e-13
or O 0 1.1112939453210291e-13
incorrect O 0 5.851349266228212e-11
subcellular O 0 3.307660279006086e-08
localization O 0 1.3716801561258762e-07
is O 0 3.6373557161031855e-13
postulated O 0 3.0711478499201306e-11
to O 0 4.972699769317801e-13
be O 0 7.720646360729819e-14
important O 0 5.833368727295452e-13
in O 0 5.278268599105684e-13
non B-Disease 0 7.57672069084947e-06
- I-Disease 0 0.4350467622280121
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 1.0

Epigenetic O 0 2.711834213187103e-06
loss O 0 5.8847451356314195e-08
, O 0 3.2705947867507634e-13
however O 0 4.4216635019210526e-13
, O 0 5.268242647038697e-16
has O 0 2.341853986460875e-18
not O 0 3.800406878119756e-18
received O 0 1.9576573860871166e-16
general O 0 1.6838332282860004e-14
acceptance O 0 1.872387835055722e-11
due O 0 1.197371507499767e-10
to O 0 4.869876203683621e-12
controversy O 0 1.5296586696952885e-12
regarding O 0 2.5914429022805274e-12
the O 0 4.567893372581233e-12
subcellular O 0 2.5672343895166705e-07
localization O 0 1.2226454373376328e-06
of O 0 2.5154667682159015e-08
BRCA1 O 0 1.7053376488718186e-09
proteins O 0 1.098106631666762e-12
, O 0 8.33532427921193e-15
reports O 0 2.8669862978895205e-14
of O 0 1.1574621198561647e-13
which O 0 7.434459529423421e-16
have O 0 6.202184456933959e-15
ranged O 0 9.758095720346915e-11
from O 0 4.661353226152742e-13
exclusively O 0 3.989717931029979e-11
nuclear O 0 6.414720976621879e-10
, O 0 1.0743966480375455e-13
to O 0 4.091487131735461e-12
conditionally O 0 1.6379712863834328e-10
nuclear O 0 1.094695445402749e-09
, O 0 1.4463538195895118e-14
to O 0 1.4233721623221895e-12
the O 0 1.4275335080693452e-10
ER O 0 4.327594524511369e-06
/ O 0 5.732666341629056e-09
golgi O 0 9.935398992411137e-08
, O 0 2.156369294280605e-13
to O 0 9.049131236005259e-12
cytoplasmic O 0 1.7096439819397347e-08
invaginations O 0 7.748936070584023e-08
into O 0 8.487316405236811e-11
the O 0 6.533979607370455e-11
nucleus O 0 1.5687227516991697e-08
. O 0 1.9787471661203426e-09

In O 0 2.7796318025075095e-10
an O 0 9.752465762041806e-13
attempt O 0 2.8799056472905704e-09
to O 0 5.139069170212451e-10
resolve O 0 5.362947490539227e-07
this O 0 3.26953611753944e-12
issue O 0 3.715300636586427e-12
, O 0 1.2765804648724906e-14
we O 0 1.9536804086398712e-13
have O 0 1.6462844271408067e-13
comprehensively O 0 2.8188538170326183e-09
characterized O 0 5.486649329311533e-12
19 O 0 7.38314062664891e-11
anti O 0 3.7505262784343074e-10
- O 0 8.864239120498496e-09
BRCA1 O 0 1.565475971077035e-09
antibodies O 0 1.6183224899046778e-11
. O 0 1.9168495957178067e-10

These O 0 4.3022207324439066e-11
reagents O 0 1.2470942334363855e-10
detect O 0 2.565661875661429e-12
a O 0 1.1254469849553833e-13
220 O 0 9.731516287247999e-11
- O 0 4.682256249388672e-10
kD O 0 2.297113432803144e-08
protein O 0 5.843321937426538e-10
localized O 0 1.9537440554273644e-09
in O 0 6.377940168188212e-13
discrete O 0 1.5404964803789056e-10
nuclear O 0 4.758923921599489e-09
foci O 0 2.0843691217464766e-08
in O 0 1.5095325163472229e-12
all O 0 1.3692615834573485e-12
epithelial O 0 2.913001506676949e-10
cell O 0 1.8216549102501034e-10
lines O 0 1.7395136980152826e-12
, O 0 2.5110654357334277e-16
including O 0 2.0162974770255318e-16
those O 0 1.588102919840035e-14
derived O 0 1.367513567662737e-11
from O 0 4.084691751504721e-10
breast B-Disease 0 1.1080060602353115e-07
malignancies I-Disease 0 1.5044988685986027e-06
. O 0 1.4892371780206304e-07

Immunohistochemical O 0 3.993880000052741e-06
staining O 0 3.8926816614548443e-07
of O 0 3.969932382830166e-09
human O 0 2.7776456690276063e-09
breast O 0 5.417869033408351e-07
specimens O 0 1.8470062979059065e-10
also O 0 3.259522101013712e-13
revealed O 0 2.9456375116865274e-09
BRCA1 O 0 2.7326285234607894e-08
nuclear O 0 7.197374429779302e-08
foci O 0 1.6232841915098106e-07
in O 0 3.056977171400632e-10
benign O 1 0.9995284080505371
breast O 1 0.9943313598632812
, O 0 1.847310193703322e-09
invasive B-Disease 0 0.0545404814183712
lobular I-Disease 1 0.999981164932251
cancers I-Disease 1 1.0
and O 0 3.2679147352610016e-06
low B-Disease 1 1.0
- I-Disease 1 1.0
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 2.4465660317218862e-05

Conversely O 0 1.0154413310203836e-08
, O 0 1.785400603401821e-12
BRCA1 O 0 4.4450426672781873e-10
expression O 0 2.5581673931962534e-11
was O 0 4.4216009326136785e-11
reduced O 0 1.487726782045673e-11
or O 0 5.834114116289035e-13
undetectable O 0 7.023838975717123e-12
in O 0 3.4810750202535212e-15
the O 0 2.1265478730692587e-14
majority O 0 6.530522108326442e-13
of O 0 5.688319260066521e-11
high O 0 7.8195903085998e-09
- O 0 2.8175385580198054e-08
grade O 0 4.08040068577975e-06
, O 0 1.3133965026668193e-09
ductal B-Disease 1 0.9847997426986694
carcinomas I-Disease 1 1.0
, O 0 1.9060634147416433e-12
suggesting O 0 9.621108597313022e-12
that O 0 1.3503400092161003e-14
absence O 0 1.561313189846203e-09
of O 0 2.259447740016185e-08
BRCA1 O 0 2.7199962282509205e-09
may O 0 2.155843049651135e-13
contribute O 0 3.9487814060268356e-12
to O 0 8.457234478703723e-13
the O 0 6.124744266443327e-13
pathogenesis O 0 1.192576593034289e-09
of O 0 2.065709062137877e-11
a O 0 3.165582487980878e-13
significant O 0 2.433246746452733e-12
percentage O 0 2.5156334793052793e-09
of O 0 9.353032931480598e-11
sporadic B-Disease 0 5.420814341050573e-05
breast I-Disease 0 1.8184136933996342e-05
cancers I-Disease 0 2.9878923669457436e-05
. O 0 7.318163852687576e-09
. O 0 9.686677771014729e-08

